data_6l7k_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6l7k _Structure_validation_residue.Date_analyzed 2020-11-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 4' ' ' SER . 16.9 t70 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.684 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 165.2 -164.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 0.0 109.729 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.684 ' N ' ' OG ' ' A' ' 4' ' ' SER . 43.2 m -102.13 146.74 27.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.663 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.59 ' CD1' ' C ' ' A' ' 5' ' ' THR . 4.4 m95 -151.39 169.26 22.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 8' ' ' VAL . 18.1 pttp -152.58 128.41 10.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.097 -1.002 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -37.45 107.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -97.69 -25.93 14.92 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HB2' HD12 ' A' ' 127' ' ' ILE . 1.7 mtp180 -140.55 160.0 40.96 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.097 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.518 ' CB ' ' OD2' ' A' ' 34' ' ' ASP . 31.0 t -179.92 157.27 0.69 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 125' ' ' LYS . 10.6 pt-20 -166.78 166.27 15.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.256 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.37 -6.77 0.59 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.547 -0.72 . . . . 0.0 109.738 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.507 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -47.94 -22.44 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.997 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' CA ' ' HE ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -71.99 -48.16 46.89 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.996 -1.065 . . . . 0.0 108.868 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -59.92 -36.68 77.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.592 ' O ' ' SD ' ' A' ' 21' ' ' MET . 49.6 t80 -68.23 -64.02 0.94 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.817 0.818 . . . . 0.0 108.93 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 23' ' ' VAL . 10.0 mmt -56.52 -23.38 39.28 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.427 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.52 -23.97 34.32 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.057 -1.027 . . . . 0.0 109.118 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.789 ' HZ2' ' HB ' ' A' ' 122' ' ' VAL . 6.7 tptm -74.45 -43.8 54.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -0.912 . . . . 0.0 108.995 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.592 ' SD ' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -58.76 -14.3 8.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.648 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.21 29.64 40.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 24' ' ' ASN . 2.1 t -79.33 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.391 -1.064 . . . . 0.0 109.444 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.3 m-80 -43.47 168.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.374 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -78.8 -2.32 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.38 -59.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -62.38 -24.19 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.47 ' HE ' ' CA ' ' A' ' 15' ' ' ASP . 50.9 ttt180 -73.03 -47.28 46.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.508 -0.745 . . . . 0.0 109.208 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -68.96 -33.12 73.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 mt -86.52 -13.03 47.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.934 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 27' ' ' LYS . . . -77.13 -52.62 8.97 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.165 0.507 . . . . 0.0 109.866 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.19 -28.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.692 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 31' ' ' ALA . 23.8 m170 -74.6 46.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' OD2' ' CB ' ' A' ' 11' ' ' SER . 6.1 p30 -66.38 115.12 5.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -147.74 43.21 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.465 ' H ' ' CG1' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -89.06 165.02 14.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -109.19 149.59 29.15 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -143.67 127.05 16.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.922 -1.111 . . . . 0.0 110.332 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 m -103.14 111.41 23.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.516 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 3.7 mp -109.4 142.42 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 111.515 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -135.26 152.25 51.35 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.605 ' O ' ' NE2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -135.56 142.69 45.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 110.018 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 45' ' ' ASN . 4.9 mm-40 -142.15 78.86 1.64 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.49 -88.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -113.66 29.16 8.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -1.102 . . . . 0.0 109.997 -179.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.9 110.5 5.57 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.401 ' CZ ' ' HG3' ' A' ' 42' ' ' GLN . 6.0 m-85 -104.32 162.3 13.33 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.8 m -153.96 102.99 2.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 p -107.16 129.5 60.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -119.11 100.17 7.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.819 . . . . 0.0 109.388 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.23 160.45 31.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 108.833 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -160.48 106.93 1.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.088 -1.008 . . . . 0.0 109.303 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.684 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -129.31 144.29 51.17 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.77 7.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.985 -1.072 . . . . 0.0 109.387 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.684 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.6 OUTLIER -115.22 -20.09 10.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 111.35 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 165.57 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.55 -1.344 . . . . 0.0 109.423 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -62.35 149.45 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.343 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.697 HG21 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -136.98 174.21 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.697 ' H ' HG21 ' A' ' 58' ' ' ILE . 6.5 pt-20 -154.21 146.29 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.8 m -151.07 110.7 4.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.835 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -108.47 141.27 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.41 172.49 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.777 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 44.8 tt0 -98.37 164.74 12.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.456 HD11 ' C ' ' A' ' 64' ' ' LEU . 2.7 pp -82.04 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.842 -1.162 . . . . 0.0 109.593 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -31.99 6.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.1 p -88.4 117.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -1.23 . . . . 0.0 109.911 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -55.98 145.14 26.17 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.013 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -153.53 -171.6 3.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.46 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.1 OUTLIER -130.55 150.68 51.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.995 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.69 133.65 12.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -88.97 149.24 23.38 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 75' ' ' GLY . 52.5 mt -99.53 146.82 25.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.425 -0.797 . . . . 0.0 109.374 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.89 -32.97 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.714 . . . . 0.0 109.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.67 12.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.84 27.75 72.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -99.33 162.23 13.16 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.193 -1.18 . . . . 0.0 109.471 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.482 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.8 tt0 -132.33 118.59 19.61 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -135.22 162.9 31.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.679 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.44 ' HB3' HH21 ' A' ' 79' ' ' ARG . 6.0 ptm85 -142.26 142.91 32.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.77 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.06 -117.43 0.64 Allowed Glycine 0 N--CA 1.476 1.35 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.4 157.54 0.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.138 -1.213 . . . . 0.0 110.913 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.497 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 6.1 m95 -102.27 141.56 34.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.639 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.2 m -142.23 156.28 45.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.097 -1.002 . . . . 0.0 108.667 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 121.37 27.11 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.115 -1.616 . . . . 0.0 110.038 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.51 107.83 17.15 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.643 ' C ' HD21 ' A' ' 87' ' ' ASN . . . 62.17 -102.22 0.45 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.643 HD21 ' C ' ' A' ' 86' ' ' GLY . 1.7 m120 -124.84 33.52 5.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -1.14 . . . . 0.0 109.838 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -141.43 163.64 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.062 -1.024 . . . . 0.0 109.772 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mt -102.79 104.42 14.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 108.586 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.639 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -73.55 164.42 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.987 . . . . 0.0 110.247 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.6 94.69 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.667 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 35.4 mttm -88.63 105.21 17.51 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 108.835 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -116.22 136.77 52.72 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.886 0.85 . . . . 0.0 110.091 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -116.84 116.32 27.23 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.607 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.6 mtp180 -53.01 114.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.808 . . . . 0.0 108.847 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -70.32 -12.74 61.79 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.501 1.143 . . . . 0.0 109.377 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.67 -50.96 11.38 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -132.57 11.64 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.2 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.56 41.7 12.98 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.744 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.5 m-80 -78.04 19.78 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -1.199 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.744 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.9 pt-20 42.7 158.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.016 0.912 . . . . 0.0 111.212 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.475 ' C ' ' CD2' ' A' ' 102' ' ' LEU . 6.4 tt -157.39 127.12 6.12 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.499 ' O ' HG21 ' A' ' 118' ' ' VAL . 5.6 t30 -116.93 113.84 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.087 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 116' ' ' THR . 1.8 t -125.41 175.98 7.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.179 -0.951 . . . . 0.0 111.174 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 43.8 t -144.86 146.94 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.8 132.5 54.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.149 -0.969 . . . . 0.0 109.909 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.08 157.77 45.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.434 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.2 mt -125.66 82.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 120.917 -1.115 . . . . 0.0 108.627 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 111' ' ' ASP . 63.7 mt -63.02 92.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.223 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.49 -78.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -130.61 29.14 4.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.127 -1.219 . . . . 0.0 110.197 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.85 136.89 40.95 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.244 -0.91 . . . . 0.0 108.883 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -98.03 110.92 23.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.903 -1.123 . . . . 0.0 109.906 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.401 HG21 HD12 ' A' ' 109' ' ' ILE . 47.6 t -92.35 113.39 27.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.309 -0.956 . . . . 0.0 108.577 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.536 ' HB3' ' HH ' ' A' ' 117' ' ' TYR . 6.6 tt0 -115.79 103.67 10.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.681 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.512 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.41 144.11 31.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.555 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -125.34 151.13 46.47 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.847 0.832 . . . . 0.0 109.471 178.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 103' ' ' ASN . 8.4 t -118.2 147.48 21.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.524 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.91 110.7 5.39 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.882 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 48.54 18.67 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.184 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.17 28.3 3.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.789 ' HB ' ' HZ2' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -123.33 177.11 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 43.0 tt0 -155.44 117.04 4.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.242 -1.383 . . . . 0.0 111.368 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' A' ' 17' ' ' PHE . . . -106.77 150.62 26.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.526 ' NZ ' ' OE2' ' A' ' 12' ' ' GLU . 2.6 mtmm -126.99 137.48 53.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.904 -1.123 . . . . 0.0 110.48 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -140.14 114.01 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.1 mp -109.45 130.86 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 0.0 111.108 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -99.95 176.26 5.49 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.424 0.631 . . . . 0.0 109.407 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -164.58 151.29 11.03 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -47.43 132.89 13.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 2.3 p-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.52 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.138 0.494 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 5' ' ' THR . 28.2 t -179.07 -163.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 109.619 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 70.6 m -91.86 147.35 23.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.104 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.573 ' CD1' ' C ' ' A' ' 5' ' ' THR . 14.9 m95 -151.09 168.73 23.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 7.4 mtpt -150.63 128.53 11.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.388 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.558 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -42.55 106.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.06 -30.24 13.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.475 ' O ' ' OG ' ' A' ' 11' ' ' SER . 4.8 mtt180 -148.97 164.95 33.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.98 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 62.5 m -171.77 178.09 3.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.366 -0.834 . . . . 0.0 108.992 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -156.19 158.69 38.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.12 . . . . 0.0 110.104 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.2 m-20 57.71 -109.57 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.692 -0.63 . . . . 0.0 109.739 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE2' ' NH1' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 71.55 -51.3 0.69 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.84 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -62.8 -40.55 97.71 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.955 -1.091 . . . . 0.0 108.97 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -70.31 -31.0 68.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -74.18 -56.93 4.33 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.561 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 11.7 mmt -60.1 -32.83 71.34 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.42 -37.49 74.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -63.98 -41.05 97.64 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.593 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB2' HG21 ' A' ' 23' ' ' VAL . 2.4 mtm -66.48 -8.33 25.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.199 -0.938 . . . . 0.0 109.086 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.61 32.6 10.03 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.472 HG22 ' SD ' ' A' ' 18' ' ' MET . 26.6 t -94.05 140.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -1.146 . . . . 0.0 109.553 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.35 157.82 4.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.361 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm -82.24 -1.23 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.213 1.006 . . . . 0.0 109.142 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -80.1 -59.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -56.55 -33.9 66.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 108.85 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.621 HH11 ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -65.69 -52.09 54.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.75 -33.84 57.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.413 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.51 -13.23 46.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.023 0.916 . . . . 0.0 109.518 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASP . . . -84.3 -51.03 7.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.7 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.621 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -42.59 -57.53 2.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.502 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -75.69 44.79 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ALA . 63.7 t0 -116.02 101.48 8.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -84.66 43.55 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.406 -0.809 . . . . 0.0 109.357 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.47 HD13 HD22 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -47.09 155.65 0.27 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.748 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -105.74 148.21 27.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.821 -0.549 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 128' ' ' PHE . 2.5 mp -139.28 123.64 18.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 m -101.91 107.94 19.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.02 133.6 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.16 -0.962 . . . . 0.0 110.747 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.48 152.08 48.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -130.05 147.83 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 109.863 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -145.1 79.18 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.82 -87.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -125.8 28.58 6.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -1.093 . . . . 0.0 110.093 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -147.75 110.04 4.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -98.12 174.4 6.55 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.508 0.671 . . . . 0.0 109.799 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -152.27 103.87 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -96.25 114.77 33.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -105.11 100.23 9.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.832 . . . . 0.0 109.345 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 49.6 mp0 -74.64 152.82 39.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.034 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.38 105.95 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.157 0.98 . . . . 0.0 108.546 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.699 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -131.12 144.49 51.44 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.15 7.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.983 -1.073 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.699 ' H ' ' C ' ' A' ' 53' ' ' SER . 72.6 m-85 -109.79 -25.88 10.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -0.978 . . . . 0.0 111.235 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER 165.65 87.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.704 -1.248 . . . . 0.0 109.312 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -62.29 139.81 58.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.42 -0.8 . . . . 0.0 109.643 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.687 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -132.26 174.35 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.874 0.845 . . . . 0.0 110.247 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.687 ' H ' HG21 ' A' ' 58' ' ' ILE . 5.0 pt-20 -151.39 142.98 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.56 127.03 5.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.549 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -78.58 163.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.368 -0.832 . . . . 0.0 109.242 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.588 ' CE2' ' SG ' ' A' ' 70' ' ' CYS . 36.0 m-85 -143.37 117.87 9.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 64' ' ' LEU . 1.1 tm-20 -111.32 164.31 13.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.037 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.623 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 95.7 mt -103.34 118.24 36.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 109.915 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.58 18.37 41.73 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.46 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.622 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.0 t -141.37 105.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.948 -1.325 . . . . 0.0 109.568 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -56.29 143.52 33.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.898 . . . . 0.0 109.871 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -153.84 -170.85 3.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -132.34 151.07 52.01 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.563 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.588 ' SG ' ' CE2' ' A' ' 62' ' ' PHE . 68.1 m -149.42 127.82 12.23 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.66 144.47 25.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 110.343 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 73' ' ' ALA . 70.7 mt -99.35 146.88 25.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.634 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.99 -29.37 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.797 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.561 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 15.7 m-20 -66.62 17.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.164 -0.96 . . . . 0.0 109.241 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.634 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 63.57 26.92 70.18 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 161.88 13.33 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.233 -1.157 . . . . 0.0 109.696 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.497 ' O ' ' OG1' ' A' ' 96' ' ' THR . 40.7 tt0 -132.62 117.53 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.68 157.0 41.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.987 -1.07 . . . . 0.0 110.626 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 21.4 ptt85 -140.51 142.48 35.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.838 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.61 -119.63 0.8 Allowed Glycine 0 N--CA 1.475 1.277 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.504 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.8 159.62 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.153 -1.204 . . . . 0.0 110.403 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.41 143.12 32.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.229 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -137.32 157.06 47.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.75 128.28 44.29 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.315 -1.491 . . . . 0.0 108.273 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.529 ' HG3' HD13 ' A' ' 90' ' ' ILE . 30.6 mt-10 -128.36 117.8 22.07 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.75 -106.88 1.19 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.461 ' C ' HD21 ' A' ' 87' ' ' ASN . 0.3 OUTLIER -125.17 34.42 4.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.162 . . . . 0.0 110.55 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.76 147.33 32.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.693 -1.254 . . . . 0.0 110.242 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt -92.75 113.55 25.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -84.78 165.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 110.766 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.37 95.93 0.17 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.661 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.4 ptpt -87.69 104.97 17.04 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.27 -1.135 . . . . 0.0 108.757 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.438 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m-30 -117.65 145.96 44.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.9 0.857 . . . . 0.0 110.314 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -125.92 123.86 39.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 34.3 mtp180 -57.74 115.22 2.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -69.38 -12.42 61.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.423 1.106 . . . . 0.0 109.466 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.32 -46.62 13.37 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.61 ' ND2' ' ND2' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -132.54 8.67 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.137 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 43.35 41.53 5.19 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.61 ' ND2' ' ND2' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -77.01 15.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.679 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.0 mt-10 52.51 150.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.646 0.736 . . . . 0.0 110.651 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tp -152.77 128.06 9.86 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.638 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER -116.27 118.64 33.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 108.779 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 116' ' ' THR . 1.6 t -129.05 176.2 8.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.162 -0.961 . . . . 0.0 110.559 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 45.5 t -145.52 160.69 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -135.09 135.11 40.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -140.36 158.35 44.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 109.105 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.12 82.3 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 111' ' ' ASP . 32.2 mt -63.82 91.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.107 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.05 -80.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -130.85 29.5 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 129' ' ' LYS . 6.9 mt-10 -133.05 141.12 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 0.0 108.969 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.4 tp -101.0 114.58 28.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.88 -1.137 . . . . 0.0 108.859 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.9 t -104.9 106.77 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.325 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.485 ' OE1' ' OH ' ' A' ' 117' ' ' TYR . 20.5 tt0 -105.79 108.16 19.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.469 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.7 OUTLIER -97.01 147.37 24.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.128 -0.983 . . . . 0.0 109.885 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 123' ' ' GLU . 2.7 m-85 -121.36 158.36 28.42 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.436 -0.79 . . . . 0.0 109.158 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 103' ' ' ASN . 10.8 t -131.2 147.07 32.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.566 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.1 t80 -147.38 110.25 4.73 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.099 -1.041 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 45.99 20.45 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.124 0.488 . . . . 0.0 111.238 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.81 28.32 3.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.566 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.62 176.52 5.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.7 mt-10 -156.13 126.69 6.74 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.123 -1.431 . . . . 0.0 111.284 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.36 159.07 20.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -134.11 137.41 44.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.874 -1.141 . . . . 0.0 110.877 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.644 ' NH1' ' CE2' ' A' ' 14' ' ' TYR . 6.7 mmt180 -129.77 114.13 15.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.7 mt -113.01 122.72 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.01 -1.056 . . . . 0.0 111.14 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.8 m-30 -104.92 174.11 6.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.736 . . . . 0.0 109.138 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 112' ' ' GLU . 30.4 tttp -161.81 159.78 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.324 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -47.77 131.62 14.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.931 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.3 t0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.479 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 19.1 t0 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 40' ' ' ILE . 1.4 t -177.47 -138.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.688 . . . . 0.0 110.018 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 131' ' ' ASP . 28.6 m -89.41 148.39 23.51 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.931 0.872 . . . . 0.0 111.482 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.708 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 17.1 m95 -144.81 168.66 19.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 2.4 pttp -152.5 125.53 8.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.513 -1.367 . . . . 0.0 110.843 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.603 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -44.04 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.285 -0.884 . . . . 0.0 109.769 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.44 -30.66 16.35 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB2' HD12 ' A' ' 127' ' ' ILE . 6.6 mtp85 -151.3 175.33 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.677 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 12.3 t -171.33 178.11 3.36 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.226 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.75 154.72 35.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 21.7 m-20 57.68 -109.51 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.823 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.562 ' CD2' ' OD1' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.03 -52.71 0.69 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 15' ' ' ASP . 12.0 p-10 -59.71 -45.96 90.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.598 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.14 -34.62 76.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -69.79 -63.75 1.02 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.412 ' HE2' ' SD ' ' A' ' 21' ' ' MET . 2.2 mmt -55.9 -24.73 39.15 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.358 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -82.66 -23.05 34.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.065 -1.022 . . . . 0.0 109.379 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -77.33 -37.07 53.25 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.193 -0.942 . . . . 0.0 109.258 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.412 ' SD ' ' HE2' ' A' ' 18' ' ' MET . 0.6 OUTLIER -67.47 -11.33 57.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.574 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.69 31.13 37.26 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 24' ' ' ASN . 5.8 t -78.78 136.86 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -1.159 . . . . 0.0 109.497 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' VAL . 5.8 m-80 -42.48 164.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.227 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.6 mm -81.79 -1.55 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.21 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.51 -59.92 2.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -64.78 -28.23 69.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.588 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -71.62 -42.5 67.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.388 -0.82 . . . . 0.0 108.977 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -63.68 -35.42 80.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.147 -0.971 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.57 -13.14 46.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.013 0.911 . . . . 0.0 109.632 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.577 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -44.14 -16.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.583 ' N ' ' O ' ' A' ' 31' ' ' ALA . 20.7 t-80 -70.9 41.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.409 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' CD2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -50.4 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.7 OUTLIER -147.8 42.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.516 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -96.52 175.18 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.523 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.462 ' N ' HD11 ' A' ' 36' ' ' LEU . 37.7 mttt -129.74 152.01 49.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.636 -0.665 . . . . 0.0 109.497 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.457 ' N ' HD21 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -142.81 150.38 39.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.702 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.563 ' HG1' ' HB3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -111.57 106.44 15.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.627 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -96.25 124.21 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 109.923 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.25 152.48 48.05 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.442 ' HG2' ' CE2' ' A' ' 47' ' ' PHE . 73.5 mt-30 -126.19 149.22 49.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.954 -1.091 . . . . 0.0 110.602 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' OE1' ' CD ' ' A' ' 46' ' ' LYS . 20.1 mt-10 -144.73 79.0 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.526 -0.733 . . . . 0.0 109.164 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.51 -88.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.619 ' N ' HD21 ' A' ' 45' ' ' ASN . 0.6 OUTLIER -122.8 28.55 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -1.075 . . . . 0.0 109.736 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.454 ' CD ' ' OE1' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.01 109.87 4.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.442 ' CE2' ' HG2' ' A' ' 42' ' ' GLN . 3.5 m-30 -93.24 173.26 7.81 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -153.38 103.73 2.7 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 108.813 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 40' ' ' ILE . 96.7 t -99.68 121.62 50.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.634 -0.666 . . . . 0.0 109.446 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.563 ' HB3' ' HG1' ' A' ' 39' ' ' THR . 14.5 tttt -108.63 100.07 9.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.36 155.06 41.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.941 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -158.6 107.05 1.93 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.116 -0.99 . . . . 0.0 109.013 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.752 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -141.83 144.56 33.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.46 7.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.025 -1.047 . . . . 0.0 109.189 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.752 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.0 m-85 -105.42 -25.71 12.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.278 -0.888 . . . . 0.0 110.835 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 8.2 mtp180 159.92 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.913 -1.117 . . . . 0.0 109.166 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -62.5 144.43 56.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 0.0 109.333 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.706 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -136.65 174.02 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 110.34 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.706 ' H ' HG21 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -149.06 129.56 13.93 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 87.7 m -145.75 128.56 16.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.564 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -75.5 164.98 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.269 -0.894 . . . . 0.0 108.957 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.608 ' C ' ' CD2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -144.57 116.49 8.3 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.588 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -116.47 174.55 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.7 119.45 38.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 110.505 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.22 -5.72 83.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.319 -0.943 . . . . 0.0 110.838 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 1.6 t -103.45 105.27 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.834 -1.392 . . . . 0.0 110.13 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -61.25 143.05 56.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.439 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.17 -171.4 3.82 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.539 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.1 OUTLIER -138.87 153.03 48.28 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.403 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 10.2 t -156.96 138.55 14.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.489 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -95.59 143.27 27.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' ALA . 19.3 mt -92.57 146.9 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.45 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.696 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.92 -33.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.742 . . . . 0.0 109.796 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -60.05 8.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.696 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 71.61 26.29 73.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.482 ' OG1' ' OD1' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -100.09 161.87 13.34 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.22 -1.165 . . . . 0.0 109.549 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.426 ' O ' ' OG1' ' A' ' 96' ' ' THR . 83.7 tt0 -132.92 121.06 22.29 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.669 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -137.93 162.99 32.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.895 -1.128 . . . . 0.0 110.821 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -143.59 146.16 33.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.708 . . . . 0.0 109.954 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.67 -118.67 0.71 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.55 157.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -1.231 . . . . 0.0 110.808 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 6.4 m95 -102.1 141.61 34.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.608 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.6 t -139.57 156.8 46.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 108.555 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.51 130.31 35.26 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.294 -1.504 . . . . 0.0 108.032 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.05 122.29 26.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.62 -108.14 1.42 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -125.02 33.93 5.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -1.183 . . . . 0.0 110.313 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 160.89 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.757 -1.215 . . . . 0.0 110.238 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.99 113.26 25.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.608 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -82.17 164.77 2.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 110.534 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.95 96.08 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.653 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 9.6 mtpm? -89.33 106.16 18.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.196 -1.179 . . . . 0.0 109.031 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -116.23 136.78 52.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.772 0.796 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -115.68 117.82 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.468 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.2 mtp180 -57.05 115.06 2.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -75.22 -12.61 60.32 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.497 1.141 . . . . 0.0 109.443 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -90.83 -35.76 14.62 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.872 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 0.7 OUTLIER -132.55 4.06 3.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.337 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.11 29.8 0.66 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.705 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.4 t-20 -76.96 18.66 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -1.177 . . . . 0.0 109.289 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.705 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.4 pt-20 43.93 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.922 0.867 . . . . 0.0 111.101 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 tp -158.19 128.32 6.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -116.51 115.19 25.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 108.8 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.8 t -127.0 176.42 7.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.336 -0.853 . . . . 0.0 110.908 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -147.84 156.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -131.42 134.23 46.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -142.36 158.08 44.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 108.912 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.57 83.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.301 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.0 mm -64.57 92.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.334 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.53 -80.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -128.53 29.02 5.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -1.172 . . . . 0.0 110.251 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.1 130.94 39.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.65 112.29 24.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 108.478 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.97 107.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.9 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.22 106.26 16.64 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.477 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.4 OUTLIER -102.89 145.88 29.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 110.158 -178.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.663 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.8 OUTLIER -124.38 155.27 39.07 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.881 0.848 . . . . 0.0 109.484 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 103' ' ' ASN . 11.7 t -124.6 147.58 29.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.541 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -146.0 110.6 5.12 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.998 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 47.73 19.34 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.237 0.542 . . . . 0.0 111.129 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.37 28.41 3.55 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.46 176.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.67 125.18 6.34 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 118.221 -1.391 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.401 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -115.66 149.5 38.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.415 ' O ' ' OG ' ' A' ' 11' ' ' SER . 12.1 ttpp -129.05 138.67 52.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.896 -1.128 . . . . 0.0 110.581 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -132.47 115.05 15.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.484 HD12 ' HB2' ' A' ' 10' ' ' ARG . 10.4 mt -104.74 123.68 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.603 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 6.1 m-30 -102.17 176.95 5.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -155.05 168.34 27.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 131' ' ' ASP . 10.9 ptpt -50.58 138.74 17.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 109.629 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' HB2' HG22 ' A' ' 5' ' ' THR . 5.7 t70 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.361 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 4' ' ' SER . 12.5 t0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.221 0.534 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.3 m 161.9 -164.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.575 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.596 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 49.3 m -95.88 143.63 26.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.596 ' CD1' ' C ' ' A' ' 5' ' ' THR . 4.9 m95 -150.08 169.01 22.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.234 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HD2' ' HZ3' ' A' ' 37' ' ' LYS . 6.4 ptmm? -152.76 133.98 14.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 109.693 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.53 ' CG1' ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.51 106.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.0 109.508 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 32.3 t0 -98.26 -31.34 12.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -146.22 164.24 32.89 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.503 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 2.8 t -166.02 178.12 6.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.46 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -156.61 155.17 31.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 0.0 109.887 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.6 m-20 58.43 -108.82 0.43 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 109.953 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.565 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER 73.03 -52.19 0.71 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.159 -0.963 . . . . 0.0 110.19 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.578 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 17.3 t70 -59.37 -49.99 75.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.099 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -59.65 -33.23 71.27 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.625 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 65.5 t80 -71.34 -63.67 1.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.484 ' O ' HG23 ' A' ' 23' ' ' VAL . 11.5 mmt -54.19 -25.4 22.58 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.482 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -77.41 -35.19 54.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.03 -1.044 . . . . 0.0 109.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.282 -0.887 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.625 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.3 mtp -68.5 -6.29 24.32 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.115 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.37 32.54 62.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 18' ' ' MET . 4.0 t -74.76 129.68 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -1.207 . . . . 0.0 109.394 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.755 HD21 ' H ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -42.45 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 109.361 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.755 ' H ' HD21 ' A' ' 24' ' ' ASN . 1.5 mm -80.45 -1.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 0.0 109.166 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -82.39 -60.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HB3' ' HZ3' ' A' ' 27' ' ' LYS . 4.2 mtpm? -56.82 -38.33 72.45 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.578 ' NE ' ' OD1' ' A' ' 15' ' ' ASP . 19.9 tpt180 -61.31 -52.7 63.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.74 -38.39 33.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.331 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.64 -13.08 46.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -78.52 -48.96 14.22 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.164 0.506 . . . . 0.0 109.661 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.17 -21.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -0.822 . . . . 0.0 109.478 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.9 t-80 -73.8 35.03 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -44.09 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.476 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 6.7 t-20 -147.83 42.69 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.557 HD21 ' H ' ' A' ' 36' ' ' LEU . 0.9 OUTLIER -95.66 167.89 11.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.994 -1.066 . . . . 0.0 110.566 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.506 ' HZ3' ' HD2' ' A' ' 7' ' ' LYS . 4.4 mttm -108.14 142.55 38.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.532 HD22 HD12 ' A' ' 36' ' ' LEU . 1.9 mp -137.19 128.98 28.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.657 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m -102.69 119.16 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 4.3 mp -107.9 119.73 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.659 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.14 151.74 37.0 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.83 145.45 50.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -140.77 79.09 1.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 -83.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' GLU . 21.8 m-20 -124.9 28.67 6.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -1.134 . . . . 0.0 110.148 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' NZ ' ' OG1' ' A' ' 48' ' ' THR . 1.9 tmtm? -150.79 109.84 3.91 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.34 173.6 7.45 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.361 0.6 . . . . 0.0 109.735 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.625 ' OG1' ' NZ ' ' A' ' 46' ' ' LYS . 43.6 m -153.52 103.87 2.69 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.35 -0.843 . . . . 0.0 108.744 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.6 t -99.42 115.77 41.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -101.4 100.44 10.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.08 158.25 35.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 108.865 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -160.13 107.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.735 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -139.42 144.64 38.18 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.13 7.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.079 -1.013 . . . . 0.0 109.376 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.735 ' H ' ' C ' ' A' ' 53' ' ' SER . 28.2 t80 -107.45 -25.4 11.43 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.164 -0.96 . . . . 0.0 111.065 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 159.97 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.902 -1.124 . . . . 0.0 109.084 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -62.12 148.79 43.24 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.716 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.11 174.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.716 ' H ' HG21 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -149.54 127.3 11.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.7 131.92 20.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.418 HG13 ' NZ ' ' A' ' 46' ' ' LYS . 1.7 t -85.05 153.98 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.353 -0.842 . . . . 0.0 108.81 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CE1' ' SG ' ' A' ' 70' ' ' CYS . 41.1 m-85 -135.3 117.13 15.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 3.2 mp0 -104.12 172.49 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 108.902 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.411 HD21 ' HA ' ' A' ' 64' ' ' LEU . 80.2 mt -103.74 111.77 24.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 0.0 110.317 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.2 -31.7 7.71 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 16.6 t -82.82 110.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.263 . . . . 0.0 109.877 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -60.17 143.24 52.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.085 -1.009 . . . . 0.0 109.437 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.05 -171.35 3.91 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -138.16 150.42 46.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.978 -1.076 . . . . 0.0 110.444 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' CE1' ' A' ' 62' ' ' PHE . 89.1 m -151.91 134.76 15.61 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.717 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -96.24 146.1 24.99 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.265 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 73' ' ' ALA . 17.2 mt -94.69 146.93 23.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.547 -0.721 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.667 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.31 -34.63 1.26 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.683 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -57.74 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.667 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 77.66 25.68 62.39 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.673 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.06 161.49 13.58 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.245 -1.15 . . . . 0.0 109.597 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -133.62 123.07 24.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.611 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.7 162.52 32.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.851 -1.156 . . . . 0.0 110.72 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.77 144.34 31.13 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.485 -0.759 . . . . 0.0 110.046 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.46 -117.66 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 N-CA-C 107.901 -2.079 . . . . 0.0 107.901 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.502 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.69 158.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -1.184 . . . . 0.0 110.572 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.473 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.9 m95 -102.13 143.7 31.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.6 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -140.41 157.22 45.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.06 129.33 36.38 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.149 -1.594 . . . . 0.0 108.136 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.94 119.29 22.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.09 -107.35 1.29 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -125.14 34.33 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -1.158 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 157.11 43.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.804 -1.185 . . . . 0.0 110.229 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.43 110.78 22.78 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -78.45 164.87 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.12 -0.988 . . . . 0.0 110.429 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.402 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.0 96.05 0.17 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.657 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.5 mttp -88.14 105.19 17.34 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.201 -1.176 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.422 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 5.5 m-30 -118.22 140.01 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.221 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -121.87 120.9 35.88 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.673 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 0.4 OUTLIER -53.27 114.86 1.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -12.2 61.44 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.482 1.134 . . . . 0.0 109.406 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.17 -48.82 12.55 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.622 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -132.53 11.38 4.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 110.166 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.0 44.25 13.63 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.745 ' O ' ' O ' ' A' ' 101' ' ' GLU . 42.4 m-20 -80.08 20.04 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -1.065 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.745 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.3 pt-20 42.97 158.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.005 0.907 . . . . 0.0 111.184 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.487 ' C ' ' CD2' ' A' ' 102' ' ' LEU . 6.6 tt -160.49 124.97 3.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.4 t-20 -113.41 112.72 24.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.036 -1.04 . . . . 0.0 109.118 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.7 t -125.3 176.51 6.72 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 111.13 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 46.2 t -148.71 156.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -124.34 133.88 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -134.78 157.98 45.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.436 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.4 mm -122.03 82.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 121.074 -1.016 . . . . 0.0 108.304 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 111' ' ' ASP . 15.9 mt -63.44 92.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.65 -80.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.5 m-20 -128.08 29.48 5.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -1.194 . . . . 0.0 110.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.02 145.24 45.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 108.943 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.63 114.39 28.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.969 -1.082 . . . . 0.0 109.254 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.48 HG21 HG23 ' A' ' 127' ' ' ILE . 39.5 t -99.59 109.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 47.1 tt0 -107.1 104.1 13.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.508 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -100.96 145.59 28.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.215 -0.928 . . . . 0.0 109.998 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.703 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -128.51 152.28 48.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 103' ' ' ASN . 9.0 t -119.39 148.12 22.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG13 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.34 110.59 5.74 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.922 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 48.25 18.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.962 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.45 28.36 3.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -122.67 177.13 4.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 10.6 tt0 -154.86 122.59 5.76 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.175 -1.41 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -116.77 156.54 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -136.33 139.04 42.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.209 . . . . 0.0 111.331 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.565 ' NH2' ' OH ' ' A' ' 14' ' ' TYR . 1.5 ttm-85 -130.76 113.96 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.48 HG23 HG21 ' A' ' 114' ' ' VAL . 6.6 mt -109.18 123.47 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.932 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.485 ' CE2' HD23 ' A' ' 38' ' ' LEU . 7.7 m-30 -101.22 173.94 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.227 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -162.28 161.07 27.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.566 -0.709 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 131' ' ' ASP . 9.9 mmmt -47.71 132.36 14.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.162 -0.961 . . . . 0.0 109.643 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 130' ' ' LYS . 51.7 p30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.459 ' C ' ' OG ' ' A' ' 4' ' ' SER . 34.7 t70 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.246 0.546 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 171.4 -158.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.572 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.6 m -94.81 143.54 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.572 ' CD1' ' C ' ' A' ' 5' ' ' THR . 19.8 m95 -151.3 168.25 25.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.225 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.6 pttm -153.5 130.72 11.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.059 -1.025 . . . . 0.0 109.704 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -40.3 106.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 38.9 t0 -92.97 -30.0 15.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -147.66 164.98 31.83 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.866 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.66 178.15 5.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.358 -0.839 . . . . 0.0 109.267 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.584 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 4.2 pt-20 -152.68 151.12 30.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.02 -1.05 . . . . 0.0 110.013 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.546 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 18.7 t30 58.46 -108.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.718 -0.614 . . . . 0.0 109.903 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.546 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 76.16 -53.64 0.61 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -0.87 . . . . 0.0 109.838 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 87.6 m-20 -58.41 -52.37 65.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.022 -1.049 . . . . 0.0 108.938 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' HZ3' ' HB3' ' A' ' 16' ' ' LYS . 12.0 mtpp -57.81 -33.24 68.39 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.579 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.515 ' CZ ' ' SD ' ' A' ' 21' ' ' MET . 56.8 t80 -71.64 -61.65 1.7 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.552 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 21.7 mmt -56.24 -25.69 48.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.415 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 3.4 mm-40 -80.64 -28.48 36.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.048 -1.032 . . . . 0.0 109.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.89 -35.84 67.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.317 -0.865 . . . . 0.0 109.454 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 2.2 mtm -72.64 -6.58 45.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.166 -0.959 . . . . 0.0 108.844 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 32.42 55.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.473 HG21 ' HB2' ' A' ' 21' ' ' MET . 36.2 t -72.91 135.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -1.169 . . . . 0.0 109.383 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 23' ' ' VAL . 29.0 m120 -42.74 158.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.79 -3.06 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.221 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -84.66 -60.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.52 -29.33 69.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 6.0 ttp180 -68.48 -50.88 49.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.541 -0.725 . . . . 0.0 109.09 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -35.78 63.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.189 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.1 mt -86.46 -13.04 47.3 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.964 0.887 . . . . 0.0 109.773 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -75.8 -47.85 24.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.47 -20.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASN . 13.7 m80 -70.97 46.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -52.05 79.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.853 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' HIS . 7.1 p30 -148.36 42.86 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 109.203 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.549 ' H ' HG12 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -93.94 168.33 11.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -106.53 145.03 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.482 HD11 ' N ' ' A' ' 38' ' ' LEU . 2.1 mp -138.95 125.2 20.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 109.78 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.4 m -102.6 113.02 26.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 3.7 mp -103.08 123.64 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.715 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.37 151.96 36.74 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.492 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 12.7 pt20 -131.72 139.4 48.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.158 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 42' ' ' GLN . 19.0 mm-40 -136.14 78.95 1.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.209 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.81 -89.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.9 OUTLIER -117.51 28.77 8.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.406 -1.056 . . . . 0.0 110.12 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.88 109.98 3.92 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CE2' ' CB ' ' A' ' 42' ' ' GLN . 10.6 m-85 -100.57 173.93 6.32 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.422 0.63 . . . . 0.0 109.67 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -152.2 103.03 2.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -95.33 111.2 25.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -102.31 100.65 10.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.624 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -72.97 158.89 34.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 108.906 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.6 m -160.8 107.11 1.46 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.087 -1.008 . . . . 0.0 109.248 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.689 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -134.09 144.41 48.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 7.8 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 109.638 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.689 ' H ' ' C ' ' A' ' 53' ' ' SER . 7.8 m-85 -112.96 -23.72 9.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.156 -0.965 . . . . 0.0 111.295 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 5.3 ptm180 166.59 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.811 -1.181 . . . . 0.0 109.513 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -62.32 147.65 47.54 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.429 -0.795 . . . . 0.0 109.271 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.742 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.12 174.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.742 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.8 pt-20 -150.0 140.58 22.52 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.471 ' HG ' ' C ' ' A' ' 59' ' ' GLU . 38.9 m -151.69 127.02 9.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.65 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.66 150.74 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.28 -0.888 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.612 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -132.41 116.83 17.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.181 -0.949 . . . . 0.0 109.233 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 46.2 tt0 -126.13 169.12 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.0 109.044 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.475 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.7 mt -101.98 129.01 48.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.05 26.59 63.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 56.5 t -144.04 102.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -1.21 . . . . 0.0 109.31 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.73 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -59.12 141.06 55.1 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.104 0.954 . . . . 0.0 110.064 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.05 -171.3 3.8 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 69' ' ' ASN . 26.3 p30 -139.22 149.06 43.92 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.798 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 71' ' ' ASN . 42.8 t -139.11 170.63 15.62 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 76' ' ' THR . 2.9 m-20 -126.21 141.39 51.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.854 -1.154 . . . . 0.0 110.36 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 73' ' ' ALA . 95.5 mt -93.59 146.9 23.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.528 -0.732 . . . . 0.0 109.293 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.43 -28.43 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -0.757 . . . . 0.0 109.696 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 45.5 m-20 -70.2 19.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.285 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.59 29.94 73.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.633 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.14 162.32 13.04 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.368 -1.077 . . . . 0.0 109.43 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.416 ' C ' ' CD1' ' A' ' 78' ' ' LEU . 58.7 tt0 -132.56 114.78 14.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.596 -0.69 . . . . 0.0 109.189 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.767 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -118.18 150.31 39.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.099 -1.001 . . . . 0.0 110.318 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 69' ' ' ASN . 10.1 ptm180 -136.9 142.67 42.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.37 -118.4 0.72 Allowed Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.797 ' CB ' ' HZ3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 173.01 156.47 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -1.111 . . . . 0.0 110.362 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.575 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.54 143.45 32.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.6 -0.687 . . . . 0.0 109.162 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.604 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 11.4 t -141.59 156.8 45.66 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.02 131.63 35.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.324 -1.485 . . . . 0.0 108.125 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.28 124.2 22.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.21 -110.32 3.01 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.409 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.0 m120 -125.26 34.18 5.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -1.174 . . . . 0.0 110.414 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -149.2 162.43 40.02 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.659 -1.276 . . . . 0.0 110.323 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.77 113.29 25.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.604 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.2 pt -81.13 164.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.02 96.85 0.18 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.797 ' HZ3' ' CB ' ' A' ' 81' ' ' THR . 6.5 pttm -90.32 106.78 18.73 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.274 -1.133 . . . . 0.0 108.686 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 102' ' ' LEU . 2.6 m-30 -116.17 148.79 40.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.775 0.798 . . . . 0.0 110.365 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -134.18 116.85 15.86 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.601 0.715 . . . . 0.0 109.943 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 48.6 mtp180 -52.05 115.29 1.63 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.68 -12.66 61.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.499 1.142 . . . . 0.0 109.628 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.71 -37.95 15.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.97 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 35.4 t-20 -132.48 5.76 4.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.297 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.38 34.36 1.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 101' ' ' GLU . 5.3 m120 -75.41 20.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -1.161 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.7 pt-20 45.49 166.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.017 0.913 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 117' ' ' TYR . 19.4 tp -161.85 120.68 2.36 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -112.19 114.03 26.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 109.165 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 2.0 t -129.71 176.36 8.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.096 -1.003 . . . . 0.0 111.154 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.2 t -146.58 158.51 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -132.21 137.26 47.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.139 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -140.45 158.49 43.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.5 HG12 HD11 ' A' ' 113' ' ' LEU . 1.2 mt -124.23 82.77 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.122 -0.986 . . . . 0.0 108.753 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' ASP . 48.6 mt -61.86 92.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.092 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.94 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ILE . 21.7 m-20 -130.06 29.41 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -1.228 . . . . 0.0 110.404 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -134.43 138.14 44.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 108.776 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.5 HD11 HG12 ' A' ' 108' ' ' ILE . 5.2 tp -99.43 113.16 25.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.891 -1.13 . . . . 0.0 109.362 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.5 t -98.57 110.74 26.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.096 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -113.21 106.76 15.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.488 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -103.56 145.47 29.98 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.707 ' HB3' HD12 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -126.18 156.63 39.87 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.928 0.871 . . . . 0.0 109.599 179.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 103' ' ' ASN . 9.5 t -124.14 148.28 28.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.541 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.2 t80 -143.25 110.29 5.64 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.811 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 47.77 19.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.66 28.24 3.53 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.24 176.57 4.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 1.8 tt0 -156.02 124.19 5.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.061 -1.455 . . . . 0.0 111.362 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.68 151.94 36.24 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.584 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -128.57 140.24 51.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.881 -1.137 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.454 ' CZ ' ' HH ' ' A' ' 117' ' ' TYR . 25.7 mtp180 -133.24 113.96 13.25 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.3 mt -109.07 123.37 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.052 -1.03 . . . . 0.0 110.557 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.548 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -101.01 174.4 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.447 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -163.19 154.59 17.23 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -47.28 135.71 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.512 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.467 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 4' ' ' SER . 9.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.159 0.504 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.701 ' HG ' ' H ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 158.51 -170.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.377 -0.827 . . . . 0.0 109.3 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.701 ' H ' ' HG ' ' A' ' 4' ' ' SER . 97.5 m -86.13 150.16 24.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.579 ' NE1' ' O ' ' A' ' 4' ' ' SER . 13.1 m95 -151.36 168.14 25.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.086 -1.009 . . . . 0.0 109.818 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.2 pttp -153.53 125.79 8.0 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.534 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -37.35 106.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.581 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.97 -28.96 12.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -142.29 174.33 10.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.6 t -178.39 178.31 0.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.16 155.65 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.874 -1.141 . . . . 0.0 109.822 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 18.7 m-20 56.86 -110.08 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.588 -0.695 . . . . 0.0 109.848 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.621 ' CE2' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.59 -52.43 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.0 109.855 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.31 -48.99 77.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.885 -1.134 . . . . 0.0 108.655 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.596 ' NZ ' ' CB ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -69.12 -64.08 0.94 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.007 0.908 . . . . 0.0 108.882 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 15.4 mmt -56.41 -21.33 24.39 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 28' ' ' ARG . 33.3 tt0 -78.66 -35.15 45.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.208 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -66.99 -44.35 80.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.144 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.4 mtm -62.85 -9.22 8.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.021 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 32.3 38.13 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' ASN . 15.4 t -76.29 133.35 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -1.081 . . . . 0.0 109.559 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' VAL . 11.6 t-20 -46.81 174.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -85.24 -2.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.119 0.961 . . . . 0.0 109.266 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.8 t -80.84 -59.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.5 mptm? -66.38 -22.73 66.25 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 19' ' ' GLU . 9.2 ttm180 -73.89 -42.38 60.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 109.29 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -72.81 -34.31 66.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.892 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.9 mt -86.39 -13.03 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -72.82 -53.01 12.64 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.573 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.98 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.574 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.694 ' CE1' HD22 ' A' ' 35' ' ' ASN . 0.7 OUTLIER -91.57 46.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.621 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 69.0 m-20 -62.45 121.05 12.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.853 . . . . 0.0 109.684 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.694 HD22 ' CE1' ' A' ' 33' ' ' HIS . 67.6 m-20 -147.94 42.98 1.05 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.349 -0.844 . . . . 0.0 109.016 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.504 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -87.74 162.81 16.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.111 -0.993 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 52' ' ' SER . 3.1 mtpp -114.69 142.49 46.43 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 1.7 pt? -149.98 143.66 25.35 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.084 -1.01 . . . . 0.0 109.986 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -103.91 143.32 33.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.61 129.04 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.147 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.39 152.3 50.75 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -132.04 135.05 46.21 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.8 mm-40 -129.37 78.98 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.84 -79.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.14 29.24 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.99 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -145.16 110.59 5.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.18 159.85 14.82 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.9 m -152.21 103.12 2.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.079 -1.013 . . . . 0.0 108.269 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.88 130.87 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.61 -0.681 . . . . 0.0 109.652 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -119.63 100.55 7.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.398 -0.814 . . . . 0.0 109.572 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -75.51 156.1 35.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.214 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.1 m -158.9 106.91 1.85 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.153 0.977 . . . . 0.0 108.851 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.718 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -133.87 144.5 48.95 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.13 7.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.085 -1.01 . . . . 0.0 109.427 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.718 ' H ' ' C ' ' A' ' 53' ' ' SER . 67.1 m-85 -113.26 -19.52 11.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 111.25 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 3.4 mmt180 161.63 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.703 -1.248 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.707 HD21 ' H ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -62.89 146.81 52.0 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.495 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.72 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.1 mt -135.82 174.13 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.875 . . . . 0.0 110.146 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.72 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.2 pt-20 -152.82 145.53 24.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.6 m -152.01 110.38 3.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.64 140.06 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.269 -0.894 . . . . 0.0 108.743 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.7 OUTLIER 175.51 164.87 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.918 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.5 tt0 -88.57 169.14 11.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 2.7 pp -88.89 130.97 35.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.867 -1.146 . . . . 0.0 109.619 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.79 -27.1 9.47 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 19.1 t -93.53 117.35 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -1.22 . . . . 0.0 109.732 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.727 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.19 144.38 20.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.052 0.929 . . . . 0.0 110.049 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.36 -171.43 3.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -143.29 151.44 40.52 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.891 -1.131 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 86.6 m -146.51 127.85 14.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.491 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -85.47 143.38 28.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 110.234 -178.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.7 mt -96.37 146.9 24.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.446 -0.784 . . . . 0.0 109.359 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.651 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.88 -29.86 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.515 -0.741 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.99 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.239 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.651 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.78 28.2 69.66 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -99.9 162.44 12.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 96' ' ' THR . 20.0 tt0 -128.83 119.34 24.3 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mt -125.27 141.49 52.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.076 -1.015 . . . . 0.0 110.328 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.45 145.49 43.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.963 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.765 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 169.67 -120.61 0.88 Allowed Glycine 0 C--O 1.211 -1.303 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.566 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.38 159.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.161 -1.199 . . . . 0.0 111.029 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 21.4 m95 -101.96 140.56 36.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.578 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -137.89 157.07 47.17 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.88 128.97 44.83 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.331 -1.481 . . . . 0.0 108.238 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -134.68 122.5 22.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.41 -110.41 3.25 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -125.56 34.19 4.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.23 158.05 43.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.494 -1.379 . . . . 0.0 110.213 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mt -97.9 110.63 23.16 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.578 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.8 164.86 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 110.418 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.413 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.05 94.96 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.765 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.2 mttp -86.17 102.53 13.98 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.175 -1.191 . . . . 0.0 108.819 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.6 m-30 -116.93 149.62 39.86 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.811 0.815 . . . . 0.0 110.103 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 3.5 ptpt -143.33 124.02 14.13 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 31.5 mtp180 -48.07 115.15 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.349 -0.845 . . . . 0.0 108.804 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -70.55 -7.43 43.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.362 1.077 . . . . 0.0 109.322 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -89.68 -41.59 11.84 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.77 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -132.4 8.95 4.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.922 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.06 42.61 12.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.834 ' O ' ' O ' ' A' ' 101' ' ' GLU . 14.4 m120 -75.73 18.4 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -1.147 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.834 ' O ' ' O ' ' A' ' 100' ' ' ASN . 13.4 pt-20 38.62 154.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.107 0.956 . . . . 0.0 111.42 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 93' ' ' PHE . 15.2 tp -153.53 129.08 9.97 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.617 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -113.93 108.68 17.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 109.341 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 116' ' ' THR . 2.7 t -123.29 175.83 6.47 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.135 0.969 . . . . 0.0 111.669 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' N ' ' OG1' ' A' ' 104' ' ' THR . 45.5 t -145.04 157.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HE ' HD21 ' A' ' 113' ' ' LEU . 21.9 ttm180 -126.75 136.02 51.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.982 . . . . 0.0 109.837 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.55 158.3 44.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.104 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.09 82.38 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.079 -1.013 . . . . 0.0 108.435 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 111' ' ' ASP . 19.2 mt -62.61 92.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.886 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.12 -82.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ILE . 68.8 m-20 -130.71 29.01 4.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -1.166 . . . . 0.0 109.952 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.07 139.76 49.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.874 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.475 HD21 ' HE ' ' A' ' 106' ' ' ARG . 11.7 tp -98.87 112.15 24.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.885 -1.134 . . . . 0.0 109.051 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.507 HG21 HG22 ' A' ' 127' ' ' ILE . 20.1 t -99.51 111.53 29.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.365 -0.835 . . . . 0.0 109.472 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -111.52 106.84 15.83 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.555 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.27 143.22 32.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.709 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -127.16 148.68 50.17 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.875 0.845 . . . . 0.0 109.903 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 122' ' ' VAL . 9.6 t -112.42 148.13 15.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.519 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.1 t80 -144.01 110.67 5.6 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 49.72 17.74 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.25 28.25 3.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -122.8 177.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.3 mt-10 -154.72 116.79 4.21 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 118.309 -1.357 . . . . 0.0 111.04 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.41 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -110.41 153.76 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -133.54 138.79 46.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.824 -1.173 . . . . 0.0 111.071 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.578 ' NE ' ' OH ' ' A' ' 117' ' ' TYR . 15.1 mtm180 -132.89 120.91 22.11 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.507 HG22 HG21 ' A' ' 114' ' ' VAL . 4.3 mt -114.44 123.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.09 . . . . 0.0 111.245 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.534 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.5 m-30 -99.13 175.94 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 130' ' ' LYS . 45.9 tttt -165.92 159.3 15.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 109.159 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -47.52 132.6 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.458 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.454 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.59 ' O ' ' NE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -179.28 -168.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.163 -0.96 . . . . 0.0 109.664 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.625 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.4 m -95.53 142.02 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.644 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -151.45 169.24 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.51 139.63 20.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.858 . . . . 0.0 109.281 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' C ' ' O ' ' A' ' 7' ' ' LYS . 7.6 t -33.52 106.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 110.237 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.05 -31.69 14.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -153.86 173.89 15.32 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.611 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 13.4 t -176.37 178.17 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 0.0 109.47 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -157.25 154.08 28.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 12.3 m-20 57.92 -110.28 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.744 -0.598 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.507 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.99 -53.15 0.62 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.874 . . . . 0.0 109.922 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 15.2 p-10 -58.93 -46.42 88.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 108.827 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 78.2 mttt -63.53 -32.27 73.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.482 ' CE2' ' CE ' ' A' ' 21' ' ' MET . 85.7 t80 -72.39 -61.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.556 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 9.6 mmt -58.64 -23.89 60.02 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' HB2' HH21 ' A' ' 28' ' ' ARG . 28.0 tt0 -77.54 -35.3 53.41 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -65.59 -42.01 92.18 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.323 -0.861 . . . . 0.0 109.184 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.564 ' HG2' ' HH ' ' A' ' 119' ' ' TYR . 5.7 mtm -59.61 -13.74 10.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.926 . . . . 0.0 108.845 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.35 22.48 56.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 18' ' ' MET . 2.9 t -73.27 134.3 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -1.039 . . . . 0.0 109.45 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.9 m-80 -41.98 165.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -77.57 -1.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.247 1.022 . . . . 0.0 109.164 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.91 -59.79 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 31' ' ' ALA . 45.3 mmtt -59.24 -39.92 84.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 108.951 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.421 HH21 ' HB2' ' A' ' 19' ' ' GLU . 5.8 ttt180 -61.49 -39.94 92.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -60.89 -47.55 85.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.655 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.55 -12.98 47.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -51.73 -52.89 45.08 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.233 0.54 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -31.31 67.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.385 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.52 34.85 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.413 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -117.37 73.51 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.354 -0.842 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.694 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -86.94 43.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.245 -0.91 . . . . 0.0 109.342 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 35' ' ' ASN . 1.1 pt? -38.81 167.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.211 1.005 . . . . 0.0 111.391 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -105.69 146.4 29.8 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.58 124.08 18.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.021 -1.049 . . . . 0.0 110.325 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 m -104.05 114.77 29.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.641 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 2.2 mp -108.4 138.97 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.672 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.11 152.0 50.85 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -136.97 145.79 44.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 109.557 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -149.6 79.23 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.028 -1.045 . . . . 0.0 109.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.04 -90.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.696 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -120.59 28.77 7.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.333 -1.098 . . . . 0.0 110.453 -178.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 pttm -152.17 111.82 3.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -106.76 174.33 5.93 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.576 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.432 HG22 HG23 ' A' ' 61' ' ' VAL . 11.6 m -148.06 103.39 3.47 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.38 115.58 31.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.148 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -112.36 100.69 8.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -82.87 157.16 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -158.4 107.01 1.97 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.063 -1.023 . . . . 0.0 108.975 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.714 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -134.19 144.46 48.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.93 7.7 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.398 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.714 ' H ' ' C ' ' A' ' 53' ' ' SER . 47.7 m-85 -112.47 -20.3 11.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -0.918 . . . . 0.0 111.227 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.0 OUTLIER 163.3 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.0 109.686 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.718 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -63.38 145.86 54.72 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.716 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -137.59 174.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 0.0 110.312 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.716 ' H ' HG21 ' A' ' 58' ' ' ILE . 6.4 pt-20 -150.62 143.56 24.69 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.14 110.46 4.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.596 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -109.14 141.65 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.285 -0.884 . . . . 0.0 109.093 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.78 -179.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.849 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.9 mp0 -105.09 175.19 5.58 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 3.3 pp -93.9 119.37 32.73 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.986 -1.071 . . . . 0.0 109.203 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.0 -34.73 3.92 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.66 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 3.1 t -83.75 115.02 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.012 -1.287 . . . . 0.0 109.98 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.756 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -54.73 147.91 13.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.041 0.924 . . . . 0.0 110.207 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -160.05 -171.08 3.08 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -129.31 150.09 50.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 110.131 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 63.5 m -152.7 132.47 13.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.734 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -92.24 145.9 24.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.972 -1.08 . . . . 0.0 110.415 -178.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 73' ' ' ALA . 89.3 mt -93.91 147.02 23.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 0.0 109.342 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.643 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.49 -34.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 23.8 t0 -62.57 12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.15 27.9 73.34 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.625 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.3 OUTLIER -99.07 162.14 13.23 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.232 -1.158 . . . . 0.0 109.345 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -132.71 119.56 20.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.62 -0.675 . . . . 0.0 109.227 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.494 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.93 163.04 30.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.009 -1.057 . . . . 0.0 110.335 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -141.95 146.35 35.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.885 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.756 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 170.26 -118.7 0.77 Allowed Glycine 0 C--O 1.211 -1.287 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.19 159.51 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.268 -1.136 . . . . 0.0 110.674 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.33 145.1 29.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.58 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -141.01 157.35 45.45 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -97.51 123.19 41.29 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.456 -1.403 . . . . 0.0 108.217 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.437 ' N ' HD11 ' A' ' 84' ' ' LEU . 23.9 mt-10 -120.11 111.63 18.1 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.4 ' O ' HD13 ' A' ' 84' ' ' LEU . . . 64.47 -104.95 1.0 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 87' ' ' ASN . 3.9 t-20 -125.21 33.47 5.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -1.16 . . . . 0.0 110.262 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.51 148.26 40.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.795 -1.191 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.25 104.48 16.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.58 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -74.9 164.16 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.067 -1.02 . . . . 0.0 110.555 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.9 94.97 0.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.683 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 36.6 mtmt -88.8 103.1 15.67 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 109.151 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.2 m-30 -118.43 137.43 53.15 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.647 0.737 . . . . 0.0 109.709 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 14.1 pttt -124.97 122.89 38.61 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 99' ' ' GLY . 18.3 mtp85 -51.35 117.91 2.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 0.0 109.22 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -11.12 60.72 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.438 1.113 . . . . 0.0 109.29 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.21 -48.29 12.27 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.571 ' OD1' ' NH1' ' A' ' 95' ' ' ARG . 11.3 m120 -132.58 8.63 4.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.23 43.67 9.62 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.683 ' O ' ' O ' ' A' ' 101' ' ' GLU . 56.7 m-20 -72.38 11.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 109.524 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.683 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.2 mt-10 47.42 132.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.713 0.768 . . . . 0.0 111.162 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -135.31 132.51 37.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.9 m120 -117.01 116.49 27.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 0.0 108.931 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 116' ' ' THR . 1.8 t -128.12 176.13 7.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.796 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.4 t -146.6 155.2 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.17 136.31 51.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 109.899 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -137.36 158.68 43.89 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.44 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 2.2 mt -124.71 82.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.824 -1.173 . . . . 0.0 108.642 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 111' ' ' ASP . 21.3 mt -62.8 92.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.976 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.97 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.6 t70 -130.77 29.78 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -1.188 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -133.12 141.56 48.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.016 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 tp -97.65 110.77 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.871 -1.143 . . . . 0.0 109.195 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.59 HG23 HG23 ' A' ' 127' ' ' ILE . 8.8 t -95.21 111.9 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.937 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -114.84 107.32 15.26 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.476 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -101.42 145.31 29.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.691 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -123.11 154.97 37.89 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.837 0.827 . . . . 0.0 109.48 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 103' ' ' ASN . 9.1 t -125.59 147.1 30.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.564 ' HH ' ' HG2' ' A' ' 21' ' ' MET . 1.1 t80 -144.78 110.37 5.3 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.008 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 47.52 19.31 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.198 0.523 . . . . 0.0 111.118 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.72 28.12 3.56 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -122.24 176.58 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 3.6 mt-10 -155.68 125.9 6.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.229 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.21 153.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.42 ' O ' ' OG ' ' A' ' 11' ' ' SER . 19.5 ttpt -130.29 139.56 50.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.808 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.691 ' NH1' ' CZ ' ' A' ' 117' ' ' TYR . 41.0 mtm180 -136.74 114.03 10.79 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.59 HG23 HG23 ' A' ' 114' ' ' VAL . 5.2 mt -110.74 123.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.972 -1.08 . . . . 0.0 110.77 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.444 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 8.3 m-30 -99.18 171.0 8.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 0.0 109.502 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.76 159.62 42.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.63 -0.669 . . . . 0.0 109.21 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -57.96 134.09 56.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.2 t0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.486 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 4' ' ' SER . 5.5 m-20 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.623 ' OG ' ' N ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 159.3 -169.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.775 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.623 ' N ' ' OG ' ' A' ' 4' ' ' SER . 51.5 m -95.89 150.41 20.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.584 ' CD1' ' C ' ' A' ' 5' ' ' THR . 12.4 m95 -150.39 169.13 22.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.755 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 14.9 pttm -152.25 125.24 8.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.578 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.597 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -39.31 106.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 24.2 t0 -95.06 -29.49 14.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -147.86 162.63 38.88 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.871 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.56 178.1 7.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -154.43 158.39 39.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 6.8 m-20 58.86 -109.18 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.656 -0.653 . . . . 0.0 109.72 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 74.76 -54.22 0.67 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.658 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 2.7 m-20 -60.55 -42.37 96.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.083 -1.011 . . . . 0.0 108.574 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -64.27 -32.05 73.5 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 124' ' ' ALA . 7.5 t80 -72.9 -64.07 1.04 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -57.66 -20.85 36.39 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.616 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 2.0 tm-20 -79.77 -36.37 37.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.061 -1.024 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -67.41 -40.85 85.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.358 -0.838 . . . . 0.0 109.246 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 mtm -68.09 -6.12 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.33 -0.856 . . . . 0.0 108.999 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.53 32.43 67.76 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.5 t -72.73 128.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.486 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.7 m120 -41.76 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.355 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -76.52 -1.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.181 0.991 . . . . 0.0 109.212 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -81.86 -59.88 2.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -62.92 -30.93 71.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -44.08 72.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -62.99 -34.19 77.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 109.511 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.5 -13.26 46.52 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.968 0.89 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -80.34 -36.31 34.35 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.623 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.39 -24.34 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 1.3 m-70 -68.82 36.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.118 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.623 ' H ' ' C ' ' A' ' 32' ' ' ALA . 7.5 p-10 -42.57 89.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 109.771 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 17.1 t30 -147.7 42.72 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 108.919 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.597 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -83.23 159.87 21.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.876 . . . . 0.0 110.486 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.451 ' C ' HD13 ' A' ' 36' ' ' LEU . 13.6 mtmm -119.55 150.4 40.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.625 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 1.6 pt? -153.8 149.53 27.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.111 -0.993 . . . . 0.0 110.0 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 m -117.45 123.32 46.07 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 4.0 mp -109.37 131.43 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.676 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.65 152.26 50.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.05 149.0 41.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 0.0 109.95 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.98 79.52 1.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.096 -1.003 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 -94.52 0.64 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -127.38 28.28 5.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -1.109 . . . . 0.0 109.442 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.57 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 18.6 pttm -149.37 110.83 4.46 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.3 174.23 9.75 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.013 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -143.49 103.07 4.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.41 HG12 HG13 ' A' ' 40' ' ' ILE . 42.2 t -98.94 108.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.773 -0.579 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.16 100.0 12.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.302 -0.874 . . . . 0.0 108.748 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 58' ' ' ILE . 50.2 mt-10 -69.78 155.74 40.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.241 -0.912 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -160.83 107.24 1.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.194 -0.941 . . . . 0.0 108.818 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.755 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -143.25 144.54 32.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.77 7.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.051 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.755 ' H ' ' C ' ' A' ' 53' ' ' SER . 16.5 t80 -106.83 -24.95 11.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 110.861 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 73' ' ' ALA . 9.8 mtp180 160.01 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 109.25 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -62.45 145.86 53.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 109.18 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.73 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.8 mt -142.77 174.14 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 122.129 0.966 . . . . 0.0 110.694 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.73 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.6 pt-20 -135.42 142.52 45.64 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 t -155.05 113.76 3.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.976 -1.077 . . . . 0.0 110.306 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.18 149.35 7.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -129.94 121.07 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.033 . . . . 0.0 110.534 -179.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.441 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 50.2 tt0 -123.35 139.17 54.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.586 HD21 ' H ' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -103.23 148.83 25.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.885 -1.135 . . . . 0.0 110.283 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.8 -5.13 59.71 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.12 118.06 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.28 . . . . 0.0 109.941 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.8 m -49.32 145.4 4.55 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.294 1.045 . . . . 0.0 109.685 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.98 -168.14 2.15 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.625 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -146.46 157.21 43.72 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.532 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 15.9 t -147.66 136.05 21.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -96.54 148.33 22.94 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.939 -1.101 . . . . 0.0 110.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 73' ' ' ALA . 18.8 mt -100.94 147.08 26.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.586 -0.696 . . . . 0.0 109.527 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.728 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -39.46 -34.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.747 -0.596 . . . . 0.0 109.816 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.65 7.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.127 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.728 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 70.12 24.63 76.43 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.29 161.25 13.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.246 -1.149 . . . . 0.0 109.53 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -133.55 124.57 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.245 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.39 159.61 36.5 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.063 -1.023 . . . . 0.0 110.499 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -138.89 152.33 47.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 0.0 110.458 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.15 -110.09 0.42 Allowed Glycine 0 C--O 1.212 -1.272 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 166.74 152.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -1.216 . . . . 0.0 110.93 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 28.2 m95 -108.45 130.22 55.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.622 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 1.8 m -144.88 156.31 43.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 109.54 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -87.27 138.11 31.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.752 -1.218 . . . . 0.0 108.425 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 49.9 mt-10 -160.32 157.21 27.59 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.497 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.07 -117.72 6.49 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -125.99 33.8 4.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -1.197 . . . . 0.0 110.638 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -165.02 163.5 20.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.436 -1.415 . . . . 0.0 110.593 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.71 124.35 31.41 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.622 ' CD1' ' O ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -94.13 161.05 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.983 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.24 100.3 0.21 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.643 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 63.6 mttt -98.08 108.76 21.54 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.371 -1.076 . . . . 0.0 108.762 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' LEU . 1.5 m-30 -126.72 137.92 53.32 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.78 0.8 . . . . 0.0 110.245 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 94' ' ' LYS . 4.4 ptmm? -126.33 128.92 47.85 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 99' ' ' GLY . 35.7 mtp180 -54.64 115.27 2.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 108.993 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -10.17 57.34 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.389 1.09 . . . . 0.0 109.34 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -83.31 -47.13 11.82 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.619 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -132.44 9.26 4.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.84 44.86 18.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.64 ' O ' ' O ' ' A' ' 101' ' ' GLU . 13.9 m120 -74.42 10.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -1.173 . . . . 0.0 109.63 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.64 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.5 mt-10 49.96 136.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.764 0.792 . . . . 0.0 111.12 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' PHE . 6.3 tt -146.39 122.28 10.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.42 149.98 31.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.044 . . . . 0.0 108.554 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.7 t -159.59 175.71 12.89 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.266 -1.521 . . . . 0.0 111.315 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 106' ' ' ARG . 37.8 t -144.23 158.17 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.419 ' N ' ' CG1' ' A' ' 105' ' ' VAL . 4.0 ttm180 -131.81 134.12 45.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -137.0 157.88 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.24 82.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.069 -1.019 . . . . 0.0 108.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 111' ' ' ASP . 79.0 mt -63.03 92.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.237 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.68 -78.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 109' ' ' ILE . 20.9 p-10 -130.19 29.24 4.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.0 110.316 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -134.77 139.05 44.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 108.966 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.5 tp -102.9 114.87 29.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.009 -1.057 . . . . 0.0 109.543 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.663 HG22 HG22 ' A' ' 127' ' ' ILE . 25.1 t -102.11 107.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.399 -0.813 . . . . 0.0 109.111 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -110.1 106.97 16.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.494 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -104.76 145.43 30.37 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.702 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.22 149.8 50.87 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.94 0.876 . . . . 0.0 109.715 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 122' ' ' VAL . 3.9 t -112.91 148.01 16.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.491 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -140.64 110.28 6.38 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 47.31 19.22 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.122 0.487 . . . . 0.0 111.182 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.5 28.6 3.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 0.3 OUTLIER -124.34 177.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 33.9 mt-10 -153.5 121.23 5.98 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.378 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.425 ' HB3' ' CD1' ' A' ' 17' ' ' PHE . . . -114.0 146.19 40.5 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -125.82 140.14 52.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.929 -1.107 . . . . 0.0 111.186 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.518 ' HD2' ' HH ' ' A' ' 117' ' ' TYR . 11.9 mtt-85 -129.71 114.2 15.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.663 HG22 HG22 ' A' ' 114' ' ' VAL . 8.7 mt -111.36 123.38 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.762 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.55 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.6 m-30 -103.65 176.06 5.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.489 -0.757 . . . . 0.0 109.577 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.668 ' HZ2' ' HE2' ' A' ' 130' ' ' LYS . 24.6 tttp -163.86 152.96 14.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.668 ' HE2' ' HZ2' ' A' ' 129' ' ' LYS . 4.7 pttm -47.66 132.24 14.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 13.5 p-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 4' ' ' SER . 1.3 m-20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.676 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 163.83 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.676 ' N ' ' OG ' ' A' ' 4' ' ' SER . 96.8 m -91.49 145.27 24.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.577 ' CD1' ' C ' ' A' ' 5' ' ' THR . 8.2 m95 -151.36 168.24 25.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.315 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 3.0 ptmm? -153.18 133.76 13.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.988 -1.07 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.495 ' CG1' ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -40.2 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.426 -0.796 . . . . 0.0 109.506 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.26 -30.2 12.38 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -140.67 169.82 16.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.912 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 14.4 t -175.27 178.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.279 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -156.24 154.42 30.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.9 m-20 56.79 -109.5 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.526 -0.734 . . . . 0.0 109.792 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.68 -54.14 0.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' CG ' HH21 ' A' ' 28' ' ' ARG . 7.2 m-20 -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.664 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -66.46 -32.08 73.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.539 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 21.9 t80 -72.28 -60.29 2.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.438 ' CE ' ' CE2' ' A' ' 14' ' ' TYR . 5.3 mtt -56.41 -25.09 49.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -78.87 -30.06 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.157 -0.965 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.56 ' HZ2' ' HB ' ' A' ' 122' ' ' VAL . 8.0 tptm -69.76 -41.8 74.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -68.01 -6.41 22.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.91 . . . . 0.0 108.942 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 29.64 54.14 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.46 135.52 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -48.8 158.84 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.88 . . . . 0.0 109.37 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -82.96 -1.38 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.141 0.972 . . . . 0.0 109.237 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -80.07 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -57.34 -42.45 81.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.522 HH21 ' CG ' ' A' ' 15' ' ' ASP . 16.7 ttp85 -59.32 -46.67 87.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.456 -0.777 . . . . 0.0 109.204 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -53.59 -39.34 64.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.385 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.5 -13.59 45.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.803 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.44 -39.92 15.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.186 0.517 . . . . 0.0 109.668 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -38.64 -27.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.678 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 35' ' ' ASN . 46.5 m170 -70.04 39.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.908 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 32' ' ' ALA . 6.8 t0 -43.5 90.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.591 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 33' ' ' HIS . 5.8 m120 -147.7 42.97 1.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.555 ' H ' HD22 ' A' ' 36' ' ' LEU . 1.1 pt? -90.6 163.52 14.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -106.17 135.19 48.07 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.404 ' CD1' ' N ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -132.91 128.54 36.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.975 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.449 HG23 ' HA ' ' A' ' 5' ' ' THR . 0.3 OUTLIER -102.87 120.71 41.09 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.028 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.78 123.17 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 0.0 110.829 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.02 151.93 38.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.446 ' CD ' ' OD2' ' A' ' 3' ' ' ASP . 20.7 pt20 -133.37 148.95 51.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.005 -1.059 . . . . 0.0 110.188 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.513 ' OE2' ' CD ' ' A' ' 46' ' ' LYS . 58.6 mt-10 -147.73 79.31 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.183 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.14 -92.72 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.572 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.31 28.42 7.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -1.059 . . . . 0.0 109.358 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.513 ' CD ' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -140.67 109.74 6.14 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 19.1 m-85 -103.06 173.36 6.34 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -154.88 103.61 2.43 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.73 110.29 25.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -95.52 100.26 12.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.1 mp0 -73.88 159.75 32.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.4 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 2.3 m -160.16 107.02 1.59 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.081 -1.012 . . . . 0.0 109.163 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.696 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -125.68 144.31 50.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.03 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.218 -0.927 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.696 ' H ' ' C ' ' A' ' 53' ' ' SER . 20.6 t80 -125.02 -19.62 5.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 111.782 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 177.02 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.303 -1.498 . . . . 0.0 110.084 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.704 HD21 ' H ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -62.89 145.58 54.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.999 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.694 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.79 174.19 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.694 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.4 pt-20 -147.05 143.99 28.77 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.22 110.57 4.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.5 146.22 6.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 4.6 p90 -160.46 153.75 21.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.561 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.2 tt0 -129.15 122.72 30.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 64' ' ' LEU . 3.0 pp -56.86 126.74 28.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.04 -1.037 . . . . 0.0 109.853 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.97 3.4 24.81 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.67 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 18.5 t -144.17 113.63 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.321 . . . . 0.0 109.777 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.788 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.5 m -55.48 147.64 17.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.958 0.885 . . . . 0.0 110.308 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.67 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -156.59 -171.0 3.52 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -134.05 153.24 51.93 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 34.9 t -156.84 131.62 8.86 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.494 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -95.79 145.42 25.35 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' GLY . 19.5 mt -95.85 146.89 24.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.667 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.44 -34.96 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.65 -0.656 . . . . 0.0 109.897 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.58 3.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.667 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.37 25.27 66.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.698 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.21 161.67 13.46 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.172 -1.193 . . . . 0.0 109.555 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -133.33 121.24 22.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.401 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -135.56 161.68 34.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.946 -1.096 . . . . 0.0 110.216 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.486 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.7 OUTLIER -144.48 148.24 34.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 109.65 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.788 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.23 -116.95 0.69 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 174.03 159.26 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.324 . . . . 0.0 111.093 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 12.8 m95 -102.2 141.67 34.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.588 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -138.79 156.9 46.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.54 128.72 42.63 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.353 -1.467 . . . . 0.0 108.408 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 14.3 pt-20 -129.61 129.33 44.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.74 -108.56 0.73 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -125.51 34.12 4.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.177 -1.19 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.95 156.23 44.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.179 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.5 mt -97.1 110.83 23.3 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.3 164.72 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.149 -0.969 . . . . 0.0 110.522 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.421 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -146.97 95.19 0.17 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.71 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.0 ptmm? -86.85 102.41 14.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.122 -1.222 . . . . 0.0 109.102 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.5 m-30 -116.0 142.68 46.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.775 0.798 . . . . 0.0 109.801 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 31.8 pttt -133.34 124.02 26.47 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.698 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 25.5 mtt180 -44.67 116.8 1.13 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.383 -0.823 . . . . 0.0 108.886 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -7.19 41.05 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.66 -45.9 10.56 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.516 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -132.6 8.46 4.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 47.31 45.16 21.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 21.4 m-20 -73.12 12.57 0.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.4 mt-10 49.66 146.17 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.903 0.859 . . . . 0.0 111.32 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 93' ' ' PHE . 8.3 tt -149.93 126.04 10.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 118' ' ' VAL . 13.5 t30 -111.65 112.44 24.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.415 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.9 t -124.53 176.43 6.52 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 110.994 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.1 t -148.54 154.93 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -126.65 130.29 50.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 109.688 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -129.44 158.98 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 109.083 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -120.08 82.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 111' ' ' ASP . 9.5 mt -64.38 91.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.735 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 51.38 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.1 p-10 -125.05 29.84 6.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -1.173 . . . . 0.0 110.422 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -138.3 147.7 43.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.029 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 tp -107.76 112.42 25.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.031 -1.043 . . . . 0.0 109.477 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 127' ' ' ILE . 3.4 t -94.77 115.16 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -114.56 103.32 10.9 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.508 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.3 OUTLIER -103.0 145.94 29.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.909 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -128.17 152.65 47.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.96 0.886 . . . . 0.0 109.641 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASN . 11.0 t -120.09 149.24 22.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.591 ' CE1' ' OE2' ' A' ' 120' ' ' GLU . 1.2 t80 -143.47 110.88 5.82 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.929 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.591 ' OE2' ' CE1' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 46.15 20.16 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.053 178.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.68 28.55 3.42 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.9 176.58 5.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 39.0 tt0 -156.06 125.55 6.28 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.067 -1.453 . . . . 0.0 111.427 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.408 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -121.31 151.42 40.1 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.432 ' O ' ' OG ' ' A' ' 11' ' ' SER . 5.3 ttpt -132.31 139.61 48.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 0.0 111.282 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HE ' ' HH ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -135.14 114.42 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.618 HG23 HG23 ' A' ' 114' ' ' VAL . 3.3 mt -108.76 125.39 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.036 -1.04 . . . . 0.0 110.817 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.493 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 6.5 m-30 -97.7 174.6 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.248 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.741 ' HE2' ' HZ2' ' A' ' 130' ' ' LYS . 43.4 tttm -160.65 156.63 25.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.524 -0.735 . . . . 0.0 109.273 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.741 ' HZ2' ' HE2' ' A' ' 129' ' ' LYS . 13.3 pttp -49.13 128.91 17.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.592 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.508 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 4' ' ' SER . 20.2 p-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.251 0.548 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.58 -166.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.58 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 36.2 m -90.94 147.08 23.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.365 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.58 ' CD1' ' C ' ' A' ' 5' ' ' THR . 15.4 m95 -151.69 169.24 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 109.646 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' VAL . 36.7 pttt -153.2 126.96 8.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.029 -1.044 . . . . 0.0 109.768 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -36.4 106.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.382 -0.824 . . . . 0.0 109.422 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -91.1 -29.5 17.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' NH1' HG22 ' A' ' 127' ' ' ILE . 62.2 mtm-85 -151.54 166.68 30.4 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.225 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.4 t -177.15 166.46 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.507 -0.745 . . . . 0.0 109.091 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -166.75 166.17 15.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 0.0 110.448 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 58.9 21.78 9.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.581 -0.699 . . . . 0.0 110.243 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.59 ' OH ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.61 -57.29 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.599 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 19' ' ' GLU . 2.6 m-20 -45.85 -52.93 10.55 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.011 -1.056 . . . . 0.0 109.161 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -54.65 -41.68 70.38 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -67.84 -63.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -20.82 2.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 15' ' ' ASP . 39.1 tt0 -79.24 -38.13 36.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -65.81 -37.32 85.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.505 ' HB2' HG21 ' A' ' 23' ' ' VAL . 11.3 mtm -67.73 -8.84 38.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.322 -0.861 . . . . 0.0 109.11 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 32.51 41.69 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 21' ' ' MET . 17.7 t -80.02 139.2 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -1.108 . . . . 0.0 109.585 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' VAL . 62.6 t30 -44.83 170.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.302 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.593 ' CD1' ' CZ ' ' A' ' 28' ' ' ARG . 3.7 mm -85.33 -5.1 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.017 . . . . 0.0 109.34 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.88 -60.04 2.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 49.3 mttp -63.97 -24.06 67.58 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.593 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 23.4 ttp180 -73.04 -47.8 41.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.553 -0.717 . . . . 0.0 109.361 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -66.96 -34.84 78.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.793 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.71 -13.07 46.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 110.064 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 27' ' ' LYS . . . -74.82 -25.92 59.36 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.167 0.508 . . . . 0.0 109.824 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -70.94 -61.0 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.103 -0.998 . . . . 0.0 109.509 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 82.2 t60 -70.71 46.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.451 -0.78 . . . . 0.0 109.434 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 32' ' ' ALA . 37.8 t0 -88.94 127.54 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -123.78 43.08 3.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -68.95 159.91 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.902 0.858 . . . . 0.0 111.008 -178.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -107.64 149.06 28.53 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 38' ' ' LEU . 2.6 mp -139.17 129.01 24.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.015 . . . . 0.0 109.952 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 m -99.96 105.86 17.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.521 HG13 HG21 ' A' ' 49' ' ' VAL . 3.7 mp -95.65 123.4 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 110.926 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.01 151.79 41.54 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -129.66 148.24 51.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.024 -1.048 . . . . 0.0 109.843 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' ASN . 27.9 mt-10 -144.72 78.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.66 -81.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' GLU . 11.7 p-10 -125.56 28.87 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.67 109.67 4.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.36 166.81 12.39 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.5 m -156.17 103.67 2.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.521 HG21 HG13 ' A' ' 40' ' ' ILE . 13.7 p -105.97 118.67 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.491 -0.755 . . . . 0.0 109.486 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -100.01 100.25 11.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.565 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 1.8 mp0 -70.51 156.3 39.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.935 . . . . 0.0 109.05 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -158.86 106.93 1.86 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.073 -1.017 . . . . 0.0 109.022 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.685 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.61 144.64 50.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.01 7.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 109.858 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.687 ' CZ ' ' NH2' ' A' ' 56' ' ' ARG . 6.0 t80 -112.29 -20.45 11.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 111.128 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.687 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER 160.44 89.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.843 -1.16 . . . . 0.0 109.317 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -62.18 148.17 45.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.7 HG21 ' H ' ' A' ' 59' ' ' GLU . 2.0 mt -138.11 174.19 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.032 0.92 . . . . 0.0 110.338 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.7 ' H ' HG21 ' A' ' 58' ' ' ILE . 5.8 pt-20 -141.79 143.29 33.37 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.9 m -150.75 117.52 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 110.263 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.08 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -137.82 165.93 25.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 23.8 tt0 -152.39 169.71 21.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.457 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 78.3 mt -100.74 118.88 37.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 110.197 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.87 24.56 27.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.345 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.636 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 21.0 t -144.05 102.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.05 -1.265 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.8 143.12 43.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.752 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.81 -171.03 3.82 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.41 149.73 45.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.481 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 50.0 t -151.91 135.66 16.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.43 143.91 28.36 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 110.163 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.1 mt -91.82 147.04 23.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.551 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.671 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.67 -33.86 1.33 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.702 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.68 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.671 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 78.34 25.33 61.54 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 161.7 13.43 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.236 -1.155 . . . . 0.0 109.692 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 96' ' ' THR . 19.0 tt0 -133.09 125.88 30.55 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.78 164.76 27.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.969 -1.082 . . . . 0.0 110.574 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HG2' ' HZ3' ' A' ' 94' ' ' LYS . 14.6 ttm180 -147.85 143.15 27.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.738 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.66 -119.59 0.83 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.498 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.05 158.95 0.12 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.211 -1.17 . . . . 0.0 110.53 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.484 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.2 m95 -102.0 143.26 32.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.9 m -138.76 157.14 46.64 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.26 129.22 43.64 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.364 -1.46 . . . . 0.0 108.286 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.455 ' CD ' ' O ' ' A' ' 85' ' ' GLU . 1.3 pp20? -131.31 125.43 32.76 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.51 -109.45 1.58 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -125.47 33.84 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -1.156 . . . . 0.0 110.216 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.403 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.38 155.86 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.77 -1.206 . . . . 0.0 110.165 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mt -97.58 111.23 23.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.66 164.81 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 110.476 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.25 95.41 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.722 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 12.5 ptmt -86.17 102.78 14.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.189 -1.183 . . . . 0.0 108.478 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 102' ' ' LEU . 5.1 m-30 -118.95 145.72 45.56 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.823 0.821 . . . . 0.0 110.146 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.558 ' HZ3' ' HG2' ' A' ' 79' ' ' ARG . 20.3 pttm -132.46 121.58 23.59 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 99' ' ' GLY . 49.0 mtp180 -46.95 114.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.398 -0.814 . . . . 0.0 109.026 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.49 -10.15 53.63 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 122.492 1.139 . . . . 0.0 109.28 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -79.03 -50.44 11.07 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.464 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -132.34 9.54 4.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.393 -0.817 . . . . 0.0 109.84 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.78 47.22 31.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.649 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.5 m120 -77.92 14.01 1.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -1.146 . . . . 0.0 109.581 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.8 mt-10 50.88 142.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.616 0.722 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -144.89 131.71 20.13 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -114.9 111.76 21.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 0.0 108.866 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 2.2 t -126.86 176.4 7.32 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.075 -1.016 . . . . 0.0 111.184 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.2 t -147.92 162.34 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.484 ' NH1' ' CH2' ' A' ' 82' ' ' TRP . 12.9 ttm180 -133.4 139.48 46.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.924 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -141.42 158.75 43.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.133 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -119.21 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.0 mm -61.55 92.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.009 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.53 -78.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 109' ' ' ILE . 14.4 m-20 -130.73 29.9 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -1.151 . . . . 0.0 110.213 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -136.98 146.48 45.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.121 -0.987 . . . . 0.0 109.164 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.9 tp -102.23 115.64 30.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.995 -1.066 . . . . 0.0 109.219 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.491 HG23 HG23 ' A' ' 127' ' ' ILE . 5.6 t -105.16 107.61 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 109.288 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.497 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 12.5 tt0 -107.43 109.46 21.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.483 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -99.83 144.7 28.59 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 109.767 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.681 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -127.22 150.76 49.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.841 0.829 . . . . 0.0 109.51 179.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASN . 11.2 t -119.77 147.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.561 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -145.03 110.75 5.38 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.138 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 50.01 17.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.299 0.571 . . . . 0.0 110.979 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.29 27.76 3.8 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -121.42 176.34 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 2.3 mt-10 -156.05 117.23 3.85 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.09 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.17 166.94 10.81 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -145.26 137.47 25.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.912 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.59 ' NE ' ' OH ' ' A' ' 14' ' ' TYR . 14.6 mtt180 -125.15 114.1 18.58 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.491 HG23 HG23 ' A' ' 114' ' ' VAL . 7.3 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 110.352 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.534 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 11.4 m-30 -100.93 166.21 10.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -150.96 146.75 26.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.58 -0.7 . . . . 0.0 109.121 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -47.83 136.43 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.496 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 130' ' ' LYS . 11.7 p30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.451 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 4' ' ' SER . 26.6 t70 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.16 0.505 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 160.29 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 109.598 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.582 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.7 m -98.03 142.59 29.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.304 -0.872 . . . . 0.0 109.352 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.582 ' CD1' ' C ' ' A' ' 5' ' ' THR . 4.4 m95 -147.29 169.43 19.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.303 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 8' ' ' VAL . 11.9 pttm -151.9 130.7 12.43 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.022 -1.049 . . . . 0.0 109.477 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -39.83 106.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.364 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.44 -32.28 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.498 ' O ' ' OG ' ' A' ' 11' ' ' SER . 15.8 mtm-85 -142.58 164.65 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.686 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 67.3 m -170.47 178.22 3.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 109.294 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -155.19 157.5 37.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.056 . . . . 0.0 110.006 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 10.8 m-20 58.02 -109.53 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.678 . . . . 0.0 109.854 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 71.69 -51.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -61.36 -46.03 91.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.955 -1.091 . . . . 0.0 108.597 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -63.34 -33.84 76.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CE2' ' CE ' ' A' ' 21' ' ' MET . 91.0 t80 -71.39 -61.4 1.79 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.795 0.807 . . . . 0.0 108.883 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 23' ' ' VAL . 14.3 mmt -59.04 -23.78 62.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -74.76 -37.82 62.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.24 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -64.67 -46.38 82.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.341 -0.849 . . . . 0.0 109.028 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG2' ' HH ' ' A' ' 119' ' ' TYR . 4.8 mtm -61.81 -9.07 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.041 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.26 28.02 62.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 18' ' ' MET . 3.8 t -74.85 132.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -1.091 . . . . 0.0 109.553 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.739 HD21 ' N ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -49.31 167.15 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.739 ' N ' HD21 ' A' ' 24' ' ' ASN . 1.5 mm -82.03 -1.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.181 0.991 . . . . 0.0 109.22 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -73.69 -59.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.456 0.646 . . . . 0.0 109.386 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.445 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -64.22 -29.56 70.66 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.071 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 14.3 ttp180 -72.71 -30.69 64.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.642 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -75.4 -40.02 58.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.38 -13.14 47.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.01 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 33' ' ' HIS . . . -84.7 -49.56 8.4 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.212 0.529 . . . . 0.0 109.626 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.2 -1.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.609 ' H ' ' C ' ' A' ' 31' ' ' ALA . 81.4 m-70 -140.1 46.26 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.609 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 36' ' ' LEU . 25.6 t0 -125.56 95.95 4.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.456 ' HA ' HG12 ' A' ' 8' ' ' VAL . 3.6 p-10 -71.48 43.57 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.353 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.502 HD12 HD23 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -43.77 155.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.901 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -106.57 148.7 27.95 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.502 HD23 HD12 ' A' ' 36' ' ' LEU . 2.7 mp -138.92 126.53 21.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -98.29 111.78 24.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.8 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 3.9 mp -100.76 120.48 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.448 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -120.98 151.99 39.08 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.583 ' N ' ' OE1' ' A' ' 42' ' ' GLN . 1.6 pm0 -130.88 147.06 52.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 45' ' ' ASN . 38.5 mm-40 -144.04 78.88 1.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.65 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.639 HD21 ' H ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -124.53 28.81 6.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -1.145 . . . . 0.0 110.347 -178.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.22 109.88 4.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -94.65 171.02 9.05 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m -155.9 103.5 2.24 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 0.0 108.992 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.67 115.69 41.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.326 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -101.09 100.25 10.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 52' ' ' SER . 5.3 tt0 -69.86 157.78 36.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 108.736 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.422 ' N ' ' CG ' ' A' ' 51' ' ' GLU . 2.3 m -160.12 107.02 1.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.152 -0.968 . . . . 0.0 109.015 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.715 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -137.05 144.36 43.15 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.18 7.62 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 109.236 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.715 ' H ' ' C ' ' A' ' 53' ' ' SER . 60.2 m-85 -109.38 -25.02 10.76 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.296 -0.878 . . . . 0.0 111.1 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 2.7 ptm180 164.34 86.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.171 . . . . 0.0 109.44 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -62.61 146.4 52.1 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.299 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.707 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -140.56 174.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.127 -0.983 . . . . 0.0 110.409 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.707 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.9 pt-20 -146.34 142.76 28.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 98.9 m -151.25 125.06 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -86.38 150.35 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -136.38 131.08 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.922 -1.112 . . . . 0.0 110.416 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -120.98 170.03 9.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.61 118.94 37.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.061 -1.024 . . . . 0.0 110.333 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.08 22.87 36.79 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.479 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 12.7 t -143.71 105.85 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.959 -1.318 . . . . 0.0 109.401 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.48 142.37 44.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.637 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -149.45 -171.36 3.87 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -139.41 154.02 47.72 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.659 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.1 t -153.45 135.54 14.78 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 76' ' ' THR . 5.8 p30 -93.73 143.39 26.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.934 -1.104 . . . . 0.0 110.231 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.4 mt -92.53 146.89 23.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.683 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.67 -34.79 0.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 0.0 109.813 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.29 8.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 72.54 27.09 70.15 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.68 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.03 162.17 13.14 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.181 -1.188 . . . . 0.0 109.624 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -132.55 120.41 21.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -133.15 162.28 32.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.932 -1.105 . . . . 0.0 110.582 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -146.31 146.88 30.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.538 -0.726 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.52 -119.52 0.79 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.49 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.88 156.87 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.3 -1.117 . . . . 0.0 110.65 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.523 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 5.2 m95 -102.85 143.48 32.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -142.08 122.35 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.475 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 118.75 7.92 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 119.951 -1.718 . . . . 0.0 109.857 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.04 115.82 29.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.67 -103.54 0.33 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.35 33.77 5.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -140.98 143.13 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.735 -1.228 . . . . 0.0 110.251 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.12 104.53 17.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.781 ' CG1' ' O ' ' A' ' 83' ' ' SER . 0.9 OUTLIER -81.64 163.5 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.733 -1.229 . . . . 0.0 110.04 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.19 95.86 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.714 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.1 mttm -85.75 103.35 14.45 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.401 -1.058 . . . . 0.0 108.463 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.44 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -115.71 148.27 39.94 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.82 0.819 . . . . 0.0 110.154 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -133.41 120.9 21.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.451 0.643 . . . . 0.0 109.526 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.68 HH21 ' CG2' ' A' ' 76' ' ' THR . 23.8 mtp85 -53.1 115.32 1.81 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -13.41 61.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.456 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.609 ' C ' HD21 ' A' ' 98' ' ' ASN . 52.9 t0 -77.84 -49.89 13.38 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.768 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.609 HD21 ' C ' ' A' ' 97' ' ' ASP . 1.0 OUTLIER -132.33 11.2 4.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.964 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.46 42.31 9.67 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.674 ' O ' ' O ' ' A' ' 101' ' ' GLU . 74.5 m-20 -75.6 19.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -1.154 . . . . 0.0 109.512 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.674 ' O ' ' O ' ' A' ' 100' ' ' ASN . 15.6 pt-20 45.07 164.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.816 0.817 . . . . 0.0 110.911 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 117' ' ' TYR . 6.6 tp -165.12 127.25 2.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.611 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.6 OUTLIER -114.4 115.96 28.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.002 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 116' ' ' THR . 1.8 t -126.19 176.32 7.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.14 -0.975 . . . . 0.0 110.807 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -149.71 153.38 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.654 ' HE ' ' NE2' ' A' ' 115' ' ' GLN . 7.4 mtt180 -125.92 136.51 53.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.789 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -138.16 158.54 44.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.72 82.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.564 ' O ' ' N ' ' A' ' 111' ' ' ASP . 22.4 mt -63.58 91.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.38 -81.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -127.89 29.34 5.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -1.191 . . . . 0.0 110.271 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -134.6 144.23 47.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.5 tp -105.36 113.34 26.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.873 -1.142 . . . . 0.0 109.085 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.596 HG23 HG22 ' A' ' 127' ' ' ILE . 11.1 t -99.49 108.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.654 ' NE2' ' HE ' ' A' ' 106' ' ' ARG . 11.1 tt0 -105.52 106.65 17.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.487 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -100.33 145.78 27.73 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 110.114 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -121.99 157.03 32.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.782 0.801 . . . . 0.0 109.191 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 103' ' ' ASN . 11.9 t -127.46 147.82 32.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.544 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.2 t80 -146.53 110.58 5.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.056 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 45.77 20.29 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.134 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.8 28.54 3.39 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.72 176.65 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 66.1 tt0 -155.91 125.28 6.25 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.401 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.415 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -115.6 152.92 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -133.92 136.91 44.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.773 -1.204 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.08 114.05 14.08 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.596 HG22 HG23 ' A' ' 114' ' ' VAL . 4.4 mt -107.67 123.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.989 . . . . 0.0 110.685 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -101.05 176.02 5.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.365 -0.834 . . . . 0.0 108.786 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -165.31 156.63 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.416 -0.803 . . . . 0.0 109.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -47.64 129.17 13.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.453 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.7 t70 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.72 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 85.2 m -102.16 143.26 32.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 109.721 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.571 ' CD1' ' C ' ' A' ' 5' ' ' THR . 11.5 m95 -148.69 168.72 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.14 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 8' ' ' VAL . 9.7 pttm -153.21 130.91 11.56 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 0.0 109.588 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -38.39 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.8 -27.05 21.36 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -154.62 167.84 28.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.143 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -177.94 164.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 14' ' ' TYR . 6.7 pt-20 -166.76 166.45 15.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.81 -1.181 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.12 -5.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.653 -0.654 . . . . 0.0 110.191 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -46.78 -61.23 1.94 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.966 -1.084 . . . . 0.0 110.021 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 6.1 p-10 -44.92 -44.78 9.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.984 -1.073 . . . . 0.0 109.247 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.633 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -62.7 -41.62 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 108.664 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.483 ' CE2' ' HE1' ' A' ' 18' ' ' MET . 23.5 t80 -68.59 -54.82 14.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.384 -0.823 . . . . 0.0 108.949 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 7.2 mmt -57.96 -31.11 66.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' A' ' 28' ' ' ARG . 26.2 tt0 -74.8 -25.33 58.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -70.68 -48.66 53.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 ttm -59.44 -10.22 3.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.058 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.81 32.4 27.0 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' ASN . 13.8 t -77.03 132.41 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -1.077 . . . . 0.0 109.55 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' VAL . 3.2 t-20 -48.32 177.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.322 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.62 -2.82 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 109.41 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG21 ' OD1' ' A' ' 24' ' ' ASN . 21.9 t -82.85 -60.05 2.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -65.45 -25.96 67.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.43 HH21 ' HB2' ' A' ' 19' ' ' GLU . 21.3 ttp180 -73.25 -43.4 61.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.406 -0.809 . . . . 0.0 109.263 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -70.44 -32.72 70.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.1 mt -86.45 -13.7 45.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -85.96 -47.17 9.86 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.75 -22.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' ASN . 22.1 t-160 -69.29 37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' A' ' 32' ' ' ALA . 5.3 p30 -49.92 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.838 . . . . 0.0 109.594 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.4 OUTLIER -147.26 43.22 1.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 108.862 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.583 HD21 ' H ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -92.72 168.54 11.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 111.238 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -108.83 150.22 27.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -139.64 120.0 13.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.991 -1.068 . . . . 0.0 110.329 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -101.79 111.38 23.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 4.4 mp -111.18 144.04 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 111.41 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -133.76 152.39 51.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -128.11 146.17 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -143.17 79.06 1.63 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.978 . . . . 0.0 109.616 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.01 -88.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.8 29.11 6.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.0 110.272 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -151.52 110.07 3.8 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -100.34 174.18 6.24 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.506 0.669 . . . . 0.0 109.919 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -148.86 103.23 3.35 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.8 t -96.06 110.92 25.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.749 -0.594 . . . . 0.0 109.571 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -100.77 100.24 10.88 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.3 mt-10 -73.89 159.35 32.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 109.004 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -161.99 107.15 1.25 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.143 -0.973 . . . . 0.0 109.096 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.716 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -135.0 144.29 47.29 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.64 7.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.987 -1.071 . . . . 0.0 109.156 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.716 ' H ' ' C ' ' A' ' 53' ' ' SER . 82.8 m-85 -113.16 -19.74 11.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.393 -0.817 . . . . 0.0 111.097 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.3 mmt180 162.8 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 109.556 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.68 HD21 ' H ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -63.1 148.69 47.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.278 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.733 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -142.85 174.31 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 121.192 -0.943 . . . . 0.0 110.471 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.733 ' H ' HG21 ' A' ' 58' ' ' ILE . 7.7 pt-20 -146.88 143.72 28.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.3 m -153.25 117.71 4.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.36 151.07 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -138.78 155.13 48.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.947 -1.096 . . . . 0.0 110.433 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.515 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 50.2 tt0 -150.01 168.41 23.95 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.515 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 14.5 mt -99.64 123.94 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.008 -1.058 . . . . 0.0 110.274 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 28.72 40.73 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.616 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 42.4 t -144.05 102.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.091 -1.24 . . . . 0.0 109.201 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -57.78 141.67 48.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.201 -0.937 . . . . 0.0 109.955 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.616 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.4 -171.6 3.98 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -138.67 150.6 46.39 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.65 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.5 t -151.44 136.33 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.642 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -95.09 144.76 25.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 110.225 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 73' ' ' ALA . 98.0 mt -93.27 146.79 23.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.659 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.81 -35.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 19.5 t70 -57.8 4.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.142 -0.974 . . . . 0.0 109.444 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.659 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.31 26.28 64.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.14 161.99 13.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.482 ' HG2' ' HG1' ' A' ' 96' ' ' THR . 30.3 tt0 -132.86 122.27 24.15 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -133.79 163.85 28.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.014 -1.054 . . . . 0.0 110.541 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.15 142.19 28.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.135 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.747 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.89 -117.01 0.63 Allowed Glycine 0 N--CA 1.477 1.382 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.479 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.42 157.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.21 -1.17 . . . . 0.0 110.428 179.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.7 m95 -101.99 143.11 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.592 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.4 t -140.51 156.7 46.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 108.565 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -94.31 128.27 40.7 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.321 -1.487 . . . . 0.0 108.1 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 12.8 pt-20 -133.31 125.03 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.01 -109.66 2.7 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.67 34.37 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -1.176 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -148.3 160.77 42.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.503 -1.373 . . . . 0.0 110.61 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.06 110.37 22.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.592 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.86 164.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 110.522 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.71 95.41 0.17 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.652 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 50.9 mttt -87.49 104.78 16.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.214 -1.168 . . . . 0.0 109.242 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.9 m-30 -118.19 127.27 53.59 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.735 0.778 . . . . 0.0 109.849 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -113.07 120.6 41.87 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.493 ' CD ' ' OH ' ' A' ' 119' ' ' TYR . 43.3 mtp180 -48.05 115.11 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.482 ' HG1' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -80.58 -10.4 59.74 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.485 1.136 . . . . 0.0 109.113 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.98 -26.61 18.3 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.789 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -132.06 4.6 4.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.965 . . . . 0.0 109.415 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 49.99 45.57 41.72 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.547 ' OD1' ' N ' ' A' ' 101' ' ' GLU . 30.8 t-20 -88.23 -122.48 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.25 -1.147 . . . . 0.0 109.008 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.0 pt-20 -175.29 138.55 0.42 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.353 0.597 . . . . 0.0 110.179 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 tt -141.17 119.2 11.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -110.16 112.34 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 108.693 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 116' ' ' THR . 2.1 t -122.65 174.95 6.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.139 0.971 . . . . 0.0 111.643 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.7 t -142.98 149.23 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -126.22 132.46 51.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -135.07 157.76 46.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.412 HG12 HD11 ' A' ' 113' ' ' LEU . 1.0 OUTLIER -128.06 82.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.073 -1.017 . . . . 0.0 108.63 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 111' ' ' ASP . 62.8 mt -63.6 92.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.211 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.91 -77.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.9 m-20 -130.55 29.43 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -1.179 . . . . 0.0 110.404 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -135.34 134.56 39.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.223 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 6.4 tp -100.14 112.96 25.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.497 HG21 HD11 ' A' ' 109' ' ' ILE . 14.9 t -99.59 106.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.336 -0.945 . . . . 0.0 108.807 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.609 ' NE2' ' OH ' ' A' ' 117' ' ' TYR . 10.0 tt0 -111.1 104.61 13.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 108.984 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.524 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.3 144.4 30.84 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 0.0 109.464 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.711 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.02 144.67 51.26 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 109.687 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.668 HG23 ' HG2' ' A' ' 123' ' ' GLU . 13.2 t -110.58 147.31 14.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.525 ' N ' HG12 ' A' ' 122' ' ' VAL . 2.4 t80 -148.22 114.18 5.78 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 52.85 14.92 0.48 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.87 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.3 28.37 3.83 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.78 176.73 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.668 ' HG2' HG23 ' A' ' 118' ' ' VAL . 19.6 mt-10 -155.56 111.79 3.13 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.454 -1.299 . . . . 0.0 110.787 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.01 153.47 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.06 138.27 49.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.994 -1.066 . . . . 0.0 110.68 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -131.7 114.11 14.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.9 mt -107.69 123.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.584 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 7.5 m-30 -99.73 176.17 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.288 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -161.45 146.28 13.45 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -47.8 133.67 13.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.524 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.498 ' OD1' ' OE1' ' A' ' 42' ' ' GLN . 4.0 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.621 ' HG ' ' HE1' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -175.22 -151.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 110.518 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.608 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 23.6 m -106.77 131.09 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.416 -0.802 . . . . 0.0 110.192 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.693 ' CZ3' ' N ' ' A' ' 130' ' ' LYS . 49.9 m95 -145.05 158.04 43.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -147.81 153.59 39.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.704 -1.247 . . . . 0.0 110.668 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.431 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 2.7 t -42.47 106.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.716 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -97.16 -31.07 12.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HB2' HD12 ' A' ' 127' ' ' ILE . 50.8 mtt85 -152.85 172.07 17.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 13.8 t -173.22 177.38 2.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.947 -1.096 . . . . 0.0 109.723 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.99 162.19 40.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.858 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 4.6 m-20 59.58 -109.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.582 -0.699 . . . . 0.0 109.865 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.678 ' CE1' ' NH2' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 72.06 -52.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -0.967 . . . . 0.0 109.703 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 13.2 p-10 -60.94 -44.42 97.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.561 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -63.62 -32.07 73.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -71.77 -64.02 1.01 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.063 0.935 . . . . 0.0 108.619 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -58.27 -24.0 58.02 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.455 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 24.2 tp10 -79.86 -29.1 39.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 109.295 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.684 ' HZ3' ' HB ' ' A' ' 122' ' ' VAL . 3.8 tptm -71.37 -42.66 68.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.077 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.7 mtm -67.41 -6.37 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.343 -0.848 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.49 64.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.86 130.81 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -1.162 . . . . 0.0 109.578 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.657 ' N ' HD21 ' A' ' 24' ' ' ASN . 1.1 m120 -50.09 174.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.945 . . . . 0.0 109.368 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -84.47 -1.4 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 122.159 0.98 . . . . 0.0 109.175 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.09 -59.87 2.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -37.93 71.8 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HB3' ' A' ' 15' ' ' ASP . 2.1 ttt85 -64.41 -50.3 68.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -50.07 -36.41 29.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.001 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.47 -13.11 47.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.085 0.945 . . . . 0.0 109.384 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' ASP . . . -84.39 -37.01 22.04 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.658 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.73 -37.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.346 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.413 ' C ' ' H ' ' A' ' 35' ' ' ASN . 76.0 m80 -98.52 33.97 2.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.109 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ALA . 22.1 t70 -79.25 38.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.461 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 33' ' ' HIS . 25.4 p30 -73.7 43.7 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 34' ' ' ASP . 2.6 pt? -52.99 170.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.13 0.967 . . . . 0.0 111.576 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -110.47 148.2 32.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.512 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 0.6 OUTLIER -137.17 123.98 21.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.92 -1.113 . . . . 0.0 110.54 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.77 109.08 21.07 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 mp -103.33 127.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 0.0 110.801 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -128.45 151.75 49.03 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.498 ' OE1' ' OD1' ' A' ' 3' ' ' ASP . 6.7 pt20 -141.29 140.18 33.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.839 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.43 78.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.43 -88.5 0.03 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.626 -0.989 . . . . 0.0 110.626 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.675 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -116.72 28.99 8.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -1.094 . . . . 0.0 110.348 -178.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -145.65 110.25 5.08 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.414 ' O ' HG22 ' A' ' 61' ' ' VAL . 13.9 m-85 -104.86 168.52 9.01 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -156.0 103.54 2.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.137 -0.977 . . . . 0.0 109.057 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.42 121.87 49.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -112.54 100.36 8.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' ILE . 92.0 mt-10 -77.48 157.44 30.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.104 -0.998 . . . . 0.0 109.318 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -159.46 106.82 1.73 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.229 -0.92 . . . . 0.0 108.984 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.68 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -131.05 144.46 51.47 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.01 7.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.175 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.68 ' H ' ' C ' ' A' ' 53' ' ' SER . 70.9 t80 -114.47 -17.64 11.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 111.173 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 6.4 mtp85 161.71 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.714 -1.241 . . . . 0.0 109.205 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -63.03 144.12 57.17 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.339 -0.85 . . . . 0.0 109.632 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.671 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -136.35 174.23 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.86 0.838 . . . . 0.0 110.08 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.671 ' H ' HG21 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -156.65 156.07 32.85 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.9 109.11 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.82 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.639 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -104.53 153.45 6.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 1.7 m-85 176.42 -179.21 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.833 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.1 tt0 -117.66 168.33 10.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.504 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 19.2 mt -81.33 139.09 35.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.04 23.24 28.01 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.64 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 52.0 t -143.92 103.76 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -1.197 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.766 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.7 143.19 25.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.946 . . . . 0.0 109.811 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.71 -171.62 3.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.567 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 5.2 p30 -137.2 151.43 48.75 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 110.312 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 71.3 m -156.89 137.41 13.09 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.608 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -92.53 143.9 25.88 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 0.0 110.416 -178.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 96.0 mt -93.22 146.97 23.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.397 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.655 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.29 -34.04 0.45 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.907 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.22 12.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 68.74 27.13 74.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.19 162.31 13.05 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.258 -1.142 . . . . 0.0 109.634 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 96' ' ' THR . 30.6 tt0 -132.22 118.7 19.86 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.414 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -133.78 162.49 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.098 . . . . 0.0 110.797 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 9.8 ptm180 -143.23 142.92 31.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.83 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.4 -117.78 0.67 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.64 158.11 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.049 -1.265 . . . . 0.0 110.693 179.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.432 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.77 142.52 32.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -138.78 157.05 46.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -96.56 125.85 41.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.351 -1.468 . . . . 0.0 108.234 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -123.57 111.13 15.89 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.52 -105.19 1.07 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -125.13 33.65 5.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -1.136 . . . . 0.0 110.146 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -140.8 149.18 41.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.797 -1.19 . . . . 0.0 110.229 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -96.05 107.35 19.64 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -78.32 164.22 3.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 110.684 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.15 94.78 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.684 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.1 mtpm? -87.98 104.23 16.44 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.25 -1.147 . . . . 0.0 108.879 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.426 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -116.33 139.11 50.75 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.865 0.841 . . . . 0.0 110.18 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -121.72 121.03 36.38 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 15.7 mtp180 -53.81 115.03 1.78 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -68.01 -12.37 60.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.368 1.08 . . . . 0.0 109.396 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.88 -52.14 9.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.529 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 1.5 t-20 -132.62 14.55 4.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.65 44.05 11.84 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.751 ' O ' ' O ' ' A' ' 101' ' ' GLU . 49.7 m-20 -76.18 19.22 0.25 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -1.095 . . . . 0.0 109.724 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.751 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.2 pt-20 42.77 158.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.062 0.934 . . . . 0.0 111.247 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.494 ' C ' ' CD2' ' A' ' 102' ' ' LEU . 6.1 tt -160.14 123.65 3.56 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.0 m120 -113.45 113.87 25.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.097 -1.002 . . . . 0.0 109.028 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.8 t -126.0 176.56 6.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 111.071 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.4 t -148.85 150.82 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -127.77 135.13 49.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.549 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -141.89 158.6 43.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 mm -119.39 82.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.725 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.7 mp -65.22 91.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 121.633 0.73 . . . . 0.0 109.893 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.34 -76.15 0.0 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 109' ' ' ILE . 10.2 t70 -124.45 29.64 6.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.239 . . . . 0.0 110.838 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -145.55 136.97 25.07 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.031 -1.043 . . . . 0.0 109.33 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.31 110.77 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.5 t -95.93 118.05 41.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 110.08 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.84 103.06 8.79 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.477 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.3 OUTLIER -105.33 147.16 28.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.155 -0.965 . . . . 0.0 110.182 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -126.82 152.85 46.41 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 109.252 178.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 103' ' ' ASN . 5.7 t -121.2 148.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.52 ' N ' HG13 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.94 110.52 5.57 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.878 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 47.16 19.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.146 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.43 28.56 3.47 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.684 ' HB ' ' HZ3' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -123.81 177.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.031 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 58.9 tt0 -155.65 122.29 5.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.391 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.47 141.02 47.61 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.489 ' O ' ' OG ' ' A' ' 11' ' ' SER . 11.2 ttmm -119.83 140.59 50.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.778 -1.201 . . . . 0.0 111.111 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.678 ' NH2' ' CE1' ' A' ' 14' ' ' TYR . 61.3 mtp85 -134.9 113.75 11.85 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 10' ' ' ARG . 3.5 mt -108.8 124.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.709 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.512 ' CZ ' HD12 ' A' ' 38' ' ' LEU . 7.1 m-30 -98.21 177.95 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.938 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.507 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 20.0 tttp -158.29 147.22 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.693 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 16.4 pttp -46.69 129.02 11.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' OD2' ' A' ' 131' ' ' ASP . 7.3 p30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.485 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.473 ' HB3' ' HE1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -168.54 -151.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.366 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.604 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 47.5 m -108.8 126.43 53.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.604 ' CD1' ' C ' ' A' ' 5' ' ' THR . 37.6 m95 -142.12 168.59 19.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.337 -0.852 . . . . 0.0 108.703 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.5 pttp -152.44 143.37 23.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.701 -1.249 . . . . 0.0 110.506 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.51 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -43.25 107.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.451 -0.78 . . . . 0.0 109.953 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.76 -31.15 12.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -149.12 164.71 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.727 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -170.46 169.79 7.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.258 -0.901 . . . . 0.0 109.255 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 14' ' ' TYR . 8.1 pt-20 -166.65 166.68 15.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.934 -1.104 . . . . 0.0 110.434 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 14' ' ' TYR . 2.5 m-20 62.57 -10.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.615 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -43.44 -59.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.019 -1.051 . . . . 0.0 109.863 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.59 -45.76 38.51 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.95 -1.094 . . . . 0.0 109.243 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -59.6 -40.66 88.21 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 20' ' ' LYS . 24.4 t80 -67.39 -62.88 1.21 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -30.77 9.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -73.42 -29.27 62.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.072 -1.018 . . . . 0.0 109.128 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 17' ' ' PHE . 4.2 tptp -67.94 -48.36 66.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.2 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.92 -6.95 4.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.53 26.26 47.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.9 t -72.78 136.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -1.059 . . . . 0.0 109.525 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -53.25 174.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.59 -1.98 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.093 0.949 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.9 -60.09 2.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 6.3 mptt -65.95 -21.15 66.41 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -72.64 -43.56 63.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 109.43 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -70.35 -33.45 71.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.62 -13.12 46.59 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.937 0.875 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.502 ' O ' ' OD2' ' A' ' 34' ' ' ASP . . . -83.83 -52.97 5.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.245 0.545 . . . . 0.0 109.89 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.13 -50.6 4.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 33' ' ' HIS . 12.3 m-70 -73.66 46.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.502 ' OD2' ' O ' ' A' ' 31' ' ' ALA . 46.6 m-20 -71.23 136.56 48.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -147.37 43.06 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.684 ' CD2' HH12 ' A' ' 126' ' ' ARG . 0.8 OUTLIER -84.27 162.87 19.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 110.948 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -107.71 147.0 31.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.538 HD12 ' CE2' ' A' ' 128' ' ' PHE . 3.6 mp -136.6 121.04 18.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 110.019 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 m -92.1 104.58 16.95 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -97.69 117.84 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.22 151.92 38.45 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.444 ' CD ' ' CE2' ' A' ' 47' ' ' PHE . 49.1 tt0 -129.28 146.55 51.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.136 -0.978 . . . . 0.0 109.813 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -145.24 79.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.39 -92.95 0.16 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.04 28.56 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.382 -1.069 . . . . 0.0 109.758 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -145.96 109.6 4.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.444 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 14.1 m-85 -96.7 173.92 7.08 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.765 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -153.47 104.04 2.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 51' ' ' GLU . 2.5 t -101.22 112.79 35.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.57 -0.707 . . . . 0.0 109.373 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HB3' ' HZ2' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -100.47 100.6 11.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.885 . . . . 0.0 109.404 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.582 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.0 mp0 -72.65 155.73 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.183 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m -159.34 106.71 1.75 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.119 -0.988 . . . . 0.0 108.892 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.7 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -130.44 144.28 51.3 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.94 8.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.27 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.7 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -117.03 -19.83 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 111.422 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 6.9 ptt180 167.7 84.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.641 -1.287 . . . . 0.0 109.575 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -63.14 143.98 57.31 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 109.521 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.699 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -135.89 174.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.182 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.699 ' H ' HG21 ' A' ' 58' ' ' ILE . 5.9 pt-20 -154.1 142.4 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.37 131.64 6.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.546 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -75.13 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.245 -0.91 . . . . 0.0 108.546 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -148.02 118.51 7.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.026 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.427 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 26.6 tt0 -130.32 146.82 51.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.5 HD11 ' O ' ' A' ' 64' ' ' LEU . 2.5 pp -95.73 130.5 42.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.784 -1.197 . . . . 0.0 109.597 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.05 8.17 42.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.595 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 46.9 t -144.29 103.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.079 -1.248 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.736 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -57.16 145.1 32.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.206 1.003 . . . . 0.0 110.049 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.69 -170.77 3.53 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.509 ' ND2' ' C ' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -145.0 149.13 34.6 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.738 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.421 ' SG ' ' N ' ' A' ' 71' ' ' ASN . 43.6 t -150.29 170.43 19.02 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 76' ' ' THR . 1.5 p-10 -120.52 145.86 46.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.959 -1.088 . . . . 0.0 110.311 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 73' ' ' ALA . 15.5 mt -93.82 146.9 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.545 -0.722 . . . . 0.0 109.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.687 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.56 -36.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.725 . . . . 0.0 109.833 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 38.2 t0 -57.83 6.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 109.437 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.687 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 73.86 26.16 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.25 162.17 13.13 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.204 -1.174 . . . . 0.0 109.621 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' THR . 29.3 tt0 -132.45 124.25 28.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.497 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.66 166.11 23.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.957 -1.089 . . . . 0.0 110.727 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -148.42 141.35 24.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.422 -0.799 . . . . 0.0 109.912 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.736 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.64 -118.0 0.71 Allowed Glycine 0 N--CA 1.475 1.281 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.579 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 172.61 159.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -1.176 . . . . 0.0 110.499 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.58 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 2.3 m95 -103.1 144.62 31.06 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.39 157.68 44.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -89.6 127.89 35.96 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.166 -1.584 . . . . 0.0 108.255 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.83 122.03 34.98 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.532 ' C ' HD21 ' A' ' 87' ' ' ASN . . . 56.79 -107.7 1.0 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.532 HD21 ' C ' ' A' ' 86' ' ' GLY . 1.5 m120 -125.28 33.3 5.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -1.133 . . . . 0.0 110.065 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 1.3 mptt -141.53 159.44 42.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.879 -1.138 . . . . 0.0 109.924 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.429 ' O ' HG13 ' A' ' 105' ' ' VAL . 16.1 mt -98.27 108.87 21.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -76.8 164.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.012 -1.055 . . . . 0.0 110.305 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.421 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.77 96.27 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.638 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -89.65 105.59 17.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.142 -1.21 . . . . 0.0 108.897 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.409 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.1 m-30 -118.08 125.36 50.15 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.821 0.82 . . . . 0.0 109.999 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -108.89 118.35 36.56 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.494 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 63.9 mtp180 -46.42 114.89 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.19 -10.35 59.64 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.533 1.159 . . . . 0.0 109.125 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.88 -26.15 19.49 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.61 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.16 2.1 3.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 52.76 45.71 60.44 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.494 ' H ' ' HB2' ' A' ' 95' ' ' ARG . 15.7 t-20 -89.39 -122.07 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.367 -1.078 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.401 ' H ' ' CG ' ' A' ' 100' ' ' ASN . 4.8 pt-20 -175.45 138.89 0.42 Allowed 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.948 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 tt -144.02 120.34 10.91 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.555 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -107.48 107.79 18.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.789 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 2.1 t -121.55 175.92 5.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.992 . . . . 0.0 111.559 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 89' ' ' LEU . 33.3 t -148.19 159.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.675 ' NE ' ' NE2' ' A' ' 115' ' ' GLN . 9.8 ttm180 -134.63 136.97 43.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -145.71 159.12 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 109.08 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.4 83.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.683 ' O ' ' N ' ' A' ' 111' ' ' ASP . 44.4 mt -64.23 91.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.26 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.89 -80.52 0.0 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 109' ' ' ILE . 2.2 p30 -119.6 30.11 7.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -1.203 . . . . 0.0 111.052 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 129' ' ' LYS . 2.6 mt-10 -145.07 132.75 20.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.859 -1.151 . . . . 0.0 109.475 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.7 OUTLIER -98.12 113.93 25.97 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.431 HG12 HG12 ' A' ' 127' ' ' ILE . 2.1 t -108.26 113.82 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.617 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.675 ' NE2' ' NE ' ' A' ' 106' ' ' ARG . 11.0 tt0 -110.29 105.29 14.27 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.525 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -99.59 146.35 26.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.116 -0.99 . . . . 0.0 110.006 -178.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.729 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -131.17 145.64 52.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.873 0.844 . . . . 0.0 109.737 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 122' ' ' VAL . 11.7 t -111.86 148.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.514 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.6 t80 -147.23 112.09 5.39 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.032 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 51.5 16.35 0.43 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.875 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.79 28.24 3.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -121.97 176.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 pt-20 -155.57 113.46 3.37 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.008 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.75 156.84 17.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -134.06 136.08 43.73 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.012 -1.055 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.684 HH12 ' CD2' ' A' ' 36' ' ' LEU . 4.2 mmm180 -125.32 116.2 21.55 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 7.0 mt -110.64 124.17 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.538 ' CE2' HD12 ' A' ' 38' ' ' LEU . 8.9 m-30 -98.99 176.38 5.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.146 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 3.8 tppt? -155.66 150.16 26.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.528 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 12.3 tttt -46.94 135.46 9.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.456 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.6 m-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.1 m 161.63 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.617 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.3 m -103.63 140.76 37.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.617 ' CD1' ' C ' ' A' ' 5' ' ' THR . 5.3 m95 -148.04 168.88 21.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 8' ' ' VAL . 6.5 pttp -153.36 132.71 12.8 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.58 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.56 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -0.893 . . . . 0.0 109.628 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 17.7 t0 -94.73 -28.4 15.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -148.39 171.84 15.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.716 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 15.4 t -171.86 178.34 3.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.19 151.21 30.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.796 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.55 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 21.9 t-20 58.66 -108.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.0 109.842 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.593 ' CD2' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER 75.55 -54.13 0.64 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.0 110.017 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.92 -45.99 91.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.034 -1.041 . . . . 0.0 109.099 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.56 -30.72 71.09 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.643 ' CZ ' ' SD ' ' A' ' 21' ' ' MET . 15.1 t80 -72.19 -57.07 4.54 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.193 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.568 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 2.5 mpp? -59.14 -28.61 66.71 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.85 -27.71 55.18 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.149 -0.97 . . . . 0.0 109.254 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -71.54 -42.59 67.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.238 -0.913 . . . . 0.0 109.414 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.662 ' SD ' ' CE2' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -68.76 -5.41 20.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.043 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.11 25.14 56.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 24' ' ' ASN . 60.9 t -67.33 116.93 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.159 . . . . 0.0 109.461 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 23' ' ' VAL . 2.5 m-20 -41.79 155.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -67.48 -2.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 0.0 109.084 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.448 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.7 t -82.59 -60.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.95 -30.72 69.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -50.19 61.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -56.1 -34.17 65.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.57 -13.22 46.43 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.967 0.889 . . . . 0.0 109.759 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -84.64 -37.97 20.41 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.256 0.551 . . . . 0.0 109.603 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -44.66 -14.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.305 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.4 m-70 -70.44 46.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.178 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -54.47 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.463 -0.773 . . . . 0.0 109.878 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.4 OUTLIER -148.22 42.38 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.275 -0.89 . . . . 0.0 109.12 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.58 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -84.31 159.09 20.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 52' ' ' SER . 11.4 ttpt -119.49 145.83 45.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 1.6 pt? -154.5 142.48 20.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.975 -1.078 . . . . 0.0 110.346 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 m -108.17 124.92 51.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 3.5 mp -109.95 124.98 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 110.81 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 151.62 36.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.3 148.77 48.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.994 -1.066 . . . . 0.0 110.071 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -148.46 79.09 1.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.36 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.17 -89.93 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -123.45 28.42 7.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -1.096 . . . . 0.0 109.71 -179.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -144.51 110.54 5.43 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.462 ' O ' HG22 ' A' ' 61' ' ' VAL . 1.3 p90 -111.46 173.68 6.23 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.395 0.617 . . . . 0.0 109.686 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.7 m -150.81 103.09 3.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.486 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 17.7 t -90.93 108.49 19.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.623 -0.673 . . . . 0.0 109.563 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -99.42 100.2 11.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.486 ' OE2' ' O ' ' A' ' 49' ' ' VAL . 3.6 mp0 -78.01 159.73 28.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 37' ' ' LYS . 1.7 m -159.96 106.65 1.62 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.669 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.661 ' C ' ' H ' ' A' ' 55' ' ' PHE . 1.8 p -127.25 144.31 51.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.88 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 109.588 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.661 ' H ' ' C ' ' A' ' 53' ' ' SER . 9.4 t80 -123.43 -11.74 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 111.641 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.1 mmt180 164.72 84.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.459 -1.401 . . . . 0.0 109.883 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -63.9 147.46 51.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.463 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.708 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -138.19 174.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 110.072 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.708 ' H ' HG21 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.6 135.41 11.74 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.55 109.15 4.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -105.22 153.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.9 OUTLIER 175.95 -179.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.142 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.53 137.23 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.93 142.04 57.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.16 -34.33 5.48 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.493 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 6.2 p -102.63 125.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.244 . . . . 0.0 109.974 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.62 142.99 51.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.91 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.493 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.72 -171.62 3.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.518 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.544 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 2.0 p-10 -135.94 150.74 49.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.088 -1.007 . . . . 0.0 110.345 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 60.5 m -155.79 135.88 12.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 76' ' ' THR . 2.2 p30 -95.21 144.56 25.71 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.916 -1.115 . . . . 0.0 110.607 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 75' ' ' GLY . 16.6 mt -90.87 146.9 23.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.59 -0.694 . . . . 0.0 109.222 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.656 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.76 -35.17 1.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.755 . . . . 0.0 109.723 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.0 4.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.81 26.43 62.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.0 162.19 13.14 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.303 -1.116 . . . . 0.0 109.517 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.501 ' HG2' ' HG1' ' A' ' 96' ' ' THR . 31.3 tt0 -132.82 121.13 22.5 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.454 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -135.02 162.9 31.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.88 -1.137 . . . . 0.0 110.51 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.59 143.2 31.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 109.894 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.35 -116.62 0.62 Allowed Glycine 0 N--CA 1.477 1.368 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 171.37 158.42 0.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 0.0 110.813 179.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.438 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.6 141.48 34.4 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -139.53 157.17 46.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.935 . . . . 0.0 108.527 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -94.53 126.48 39.84 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.35 -1.469 . . . . 0.0 108.187 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -129.37 120.62 25.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 -108.26 2.05 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -125.37 34.28 4.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -1.156 . . . . 0.0 110.549 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 161.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.6 -1.313 . . . . 0.0 110.412 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 mt -100.98 108.01 19.63 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -75.52 164.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.436 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.89 94.63 0.16 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.697 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 5.6 mtmm -88.5 102.97 15.44 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.115 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 3.7 m-30 -116.15 129.89 56.54 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.802 0.811 . . . . 0.0 109.792 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -113.06 118.2 34.13 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 99' ' ' GLY . 42.7 mtp180 -51.07 114.99 1.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.501 ' HG1' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -83.75 -11.68 56.79 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.485 1.136 . . . . 0.0 109.086 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.22 -23.44 21.26 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -132.1 -0.87 3.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.226 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 54.58 43.48 78.47 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.597 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 16.6 t-20 -92.26 -122.85 0.08 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -1.162 . . . . 0.0 109.244 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 4.3 pt-20 -174.91 138.39 0.46 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -136.0 111.29 9.06 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.401 ' O ' HG21 ' A' ' 118' ' ' VAL . 0.7 OUTLIER -104.69 108.19 19.52 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 116' ' ' THR . 2.7 t -122.28 176.14 6.02 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.148 0.975 . . . . 0.0 112.099 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.41 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.7 t -145.81 147.4 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -123.64 132.88 53.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 110.198 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -131.55 158.6 40.51 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -124.49 82.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.13 -0.981 . . . . 0.0 108.43 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 111' ' ' ASP . 27.7 mt -64.33 91.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.929 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.78 -81.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -125.17 29.56 6.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -1.2 . . . . 0.0 110.187 -179.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.68 138.33 40.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.172 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.0 tp -103.3 111.79 24.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.039 -1.038 . . . . 0.0 109.535 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.457 HG23 HG23 ' A' ' 127' ' ' ILE . 3.3 t -95.8 109.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.052 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -112.06 103.96 12.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.308 -0.87 . . . . 0.0 108.661 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.25 143.16 32.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.551 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.697 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -125.57 147.14 49.38 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.786 0.803 . . . . 0.0 109.35 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 122' ' ' VAL . 12.6 t -114.58 149.88 16.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.662 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 1.6 t80 -143.67 110.96 5.8 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.847 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 48.67 18.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.245 0.545 . . . . 0.0 110.944 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.49 28.43 3.51 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -122.71 176.11 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 9.9 pt-20 -156.47 123.87 5.4 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.539 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.405 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -119.84 152.74 36.83 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.458 ' O ' ' OG ' ' A' ' 11' ' ' SER . 16.9 ttpt -131.62 140.08 49.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.769 -1.207 . . . . 0.0 111.279 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -133.12 114.16 13.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.457 HG23 HG23 ' A' ' 114' ' ' VAL . 2.6 mt -105.31 124.25 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.084 -1.01 . . . . 0.0 110.987 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.531 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -95.53 175.91 6.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.512 -0.742 . . . . 0.0 109.555 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -164.52 148.83 9.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.519 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 20.7 mtmm -47.72 134.34 12.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.49 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.618 ' HG ' ' HE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -174.27 -152.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.146 -0.971 . . . . 0.0 110.398 -179.376 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.595 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 29.0 m -107.2 129.32 54.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.814 . . . . 0.0 110.199 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.684 ' CE3' ' N ' ' A' ' 130' ' ' LYS . 43.4 m95 -142.44 167.84 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 10.3 pttp -152.72 138.73 18.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.84 -1.162 . . . . 0.0 110.741 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' CG1' ' N ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -38.64 107.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.52 -0.738 . . . . 0.0 109.965 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -97.06 -32.42 11.99 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.5 ' O ' ' OG ' ' A' ' 11' ' ' SER . 14.5 mtt-85 -150.45 178.27 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.646 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 73.8 m -171.41 177.99 3.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.272 -0.893 . . . . 0.0 109.412 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -150.12 149.23 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.033 . . . . 0.0 109.888 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 15' ' ' ASP . 48.2 t-20 63.52 -104.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.61 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.44 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER 69.14 -44.04 0.53 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 13' ' ' ASN . 54.5 m-20 -63.68 -47.76 79.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 108.751 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB2' HD22 ' A' ' 13' ' ' ASN . 24.7 mmtp -61.07 -37.26 82.05 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.473 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 68.4 t80 -69.3 -63.76 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -54.53 -24.94 22.89 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.042 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -79.36 -26.81 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -43.89 62.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 109.032 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.473 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -67.85 -6.13 20.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 108.961 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.1 31.93 53.97 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -77.66 158.42 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 109.514 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.723 ' ND2' ' H ' ' A' ' 25' ' ' ILE . 1.1 t30 -75.0 175.64 7.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.723 ' H ' ' ND2' ' A' ' 24' ' ' ASN . 1.5 mm -84.68 -1.33 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG22 ' ND2' ' A' ' 24' ' ' ASN . 42.5 t -78.48 -59.88 2.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 121.451 0.643 . . . . 0.0 109.268 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.1 mttp -63.58 -27.3 69.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 108.669 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.2 -42.15 72.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.37 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -66.74 -34.59 78.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.1 mt -86.25 -13.09 47.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.582 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.74 -47.39 19.16 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.808 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.54 -64.96 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.94 . . . . 0.0 109.645 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.24 46.12 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.878 . . . . 0.0 109.357 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 15.0 t70 -89.47 160.53 16.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 109.769 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 4.4 m-20 -143.19 42.96 1.54 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.356 -0.84 . . . . 0.0 108.991 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.642 ' N ' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -54.89 148.09 13.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.613 ' HZ3' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -119.07 139.73 51.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -146.63 153.04 39.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.909 -1.119 . . . . 0.0 110.268 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -115.03 109.53 18.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.51 119.28 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 110.169 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.34 151.67 36.52 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -135.47 139.97 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 45' ' ' ASN . 7.2 mt-10 -139.01 78.82 1.69 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.06 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 43' ' ' GLU . 6.0 p-10 -118.79 28.94 8.0 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.301 -1.117 . . . . 0.0 110.507 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -154.47 111.05 3.29 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.4 p90 -107.93 173.48 6.3 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.752 -0.592 . . . . 0.0 109.491 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -155.87 103.43 2.24 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.006 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.88 109.15 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.506 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -99.76 99.65 10.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.634 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . 26.5 mt-10 -72.89 156.81 38.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.033 -1.042 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.6 m -161.78 107.23 1.29 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.198 -0.939 . . . . 0.0 109.029 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.731 ' C ' ' H ' ' A' ' 55' ' ' PHE . 6.4 p -139.96 144.43 37.05 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.18 7.6 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.731 ' H ' ' C ' ' A' ' 53' ' ' SER . 38.1 m-85 -107.96 -23.57 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 111.049 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.2 mtp-105 160.49 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.667 HD21 ' H ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -62.78 145.24 55.36 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.712 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.688 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.18 174.56 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.406 -0.809 . . . . 0.0 109.825 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.688 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.2 pt-20 -154.19 143.1 21.06 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.8 108.71 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.656 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -107.32 151.57 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.238 -0.914 . . . . 0.0 109.799 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 1.8 m-85 176.32 -179.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.808 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 27.8 tt0 -107.39 167.71 9.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.574 -0.704 . . . . 0.0 109.175 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.542 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.5 mt -80.14 130.23 35.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.36 -30.18 10.31 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.628 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 57.6 t -84.09 110.88 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.248 . . . . 0.0 110.033 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -57.57 143.67 40.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -150.63 -171.6 3.97 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.566 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -138.18 149.63 46.02 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.131 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 57.2 m -156.15 137.78 14.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -93.61 144.05 25.74 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.358 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 74' ' ' ASP . 48.2 mt -93.98 146.97 23.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.565 -0.709 . . . . 0.0 109.421 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.623 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.63 -28.47 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.582 -0.699 . . . . 0.0 109.745 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.9 17.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.75 26.34 66.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.474 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.02 161.92 13.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.287 -1.125 . . . . 0.0 109.565 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -132.85 119.98 20.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.485 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.17 161.95 33.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.882 -1.136 . . . . 0.0 110.684 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 19.9 ptt180 -143.16 141.91 31.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 110.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.95 -116.01 0.59 Allowed Glycine 0 N--CA 1.476 1.352 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.538 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 170.76 157.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -1.187 . . . . 0.0 110.603 179.308 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.615 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.1 m95 -102.25 144.07 31.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.636 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -144.54 155.98 43.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.057 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.71 119.19 26.68 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.312 -1.492 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -109.33 104.58 13.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.68 -101.34 0.51 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -124.77 33.45 5.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -1.174 . . . . 0.0 110.177 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -140.75 157.23 45.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.816 -1.177 . . . . 0.0 109.961 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -100.1 101.85 13.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -72.12 163.62 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 110.396 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -146.96 95.66 0.17 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.643 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 3.8 tttm -90.25 104.92 17.44 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.181 -1.188 . . . . 0.0 108.636 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 2.9 m-30 -117.79 125.06 49.89 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.845 0.831 . . . . 0.0 109.766 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.614 ' NZ ' ' CE ' ' A' ' 92' ' ' LYS . 15.2 mttp -105.63 116.41 31.9 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 39.5 mtp180 -54.45 114.74 1.78 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.37 -13.08 61.38 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.529 1.157 . . . . 0.0 109.433 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.95 -47.08 15.57 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.67 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 99' ' ' GLY . 31.9 m-80 -132.61 7.83 4.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 110.074 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.16 42.18 8.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.672 ' O ' ' O ' ' A' ' 101' ' ' GLU . 14.8 m-80 -78.05 12.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 0.0 109.513 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.3 mt-10 47.79 128.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.548 0.689 . . . . 0.0 111.003 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.23 120.77 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER -108.18 107.83 18.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.062 -179.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.9 t -122.91 176.41 6.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.208 -0.933 . . . . 0.0 111.137 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.401 ' N ' ' OG1' ' A' ' 104' ' ' THR . 89.1 t -148.38 159.63 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.615 ' NH1' ' CH2' ' A' ' 82' ' ' TRP . 50.6 ttm-85 -131.3 136.87 48.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.725 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -139.39 158.55 43.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 109.298 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.2 mm -122.19 82.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.722 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.3 mm -68.38 91.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.374 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 41.43 -80.42 0.0 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.722 ' N ' ' O ' ' A' ' 109' ' ' ILE . 5.3 m-20 -118.18 29.5 7.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.252 . . . . 0.0 110.884 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -146.9 134.5 20.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.127 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.5 115.96 29.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 108.28 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.966 -1.084 . . . . 0.0 110.294 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -117.17 103.26 10.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.521 ' O ' ' OG1' ' A' ' 104' ' ' THR . 1.1 m -102.39 148.49 25.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 110.103 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.716 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.51 151.94 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.482 178.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 103' ' ' ASN . 8.2 t -118.71 148.08 21.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.549 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.42 110.77 5.54 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.96 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 47.86 19.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.025 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.38 28.46 3.53 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.549 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.3 176.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 1.9 mt-10 -155.67 119.57 4.5 Favored 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.123 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.404 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -111.64 148.9 32.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -125.57 138.52 53.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.926 -1.109 . . . . 0.0 110.829 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.44 ' CZ ' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mmt85 -128.17 127.17 42.45 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 mt -118.01 123.71 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.507 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -97.96 176.62 5.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.495 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 24.6 tttt -155.24 142.46 19.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.684 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 3.3 pttp -47.5 132.13 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 109.764 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 129' ' ' LYS . 19.6 m-20 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.472 ' O ' ' OG ' ' A' ' 4' ' ' SER . 1.5 p30 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.475 ' HB2' ' HE1' ' A' ' 6' ' ' TRP . 1.2 m -169.38 -149.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.091 -1.005 . . . . 0.0 110.289 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.62 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 6.4 m -103.1 129.84 50.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.413 -0.804 . . . . 0.0 109.987 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.692 ' CZ3' ' N ' ' A' ' 130' ' ' LYS . 56.3 m95 -148.21 167.61 24.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 108.865 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -152.76 139.53 18.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.699 -1.251 . . . . 0.0 110.62 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.585 ' CG1' ' H ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -45.28 107.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -99.85 -29.79 12.4 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 mmt-85 -141.52 171.16 14.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.64 -0.662 . . . . 0.0 109.535 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 28.3 t -173.25 178.0 2.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.395 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -155.88 156.87 35.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.133 -0.979 . . . . 0.0 109.862 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.8 m-20 58.77 -109.56 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.605 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.504 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 73.77 -52.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.232 -0.918 . . . . 0.0 109.975 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.03 -49.15 78.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 108.919 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.38 -33.79 72.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.611 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 65.3 t80 -71.32 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.457 ' CE ' ' CZ ' ' A' ' 14' ' ' TYR . 21.9 mmt -55.58 -22.37 21.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.91 -33.62 45.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.274 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' NZ ' ' HB ' ' A' ' 122' ' ' VAL . 14.6 mmtp -68.36 -42.05 79.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.611 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -66.82 -7.42 21.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.119 -0.988 . . . . 0.0 108.953 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.53 26.88 62.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 24' ' ' ASN . 41.3 t -66.34 122.27 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -1.075 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.1 m-20 -43.47 168.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -78.87 -1.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 122.141 0.972 . . . . 0.0 109.193 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.18 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -62.27 -31.0 71.52 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 18.4 ttp180 -69.6 -45.89 67.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 109.183 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -57.4 -37.22 72.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.267 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD21 ' HA ' ' A' ' 30' ' ' LEU . 96.0 mt -86.5 -12.9 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.035 0.922 . . . . 0.0 109.677 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -70.86 -47.44 59.3 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.61 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.41 -21.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' ASN . 70.9 t60 -69.07 36.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -51.59 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 33' ' ' HIS . 1.1 m-20 -147.92 42.45 1.04 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.903 . . . . 0.0 109.048 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.585 ' H ' ' CG1' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -89.95 162.39 15.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 110.461 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -108.34 144.91 35.24 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -138.49 123.75 19.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 110.074 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 104.67 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.1 mp -97.59 127.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.928 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.9 151.88 49.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -130.35 143.27 50.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 45' ' ' ASN . 8.6 mt-10 -138.7 79.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.83 -82.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -124.88 28.28 6.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -1.133 . . . . 0.0 110.204 -178.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.84 109.9 4.34 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.608 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -97.51 172.81 7.5 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.753 -0.592 . . . . 0.0 109.728 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.0 m -154.27 104.28 2.59 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.384 -0.823 . . . . 0.0 108.832 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.54 116.5 42.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -109.92 100.54 9.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 109.628 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -77.64 157.53 30.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.066 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.4 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER -157.41 106.62 2.15 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 108.891 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.714 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.38 144.64 50.67 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.39 7.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.058 . . . . 0.0 109.642 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.714 ' H ' ' C ' ' A' ' 53' ' ' SER . 91.0 t80 -108.01 -23.83 11.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.0 111.046 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 161.2 88.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.975 -1.078 . . . . 0.0 109.009 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 16.7 p-10 -62.72 143.82 57.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.397 -0.814 . . . . 0.0 109.766 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.657 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.1 mt -134.24 173.76 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.413 -0.804 . . . . 0.0 110.203 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.657 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.3 pt-20 -157.38 142.95 17.35 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 60' ' ' CYS . 14.2 p -163.61 128.09 2.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.497 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -82.59 160.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.507 -0.746 . . . . 0.0 109.123 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.608 ' CE2' ' CB ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -156.36 133.18 10.35 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.475 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.496 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 18.4 tt0 -105.55 168.47 9.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.489 -0.757 . . . . 0.0 109.005 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.496 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 13.0 mt -88.84 122.5 32.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 0.0 110.081 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 30.13 27.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 81' ' ' THR . 23.5 t -144.18 102.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.275 . . . . 0.0 109.413 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 2.3 m -47.59 145.88 2.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.427 1.108 . . . . 0.0 109.876 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -165.93 -167.23 1.04 Allowed 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.677 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -147.84 157.59 43.61 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.875 -178.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.5 t -150.34 137.59 19.53 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.633 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -98.08 149.49 22.44 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.001 -1.062 . . . . 0.0 110.184 -178.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 75' ' ' GLY . 27.7 mt -96.9 146.83 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.55 -0.719 . . . . 0.0 109.552 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.692 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.65 -34.67 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.628 -0.67 . . . . 0.0 109.719 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.76 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.2 -0.938 . . . . 0.0 109.28 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.692 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 74.3 25.15 71.45 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.1 tt0 -133.4 126.16 30.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -132.97 160.06 38.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.936 -1.103 . . . . 0.0 110.322 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -135.23 149.22 49.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.434 -0.791 . . . . 0.0 110.248 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.723 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.07 -111.12 0.46 Allowed Glycine 0 C--O 1.211 -1.289 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 167.57 154.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.984 -1.304 . . . . 0.0 110.604 178.11 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.486 ' NE1' ' CZ ' ' A' ' 93' ' ' PHE . 74.1 m95 -102.12 133.38 47.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.587 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.9 m -138.2 157.18 46.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.947 -1.096 . . . . 0.0 109.338 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.86 128.55 41.7 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.519 -1.363 . . . . 0.0 108.193 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -129.06 118.73 23.01 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.6 -107.12 1.48 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -125.3 34.34 4.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.48 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -148.3 150.18 33.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.723 -1.236 . . . . 0.0 110.45 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 106' ' ' ARG . 2.0 mt -92.2 115.69 28.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.587 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -87.04 163.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.143 -0.973 . . . . 0.0 110.489 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.413 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.43 94.34 0.16 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.723 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 47.7 mttt -87.14 102.14 14.17 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.182 -1.187 . . . . 0.0 108.473 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.2 m-30 -122.32 137.18 54.94 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.807 0.813 . . . . 0.0 110.346 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' ARG . 9.5 ptpt -127.75 126.07 41.11 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' GLY . 43.4 mtp180 -43.79 115.46 0.81 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.313 -0.867 . . . . 0.0 108.881 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.04 -5.42 17.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.401 1.096 . . . . 0.0 109.37 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -85.86 -48.61 8.6 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.307 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -132.43 9.11 4.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.462 -0.774 . . . . 0.0 109.614 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.59 47.05 30.09 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 58.5 m-20 -72.17 11.17 0.61 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -1.224 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.2 mt-10 48.8 134.42 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.823 0.821 . . . . 0.0 111.349 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 93' ' ' PHE . 9.4 tt -139.24 131.44 28.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER -114.15 112.6 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.025 . . . . 0.0 109.233 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.8 t -125.26 174.59 8.01 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.111 -0.993 . . . . 0.0 111.159 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 106' ' ' ARG . 48.1 t -145.93 163.92 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.475 ' N ' ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -138.18 135.89 36.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.713 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -139.21 158.91 43.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.088 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.15 82.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.649 ' O ' ' N ' ' A' ' 111' ' ' ASP . 20.9 mt -65.72 91.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.146 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.84 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 109' ' ' ILE . 30.6 m-20 -119.17 29.87 7.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -1.211 . . . . 0.0 110.666 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -140.98 134.12 29.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.046 -1.034 . . . . 0.0 109.566 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 1.5 tt -98.3 110.0 22.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 108.344 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 109' ' ' ILE . 2.1 t -97.21 118.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 110.345 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.401 ' HG2' ' CZ ' ' A' ' 117' ' ' TYR . 18.4 tt0 -120.06 104.97 10.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.486 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -104.49 146.16 29.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.124 -0.985 . . . . 0.0 110.264 -178.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.79 ' HH ' ' HD3' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -126.04 150.8 47.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.787 0.803 . . . . 0.0 109.184 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 122' ' ' VAL . 13.8 t -118.87 148.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.528 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.3 t80 -145.6 111.32 5.49 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.924 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 51.76 16.3 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.319 0.581 . . . . 0.0 110.949 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.06 28.04 3.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -121.39 176.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.3 mt-10 -155.99 118.52 4.13 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.175 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -111.15 150.69 29.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.483 ' O ' ' OG ' ' A' ' 11' ' ' SER . 11.9 ttpt -131.52 139.14 49.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.833 -1.167 . . . . 0.0 111.331 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.79 ' HD3' ' HH ' ' A' ' 117' ' ' TYR . 22.9 mtp180 -133.64 115.02 14.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 2.6 mt -104.57 129.95 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.573 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.533 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.3 m-30 -98.69 177.46 5.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.513 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 16.8 tptm -152.94 143.91 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.692 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -47.26 133.68 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.185 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.463 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 4' ' ' SER . 35.5 t0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.282 0.563 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 168.24 -159.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.38 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.551 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 88.9 m -94.42 145.39 24.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 5' ' ' THR . 20.6 m95 -151.79 167.54 27.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.9 ptmt -154.24 133.57 12.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.484 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -42.09 106.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -98.48 -27.82 13.88 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -142.71 169.62 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.912 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 26.1 t -172.39 178.14 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.838 . . . . 0.0 109.43 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -153.86 154.68 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.4 m-20 56.34 -109.71 0.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.475 -0.766 . . . . 0.0 109.61 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER 75.87 -54.21 0.62 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.315 -0.865 . . . . 0.0 109.723 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.64 -58.98 5.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.011 -1.055 . . . . 0.0 108.567 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -52.42 -35.55 52.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.358 -0.839 . . . . 0.0 108.913 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.681 ' CZ ' ' SD ' ' A' ' 21' ' ' MET . 30.6 t80 -68.46 -61.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.265 -0.897 . . . . 0.0 108.752 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 9.7 mmt -49.59 -33.94 16.47 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.641 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.15 -37.67 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.071 . . . . 0.0 109.447 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -62.81 -43.19 99.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.626 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.681 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 1.7 mtm -70.22 -3.17 15.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.211 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 32.5 61.99 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 24' ' ' ASN . 25.3 t -74.11 138.02 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 109.385 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 23' ' ' VAL . 31.8 m-20 -45.75 172.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.357 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.62 ' CD1' HH11 ' A' ' 28' ' ' ARG . 1.6 mm -83.77 -2.22 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.276 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -81.32 -60.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 2.4 mptm? -65.88 -20.14 66.12 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.62 HH11 ' CD1' ' A' ' 25' ' ' ILE . 3.2 tmm_? -75.44 -45.17 40.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.492 -0.755 . . . . 0.0 109.128 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.29 -36.34 74.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.571 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 mt -86.55 -13.23 46.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.753 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 27' ' ' LYS . . . -60.98 -52.95 62.85 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.14 -32.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.459 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 33.7 m170 -74.57 42.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' ND2' ' A' ' 35' ' ' ASN . 1.2 p30 -63.21 112.12 2.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 34' ' ' ASP . 3.0 m120 -147.57 42.88 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.31 -0.868 . . . . 0.0 109.242 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.557 ' H ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -82.08 158.91 23.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' SER . 7.0 tttt -113.58 138.18 50.53 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 1.9 pt? -147.45 145.29 29.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.989 -1.069 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 m -110.2 125.23 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 4.2 mp -110.89 133.27 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.486 -179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.88 152.1 51.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -138.08 141.14 40.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 45' ' ' ASN . 35.5 mt-10 -138.59 78.92 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.416 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.27 -82.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.37 29.32 7.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -1.095 . . . . 0.0 110.114 -178.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.53 110.73 4.85 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.47 166.78 10.2 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.3 m -153.72 103.2 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 108.615 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.94 114.37 41.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.579 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -106.65 100.02 9.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.582 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.79 155.64 26.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' LYS . 92.4 p -159.76 107.5 1.71 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.234 1.016 . . . . 0.0 109.077 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 m -118.67 -163.16 0.94 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.41 8.73 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.345 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 21.0 m-85 -125.35 -12.69 6.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 112.108 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER 165.59 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.233 -1.542 . . . . 0.0 110.026 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -62.95 145.48 55.21 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.391 -0.818 . . . . 0.0 109.217 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.683 HG21 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -131.13 174.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.348 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.683 ' H ' HG21 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -151.11 130.17 12.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.7 m -133.22 110.41 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.389 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.594 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.08 142.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.221 -0.924 . . . . 0.0 108.992 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER 176.16 173.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.672 -1.211 . . . . 0.0 110.785 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.89 162.38 13.17 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.487 HD11 ' C ' ' A' ' 64' ' ' LEU . 2.1 pp -82.32 135.22 35.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.918 -1.113 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.79 20.33 13.24 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 65.7 t -143.87 106.25 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.34 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -49.81 144.44 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.113 0.959 . . . . 0.0 110.25 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.612 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -156.74 -171.8 3.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -127.19 152.37 47.45 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.054 -1.028 . . . . 0.0 110.347 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.9 t -153.96 129.1 9.65 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.533 ' N ' ' ND2' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -88.35 149.53 23.7 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.112 -0.993 . . . . 0.0 110.239 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 73' ' ' ALA . 74.6 mt -100.73 146.85 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.325 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.622 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.28 -33.75 1.04 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.797 . . . . 0.0 109.86 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 14.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.622 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 67.56 28.64 73.58 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.451 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -99.41 162.12 13.22 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.506 ' HG2' ' HG1' ' A' ' 96' ' ' THR . 74.2 tt0 -132.36 118.75 19.79 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.59 162.89 30.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 0.0 110.495 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -143.63 141.17 30.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.807 . . . . 0.0 109.831 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.821 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.91 -117.39 0.64 Allowed Glycine 0 N--CA 1.476 1.351 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.2 159.24 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.025 -1.279 . . . . 0.0 110.898 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CZ ' ' A' ' 93' ' ' PHE . 15.3 m95 -101.91 142.58 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.594 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.9 m -140.68 157.6 45.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -92.79 127.17 38.2 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.306 -1.496 . . . . 0.0 108.194 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.93 121.61 36.56 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.57 -105.55 0.37 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 2.1 p-10 -125.13 33.62 5.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.016 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -140.36 159.17 42.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.02 -1.05 . . . . 0.0 110.095 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.44 108.97 21.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -78.63 164.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.101 -1.0 . . . . 0.0 110.64 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.33 95.24 0.17 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.672 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.7 pttp -88.9 104.08 16.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.166 -1.197 . . . . 0.0 109.034 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.6 m-30 -116.92 131.96 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.37 119.38 36.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.494 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 69.1 mtp180 -52.71 115.14 1.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.336 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.506 ' HG1' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -83.38 -11.95 57.03 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.387 1.089 . . . . 0.0 109.219 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.62 -26.94 24.13 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.832 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -132.18 -0.18 3.72 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 57.21 45.09 93.0 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.582 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 20.2 t-20 -91.76 -122.62 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.274 -1.133 . . . . 0.0 109.227 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.7 pt-20 -175.54 137.3 0.36 Allowed 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.138 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 93' ' ' PHE . 55.2 tp -134.25 108.98 8.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -101.32 105.68 16.77 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 2.4 t -121.09 176.13 5.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 112.017 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.408 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.6 t -148.2 154.26 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.484 HH11 HD21 ' A' ' 113' ' ' LEU . 55.0 mtp180 -127.01 131.45 51.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 109.987 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -129.31 159.18 36.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.425 -0.797 . . . . 0.0 109.032 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.8 82.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.598 ' O ' ' N ' ' A' ' 111' ' ' ASP . 15.5 mt -63.53 91.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.798 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.0 -81.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.3 m-20 -125.6 29.31 6.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.481 ' HG2' ' HZ2' ' A' ' 129' ' ' LYS . 2.3 mt-10 -137.37 147.19 45.32 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 108.735 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.484 HD21 HH11 ' A' ' 106' ' ' ARG . 10.5 tp -107.72 110.52 22.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.499 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 127' ' ' ILE . 2.5 t -90.59 115.68 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.439 -0.788 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -114.04 103.26 10.97 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.542 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.05 145.28 29.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -127.33 149.91 49.83 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.471 178.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 103' ' ' ASN . 6.9 t -117.1 150.23 19.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.582 ' CE1' ' OD1' ' A' ' 100' ' ' ASN . 1.1 t80 -142.56 110.06 5.73 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.754 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 45.57 20.44 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 119' ' ' TYR . . . 112.91 28.63 3.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.554 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.58 176.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.41 ' H ' HG23 ' A' ' 122' ' ' VAL . 2.7 tt0 -155.98 125.82 6.45 Favored 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 118.045 -1.462 . . . . 0.0 111.406 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.401 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -122.77 151.19 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.493 ' O ' ' OG ' ' A' ' 11' ' ' SER . 19.5 ttpt -130.03 140.21 50.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.916 -1.115 . . . . 0.0 111.112 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.463 ' CZ ' ' OH ' ' A' ' 117' ' ' TYR . 11.0 ttm180 -137.41 114.11 10.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.445 HG23 HG22 ' A' ' 114' ' ' VAL . 2.2 mp -105.99 131.41 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 0.0 111.132 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.552 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 3.0 m-30 -100.9 176.05 5.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.481 ' HZ2' ' HG2' ' A' ' 112' ' ' GLU . 28.1 tttp -165.16 157.08 15.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.804 . . . . 0.0 109.245 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -47.27 130.16 12.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.397 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 4' ' ' SER . 2.8 p30 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.622 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.1 t 162.47 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.622 ' N ' ' OG ' ' A' ' 4' ' ' SER . 90.6 m -89.96 145.51 25.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.566 ' CD1' ' C ' ' A' ' 5' ' ' THR . 12.2 m95 -151.41 168.26 25.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 109.542 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.4 pttp -153.15 133.53 13.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.965 . . . . 0.0 109.445 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.526 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -38.15 106.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.269 -0.894 . . . . 0.0 109.622 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -93.59 -28.25 16.14 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' OG ' ' A' ' 11' ' ' SER . 25.6 mtm180 -152.73 173.14 15.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.882 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 51.5 m -172.98 178.22 2.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 0.0 109.145 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.578 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 3.1 pt-20 -157.06 154.55 29.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.067 -1.02 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.3 m-20 56.5 -109.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 109.826 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.5 -53.47 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.356 -0.84 . . . . 0.0 109.701 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -48.67 80.77 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.994 -1.066 . . . . 0.0 108.76 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -60.2 -33.26 71.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.652 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 49.1 t80 -72.0 -62.85 1.28 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.567 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 25.9 mmt -56.48 -23.57 40.15 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.345 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.95 -37.59 54.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.057 -1.027 . . . . 0.0 109.243 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -64.66 -39.93 94.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.195 -0.941 . . . . 0.0 109.21 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.6 mtp -65.12 -9.61 24.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.118 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.91 29.93 27.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 24' ' ' ASN . 19.5 t -79.78 126.3 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -1.144 . . . . 0.0 109.441 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 23' ' ' VAL . 9.8 m-80 -42.4 165.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.13 -1.99 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.158 0.98 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -80.26 -59.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -65.06 -22.56 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -73.15 -44.49 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -70.77 -33.05 70.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.49 -13.21 46.7 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.007 0.908 . . . . 0.0 109.752 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -78.63 -45.64 21.08 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.608 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.575 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.06 -22.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 31' ' ' ALA . 31.6 m170 -69.28 37.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.302 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.575 ' H ' ' C ' ' A' ' 32' ' ' ALA . 2.4 m-20 -51.05 95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.557 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' HIS . 12.0 m120 -147.66 42.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.307 -0.871 . . . . 0.0 109.206 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.569 HD21 ' H ' ' A' ' 36' ' ' LEU . 0.9 OUTLIER -97.69 170.74 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -179.084 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -108.65 142.19 39.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.746 -0.596 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.535 HD22 HD12 ' A' ' 36' ' ' LEU . 1.9 mp -139.12 128.26 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -102.81 117.08 33.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.95 122.86 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.622 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.43 151.8 37.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.58 145.08 50.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -139.49 78.95 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.6 -81.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 43' ' ' GLU . 19.8 m120 -122.37 28.85 7.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -1.127 . . . . 0.0 110.253 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -153.57 110.12 3.37 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -94.19 173.91 7.41 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.791 -0.568 . . . . 0.0 109.485 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.5 m -155.81 103.49 2.26 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.152 -0.967 . . . . 0.0 108.99 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.6 t -98.19 113.14 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.66 -0.65 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -99.97 100.45 11.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.2 tt0 -72.81 155.88 39.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.173 -0.954 . . . . 0.0 108.818 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -160.48 107.04 1.52 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.168 -0.958 . . . . 0.0 109.021 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.731 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -137.0 144.25 43.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.64 7.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.024 -1.048 . . . . 0.0 109.069 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.731 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.3 m-85 -112.41 -31.18 6.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.27 -0.894 . . . . 0.0 111.476 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.0 tpp85 177.84 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.655 -1.278 . . . . 0.0 109.378 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.756 HD21 ' H ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -63.18 140.29 58.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.094 179.657 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.715 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -139.17 174.41 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.715 ' H ' HG21 ' A' ' 58' ' ' ILE . 5.2 pt-20 -152.0 141.64 21.79 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -151.46 132.21 14.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.17 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.301 -0.874 . . . . 0.0 108.847 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.34 167.35 21.19 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.115 -0.991 . . . . 0.0 109.947 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 26.5 tt0 -159.95 168.06 26.56 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.527 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 31.2 mt -98.59 122.23 41.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.25 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 24.47 47.37 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.501 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.62 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 89.5 t -144.18 102.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.275 . . . . 0.0 109.416 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.75 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.29 141.29 54.77 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.169 0.985 . . . . 0.0 110.062 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.62 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.06 -171.29 3.79 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.574 ' C ' HD21 ' A' ' 69' ' ' ASN . 0.4 OUTLIER -142.41 151.16 41.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.836 -1.146 . . . . 0.0 110.799 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.445 ' SG ' ' N ' ' A' ' 71' ' ' ASN . 49.5 t -144.83 170.69 15.64 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 76' ' ' THR . 1.5 p-10 -126.12 141.26 52.02 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.864 -1.147 . . . . 0.0 110.396 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.9 mt -93.12 146.85 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.542 -0.724 . . . . 0.0 109.371 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.639 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.09 -28.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.837 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.567 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 47.5 m-20 -67.68 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.28 27.78 68.16 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.523 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.03 162.02 13.24 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.424 -1.045 . . . . 0.0 109.399 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' C ' ' CD1' ' A' ' 78' ' ' LEU . 69.4 tt0 -132.86 116.29 16.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.755 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -119.66 150.93 39.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.011 . . . . 0.0 110.404 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -136.87 140.59 42.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.877 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.92 -117.24 0.63 Allowed Glycine 0 N--CA 1.477 1.378 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.5 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.8 159.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -1.181 . . . . 0.0 110.54 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.0 m95 -101.77 142.84 32.48 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.597 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.0 m -138.35 157.23 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -96.18 127.35 42.1 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.352 -1.468 . . . . 0.0 108.205 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -127.32 114.74 17.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.21 -106.45 1.33 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -125.17 34.31 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -1.131 . . . . 0.0 110.427 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.57 150.67 37.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 110.314 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.55 109.99 21.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.597 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -80.12 164.58 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.119 -0.988 . . . . 0.0 110.538 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.69 95.84 0.17 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.681 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 14.0 ptmt -86.41 107.04 17.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.27 -1.135 . . . . 0.0 108.678 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -117.07 140.35 49.6 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.84 0.828 . . . . 0.0 110.234 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -125.48 113.27 17.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.47 0.652 . . . . 0.0 109.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 99' ' ' GLY . 30.9 mtp180 -51.51 114.82 1.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -13.76 62.41 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.355 1.074 . . . . 0.0 109.628 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.48 -48.35 15.52 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.786 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' GLY . 34.4 m120 -132.54 10.68 4.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.151 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 44.46 39.36 5.7 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.716 ' O ' ' O ' ' A' ' 101' ' ' GLU . 2.4 m120 -75.17 18.95 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.168 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.716 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.0 pt-20 43.7 161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.929 . . . . 0.0 111.239 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.48 ' C ' ' CD2' ' A' ' 102' ' ' LEU . 6.3 tt -161.23 123.83 3.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.6 OUTLIER -112.18 113.92 26.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 109.143 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 116' ' ' THR . 2.1 t -124.69 176.11 6.78 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.186 -0.946 . . . . 0.0 110.948 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.9 t -149.59 154.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -127.05 136.5 52.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.67 158.63 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -121.29 82.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 121.117 -0.989 . . . . 0.0 108.38 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.555 ' O ' ' N ' ' A' ' 111' ' ' ASP . 24.2 mt -63.54 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.765 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.47 -81.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -129.21 29.17 5.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -1.187 . . . . 0.0 110.206 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.36 142.54 48.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 108.75 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.2 tp -103.28 110.34 22.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.932 -1.105 . . . . 0.0 109.266 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.601 HG21 HG22 ' A' ' 127' ' ' ILE . 18.1 t -95.83 110.15 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -108.45 106.86 17.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.503 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -100.92 144.6 29.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.166 -0.959 . . . . 0.0 109.792 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.3 OUTLIER -123.27 152.59 41.21 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.816 0.817 . . . . 0.0 109.161 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 103' ' ' ASN . 11.2 t -121.93 147.76 25.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.546 ' N ' HG13 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -144.5 110.67 5.48 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.973 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 48.59 18.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.26 0.552 . . . . 0.0 111.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.34 28.33 3.58 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -122.71 176.91 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.39 124.58 6.24 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.303 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.419 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -116.14 154.38 30.11 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.578 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 5.5 ttmt -131.99 139.72 48.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 111.175 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -135.58 113.93 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 114' ' ' VAL . 5.4 mt -109.16 123.83 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.084 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.526 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -98.83 176.01 5.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 130' ' ' LYS . 3.0 tttp -163.78 161.65 23.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.468 ' H ' ' HG2' ' A' ' 129' ' ' LYS . 10.7 ptpt -47.61 132.3 14.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.498 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 4' ' ' SER . 11.1 t70 . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 5' ' ' THR . 28.8 t 167.5 -136.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.519 ' N ' ' OG ' ' A' ' 4' ' ' SER . 18.2 m -89.3 131.14 35.54 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.952 0.882 . . . . 0.0 111.946 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.855 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 9.6 m95 -123.41 170.62 10.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.488 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 13.9 pttp -144.57 122.43 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 110.123 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.588 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -42.35 107.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -94.69 -30.33 14.35 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -150.27 165.2 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.727 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 11.8 t -168.47 178.32 4.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.367 -0.833 . . . . 0.0 109.267 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -155.29 156.21 35.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.57 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 16.2 m-20 59.68 -109.04 0.41 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.924 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.544 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 73.07 -52.25 0.71 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.37 -43.61 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.956 -1.09 . . . . 0.0 109.019 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -67.55 -31.56 71.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -73.43 -57.0 4.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.598 ' C ' HH22 ' A' ' 28' ' ' ARG . 16.1 mmt -60.33 -29.16 68.7 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.567 ' N ' HH22 ' A' ' 28' ' ' ARG . 16.5 tp10 -77.12 -27.97 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.241 -0.912 . . . . 0.0 109.633 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -73.57 -37.66 65.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.489 ' HB2' HG21 ' A' ' 23' ' ' VAL . 2.1 mtm -69.16 -8.35 44.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.142 -0.973 . . . . 0.0 108.932 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.26 29.47 37.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 23.7 t -77.18 127.17 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -1.208 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.695 ' H ' ' ND2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -42.61 164.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.643 ' CD1' ' HE ' ' A' ' 28' ' ' ARG . 1.3 mm -80.04 -1.33 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.18 0.99 . . . . 0.0 109.178 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 t -81.36 -59.85 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -63.85 -28.84 70.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.643 ' HE ' ' CD1' ' A' ' 25' ' ' ILE . 9.9 ttm-85 -70.64 -43.85 68.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.369 -0.832 . . . . 0.0 109.249 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.06 -33.02 74.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.414 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 -13.63 44.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.12 -36.13 19.77 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.654 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . -44.6 -15.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.592 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 35' ' ' ASN . 14.1 m80 -80.24 46.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.586 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -44.81 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 33' ' ' HIS . 62.6 t-20 -147.67 42.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.401 -0.812 . . . . 0.0 109.142 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.526 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -97.55 175.75 6.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.81 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.52 152.54 37.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.442 HD23 ' CE2' ' A' ' 128' ' ' PHE . 3.3 mp -139.83 128.94 23.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.569 ' HG1' ' HB3' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -97.86 104.15 16.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.855 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -105.65 126.43 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -132.71 152.07 51.81 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -135.35 142.81 45.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.913 -1.117 . . . . 0.0 110.05 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' ASN . 24.2 mm-40 -140.23 78.92 1.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.73 -86.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -117.58 29.19 8.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -146.1 110.77 5.17 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.41 166.56 10.67 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 61' ' ' VAL . 26.1 m -154.16 103.25 2.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 108.652 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.614 HG22 HG23 ' A' ' 40' ' ' ILE . 87.5 t -104.41 141.36 20.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.569 ' HB3' ' HG1' ' A' ' 39' ' ' THR . 6.3 tttp -135.34 100.15 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.934 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.55 157.21 37.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 108.71 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -156.56 107.06 2.36 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.075 -1.016 . . . . 0.0 109.174 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.74 ' C ' ' H ' ' A' ' 55' ' ' PHE . 2.2 p -137.67 144.64 41.92 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.42 7.51 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.995 -1.065 . . . . 0.0 109.266 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.74 ' H ' ' C ' ' A' ' 53' ' ' SER . 88.4 t80 -104.63 -26.8 12.18 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 110.85 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 160.08 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 109.027 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -62.35 145.31 54.21 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.442 -0.787 . . . . 0.0 109.449 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.69 HG21 ' H ' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -133.76 173.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.214 -0.929 . . . . 0.0 110.186 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.69 ' H ' HG21 ' A' ' 58' ' ' ILE . 8.5 pt-20 -149.8 147.71 28.32 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.46 0.647 . . . . 0.0 109.711 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.13 110.33 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.833 . . . . 0.0 109.242 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.592 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -109.82 143.63 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.217 -0.927 . . . . 0.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 176.29 169.84 0.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.854 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -94.56 151.13 19.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 64' ' ' LEU . 1.3 pp -76.97 133.08 39.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.924 -1.11 . . . . 0.0 109.272 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.0 21.1 11.36 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.591 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 27.9 t -143.35 106.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -1.151 . . . . 0.0 109.31 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.85 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -46.36 145.68 1.65 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.153 0.978 . . . . 0.0 110.17 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -160.45 -171.6 3.22 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.725 ' N ' HD21 ' A' ' 69' ' ' ASN . 0.6 OUTLIER -123.26 153.45 40.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 110.149 -179.663 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 93.2 m -157.79 129.29 6.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -90.68 147.92 22.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.072 -1.017 . . . . 0.0 110.259 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 52.5 mt -99.44 146.89 25.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.651 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.29 -31.68 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.838 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 21.6 t70 -65.71 15.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 109.329 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.651 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 64.94 27.16 71.84 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 162.05 13.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.312 -1.111 . . . . 0.0 109.533 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -132.47 119.71 20.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -135.8 163.85 29.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 0.0 110.448 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -142.05 140.14 32.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.74 . . . . 0.0 109.934 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.85 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.72 -117.78 0.64 Allowed Glycine 0 C--O 1.21 -1.358 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.31 157.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.107 -1.231 . . . . 0.0 110.58 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.577 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.36 142.13 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.585 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.12 157.32 45.45 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -93.21 126.63 38.42 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.306 -1.496 . . . . 0.0 108.407 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' O ' ' CE ' ' A' ' 88' ' ' LYS . 3.7 mm-40 -123.8 113.49 18.62 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.31 -105.25 0.99 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 87' ' ' ASN . 17.5 t-20 -125.17 34.17 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -1.128 . . . . 0.0 110.372 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.426 ' CE ' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -144.79 150.8 37.8 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.739 -1.226 . . . . 0.0 110.316 -179.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mt -94.77 108.77 20.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.585 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -79.4 164.0 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.099 -1.0 . . . . 0.0 110.698 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.28 95.59 0.17 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.63 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.45 108.91 19.92 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.205 -1.174 . . . . 0.0 109.016 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.501 ' HB2' HD23 ' A' ' 102' ' ' LEU . 3.0 m-30 -118.4 135.83 54.12 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.748 0.785 . . . . 0.0 109.986 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -118.01 115.25 24.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.314 0.578 . . . . 0.0 109.506 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 33.7 mtm180 -49.04 115.12 1.17 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -10.69 60.05 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.417 1.103 . . . . 0.0 109.357 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.0 -41.45 12.35 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.698 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.47 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -132.66 7.43 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.28 34.72 1.63 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.69 ' O ' ' O ' ' A' ' 101' ' ' GLU . 19.1 t-20 -74.96 18.66 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.159 -1.201 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.69 ' O ' ' O ' ' A' ' 100' ' ' ASN . 9.3 pt-20 44.5 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.012 0.91 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 93' ' ' PHE . 7.0 tt -158.5 130.63 6.82 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.68 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -117.97 118.61 32.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.96 -1.088 . . . . 0.0 109.173 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.5 t -130.47 176.46 8.13 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.12 -0.988 . . . . 0.0 110.752 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 106' ' ' ARG . 42.4 t -146.76 158.86 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.42 ' N ' ' CG1' ' A' ' 105' ' ' VAL . 10.9 ttp180 -131.65 135.23 46.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.79 158.64 43.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 108.92 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.53 83.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.72 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.7 mm -60.27 92.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.514 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 47.2 -74.86 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.72 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -125.73 30.02 5.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -1.202 . . . . 0.0 110.907 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -146.12 147.52 31.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.738 -1.227 . . . . 0.0 109.679 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.465 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 6.5 tp -102.49 115.24 30.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.049 -1.032 . . . . 0.0 108.855 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.6 t -102.7 108.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.416 ' OE1' ' OH ' ' A' ' 117' ' ' TYR . 13.3 tt0 -109.55 106.1 15.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.8 OUTLIER -103.03 145.95 29.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -124.95 158.76 32.81 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.908 0.861 . . . . 0.0 109.486 178.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 103' ' ' ASN . 10.5 t -127.46 148.46 32.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.551 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.66 110.29 5.3 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.684 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 47.37 19.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.164 0.507 . . . . 0.0 111.104 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.73 28.25 3.51 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.5 176.51 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 15.1 pt-20 -156.38 126.02 6.29 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.648 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.404 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -116.92 150.19 38.9 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.403 ' O ' ' OG ' ' A' ' 11' ' ' SER . 10.4 ttmm -126.23 139.37 53.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.773 -1.204 . . . . 0.0 110.757 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.544 ' NH1' ' OH ' ' A' ' 14' ' ' TYR . 7.0 mtt180 -129.81 114.16 15.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.01 122.72 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.035 . . . . 0.0 110.352 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.588 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 2.6 m-30 -107.1 177.15 4.94 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.775 0.797 . . . . 0.0 110.409 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -152.91 164.88 37.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 131' ' ' ASP . 16.5 pttp -47.19 138.65 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.031 . . . . 0.0 109.459 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 130' ' ' LYS . 4.9 p-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.448 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.46 ' HB3' ' H ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.838 ' CZ ' ' CG ' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 52.8 51.1 16.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.232 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 4' ' ' SER . 16.9 t70 -89.31 89.01 7.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.312 -0.868 . . . . 0.0 109.439 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.684 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 165.2 -164.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 0.0 109.729 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.684 ' N ' ' OG ' ' A' ' 4' ' ' SER . 43.2 m -102.13 146.74 27.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.663 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.838 ' CG ' ' CZ ' ' A' ' 2' ' ' PHE . 4.4 m95 -151.39 169.26 22.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 8' ' ' VAL . 18.1 pttp -152.58 128.41 10.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.097 -1.002 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -37.45 107.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -97.69 -25.93 14.92 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HB2' HD12 ' A' ' 127' ' ' ILE . 1.7 mtp180 -140.55 160.0 40.96 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.097 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.518 ' CB ' ' OD2' ' A' ' 34' ' ' ASP . 31.0 t -179.92 157.27 0.69 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 125' ' ' LYS . 10.6 pt-20 -166.78 166.27 15.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.256 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.37 -6.77 0.59 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.547 -0.72 . . . . 0.0 109.738 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.507 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -47.94 -22.44 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.997 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' CA ' ' HE ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -71.99 -48.16 46.89 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.996 -1.065 . . . . 0.0 108.868 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -59.92 -36.68 77.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.592 ' O ' ' SD ' ' A' ' 21' ' ' MET . 49.6 t80 -68.23 -64.02 0.94 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.817 0.818 . . . . 0.0 108.93 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 23' ' ' VAL . 10.0 mmt -56.52 -23.38 39.28 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.427 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.52 -23.97 34.32 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.057 -1.027 . . . . 0.0 109.118 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.789 ' HZ2' ' HB ' ' A' ' 122' ' ' VAL . 6.7 tptm -74.45 -43.8 54.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -0.912 . . . . 0.0 108.995 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.592 ' SD ' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -58.76 -14.3 8.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.648 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.21 29.64 40.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 24' ' ' ASN . 2.1 t -79.33 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.391 -1.064 . . . . 0.0 109.444 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.3 m-80 -43.47 168.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.374 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -78.8 -2.32 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.38 -59.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -62.38 -24.19 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.47 ' HE ' ' CA ' ' A' ' 15' ' ' ASP . 50.9 ttt180 -73.03 -47.28 46.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.508 -0.745 . . . . 0.0 109.208 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -68.96 -33.12 73.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 mt -86.52 -13.03 47.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.934 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 27' ' ' LYS . . . -77.13 -52.62 8.97 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.165 0.507 . . . . 0.0 109.866 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.19 -28.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.692 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 31' ' ' ALA . 23.8 m170 -74.6 46.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' OD2' ' CB ' ' A' ' 11' ' ' SER . 6.1 p30 -66.38 115.12 5.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -147.74 43.21 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.465 ' H ' ' CG1' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -89.06 165.02 14.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -109.19 149.59 29.15 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -143.67 127.05 16.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.922 -1.111 . . . . 0.0 110.332 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 m -103.14 111.41 23.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.516 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 3.7 mp -109.4 142.42 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 111.515 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -135.26 152.25 51.35 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.605 ' O ' ' NE2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -135.56 142.69 45.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 110.018 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 45' ' ' ASN . 4.9 mm-40 -142.15 78.86 1.64 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.49 -88.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -113.66 29.16 8.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -1.102 . . . . 0.0 109.997 -179.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.9 110.5 5.57 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.401 ' CZ ' ' HG3' ' A' ' 42' ' ' GLN . 6.0 m-85 -104.32 162.3 13.33 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.8 m -153.96 102.99 2.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 p -107.16 129.5 60.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -119.11 100.17 7.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.819 . . . . 0.0 109.388 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.23 160.45 31.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 108.833 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -160.48 106.93 1.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.088 -1.008 . . . . 0.0 109.303 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.684 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -129.31 144.29 51.17 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.77 7.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.985 -1.072 . . . . 0.0 109.387 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.684 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.6 OUTLIER -115.22 -20.09 10.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 111.35 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 165.57 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.55 -1.344 . . . . 0.0 109.423 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -62.35 149.45 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.343 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.697 HG21 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -136.98 174.21 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.697 ' H ' HG21 ' A' ' 58' ' ' ILE . 6.5 pt-20 -154.21 146.29 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.8 m -151.07 110.7 4.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.835 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -108.47 141.27 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.41 172.49 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.777 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 44.8 tt0 -98.37 164.74 12.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.456 HD11 ' C ' ' A' ' 64' ' ' LEU . 2.7 pp -82.04 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.842 -1.162 . . . . 0.0 109.593 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -31.99 6.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.1 p -88.4 117.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -1.23 . . . . 0.0 109.911 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -55.98 145.14 26.17 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.013 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -153.53 -171.6 3.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.46 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.1 OUTLIER -130.55 150.68 51.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.995 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.69 133.65 12.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -88.97 149.24 23.38 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 75' ' ' GLY . 52.5 mt -99.53 146.82 25.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.425 -0.797 . . . . 0.0 109.374 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.89 -32.97 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.714 . . . . 0.0 109.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.67 12.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.84 27.75 72.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -99.33 162.23 13.16 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.193 -1.18 . . . . 0.0 109.471 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.482 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.8 tt0 -132.33 118.59 19.61 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -135.22 162.9 31.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.679 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.44 ' HB3' HH21 ' A' ' 79' ' ' ARG . 6.0 ptm85 -142.26 142.91 32.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.77 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.06 -117.43 0.64 Allowed Glycine 0 N--CA 1.476 1.35 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.4 157.54 0.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.138 -1.213 . . . . 0.0 110.913 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.497 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 6.1 m95 -102.27 141.56 34.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.639 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.2 m -142.23 156.28 45.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.097 -1.002 . . . . 0.0 108.667 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 121.37 27.11 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.115 -1.616 . . . . 0.0 110.038 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.51 107.83 17.15 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.643 ' C ' HD21 ' A' ' 87' ' ' ASN . . . 62.17 -102.22 0.45 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.643 HD21 ' C ' ' A' ' 86' ' ' GLY . 1.7 m120 -124.84 33.52 5.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -1.14 . . . . 0.0 109.838 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -141.43 163.64 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.062 -1.024 . . . . 0.0 109.772 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mt -102.79 104.42 14.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 108.586 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.639 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -73.55 164.42 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.987 . . . . 0.0 110.247 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.6 94.69 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.667 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 35.4 mttm -88.63 105.21 17.51 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 108.835 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -116.22 136.77 52.72 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.886 0.85 . . . . 0.0 110.091 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -116.84 116.32 27.23 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.607 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.6 mtp180 -53.01 114.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.808 . . . . 0.0 108.847 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -70.32 -12.74 61.79 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.501 1.143 . . . . 0.0 109.377 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.67 -50.96 11.38 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -132.57 11.64 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.2 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.56 41.7 12.98 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.744 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.5 m-80 -78.04 19.78 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -1.199 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.744 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.9 pt-20 42.7 158.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.016 0.912 . . . . 0.0 111.212 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.475 ' C ' ' CD2' ' A' ' 102' ' ' LEU . 6.4 tt -157.39 127.12 6.12 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.499 ' O ' HG21 ' A' ' 118' ' ' VAL . 5.6 t30 -116.93 113.84 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.087 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 116' ' ' THR . 1.8 t -125.41 175.98 7.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.179 -0.951 . . . . 0.0 111.174 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 43.8 t -144.86 146.94 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.8 132.5 54.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.149 -0.969 . . . . 0.0 109.909 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.08 157.77 45.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.434 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.2 mt -125.66 82.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 120.917 -1.115 . . . . 0.0 108.627 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 111' ' ' ASP . 63.7 mt -63.02 92.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.223 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.49 -78.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -130.61 29.14 4.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.127 -1.219 . . . . 0.0 110.197 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.85 136.89 40.95 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.244 -0.91 . . . . 0.0 108.883 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' A' ' 2' ' ' PHE . 0.5 OUTLIER -98.03 110.92 23.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.903 -1.123 . . . . 0.0 109.906 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.401 HG21 HD12 ' A' ' 109' ' ' ILE . 47.6 t -92.35 113.39 27.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.309 -0.956 . . . . 0.0 108.577 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.536 ' HB3' ' HH ' ' A' ' 117' ' ' TYR . 6.6 tt0 -115.79 103.67 10.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.681 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.512 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.41 144.11 31.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.555 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -125.34 151.13 46.47 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.847 0.832 . . . . 0.0 109.471 178.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 103' ' ' ASN . 8.4 t -118.2 147.48 21.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.524 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.91 110.7 5.39 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.882 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 48.54 18.67 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.184 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.17 28.3 3.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.789 ' HB ' ' HZ2' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -123.33 177.11 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 43.0 tt0 -155.44 117.04 4.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.242 -1.383 . . . . 0.0 111.368 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' A' ' 17' ' ' PHE . . . -106.77 150.62 26.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.526 ' NZ ' ' OE2' ' A' ' 12' ' ' GLU . 2.6 mtmm -126.99 137.48 53.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.904 -1.123 . . . . 0.0 110.48 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -140.14 114.01 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.1 mp -109.45 130.86 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 0.0 111.108 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -99.95 176.26 5.49 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.424 0.631 . . . . 0.0 109.407 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -164.58 151.29 11.03 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -47.43 132.89 13.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 2.3 p-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.52 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.824 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER 42.8 36.03 0.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.152 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.11 76.95 8.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.937 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 5' ' ' THR . 28.2 t -179.07 -163.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 109.619 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 70.6 m -91.86 147.35 23.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.104 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.824 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 14.9 m95 -151.09 168.73 23.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 7.4 mtpt -150.63 128.53 11.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.388 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.558 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -42.55 106.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.06 -30.24 13.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.475 ' O ' ' OG ' ' A' ' 11' ' ' SER . 4.8 mtt180 -148.97 164.95 33.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.98 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 62.5 m -171.77 178.09 3.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.366 -0.834 . . . . 0.0 108.992 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -156.19 158.69 38.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.12 . . . . 0.0 110.104 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.2 m-20 57.71 -109.57 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.692 -0.63 . . . . 0.0 109.739 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE2' ' NH1' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 71.55 -51.3 0.69 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.84 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -62.8 -40.55 97.71 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.955 -1.091 . . . . 0.0 108.97 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -70.31 -31.0 68.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -74.18 -56.93 4.33 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.561 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 11.7 mmt -60.1 -32.83 71.34 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.42 -37.49 74.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -63.98 -41.05 97.64 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.593 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB2' HG21 ' A' ' 23' ' ' VAL . 2.4 mtm -66.48 -8.33 25.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.199 -0.938 . . . . 0.0 109.086 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.61 32.6 10.03 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.472 HG22 ' SD ' ' A' ' 18' ' ' MET . 26.6 t -94.05 140.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -1.146 . . . . 0.0 109.553 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.35 157.82 4.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.361 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm -82.24 -1.23 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.213 1.006 . . . . 0.0 109.142 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -80.1 -59.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -56.55 -33.9 66.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 108.85 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.621 HH11 ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -65.69 -52.09 54.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.75 -33.84 57.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.413 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.51 -13.23 46.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.023 0.916 . . . . 0.0 109.518 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASP . . . -84.3 -51.03 7.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.7 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.621 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -42.59 -57.53 2.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.502 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -75.69 44.79 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ALA . 63.7 t0 -116.02 101.48 8.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -84.66 43.55 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.406 -0.809 . . . . 0.0 109.357 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.47 HD13 HD22 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -47.09 155.65 0.27 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.748 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -105.74 148.21 27.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.821 -0.549 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 128' ' ' PHE . 2.5 mp -139.28 123.64 18.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 m -101.91 107.94 19.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.02 133.6 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.16 -0.962 . . . . 0.0 110.747 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.48 152.08 48.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -130.05 147.83 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 109.863 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -145.1 79.18 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.82 -87.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -125.8 28.58 6.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -1.093 . . . . 0.0 110.093 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -147.75 110.04 4.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -98.12 174.4 6.55 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.508 0.671 . . . . 0.0 109.799 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -152.27 103.87 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -96.25 114.77 33.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -105.11 100.23 9.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.832 . . . . 0.0 109.345 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 49.6 mp0 -74.64 152.82 39.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.034 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.38 105.95 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.157 0.98 . . . . 0.0 108.546 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.699 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -131.12 144.49 51.44 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.15 7.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.983 -1.073 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.699 ' H ' ' C ' ' A' ' 53' ' ' SER . 72.6 m-85 -109.79 -25.88 10.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -0.978 . . . . 0.0 111.235 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER 165.65 87.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.704 -1.248 . . . . 0.0 109.312 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -62.29 139.81 58.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.42 -0.8 . . . . 0.0 109.643 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.687 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -132.26 174.35 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.874 0.845 . . . . 0.0 110.247 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.687 ' H ' HG21 ' A' ' 58' ' ' ILE . 5.0 pt-20 -151.39 142.98 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.56 127.03 5.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.549 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -78.58 163.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.368 -0.832 . . . . 0.0 109.242 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.588 ' CE2' ' SG ' ' A' ' 70' ' ' CYS . 36.0 m-85 -143.37 117.87 9.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 64' ' ' LEU . 1.1 tm-20 -111.32 164.31 13.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.037 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.623 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 95.7 mt -103.34 118.24 36.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 109.915 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.58 18.37 41.73 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.46 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.622 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.0 t -141.37 105.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.948 -1.325 . . . . 0.0 109.568 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -56.29 143.52 33.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.898 . . . . 0.0 109.871 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -153.84 -170.85 3.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -132.34 151.07 52.01 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.563 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.588 ' SG ' ' CE2' ' A' ' 62' ' ' PHE . 68.1 m -149.42 127.82 12.23 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.66 144.47 25.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 110.343 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 73' ' ' ALA . 70.7 mt -99.35 146.88 25.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.634 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.99 -29.37 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.797 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.561 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 15.7 m-20 -66.62 17.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.164 -0.96 . . . . 0.0 109.241 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.634 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 63.57 26.92 70.18 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 161.88 13.33 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.233 -1.157 . . . . 0.0 109.696 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.497 ' O ' ' OG1' ' A' ' 96' ' ' THR . 40.7 tt0 -132.62 117.53 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.68 157.0 41.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.987 -1.07 . . . . 0.0 110.626 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 21.4 ptt85 -140.51 142.48 35.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.838 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.61 -119.63 0.8 Allowed Glycine 0 N--CA 1.475 1.277 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.504 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.8 159.62 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.153 -1.204 . . . . 0.0 110.403 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.41 143.12 32.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.229 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -137.32 157.06 47.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.75 128.28 44.29 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.315 -1.491 . . . . 0.0 108.273 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.529 ' HG3' HD13 ' A' ' 90' ' ' ILE . 30.6 mt-10 -128.36 117.8 22.07 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.75 -106.88 1.19 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.461 ' C ' HD21 ' A' ' 87' ' ' ASN . 0.3 OUTLIER -125.17 34.42 4.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.162 . . . . 0.0 110.55 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.76 147.33 32.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.693 -1.254 . . . . 0.0 110.242 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt -92.75 113.55 25.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -84.78 165.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 110.766 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.37 95.93 0.17 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.661 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.4 ptpt -87.69 104.97 17.04 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.27 -1.135 . . . . 0.0 108.757 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m-30 -117.65 145.96 44.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.9 0.857 . . . . 0.0 110.314 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -125.92 123.86 39.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 34.3 mtp180 -57.74 115.22 2.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -69.38 -12.42 61.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.423 1.106 . . . . 0.0 109.466 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.32 -46.62 13.37 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.61 ' ND2' ' ND2' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -132.54 8.67 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.137 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 43.35 41.53 5.19 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.61 ' ND2' ' ND2' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -77.01 15.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.679 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.0 mt-10 52.51 150.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.646 0.736 . . . . 0.0 110.651 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tp -152.77 128.06 9.86 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.638 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER -116.27 118.64 33.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 108.779 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 116' ' ' THR . 1.6 t -129.05 176.2 8.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.162 -0.961 . . . . 0.0 110.559 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 45.5 t -145.52 160.69 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -135.09 135.11 40.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -140.36 158.35 44.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 109.105 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.12 82.3 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 111' ' ' ASP . 32.2 mt -63.82 91.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.107 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.05 -80.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -130.85 29.5 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 129' ' ' LYS . 6.9 mt-10 -133.05 141.12 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 0.0 108.969 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 11.4 tp -101.0 114.58 28.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.88 -1.137 . . . . 0.0 108.859 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.9 t -104.9 106.77 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.325 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.485 ' OE1' ' OH ' ' A' ' 117' ' ' TYR . 20.5 tt0 -105.79 108.16 19.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.469 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.7 OUTLIER -97.01 147.37 24.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.128 -0.983 . . . . 0.0 109.885 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 123' ' ' GLU . 2.7 m-85 -121.36 158.36 28.42 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.436 -0.79 . . . . 0.0 109.158 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 103' ' ' ASN . 10.8 t -131.2 147.07 32.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.566 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.1 t80 -147.38 110.25 4.73 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.099 -1.041 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 45.99 20.45 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.124 0.488 . . . . 0.0 111.238 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.81 28.32 3.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.566 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.62 176.52 5.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.7 mt-10 -156.13 126.69 6.74 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.123 -1.431 . . . . 0.0 111.284 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.36 159.07 20.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -134.11 137.41 44.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.874 -1.141 . . . . 0.0 110.877 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.644 ' NH1' ' CE2' ' A' ' 14' ' ' TYR . 6.7 mmt180 -129.77 114.13 15.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.7 mt -113.01 122.72 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.01 -1.056 . . . . 0.0 111.14 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.8 m-30 -104.92 174.11 6.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.736 . . . . 0.0 109.138 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 112' ' ' GLU . 30.4 tttp -161.81 159.78 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.324 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -47.77 131.62 14.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.931 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.3 t0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.479 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.629 ' N ' ' CD1' ' A' ' 108' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.82 ' CD1' ' CE2' ' A' ' 6' ' ' TRP . 23.7 m-85 -72.16 22.68 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.259 -0.901 . . . . 0.0 108.778 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 1' ' ' ALA . 19.1 t0 32.99 57.37 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 40' ' ' ILE . 1.4 t -177.47 -138.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.688 . . . . 0.0 110.018 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 131' ' ' ASP . 28.6 m -89.41 148.39 23.51 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.931 0.872 . . . . 0.0 111.482 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.82 ' CE2' ' CD1' ' A' ' 2' ' ' PHE . 17.1 m95 -144.81 168.66 19.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 2.4 pttp -152.5 125.53 8.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.513 -1.367 . . . . 0.0 110.843 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.603 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -44.04 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.285 -0.884 . . . . 0.0 109.769 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.44 -30.66 16.35 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB2' HD12 ' A' ' 127' ' ' ILE . 6.6 mtp85 -151.3 175.33 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.677 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 12.3 t -171.33 178.11 3.36 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.226 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.75 154.72 35.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 21.7 m-20 57.68 -109.51 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.823 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.562 ' CD2' ' OD1' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.03 -52.71 0.69 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 15' ' ' ASP . 12.0 p-10 -59.71 -45.96 90.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.598 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.14 -34.62 76.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -69.79 -63.75 1.02 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.412 ' HE2' ' SD ' ' A' ' 21' ' ' MET . 2.2 mmt -55.9 -24.73 39.15 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.358 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -82.66 -23.05 34.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.065 -1.022 . . . . 0.0 109.379 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -77.33 -37.07 53.25 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.193 -0.942 . . . . 0.0 109.258 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.412 ' SD ' ' HE2' ' A' ' 18' ' ' MET . 0.6 OUTLIER -67.47 -11.33 57.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.574 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.69 31.13 37.26 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 24' ' ' ASN . 5.8 t -78.78 136.86 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -1.159 . . . . 0.0 109.497 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' VAL . 5.8 m-80 -42.48 164.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.227 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.6 mm -81.79 -1.55 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.21 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.51 -59.92 2.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -64.78 -28.23 69.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.588 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -71.62 -42.5 67.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.388 -0.82 . . . . 0.0 108.977 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -63.68 -35.42 80.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.147 -0.971 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.57 -13.14 46.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.013 0.911 . . . . 0.0 109.632 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.577 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -44.14 -16.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.583 ' N ' ' O ' ' A' ' 31' ' ' ALA . 20.7 t-80 -70.9 41.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.409 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' CD2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -50.4 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.7 OUTLIER -147.8 42.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.516 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -96.52 175.18 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.523 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.462 ' N ' HD11 ' A' ' 36' ' ' LEU . 37.7 mttt -129.74 152.01 49.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.636 -0.665 . . . . 0.0 109.497 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.457 ' N ' HD21 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -142.81 150.38 39.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.702 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.563 ' HG1' ' HB3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -111.57 106.44 15.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.627 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -96.25 124.21 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 109.923 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.25 152.48 48.05 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.442 ' HG2' ' CE2' ' A' ' 47' ' ' PHE . 73.5 mt-30 -126.19 149.22 49.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.954 -1.091 . . . . 0.0 110.602 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' OE1' ' CD ' ' A' ' 46' ' ' LYS . 20.1 mt-10 -144.73 79.0 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.526 -0.733 . . . . 0.0 109.164 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.51 -88.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.619 ' N ' HD21 ' A' ' 45' ' ' ASN . 0.6 OUTLIER -122.8 28.55 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -1.075 . . . . 0.0 109.736 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' CD ' ' OE1' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.01 109.87 4.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.442 ' CE2' ' HG2' ' A' ' 42' ' ' GLN . 3.5 m-30 -93.24 173.26 7.81 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -153.38 103.73 2.7 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 108.813 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 40' ' ' ILE . 96.7 t -99.68 121.62 50.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.634 -0.666 . . . . 0.0 109.446 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.563 ' HB3' ' HG1' ' A' ' 39' ' ' THR . 14.5 tttt -108.63 100.07 9.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.36 155.06 41.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.941 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -158.6 107.05 1.93 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.116 -0.99 . . . . 0.0 109.013 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.752 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -141.83 144.56 33.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.46 7.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.025 -1.047 . . . . 0.0 109.189 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.752 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.0 m-85 -105.42 -25.71 12.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.278 -0.888 . . . . 0.0 110.835 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 8.2 mtp180 159.92 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.913 -1.117 . . . . 0.0 109.166 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -62.5 144.43 56.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 0.0 109.333 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.706 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -136.65 174.02 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 110.34 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.706 ' H ' HG21 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -149.06 129.56 13.93 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 87.7 m -145.75 128.56 16.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.564 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -75.5 164.98 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.269 -0.894 . . . . 0.0 108.957 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.608 ' C ' ' CD2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -144.57 116.49 8.3 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.588 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -116.47 174.55 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.7 119.45 38.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 110.505 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.22 -5.72 83.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.319 -0.943 . . . . 0.0 110.838 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 1.6 t -103.45 105.27 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.834 -1.392 . . . . 0.0 110.13 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -61.25 143.05 56.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.439 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.17 -171.4 3.82 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.539 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.1 OUTLIER -138.87 153.03 48.28 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.403 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 10.2 t -156.96 138.55 14.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.489 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -95.59 143.27 27.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' ALA . 19.3 mt -92.57 146.9 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.45 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.696 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.92 -33.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.742 . . . . 0.0 109.796 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -60.05 8.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.696 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 71.61 26.29 73.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.482 ' OG1' ' OD1' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -100.09 161.87 13.34 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.22 -1.165 . . . . 0.0 109.549 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.426 ' O ' ' OG1' ' A' ' 96' ' ' THR . 83.7 tt0 -132.92 121.06 22.29 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.669 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -137.93 162.99 32.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.895 -1.128 . . . . 0.0 110.821 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -143.59 146.16 33.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.708 . . . . 0.0 109.954 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.67 -118.67 0.71 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.55 157.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -1.231 . . . . 0.0 110.808 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 6.4 m95 -102.1 141.61 34.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.608 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.6 t -139.57 156.8 46.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 108.555 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.51 130.31 35.26 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.294 -1.504 . . . . 0.0 108.032 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.05 122.29 26.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.62 -108.14 1.42 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -125.02 33.93 5.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -1.183 . . . . 0.0 110.313 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 160.89 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.757 -1.215 . . . . 0.0 110.238 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.99 113.26 25.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.608 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -82.17 164.77 2.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 110.534 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.95 96.08 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.653 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 9.6 mtpm? -89.33 106.16 18.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.196 -1.179 . . . . 0.0 109.031 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -116.23 136.78 52.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.772 0.796 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -115.68 117.82 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.468 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.2 mtp180 -57.05 115.06 2.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -75.22 -12.61 60.32 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.497 1.141 . . . . 0.0 109.443 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -90.83 -35.76 14.62 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.872 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 0.7 OUTLIER -132.55 4.06 3.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.337 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.11 29.8 0.66 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.705 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.4 t-20 -76.96 18.66 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -1.177 . . . . 0.0 109.289 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.705 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.4 pt-20 43.93 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.922 0.867 . . . . 0.0 111.101 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 tp -158.19 128.32 6.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -116.51 115.19 25.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 108.8 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.8 t -127.0 176.42 7.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.336 -0.853 . . . . 0.0 110.908 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -147.84 156.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -131.42 134.23 46.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -142.36 158.08 44.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 108.912 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.629 ' CD1' ' N ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -126.57 83.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.301 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.0 mm -64.57 92.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.334 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.53 -80.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -128.53 29.02 5.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -1.172 . . . . 0.0 110.251 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.1 130.94 39.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.65 112.29 24.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 108.478 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.97 107.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.9 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.22 106.26 16.64 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.477 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.4 OUTLIER -102.89 145.88 29.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 110.158 -178.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.663 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.8 OUTLIER -124.38 155.27 39.07 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.881 0.848 . . . . 0.0 109.484 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 103' ' ' ASN . 11.7 t -124.6 147.58 29.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.541 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -146.0 110.6 5.12 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.998 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 47.73 19.34 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.237 0.542 . . . . 0.0 111.129 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.37 28.41 3.55 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.46 176.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.67 125.18 6.34 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 118.221 -1.391 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.401 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -115.66 149.5 38.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.415 ' O ' ' OG ' ' A' ' 11' ' ' SER . 12.1 ttpp -129.05 138.67 52.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.896 -1.128 . . . . 0.0 110.581 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -132.47 115.05 15.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.484 HD12 ' HB2' ' A' ' 10' ' ' ARG . 10.4 mt -104.74 123.68 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.603 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 6.1 m-30 -102.17 176.95 5.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -155.05 168.34 27.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 131' ' ' ASP . 10.9 ptpt -50.58 138.74 17.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 109.629 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' HB2' HG22 ' A' ' 5' ' ' THR . 5.7 t70 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.361 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.845 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER 42.15 33.22 0.37 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.37 -0.831 . . . . 0.0 109.348 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 4' ' ' SER . 12.5 t0 -76.82 95.24 4.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.616 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.3 m 161.9 -164.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.575 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.596 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 49.3 m -95.88 143.63 26.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.845 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 4.9 m95 -150.08 169.01 22.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.234 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HD2' ' HZ3' ' A' ' 37' ' ' LYS . 6.4 ptmm? -152.76 133.98 14.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 109.693 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.53 ' CG1' ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.51 106.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.0 109.508 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 32.3 t0 -98.26 -31.34 12.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -146.22 164.24 32.89 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.503 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 2.8 t -166.02 178.12 6.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.46 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -156.61 155.17 31.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 0.0 109.887 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.6 m-20 58.43 -108.82 0.43 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 109.953 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.565 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER 73.03 -52.19 0.71 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.159 -0.963 . . . . 0.0 110.19 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.578 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 17.3 t70 -59.37 -49.99 75.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.099 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -59.65 -33.23 71.27 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.625 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 65.5 t80 -71.34 -63.67 1.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.484 ' O ' HG23 ' A' ' 23' ' ' VAL . 11.5 mmt -54.19 -25.4 22.58 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.482 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -77.41 -35.19 54.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.03 -1.044 . . . . 0.0 109.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.282 -0.887 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.625 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.3 mtp -68.5 -6.29 24.32 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.115 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.37 32.54 62.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 18' ' ' MET . 4.0 t -74.76 129.68 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -1.207 . . . . 0.0 109.394 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.755 HD21 ' H ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -42.45 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 109.361 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.755 ' H ' HD21 ' A' ' 24' ' ' ASN . 1.5 mm -80.45 -1.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 0.0 109.166 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -82.39 -60.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HB3' ' HZ3' ' A' ' 27' ' ' LYS . 4.2 mtpm? -56.82 -38.33 72.45 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.578 ' NE ' ' OD1' ' A' ' 15' ' ' ASP . 19.9 tpt180 -61.31 -52.7 63.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.74 -38.39 33.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.331 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.64 -13.08 46.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -78.52 -48.96 14.22 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.164 0.506 . . . . 0.0 109.661 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.17 -21.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -0.822 . . . . 0.0 109.478 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.9 t-80 -73.8 35.03 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -44.09 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.476 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 6.7 t-20 -147.83 42.69 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.557 HD21 ' H ' ' A' ' 36' ' ' LEU . 0.9 OUTLIER -95.66 167.89 11.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.994 -1.066 . . . . 0.0 110.566 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.506 ' HZ3' ' HD2' ' A' ' 7' ' ' LYS . 4.4 mttm -108.14 142.55 38.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.532 HD22 HD12 ' A' ' 36' ' ' LEU . 1.9 mp -137.19 128.98 28.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.657 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m -102.69 119.16 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 4.3 mp -107.9 119.73 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.659 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.14 151.74 37.0 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.83 145.45 50.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -140.77 79.09 1.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 -83.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' GLU . 21.8 m-20 -124.9 28.67 6.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -1.134 . . . . 0.0 110.148 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' NZ ' ' OG1' ' A' ' 48' ' ' THR . 1.9 tmtm? -150.79 109.84 3.91 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.34 173.6 7.45 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.361 0.6 . . . . 0.0 109.735 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.625 ' OG1' ' NZ ' ' A' ' 46' ' ' LYS . 43.6 m -153.52 103.87 2.69 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.35 -0.843 . . . . 0.0 108.744 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.6 t -99.42 115.77 41.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -101.4 100.44 10.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.08 158.25 35.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 108.865 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -160.13 107.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.735 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -139.42 144.64 38.18 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.13 7.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.079 -1.013 . . . . 0.0 109.376 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.735 ' H ' ' C ' ' A' ' 53' ' ' SER . 28.2 t80 -107.45 -25.4 11.43 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.164 -0.96 . . . . 0.0 111.065 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 159.97 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.902 -1.124 . . . . 0.0 109.084 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -62.12 148.79 43.24 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.716 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.11 174.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.716 ' H ' HG21 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -149.54 127.3 11.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.7 131.92 20.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.418 HG13 ' NZ ' ' A' ' 46' ' ' LYS . 1.7 t -85.05 153.98 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.353 -0.842 . . . . 0.0 108.81 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CE1' ' SG ' ' A' ' 70' ' ' CYS . 41.1 m-85 -135.3 117.13 15.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 3.2 mp0 -104.12 172.49 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 108.902 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.411 HD21 ' HA ' ' A' ' 64' ' ' LEU . 80.2 mt -103.74 111.77 24.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 0.0 110.317 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.2 -31.7 7.71 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 16.6 t -82.82 110.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.263 . . . . 0.0 109.877 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -60.17 143.24 52.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.085 -1.009 . . . . 0.0 109.437 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.05 -171.35 3.91 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -138.16 150.42 46.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.978 -1.076 . . . . 0.0 110.444 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' CE1' ' A' ' 62' ' ' PHE . 89.1 m -151.91 134.76 15.61 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.717 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -96.24 146.1 24.99 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.265 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 73' ' ' ALA . 17.2 mt -94.69 146.93 23.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.547 -0.721 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.667 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.31 -34.63 1.26 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.683 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -57.74 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.667 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 77.66 25.68 62.39 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.673 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.06 161.49 13.58 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.245 -1.15 . . . . 0.0 109.597 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -133.62 123.07 24.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.611 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.7 162.52 32.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.851 -1.156 . . . . 0.0 110.72 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.77 144.34 31.13 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.485 -0.759 . . . . 0.0 110.046 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.46 -117.66 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 N-CA-C 107.901 -2.079 . . . . 0.0 107.901 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.502 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.69 158.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -1.184 . . . . 0.0 110.572 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.473 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.9 m95 -102.13 143.7 31.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.6 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -140.41 157.22 45.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.06 129.33 36.38 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.149 -1.594 . . . . 0.0 108.136 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.94 119.29 22.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.09 -107.35 1.29 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -125.14 34.33 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -1.158 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 157.11 43.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.804 -1.185 . . . . 0.0 110.229 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.43 110.78 22.78 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -78.45 164.87 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.12 -0.988 . . . . 0.0 110.429 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.402 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.0 96.05 0.17 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.657 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.5 mttp -88.14 105.19 17.34 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.201 -1.176 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.422 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 5.5 m-30 -118.22 140.01 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.221 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -121.87 120.9 35.88 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.673 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 0.4 OUTLIER -53.27 114.86 1.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -12.2 61.44 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.482 1.134 . . . . 0.0 109.406 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.17 -48.82 12.55 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.622 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -132.53 11.38 4.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 110.166 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.0 44.25 13.63 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.745 ' O ' ' O ' ' A' ' 101' ' ' GLU . 42.4 m-20 -80.08 20.04 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -1.065 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.745 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.3 pt-20 42.97 158.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.005 0.907 . . . . 0.0 111.184 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.487 ' C ' ' CD2' ' A' ' 102' ' ' LEU . 6.6 tt -160.49 124.97 3.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.4 t-20 -113.41 112.72 24.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.036 -1.04 . . . . 0.0 109.118 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.7 t -125.3 176.51 6.72 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 111.13 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 46.2 t -148.71 156.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -124.34 133.88 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -134.78 157.98 45.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.436 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.4 mm -122.03 82.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 121.074 -1.016 . . . . 0.0 108.304 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 111' ' ' ASP . 15.9 mt -63.44 92.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.65 -80.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.5 m-20 -128.08 29.48 5.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -1.194 . . . . 0.0 110.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.02 145.24 45.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 108.943 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.451 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 12.4 tp -103.63 114.39 28.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.969 -1.082 . . . . 0.0 109.254 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.48 HG21 HG23 ' A' ' 127' ' ' ILE . 39.5 t -99.59 109.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 47.1 tt0 -107.1 104.1 13.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.508 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -100.96 145.59 28.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.215 -0.928 . . . . 0.0 109.998 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.703 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -128.51 152.28 48.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 103' ' ' ASN . 9.0 t -119.39 148.12 22.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG13 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.34 110.59 5.74 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.922 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 48.25 18.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.962 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.45 28.36 3.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -122.67 177.13 4.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 10.6 tt0 -154.86 122.59 5.76 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.175 -1.41 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -116.77 156.54 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -136.33 139.04 42.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.209 . . . . 0.0 111.331 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.565 ' NH2' ' OH ' ' A' ' 14' ' ' TYR . 1.5 ttm-85 -130.76 113.96 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.48 HG23 HG21 ' A' ' 114' ' ' VAL . 6.6 mt -109.18 123.47 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.932 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.485 ' CE2' HD23 ' A' ' 38' ' ' LEU . 7.7 m-30 -101.22 173.94 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.227 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -162.28 161.07 27.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.566 -0.709 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 131' ' ' ASP . 9.9 mmmt -47.71 132.36 14.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.162 -0.961 . . . . 0.0 109.643 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 130' ' ' LYS . 51.7 p30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.58 ' C ' ' H ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.836 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -75.11 26.69 0.09 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.214 -0.929 . . . . 0.0 109.137 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 1' ' ' ALA . 34.7 t70 -70.49 81.64 0.57 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.63 -0.669 . . . . 0.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 171.4 -158.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.572 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.6 m -94.81 143.54 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.836 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 19.8 m95 -151.3 168.25 25.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.225 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.6 pttm -153.5 130.72 11.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.059 -1.025 . . . . 0.0 109.704 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -40.3 106.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 38.9 t0 -92.97 -30.0 15.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -147.66 164.98 31.83 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.866 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.66 178.15 5.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.358 -0.839 . . . . 0.0 109.267 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.584 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 4.2 pt-20 -152.68 151.12 30.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.02 -1.05 . . . . 0.0 110.013 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.546 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 18.7 t30 58.46 -108.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.718 -0.614 . . . . 0.0 109.903 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.546 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 76.16 -53.64 0.61 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -0.87 . . . . 0.0 109.838 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 87.6 m-20 -58.41 -52.37 65.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.022 -1.049 . . . . 0.0 108.938 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' HZ3' ' HB3' ' A' ' 16' ' ' LYS . 12.0 mtpp -57.81 -33.24 68.39 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.579 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.515 ' CZ ' ' SD ' ' A' ' 21' ' ' MET . 56.8 t80 -71.64 -61.65 1.7 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.552 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 21.7 mmt -56.24 -25.69 48.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.415 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 3.4 mm-40 -80.64 -28.48 36.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.048 -1.032 . . . . 0.0 109.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.89 -35.84 67.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.317 -0.865 . . . . 0.0 109.454 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 2.2 mtm -72.64 -6.58 45.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.166 -0.959 . . . . 0.0 108.844 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 32.42 55.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.473 HG21 ' HB2' ' A' ' 21' ' ' MET . 36.2 t -72.91 135.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -1.169 . . . . 0.0 109.383 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 23' ' ' VAL . 29.0 m120 -42.74 158.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.79 -3.06 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.221 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -84.66 -60.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.52 -29.33 69.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 6.0 ttp180 -68.48 -50.88 49.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.541 -0.725 . . . . 0.0 109.09 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -35.78 63.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.189 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.1 mt -86.46 -13.04 47.3 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.964 0.887 . . . . 0.0 109.773 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -75.8 -47.85 24.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.47 -20.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASN . 13.7 m80 -70.97 46.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -52.05 79.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.853 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' HIS . 7.1 p30 -148.36 42.86 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 109.203 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.549 ' H ' HG12 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -93.94 168.33 11.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -106.53 145.03 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.482 HD11 ' N ' ' A' ' 38' ' ' LEU . 2.1 mp -138.95 125.2 20.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 109.78 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.4 m -102.6 113.02 26.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 3.7 mp -103.08 123.64 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.715 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.37 151.96 36.74 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.492 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 12.7 pt20 -131.72 139.4 48.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.158 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 42' ' ' GLN . 19.0 mm-40 -136.14 78.95 1.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.209 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.81 -89.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.9 OUTLIER -117.51 28.77 8.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.406 -1.056 . . . . 0.0 110.12 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.88 109.98 3.92 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CE2' ' CB ' ' A' ' 42' ' ' GLN . 10.6 m-85 -100.57 173.93 6.32 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.422 0.63 . . . . 0.0 109.67 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -152.2 103.03 2.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -95.33 111.2 25.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -102.31 100.65 10.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.624 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -72.97 158.89 34.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 108.906 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.6 m -160.8 107.11 1.46 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.087 -1.008 . . . . 0.0 109.248 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.689 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -134.09 144.41 48.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 7.8 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 109.638 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.689 ' H ' ' C ' ' A' ' 53' ' ' SER . 7.8 m-85 -112.96 -23.72 9.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.156 -0.965 . . . . 0.0 111.295 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 5.3 ptm180 166.59 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.811 -1.181 . . . . 0.0 109.513 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -62.32 147.65 47.54 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.429 -0.795 . . . . 0.0 109.271 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.742 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.12 174.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.742 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.8 pt-20 -150.0 140.58 22.52 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.471 ' HG ' ' C ' ' A' ' 59' ' ' GLU . 38.9 m -151.69 127.02 9.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.65 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.66 150.74 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.28 -0.888 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.612 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -132.41 116.83 17.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.181 -0.949 . . . . 0.0 109.233 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 46.2 tt0 -126.13 169.12 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.0 109.044 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.475 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.7 mt -101.98 129.01 48.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.05 26.59 63.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 56.5 t -144.04 102.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -1.21 . . . . 0.0 109.31 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.73 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -59.12 141.06 55.1 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.104 0.954 . . . . 0.0 110.064 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.05 -171.3 3.8 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 69' ' ' ASN . 26.3 p30 -139.22 149.06 43.92 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.798 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 71' ' ' ASN . 42.8 t -139.11 170.63 15.62 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 76' ' ' THR . 2.9 m-20 -126.21 141.39 51.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.854 -1.154 . . . . 0.0 110.36 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 73' ' ' ALA . 95.5 mt -93.59 146.9 23.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.528 -0.732 . . . . 0.0 109.293 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.43 -28.43 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -0.757 . . . . 0.0 109.696 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 45.5 m-20 -70.2 19.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.285 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.59 29.94 73.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.633 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.14 162.32 13.04 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.368 -1.077 . . . . 0.0 109.43 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.416 ' C ' ' CD1' ' A' ' 78' ' ' LEU . 58.7 tt0 -132.56 114.78 14.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.596 -0.69 . . . . 0.0 109.189 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.767 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -118.18 150.31 39.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.099 -1.001 . . . . 0.0 110.318 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 69' ' ' ASN . 10.1 ptm180 -136.9 142.67 42.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.37 -118.4 0.72 Allowed Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.797 ' CB ' ' HZ3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 173.01 156.47 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -1.111 . . . . 0.0 110.362 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.575 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.54 143.45 32.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.6 -0.687 . . . . 0.0 109.162 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.604 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 11.4 t -141.59 156.8 45.66 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.02 131.63 35.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.324 -1.485 . . . . 0.0 108.125 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.28 124.2 22.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.21 -110.32 3.01 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.409 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.0 m120 -125.26 34.18 5.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -1.174 . . . . 0.0 110.414 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -149.2 162.43 40.02 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.659 -1.276 . . . . 0.0 110.323 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.77 113.29 25.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.604 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.2 pt -81.13 164.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.02 96.85 0.18 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.797 ' HZ3' ' CB ' ' A' ' 81' ' ' THR . 6.5 pttm -90.32 106.78 18.73 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.274 -1.133 . . . . 0.0 108.686 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 102' ' ' LEU . 2.6 m-30 -116.17 148.79 40.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.775 0.798 . . . . 0.0 110.365 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -134.18 116.85 15.86 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.601 0.715 . . . . 0.0 109.943 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 48.6 mtp180 -52.05 115.29 1.63 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.68 -12.66 61.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.499 1.142 . . . . 0.0 109.628 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.71 -37.95 15.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.97 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 35.4 t-20 -132.48 5.76 4.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.297 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.38 34.36 1.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 101' ' ' GLU . 5.3 m120 -75.41 20.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -1.161 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.7 pt-20 45.49 166.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.017 0.913 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 117' ' ' TYR . 19.4 tp -161.85 120.68 2.36 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -112.19 114.03 26.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 109.165 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 2.0 t -129.71 176.36 8.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.096 -1.003 . . . . 0.0 111.154 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.2 t -146.58 158.51 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -132.21 137.26 47.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.139 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -140.45 158.49 43.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.5 HG12 HD11 ' A' ' 113' ' ' LEU . 1.2 mt -124.23 82.77 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.122 -0.986 . . . . 0.0 108.753 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' ASP . 48.6 mt -61.86 92.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.092 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.94 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ILE . 21.7 m-20 -130.06 29.41 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -1.228 . . . . 0.0 110.404 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -134.43 138.14 44.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 108.776 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.2 tp -99.43 113.16 25.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.891 -1.13 . . . . 0.0 109.362 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.5 t -98.57 110.74 26.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.096 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -113.21 106.76 15.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.488 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -103.56 145.47 29.98 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.707 ' HB3' HD12 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -126.18 156.63 39.87 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.928 0.871 . . . . 0.0 109.599 179.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 103' ' ' ASN . 9.5 t -124.14 148.28 28.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.541 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.2 t80 -143.25 110.29 5.64 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.811 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 47.77 19.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.66 28.24 3.53 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.24 176.57 4.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 1.8 tt0 -156.02 124.19 5.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.061 -1.455 . . . . 0.0 111.362 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.68 151.94 36.24 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.584 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -128.57 140.24 51.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.881 -1.137 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.454 ' CZ ' ' HH ' ' A' ' 117' ' ' TYR . 25.7 mtp180 -133.24 113.96 13.25 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.3 mt -109.07 123.37 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.052 -1.03 . . . . 0.0 110.557 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.548 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -101.01 174.4 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.447 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -163.19 154.59 17.23 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -47.28 135.71 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.512 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.467 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.896 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.2 OUTLIER 40.93 32.42 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.292 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 4' ' ' SER . 9.1 m-20 -73.18 97.26 2.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.0 109.722 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.701 ' HG ' ' H ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 158.51 -170.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.377 -0.827 . . . . 0.0 109.3 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.701 ' H ' ' HG ' ' A' ' 4' ' ' SER . 97.5 m -86.13 150.16 24.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.896 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 13.1 m95 -151.36 168.14 25.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.086 -1.009 . . . . 0.0 109.818 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.2 pttp -153.53 125.79 8.0 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.534 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -37.35 106.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.581 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.97 -28.96 12.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -142.29 174.33 10.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.6 t -178.39 178.31 0.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.16 155.65 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.874 -1.141 . . . . 0.0 109.822 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 18.7 m-20 56.86 -110.08 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.588 -0.695 . . . . 0.0 109.848 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.621 ' CE2' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.59 -52.43 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.0 109.855 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.31 -48.99 77.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.885 -1.134 . . . . 0.0 108.655 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.596 ' NZ ' ' CB ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -69.12 -64.08 0.94 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.007 0.908 . . . . 0.0 108.882 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 15.4 mmt -56.41 -21.33 24.39 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 28' ' ' ARG . 33.3 tt0 -78.66 -35.15 45.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.208 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -66.99 -44.35 80.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.144 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.4 mtm -62.85 -9.22 8.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.021 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 32.3 38.13 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' ASN . 15.4 t -76.29 133.35 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -1.081 . . . . 0.0 109.559 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 23' ' ' VAL . 11.6 t-20 -46.81 174.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -85.24 -2.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.119 0.961 . . . . 0.0 109.266 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.8 t -80.84 -59.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.5 mptm? -66.38 -22.73 66.25 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 19' ' ' GLU . 9.2 ttm180 -73.89 -42.38 60.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 109.29 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -72.81 -34.31 66.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.892 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.9 mt -86.39 -13.03 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -72.82 -53.01 12.64 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.573 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.98 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.574 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.694 ' CE1' HD22 ' A' ' 35' ' ' ASN . 0.7 OUTLIER -91.57 46.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.621 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 69.0 m-20 -62.45 121.05 12.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.853 . . . . 0.0 109.684 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.694 HD22 ' CE1' ' A' ' 33' ' ' HIS . 67.6 m-20 -147.94 42.98 1.05 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.349 -0.844 . . . . 0.0 109.016 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.504 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -87.74 162.81 16.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.111 -0.993 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 52' ' ' SER . 3.1 mtpp -114.69 142.49 46.43 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 1.7 pt? -149.98 143.66 25.35 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.084 -1.01 . . . . 0.0 109.986 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -103.91 143.32 33.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.61 129.04 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.147 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.39 152.3 50.75 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -132.04 135.05 46.21 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.8 mm-40 -129.37 78.98 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.84 -79.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.14 29.24 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.99 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -145.16 110.59 5.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.18 159.85 14.82 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.9 m -152.21 103.12 2.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.079 -1.013 . . . . 0.0 108.269 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.88 130.87 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.61 -0.681 . . . . 0.0 109.652 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -119.63 100.55 7.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.398 -0.814 . . . . 0.0 109.572 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -75.51 156.1 35.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.214 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.1 m -158.9 106.91 1.85 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.153 0.977 . . . . 0.0 108.851 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.718 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -133.87 144.5 48.95 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.13 7.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.085 -1.01 . . . . 0.0 109.427 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.718 ' H ' ' C ' ' A' ' 53' ' ' SER . 67.1 m-85 -113.26 -19.52 11.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 111.25 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 3.4 mmt180 161.63 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.703 -1.248 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.707 HD21 ' H ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -62.89 146.81 52.0 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.495 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.72 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.1 mt -135.82 174.13 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.875 . . . . 0.0 110.146 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.72 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.2 pt-20 -152.82 145.53 24.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.6 m -152.01 110.38 3.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.64 140.06 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.269 -0.894 . . . . 0.0 108.743 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.7 OUTLIER 175.51 164.87 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.918 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.5 tt0 -88.57 169.14 11.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 2.7 pp -88.89 130.97 35.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.867 -1.146 . . . . 0.0 109.619 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.79 -27.1 9.47 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 19.1 t -93.53 117.35 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -1.22 . . . . 0.0 109.732 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.727 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.19 144.38 20.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.052 0.929 . . . . 0.0 110.049 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.36 -171.43 3.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -143.29 151.44 40.52 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.891 -1.131 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 86.6 m -146.51 127.85 14.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.491 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -85.47 143.38 28.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 110.234 -178.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.7 mt -96.37 146.9 24.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.446 -0.784 . . . . 0.0 109.359 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.651 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.88 -29.86 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.515 -0.741 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.99 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.239 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.651 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.78 28.2 69.66 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -99.9 162.44 12.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 96' ' ' THR . 20.0 tt0 -128.83 119.34 24.3 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mt -125.27 141.49 52.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.076 -1.015 . . . . 0.0 110.328 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.45 145.49 43.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.963 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.765 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 169.67 -120.61 0.88 Allowed Glycine 0 C--O 1.211 -1.303 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.566 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.38 159.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.161 -1.199 . . . . 0.0 111.029 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.466 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 21.4 m95 -101.96 140.56 36.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.578 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -137.89 157.07 47.17 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.88 128.97 44.83 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.331 -1.481 . . . . 0.0 108.238 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -134.68 122.5 22.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.41 -110.41 3.25 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -125.56 34.19 4.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.23 158.05 43.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.494 -1.379 . . . . 0.0 110.213 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mt -97.9 110.63 23.16 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.578 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.8 164.86 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 110.418 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.413 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.05 94.96 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.765 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.2 mttp -86.17 102.53 13.98 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.175 -1.191 . . . . 0.0 108.819 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.6 m-30 -116.93 149.62 39.86 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.811 0.815 . . . . 0.0 110.103 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 3.5 ptpt -143.33 124.02 14.13 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 31.5 mtp180 -48.07 115.15 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.349 -0.845 . . . . 0.0 108.804 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -70.55 -7.43 43.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.362 1.077 . . . . 0.0 109.322 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -89.68 -41.59 11.84 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.77 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -132.4 8.95 4.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.922 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.06 42.61 12.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.834 ' O ' ' O ' ' A' ' 101' ' ' GLU . 14.4 m120 -75.73 18.4 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -1.147 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.834 ' O ' ' O ' ' A' ' 100' ' ' ASN . 13.4 pt-20 38.62 154.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.107 0.956 . . . . 0.0 111.42 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.599 ' N ' ' O ' ' A' ' 93' ' ' PHE . 15.2 tp -153.53 129.08 9.97 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.617 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -113.93 108.68 17.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 109.341 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 116' ' ' THR . 2.7 t -123.29 175.83 6.47 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.135 0.969 . . . . 0.0 111.669 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' N ' ' OG1' ' A' ' 104' ' ' THR . 45.5 t -145.04 157.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HE ' HD21 ' A' ' 113' ' ' LEU . 21.9 ttm180 -126.75 136.02 51.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.982 . . . . 0.0 109.837 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.55 158.3 44.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.104 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.09 82.38 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.079 -1.013 . . . . 0.0 108.435 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 111' ' ' ASP . 19.2 mt -62.61 92.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.886 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.12 -82.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ILE . 68.8 m-20 -130.71 29.01 4.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -1.166 . . . . 0.0 109.952 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.07 139.76 49.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.874 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 11.7 tp -98.87 112.15 24.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.885 -1.134 . . . . 0.0 109.051 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.507 HG21 HG22 ' A' ' 127' ' ' ILE . 20.1 t -99.51 111.53 29.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.365 -0.835 . . . . 0.0 109.472 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -111.52 106.84 15.83 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.555 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.27 143.22 32.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.709 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -127.16 148.68 50.17 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.875 0.845 . . . . 0.0 109.903 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 122' ' ' VAL . 9.6 t -112.42 148.13 15.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.519 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.1 t80 -144.01 110.67 5.6 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 49.72 17.74 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.25 28.25 3.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -122.8 177.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.3 mt-10 -154.72 116.79 4.21 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 118.309 -1.357 . . . . 0.0 111.04 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.41 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -110.41 153.76 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -133.54 138.79 46.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.824 -1.173 . . . . 0.0 111.071 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.578 ' NE ' ' OH ' ' A' ' 117' ' ' TYR . 15.1 mtm180 -132.89 120.91 22.11 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.507 HG22 HG21 ' A' ' 114' ' ' VAL . 4.3 mt -114.44 123.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.09 . . . . 0.0 111.245 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.534 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.5 m-30 -99.13 175.94 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 130' ' ' LYS . 45.9 tttt -165.92 159.3 15.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 109.159 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -47.52 132.6 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.458 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.454 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.291 0.567 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.833 ' CE1' ' CE3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 40.25 32.08 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.852 . . . . 0.0 109.369 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 1' ' ' ALA . 10.5 m-20 -75.35 78.59 2.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.642 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.59 ' O ' ' NE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -179.28 -168.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.163 -0.96 . . . . 0.0 109.664 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.625 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.4 m -95.53 142.02 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.833 ' CE3' ' CE1' ' A' ' 2' ' ' PHE . 0.9 OUTLIER -151.45 169.24 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.51 139.63 20.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.858 . . . . 0.0 109.281 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' C ' ' O ' ' A' ' 7' ' ' LYS . 7.6 t -33.52 106.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 110.237 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.05 -31.69 14.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -153.86 173.89 15.32 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.611 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 13.4 t -176.37 178.17 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 0.0 109.47 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -157.25 154.08 28.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 12.3 m-20 57.92 -110.28 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.744 -0.598 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.507 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.99 -53.15 0.62 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.874 . . . . 0.0 109.922 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 15.2 p-10 -58.93 -46.42 88.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 108.827 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 78.2 mttt -63.53 -32.27 73.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.482 ' CE2' ' CE ' ' A' ' 21' ' ' MET . 85.7 t80 -72.39 -61.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.556 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 9.6 mmt -58.64 -23.89 60.02 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' HB2' HH21 ' A' ' 28' ' ' ARG . 28.0 tt0 -77.54 -35.3 53.41 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -65.59 -42.01 92.18 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.323 -0.861 . . . . 0.0 109.184 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.564 ' HG2' ' HH ' ' A' ' 119' ' ' TYR . 5.7 mtm -59.61 -13.74 10.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.926 . . . . 0.0 108.845 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.35 22.48 56.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 18' ' ' MET . 2.9 t -73.27 134.3 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -1.039 . . . . 0.0 109.45 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.9 m-80 -41.98 165.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -77.57 -1.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.247 1.022 . . . . 0.0 109.164 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.91 -59.79 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 31' ' ' ALA . 45.3 mmtt -59.24 -39.92 84.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 108.951 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.421 HH21 ' HB2' ' A' ' 19' ' ' GLU . 5.8 ttt180 -61.49 -39.94 92.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -60.89 -47.55 85.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.655 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.55 -12.98 47.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -51.73 -52.89 45.08 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.233 0.54 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -31.31 67.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.385 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.52 34.85 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.413 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -117.37 73.51 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.354 -0.842 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.694 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -86.94 43.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.245 -0.91 . . . . 0.0 109.342 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 35' ' ' ASN . 1.1 pt? -38.81 167.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.211 1.005 . . . . 0.0 111.391 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -105.69 146.4 29.8 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.58 124.08 18.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.021 -1.049 . . . . 0.0 110.325 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 m -104.05 114.77 29.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.641 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 2.2 mp -108.4 138.97 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.672 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.11 152.0 50.85 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -136.97 145.79 44.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 109.557 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -149.6 79.23 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.028 -1.045 . . . . 0.0 109.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.04 -90.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.696 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -120.59 28.77 7.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.333 -1.098 . . . . 0.0 110.453 -178.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 pttm -152.17 111.82 3.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -106.76 174.33 5.93 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.576 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.432 HG22 HG23 ' A' ' 61' ' ' VAL . 11.6 m -148.06 103.39 3.47 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.38 115.58 31.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.148 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -112.36 100.69 8.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -82.87 157.16 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -158.4 107.01 1.97 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.063 -1.023 . . . . 0.0 108.975 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.714 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -134.19 144.46 48.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.93 7.7 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.398 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.714 ' H ' ' C ' ' A' ' 53' ' ' SER . 47.7 m-85 -112.47 -20.3 11.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -0.918 . . . . 0.0 111.227 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.0 OUTLIER 163.3 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.0 109.686 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.718 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -63.38 145.86 54.72 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.716 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -137.59 174.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 0.0 110.312 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.716 ' H ' HG21 ' A' ' 58' ' ' ILE . 6.4 pt-20 -150.62 143.56 24.69 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.14 110.46 4.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.596 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -109.14 141.65 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.285 -0.884 . . . . 0.0 109.093 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.78 -179.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.849 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.9 mp0 -105.09 175.19 5.58 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 3.3 pp -93.9 119.37 32.73 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.986 -1.071 . . . . 0.0 109.203 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.0 -34.73 3.92 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.66 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 3.1 t -83.75 115.02 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.012 -1.287 . . . . 0.0 109.98 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.756 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -54.73 147.91 13.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.041 0.924 . . . . 0.0 110.207 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -160.05 -171.08 3.08 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -129.31 150.09 50.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 110.131 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 63.5 m -152.7 132.47 13.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.734 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -92.24 145.9 24.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.972 -1.08 . . . . 0.0 110.415 -178.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 73' ' ' ALA . 89.3 mt -93.91 147.02 23.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 0.0 109.342 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.643 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.49 -34.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 23.8 t0 -62.57 12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.15 27.9 73.34 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.625 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.3 OUTLIER -99.07 162.14 13.23 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.232 -1.158 . . . . 0.0 109.345 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -132.71 119.56 20.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.62 -0.675 . . . . 0.0 109.227 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.494 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.93 163.04 30.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.009 -1.057 . . . . 0.0 110.335 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -141.95 146.35 35.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.885 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.756 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 170.26 -118.7 0.77 Allowed Glycine 0 C--O 1.211 -1.287 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.19 159.51 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.268 -1.136 . . . . 0.0 110.674 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.33 145.1 29.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.58 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -141.01 157.35 45.45 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -97.51 123.19 41.29 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.456 -1.403 . . . . 0.0 108.217 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' N ' HD11 ' A' ' 84' ' ' LEU . 23.9 mt-10 -120.11 111.63 18.1 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.4 ' O ' HD13 ' A' ' 84' ' ' LEU . . . 64.47 -104.95 1.0 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 87' ' ' ASN . 3.9 t-20 -125.21 33.47 5.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -1.16 . . . . 0.0 110.262 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.51 148.26 40.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.795 -1.191 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.25 104.48 16.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.58 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -74.9 164.16 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.067 -1.02 . . . . 0.0 110.555 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.9 94.97 0.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.683 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 36.6 mtmt -88.8 103.1 15.67 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 109.151 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.2 m-30 -118.43 137.43 53.15 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.647 0.737 . . . . 0.0 109.709 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 14.1 pttt -124.97 122.89 38.61 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 99' ' ' GLY . 18.3 mtp85 -51.35 117.91 2.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 0.0 109.22 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -11.12 60.72 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.438 1.113 . . . . 0.0 109.29 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.21 -48.29 12.27 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.571 ' OD1' ' NH1' ' A' ' 95' ' ' ARG . 11.3 m120 -132.58 8.63 4.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.23 43.67 9.62 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.683 ' O ' ' O ' ' A' ' 101' ' ' GLU . 56.7 m-20 -72.38 11.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 109.524 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.683 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.2 mt-10 47.42 132.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.713 0.768 . . . . 0.0 111.162 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -135.31 132.51 37.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.9 m120 -117.01 116.49 27.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 0.0 108.931 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 116' ' ' THR . 1.8 t -128.12 176.13 7.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.796 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.4 t -146.6 155.2 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.17 136.31 51.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 109.899 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -137.36 158.68 43.89 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.44 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 2.2 mt -124.71 82.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.824 -1.173 . . . . 0.0 108.642 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 111' ' ' ASP . 21.3 mt -62.8 92.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.976 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.97 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.6 t70 -130.77 29.78 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -1.188 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -133.12 141.56 48.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.016 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 7.1 tp -97.65 110.77 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.871 -1.143 . . . . 0.0 109.195 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.59 HG23 HG23 ' A' ' 127' ' ' ILE . 8.8 t -95.21 111.9 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.937 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -114.84 107.32 15.26 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.476 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -101.42 145.31 29.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.691 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -123.11 154.97 37.89 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.837 0.827 . . . . 0.0 109.48 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 103' ' ' ASN . 9.1 t -125.59 147.1 30.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.564 ' HH ' ' HG2' ' A' ' 21' ' ' MET . 1.1 t80 -144.78 110.37 5.3 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.008 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 47.52 19.31 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.198 0.523 . . . . 0.0 111.118 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.72 28.12 3.56 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -122.24 176.58 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 3.6 mt-10 -155.68 125.9 6.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.229 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.21 153.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.42 ' O ' ' OG ' ' A' ' 11' ' ' SER . 19.5 ttpt -130.29 139.56 50.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.808 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.691 ' NH1' ' CZ ' ' A' ' 117' ' ' TYR . 41.0 mtm180 -136.74 114.03 10.79 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.59 HG23 HG23 ' A' ' 114' ' ' VAL . 5.2 mt -110.74 123.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.972 -1.08 . . . . 0.0 110.77 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.444 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 8.3 m-30 -99.18 171.0 8.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 0.0 109.502 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.76 159.62 42.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.63 -0.669 . . . . 0.0 109.21 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -57.96 134.09 56.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.2 t0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.486 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.254 0.549 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.846 ' CZ ' ' CD2' ' A' ' 6' ' ' TRP . 1.4 t80 42.69 38.38 1.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.314 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 4' ' ' SER . 5.5 m-20 -78.46 96.4 5.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 109.499 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.623 ' OG ' ' N ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 159.3 -169.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.775 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.623 ' N ' ' OG ' ' A' ' 4' ' ' SER . 51.5 m -95.89 150.41 20.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.846 ' CD2' ' CZ ' ' A' ' 2' ' ' PHE . 12.4 m95 -150.39 169.13 22.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.755 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 14.9 pttm -152.25 125.24 8.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.578 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.597 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -39.31 106.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 24.2 t0 -95.06 -29.49 14.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -147.86 162.63 38.88 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.871 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.56 178.1 7.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -154.43 158.39 39.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 6.8 m-20 58.86 -109.18 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.656 -0.653 . . . . 0.0 109.72 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 74.76 -54.22 0.67 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.658 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 2.7 m-20 -60.55 -42.37 96.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.083 -1.011 . . . . 0.0 108.574 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -64.27 -32.05 73.5 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 124' ' ' ALA . 7.5 t80 -72.9 -64.07 1.04 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -57.66 -20.85 36.39 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.616 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 2.0 tm-20 -79.77 -36.37 37.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.061 -1.024 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -67.41 -40.85 85.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.358 -0.838 . . . . 0.0 109.246 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 mtm -68.09 -6.12 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.33 -0.856 . . . . 0.0 108.999 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.53 32.43 67.76 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.5 t -72.73 128.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.486 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.7 m120 -41.76 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.355 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -76.52 -1.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.181 0.991 . . . . 0.0 109.212 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -81.86 -59.88 2.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -62.92 -30.93 71.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -44.08 72.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -62.99 -34.19 77.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 109.511 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.5 -13.26 46.52 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.968 0.89 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -80.34 -36.31 34.35 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.623 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.39 -24.34 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 1.3 m-70 -68.82 36.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.118 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.623 ' H ' ' C ' ' A' ' 32' ' ' ALA . 7.5 p-10 -42.57 89.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 109.771 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 17.1 t30 -147.7 42.72 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 108.919 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.597 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -83.23 159.87 21.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.876 . . . . 0.0 110.486 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.451 ' C ' HD13 ' A' ' 36' ' ' LEU . 13.6 mtmm -119.55 150.4 40.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.625 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 1.6 pt? -153.8 149.53 27.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.111 -0.993 . . . . 0.0 110.0 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 m -117.45 123.32 46.07 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 4.0 mp -109.37 131.43 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.676 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.65 152.26 50.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.05 149.0 41.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 0.0 109.95 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.98 79.52 1.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.096 -1.003 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 -94.52 0.64 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -127.38 28.28 5.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -1.109 . . . . 0.0 109.442 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.57 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 18.6 pttm -149.37 110.83 4.46 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.3 174.23 9.75 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.013 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -143.49 103.07 4.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.41 HG12 HG13 ' A' ' 40' ' ' ILE . 42.2 t -98.94 108.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.773 -0.579 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.16 100.0 12.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.302 -0.874 . . . . 0.0 108.748 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 58' ' ' ILE . 50.2 mt-10 -69.78 155.74 40.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.241 -0.912 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -160.83 107.24 1.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.194 -0.941 . . . . 0.0 108.818 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.755 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -143.25 144.54 32.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.77 7.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.051 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.755 ' H ' ' C ' ' A' ' 53' ' ' SER . 16.5 t80 -106.83 -24.95 11.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 110.861 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 73' ' ' ALA . 9.8 mtp180 160.01 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 109.25 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -62.45 145.86 53.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 109.18 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.73 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.8 mt -142.77 174.14 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 122.129 0.966 . . . . 0.0 110.694 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.73 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.6 pt-20 -135.42 142.52 45.64 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 t -155.05 113.76 3.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.976 -1.077 . . . . 0.0 110.306 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.18 149.35 7.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -129.94 121.07 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.033 . . . . 0.0 110.534 -179.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 50.2 tt0 -123.35 139.17 54.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.586 HD21 ' H ' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -103.23 148.83 25.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.885 -1.135 . . . . 0.0 110.283 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.8 -5.13 59.71 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.12 118.06 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.28 . . . . 0.0 109.941 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.8 m -49.32 145.4 4.55 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.294 1.045 . . . . 0.0 109.685 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.98 -168.14 2.15 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.625 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -146.46 157.21 43.72 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.532 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 15.9 t -147.66 136.05 21.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -96.54 148.33 22.94 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.939 -1.101 . . . . 0.0 110.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 73' ' ' ALA . 18.8 mt -100.94 147.08 26.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.586 -0.696 . . . . 0.0 109.527 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.728 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -39.46 -34.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.747 -0.596 . . . . 0.0 109.816 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.65 7.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.127 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.728 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 70.12 24.63 76.43 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.29 161.25 13.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.246 -1.149 . . . . 0.0 109.53 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -133.55 124.57 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.245 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.39 159.61 36.5 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.063 -1.023 . . . . 0.0 110.499 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -138.89 152.33 47.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 0.0 110.458 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.15 -110.09 0.42 Allowed Glycine 0 C--O 1.212 -1.272 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 166.74 152.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -1.216 . . . . 0.0 110.93 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 28.2 m95 -108.45 130.22 55.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.622 ' O ' ' CD1' ' A' ' 90' ' ' ILE . 1.8 m -144.88 156.31 43.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 109.54 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -87.27 138.11 31.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.752 -1.218 . . . . 0.0 108.425 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 49.9 mt-10 -160.32 157.21 27.59 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.497 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.07 -117.72 6.49 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -125.99 33.8 4.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -1.197 . . . . 0.0 110.638 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -165.02 163.5 20.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.436 -1.415 . . . . 0.0 110.593 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.71 124.35 31.41 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.622 ' CD1' ' O ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -94.13 161.05 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.983 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.24 100.3 0.21 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.643 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 63.6 mttt -98.08 108.76 21.54 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.371 -1.076 . . . . 0.0 108.762 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' LEU . 1.5 m-30 -126.72 137.92 53.32 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.78 0.8 . . . . 0.0 110.245 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 94' ' ' LYS . 4.4 ptmm? -126.33 128.92 47.85 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 99' ' ' GLY . 35.7 mtp180 -54.64 115.27 2.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 108.993 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -10.17 57.34 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.389 1.09 . . . . 0.0 109.34 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -83.31 -47.13 11.82 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.619 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -132.44 9.26 4.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.84 44.86 18.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.64 ' O ' ' O ' ' A' ' 101' ' ' GLU . 13.9 m120 -74.42 10.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -1.173 . . . . 0.0 109.63 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.64 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.5 mt-10 49.96 136.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.764 0.792 . . . . 0.0 111.12 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' PHE . 6.3 tt -146.39 122.28 10.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.42 149.98 31.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.044 . . . . 0.0 108.554 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.7 t -159.59 175.71 12.89 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.266 -1.521 . . . . 0.0 111.315 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 106' ' ' ARG . 37.8 t -144.23 158.17 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.419 ' N ' ' CG1' ' A' ' 105' ' ' VAL . 4.0 ttm180 -131.81 134.12 45.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -137.0 157.88 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.24 82.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.069 -1.019 . . . . 0.0 108.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 111' ' ' ASP . 79.0 mt -63.03 92.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.237 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.68 -78.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 109' ' ' ILE . 20.9 p-10 -130.19 29.24 4.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.0 110.316 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -134.77 139.05 44.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 108.966 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 2' ' ' PHE . 7.5 tp -102.9 114.87 29.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.009 -1.057 . . . . 0.0 109.543 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.663 HG22 HG22 ' A' ' 127' ' ' ILE . 25.1 t -102.11 107.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.399 -0.813 . . . . 0.0 109.111 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -110.1 106.97 16.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.494 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -104.76 145.43 30.37 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.702 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.22 149.8 50.87 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.94 0.876 . . . . 0.0 109.715 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 122' ' ' VAL . 3.9 t -112.91 148.01 16.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.491 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -140.64 110.28 6.38 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 47.31 19.22 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.122 0.487 . . . . 0.0 111.182 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.5 28.6 3.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 0.3 OUTLIER -124.34 177.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 33.9 mt-10 -153.5 121.23 5.98 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.378 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.425 ' HB3' ' CD1' ' A' ' 17' ' ' PHE . . . -114.0 146.19 40.5 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -125.82 140.14 52.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.929 -1.107 . . . . 0.0 111.186 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.518 ' HD2' ' HH ' ' A' ' 117' ' ' TYR . 11.9 mtt-85 -129.71 114.2 15.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.663 HG22 HG22 ' A' ' 114' ' ' VAL . 8.7 mt -111.36 123.38 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.762 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.55 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.6 m-30 -103.65 176.06 5.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.489 -0.757 . . . . 0.0 109.577 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.668 ' HZ2' ' HE2' ' A' ' 130' ' ' LYS . 24.6 tttp -163.86 152.96 14.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.668 ' HE2' ' HZ2' ' A' ' 129' ' ' LYS . 4.7 pttm -47.66 132.24 14.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 13.5 p-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.293 0.568 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.853 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER 68.48 31.14 4.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 4' ' ' SER . 1.3 m-20 -75.86 92.91 3.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.676 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 163.83 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.676 ' N ' ' OG ' ' A' ' 4' ' ' SER . 96.8 m -91.49 145.27 24.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.853 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 8.2 m95 -151.36 168.24 25.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.315 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 3.0 ptmm? -153.18 133.76 13.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.988 -1.07 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.495 ' CG1' ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -40.2 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.426 -0.796 . . . . 0.0 109.506 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.26 -30.2 12.38 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -140.67 169.82 16.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.912 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 14.4 t -175.27 178.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.279 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -156.24 154.42 30.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.9 m-20 56.79 -109.5 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.526 -0.734 . . . . 0.0 109.792 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.68 -54.14 0.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' CG ' HH21 ' A' ' 28' ' ' ARG . 7.2 m-20 -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.664 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -66.46 -32.08 73.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.539 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 21.9 t80 -72.28 -60.29 2.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.438 ' CE ' ' CE2' ' A' ' 14' ' ' TYR . 5.3 mtt -56.41 -25.09 49.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -78.87 -30.06 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.157 -0.965 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.56 ' HZ2' ' HB ' ' A' ' 122' ' ' VAL . 8.0 tptm -69.76 -41.8 74.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -68.01 -6.41 22.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.91 . . . . 0.0 108.942 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 29.64 54.14 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.46 135.52 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -48.8 158.84 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.88 . . . . 0.0 109.37 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -82.96 -1.38 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.141 0.972 . . . . 0.0 109.237 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -80.07 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -57.34 -42.45 81.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.522 HH21 ' CG ' ' A' ' 15' ' ' ASP . 16.7 ttp85 -59.32 -46.67 87.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.456 -0.777 . . . . 0.0 109.204 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -53.59 -39.34 64.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.385 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.5 -13.59 45.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.803 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.44 -39.92 15.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.186 0.517 . . . . 0.0 109.668 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -38.64 -27.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.678 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 35' ' ' ASN . 46.5 m170 -70.04 39.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.908 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 32' ' ' ALA . 6.8 t0 -43.5 90.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.591 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 33' ' ' HIS . 5.8 m120 -147.7 42.97 1.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.555 ' H ' HD22 ' A' ' 36' ' ' LEU . 1.1 pt? -90.6 163.52 14.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -106.17 135.19 48.07 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.404 ' CD1' ' N ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -132.91 128.54 36.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.975 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.449 HG23 ' HA ' ' A' ' 5' ' ' THR . 0.3 OUTLIER -102.87 120.71 41.09 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.028 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.78 123.17 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 0.0 110.829 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.02 151.93 38.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.446 ' CD ' ' OD2' ' A' ' 3' ' ' ASP . 20.7 pt20 -133.37 148.95 51.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.005 -1.059 . . . . 0.0 110.188 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.513 ' OE2' ' CD ' ' A' ' 46' ' ' LYS . 58.6 mt-10 -147.73 79.31 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.183 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.14 -92.72 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.572 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.31 28.42 7.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -1.059 . . . . 0.0 109.358 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.513 ' CD ' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -140.67 109.74 6.14 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 19.1 m-85 -103.06 173.36 6.34 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -154.88 103.61 2.43 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.73 110.29 25.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -95.52 100.26 12.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.1 mp0 -73.88 159.75 32.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.4 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 2.3 m -160.16 107.02 1.59 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.081 -1.012 . . . . 0.0 109.163 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.696 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -125.68 144.31 50.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.03 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.218 -0.927 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.696 ' H ' ' C ' ' A' ' 53' ' ' SER . 20.6 t80 -125.02 -19.62 5.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 111.782 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 177.02 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.303 -1.498 . . . . 0.0 110.084 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.704 HD21 ' H ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -62.89 145.58 54.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.999 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.694 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.79 174.19 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.694 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.4 pt-20 -147.05 143.99 28.77 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.22 110.57 4.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.5 146.22 6.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 4.6 p90 -160.46 153.75 21.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.561 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.2 tt0 -129.15 122.72 30.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 64' ' ' LEU . 3.0 pp -56.86 126.74 28.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.04 -1.037 . . . . 0.0 109.853 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.97 3.4 24.81 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.67 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 18.5 t -144.17 113.63 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.321 . . . . 0.0 109.777 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.788 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.5 m -55.48 147.64 17.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.958 0.885 . . . . 0.0 110.308 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.67 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -156.59 -171.0 3.52 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -134.05 153.24 51.93 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 34.9 t -156.84 131.62 8.86 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.494 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -95.79 145.42 25.35 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' GLY . 19.5 mt -95.85 146.89 24.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.667 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.44 -34.96 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.65 -0.656 . . . . 0.0 109.897 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.58 3.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.667 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.37 25.27 66.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.698 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.21 161.67 13.46 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.172 -1.193 . . . . 0.0 109.555 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -133.33 121.24 22.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.401 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -135.56 161.68 34.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.946 -1.096 . . . . 0.0 110.216 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.486 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.7 OUTLIER -144.48 148.24 34.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 109.65 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.788 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.23 -116.95 0.69 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 174.03 159.26 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.324 . . . . 0.0 111.093 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 12.8 m95 -102.2 141.67 34.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.588 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -138.79 156.9 46.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.54 128.72 42.63 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.353 -1.467 . . . . 0.0 108.408 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 14.3 pt-20 -129.61 129.33 44.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.74 -108.56 0.73 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -125.51 34.12 4.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.177 -1.19 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.95 156.23 44.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.179 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.5 mt -97.1 110.83 23.3 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.3 164.72 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.149 -0.969 . . . . 0.0 110.522 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.421 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -146.97 95.19 0.17 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.71 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.0 ptmm? -86.85 102.41 14.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.122 -1.222 . . . . 0.0 109.102 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.5 m-30 -116.0 142.68 46.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.775 0.798 . . . . 0.0 109.801 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 31.8 pttt -133.34 124.02 26.47 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.698 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 25.5 mtt180 -44.67 116.8 1.13 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.383 -0.823 . . . . 0.0 108.886 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -7.19 41.05 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.66 -45.9 10.56 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.516 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -132.6 8.46 4.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 47.31 45.16 21.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 21.4 m-20 -73.12 12.57 0.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.4 mt-10 49.66 146.17 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.903 0.859 . . . . 0.0 111.32 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 93' ' ' PHE . 8.3 tt -149.93 126.04 10.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 118' ' ' VAL . 13.5 t30 -111.65 112.44 24.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.415 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.9 t -124.53 176.43 6.52 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 110.994 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.1 t -148.54 154.93 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -126.65 130.29 50.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 109.688 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -129.44 158.98 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 109.083 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 2' ' ' PHE . 1.4 mm -120.08 82.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 111' ' ' ASP . 9.5 mt -64.38 91.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.735 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 51.38 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.1 p-10 -125.05 29.84 6.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -1.173 . . . . 0.0 110.422 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -138.3 147.7 43.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.029 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 11.0 tp -107.76 112.42 25.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.031 -1.043 . . . . 0.0 109.477 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 127' ' ' ILE . 3.4 t -94.77 115.16 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -114.56 103.32 10.9 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.508 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.3 OUTLIER -103.0 145.94 29.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.909 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -128.17 152.65 47.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.96 0.886 . . . . 0.0 109.641 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASN . 11.0 t -120.09 149.24 22.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.591 ' CE1' ' OE2' ' A' ' 120' ' ' GLU . 1.2 t80 -143.47 110.88 5.82 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.929 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.591 ' OE2' ' CE1' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 46.15 20.16 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.053 178.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.68 28.55 3.42 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.9 176.58 5.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 39.0 tt0 -156.06 125.55 6.28 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.067 -1.453 . . . . 0.0 111.427 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.408 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -121.31 151.42 40.1 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.432 ' O ' ' OG ' ' A' ' 11' ' ' SER . 5.3 ttpt -132.31 139.61 48.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 0.0 111.282 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HE ' ' HH ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -135.14 114.42 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.618 HG23 HG23 ' A' ' 114' ' ' VAL . 3.3 mt -108.76 125.39 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.036 -1.04 . . . . 0.0 110.817 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.493 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 6.5 m-30 -97.7 174.6 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.248 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.741 ' HE2' ' HZ2' ' A' ' 130' ' ' LYS . 43.4 tttm -160.65 156.63 25.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.524 -0.735 . . . . 0.0 109.273 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.741 ' HZ2' ' HE2' ' A' ' 129' ' ' LYS . 13.3 pttp -49.13 128.91 17.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.592 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.508 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.801 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.7 OUTLIER 42.52 33.79 0.48 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.455 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 4' ' ' SER . 20.2 p-10 -77.65 93.86 4.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.588 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.58 -166.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.58 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 36.2 m -90.94 147.08 23.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.365 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.801 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 15.4 m95 -151.69 169.24 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 109.646 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' VAL . 36.7 pttt -153.2 126.96 8.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.029 -1.044 . . . . 0.0 109.768 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -36.4 106.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.382 -0.824 . . . . 0.0 109.422 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -91.1 -29.5 17.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' NH1' HG22 ' A' ' 127' ' ' ILE . 62.2 mtm-85 -151.54 166.68 30.4 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.225 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.4 t -177.15 166.46 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.507 -0.745 . . . . 0.0 109.091 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -166.75 166.17 15.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 0.0 110.448 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 58.9 21.78 9.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.581 -0.699 . . . . 0.0 110.243 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.59 ' OH ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.61 -57.29 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.599 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 19' ' ' GLU . 2.6 m-20 -45.85 -52.93 10.55 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.011 -1.056 . . . . 0.0 109.161 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -54.65 -41.68 70.38 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -67.84 -63.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -20.82 2.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 15' ' ' ASP . 39.1 tt0 -79.24 -38.13 36.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -65.81 -37.32 85.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.505 ' HB2' HG21 ' A' ' 23' ' ' VAL . 11.3 mtm -67.73 -8.84 38.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.322 -0.861 . . . . 0.0 109.11 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 32.51 41.69 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 21' ' ' MET . 17.7 t -80.02 139.2 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -1.108 . . . . 0.0 109.585 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' VAL . 62.6 t30 -44.83 170.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.302 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.593 ' CD1' ' CZ ' ' A' ' 28' ' ' ARG . 3.7 mm -85.33 -5.1 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.017 . . . . 0.0 109.34 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.88 -60.04 2.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 49.3 mttp -63.97 -24.06 67.58 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.593 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 23.4 ttp180 -73.04 -47.8 41.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.553 -0.717 . . . . 0.0 109.361 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -66.96 -34.84 78.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.793 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.71 -13.07 46.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 110.064 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 27' ' ' LYS . . . -74.82 -25.92 59.36 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.167 0.508 . . . . 0.0 109.824 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -70.94 -61.0 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.103 -0.998 . . . . 0.0 109.509 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 82.2 t60 -70.71 46.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.451 -0.78 . . . . 0.0 109.434 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 32' ' ' ALA . 37.8 t0 -88.94 127.54 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -123.78 43.08 3.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -68.95 159.91 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.902 0.858 . . . . 0.0 111.008 -178.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -107.64 149.06 28.53 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 38' ' ' LEU . 2.6 mp -139.17 129.01 24.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.015 . . . . 0.0 109.952 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 m -99.96 105.86 17.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.521 HG13 HG21 ' A' ' 49' ' ' VAL . 3.7 mp -95.65 123.4 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 110.926 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.01 151.79 41.54 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -129.66 148.24 51.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.024 -1.048 . . . . 0.0 109.843 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' ASN . 27.9 mt-10 -144.72 78.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.66 -81.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' GLU . 11.7 p-10 -125.56 28.87 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.67 109.67 4.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.36 166.81 12.39 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.5 m -156.17 103.67 2.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.521 HG21 HG13 ' A' ' 40' ' ' ILE . 13.7 p -105.97 118.67 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.491 -0.755 . . . . 0.0 109.486 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -100.01 100.25 11.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.565 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 1.8 mp0 -70.51 156.3 39.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.935 . . . . 0.0 109.05 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -158.86 106.93 1.86 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.073 -1.017 . . . . 0.0 109.022 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.685 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.61 144.64 50.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.01 7.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 109.858 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.687 ' CZ ' ' NH2' ' A' ' 56' ' ' ARG . 6.0 t80 -112.29 -20.45 11.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 111.128 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.687 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER 160.44 89.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.843 -1.16 . . . . 0.0 109.317 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -62.18 148.17 45.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.7 HG21 ' H ' ' A' ' 59' ' ' GLU . 2.0 mt -138.11 174.19 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.032 0.92 . . . . 0.0 110.338 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.7 ' H ' HG21 ' A' ' 58' ' ' ILE . 5.8 pt-20 -141.79 143.29 33.37 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.9 m -150.75 117.52 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 110.263 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.08 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -137.82 165.93 25.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 23.8 tt0 -152.39 169.71 21.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.457 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 78.3 mt -100.74 118.88 37.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 110.197 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.87 24.56 27.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.345 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.636 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 21.0 t -144.05 102.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.05 -1.265 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.8 143.12 43.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.752 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.81 -171.03 3.82 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.41 149.73 45.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.481 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 50.0 t -151.91 135.66 16.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.43 143.91 28.36 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 110.163 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.1 mt -91.82 147.04 23.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.551 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.671 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.67 -33.86 1.33 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.702 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.68 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.671 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 78.34 25.33 61.54 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 161.7 13.43 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.236 -1.155 . . . . 0.0 109.692 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 96' ' ' THR . 19.0 tt0 -133.09 125.88 30.55 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.78 164.76 27.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.969 -1.082 . . . . 0.0 110.574 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HG2' ' HZ3' ' A' ' 94' ' ' LYS . 14.6 ttm180 -147.85 143.15 27.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.738 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.66 -119.59 0.83 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.498 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.05 158.95 0.12 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.211 -1.17 . . . . 0.0 110.53 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.484 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.2 m95 -102.0 143.26 32.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.9 m -138.76 157.14 46.64 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.26 129.22 43.64 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.364 -1.46 . . . . 0.0 108.286 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.455 ' CD ' ' O ' ' A' ' 85' ' ' GLU . 1.3 pp20? -131.31 125.43 32.76 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.51 -109.45 1.58 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -125.47 33.84 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -1.156 . . . . 0.0 110.216 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.403 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.38 155.86 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.77 -1.206 . . . . 0.0 110.165 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mt -97.58 111.23 23.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.66 164.81 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 110.476 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.25 95.41 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.722 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 12.5 ptmt -86.17 102.78 14.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.189 -1.183 . . . . 0.0 108.478 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 102' ' ' LEU . 5.1 m-30 -118.95 145.72 45.56 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.823 0.821 . . . . 0.0 110.146 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.558 ' HZ3' ' HG2' ' A' ' 79' ' ' ARG . 20.3 pttm -132.46 121.58 23.59 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 99' ' ' GLY . 49.0 mtp180 -46.95 114.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.398 -0.814 . . . . 0.0 109.026 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.49 -10.15 53.63 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 122.492 1.139 . . . . 0.0 109.28 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -79.03 -50.44 11.07 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.464 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -132.34 9.54 4.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.393 -0.817 . . . . 0.0 109.84 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.78 47.22 31.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.649 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.5 m120 -77.92 14.01 1.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -1.146 . . . . 0.0 109.581 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.8 mt-10 50.88 142.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.616 0.722 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -144.89 131.71 20.13 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -114.9 111.76 21.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 0.0 108.866 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 2.2 t -126.86 176.4 7.32 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.075 -1.016 . . . . 0.0 111.184 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.2 t -147.92 162.34 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.484 ' NH1' ' CH2' ' A' ' 82' ' ' TRP . 12.9 ttm180 -133.4 139.48 46.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.924 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -141.42 158.75 43.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.133 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 2' ' ' PHE . 1.4 mm -119.21 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.0 mm -61.55 92.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.009 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.53 -78.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 109' ' ' ILE . 14.4 m-20 -130.73 29.9 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -1.151 . . . . 0.0 110.213 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -136.98 146.48 45.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.121 -0.987 . . . . 0.0 109.164 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 11.9 tp -102.23 115.64 30.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.995 -1.066 . . . . 0.0 109.219 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.491 HG23 HG23 ' A' ' 127' ' ' ILE . 5.6 t -105.16 107.61 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 109.288 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.497 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 12.5 tt0 -107.43 109.46 21.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.483 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -99.83 144.7 28.59 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 109.767 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.681 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -127.22 150.76 49.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.841 0.829 . . . . 0.0 109.51 179.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASN . 11.2 t -119.77 147.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.561 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -145.03 110.75 5.38 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.138 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 50.01 17.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.299 0.571 . . . . 0.0 110.979 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.29 27.76 3.8 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -121.42 176.34 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 2.3 mt-10 -156.05 117.23 3.85 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.09 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.17 166.94 10.81 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -145.26 137.47 25.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.912 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.59 ' NE ' ' OH ' ' A' ' 14' ' ' TYR . 14.6 mtt180 -125.15 114.1 18.58 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.491 HG23 HG23 ' A' ' 114' ' ' VAL . 7.3 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 110.352 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.534 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 11.4 m-30 -100.93 166.21 10.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -150.96 146.75 26.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.58 -0.7 . . . . 0.0 109.121 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -47.83 136.43 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.496 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 130' ' ' LYS . 11.7 p30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.451 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.859 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.3 OUTLIER 39.43 30.68 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.267 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 4' ' ' SER . 26.6 t70 -72.51 96.84 1.99 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.486 -0.759 . . . . 0.0 109.748 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 160.29 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 109.598 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.582 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.7 m -98.03 142.59 29.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.304 -0.872 . . . . 0.0 109.352 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.859 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 4.4 m95 -147.29 169.43 19.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.303 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 8' ' ' VAL . 11.9 pttm -151.9 130.7 12.43 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.022 -1.049 . . . . 0.0 109.477 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -39.83 106.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.364 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.44 -32.28 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.498 ' O ' ' OG ' ' A' ' 11' ' ' SER . 15.8 mtm-85 -142.58 164.65 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.686 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 67.3 m -170.47 178.22 3.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 109.294 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -155.19 157.5 37.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.056 . . . . 0.0 110.006 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 10.8 m-20 58.02 -109.53 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.678 . . . . 0.0 109.854 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 71.69 -51.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -61.36 -46.03 91.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.955 -1.091 . . . . 0.0 108.597 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -63.34 -33.84 76.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CE2' ' CE ' ' A' ' 21' ' ' MET . 91.0 t80 -71.39 -61.4 1.79 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.795 0.807 . . . . 0.0 108.883 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 23' ' ' VAL . 14.3 mmt -59.04 -23.78 62.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -74.76 -37.82 62.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.24 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -64.67 -46.38 82.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.341 -0.849 . . . . 0.0 109.028 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.482 ' HG2' ' HH ' ' A' ' 119' ' ' TYR . 4.8 mtm -61.81 -9.07 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.041 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.26 28.02 62.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 18' ' ' MET . 3.8 t -74.85 132.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -1.091 . . . . 0.0 109.553 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.739 HD21 ' N ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -49.31 167.15 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.739 ' N ' HD21 ' A' ' 24' ' ' ASN . 1.5 mm -82.03 -1.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.181 0.991 . . . . 0.0 109.22 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -73.69 -59.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.456 0.646 . . . . 0.0 109.386 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.445 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -64.22 -29.56 70.66 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.071 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 14.3 ttp180 -72.71 -30.69 64.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.642 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -75.4 -40.02 58.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.38 -13.14 47.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.01 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 33' ' ' HIS . . . -84.7 -49.56 8.4 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.212 0.529 . . . . 0.0 109.626 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.2 -1.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.609 ' H ' ' C ' ' A' ' 31' ' ' ALA . 81.4 m-70 -140.1 46.26 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.609 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 36' ' ' LEU . 25.6 t0 -125.56 95.95 4.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.456 ' HA ' HG12 ' A' ' 8' ' ' VAL . 3.6 p-10 -71.48 43.57 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.353 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.502 HD12 HD23 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -43.77 155.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.901 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -106.57 148.7 27.95 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.502 HD23 HD12 ' A' ' 36' ' ' LEU . 2.7 mp -138.92 126.53 21.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -98.29 111.78 24.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.8 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 3.9 mp -100.76 120.48 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.448 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -120.98 151.99 39.08 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.583 ' N ' ' OE1' ' A' ' 42' ' ' GLN . 1.6 pm0 -130.88 147.06 52.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 45' ' ' ASN . 38.5 mm-40 -144.04 78.88 1.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.65 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.639 HD21 ' H ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -124.53 28.81 6.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -1.145 . . . . 0.0 110.347 -178.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.22 109.88 4.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -94.65 171.02 9.05 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m -155.9 103.5 2.24 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 0.0 108.992 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.67 115.69 41.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.326 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -101.09 100.25 10.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 52' ' ' SER . 5.3 tt0 -69.86 157.78 36.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 108.736 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.422 ' N ' ' CG ' ' A' ' 51' ' ' GLU . 2.3 m -160.12 107.02 1.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.152 -0.968 . . . . 0.0 109.015 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.715 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -137.05 144.36 43.15 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.18 7.62 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 109.236 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.715 ' H ' ' C ' ' A' ' 53' ' ' SER . 60.2 m-85 -109.38 -25.02 10.76 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.296 -0.878 . . . . 0.0 111.1 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 2.7 ptm180 164.34 86.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.171 . . . . 0.0 109.44 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -62.61 146.4 52.1 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.299 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.707 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -140.56 174.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.127 -0.983 . . . . 0.0 110.409 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.707 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.9 pt-20 -146.34 142.76 28.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 98.9 m -151.25 125.06 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -86.38 150.35 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -136.38 131.08 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.922 -1.112 . . . . 0.0 110.416 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -120.98 170.03 9.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.61 118.94 37.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.061 -1.024 . . . . 0.0 110.333 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.08 22.87 36.79 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.479 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 12.7 t -143.71 105.85 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.959 -1.318 . . . . 0.0 109.401 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.48 142.37 44.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.637 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -149.45 -171.36 3.87 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -139.41 154.02 47.72 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.659 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.1 t -153.45 135.54 14.78 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 76' ' ' THR . 5.8 p30 -93.73 143.39 26.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.934 -1.104 . . . . 0.0 110.231 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.4 mt -92.53 146.89 23.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.683 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.67 -34.79 0.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 0.0 109.813 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.29 8.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 72.54 27.09 70.15 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.68 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.03 162.17 13.14 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.181 -1.188 . . . . 0.0 109.624 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -132.55 120.41 21.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -133.15 162.28 32.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.932 -1.105 . . . . 0.0 110.582 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -146.31 146.88 30.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.538 -0.726 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.52 -119.52 0.79 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.49 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.88 156.87 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.3 -1.117 . . . . 0.0 110.65 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.523 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 5.2 m95 -102.85 143.48 32.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -142.08 122.35 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.475 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 118.75 7.92 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 119.951 -1.718 . . . . 0.0 109.857 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.04 115.82 29.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.67 -103.54 0.33 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.35 33.77 5.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -140.98 143.13 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.735 -1.228 . . . . 0.0 110.251 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.12 104.53 17.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.781 ' CG1' ' O ' ' A' ' 83' ' ' SER . 0.9 OUTLIER -81.64 163.5 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.733 -1.229 . . . . 0.0 110.04 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.19 95.86 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.714 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.1 mttm -85.75 103.35 14.45 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.401 -1.058 . . . . 0.0 108.463 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.44 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -115.71 148.27 39.94 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.82 0.819 . . . . 0.0 110.154 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -133.41 120.9 21.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.451 0.643 . . . . 0.0 109.526 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.68 HH21 ' CG2' ' A' ' 76' ' ' THR . 23.8 mtp85 -53.1 115.32 1.81 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -13.41 61.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.456 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.609 ' C ' HD21 ' A' ' 98' ' ' ASN . 52.9 t0 -77.84 -49.89 13.38 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.768 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.609 HD21 ' C ' ' A' ' 97' ' ' ASP . 1.0 OUTLIER -132.33 11.2 4.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.964 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.46 42.31 9.67 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.674 ' O ' ' O ' ' A' ' 101' ' ' GLU . 74.5 m-20 -75.6 19.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -1.154 . . . . 0.0 109.512 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.674 ' O ' ' O ' ' A' ' 100' ' ' ASN . 15.6 pt-20 45.07 164.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.816 0.817 . . . . 0.0 110.911 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 117' ' ' TYR . 6.6 tp -165.12 127.25 2.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.611 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.6 OUTLIER -114.4 115.96 28.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.002 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 116' ' ' THR . 1.8 t -126.19 176.32 7.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.14 -0.975 . . . . 0.0 110.807 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -149.71 153.38 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.654 ' HE ' ' NE2' ' A' ' 115' ' ' GLN . 7.4 mtt180 -125.92 136.51 53.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.789 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -138.16 158.54 44.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.72 82.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.564 ' O ' ' N ' ' A' ' 111' ' ' ASP . 22.4 mt -63.58 91.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.38 -81.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -127.89 29.34 5.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -1.191 . . . . 0.0 110.271 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -134.6 144.23 47.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 11.5 tp -105.36 113.34 26.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.873 -1.142 . . . . 0.0 109.085 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.596 HG23 HG22 ' A' ' 127' ' ' ILE . 11.1 t -99.49 108.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.654 ' NE2' ' HE ' ' A' ' 106' ' ' ARG . 11.1 tt0 -105.52 106.65 17.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.487 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -100.33 145.78 27.73 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 110.114 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -121.99 157.03 32.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.782 0.801 . . . . 0.0 109.191 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 103' ' ' ASN . 11.9 t -127.46 147.82 32.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.544 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.2 t80 -146.53 110.58 5.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.056 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 45.77 20.29 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.134 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.8 28.54 3.39 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.72 176.65 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 66.1 tt0 -155.91 125.28 6.25 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.401 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.415 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -115.6 152.92 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -133.92 136.91 44.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.773 -1.204 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.08 114.05 14.08 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.596 HG22 HG23 ' A' ' 114' ' ' VAL . 4.4 mt -107.67 123.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.989 . . . . 0.0 110.685 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -101.05 176.02 5.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.365 -0.834 . . . . 0.0 108.786 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -165.31 156.63 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.416 -0.803 . . . . 0.0 109.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -47.64 129.17 13.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.481 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.453 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.323 0.583 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.708 ' CZ ' ' CG ' ' A' ' 6' ' ' TRP . 0.7 OUTLIER 50.52 49.4 20.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.235 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.7 t70 -92.02 90.65 7.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.831 . . . . 0.0 109.196 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.72 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 85.2 m -102.16 143.26 32.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 109.721 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.708 ' CG ' ' CZ ' ' A' ' 2' ' ' PHE . 11.5 m95 -148.69 168.72 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.14 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 8' ' ' VAL . 9.7 pttm -153.21 130.91 11.56 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 0.0 109.588 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -38.39 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.8 -27.05 21.36 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -154.62 167.84 28.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.143 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -177.94 164.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 14' ' ' TYR . 6.7 pt-20 -166.76 166.45 15.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.81 -1.181 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.12 -5.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.653 -0.654 . . . . 0.0 110.191 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -46.78 -61.23 1.94 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.966 -1.084 . . . . 0.0 110.021 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 6.1 p-10 -44.92 -44.78 9.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.984 -1.073 . . . . 0.0 109.247 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.633 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -62.7 -41.62 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 108.664 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.483 ' CE2' ' HE1' ' A' ' 18' ' ' MET . 23.5 t80 -68.59 -54.82 14.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.384 -0.823 . . . . 0.0 108.949 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 7.2 mmt -57.96 -31.11 66.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' A' ' 28' ' ' ARG . 26.2 tt0 -74.8 -25.33 58.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -70.68 -48.66 53.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 ttm -59.44 -10.22 3.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.058 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.81 32.4 27.0 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' ASN . 13.8 t -77.03 132.41 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -1.077 . . . . 0.0 109.55 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' VAL . 3.2 t-20 -48.32 177.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.322 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.62 -2.82 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 109.41 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG21 ' OD1' ' A' ' 24' ' ' ASN . 21.9 t -82.85 -60.05 2.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -65.45 -25.96 67.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.43 HH21 ' HB2' ' A' ' 19' ' ' GLU . 21.3 ttp180 -73.25 -43.4 61.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.406 -0.809 . . . . 0.0 109.263 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -70.44 -32.72 70.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.1 mt -86.45 -13.7 45.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -85.96 -47.17 9.86 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.75 -22.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' ASN . 22.1 t-160 -69.29 37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' A' ' 32' ' ' ALA . 5.3 p30 -49.92 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.838 . . . . 0.0 109.594 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.4 OUTLIER -147.26 43.22 1.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 108.862 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.583 HD21 ' H ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -92.72 168.54 11.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 111.238 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -108.83 150.22 27.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -139.64 120.0 13.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.991 -1.068 . . . . 0.0 110.329 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -101.79 111.38 23.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 4.4 mp -111.18 144.04 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 111.41 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -133.76 152.39 51.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -128.11 146.17 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -143.17 79.06 1.63 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.978 . . . . 0.0 109.616 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.01 -88.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.8 29.11 6.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.0 110.272 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -151.52 110.07 3.8 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -100.34 174.18 6.24 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.506 0.669 . . . . 0.0 109.919 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -148.86 103.23 3.35 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.8 t -96.06 110.92 25.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.749 -0.594 . . . . 0.0 109.571 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -100.77 100.24 10.88 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.3 mt-10 -73.89 159.35 32.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 109.004 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -161.99 107.15 1.25 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.143 -0.973 . . . . 0.0 109.096 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.716 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -135.0 144.29 47.29 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.64 7.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.987 -1.071 . . . . 0.0 109.156 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.716 ' H ' ' C ' ' A' ' 53' ' ' SER . 82.8 m-85 -113.16 -19.74 11.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.393 -0.817 . . . . 0.0 111.097 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.3 mmt180 162.8 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 109.556 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.68 HD21 ' H ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -63.1 148.69 47.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.278 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.733 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -142.85 174.31 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 121.192 -0.943 . . . . 0.0 110.471 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.733 ' H ' HG21 ' A' ' 58' ' ' ILE . 7.7 pt-20 -146.88 143.72 28.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.3 m -153.25 117.71 4.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.36 151.07 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -138.78 155.13 48.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.947 -1.096 . . . . 0.0 110.433 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.515 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 50.2 tt0 -150.01 168.41 23.95 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.515 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 14.5 mt -99.64 123.94 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.008 -1.058 . . . . 0.0 110.274 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 28.72 40.73 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.616 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 42.4 t -144.05 102.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.091 -1.24 . . . . 0.0 109.201 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -57.78 141.67 48.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.201 -0.937 . . . . 0.0 109.955 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.616 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.4 -171.6 3.98 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -138.67 150.6 46.39 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.65 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.5 t -151.44 136.33 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.642 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -95.09 144.76 25.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 110.225 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 73' ' ' ALA . 98.0 mt -93.27 146.79 23.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.659 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.81 -35.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 19.5 t70 -57.8 4.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.142 -0.974 . . . . 0.0 109.444 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.659 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.31 26.28 64.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.14 161.99 13.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.482 ' HG2' ' HG1' ' A' ' 96' ' ' THR . 30.3 tt0 -132.86 122.27 24.15 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -133.79 163.85 28.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.014 -1.054 . . . . 0.0 110.541 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.15 142.19 28.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.135 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.747 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.89 -117.01 0.63 Allowed Glycine 0 N--CA 1.477 1.382 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.479 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.42 157.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.21 -1.17 . . . . 0.0 110.428 179.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.7 m95 -101.99 143.11 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.592 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.4 t -140.51 156.7 46.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 108.565 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -94.31 128.27 40.7 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.321 -1.487 . . . . 0.0 108.1 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 12.8 pt-20 -133.31 125.03 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.01 -109.66 2.7 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.67 34.37 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -1.176 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -148.3 160.77 42.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.503 -1.373 . . . . 0.0 110.61 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.06 110.37 22.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.592 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.86 164.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 110.522 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.71 95.41 0.17 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.652 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 50.9 mttt -87.49 104.78 16.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.214 -1.168 . . . . 0.0 109.242 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.9 m-30 -118.19 127.27 53.59 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.735 0.778 . . . . 0.0 109.849 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -113.07 120.6 41.87 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.493 ' CD ' ' OH ' ' A' ' 119' ' ' TYR . 43.3 mtp180 -48.05 115.11 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.482 ' HG1' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -80.58 -10.4 59.74 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.485 1.136 . . . . 0.0 109.113 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.98 -26.61 18.3 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.789 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -132.06 4.6 4.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.965 . . . . 0.0 109.415 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 49.99 45.57 41.72 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.547 ' OD1' ' N ' ' A' ' 101' ' ' GLU . 30.8 t-20 -88.23 -122.48 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.25 -1.147 . . . . 0.0 109.008 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.0 pt-20 -175.29 138.55 0.42 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.353 0.597 . . . . 0.0 110.179 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 tt -141.17 119.2 11.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -110.16 112.34 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 108.693 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 116' ' ' THR . 2.1 t -122.65 174.95 6.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.139 0.971 . . . . 0.0 111.643 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.7 t -142.98 149.23 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -126.22 132.46 51.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -135.07 157.76 46.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.412 HG12 HD11 ' A' ' 113' ' ' LEU . 1.0 OUTLIER -128.06 82.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.073 -1.017 . . . . 0.0 108.63 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 111' ' ' ASP . 62.8 mt -63.6 92.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.211 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.91 -77.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.9 m-20 -130.55 29.43 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -1.179 . . . . 0.0 110.404 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -135.34 134.56 39.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.223 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.608 ' HB2' ' CE1' ' A' ' 2' ' ' PHE . 6.4 tp -100.14 112.96 25.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.497 HG21 HD11 ' A' ' 109' ' ' ILE . 14.9 t -99.59 106.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.336 -0.945 . . . . 0.0 108.807 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.609 ' NE2' ' OH ' ' A' ' 117' ' ' TYR . 10.0 tt0 -111.1 104.61 13.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 108.984 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.524 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.3 144.4 30.84 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 0.0 109.464 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.711 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.02 144.67 51.26 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 109.687 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.668 HG23 ' HG2' ' A' ' 123' ' ' GLU . 13.2 t -110.58 147.31 14.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.525 ' N ' HG12 ' A' ' 122' ' ' VAL . 2.4 t80 -148.22 114.18 5.78 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 52.85 14.92 0.48 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.87 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.3 28.37 3.83 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.78 176.73 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.668 ' HG2' HG23 ' A' ' 118' ' ' VAL . 19.6 mt-10 -155.56 111.79 3.13 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.454 -1.299 . . . . 0.0 110.787 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.01 153.47 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.06 138.27 49.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.994 -1.066 . . . . 0.0 110.68 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -131.7 114.11 14.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.9 mt -107.69 123.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.584 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 7.5 m-30 -99.73 176.17 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.288 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -161.45 146.28 13.45 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -47.8 133.67 13.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.524 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.584 ' C ' ' H ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.746 ' CG ' ' CZ2' ' A' ' 6' ' ' TRP . 7.5 m-85 -65.86 5.86 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 0.0 109.417 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.584 ' H ' ' C ' ' A' ' 1' ' ' ALA . 4.0 m-20 36.84 56.85 1.19 Allowed 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.621 ' HG ' ' HE1' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -175.22 -151.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 110.518 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.608 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 23.6 m -106.77 131.09 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.416 -0.802 . . . . 0.0 110.192 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.746 ' CZ2' ' CG ' ' A' ' 2' ' ' PHE . 49.9 m95 -145.05 158.04 43.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -147.81 153.59 39.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.704 -1.247 . . . . 0.0 110.668 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.431 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 2.7 t -42.47 106.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.716 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -97.16 -31.07 12.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HB2' HD12 ' A' ' 127' ' ' ILE . 50.8 mtt85 -152.85 172.07 17.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 13.8 t -173.22 177.38 2.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.947 -1.096 . . . . 0.0 109.723 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.99 162.19 40.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.858 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 4.6 m-20 59.58 -109.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.582 -0.699 . . . . 0.0 109.865 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.678 ' CE1' ' NH2' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 72.06 -52.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -0.967 . . . . 0.0 109.703 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 13.2 p-10 -60.94 -44.42 97.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.561 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -63.62 -32.07 73.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -71.77 -64.02 1.01 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.063 0.935 . . . . 0.0 108.619 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -58.27 -24.0 58.02 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.455 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 24.2 tp10 -79.86 -29.1 39.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 109.295 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.684 ' HZ3' ' HB ' ' A' ' 122' ' ' VAL . 3.8 tptm -71.37 -42.66 68.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.077 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.7 mtm -67.41 -6.37 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.343 -0.848 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.49 64.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.86 130.81 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -1.162 . . . . 0.0 109.578 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.657 ' N ' HD21 ' A' ' 24' ' ' ASN . 1.1 m120 -50.09 174.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.945 . . . . 0.0 109.368 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -84.47 -1.4 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 122.159 0.98 . . . . 0.0 109.175 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.09 -59.87 2.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -37.93 71.8 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HB3' ' A' ' 15' ' ' ASP . 2.1 ttt85 -64.41 -50.3 68.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -50.07 -36.41 29.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.001 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.47 -13.11 47.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.085 0.945 . . . . 0.0 109.384 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' ASP . . . -84.39 -37.01 22.04 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.658 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.73 -37.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.346 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.413 ' C ' ' H ' ' A' ' 35' ' ' ASN . 76.0 m80 -98.52 33.97 2.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.109 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ALA . 22.1 t70 -79.25 38.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.461 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 33' ' ' HIS . 25.4 p30 -73.7 43.7 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 34' ' ' ASP . 2.6 pt? -52.99 170.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.13 0.967 . . . . 0.0 111.576 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -110.47 148.2 32.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.512 HD12 ' CZ ' ' A' ' 128' ' ' PHE . 0.6 OUTLIER -137.17 123.98 21.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.92 -1.113 . . . . 0.0 110.54 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.77 109.08 21.07 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 mp -103.33 127.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 0.0 110.801 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -128.45 151.75 49.03 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.498 ' OE1' ' OD1' ' A' ' 3' ' ' ASP . 6.7 pt20 -141.29 140.18 33.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.839 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.43 78.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.43 -88.5 0.03 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.626 -0.989 . . . . 0.0 110.626 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.675 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -116.72 28.99 8.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -1.094 . . . . 0.0 110.348 -178.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -145.65 110.25 5.08 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.414 ' O ' HG22 ' A' ' 61' ' ' VAL . 13.9 m-85 -104.86 168.52 9.01 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -156.0 103.54 2.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.137 -0.977 . . . . 0.0 109.057 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.42 121.87 49.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -112.54 100.36 8.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' ILE . 92.0 mt-10 -77.48 157.44 30.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.104 -0.998 . . . . 0.0 109.318 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -159.46 106.82 1.73 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.229 -0.92 . . . . 0.0 108.984 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.68 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -131.05 144.46 51.47 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.01 7.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.175 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.68 ' H ' ' C ' ' A' ' 53' ' ' SER . 70.9 t80 -114.47 -17.64 11.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 111.173 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 6.4 mtp85 161.71 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.714 -1.241 . . . . 0.0 109.205 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -63.03 144.12 57.17 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.339 -0.85 . . . . 0.0 109.632 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.671 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -136.35 174.23 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.86 0.838 . . . . 0.0 110.08 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.671 ' H ' HG21 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -156.65 156.07 32.85 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.9 109.11 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.82 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.639 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -104.53 153.45 6.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 1.7 m-85 176.42 -179.21 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.833 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.1 tt0 -117.66 168.33 10.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.504 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 19.2 mt -81.33 139.09 35.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.04 23.24 28.01 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.64 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 52.0 t -143.92 103.76 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -1.197 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.766 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.7 143.19 25.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.946 . . . . 0.0 109.811 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.71 -171.62 3.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.567 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 5.2 p30 -137.2 151.43 48.75 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 110.312 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 71.3 m -156.89 137.41 13.09 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.608 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -92.53 143.9 25.88 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 0.0 110.416 -178.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 96.0 mt -93.22 146.97 23.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.397 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.655 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.29 -34.04 0.45 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.907 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.22 12.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 68.74 27.13 74.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.19 162.31 13.05 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.258 -1.142 . . . . 0.0 109.634 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 96' ' ' THR . 30.6 tt0 -132.22 118.7 19.86 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.414 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -133.78 162.49 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.098 . . . . 0.0 110.797 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 9.8 ptm180 -143.23 142.92 31.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.83 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.4 -117.78 0.67 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.64 158.11 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.049 -1.265 . . . . 0.0 110.693 179.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.432 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.77 142.52 32.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -138.78 157.05 46.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -96.56 125.85 41.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.351 -1.468 . . . . 0.0 108.234 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -123.57 111.13 15.89 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.52 -105.19 1.07 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -125.13 33.65 5.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -1.136 . . . . 0.0 110.146 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -140.8 149.18 41.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.797 -1.19 . . . . 0.0 110.229 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -96.05 107.35 19.64 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -78.32 164.22 3.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 110.684 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.15 94.78 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.684 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.1 mtpm? -87.98 104.23 16.44 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.25 -1.147 . . . . 0.0 108.879 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.426 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -116.33 139.11 50.75 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.865 0.841 . . . . 0.0 110.18 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -121.72 121.03 36.38 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 15.7 mtp180 -53.81 115.03 1.78 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -68.01 -12.37 60.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.368 1.08 . . . . 0.0 109.396 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.88 -52.14 9.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.529 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 1.5 t-20 -132.62 14.55 4.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.65 44.05 11.84 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.751 ' O ' ' O ' ' A' ' 101' ' ' GLU . 49.7 m-20 -76.18 19.22 0.25 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -1.095 . . . . 0.0 109.724 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.751 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.2 pt-20 42.77 158.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.062 0.934 . . . . 0.0 111.247 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.494 ' C ' ' CD2' ' A' ' 102' ' ' LEU . 6.1 tt -160.14 123.65 3.56 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.0 m120 -113.45 113.87 25.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.097 -1.002 . . . . 0.0 109.028 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.8 t -126.0 176.56 6.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 111.071 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.4 t -148.85 150.82 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -127.77 135.13 49.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.549 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -141.89 158.6 43.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.593 HG23 ' CZ ' ' A' ' 2' ' ' PHE . 1.6 mm -119.39 82.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.725 ' O ' ' N ' ' A' ' 111' ' ' ASP . 1.7 mp -65.22 91.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 121.633 0.73 . . . . 0.0 109.893 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.34 -76.15 0.0 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 109' ' ' ILE . 10.2 t70 -124.45 29.64 6.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.239 . . . . 0.0 110.838 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -145.55 136.97 25.07 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.031 -1.043 . . . . 0.0 109.33 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.31 110.77 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.5 t -95.93 118.05 41.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 110.08 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.84 103.06 8.79 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.477 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.3 OUTLIER -105.33 147.16 28.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.155 -0.965 . . . . 0.0 110.182 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -126.82 152.85 46.41 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 109.252 178.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 103' ' ' ASN . 5.7 t -121.2 148.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.52 ' N ' HG13 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.94 110.52 5.57 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.878 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 47.16 19.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.146 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.43 28.56 3.47 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.684 ' HB ' ' HZ3' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -123.81 177.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.031 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 58.9 tt0 -155.65 122.29 5.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.391 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.47 141.02 47.61 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.489 ' O ' ' OG ' ' A' ' 11' ' ' SER . 11.2 ttmm -119.83 140.59 50.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.778 -1.201 . . . . 0.0 111.111 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.678 ' NH2' ' CE1' ' A' ' 14' ' ' TYR . 61.3 mtp85 -134.9 113.75 11.85 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 10' ' ' ARG . 3.5 mt -108.8 124.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.709 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.512 ' CZ ' HD12 ' A' ' 38' ' ' LEU . 7.1 m-30 -98.21 177.95 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.938 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.507 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 20.0 tttp -158.29 147.22 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.693 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 16.4 pttp -46.69 129.02 11.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' OD2' ' A' ' 131' ' ' ASP . 7.3 p30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.485 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.651 ' C ' ' H ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.454 0.645 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.829 ' HB3' ' NE1' ' A' ' 6' ' ' TRP . 1.3 m-85 -63.13 10.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 109.608 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.651 ' H ' ' C ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER 37.72 45.07 0.61 Allowed 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.473 ' HB3' ' HE1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -168.54 -151.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.366 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.604 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 47.5 m -108.8 126.43 53.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.829 ' NE1' ' HB3' ' A' ' 2' ' ' PHE . 37.6 m95 -142.12 168.59 19.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.337 -0.852 . . . . 0.0 108.703 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.5 pttp -152.44 143.37 23.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.701 -1.249 . . . . 0.0 110.506 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.51 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -43.25 107.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.451 -0.78 . . . . 0.0 109.953 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.76 -31.15 12.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -149.12 164.71 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.727 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -170.46 169.79 7.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.258 -0.901 . . . . 0.0 109.255 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 14' ' ' TYR . 8.1 pt-20 -166.65 166.68 15.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.934 -1.104 . . . . 0.0 110.434 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 14' ' ' TYR . 2.5 m-20 62.57 -10.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.615 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -43.44 -59.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.019 -1.051 . . . . 0.0 109.863 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.59 -45.76 38.51 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.95 -1.094 . . . . 0.0 109.243 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -59.6 -40.66 88.21 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 20' ' ' LYS . 24.4 t80 -67.39 -62.88 1.21 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -30.77 9.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -73.42 -29.27 62.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.072 -1.018 . . . . 0.0 109.128 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 17' ' ' PHE . 4.2 tptp -67.94 -48.36 66.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.2 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.92 -6.95 4.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.53 26.26 47.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.9 t -72.78 136.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -1.059 . . . . 0.0 109.525 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -53.25 174.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.59 -1.98 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.093 0.949 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.9 -60.09 2.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 6.3 mptt -65.95 -21.15 66.41 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -72.64 -43.56 63.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 109.43 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -70.35 -33.45 71.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.62 -13.12 46.59 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.937 0.875 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.502 ' O ' ' OD2' ' A' ' 34' ' ' ASP . . . -83.83 -52.97 5.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.245 0.545 . . . . 0.0 109.89 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.13 -50.6 4.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 33' ' ' HIS . 12.3 m-70 -73.66 46.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.502 ' OD2' ' O ' ' A' ' 31' ' ' ALA . 46.6 m-20 -71.23 136.56 48.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -147.37 43.06 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.684 ' CD2' HH12 ' A' ' 126' ' ' ARG . 0.8 OUTLIER -84.27 162.87 19.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 110.948 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -107.71 147.0 31.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.538 HD12 ' CE2' ' A' ' 128' ' ' PHE . 3.6 mp -136.6 121.04 18.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 110.019 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 m -92.1 104.58 16.95 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -97.69 117.84 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.22 151.92 38.45 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.444 ' CD ' ' CE2' ' A' ' 47' ' ' PHE . 49.1 tt0 -129.28 146.55 51.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.136 -0.978 . . . . 0.0 109.813 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -145.24 79.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.39 -92.95 0.16 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.04 28.56 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.382 -1.069 . . . . 0.0 109.758 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -145.96 109.6 4.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.444 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 14.1 m-85 -96.7 173.92 7.08 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.765 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -153.47 104.04 2.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 51' ' ' GLU . 2.5 t -101.22 112.79 35.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.57 -0.707 . . . . 0.0 109.373 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HB3' ' HZ2' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -100.47 100.6 11.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.885 . . . . 0.0 109.404 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.582 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.0 mp0 -72.65 155.73 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.183 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 m -159.34 106.71 1.75 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.119 -0.988 . . . . 0.0 108.892 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.7 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -130.44 144.28 51.3 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.94 8.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.27 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.7 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -117.03 -19.83 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 111.422 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 6.9 ptt180 167.7 84.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.641 -1.287 . . . . 0.0 109.575 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -63.14 143.98 57.31 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 109.521 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.699 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -135.89 174.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.182 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.699 ' H ' HG21 ' A' ' 58' ' ' ILE . 5.9 pt-20 -154.1 142.4 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.37 131.64 6.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.546 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -75.13 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.245 -0.91 . . . . 0.0 108.546 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -148.02 118.51 7.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.026 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.427 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 26.6 tt0 -130.32 146.82 51.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.5 HD11 ' O ' ' A' ' 64' ' ' LEU . 2.5 pp -95.73 130.5 42.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.784 -1.197 . . . . 0.0 109.597 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.05 8.17 42.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.595 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 46.9 t -144.29 103.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.079 -1.248 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.736 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -57.16 145.1 32.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.206 1.003 . . . . 0.0 110.049 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.69 -170.77 3.53 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.509 ' ND2' ' C ' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -145.0 149.13 34.6 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.738 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.421 ' SG ' ' N ' ' A' ' 71' ' ' ASN . 43.6 t -150.29 170.43 19.02 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 76' ' ' THR . 1.5 p-10 -120.52 145.86 46.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.959 -1.088 . . . . 0.0 110.311 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 73' ' ' ALA . 15.5 mt -93.82 146.9 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.545 -0.722 . . . . 0.0 109.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.687 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.56 -36.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.725 . . . . 0.0 109.833 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 38.2 t0 -57.83 6.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 109.437 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.687 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 73.86 26.16 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.25 162.17 13.13 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.204 -1.174 . . . . 0.0 109.621 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' THR . 29.3 tt0 -132.45 124.25 28.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.497 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.66 166.11 23.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.957 -1.089 . . . . 0.0 110.727 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -148.42 141.35 24.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.422 -0.799 . . . . 0.0 109.912 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.736 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.64 -118.0 0.71 Allowed Glycine 0 N--CA 1.475 1.281 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.579 ' OG1' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 172.61 159.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -1.176 . . . . 0.0 110.499 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.58 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 2.3 m95 -103.1 144.62 31.06 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.39 157.68 44.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -89.6 127.89 35.96 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.166 -1.584 . . . . 0.0 108.255 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.83 122.03 34.98 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.532 ' C ' HD21 ' A' ' 87' ' ' ASN . . . 56.79 -107.7 1.0 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.532 HD21 ' C ' ' A' ' 86' ' ' GLY . 1.5 m120 -125.28 33.3 5.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -1.133 . . . . 0.0 110.065 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 1.3 mptt -141.53 159.44 42.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.879 -1.138 . . . . 0.0 109.924 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.429 ' O ' HG13 ' A' ' 105' ' ' VAL . 16.1 mt -98.27 108.87 21.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -76.8 164.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.012 -1.055 . . . . 0.0 110.305 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.421 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.77 96.27 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.638 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -89.65 105.59 17.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.142 -1.21 . . . . 0.0 108.897 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.409 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.1 m-30 -118.08 125.36 50.15 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.821 0.82 . . . . 0.0 109.999 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -108.89 118.35 36.56 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.494 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 63.9 mtp180 -46.42 114.89 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.19 -10.35 59.64 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.533 1.159 . . . . 0.0 109.125 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.88 -26.15 19.49 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.61 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.16 2.1 3.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 52.76 45.71 60.44 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.494 ' H ' ' HB2' ' A' ' 95' ' ' ARG . 15.7 t-20 -89.39 -122.07 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.367 -1.078 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.401 ' H ' ' CG ' ' A' ' 100' ' ' ASN . 4.8 pt-20 -175.45 138.89 0.42 Allowed 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.948 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 tt -144.02 120.34 10.91 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.555 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -107.48 107.79 18.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.789 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 2.1 t -121.55 175.92 5.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.992 . . . . 0.0 111.559 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 89' ' ' LEU . 33.3 t -148.19 159.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.675 ' NE ' ' NE2' ' A' ' 115' ' ' GLN . 9.8 ttm180 -134.63 136.97 43.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -145.71 159.12 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 109.08 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.695 ' CG2' ' CE2' ' A' ' 2' ' ' PHE . 0.8 OUTLIER -120.4 83.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.683 ' O ' ' N ' ' A' ' 111' ' ' ASP . 44.4 mt -64.23 91.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.26 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.89 -80.52 0.0 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 109' ' ' ILE . 2.2 p30 -119.6 30.11 7.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -1.203 . . . . 0.0 111.052 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 129' ' ' LYS . 2.6 mt-10 -145.07 132.75 20.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.859 -1.151 . . . . 0.0 109.475 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.7 OUTLIER -98.12 113.93 25.97 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.431 HG12 HG12 ' A' ' 127' ' ' ILE . 2.1 t -108.26 113.82 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.617 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.675 ' NE2' ' NE ' ' A' ' 106' ' ' ARG . 11.0 tt0 -110.29 105.29 14.27 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.525 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -99.59 146.35 26.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.116 -0.99 . . . . 0.0 110.006 -178.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.729 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -131.17 145.64 52.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.873 0.844 . . . . 0.0 109.737 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 122' ' ' VAL . 11.7 t -111.86 148.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.514 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.6 t80 -147.23 112.09 5.39 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.032 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 51.5 16.35 0.43 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.875 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.79 28.24 3.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -121.97 176.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 pt-20 -155.57 113.46 3.37 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.008 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.75 156.84 17.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -134.06 136.08 43.73 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.012 -1.055 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.684 HH12 ' CD2' ' A' ' 36' ' ' LEU . 4.2 mmm180 -125.32 116.2 21.55 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 7.0 mt -110.64 124.17 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.538 ' CE2' HD12 ' A' ' 38' ' ' LEU . 8.9 m-30 -98.99 176.38 5.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.146 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 3.8 tppt? -155.66 150.16 26.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.528 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 12.3 tttt -46.94 135.46 9.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.456 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.808 ' CZ ' ' CD2' ' A' ' 6' ' ' TRP . 1.4 t80 38.6 31.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.779 . . . . 0.0 109.227 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.6 m-20 -71.45 95.96 1.44 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.548 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.1 m 161.63 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.617 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.3 m -103.63 140.76 37.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.808 ' CD2' ' CZ ' ' A' ' 2' ' ' PHE . 5.3 m95 -148.04 168.88 21.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 8' ' ' VAL . 6.5 pttp -153.36 132.71 12.8 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.58 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.56 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -0.893 . . . . 0.0 109.628 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 17.7 t0 -94.73 -28.4 15.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -148.39 171.84 15.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.716 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 15.4 t -171.86 178.34 3.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.19 151.21 30.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.796 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.55 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 21.9 t-20 58.66 -108.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.0 109.842 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.593 ' CD2' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER 75.55 -54.13 0.64 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.0 110.017 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.92 -45.99 91.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.034 -1.041 . . . . 0.0 109.099 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.56 -30.72 71.09 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.643 ' CZ ' ' SD ' ' A' ' 21' ' ' MET . 15.1 t80 -72.19 -57.07 4.54 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.193 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.568 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 2.5 mpp? -59.14 -28.61 66.71 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.85 -27.71 55.18 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.149 -0.97 . . . . 0.0 109.254 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -71.54 -42.59 67.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.238 -0.913 . . . . 0.0 109.414 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.662 ' SD ' ' CE2' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -68.76 -5.41 20.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.043 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.11 25.14 56.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 24' ' ' ASN . 60.9 t -67.33 116.93 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.159 . . . . 0.0 109.461 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 23' ' ' VAL . 2.5 m-20 -41.79 155.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -67.48 -2.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 0.0 109.084 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.448 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.7 t -82.59 -60.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.95 -30.72 69.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -50.19 61.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -56.1 -34.17 65.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.57 -13.22 46.43 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.967 0.889 . . . . 0.0 109.759 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -84.64 -37.97 20.41 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.256 0.551 . . . . 0.0 109.603 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -44.66 -14.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.305 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.4 m-70 -70.44 46.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.178 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -54.47 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.463 -0.773 . . . . 0.0 109.878 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.4 OUTLIER -148.22 42.38 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.275 -0.89 . . . . 0.0 109.12 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.58 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -84.31 159.09 20.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 52' ' ' SER . 11.4 ttpt -119.49 145.83 45.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 1.6 pt? -154.5 142.48 20.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.975 -1.078 . . . . 0.0 110.346 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 m -108.17 124.92 51.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 3.5 mp -109.95 124.98 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 110.81 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 151.62 36.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.3 148.77 48.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.994 -1.066 . . . . 0.0 110.071 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -148.46 79.09 1.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.36 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.17 -89.93 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -123.45 28.42 7.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -1.096 . . . . 0.0 109.71 -179.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -144.51 110.54 5.43 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' O ' HG22 ' A' ' 61' ' ' VAL . 1.3 p90 -111.46 173.68 6.23 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.395 0.617 . . . . 0.0 109.686 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.7 m -150.81 103.09 3.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.486 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 17.7 t -90.93 108.49 19.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.623 -0.673 . . . . 0.0 109.563 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -99.42 100.2 11.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' OE2' ' O ' ' A' ' 49' ' ' VAL . 3.6 mp0 -78.01 159.73 28.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 37' ' ' LYS . 1.7 m -159.96 106.65 1.62 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.669 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.661 ' C ' ' H ' ' A' ' 55' ' ' PHE . 1.8 p -127.25 144.31 51.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.88 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 109.588 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.661 ' H ' ' C ' ' A' ' 53' ' ' SER . 9.4 t80 -123.43 -11.74 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 111.641 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.1 mmt180 164.72 84.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.459 -1.401 . . . . 0.0 109.883 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -63.9 147.46 51.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.463 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.708 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -138.19 174.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 110.072 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.708 ' H ' HG21 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.6 135.41 11.74 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.55 109.15 4.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -105.22 153.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.9 OUTLIER 175.95 -179.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.142 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -117.53 137.23 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.93 142.04 57.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.16 -34.33 5.48 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.493 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 6.2 p -102.63 125.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.244 . . . . 0.0 109.974 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.62 142.99 51.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.91 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.493 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.72 -171.62 3.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.518 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.544 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 2.0 p-10 -135.94 150.74 49.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.088 -1.007 . . . . 0.0 110.345 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 60.5 m -155.79 135.88 12.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 76' ' ' THR . 2.2 p30 -95.21 144.56 25.71 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.916 -1.115 . . . . 0.0 110.607 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 75' ' ' GLY . 16.6 mt -90.87 146.9 23.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.59 -0.694 . . . . 0.0 109.222 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.656 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.76 -35.17 1.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.755 . . . . 0.0 109.723 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.0 4.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.81 26.43 62.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.0 162.19 13.14 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.303 -1.116 . . . . 0.0 109.517 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.501 ' HG2' ' HG1' ' A' ' 96' ' ' THR . 31.3 tt0 -132.82 121.13 22.5 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.454 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -135.02 162.9 31.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.88 -1.137 . . . . 0.0 110.51 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.59 143.2 31.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 109.894 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.35 -116.62 0.62 Allowed Glycine 0 N--CA 1.477 1.368 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 171.37 158.42 0.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 0.0 110.813 179.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.438 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.6 141.48 34.4 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -139.53 157.17 46.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.935 . . . . 0.0 108.527 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -94.53 126.48 39.84 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.35 -1.469 . . . . 0.0 108.187 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -129.37 120.62 25.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 -108.26 2.05 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -125.37 34.28 4.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -1.156 . . . . 0.0 110.549 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 161.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.6 -1.313 . . . . 0.0 110.412 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 mt -100.98 108.01 19.63 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -75.52 164.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.436 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.89 94.63 0.16 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.697 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 5.6 mtmm -88.5 102.97 15.44 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.115 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 3.7 m-30 -116.15 129.89 56.54 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.802 0.811 . . . . 0.0 109.792 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -113.06 118.2 34.13 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 99' ' ' GLY . 42.7 mtp180 -51.07 114.99 1.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.501 ' HG1' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -83.75 -11.68 56.79 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.485 1.136 . . . . 0.0 109.086 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.22 -23.44 21.26 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -132.1 -0.87 3.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.226 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 54.58 43.48 78.47 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.597 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 16.6 t-20 -92.26 -122.85 0.08 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -1.162 . . . . 0.0 109.244 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 4.3 pt-20 -174.91 138.39 0.46 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -136.0 111.29 9.06 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.401 ' O ' HG21 ' A' ' 118' ' ' VAL . 0.7 OUTLIER -104.69 108.19 19.52 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 116' ' ' THR . 2.7 t -122.28 176.14 6.02 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.148 0.975 . . . . 0.0 112.099 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.41 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.7 t -145.81 147.4 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -123.64 132.88 53.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 110.198 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -131.55 158.6 40.51 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -124.49 82.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.13 -0.981 . . . . 0.0 108.43 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 111' ' ' ASP . 27.7 mt -64.33 91.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.929 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.78 -81.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -125.17 29.56 6.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -1.2 . . . . 0.0 110.187 -179.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.68 138.33 40.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.172 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 7.0 tp -103.3 111.79 24.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.039 -1.038 . . . . 0.0 109.535 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.457 HG23 HG23 ' A' ' 127' ' ' ILE . 3.3 t -95.8 109.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.052 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -112.06 103.96 12.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.308 -0.87 . . . . 0.0 108.661 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.25 143.16 32.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.551 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.697 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -125.57 147.14 49.38 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.786 0.803 . . . . 0.0 109.35 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 122' ' ' VAL . 12.6 t -114.58 149.88 16.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.662 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 1.6 t80 -143.67 110.96 5.8 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.847 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 48.67 18.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.245 0.545 . . . . 0.0 110.944 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.49 28.43 3.51 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -122.71 176.11 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 9.9 pt-20 -156.47 123.87 5.4 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.539 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.405 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -119.84 152.74 36.83 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.458 ' O ' ' OG ' ' A' ' 11' ' ' SER . 16.9 ttpt -131.62 140.08 49.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.769 -1.207 . . . . 0.0 111.279 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -133.12 114.16 13.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.457 HG23 HG23 ' A' ' 114' ' ' VAL . 2.6 mt -105.31 124.25 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.084 -1.01 . . . . 0.0 110.987 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.531 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -95.53 175.91 6.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.512 -0.742 . . . . 0.0 109.555 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -164.52 148.83 9.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.519 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 20.7 mtmm -47.72 134.34 12.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.49 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.693 ' H2 ' HD11 ' A' ' 108' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.264 0.554 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.75 ' CG ' ' CE2' ' A' ' 6' ' ' TRP . 1.4 m-85 -68.67 14.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 0.0 109.235 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.624 ' H ' ' C ' ' A' ' 1' ' ' ALA . 23.1 t0 40.53 47.9 2.4 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.618 ' HG ' ' HE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -174.27 -152.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.146 -0.971 . . . . 0.0 110.398 -179.376 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.595 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 29.0 m -107.2 129.32 54.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.814 . . . . 0.0 110.199 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.75 ' CE2' ' CG ' ' A' ' 2' ' ' PHE . 43.4 m95 -142.44 167.84 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 10.3 pttp -152.72 138.73 18.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.84 -1.162 . . . . 0.0 110.741 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' CG1' ' N ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -38.64 107.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.52 -0.738 . . . . 0.0 109.965 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -97.06 -32.42 11.99 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.5 ' O ' ' OG ' ' A' ' 11' ' ' SER . 14.5 mtt-85 -150.45 178.27 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.646 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 73.8 m -171.41 177.99 3.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.272 -0.893 . . . . 0.0 109.412 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -150.12 149.23 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.033 . . . . 0.0 109.888 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 15' ' ' ASP . 48.2 t-20 63.52 -104.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.61 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.44 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER 69.14 -44.04 0.53 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 13' ' ' ASN . 54.5 m-20 -63.68 -47.76 79.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 108.751 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB2' HD22 ' A' ' 13' ' ' ASN . 24.7 mmtp -61.07 -37.26 82.05 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.473 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 68.4 t80 -69.3 -63.76 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -54.53 -24.94 22.89 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.042 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -79.36 -26.81 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -43.89 62.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 109.032 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.473 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -67.85 -6.13 20.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 108.961 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.1 31.93 53.97 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -77.66 158.42 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 109.514 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.723 ' ND2' ' H ' ' A' ' 25' ' ' ILE . 1.1 t30 -75.0 175.64 7.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.723 ' H ' ' ND2' ' A' ' 24' ' ' ASN . 1.5 mm -84.68 -1.33 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG22 ' ND2' ' A' ' 24' ' ' ASN . 42.5 t -78.48 -59.88 2.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 121.451 0.643 . . . . 0.0 109.268 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.1 mttp -63.58 -27.3 69.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 108.669 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.2 -42.15 72.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.37 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -66.74 -34.59 78.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.1 mt -86.25 -13.09 47.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.582 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.74 -47.39 19.16 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.808 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.54 -64.96 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.94 . . . . 0.0 109.645 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.24 46.12 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.878 . . . . 0.0 109.357 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 15.0 t70 -89.47 160.53 16.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 109.769 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 4.4 m-20 -143.19 42.96 1.54 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.356 -0.84 . . . . 0.0 108.991 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.642 ' N ' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -54.89 148.09 13.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.613 ' HZ3' ' HB3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -119.07 139.73 51.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -146.63 153.04 39.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.909 -1.119 . . . . 0.0 110.268 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -115.03 109.53 18.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.51 119.28 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 110.169 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.34 151.67 36.52 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -135.47 139.97 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 45' ' ' ASN . 7.2 mt-10 -139.01 78.82 1.69 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.06 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 43' ' ' GLU . 6.0 p-10 -118.79 28.94 8.0 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.301 -1.117 . . . . 0.0 110.507 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -154.47 111.05 3.29 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.4 p90 -107.93 173.48 6.3 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.752 -0.592 . . . . 0.0 109.491 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -155.87 103.43 2.24 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.006 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.88 109.15 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.506 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -99.76 99.65 10.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.634 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . 26.5 mt-10 -72.89 156.81 38.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.033 -1.042 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.6 m -161.78 107.23 1.29 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.198 -0.939 . . . . 0.0 109.029 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.731 ' C ' ' H ' ' A' ' 55' ' ' PHE . 6.4 p -139.96 144.43 37.05 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.18 7.6 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.731 ' H ' ' C ' ' A' ' 53' ' ' SER . 38.1 m-85 -107.96 -23.57 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 111.049 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.2 mtp-105 160.49 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.667 HD21 ' H ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -62.78 145.24 55.36 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.712 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.688 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.18 174.56 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.406 -0.809 . . . . 0.0 109.825 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.688 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.2 pt-20 -154.19 143.1 21.06 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.8 108.71 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.656 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -107.32 151.57 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.238 -0.914 . . . . 0.0 109.799 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 1.8 m-85 176.32 -179.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.808 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 27.8 tt0 -107.39 167.71 9.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.574 -0.704 . . . . 0.0 109.175 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.542 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.5 mt -80.14 130.23 35.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.36 -30.18 10.31 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.628 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 57.6 t -84.09 110.88 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.248 . . . . 0.0 110.033 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -57.57 143.67 40.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -150.63 -171.6 3.97 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.566 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -138.18 149.63 46.02 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.131 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 57.2 m -156.15 137.78 14.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -93.61 144.05 25.74 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.358 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 74' ' ' ASP . 48.2 mt -93.98 146.97 23.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.565 -0.709 . . . . 0.0 109.421 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.623 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.63 -28.47 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.582 -0.699 . . . . 0.0 109.745 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.9 17.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.75 26.34 66.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.474 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.02 161.92 13.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.287 -1.125 . . . . 0.0 109.565 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -132.85 119.98 20.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.485 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.17 161.95 33.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.882 -1.136 . . . . 0.0 110.684 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 19.9 ptt180 -143.16 141.91 31.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 110.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.95 -116.01 0.59 Allowed Glycine 0 N--CA 1.476 1.352 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.538 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 170.76 157.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -1.187 . . . . 0.0 110.603 179.308 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.615 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.1 m95 -102.25 144.07 31.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.636 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -144.54 155.98 43.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.057 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.71 119.19 26.68 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.312 -1.492 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -109.33 104.58 13.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.68 -101.34 0.51 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -124.77 33.45 5.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -1.174 . . . . 0.0 110.177 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -140.75 157.23 45.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.816 -1.177 . . . . 0.0 109.961 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -100.1 101.85 13.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -72.12 163.62 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 110.396 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -146.96 95.66 0.17 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.643 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 3.8 tttm -90.25 104.92 17.44 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.181 -1.188 . . . . 0.0 108.636 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 2.9 m-30 -117.79 125.06 49.89 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.845 0.831 . . . . 0.0 109.766 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.614 ' NZ ' ' CE ' ' A' ' 92' ' ' LYS . 15.2 mttp -105.63 116.41 31.9 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 39.5 mtp180 -54.45 114.74 1.78 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.37 -13.08 61.38 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.529 1.157 . . . . 0.0 109.433 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.95 -47.08 15.57 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.67 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 99' ' ' GLY . 31.9 m-80 -132.61 7.83 4.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 110.074 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.16 42.18 8.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.672 ' O ' ' O ' ' A' ' 101' ' ' GLU . 14.8 m-80 -78.05 12.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 0.0 109.513 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.3 mt-10 47.79 128.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.548 0.689 . . . . 0.0 111.003 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.23 120.77 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER -108.18 107.83 18.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.062 -179.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.9 t -122.91 176.41 6.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.208 -0.933 . . . . 0.0 111.137 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.401 ' N ' ' OG1' ' A' ' 104' ' ' THR . 89.1 t -148.38 159.63 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.615 ' NH1' ' CH2' ' A' ' 82' ' ' TRP . 50.6 ttm-85 -131.3 136.87 48.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.725 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -139.39 158.55 43.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 109.298 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.693 HD11 ' H2 ' ' A' ' 1' ' ' ALA . 1.2 mm -122.19 82.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.722 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.3 mm -68.38 91.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.374 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 41.43 -80.42 0.0 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.722 ' N ' ' O ' ' A' ' 109' ' ' ILE . 5.3 m-20 -118.18 29.5 7.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.252 . . . . 0.0 110.884 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -146.9 134.5 20.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.127 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.5 115.96 29.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 108.28 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.966 -1.084 . . . . 0.0 110.294 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -117.17 103.26 10.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.521 ' O ' ' OG1' ' A' ' 104' ' ' THR . 1.1 m -102.39 148.49 25.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 110.103 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.716 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.51 151.94 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.482 178.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 103' ' ' ASN . 8.2 t -118.71 148.08 21.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.549 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.42 110.77 5.54 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.96 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 47.86 19.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.025 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.38 28.46 3.53 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.549 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.3 176.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 1.9 mt-10 -155.67 119.57 4.5 Favored 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.123 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.404 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -111.64 148.9 32.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -125.57 138.52 53.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.926 -1.109 . . . . 0.0 110.829 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.44 ' CZ ' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mmt85 -128.17 127.17 42.45 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 mt -118.01 123.71 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.507 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -97.96 176.62 5.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.495 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 24.6 tttt -155.24 142.46 19.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.684 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 3.3 pttp -47.5 132.13 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 109.764 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 129' ' ' LYS . 19.6 m-20 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.729 ' C ' ' H ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.791 ' CG ' ' CZ2' ' A' ' 6' ' ' TRP . 18.1 m-85 -58.42 9.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.729 ' H ' ' C ' ' A' ' 1' ' ' ALA . 1.5 p30 38.03 51.17 1.42 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 2' ' ' PHE . 1.2 m -169.38 -149.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.091 -1.005 . . . . 0.0 110.289 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.62 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 6.4 m -103.1 129.84 50.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.413 -0.804 . . . . 0.0 109.987 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.791 ' CZ2' ' CG ' ' A' ' 2' ' ' PHE . 56.3 m95 -148.21 167.61 24.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 108.865 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -152.76 139.53 18.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.699 -1.251 . . . . 0.0 110.62 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.585 ' CG1' ' H ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -45.28 107.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -99.85 -29.79 12.4 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 mmt-85 -141.52 171.16 14.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.64 -0.662 . . . . 0.0 109.535 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 28.3 t -173.25 178.0 2.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.395 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -155.88 156.87 35.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.133 -0.979 . . . . 0.0 109.862 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.8 m-20 58.77 -109.56 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.605 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.504 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 73.77 -52.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.232 -0.918 . . . . 0.0 109.975 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.03 -49.15 78.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 108.919 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.38 -33.79 72.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.611 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 65.3 t80 -71.32 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.457 ' CE ' ' CZ ' ' A' ' 14' ' ' TYR . 21.9 mmt -55.58 -22.37 21.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.91 -33.62 45.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.274 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' NZ ' ' HB ' ' A' ' 122' ' ' VAL . 14.6 mmtp -68.36 -42.05 79.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.611 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -66.82 -7.42 21.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.119 -0.988 . . . . 0.0 108.953 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.53 26.88 62.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 24' ' ' ASN . 41.3 t -66.34 122.27 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -1.075 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.1 m-20 -43.47 168.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -78.87 -1.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 122.141 0.972 . . . . 0.0 109.193 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.18 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -62.27 -31.0 71.52 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 18.4 ttp180 -69.6 -45.89 67.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 109.183 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -57.4 -37.22 72.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.267 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD21 ' HA ' ' A' ' 30' ' ' LEU . 96.0 mt -86.5 -12.9 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.035 0.922 . . . . 0.0 109.677 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -70.86 -47.44 59.3 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.61 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.41 -21.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' ASN . 70.9 t60 -69.07 36.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -51.59 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 33' ' ' HIS . 1.1 m-20 -147.92 42.45 1.04 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.903 . . . . 0.0 109.048 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.585 ' H ' ' CG1' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -89.95 162.39 15.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 110.461 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -108.34 144.91 35.24 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -138.49 123.75 19.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 110.074 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 104.67 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.1 mp -97.59 127.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.928 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.9 151.88 49.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -130.35 143.27 50.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 45' ' ' ASN . 8.6 mt-10 -138.7 79.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.83 -82.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -124.88 28.28 6.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -1.133 . . . . 0.0 110.204 -178.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.84 109.9 4.34 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.608 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -97.51 172.81 7.5 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.753 -0.592 . . . . 0.0 109.728 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.0 m -154.27 104.28 2.59 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.384 -0.823 . . . . 0.0 108.832 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.54 116.5 42.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -109.92 100.54 9.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 109.628 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -77.64 157.53 30.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.066 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.4 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER -157.41 106.62 2.15 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 108.891 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.714 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.38 144.64 50.67 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.39 7.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.058 . . . . 0.0 109.642 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.714 ' H ' ' C ' ' A' ' 53' ' ' SER . 91.0 t80 -108.01 -23.83 11.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.0 111.046 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 161.2 88.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.975 -1.078 . . . . 0.0 109.009 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 16.7 p-10 -62.72 143.82 57.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.397 -0.814 . . . . 0.0 109.766 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.657 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.1 mt -134.24 173.76 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.413 -0.804 . . . . 0.0 110.203 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.657 ' H ' HG21 ' A' ' 58' ' ' ILE . 4.3 pt-20 -157.38 142.95 17.35 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 60' ' ' CYS . 14.2 p -163.61 128.09 2.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.497 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -82.59 160.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.507 -0.746 . . . . 0.0 109.123 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.608 ' CE2' ' CB ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -156.36 133.18 10.35 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.475 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.496 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 18.4 tt0 -105.55 168.47 9.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.489 -0.757 . . . . 0.0 109.005 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.496 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 13.0 mt -88.84 122.5 32.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 0.0 110.081 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 30.13 27.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 81' ' ' THR . 23.5 t -144.18 102.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.275 . . . . 0.0 109.413 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 2.3 m -47.59 145.88 2.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.427 1.108 . . . . 0.0 109.876 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -165.93 -167.23 1.04 Allowed 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.677 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -147.84 157.59 43.61 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.875 -178.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.5 t -150.34 137.59 19.53 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.633 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -98.08 149.49 22.44 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.001 -1.062 . . . . 0.0 110.184 -178.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 75' ' ' GLY . 27.7 mt -96.9 146.83 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.55 -0.719 . . . . 0.0 109.552 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.692 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.65 -34.67 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.628 -0.67 . . . . 0.0 109.719 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.76 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.2 -0.938 . . . . 0.0 109.28 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.692 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 74.3 25.15 71.45 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.1 tt0 -133.4 126.16 30.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -132.97 160.06 38.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.936 -1.103 . . . . 0.0 110.322 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -135.23 149.22 49.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.434 -0.791 . . . . 0.0 110.248 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.723 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.07 -111.12 0.46 Allowed Glycine 0 C--O 1.211 -1.289 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 167.57 154.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.984 -1.304 . . . . 0.0 110.604 178.11 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.486 ' NE1' ' CZ ' ' A' ' 93' ' ' PHE . 74.1 m95 -102.12 133.38 47.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.587 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.9 m -138.2 157.18 46.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.947 -1.096 . . . . 0.0 109.338 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.86 128.55 41.7 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.519 -1.363 . . . . 0.0 108.193 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -129.06 118.73 23.01 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.6 -107.12 1.48 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -125.3 34.34 4.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.48 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -148.3 150.18 33.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.723 -1.236 . . . . 0.0 110.45 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 106' ' ' ARG . 2.0 mt -92.2 115.69 28.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.587 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -87.04 163.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.143 -0.973 . . . . 0.0 110.489 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.413 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.43 94.34 0.16 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.723 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 47.7 mttt -87.14 102.14 14.17 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.182 -1.187 . . . . 0.0 108.473 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.2 m-30 -122.32 137.18 54.94 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.807 0.813 . . . . 0.0 110.346 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' ARG . 9.5 ptpt -127.75 126.07 41.11 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' GLY . 43.4 mtp180 -43.79 115.46 0.81 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.313 -0.867 . . . . 0.0 108.881 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.04 -5.42 17.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.401 1.096 . . . . 0.0 109.37 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -85.86 -48.61 8.6 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.307 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -132.43 9.11 4.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.462 -0.774 . . . . 0.0 109.614 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.59 47.05 30.09 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 58.5 m-20 -72.17 11.17 0.61 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -1.224 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.2 mt-10 48.8 134.42 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.823 0.821 . . . . 0.0 111.349 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 93' ' ' PHE . 9.4 tt -139.24 131.44 28.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER -114.15 112.6 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.025 . . . . 0.0 109.233 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.8 t -125.26 174.59 8.01 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.111 -0.993 . . . . 0.0 111.159 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 106' ' ' ARG . 48.1 t -145.93 163.92 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.475 ' N ' ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -138.18 135.89 36.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.713 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -139.21 158.91 43.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.088 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.73 ' CG2' ' CE2' ' A' ' 2' ' ' PHE . 1.1 mt -123.15 82.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.649 ' O ' ' N ' ' A' ' 111' ' ' ASP . 20.9 mt -65.72 91.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.146 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.84 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 109' ' ' ILE . 30.6 m-20 -119.17 29.87 7.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -1.211 . . . . 0.0 110.666 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -140.98 134.12 29.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.046 -1.034 . . . . 0.0 109.566 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.51 HD12 ' H ' ' A' ' 2' ' ' PHE . 1.5 tt -98.3 110.0 22.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 108.344 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 109' ' ' ILE . 2.1 t -97.21 118.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 110.345 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.401 ' HG2' ' CZ ' ' A' ' 117' ' ' TYR . 18.4 tt0 -120.06 104.97 10.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.486 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -104.49 146.16 29.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.124 -0.985 . . . . 0.0 110.264 -178.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.79 ' HH ' ' HD3' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -126.04 150.8 47.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.787 0.803 . . . . 0.0 109.184 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 122' ' ' VAL . 13.8 t -118.87 148.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.528 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.3 t80 -145.6 111.32 5.49 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.924 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 51.76 16.3 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.319 0.581 . . . . 0.0 110.949 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.06 28.04 3.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -121.39 176.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.3 mt-10 -155.99 118.52 4.13 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.175 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -111.15 150.69 29.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.483 ' O ' ' OG ' ' A' ' 11' ' ' SER . 11.9 ttpt -131.52 139.14 49.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.833 -1.167 . . . . 0.0 111.331 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.79 ' HD3' ' HH ' ' A' ' 117' ' ' TYR . 22.9 mtp180 -133.64 115.02 14.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 2.6 mt -104.57 129.95 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.573 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.533 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.3 m-30 -98.69 177.46 5.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.513 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 16.8 tptm -152.94 143.91 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.692 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -47.26 133.68 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.185 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.463 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.592 ' H3 ' HE22 ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.846 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 41.71 31.96 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.853 . . . . 0.0 109.231 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 4' ' ' SER . 35.5 t0 -75.92 86.64 2.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 109.639 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 168.24 -159.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.38 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.551 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 88.9 m -94.42 145.39 24.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.846 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 20.6 m95 -151.79 167.54 27.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.9 ptmt -154.24 133.57 12.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.484 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -42.09 106.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -98.48 -27.82 13.88 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -142.71 169.62 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.912 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 26.1 t -172.39 178.14 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.838 . . . . 0.0 109.43 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -153.86 154.68 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.4 m-20 56.34 -109.71 0.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.475 -0.766 . . . . 0.0 109.61 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER 75.87 -54.21 0.62 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.315 -0.865 . . . . 0.0 109.723 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.64 -58.98 5.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.011 -1.055 . . . . 0.0 108.567 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -52.42 -35.55 52.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.358 -0.839 . . . . 0.0 108.913 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.681 ' CZ ' ' SD ' ' A' ' 21' ' ' MET . 30.6 t80 -68.46 -61.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.265 -0.897 . . . . 0.0 108.752 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 9.7 mmt -49.59 -33.94 16.47 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.641 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.15 -37.67 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.071 . . . . 0.0 109.447 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -62.81 -43.19 99.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.626 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.681 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 1.7 mtm -70.22 -3.17 15.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.211 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 32.5 61.99 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 24' ' ' ASN . 25.3 t -74.11 138.02 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 109.385 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 23' ' ' VAL . 31.8 m-20 -45.75 172.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.357 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.62 ' CD1' HH11 ' A' ' 28' ' ' ARG . 1.6 mm -83.77 -2.22 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.276 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -81.32 -60.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 2.4 mptm? -65.88 -20.14 66.12 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.62 HH11 ' CD1' ' A' ' 25' ' ' ILE . 3.2 tmm_? -75.44 -45.17 40.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.492 -0.755 . . . . 0.0 109.128 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.29 -36.34 74.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.571 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 mt -86.55 -13.23 46.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.753 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 27' ' ' LYS . . . -60.98 -52.95 62.85 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.14 -32.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.459 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 33.7 m170 -74.57 42.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' ND2' ' A' ' 35' ' ' ASN . 1.2 p30 -63.21 112.12 2.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 34' ' ' ASP . 3.0 m120 -147.57 42.88 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.31 -0.868 . . . . 0.0 109.242 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.557 ' H ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -82.08 158.91 23.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' SER . 7.0 tttt -113.58 138.18 50.53 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 1.9 pt? -147.45 145.29 29.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.989 -1.069 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 m -110.2 125.23 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 4.2 mp -110.89 133.27 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.486 -179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.88 152.1 51.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.592 HE22 ' H3 ' ' A' ' 1' ' ' ALA . 17.0 pt20 -138.08 141.14 40.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 45' ' ' ASN . 35.5 mt-10 -138.59 78.92 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.416 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.27 -82.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.37 29.32 7.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -1.095 . . . . 0.0 110.114 -178.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.53 110.73 4.85 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.47 166.78 10.2 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.3 m -153.72 103.2 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 108.615 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.94 114.37 41.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.579 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -106.65 100.02 9.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.582 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.79 155.64 26.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' LYS . 92.4 p -159.76 107.5 1.71 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.234 1.016 . . . . 0.0 109.077 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 m -118.67 -163.16 0.94 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.41 8.73 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.345 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 21.0 m-85 -125.35 -12.69 6.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 112.108 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER 165.59 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.233 -1.542 . . . . 0.0 110.026 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -62.95 145.48 55.21 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.391 -0.818 . . . . 0.0 109.217 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.683 HG21 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -131.13 174.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.348 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.683 ' H ' HG21 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -151.11 130.17 12.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.7 m -133.22 110.41 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.389 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.594 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.08 142.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.221 -0.924 . . . . 0.0 108.992 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER 176.16 173.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.672 -1.211 . . . . 0.0 110.785 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.89 162.38 13.17 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.487 HD11 ' C ' ' A' ' 64' ' ' LEU . 2.1 pp -82.32 135.22 35.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.918 -1.113 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.79 20.33 13.24 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 65.7 t -143.87 106.25 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.34 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -49.81 144.44 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.113 0.959 . . . . 0.0 110.25 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.612 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -156.74 -171.8 3.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -127.19 152.37 47.45 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.054 -1.028 . . . . 0.0 110.347 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.9 t -153.96 129.1 9.65 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.533 ' N ' ' ND2' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -88.35 149.53 23.7 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.112 -0.993 . . . . 0.0 110.239 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 73' ' ' ALA . 74.6 mt -100.73 146.85 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.325 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.622 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.28 -33.75 1.04 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.797 . . . . 0.0 109.86 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 14.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.622 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 67.56 28.64 73.58 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.451 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -99.41 162.12 13.22 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.506 ' HG2' ' HG1' ' A' ' 96' ' ' THR . 74.2 tt0 -132.36 118.75 19.79 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.59 162.89 30.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 0.0 110.495 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -143.63 141.17 30.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.807 . . . . 0.0 109.831 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.821 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.91 -117.39 0.64 Allowed Glycine 0 N--CA 1.476 1.351 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.2 159.24 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.025 -1.279 . . . . 0.0 110.898 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CZ ' ' A' ' 93' ' ' PHE . 15.3 m95 -101.91 142.58 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.594 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.9 m -140.68 157.6 45.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -92.79 127.17 38.2 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.306 -1.496 . . . . 0.0 108.194 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.93 121.61 36.56 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.57 -105.55 0.37 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 2.1 p-10 -125.13 33.62 5.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.016 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -140.36 159.17 42.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.02 -1.05 . . . . 0.0 110.095 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.44 108.97 21.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -78.63 164.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.101 -1.0 . . . . 0.0 110.64 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.33 95.24 0.17 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.672 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.7 pttp -88.9 104.08 16.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.166 -1.197 . . . . 0.0 109.034 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.6 m-30 -116.92 131.96 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.37 119.38 36.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.494 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 69.1 mtp180 -52.71 115.14 1.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.336 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.506 ' HG1' ' HG2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -83.38 -11.95 57.03 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.387 1.089 . . . . 0.0 109.219 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.62 -26.94 24.13 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.832 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -132.18 -0.18 3.72 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 57.21 45.09 93.0 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.582 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 20.2 t-20 -91.76 -122.62 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.274 -1.133 . . . . 0.0 109.227 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.7 pt-20 -175.54 137.3 0.36 Allowed 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.138 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 93' ' ' PHE . 55.2 tp -134.25 108.98 8.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -101.32 105.68 16.77 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 2.4 t -121.09 176.13 5.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 112.017 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.408 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.6 t -148.2 154.26 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.484 HH11 HD21 ' A' ' 113' ' ' LEU . 55.0 mtp180 -127.01 131.45 51.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 109.987 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -129.31 159.18 36.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.425 -0.797 . . . . 0.0 109.032 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.8 82.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.598 ' O ' ' N ' ' A' ' 111' ' ' ASP . 15.5 mt -63.53 91.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.798 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.0 -81.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.3 m-20 -125.6 29.31 6.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.481 ' HG2' ' HZ2' ' A' ' 129' ' ' LYS . 2.3 mt-10 -137.37 147.19 45.32 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 108.735 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.484 HD21 HH11 ' A' ' 106' ' ' ARG . 10.5 tp -107.72 110.52 22.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.499 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 127' ' ' ILE . 2.5 t -90.59 115.68 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.439 -0.788 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -114.04 103.26 10.97 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.542 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.05 145.28 29.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -127.33 149.91 49.83 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.471 178.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 103' ' ' ASN . 6.9 t -117.1 150.23 19.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.582 ' CE1' ' OD1' ' A' ' 100' ' ' ASN . 1.1 t80 -142.56 110.06 5.73 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.754 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 45.57 20.44 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 119' ' ' TYR . . . 112.91 28.63 3.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.554 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.58 176.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.41 ' H ' HG23 ' A' ' 122' ' ' VAL . 2.7 tt0 -155.98 125.82 6.45 Favored 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 118.045 -1.462 . . . . 0.0 111.406 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.401 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -122.77 151.19 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.493 ' O ' ' OG ' ' A' ' 11' ' ' SER . 19.5 ttpt -130.03 140.21 50.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.916 -1.115 . . . . 0.0 111.112 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.463 ' CZ ' ' OH ' ' A' ' 117' ' ' TYR . 11.0 ttm180 -137.41 114.11 10.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.445 HG23 HG22 ' A' ' 114' ' ' VAL . 2.2 mp -105.99 131.41 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 0.0 111.132 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.552 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 3.0 m-30 -100.9 176.05 5.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.481 ' HZ2' ' HG2' ' A' ' 112' ' ' GLU . 28.1 tttp -165.16 157.08 15.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.804 . . . . 0.0 109.245 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -47.27 130.16 12.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.397 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.848 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.2 OUTLIER 42.32 33.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.323 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 4' ' ' SER . 2.8 p30 -76.82 93.56 3.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.601 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.622 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.1 t 162.47 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.622 ' N ' ' OG ' ' A' ' 4' ' ' SER . 90.6 m -89.96 145.51 25.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.848 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 12.2 m95 -151.41 168.26 25.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 109.542 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.4 pttp -153.15 133.53 13.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.965 . . . . 0.0 109.445 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -38.15 106.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.269 -0.894 . . . . 0.0 109.622 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -93.59 -28.25 16.14 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' OG ' ' A' ' 11' ' ' SER . 25.6 mtm180 -152.73 173.14 15.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.882 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 51.5 m -172.98 178.22 2.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 0.0 109.145 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 3.1 pt-20 -157.06 154.55 29.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.067 -1.02 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.3 m-20 56.5 -109.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 109.826 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.5 -53.47 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.356 -0.84 . . . . 0.0 109.701 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -48.67 80.77 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.994 -1.066 . . . . 0.0 108.76 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -60.2 -33.26 71.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.652 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 49.1 t80 -72.0 -62.85 1.28 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.567 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 25.9 mmt -56.48 -23.57 40.15 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.345 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.95 -37.59 54.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.057 -1.027 . . . . 0.0 109.243 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -64.66 -39.93 94.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.195 -0.941 . . . . 0.0 109.21 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.6 mtp -65.12 -9.61 24.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.118 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.91 29.93 27.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 24' ' ' ASN . 19.5 t -79.78 126.3 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -1.144 . . . . 0.0 109.441 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 23' ' ' VAL . 9.8 m-80 -42.4 165.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.13 -1.99 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.158 0.98 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -80.26 -59.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -65.06 -22.56 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -73.15 -44.49 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -70.77 -33.05 70.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.49 -13.21 46.7 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.007 0.908 . . . . 0.0 109.752 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -78.63 -45.64 21.08 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.608 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.575 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.06 -22.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 31' ' ' ALA . 31.6 m170 -69.28 37.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.302 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.575 ' H ' ' C ' ' A' ' 32' ' ' ALA . 2.4 m-20 -51.05 95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.557 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' HIS . 12.0 m120 -147.66 42.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.307 -0.871 . . . . 0.0 109.206 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.569 HD21 ' H ' ' A' ' 36' ' ' LEU . 0.9 OUTLIER -97.69 170.74 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -179.084 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -108.65 142.19 39.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.746 -0.596 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.535 HD22 HD12 ' A' ' 36' ' ' LEU . 1.9 mp -139.12 128.26 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -102.81 117.08 33.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.95 122.86 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.622 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.43 151.8 37.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.58 145.08 50.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -139.49 78.95 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.6 -81.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 43' ' ' GLU . 19.8 m120 -122.37 28.85 7.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -1.127 . . . . 0.0 110.253 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -153.57 110.12 3.37 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -94.19 173.91 7.41 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.791 -0.568 . . . . 0.0 109.485 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.5 m -155.81 103.49 2.26 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.152 -0.967 . . . . 0.0 108.99 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.6 t -98.19 113.14 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.66 -0.65 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -99.97 100.45 11.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.2 tt0 -72.81 155.88 39.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.173 -0.954 . . . . 0.0 108.818 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -160.48 107.04 1.52 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.168 -0.958 . . . . 0.0 109.021 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.731 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -137.0 144.25 43.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.64 7.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.024 -1.048 . . . . 0.0 109.069 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.731 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.3 m-85 -112.41 -31.18 6.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.27 -0.894 . . . . 0.0 111.476 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.0 tpp85 177.84 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.655 -1.278 . . . . 0.0 109.378 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.756 HD21 ' H ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -63.18 140.29 58.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.094 179.657 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.715 HG21 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -139.17 174.41 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.715 ' H ' HG21 ' A' ' 58' ' ' ILE . 5.2 pt-20 -152.0 141.64 21.79 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -151.46 132.21 14.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.17 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.301 -0.874 . . . . 0.0 108.847 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.34 167.35 21.19 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.115 -0.991 . . . . 0.0 109.947 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 26.5 tt0 -159.95 168.06 26.56 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.527 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 31.2 mt -98.59 122.23 41.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.25 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 24.47 47.37 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.501 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.62 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 89.5 t -144.18 102.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.275 . . . . 0.0 109.416 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.75 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.29 141.29 54.77 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.169 0.985 . . . . 0.0 110.062 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.62 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.06 -171.29 3.79 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.574 ' C ' HD21 ' A' ' 69' ' ' ASN . 0.4 OUTLIER -142.41 151.16 41.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.836 -1.146 . . . . 0.0 110.799 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.445 ' SG ' ' N ' ' A' ' 71' ' ' ASN . 49.5 t -144.83 170.69 15.64 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 76' ' ' THR . 1.5 p-10 -126.12 141.26 52.02 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.864 -1.147 . . . . 0.0 110.396 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.9 mt -93.12 146.85 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.542 -0.724 . . . . 0.0 109.371 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.639 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.09 -28.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.837 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.567 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 47.5 m-20 -67.68 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.28 27.78 68.16 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.523 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.03 162.02 13.24 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.424 -1.045 . . . . 0.0 109.399 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' C ' ' CD1' ' A' ' 78' ' ' LEU . 69.4 tt0 -132.86 116.29 16.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.755 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -119.66 150.93 39.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.011 . . . . 0.0 110.404 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -136.87 140.59 42.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.877 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.92 -117.24 0.63 Allowed Glycine 0 N--CA 1.477 1.378 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.5 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.8 159.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -1.181 . . . . 0.0 110.54 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.0 m95 -101.77 142.84 32.48 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.597 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.0 m -138.35 157.23 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -96.18 127.35 42.1 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.352 -1.468 . . . . 0.0 108.205 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -127.32 114.74 17.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.21 -106.45 1.33 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -125.17 34.31 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -1.131 . . . . 0.0 110.427 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.57 150.67 37.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 110.314 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.55 109.99 21.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.597 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -80.12 164.58 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.119 -0.988 . . . . 0.0 110.538 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.69 95.84 0.17 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.681 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 14.0 ptmt -86.41 107.04 17.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.27 -1.135 . . . . 0.0 108.678 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -117.07 140.35 49.6 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.84 0.828 . . . . 0.0 110.234 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -125.48 113.27 17.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.47 0.652 . . . . 0.0 109.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 99' ' ' GLY . 30.9 mtp180 -51.51 114.82 1.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.87 -13.76 62.41 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.355 1.074 . . . . 0.0 109.628 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.48 -48.35 15.52 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.786 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' GLY . 34.4 m120 -132.54 10.68 4.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.151 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 44.46 39.36 5.7 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.716 ' O ' ' O ' ' A' ' 101' ' ' GLU . 2.4 m120 -75.17 18.95 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.168 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.716 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.0 pt-20 43.7 161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.929 . . . . 0.0 111.239 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.48 ' C ' ' CD2' ' A' ' 102' ' ' LEU . 6.3 tt -161.23 123.83 3.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.6 OUTLIER -112.18 113.92 26.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 109.143 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 116' ' ' THR . 2.1 t -124.69 176.11 6.78 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.186 -0.946 . . . . 0.0 110.948 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.9 t -149.59 154.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -127.05 136.5 52.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.67 158.63 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -121.29 82.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 121.117 -0.989 . . . . 0.0 108.38 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.555 ' O ' ' N ' ' A' ' 111' ' ' ASP . 24.2 mt -63.54 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.765 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.47 -81.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -129.21 29.17 5.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -1.187 . . . . 0.0 110.206 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.36 142.54 48.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 108.75 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 12.2 tp -103.28 110.34 22.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.932 -1.105 . . . . 0.0 109.266 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.601 HG21 HG22 ' A' ' 127' ' ' ILE . 18.1 t -95.83 110.15 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -108.45 106.86 17.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.503 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -100.92 144.6 29.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.166 -0.959 . . . . 0.0 109.792 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.3 OUTLIER -123.27 152.59 41.21 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.816 0.817 . . . . 0.0 109.161 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 103' ' ' ASN . 11.2 t -121.93 147.76 25.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.546 ' N ' HG13 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -144.5 110.67 5.48 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.973 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 48.59 18.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.26 0.552 . . . . 0.0 111.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.34 28.33 3.58 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -122.71 176.91 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.39 124.58 6.24 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.303 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.419 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -116.14 154.38 30.11 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.578 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 5.5 ttmt -131.99 139.72 48.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 111.175 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -135.58 113.93 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.601 HG22 HG21 ' A' ' 114' ' ' VAL . 5.4 mt -109.16 123.83 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.084 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.526 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -98.83 176.01 5.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 130' ' ' LYS . 3.0 tttp -163.78 161.65 23.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.468 ' H ' ' HG2' ' A' ' 129' ' ' LYS . 10.7 ptpt -47.61 132.3 14.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.498 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.74 ' O ' ' C ' ' A' ' 3' ' ' ASP . 11.7 m-85 -79.09 25.8 0.28 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.959 . . . . 0.0 109.718 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.74 ' C ' ' O ' ' A' ' 2' ' ' PHE . 11.1 t70 -13.55 83.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.706 ' N ' ' O ' ' A' ' 2' ' ' PHE . 28.8 t 167.5 -136.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.519 ' N ' ' OG ' ' A' ' 4' ' ' SER . 18.2 m -89.3 131.14 35.54 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.952 0.882 . . . . 0.0 111.946 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.855 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 9.6 m95 -123.41 170.62 10.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.488 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 13.9 pttp -144.57 122.43 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 110.123 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.588 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -42.35 107.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -94.69 -30.33 14.35 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -150.27 165.2 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.727 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 11.8 t -168.47 178.32 4.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.367 -0.833 . . . . 0.0 109.267 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -155.29 156.21 35.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.57 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 16.2 m-20 59.68 -109.04 0.41 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.924 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.544 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 73.07 -52.25 0.71 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.37 -43.61 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.956 -1.09 . . . . 0.0 109.019 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -67.55 -31.56 71.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -73.43 -57.0 4.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.598 ' C ' HH22 ' A' ' 28' ' ' ARG . 16.1 mmt -60.33 -29.16 68.7 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.567 ' N ' HH22 ' A' ' 28' ' ' ARG . 16.5 tp10 -77.12 -27.97 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.241 -0.912 . . . . 0.0 109.633 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -73.57 -37.66 65.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.489 ' HB2' HG21 ' A' ' 23' ' ' VAL . 2.1 mtm -69.16 -8.35 44.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.142 -0.973 . . . . 0.0 108.932 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.26 29.47 37.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 23.7 t -77.18 127.17 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -1.208 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.695 ' H ' ' ND2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -42.61 164.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.643 ' CD1' ' HE ' ' A' ' 28' ' ' ARG . 1.3 mm -80.04 -1.33 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.18 0.99 . . . . 0.0 109.178 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 t -81.36 -59.85 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -63.85 -28.84 70.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.643 ' HE ' ' CD1' ' A' ' 25' ' ' ILE . 9.9 ttm-85 -70.64 -43.85 68.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.369 -0.832 . . . . 0.0 109.249 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.06 -33.02 74.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.414 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 -13.63 44.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.12 -36.13 19.77 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.654 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . -44.6 -15.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.592 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 35' ' ' ASN . 14.1 m80 -80.24 46.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.586 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -44.81 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 33' ' ' HIS . 62.6 t-20 -147.67 42.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.401 -0.812 . . . . 0.0 109.142 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.526 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -97.55 175.75 6.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.81 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.52 152.54 37.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.442 HD23 ' CE2' ' A' ' 128' ' ' PHE . 3.3 mp -139.83 128.94 23.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.569 ' HG1' ' HB3' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -97.86 104.15 16.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.855 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -105.65 126.43 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -132.71 152.07 51.81 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -135.35 142.81 45.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.913 -1.117 . . . . 0.0 110.05 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' ASN . 24.2 mm-40 -140.23 78.92 1.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.73 -86.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -117.58 29.19 8.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -146.1 110.77 5.17 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.41 166.56 10.67 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 61' ' ' VAL . 26.1 m -154.16 103.25 2.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 108.652 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.614 HG22 HG23 ' A' ' 40' ' ' ILE . 87.5 t -104.41 141.36 20.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.569 ' HB3' ' HG1' ' A' ' 39' ' ' THR . 6.3 tttp -135.34 100.15 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.934 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.55 157.21 37.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 108.71 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -156.56 107.06 2.36 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.075 -1.016 . . . . 0.0 109.174 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.74 ' C ' ' H ' ' A' ' 55' ' ' PHE . 2.2 p -137.67 144.64 41.92 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.42 7.51 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.995 -1.065 . . . . 0.0 109.266 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.74 ' H ' ' C ' ' A' ' 53' ' ' SER . 88.4 t80 -104.63 -26.8 12.18 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 110.85 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 160.08 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 109.027 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -62.35 145.31 54.21 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.442 -0.787 . . . . 0.0 109.449 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.69 HG21 ' H ' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -133.76 173.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.214 -0.929 . . . . 0.0 110.186 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.69 ' H ' HG21 ' A' ' 58' ' ' ILE . 8.5 pt-20 -149.8 147.71 28.32 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.46 0.647 . . . . 0.0 109.711 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.13 110.33 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.833 . . . . 0.0 109.242 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.592 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -109.82 143.63 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.217 -0.927 . . . . 0.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 176.29 169.84 0.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.854 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -94.56 151.13 19.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 64' ' ' LEU . 1.3 pp -76.97 133.08 39.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.924 -1.11 . . . . 0.0 109.272 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.0 21.1 11.36 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.591 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 27.9 t -143.35 106.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -1.151 . . . . 0.0 109.31 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.85 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -46.36 145.68 1.65 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.153 0.978 . . . . 0.0 110.17 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -160.45 -171.6 3.22 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.725 ' N ' HD21 ' A' ' 69' ' ' ASN . 0.6 OUTLIER -123.26 153.45 40.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 110.149 -179.663 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 93.2 m -157.79 129.29 6.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -90.68 147.92 22.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.072 -1.017 . . . . 0.0 110.259 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 52.5 mt -99.44 146.89 25.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.651 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.29 -31.68 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.838 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 21.6 t70 -65.71 15.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 109.329 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.651 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 64.94 27.16 71.84 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 162.05 13.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.312 -1.111 . . . . 0.0 109.533 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -132.47 119.71 20.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -135.8 163.85 29.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 0.0 110.448 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -142.05 140.14 32.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.74 . . . . 0.0 109.934 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.85 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.72 -117.78 0.64 Allowed Glycine 0 C--O 1.21 -1.358 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.31 157.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.107 -1.231 . . . . 0.0 110.58 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.577 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.36 142.13 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.585 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.12 157.32 45.45 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -93.21 126.63 38.42 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.306 -1.496 . . . . 0.0 108.407 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' O ' ' CE ' ' A' ' 88' ' ' LYS . 3.7 mm-40 -123.8 113.49 18.62 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.31 -105.25 0.99 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 87' ' ' ASN . 17.5 t-20 -125.17 34.17 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -1.128 . . . . 0.0 110.372 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.426 ' CE ' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -144.79 150.8 37.8 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.739 -1.226 . . . . 0.0 110.316 -179.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mt -94.77 108.77 20.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.585 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -79.4 164.0 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.099 -1.0 . . . . 0.0 110.698 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 104' ' ' THR . . . -147.28 95.59 0.17 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.63 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.45 108.91 19.92 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.205 -1.174 . . . . 0.0 109.016 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.501 ' HB2' HD23 ' A' ' 102' ' ' LEU . 3.0 m-30 -118.4 135.83 54.12 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.748 0.785 . . . . 0.0 109.986 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -118.01 115.25 24.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.314 0.578 . . . . 0.0 109.506 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 33.7 mtm180 -49.04 115.12 1.17 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -10.69 60.05 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.417 1.103 . . . . 0.0 109.357 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.0 -41.45 12.35 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.698 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.47 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -132.66 7.43 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.28 34.72 1.63 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.69 ' O ' ' O ' ' A' ' 101' ' ' GLU . 19.1 t-20 -74.96 18.66 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.159 -1.201 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.69 ' O ' ' O ' ' A' ' 100' ' ' ASN . 9.3 pt-20 44.5 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.012 0.91 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 93' ' ' PHE . 7.0 tt -158.5 130.63 6.82 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.68 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -117.97 118.61 32.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.96 -1.088 . . . . 0.0 109.173 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.5 t -130.47 176.46 8.13 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.12 -0.988 . . . . 0.0 110.752 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 106' ' ' ARG . 42.4 t -146.76 158.86 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.42 ' N ' ' CG1' ' A' ' 105' ' ' VAL . 10.9 ttp180 -131.65 135.23 46.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.79 158.64 43.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 108.92 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.53 83.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.72 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.7 mm -60.27 92.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.514 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 47.2 -74.86 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.72 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -125.73 30.02 5.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -1.202 . . . . 0.0 110.907 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -146.12 147.52 31.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.738 -1.227 . . . . 0.0 109.679 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.465 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 6.5 tp -102.49 115.24 30.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.049 -1.032 . . . . 0.0 108.855 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.6 t -102.7 108.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.416 ' OE1' ' OH ' ' A' ' 117' ' ' TYR . 13.3 tt0 -109.55 106.1 15.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.8 OUTLIER -103.03 145.95 29.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -124.95 158.76 32.81 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.908 0.861 . . . . 0.0 109.486 178.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 103' ' ' ASN . 10.5 t -127.46 148.46 32.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.551 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.66 110.29 5.3 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.684 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 47.37 19.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.164 0.507 . . . . 0.0 111.104 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.73 28.25 3.51 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.5 176.51 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 15.1 pt-20 -156.38 126.02 6.29 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.648 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.404 ' O ' ' CG2' ' A' ' 116' ' ' THR . . . -116.92 150.19 38.9 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.403 ' O ' ' OG ' ' A' ' 11' ' ' SER . 10.4 ttmm -126.23 139.37 53.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.773 -1.204 . . . . 0.0 110.757 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.544 ' NH1' ' OH ' ' A' ' 14' ' ' TYR . 7.0 mtt180 -129.81 114.16 15.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.01 122.72 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.035 . . . . 0.0 110.352 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.588 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 2.6 m-30 -107.1 177.15 4.94 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.775 0.797 . . . . 0.0 110.409 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -152.91 164.88 37.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 131' ' ' ASP . 16.5 pttp -47.19 138.65 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.031 . . . . 0.0 109.459 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 130' ' ' LYS . 4.9 p-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.448 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 4' ' ' SER . 16.9 t70 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.684 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 165.2 -164.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 0.0 109.729 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.684 ' N ' ' OG ' ' A' ' 4' ' ' SER . 43.2 m -102.13 146.74 27.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.663 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.59 ' CD1' ' C ' ' A' ' 5' ' ' THR . 4.4 m95 -151.39 169.26 22.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 8' ' ' VAL . 18.1 pttp -152.58 128.41 10.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.097 -1.002 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.572 HG13 ' HA ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -37.45 107.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -97.69 -25.93 14.92 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.7 mtp180 -140.55 160.0 40.96 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.097 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.518 ' CB ' ' OD2' ' A' ' 34' ' ' ASP . 31.0 t -179.92 157.27 0.69 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' A' ' 125' ' ' LYS . 10.6 pt-20 -166.78 166.27 15.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.256 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.37 -6.77 0.59 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.547 -0.72 . . . . 0.0 109.738 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -47.94 -22.44 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.997 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.48 ' CA ' ' HE ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -71.99 -48.16 46.89 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.996 -1.065 . . . . 0.0 108.868 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -59.92 -36.68 77.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.956 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 49.6 t80 -68.23 -64.02 0.94 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.817 0.818 . . . . 0.0 108.93 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.0 mmt -56.52 -23.38 39.28 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.427 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.52 -23.97 34.32 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.057 -1.027 . . . . 0.0 109.118 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -74.45 -43.8 54.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -0.912 . . . . 0.0 108.995 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.592 ' SD ' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -58.76 -14.3 8.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.648 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.21 29.64 40.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 24' ' ' ASN . 2.1 t -79.33 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.391 -1.064 . . . . 0.0 109.444 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 23' ' ' VAL . 3.2 m120 -43.47 168.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.374 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -78.8 -2.32 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.38 -59.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.696 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -62.38 -24.19 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HE ' ' CA ' ' A' ' 15' ' ' ASP . 50.9 ttt180 -73.03 -47.28 46.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.508 -0.745 . . . . 0.0 109.208 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -68.96 -33.12 73.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 mt -86.52 -13.03 47.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.934 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -77.13 -52.62 8.97 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.165 0.507 . . . . 0.0 109.866 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.19 -28.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.692 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 31' ' ' ALA . 23.8 m170 -74.6 46.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' OD2' ' CB ' ' A' ' 11' ' ' SER . 6.1 p30 -66.38 115.12 5.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.572 ' HA ' HG13 ' A' ' 8' ' ' VAL . 10.4 m120 -147.74 43.21 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -89.06 165.02 14.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.469 ' C ' HD12 ' A' ' 38' ' ' LEU . 2.2 tttp -109.19 149.59 29.15 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -143.67 127.05 16.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.922 -1.111 . . . . 0.0 110.332 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 40' ' ' ILE . 3.0 m -103.14 111.41 23.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.787 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.7 mp -109.4 142.42 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 111.515 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -135.26 152.25 51.35 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.459 ' NE2' ' H ' ' A' ' 44' ' ' GLY . 2.1 tm0? -135.56 142.69 45.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 110.018 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 45' ' ' ASN . 4.9 mm-40 -142.15 78.86 1.64 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.459 ' H ' ' NE2' ' A' ' 42' ' ' GLN . . . 52.49 -88.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -113.66 29.16 8.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -1.102 . . . . 0.0 109.997 -179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.9 110.5 5.57 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.415 ' CZ ' ' HG3' ' A' ' 42' ' ' GLN . 6.0 m-85 -104.32 162.3 13.33 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.468 HG23 HG13 ' A' ' 61' ' ' VAL . 30.8 m -153.96 102.99 2.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 p -107.16 129.5 60.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -119.11 100.17 7.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.819 . . . . 0.0 109.388 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.23 160.45 31.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 108.833 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -160.48 106.93 1.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.088 -1.008 . . . . 0.0 109.303 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.644 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -129.31 144.29 51.17 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.77 7.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.985 -1.072 . . . . 0.0 109.387 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.644 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.6 OUTLIER -115.22 -20.09 10.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 111.35 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 165.57 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.55 -1.344 . . . . 0.0 109.423 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -62.35 149.45 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.343 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -136.98 174.21 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 58' ' ' ILE . 6.5 pt-20 -154.21 146.29 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.8 m -151.07 110.7 4.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.835 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -108.47 141.27 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.41 172.49 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.777 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 44.8 tt0 -98.37 164.74 12.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 64' ' ' LEU . 2.7 pp -82.04 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.842 -1.162 . . . . 0.0 109.593 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -31.99 6.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.1 p -88.4 117.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -1.23 . . . . 0.0 109.911 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -55.98 145.14 26.17 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.013 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -153.53 -171.6 3.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -130.55 150.68 51.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.995 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.69 133.65 12.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -88.97 149.24 23.38 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 75' ' ' GLY . 52.5 mt -99.53 146.82 25.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.425 -0.797 . . . . 0.0 109.374 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.89 -32.97 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.714 . . . . 0.0 109.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.67 12.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.84 27.75 72.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.421 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -99.33 162.23 13.16 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.193 -1.18 . . . . 0.0 109.471 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.473 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.8 tt0 -132.33 118.59 19.61 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -135.22 162.9 31.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.679 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB3' HH21 ' A' ' 79' ' ' ARG . 6.0 ptm85 -142.26 142.91 32.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.764 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.06 -117.43 0.64 Allowed Glycine 0 N--CA 1.476 1.35 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.4 157.54 0.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.138 -1.213 . . . . 0.0 110.913 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.496 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 6.1 m95 -102.27 141.56 34.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.639 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.2 m -142.23 156.28 45.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.097 -1.002 . . . . 0.0 108.667 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 121.37 27.11 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.115 -1.616 . . . . 0.0 110.038 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.51 107.83 17.15 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.17 -102.22 0.45 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -124.84 33.52 5.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -1.14 . . . . 0.0 109.838 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 163.64 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.062 -1.024 . . . . 0.0 109.772 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mt -102.79 104.42 14.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 108.586 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.639 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -73.55 164.42 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.987 . . . . 0.0 110.247 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.6 94.69 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.662 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 35.4 mttm -88.63 105.21 17.51 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 108.835 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -116.22 136.77 52.72 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.886 0.85 . . . . 0.0 110.091 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -116.84 116.32 27.23 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.607 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.6 mtp180 -53.01 114.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.808 . . . . 0.0 108.847 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -70.32 -12.74 61.79 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.501 1.143 . . . . 0.0 109.377 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.67 -50.96 11.38 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -132.57 11.64 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.2 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.56 41.7 12.98 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.744 ' O ' ' O ' ' A' ' 101' ' ' GLU . 2.4 m120 -78.04 19.78 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -1.199 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.744 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.9 pt-20 42.7 158.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.016 0.912 . . . . 0.0 111.212 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 103' ' ' ASN . 6.4 tt -157.39 127.12 6.12 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.745 ' N ' HD23 ' A' ' 102' ' ' LEU . 5.6 t30 -116.93 113.84 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.087 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -125.41 175.98 7.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.179 -0.951 . . . . 0.0 111.174 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 43.8 t -144.86 146.94 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.8 132.5 54.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.149 -0.969 . . . . 0.0 109.909 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.08 157.77 45.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.446 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.2 mt -125.66 82.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 120.917 -1.115 . . . . 0.0 108.627 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 111' ' ' ASP . 63.7 mt -63.02 92.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.223 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.49 -78.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -130.61 29.14 4.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.127 -1.219 . . . . 0.0 110.197 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.85 136.89 40.95 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.244 -0.91 . . . . 0.0 108.883 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -98.03 110.92 23.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.903 -1.123 . . . . 0.0 109.906 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.6 t -92.35 113.39 27.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.309 -0.956 . . . . 0.0 108.577 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.445 ' CD ' ' OH ' ' A' ' 117' ' ' TYR . 48.9 tt0 -115.79 103.67 10.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.681 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.41 144.11 31.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.555 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -125.34 151.13 46.47 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.847 0.832 . . . . 0.0 109.471 178.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 122' ' ' VAL . 8.4 t -118.2 147.48 21.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.521 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.91 110.7 5.39 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.882 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 48.54 18.67 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.184 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.17 28.3 3.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.33 177.11 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.01 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 43.0 tt0 -155.44 117.04 4.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.242 -1.383 . . . . 0.0 111.368 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.956 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -106.77 150.62 26.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 12' ' ' GLU . 2.6 mtmm -126.99 137.48 53.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.904 -1.123 . . . . 0.0 110.48 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -140.14 114.01 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.1 mp -109.45 130.86 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 0.0 111.108 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.522 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -99.95 176.26 5.49 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.424 0.631 . . . . 0.0 109.407 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -164.58 151.29 11.03 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -47.43 132.89 13.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 2.3 p-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.52 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.138 0.494 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 5' ' ' THR . 28.2 t -179.07 -163.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 109.619 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 70.6 m -91.86 147.35 23.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.104 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.573 ' CD1' ' C ' ' A' ' 5' ' ' THR . 14.9 m95 -151.09 168.73 23.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 7.4 mtpt -150.63 128.53 11.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.388 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.72 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -42.55 106.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.06 -30.24 13.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -148.97 164.95 33.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.98 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.5 m -171.77 178.09 3.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.366 -0.834 . . . . 0.0 108.992 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -156.19 158.69 38.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.12 . . . . 0.0 110.104 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.2 m-20 57.71 -109.57 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.692 -0.63 . . . . 0.0 109.739 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE2' ' NH1' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 71.55 -51.3 0.69 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.84 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HB3' HH21 ' A' ' 28' ' ' ARG . 7.7 p-10 -62.8 -40.55 97.71 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.955 -1.091 . . . . 0.0 108.97 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -70.31 -31.0 68.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.882 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 78.5 t80 -74.18 -56.93 4.33 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.561 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 11.7 mmt -60.1 -32.83 71.34 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.42 -37.49 74.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -63.98 -41.05 97.64 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.593 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 23' ' ' VAL . 2.4 mtm -66.48 -8.33 25.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.199 -0.938 . . . . 0.0 109.086 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.61 32.6 10.03 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.471 HG21 ' SD ' ' A' ' 18' ' ' MET . 26.6 t -94.05 140.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -1.146 . . . . 0.0 109.553 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.35 157.82 4.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.361 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm -82.24 -1.23 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.213 1.006 . . . . 0.0 109.142 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -80.1 -59.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -56.55 -33.9 66.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 108.85 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.604 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -65.69 -52.09 54.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.75 -33.84 57.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.413 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.51 -13.23 46.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.023 0.916 . . . . 0.0 109.518 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASP . . . -84.3 -51.03 7.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.7 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.59 -57.53 2.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.502 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -75.69 44.79 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ALA . 63.7 t0 -116.02 101.48 8.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' HA ' HG13 ' A' ' 8' ' ' VAL . 17.3 m-20 -84.66 43.55 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.406 -0.809 . . . . 0.0 109.357 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.72 HD23 HG11 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -47.09 155.65 0.27 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.748 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -105.74 148.21 27.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.821 -0.549 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.52 HD22 ' CE2' ' A' ' 128' ' ' PHE . 2.5 mp -139.28 123.64 18.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 m -101.91 107.94 19.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.1 mp -101.02 133.6 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.16 -0.962 . . . . 0.0 110.747 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.48 152.08 48.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -130.05 147.83 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 109.863 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -145.1 79.18 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.82 -87.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 7.8 p-10 -125.8 28.58 6.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -1.093 . . . . 0.0 110.093 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -147.75 110.04 4.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -98.12 174.4 6.55 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.508 0.671 . . . . 0.0 109.799 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -152.27 103.87 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -96.25 114.77 33.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -105.11 100.23 9.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.832 . . . . 0.0 109.345 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -74.64 152.82 39.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.034 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.38 105.95 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.157 0.98 . . . . 0.0 108.546 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.658 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -131.12 144.49 51.44 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.15 7.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.983 -1.073 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 53' ' ' SER . 72.6 m-85 -109.79 -25.88 10.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -0.978 . . . . 0.0 111.235 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER 165.65 87.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.704 -1.248 . . . . 0.0 109.312 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -62.29 139.81 58.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.42 -0.8 . . . . 0.0 109.643 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.602 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -132.26 174.35 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.874 0.845 . . . . 0.0 110.247 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.602 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.0 pt-20 -151.39 142.98 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.56 127.03 5.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.549 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -78.58 163.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.368 -0.832 . . . . 0.0 109.242 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.588 ' CE2' ' SG ' ' A' ' 70' ' ' CYS . 36.0 m-85 -143.37 117.87 9.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 64' ' ' LEU . 1.1 tm-20 -111.32 164.31 13.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.037 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.604 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 95.7 mt -103.34 118.24 36.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 109.915 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.58 18.37 41.73 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.46 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.622 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.0 t -141.37 105.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.948 -1.325 . . . . 0.0 109.568 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -56.29 143.52 33.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.898 . . . . 0.0 109.871 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -153.84 -170.85 3.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -132.34 151.07 52.01 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.563 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.588 ' SG ' ' CE2' ' A' ' 62' ' ' PHE . 68.1 m -149.42 127.82 12.23 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.554 ' OD1' HG21 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -89.66 144.47 25.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 110.343 -178.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.672 ' CD1' HD11 ' A' ' 78' ' ' LEU . 70.7 mt -99.35 146.88 25.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.99 -29.37 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.797 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.561 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 15.7 m-20 -66.62 17.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.164 -0.96 . . . . 0.0 109.241 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 63.57 26.92 70.18 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 161.88 13.33 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.233 -1.157 . . . . 0.0 109.696 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.497 ' O ' ' OG1' ' A' ' 96' ' ' THR . 40.7 tt0 -132.62 117.53 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.672 HD11 ' CD1' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -127.68 157.0 41.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.987 -1.07 . . . . 0.0 110.626 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 21.4 ptt85 -140.51 142.48 35.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.838 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.61 -119.63 0.8 Allowed Glycine 0 N--CA 1.475 1.277 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.504 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.8 159.62 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.153 -1.204 . . . . 0.0 110.403 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.41 143.12 32.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.229 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -137.32 157.06 47.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -97.75 128.28 44.29 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.315 -1.491 . . . . 0.0 108.273 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.646 ' N ' HD12 ' A' ' 84' ' ' LEU . 30.6 mt-10 -128.36 117.8 22.07 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.75 -106.88 1.19 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.405 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 37.4 t-20 -125.17 34.42 4.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.162 . . . . 0.0 110.55 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.405 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -144.76 147.33 32.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.693 -1.254 . . . . 0.0 110.242 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt -92.75 113.55 25.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -84.78 165.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 110.766 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.37 95.93 0.17 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.655 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.4 ptpt -87.69 104.97 17.04 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.27 -1.135 . . . . 0.0 108.757 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m-30 -117.65 145.96 44.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.9 0.857 . . . . 0.0 110.314 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -125.92 123.86 39.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 34.3 mtp180 -57.74 115.22 2.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -69.38 -12.42 61.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.423 1.106 . . . . 0.0 109.466 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.32 -46.62 13.37 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.468 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -132.54 8.67 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.137 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 43.35 41.53 5.19 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 101' ' ' GLU . 7.1 m-20 -77.01 15.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.679 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.0 mt-10 52.51 150.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.646 0.736 . . . . 0.0 110.651 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 103' ' ' ASN . 3.4 tp -152.77 128.06 9.86 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.638 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER -116.27 118.64 33.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 108.779 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.6 t -129.05 176.2 8.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.162 -0.961 . . . . 0.0 110.559 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 106' ' ' ARG . 45.5 t -145.52 160.69 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.453 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.6 ttt85 -135.09 135.11 40.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -140.36 158.35 44.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 109.105 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.12 82.3 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.699 HD12 HG21 ' A' ' 114' ' ' VAL . 32.2 mt -63.82 91.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.107 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.05 -80.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -130.85 29.5 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 129' ' ' LYS . 6.9 mt-10 -133.05 141.12 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 0.0 108.969 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 128' ' ' PHE . 11.4 tp -101.0 114.58 28.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.88 -1.137 . . . . 0.0 108.859 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.699 HG21 HD12 ' A' ' 109' ' ' ILE . 12.9 t -104.9 106.77 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.325 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -105.79 108.16 19.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.01 147.37 24.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.128 -0.983 . . . . 0.0 109.885 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.646 ' O ' ' HA ' ' A' ' 123' ' ' GLU . 2.7 m-85 -121.36 158.36 28.42 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.436 -0.79 . . . . 0.0 109.158 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 103' ' ' ASN . 10.8 t -131.2 147.07 32.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.567 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -147.38 110.25 4.73 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.099 -1.041 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 45.99 20.45 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.124 0.488 . . . . 0.0 111.238 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.81 28.32 3.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.62 176.52 5.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.7 mt-10 -156.13 126.69 6.74 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.123 -1.431 . . . . 0.0 111.284 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -114.36 159.07 20.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -134.11 137.41 44.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.874 -1.141 . . . . 0.0 110.877 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.644 ' NH1' ' CE2' ' A' ' 14' ' ' TYR . 6.7 mmt180 -129.77 114.13 15.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 8.7 mt -113.01 122.72 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.01 -1.056 . . . . 0.0 111.14 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.8 m-30 -104.92 174.11 6.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.736 . . . . 0.0 109.138 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 112' ' ' GLU . 30.4 tttp -161.81 159.78 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.324 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -47.77 131.62 14.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.931 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.3 t0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.479 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 19.1 t0 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 40' ' ' ILE . 1.4 t -177.47 -138.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.688 . . . . 0.0 110.018 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.6 m -89.41 148.39 23.51 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.931 0.872 . . . . 0.0 111.482 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.708 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 17.1 m95 -144.81 168.66 19.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 2.4 pttp -152.5 125.53 8.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.513 -1.367 . . . . 0.0 110.843 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.609 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -44.04 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.285 -0.884 . . . . 0.0 109.769 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.44 -30.66 16.35 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HB2' HD12 ' A' ' 127' ' ' ILE . 6.6 mtp85 -151.3 175.33 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.677 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 t -171.33 178.11 3.36 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.226 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.75 154.72 35.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 21.7 m-20 57.68 -109.51 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.823 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.562 ' CD2' ' OD1' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.03 -52.71 0.69 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 15' ' ' ASP . 12.0 p-10 -59.71 -45.96 90.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.598 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.14 -34.62 76.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 69.7 t80 -69.79 -63.75 1.02 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mmt -55.9 -24.73 39.15 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.358 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -82.66 -23.05 34.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.065 -1.022 . . . . 0.0 109.379 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -77.33 -37.07 53.25 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.193 -0.942 . . . . 0.0 109.258 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.409 ' HG3' ' H ' ' A' ' 21' ' ' MET . 0.6 OUTLIER -67.47 -11.33 57.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.574 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.69 31.13 37.26 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 24' ' ' ASN . 5.8 t -78.78 136.86 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -1.159 . . . . 0.0 109.497 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' VAL . 5.8 m-80 -42.48 164.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.227 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.6 mm -81.79 -1.55 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.21 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.51 -59.92 2.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -64.78 -28.23 69.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.588 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -71.62 -42.5 67.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.388 -0.82 . . . . 0.0 108.977 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -63.68 -35.42 80.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.147 -0.971 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.57 -13.14 46.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.013 0.911 . . . . 0.0 109.632 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.577 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -44.14 -16.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.583 ' N ' ' O ' ' A' ' 31' ' ' ALA . 20.7 t-80 -70.9 41.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.409 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' CD2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -50.4 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' HIS . 52.9 t-20 -147.8 42.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.609 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -96.52 175.18 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.523 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.458 ' N ' HD12 ' A' ' 36' ' ' LEU . 37.7 mttt -129.74 152.01 49.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.636 -0.665 . . . . 0.0 109.497 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.511 HD21 ' CD2' ' A' ' 128' ' ' PHE . 0.6 OUTLIER -142.81 150.38 39.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.702 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 4' ' ' SER . 0.6 OUTLIER -111.57 106.44 15.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.627 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -96.25 124.21 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 109.923 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.25 152.48 48.05 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' A' ' 47' ' ' PHE . 73.5 mt-30 -126.19 149.22 49.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.954 -1.091 . . . . 0.0 110.602 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' OE1' ' CD ' ' A' ' 46' ' ' LYS . 20.1 mt-10 -144.73 79.0 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.526 -0.733 . . . . 0.0 109.164 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.51 -88.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 43' ' ' GLU . 2.8 m120 -122.8 28.55 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -1.075 . . . . 0.0 109.736 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.454 ' CD ' ' OE1' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.01 109.87 4.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 42' ' ' GLN . 3.5 m-30 -93.24 173.26 7.81 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -153.38 103.73 2.7 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 108.813 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.62 HG22 HG23 ' A' ' 40' ' ' ILE . 96.7 t -99.68 121.62 50.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.634 -0.666 . . . . 0.0 109.446 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -108.63 100.07 9.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.36 155.06 41.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.941 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -158.6 107.05 1.93 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.116 -0.99 . . . . 0.0 109.013 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.694 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -141.83 144.56 33.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.46 7.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.025 -1.047 . . . . 0.0 109.189 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.694 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.0 m-85 -105.42 -25.71 12.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.278 -0.888 . . . . 0.0 110.835 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 8.2 mtp180 159.92 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.913 -1.117 . . . . 0.0 109.166 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -62.5 144.43 56.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 0.0 109.333 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -136.65 174.02 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 110.34 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.591 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -149.06 129.56 13.93 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 87.7 m -145.75 128.56 16.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.564 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -75.5 164.98 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.269 -0.894 . . . . 0.0 108.957 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.608 ' C ' ' CD2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -144.57 116.49 8.3 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.588 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.411 ' H ' ' HE2' ' A' ' 68' ' ' PHE . 37.1 mt-10 -116.47 174.55 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.7 119.45 38.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 110.505 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.22 -5.72 83.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.319 -0.943 . . . . 0.0 110.838 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 1.6 t -103.45 105.27 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.834 -1.392 . . . . 0.0 110.13 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -61.25 143.05 56.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.439 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.17 -171.4 3.82 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -138.87 153.03 48.28 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.403 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 10.2 t -156.96 138.55 14.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 76' ' ' THR . 3.7 p30 -95.59 143.27 27.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' ALA . 19.3 mt -92.57 146.9 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.45 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.92 -33.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.742 . . . . 0.0 109.796 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -60.05 8.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 71.61 26.29 73.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -100.09 161.87 13.34 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.22 -1.165 . . . . 0.0 109.549 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.426 ' O ' ' OG1' ' A' ' 96' ' ' THR . 83.7 tt0 -132.92 121.06 22.29 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -137.93 162.99 32.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.895 -1.128 . . . . 0.0 110.821 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -143.59 146.16 33.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.708 . . . . 0.0 109.954 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.67 -118.67 0.71 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.554 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.55 157.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -1.231 . . . . 0.0 110.808 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 6.4 m95 -102.1 141.61 34.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.608 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.6 t -139.57 156.8 46.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 108.555 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.675 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -88.51 130.31 35.26 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.294 -1.504 . . . . 0.0 108.032 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.675 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -131.05 122.29 26.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.62 -108.14 1.42 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.423 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.4 m120 -125.02 33.93 5.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -1.183 . . . . 0.0 110.313 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -147.17 160.89 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.757 -1.215 . . . . 0.0 110.238 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.99 113.26 25.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.608 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -82.17 164.77 2.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 110.534 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.616 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.95 96.08 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.651 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 9.6 mtpm? -89.33 106.16 18.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.196 -1.179 . . . . 0.0 109.031 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -116.23 136.78 52.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.772 0.796 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -115.68 117.82 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.468 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.2 mtp180 -57.05 115.06 2.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -75.22 -12.61 60.32 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.497 1.141 . . . . 0.0 109.443 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -90.83 -35.76 14.62 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.872 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 99' ' ' GLY . 49.3 t-20 -132.55 4.06 3.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.337 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.11 29.8 0.66 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.705 ' O ' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -76.96 18.66 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -1.177 . . . . 0.0 109.289 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.705 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.4 pt-20 43.93 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.922 0.867 . . . . 0.0 111.101 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.624 HD12 ' N ' ' A' ' 103' ' ' ASN . 1.4 tp -158.19 128.32 6.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.624 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -116.51 115.19 25.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 108.8 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -127.0 176.42 7.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.336 -0.853 . . . . 0.0 110.908 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -147.84 156.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -131.42 134.23 46.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -142.36 158.08 44.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 108.912 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.57 83.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.301 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.0 mm -64.57 92.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.334 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.53 -80.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -128.53 29.02 5.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -1.172 . . . . 0.0 110.251 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.1 130.94 39.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.421 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.65 112.29 24.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 108.478 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.97 107.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.9 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.22 106.26 16.64 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.4 OUTLIER -102.89 145.88 29.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 110.158 -178.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.663 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.8 OUTLIER -124.38 155.27 39.07 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.881 0.848 . . . . 0.0 109.484 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.7 t -124.6 147.58 29.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -146.0 110.6 5.12 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.998 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 47.73 19.34 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.237 0.542 . . . . 0.0 111.129 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.37 28.41 3.55 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.46 176.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.67 125.18 6.34 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 118.221 -1.391 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -115.66 149.5 38.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -129.05 138.67 52.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.896 -1.128 . . . . 0.0 110.581 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -132.47 115.05 15.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.498 HD12 ' HB2' ' A' ' 10' ' ' ARG . 10.4 mt -104.74 123.68 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.601 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 6.1 m-30 -102.17 176.95 5.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -155.05 168.34 27.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 131' ' ' ASP . 10.9 ptpt -50.58 138.74 17.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 109.629 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' LYS . 5.7 t70 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.361 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 4' ' ' SER . 12.5 t0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.221 0.534 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.3 m 161.9 -164.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.575 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.596 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 49.3 m -95.88 143.63 26.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.596 ' CD1' ' C ' ' A' ' 5' ' ' THR . 4.9 m95 -150.08 169.01 22.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.234 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 8' ' ' VAL . 6.4 ptmm? -152.76 133.98 14.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 109.693 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.591 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.51 106.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.0 109.508 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 32.3 t0 -98.26 -31.34 12.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -146.22 164.24 32.89 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.503 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 2.8 t -166.02 178.12 6.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.46 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -156.61 155.17 31.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 0.0 109.887 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.6 m-20 58.43 -108.82 0.43 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 109.953 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.565 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER 73.03 -52.19 0.71 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.159 -0.963 . . . . 0.0 110.19 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.578 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 17.3 t70 -59.37 -49.99 75.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.099 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -59.65 -33.23 71.27 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 65.5 t80 -71.34 -63.67 1.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.5 mmt -54.19 -25.4 22.58 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.482 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -77.41 -35.19 54.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.03 -1.044 . . . . 0.0 109.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.282 -0.887 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.625 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.3 mtp -68.5 -6.29 24.32 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.115 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.37 32.54 62.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 24' ' ' ASN . 4.0 t -74.76 129.68 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -1.207 . . . . 0.0 109.394 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' VAL . 3.7 t-20 -42.45 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 109.361 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -80.45 -1.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 0.0 109.166 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -82.39 -60.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -56.82 -38.33 72.45 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.578 ' NE ' ' OD1' ' A' ' 15' ' ' ASP . 19.9 tpt180 -61.31 -52.7 63.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.74 -38.39 33.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.331 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.64 -13.08 46.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -78.52 -48.96 14.22 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.164 0.506 . . . . 0.0 109.661 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.17 -21.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -0.822 . . . . 0.0 109.478 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.9 t-80 -73.8 35.03 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -44.09 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.476 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 6.7 t-20 -147.83 42.69 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -95.66 167.89 11.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.994 -1.066 . . . . 0.0 110.566 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HZ3' ' HB3' ' A' ' 7' ' ' LYS . 4.4 mttm -108.14 142.55 38.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 36' ' ' LEU . 1.9 mp -137.19 128.98 28.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.657 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m -102.69 119.16 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.3 mp -107.9 119.73 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.659 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.14 151.74 37.0 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.83 145.45 50.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -140.77 79.09 1.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 -83.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' GLU . 21.8 m-20 -124.9 28.67 6.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -1.134 . . . . 0.0 110.148 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' NZ ' ' OG1' ' A' ' 48' ' ' THR . 1.9 tmtm? -150.79 109.84 3.91 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.34 173.6 7.45 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.361 0.6 . . . . 0.0 109.735 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.625 ' OG1' ' NZ ' ' A' ' 46' ' ' LYS . 43.6 m -153.52 103.87 2.69 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.35 -0.843 . . . . 0.0 108.744 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.6 t -99.42 115.77 41.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -101.4 100.44 10.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.08 158.25 35.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 108.865 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -160.13 107.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.683 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -139.42 144.64 38.18 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.379 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.13 7.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.079 -1.013 . . . . 0.0 109.376 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.683 ' H ' ' C ' ' A' ' 53' ' ' SER . 28.2 t80 -107.45 -25.4 11.43 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.164 -0.96 . . . . 0.0 111.065 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 159.97 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.902 -1.124 . . . . 0.0 109.084 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -62.12 148.79 43.24 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.11 174.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.6 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -149.54 127.3 11.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.7 131.92 20.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.7 t -85.05 153.98 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.353 -0.842 . . . . 0.0 108.81 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CE1' ' SG ' ' A' ' 70' ' ' CYS . 41.1 m-85 -135.3 117.13 15.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 3.2 mp0 -104.12 172.49 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 108.902 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 64' ' ' LEU . 80.2 mt -103.74 111.77 24.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 0.0 110.317 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.2 -31.7 7.71 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 16.6 t -82.82 110.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.263 . . . . 0.0 109.877 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -60.17 143.24 52.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.085 -1.009 . . . . 0.0 109.437 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.05 -171.35 3.91 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -138.16 150.42 46.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.978 -1.076 . . . . 0.0 110.444 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' CE1' ' A' ' 62' ' ' PHE . 89.1 m -151.91 134.76 15.61 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -96.24 146.1 24.99 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.265 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 73' ' ' ALA . 17.2 mt -94.69 146.93 23.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.547 -0.721 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.31 -34.63 1.26 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.683 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -57.74 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 77.66 25.68 62.39 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.68 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.06 161.49 13.58 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.245 -1.15 . . . . 0.0 109.597 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -133.62 123.07 24.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.7 162.52 32.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.851 -1.156 . . . . 0.0 110.72 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.77 144.34 31.13 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.485 -0.759 . . . . 0.0 110.046 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.46 -117.66 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 N-CA-C 107.901 -2.079 . . . . 0.0 107.901 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.529 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.69 158.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -1.184 . . . . 0.0 110.572 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.473 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.9 m95 -102.13 143.7 31.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.6 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -140.41 157.22 45.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -90.06 129.33 36.38 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.149 -1.594 . . . . 0.0 108.136 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.656 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -129.94 119.29 22.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.09 -107.35 1.29 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -125.14 34.33 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -1.158 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 157.11 43.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.804 -1.185 . . . . 0.0 110.229 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.43 110.78 22.78 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -78.45 164.87 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.12 -0.988 . . . . 0.0 110.429 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.598 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.0 96.05 0.17 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.653 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.5 mttp -88.14 105.19 17.34 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.201 -1.176 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 5.5 m-30 -118.22 140.01 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.221 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -121.87 120.9 35.88 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.68 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 0.4 OUTLIER -53.27 114.86 1.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -12.2 61.44 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.482 1.134 . . . . 0.0 109.406 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.17 -48.82 12.55 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.622 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -132.53 11.38 4.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 110.166 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.0 44.25 13.63 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.745 ' O ' ' O ' ' A' ' 101' ' ' GLU . 42.4 m-20 -80.08 20.04 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -1.065 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.745 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.3 pt-20 42.97 158.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.005 0.907 . . . . 0.0 111.184 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.6 tt -160.49 124.97 3.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.666 ' N ' HD23 ' A' ' 102' ' ' LEU . 1.4 t-20 -113.41 112.72 24.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.036 -1.04 . . . . 0.0 109.118 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.7 t -125.3 176.51 6.72 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 111.13 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 46.2 t -148.71 156.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -124.34 133.88 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -134.78 157.98 45.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.449 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.4 mm -122.03 82.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 121.074 -1.016 . . . . 0.0 108.304 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 109' ' ' ILE . 15.9 mt -63.44 92.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.65 -80.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.5 m-20 -128.08 29.48 5.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -1.194 . . . . 0.0 110.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.02 145.24 45.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 108.943 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.63 114.39 28.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.969 -1.082 . . . . 0.0 109.254 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.541 HG22 HG12 ' A' ' 127' ' ' ILE . 39.5 t -99.59 109.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 47.1 tt0 -107.1 104.1 13.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -100.96 145.59 28.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.215 -0.928 . . . . 0.0 109.998 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.703 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -128.51 152.28 48.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.0 t -119.39 148.12 22.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.34 110.59 5.74 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.922 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 48.25 18.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.962 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.45 28.36 3.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.753 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.67 177.13 4.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.543 ' N ' HG13 ' A' ' 122' ' ' VAL . 10.6 tt0 -154.86 122.59 5.76 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.175 -1.41 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.886 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.77 156.54 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -136.33 139.04 42.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.209 . . . . 0.0 111.331 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.565 ' NH2' ' OH ' ' A' ' 14' ' ' TYR . 1.5 ttm-85 -130.76 113.96 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.541 HG12 HG22 ' A' ' 114' ' ' VAL . 6.6 mt -109.18 123.47 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.932 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 38' ' ' LEU . 7.7 m-30 -101.22 173.94 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.227 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -162.28 161.07 27.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.566 -0.709 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 131' ' ' ASP . 9.9 mmmt -47.71 132.36 14.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.162 -0.961 . . . . 0.0 109.643 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 130' ' ' LYS . 51.7 p30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.459 ' C ' ' OG ' ' A' ' 4' ' ' SER . 34.7 t70 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.246 0.546 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 171.4 -158.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.572 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.6 m -94.81 143.54 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.572 ' CD1' ' C ' ' A' ' 5' ' ' THR . 19.8 m95 -151.3 168.25 25.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.225 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.6 pttm -153.5 130.72 11.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.059 -1.025 . . . . 0.0 109.704 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.605 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -40.3 106.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 38.9 t0 -92.97 -30.0 15.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -147.66 164.98 31.83 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.866 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.66 178.15 5.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.358 -0.839 . . . . 0.0 109.267 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 4.2 pt-20 -152.68 151.12 30.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.02 -1.05 . . . . 0.0 110.013 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.546 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 18.7 t30 58.46 -108.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.718 -0.614 . . . . 0.0 109.903 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.546 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 76.16 -53.64 0.61 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -0.87 . . . . 0.0 109.838 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 87.6 m-20 -58.41 -52.37 65.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.022 -1.049 . . . . 0.0 108.938 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 12.0 mtpp -57.81 -33.24 68.39 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.579 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.854 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 56.8 t80 -71.64 -61.65 1.7 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.552 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 21.7 mmt -56.24 -25.69 48.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.415 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 3.4 mm-40 -80.64 -28.48 36.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.048 -1.032 . . . . 0.0 109.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.89 -35.84 67.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.317 -0.865 . . . . 0.0 109.454 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 2.2 mtm -72.64 -6.58 45.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.166 -0.959 . . . . 0.0 108.844 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 32.42 55.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 21' ' ' MET . 36.2 t -72.91 135.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -1.169 . . . . 0.0 109.383 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 23' ' ' VAL . 29.0 m120 -42.74 158.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.79 -3.06 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.221 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -84.66 -60.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.52 -29.33 69.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -68.48 -50.88 49.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.541 -0.725 . . . . 0.0 109.09 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -35.78 63.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.189 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.1 mt -86.46 -13.04 47.3 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.964 0.887 . . . . 0.0 109.773 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -75.8 -47.85 24.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . -41.47 -20.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASN . 13.7 m80 -70.97 46.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -52.05 79.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.853 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' HIS . 7.1 p30 -148.36 42.86 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 109.203 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 36' ' ' LEU . 1.0 OUTLIER -93.94 168.33 11.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -106.53 145.03 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.527 HD22 ' CE2' ' A' ' 128' ' ' PHE . 2.1 mp -138.95 125.2 20.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 109.78 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.4 m -102.6 113.02 26.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.743 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.7 mp -103.08 123.64 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.715 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.37 151.96 36.74 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.492 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 12.7 pt20 -131.72 139.4 48.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.158 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 42' ' ' GLN . 19.0 mm-40 -136.14 78.95 1.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.209 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.81 -89.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 43' ' ' GLU . 12.5 p-10 -117.51 28.77 8.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.406 -1.056 . . . . 0.0 110.12 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.88 109.98 3.92 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CE2' ' CB ' ' A' ' 42' ' ' GLN . 10.6 m-85 -100.57 173.93 6.32 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.422 0.63 . . . . 0.0 109.67 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -152.2 103.03 2.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -95.33 111.2 25.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -102.31 100.65 10.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.624 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -72.97 158.89 34.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 108.906 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.6 m -160.8 107.11 1.46 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.087 -1.008 . . . . 0.0 109.248 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.654 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -134.09 144.41 48.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 7.8 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 109.638 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.654 ' H ' ' C ' ' A' ' 53' ' ' SER . 7.8 m-85 -112.96 -23.72 9.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.156 -0.965 . . . . 0.0 111.295 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 5.3 ptm180 166.59 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.811 -1.181 . . . . 0.0 109.513 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -62.32 147.65 47.54 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.429 -0.795 . . . . 0.0 109.271 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.12 174.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.619 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.8 pt-20 -150.0 140.58 22.52 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 59' ' ' GLU . 38.9 m -151.69 127.02 9.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.65 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.66 150.74 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.28 -0.888 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.612 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -132.41 116.83 17.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.181 -0.949 . . . . 0.0 109.233 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 46.2 tt0 -126.13 169.12 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.0 109.044 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.475 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.7 mt -101.98 129.01 48.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.05 26.59 63.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 56.5 t -144.04 102.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -1.21 . . . . 0.0 109.31 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -59.12 141.06 55.1 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.104 0.954 . . . . 0.0 110.064 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.05 -171.3 3.8 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 69' ' ' ASN . 26.3 p30 -139.22 149.06 43.92 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.798 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.685 ' O ' HD22 ' A' ' 78' ' ' LEU . 42.8 t -139.11 170.63 15.62 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 76' ' ' THR . 2.9 m-20 -126.21 141.39 51.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.854 -1.154 . . . . 0.0 110.36 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.522 ' HG ' HD21 ' A' ' 78' ' ' LEU . 95.5 mt -93.59 146.9 23.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.528 -0.732 . . . . 0.0 109.293 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.43 -28.43 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -0.757 . . . . 0.0 109.696 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 45.5 m-20 -70.2 19.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.285 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.59 29.94 73.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.633 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.14 162.32 13.04 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.368 -1.077 . . . . 0.0 109.43 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.94 ' C ' HD13 ' A' ' 78' ' ' LEU . 58.7 tt0 -132.56 114.78 14.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.596 -0.69 . . . . 0.0 109.189 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.987 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -118.18 150.31 39.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.099 -1.001 . . . . 0.0 110.318 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -136.9 142.67 42.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.37 -118.4 0.72 Allowed Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.596 ' CB ' ' HZ1' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 173.01 156.47 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -1.111 . . . . 0.0 110.362 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.575 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.54 143.45 32.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.6 -0.687 . . . . 0.0 109.162 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.604 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 11.4 t -141.59 156.8 45.66 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.757 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -89.02 131.63 35.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.324 -1.485 . . . . 0.0 108.125 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.757 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -136.28 124.2 22.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.21 -110.32 3.01 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.454 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.0 m120 -125.26 34.18 5.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -1.174 . . . . 0.0 110.414 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -149.2 162.43 40.02 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.659 -1.276 . . . . 0.0 110.323 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.77 113.29 25.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.604 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.2 pt -81.13 164.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.583 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.02 96.85 0.18 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.666 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 6.5 pttm -90.32 106.78 18.73 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.274 -1.133 . . . . 0.0 108.686 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.598 ' HB2' HD23 ' A' ' 102' ' ' LEU . 2.6 m-30 -116.17 148.79 40.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.775 0.798 . . . . 0.0 110.365 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -134.18 116.85 15.86 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.601 0.715 . . . . 0.0 109.943 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 48.6 mtp180 -52.05 115.29 1.63 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.68 -12.66 61.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.499 1.142 . . . . 0.0 109.628 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.71 -37.95 15.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.97 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 35.4 t-20 -132.48 5.76 4.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.297 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.38 34.36 1.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 101' ' ' GLU . 5.3 m120 -75.41 20.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -1.161 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.7 pt-20 45.49 166.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.017 0.913 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 117' ' ' TYR . 19.4 tp -161.85 120.68 2.36 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -112.19 114.03 26.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 109.165 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.0 t -129.71 176.36 8.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.096 -1.003 . . . . 0.0 111.154 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 106' ' ' ARG . 54.2 t -146.58 158.51 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.418 ' N ' HG12 ' A' ' 105' ' ' VAL . 22.0 ttp180 -132.21 137.26 47.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.139 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -140.45 158.49 43.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 113' ' ' LEU . 1.2 mt -124.23 82.77 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.122 -0.986 . . . . 0.0 108.753 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' ASP . 48.6 mt -61.86 92.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.092 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.94 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ILE . 21.7 m-20 -130.06 29.41 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -1.228 . . . . 0.0 110.404 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -134.43 138.14 44.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 108.776 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.481 HD12 HG12 ' A' ' 108' ' ' ILE . 5.2 tp -99.43 113.16 25.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.891 -1.13 . . . . 0.0 109.362 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.68 HG22 HG23 ' A' ' 127' ' ' ILE . 27.5 t -98.57 110.74 26.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.096 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -113.21 106.76 15.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.56 145.47 29.98 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.718 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -126.18 156.63 39.87 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.928 0.871 . . . . 0.0 109.599 179.004 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.5 t -124.14 148.28 28.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.537 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.2 t80 -143.25 110.29 5.64 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.811 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 47.77 19.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.66 28.24 3.53 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.24 176.57 4.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.511 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.8 tt0 -156.02 124.19 5.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.061 -1.455 . . . . 0.0 111.362 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.854 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -117.68 151.94 36.24 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -128.57 140.24 51.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.881 -1.137 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -133.24 113.96 13.25 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.68 HG23 HG22 ' A' ' 114' ' ' VAL . 5.3 mt -109.07 123.37 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.052 -1.03 . . . . 0.0 110.557 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.547 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -101.01 174.4 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.447 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -163.19 154.59 17.23 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -47.28 135.71 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.512 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.467 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 4' ' ' SER . 9.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.159 0.504 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.626 ' OG ' ' N ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 158.51 -170.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.377 -0.827 . . . . 0.0 109.3 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.626 ' N ' ' OG ' ' A' ' 4' ' ' SER . 97.5 m -86.13 150.16 24.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.579 ' NE1' ' O ' ' A' ' 4' ' ' SER . 13.1 m95 -151.36 168.14 25.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.086 -1.009 . . . . 0.0 109.818 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.2 pttp -153.53 125.79 8.0 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.576 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.35 106.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.581 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.97 -28.96 12.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -142.29 174.33 10.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.6 t -178.39 178.31 0.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.16 155.65 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.874 -1.141 . . . . 0.0 109.822 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 18.7 m-20 56.86 -110.08 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.588 -0.695 . . . . 0.0 109.848 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.621 ' CE2' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.59 -52.43 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.0 109.855 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.31 -48.99 77.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.885 -1.134 . . . . 0.0 108.655 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.714 ' HZ3' ' HB3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 61.0 t80 -69.12 -64.08 0.94 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.007 0.908 . . . . 0.0 108.882 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.425 ' O ' HG23 ' A' ' 23' ' ' VAL . 15.4 mmt -56.41 -21.33 24.39 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 28' ' ' ARG . 33.3 tt0 -78.66 -35.15 45.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.208 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -66.99 -44.35 80.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.144 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.4 mtm -62.85 -9.22 8.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.021 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 32.3 38.13 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' ASN . 15.4 t -76.29 133.35 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -1.081 . . . . 0.0 109.559 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.539 ' OD1' HG23 ' A' ' 26' ' ' VAL . 11.6 t-20 -46.81 174.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -85.24 -2.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.119 0.961 . . . . 0.0 109.266 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.539 HG23 ' OD1' ' A' ' 24' ' ' ASN . 65.8 t -80.84 -59.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.755 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 1.5 mptm? -66.38 -22.73 66.25 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 19' ' ' GLU . 9.2 ttm180 -73.89 -42.38 60.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 109.29 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -72.81 -34.31 66.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.892 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.9 mt -86.39 -13.03 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -72.82 -53.01 12.64 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.573 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.98 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.574 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -91.57 46.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.621 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 69.0 m-20 -62.45 121.05 12.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.853 . . . . 0.0 109.684 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' HA ' HG13 ' A' ' 8' ' ' VAL . 17.0 m120 -147.94 42.98 1.05 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.349 -0.844 . . . . 0.0 109.016 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.576 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -87.74 162.81 16.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.111 -0.993 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 52' ' ' SER . 3.1 mtpp -114.69 142.49 46.43 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.825 ' H ' HD23 ' A' ' 38' ' ' LEU . 1.7 pt? -149.98 143.66 25.35 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.084 -1.01 . . . . 0.0 109.986 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -103.91 143.32 33.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.61 129.04 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.147 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.39 152.3 50.75 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -132.04 135.05 46.21 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.8 mm-40 -129.37 78.98 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.84 -79.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.14 29.24 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.99 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -145.16 110.59 5.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.18 159.85 14.82 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.455 HG23 HG13 ' A' ' 61' ' ' VAL . 48.9 m -152.21 103.12 2.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.079 -1.013 . . . . 0.0 108.269 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.88 130.87 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.61 -0.681 . . . . 0.0 109.652 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -119.63 100.55 7.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.398 -0.814 . . . . 0.0 109.572 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -75.51 156.1 35.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.214 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.1 m -158.9 106.91 1.85 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.153 0.977 . . . . 0.0 108.851 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.658 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -133.87 144.5 48.95 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.13 7.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.085 -1.01 . . . . 0.0 109.427 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 53' ' ' SER . 67.1 m-85 -113.26 -19.52 11.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 111.25 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 3.4 mmt180 161.63 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.703 -1.248 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -62.89 146.81 52.0 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.495 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.1 mt -135.82 174.13 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.875 . . . . 0.0 110.146 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.2 pt-20 -152.82 145.53 24.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.6 m -152.01 110.38 3.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.64 140.06 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.269 -0.894 . . . . 0.0 108.743 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.7 OUTLIER 175.51 164.87 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.918 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.5 tt0 -88.57 169.14 11.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 2.7 pp -88.89 130.97 35.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.867 -1.146 . . . . 0.0 109.619 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.79 -27.1 9.47 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 19.1 t -93.53 117.35 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -1.22 . . . . 0.0 109.732 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.19 144.38 20.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.052 0.929 . . . . 0.0 110.049 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.36 -171.43 3.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -143.29 151.44 40.52 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.891 -1.131 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 86.6 m -146.51 127.85 14.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.491 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -85.47 143.38 28.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 110.234 -178.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 78' ' ' LEU . 86.7 mt -96.37 146.9 24.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.446 -0.784 . . . . 0.0 109.359 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.586 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.88 -29.86 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.515 -0.741 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.99 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.239 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.78 28.2 69.66 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -99.9 162.44 12.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' THR . 20.0 tt0 -128.83 119.34 24.3 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.563 HD23 ' C ' ' A' ' 94' ' ' LYS . 3.5 mt -125.27 141.49 52.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.076 -1.015 . . . . 0.0 110.328 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.45 145.49 43.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.963 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.765 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 169.67 -120.61 0.88 Allowed Glycine 0 C--O 1.211 -1.303 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.38 159.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.161 -1.199 . . . . 0.0 111.029 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 21.4 m95 -101.96 140.56 36.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.578 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -137.89 157.07 47.17 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -97.88 128.97 44.83 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.331 -1.481 . . . . 0.0 108.238 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.662 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.1 mm-40 -134.68 122.5 22.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.41 -110.41 3.25 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -125.56 34.19 4.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.23 158.05 43.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.494 -1.379 . . . . 0.0 110.213 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mt -97.9 110.63 23.16 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.578 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.8 164.86 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 110.418 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.05 94.96 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.765 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.2 mttp -86.17 102.53 13.98 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.175 -1.191 . . . . 0.0 108.819 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.6 m-30 -116.93 149.62 39.86 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.811 0.815 . . . . 0.0 110.103 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.563 ' C ' HD23 ' A' ' 78' ' ' LEU . 3.5 ptpt -143.33 124.02 14.13 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 31.5 mtp180 -48.07 115.15 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.349 -0.845 . . . . 0.0 108.804 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -70.55 -7.43 43.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.362 1.077 . . . . 0.0 109.322 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -89.68 -41.59 11.84 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.77 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -132.4 8.95 4.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.922 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.06 42.61 12.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.834 ' O ' ' O ' ' A' ' 101' ' ' GLU . 14.4 m120 -75.73 18.4 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -1.147 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.834 ' O ' ' O ' ' A' ' 100' ' ' ASN . 13.4 pt-20 38.62 154.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.107 0.956 . . . . 0.0 111.42 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.867 HD11 ' HB3' ' A' ' 117' ' ' TYR . 15.2 tp -153.53 129.08 9.97 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -113.93 108.68 17.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 109.341 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.7 t -123.29 175.83 6.47 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.135 0.969 . . . . 0.0 111.669 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' N ' ' OG1' ' A' ' 104' ' ' THR . 45.5 t -145.04 157.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.477 ' HE ' HD21 ' A' ' 113' ' ' LEU . 21.9 ttm180 -126.75 136.02 51.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.982 . . . . 0.0 109.837 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.55 158.3 44.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.104 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.45 HD13 HD12 ' A' ' 113' ' ' LEU . 1.4 mm -122.09 82.38 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.079 -1.013 . . . . 0.0 108.435 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 109' ' ' ILE . 19.2 mt -62.61 92.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.886 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.12 -82.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ILE . 68.8 m-20 -130.71 29.01 4.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -1.166 . . . . 0.0 109.952 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.07 139.76 49.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.874 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.477 HD21 ' HE ' ' A' ' 106' ' ' ARG . 11.7 tp -98.87 112.15 24.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.885 -1.134 . . . . 0.0 109.051 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 109' ' ' ILE . 20.1 t -99.51 111.53 29.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.365 -0.835 . . . . 0.0 109.472 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -111.52 106.84 15.83 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.27 143.22 32.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.867 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -127.16 148.68 50.17 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.875 0.845 . . . . 0.0 109.903 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.6 t -112.42 148.13 15.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.517 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -144.01 110.67 5.6 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 49.72 17.74 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.25 28.25 3.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.8 177.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.522 ' N ' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -154.72 116.79 4.21 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 118.309 -1.357 . . . . 0.0 111.04 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.909 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -110.41 153.76 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -133.54 138.79 46.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.824 -1.173 . . . . 0.0 111.071 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.578 ' NE ' ' OH ' ' A' ' 117' ' ' TYR . 15.1 mtm180 -132.89 120.91 22.11 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.482 HG12 HG22 ' A' ' 114' ' ' VAL . 4.3 mt -114.44 123.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.09 . . . . 0.0 111.245 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 38' ' ' LEU . 5.5 m-30 -99.13 175.94 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 130' ' ' LYS . 45.9 tttt -165.92 159.3 15.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 109.159 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -47.52 132.6 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.458 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.454 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.59 ' O ' ' NE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -179.28 -168.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.163 -0.96 . . . . 0.0 109.664 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.625 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.4 m -95.53 142.02 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.644 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -151.45 169.24 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.51 139.63 20.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.858 . . . . 0.0 109.281 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' C ' ' O ' ' A' ' 7' ' ' LYS . 7.6 t -33.52 106.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 110.237 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.05 -31.69 14.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -153.86 173.89 15.32 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.611 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -176.37 178.17 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 0.0 109.47 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -157.25 154.08 28.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 12.3 m-20 57.92 -110.28 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.744 -0.598 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.507 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.99 -53.15 0.62 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.874 . . . . 0.0 109.922 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 15.2 p-10 -58.93 -46.42 88.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 108.827 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 78.2 mttt -63.53 -32.27 73.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.905 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 85.7 t80 -72.39 -61.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.556 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 9.6 mmt -58.64 -23.89 60.02 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' HB2' HH21 ' A' ' 28' ' ' ARG . 28.0 tt0 -77.54 -35.3 53.41 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -65.59 -42.01 92.18 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.323 -0.861 . . . . 0.0 109.184 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.482 ' CE ' ' CE2' ' A' ' 17' ' ' PHE . 5.7 mtm -59.61 -13.74 10.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.926 . . . . 0.0 108.845 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.35 22.48 56.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 24' ' ' ASN . 2.9 t -73.27 134.3 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -1.039 . . . . 0.0 109.45 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.9 m-80 -41.98 165.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -77.57 -1.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.247 1.022 . . . . 0.0 109.164 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.91 -59.79 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 31' ' ' ALA . 45.3 mmtt -59.24 -39.92 84.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 108.951 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.44 HH21 ' HB2' ' A' ' 19' ' ' GLU . 5.8 ttt180 -61.49 -39.94 92.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -60.89 -47.55 85.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.655 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.55 -12.98 47.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -51.73 -52.89 45.08 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.233 0.54 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -31.31 67.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.385 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.52 34.85 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.413 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -117.37 73.51 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.354 -0.842 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.51 ' O ' ' O ' ' A' ' 36' ' ' LEU . 3.1 p-10 -86.94 43.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.245 -0.91 . . . . 0.0 109.342 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 35' ' ' ASN . 1.1 pt? -38.81 167.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.211 1.005 . . . . 0.0 111.391 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -105.69 146.4 29.8 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -139.58 124.08 18.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.021 -1.049 . . . . 0.0 110.325 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.536 ' C ' HD12 ' A' ' 40' ' ' ILE . 6.5 m -104.05 114.77 29.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.929 ' N ' HD12 ' A' ' 40' ' ' ILE . 2.2 mp -108.4 138.97 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.672 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.11 152.0 50.85 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -136.97 145.79 44.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 109.557 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -149.6 79.23 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.028 -1.045 . . . . 0.0 109.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.04 -90.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.696 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -120.59 28.77 7.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.333 -1.098 . . . . 0.0 110.453 -178.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 pttm -152.17 111.82 3.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -106.76 174.33 5.93 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.576 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.651 HG23 HG22 ' A' ' 61' ' ' VAL . 11.6 m -148.06 103.39 3.47 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.38 115.58 31.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.148 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -112.36 100.69 8.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -82.87 157.16 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -158.4 107.01 1.97 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.063 -1.023 . . . . 0.0 108.975 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.657 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -134.19 144.46 48.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.93 7.7 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.398 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.657 ' H ' ' C ' ' A' ' 53' ' ' SER . 47.7 m-85 -112.47 -20.3 11.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -0.918 . . . . 0.0 111.227 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.0 OUTLIER 163.3 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.0 109.686 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -63.38 145.86 54.72 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.596 HD13 ' ND2' ' A' ' 71' ' ' ASN . 1.0 OUTLIER -137.59 174.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 0.0 110.312 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 6.4 pt-20 -150.62 143.56 24.69 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.14 110.46 4.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.651 HG22 HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -109.14 141.65 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.285 -0.884 . . . . 0.0 109.093 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.78 -179.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.849 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.9 mp0 -105.09 175.19 5.58 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 64' ' ' LEU . 3.3 pp -93.9 119.37 32.73 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.986 -1.071 . . . . 0.0 109.203 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.0 -34.73 3.92 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.66 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 3.1 t -83.75 115.02 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.012 -1.287 . . . . 0.0 109.98 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -54.73 147.91 13.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.041 0.924 . . . . 0.0 110.207 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -160.05 -171.08 3.08 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -129.31 150.09 50.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 110.131 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 63.5 m -152.7 132.47 13.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.596 ' ND2' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -92.24 145.9 24.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.972 -1.08 . . . . 0.0 110.415 -178.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 73' ' ' ALA . 89.3 mt -93.91 147.02 23.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 0.0 109.342 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.61 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.49 -34.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 23.8 t0 -62.57 12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.15 27.9 73.34 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.632 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.3 OUTLIER -99.07 162.14 13.23 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.232 -1.158 . . . . 0.0 109.345 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -132.71 119.56 20.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.62 -0.675 . . . . 0.0 109.227 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.93 163.04 30.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.009 -1.057 . . . . 0.0 110.335 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -141.95 146.35 35.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.885 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.749 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 170.26 -118.7 0.77 Allowed Glycine 0 C--O 1.211 -1.287 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.19 159.51 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.268 -1.136 . . . . 0.0 110.674 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.33 145.1 29.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.58 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -141.01 157.35 45.45 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -97.51 123.19 41.29 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.456 -1.403 . . . . 0.0 108.217 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' N ' HD12 ' A' ' 84' ' ' LEU . 23.9 mt-10 -120.11 111.63 18.1 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.4 ' O ' HD11 ' A' ' 84' ' ' LEU . . . 64.47 -104.95 1.0 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 87' ' ' ASN . 41.8 t30 -125.21 33.47 5.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -1.16 . . . . 0.0 110.262 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.51 148.26 40.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.795 -1.191 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.25 104.48 16.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.58 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -74.9 164.16 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.067 -1.02 . . . . 0.0 110.555 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.9 94.97 0.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.68 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 36.6 mtmt -88.8 103.1 15.67 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 109.151 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.2 m-30 -118.43 137.43 53.15 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.647 0.737 . . . . 0.0 109.709 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 14.1 pttt -124.97 122.89 38.61 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 99' ' ' GLY . 18.3 mtp85 -51.35 117.91 2.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 0.0 109.22 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -11.12 60.72 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.438 1.113 . . . . 0.0 109.29 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.21 -48.29 12.27 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.571 ' OD1' ' NH1' ' A' ' 95' ' ' ARG . 11.3 m120 -132.58 8.63 4.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.23 43.67 9.62 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.683 ' O ' ' O ' ' A' ' 101' ' ' GLU . 56.7 m-20 -72.38 11.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 109.524 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.683 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.2 mt-10 47.42 132.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.713 0.768 . . . . 0.0 111.162 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -135.31 132.51 37.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 102' ' ' LEU . 1.9 m120 -117.01 116.49 27.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 0.0 108.931 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -128.12 176.13 7.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.796 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.4 t -146.6 155.2 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.17 136.31 51.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 109.899 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -137.36 158.68 43.89 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.45 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 2.2 mt -124.71 82.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.824 -1.173 . . . . 0.0 108.642 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 109' ' ' ILE . 21.3 mt -62.8 92.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.976 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.97 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.6 t70 -130.77 29.78 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -1.188 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -133.12 141.56 48.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.016 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 tp -97.65 110.77 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.871 -1.143 . . . . 0.0 109.195 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.514 HG22 HG23 ' A' ' 127' ' ' ILE . 8.8 t -95.21 111.9 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.937 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -114.84 107.32 15.26 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -101.42 145.31 29.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.691 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -123.11 154.97 37.89 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.837 0.827 . . . . 0.0 109.48 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.1 t -125.59 147.1 30.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.562 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -144.78 110.37 5.3 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.008 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 47.52 19.31 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.198 0.523 . . . . 0.0 111.118 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.72 28.12 3.56 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.24 176.58 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 3.6 mt-10 -155.68 125.9 6.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.229 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.905 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -118.21 153.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -130.29 139.56 50.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.808 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.691 ' NH1' ' CZ ' ' A' ' 117' ' ' TYR . 41.0 mtm180 -136.74 114.03 10.79 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.514 HG23 HG22 ' A' ' 114' ' ' VAL . 5.2 mt -110.74 123.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.972 -1.08 . . . . 0.0 110.77 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 38' ' ' LEU . 8.3 m-30 -99.18 171.0 8.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 0.0 109.502 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.76 159.62 42.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.63 -0.669 . . . . 0.0 109.21 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -57.96 134.09 56.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.2 t0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.486 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 4' ' ' SER . 5.5 m-20 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.623 ' OG ' ' N ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 159.3 -169.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.775 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.623 ' N ' ' OG ' ' A' ' 4' ' ' SER . 51.5 m -95.89 150.41 20.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.584 ' CD1' ' C ' ' A' ' 5' ' ' THR . 12.4 m95 -150.39 169.13 22.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.755 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 14.9 pttm -152.25 125.24 8.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.578 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.63 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -39.31 106.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 24.2 t0 -95.06 -29.49 14.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.409 ' HB2' HD12 ' A' ' 127' ' ' ILE . 2.5 mtt-85 -147.86 162.63 38.88 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.871 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.56 178.1 7.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -154.43 158.39 39.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 6.8 m-20 58.86 -109.18 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.656 -0.653 . . . . 0.0 109.72 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 74.76 -54.22 0.67 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.658 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 2.7 m-20 -60.55 -42.37 96.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.083 -1.011 . . . . 0.0 108.574 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -64.27 -32.05 73.5 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.84 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 7.5 t80 -72.9 -64.07 1.04 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -57.66 -20.85 36.39 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.616 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 2.0 tm-20 -79.77 -36.37 37.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.061 -1.024 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -67.41 -40.85 85.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.358 -0.838 . . . . 0.0 109.246 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 mtm -68.09 -6.12 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.33 -0.856 . . . . 0.0 108.999 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.53 32.43 67.76 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.5 t -72.73 128.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.486 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.7 m120 -41.76 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.355 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -76.52 -1.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.181 0.991 . . . . 0.0 109.212 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -81.86 -59.88 2.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -62.92 -30.93 71.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -44.08 72.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -62.99 -34.19 77.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 109.511 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.5 -13.26 46.52 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.968 0.89 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -80.34 -36.31 34.35 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.566 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.39 -24.34 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 1.3 m-70 -68.82 36.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.118 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 32' ' ' ALA . 7.5 p-10 -42.57 89.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 109.771 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 21.8 t-20 -147.7 42.72 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 108.919 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -83.23 159.87 21.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.876 . . . . 0.0 110.486 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.812 ' N ' HD12 ' A' ' 36' ' ' LEU . 13.6 mtmm -119.55 150.4 40.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.6 pt? -153.8 149.53 27.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.111 -0.993 . . . . 0.0 110.0 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 m -117.45 123.32 46.07 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.752 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.0 mp -109.37 131.43 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.676 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.65 152.26 50.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.05 149.0 41.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 0.0 109.95 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.98 79.52 1.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.096 -1.003 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 -94.52 0.64 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.48 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -127.38 28.28 5.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -1.109 . . . . 0.0 109.442 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.57 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 18.6 pttm -149.37 110.83 4.46 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.3 174.23 9.75 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.013 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -143.49 103.07 4.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG13 HG13 ' A' ' 40' ' ' ILE . 42.2 t -98.94 108.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.773 -0.579 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.16 100.0 12.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.302 -0.874 . . . . 0.0 108.748 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 58' ' ' ILE . 50.2 mt-10 -69.78 155.74 40.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.241 -0.912 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -160.83 107.24 1.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.194 -0.941 . . . . 0.0 108.818 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.702 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -143.25 144.54 32.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.77 7.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.051 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.702 ' H ' ' C ' ' A' ' 53' ' ' SER . 16.5 t80 -106.83 -24.95 11.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 110.861 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 73' ' ' ALA . 9.8 mtp180 160.01 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 109.25 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -62.45 145.86 53.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 109.18 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.8 mt -142.77 174.14 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 122.129 0.966 . . . . 0.0 110.694 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.62 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.6 pt-20 -135.42 142.52 45.64 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 t -155.05 113.76 3.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.976 -1.077 . . . . 0.0 110.306 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.18 149.35 7.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -129.94 121.07 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.033 . . . . 0.0 110.534 -179.024 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.441 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 50.2 tt0 -123.35 139.17 54.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -103.23 148.83 25.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.885 -1.135 . . . . 0.0 110.283 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.8 -5.13 59.71 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.12 118.06 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.28 . . . . 0.0 109.941 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.8 m -49.32 145.4 4.55 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.294 1.045 . . . . 0.0 109.685 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.98 -168.14 2.15 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -146.46 157.21 43.72 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.532 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 15.9 t -147.66 136.05 21.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -96.54 148.33 22.94 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.939 -1.101 . . . . 0.0 110.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 73' ' ' ALA . 18.8 mt -100.94 147.08 26.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.586 -0.696 . . . . 0.0 109.527 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.671 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -39.46 -34.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.747 -0.596 . . . . 0.0 109.816 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.65 7.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.127 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.671 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 70.12 24.63 76.43 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.29 161.25 13.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.246 -1.149 . . . . 0.0 109.53 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -133.55 124.57 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.245 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -130.39 159.61 36.5 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.063 -1.023 . . . . 0.0 110.499 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -138.89 152.33 47.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 0.0 110.458 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.15 -110.09 0.42 Allowed Glycine 0 C--O 1.212 -1.272 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 166.74 152.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -1.216 . . . . 0.0 110.93 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 28.2 m95 -108.45 130.22 55.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.649 ' H ' HD12 ' A' ' 90' ' ' ILE . 1.8 m -144.88 156.31 43.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 109.54 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.934 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -87.27 138.11 31.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.752 -1.218 . . . . 0.0 108.425 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.934 ' N ' HD12 ' A' ' 84' ' ' LEU . 49.9 mt-10 -160.32 157.21 27.59 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.497 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.07 -117.72 6.49 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -125.99 33.8 4.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -1.197 . . . . 0.0 110.638 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -165.02 163.5 20.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.436 -1.415 . . . . 0.0 110.593 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.71 124.35 31.41 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.649 HD12 ' H ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -94.13 161.05 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.983 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 104' ' ' THR . . . -148.24 100.3 0.21 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.635 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 63.6 mttt -98.08 108.76 21.54 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.371 -1.076 . . . . 0.0 108.762 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' LEU . 1.5 m-30 -126.72 137.92 53.32 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.78 0.8 . . . . 0.0 110.245 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 94' ' ' LYS . 4.4 ptmm? -126.33 128.92 47.85 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 99' ' ' GLY . 35.7 mtp180 -54.64 115.27 2.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 108.993 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -10.17 57.34 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.389 1.09 . . . . 0.0 109.34 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -83.31 -47.13 11.82 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.619 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -132.44 9.26 4.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.84 44.86 18.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.64 ' O ' ' O ' ' A' ' 101' ' ' GLU . 13.9 m120 -74.42 10.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -1.173 . . . . 0.0 109.63 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.64 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.5 mt-10 49.96 136.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.764 0.792 . . . . 0.0 111.12 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.3 tt -146.39 122.28 10.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.671 ' N ' HD23 ' A' ' 102' ' ' LEU . 4.6 m-20 -112.42 149.98 31.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.044 . . . . 0.0 108.554 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.7 t -159.59 175.71 12.89 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.266 -1.521 . . . . 0.0 111.315 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 106' ' ' ARG . 37.8 t -144.23 158.17 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 105' ' ' VAL . 4.0 ttm180 -131.81 134.12 45.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -137.0 157.88 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.24 82.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.069 -1.019 . . . . 0.0 108.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 111' ' ' ASP . 79.0 mt -63.03 92.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.237 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.68 -78.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 109' ' ' ILE . 20.9 p-10 -130.19 29.24 4.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.0 110.316 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -134.77 139.05 44.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 108.966 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.5 tp -102.9 114.87 29.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.009 -1.057 . . . . 0.0 109.543 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.662 HG22 HG23 ' A' ' 127' ' ' ILE . 25.1 t -102.11 107.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.399 -0.813 . . . . 0.0 109.111 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -110.1 106.97 16.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.76 145.43 30.37 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.702 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.22 149.8 50.87 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.94 0.876 . . . . 0.0 109.715 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 122' ' ' VAL . 3.9 t -112.91 148.01 16.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.507 ' CB ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -140.64 110.28 6.38 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 47.31 19.22 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.122 0.487 . . . . 0.0 111.182 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.5 28.6 3.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -124.34 177.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.084 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 122' ' ' VAL . 33.9 mt-10 -153.5 121.23 5.98 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.378 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.84 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -114.0 146.19 40.5 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -125.82 140.14 52.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.929 -1.107 . . . . 0.0 111.186 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -129.71 114.2 15.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.662 HG23 HG22 ' A' ' 114' ' ' VAL . 8.7 mt -111.36 123.38 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.762 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.549 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.6 m-30 -103.65 176.06 5.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.489 -0.757 . . . . 0.0 109.577 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.58 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 24.6 tttp -163.86 152.96 14.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.547 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 4.7 pttm -47.66 132.24 14.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 13.5 p-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 4' ' ' SER . 1.3 m-20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.676 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 163.83 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.676 ' N ' ' OG ' ' A' ' 4' ' ' SER . 96.8 m -91.49 145.27 24.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.577 ' CD1' ' C ' ' A' ' 5' ' ' THR . 8.2 m95 -151.36 168.24 25.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.315 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 3.0 ptmm? -153.18 133.76 13.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.988 -1.07 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.61 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -40.2 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.426 -0.796 . . . . 0.0 109.506 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.26 -30.2 12.38 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -140.67 169.82 16.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.912 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 14.4 t -175.27 178.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.279 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -156.24 154.42 30.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.9 m-20 56.79 -109.5 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.526 -0.734 . . . . 0.0 109.792 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.519 ' CE2' ' HE1' ' A' ' 18' ' ' MET . 0.3 OUTLIER 75.68 -54.14 0.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.529 ' CG ' HH21 ' A' ' 28' ' ' ARG . 7.2 m-20 -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.664 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -66.46 -32.08 73.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 21.9 t80 -72.28 -60.29 2.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.519 ' HE1' ' CE2' ' A' ' 14' ' ' TYR . 5.3 mtt -56.41 -25.09 49.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -78.87 -30.06 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.157 -0.965 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -69.76 -41.8 74.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -68.01 -6.41 22.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.91 . . . . 0.0 108.942 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 29.64 54.14 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.46 135.52 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -48.8 158.84 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.88 . . . . 0.0 109.37 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -82.96 -1.38 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.141 0.972 . . . . 0.0 109.237 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -80.07 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -57.34 -42.45 81.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.529 HH21 ' CG ' ' A' ' 15' ' ' ASP . 16.7 ttp85 -59.32 -46.67 87.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.456 -0.777 . . . . 0.0 109.204 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -53.59 -39.34 64.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.385 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.5 -13.59 45.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.803 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.44 -39.92 15.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.186 0.517 . . . . 0.0 109.668 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -38.64 -27.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.678 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 35' ' ' ASN . 46.5 m170 -70.04 39.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.908 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 32' ' ' ALA . 6.8 t0 -43.5 90.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.591 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 33' ' ' HIS . 5.8 m120 -147.7 42.97 1.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 36' ' ' LEU . 1.1 pt? -90.6 163.52 14.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -106.17 135.19 48.07 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.582 HD21 HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -132.91 128.54 36.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.975 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.446 HG23 ' HA ' ' A' ' 5' ' ' THR . 0.3 OUTLIER -102.87 120.71 41.09 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.028 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.5 mp -107.78 123.17 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 0.0 110.829 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.02 151.93 38.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.446 ' CD ' ' OD2' ' A' ' 3' ' ' ASP . 20.7 pt20 -133.37 148.95 51.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.005 -1.059 . . . . 0.0 110.188 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.513 ' OE2' ' CD ' ' A' ' 46' ' ' LYS . 58.6 mt-10 -147.73 79.31 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.183 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.14 -92.72 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.31 28.42 7.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -1.059 . . . . 0.0 109.358 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.513 ' CD ' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -140.67 109.74 6.14 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' HB2' ' CE2' ' A' ' 62' ' ' PHE . 19.1 m-85 -103.06 173.36 6.34 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -154.88 103.61 2.43 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.73 110.29 25.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -95.52 100.26 12.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.1 mp0 -73.88 159.75 32.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 51' ' ' GLU . 2.3 m -160.16 107.02 1.59 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.081 -1.012 . . . . 0.0 109.163 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -125.68 144.31 50.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.03 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.218 -0.927 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.632 ' H ' ' C ' ' A' ' 53' ' ' SER . 20.6 t80 -125.02 -19.62 5.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 111.782 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 177.02 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.303 -1.498 . . . . 0.0 110.084 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 17.5 p-10 -62.89 145.58 54.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.999 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.79 174.19 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.4 pt-20 -147.05 143.99 28.77 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.22 110.57 4.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -89.5 146.22 6.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 4.6 p90 -160.46 153.75 21.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.561 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.2 tt0 -129.15 122.72 30.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 64' ' ' LEU . 3.0 pp -56.86 126.74 28.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.04 -1.037 . . . . 0.0 109.853 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.97 3.4 24.81 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.67 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 18.5 t -144.17 113.63 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.321 . . . . 0.0 109.777 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.778 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.5 m -55.48 147.64 17.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.958 0.885 . . . . 0.0 110.308 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.67 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -156.59 -171.0 3.52 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -134.05 153.24 51.93 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 34.9 t -156.84 131.62 8.86 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -95.79 145.42 25.35 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' GLY . 19.5 mt -95.85 146.89 24.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.628 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.44 -34.96 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.65 -0.656 . . . . 0.0 109.897 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.58 3.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.628 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.37 25.27 66.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.708 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.21 161.67 13.46 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.172 -1.193 . . . . 0.0 109.555 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -133.33 121.24 22.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -135.56 161.68 34.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.946 -1.096 . . . . 0.0 110.216 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HG3' HG22 ' A' ' 67' ' ' THR . 0.7 OUTLIER -144.48 148.24 34.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 109.65 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.778 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.23 -116.95 0.69 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 174.03 159.26 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.324 . . . . 0.0 111.093 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 12.8 m95 -102.2 141.67 34.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.588 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -138.79 156.9 46.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -95.54 128.72 42.63 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.353 -1.467 . . . . 0.0 108.408 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.658 ' N ' HD12 ' A' ' 84' ' ' LEU . 14.3 pt-20 -129.61 129.33 44.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.74 -108.56 0.73 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -125.51 34.12 4.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.177 -1.19 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.95 156.23 44.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.179 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.5 mt -97.1 110.83 23.3 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.3 164.72 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.149 -0.969 . . . . 0.0 110.522 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.658 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.97 95.19 0.17 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.704 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.0 ptmm? -86.85 102.41 14.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.122 -1.222 . . . . 0.0 109.102 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.5 m-30 -116.0 142.68 46.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.775 0.798 . . . . 0.0 109.801 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 31.8 pttt -133.34 124.02 26.47 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.708 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 25.5 mtt180 -44.67 116.8 1.13 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.383 -0.823 . . . . 0.0 108.886 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -7.19 41.05 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.66 -45.9 10.56 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.516 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -132.6 8.46 4.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 47.31 45.16 21.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 21.4 m-20 -73.12 12.57 0.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.4 mt-10 49.66 146.17 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.903 0.859 . . . . 0.0 111.32 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.661 HD23 ' C ' ' A' ' 102' ' ' LEU . 8.3 tt -149.93 126.04 10.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.515 ' N ' HD23 ' A' ' 102' ' ' LEU . 13.5 t30 -111.65 112.44 24.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.415 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.9 t -124.53 176.43 6.52 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 110.994 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.1 t -148.54 154.93 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -126.65 130.29 50.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 109.688 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -129.44 158.98 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 109.083 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -120.08 82.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 109' ' ' ILE . 9.5 mt -64.38 91.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.735 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 51.38 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.1 p-10 -125.05 29.84 6.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -1.173 . . . . 0.0 110.422 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -138.3 147.7 43.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.029 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 tp -107.76 112.42 25.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.031 -1.043 . . . . 0.0 109.477 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.521 HG22 HG23 ' A' ' 127' ' ' ILE . 3.4 t -94.77 115.16 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -114.56 103.32 10.9 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -103.0 145.94 29.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.909 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -128.17 152.65 47.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.96 0.886 . . . . 0.0 109.641 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.0 t -120.09 149.24 22.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.591 ' CE1' ' OE2' ' A' ' 120' ' ' GLU . 1.2 t80 -143.47 110.88 5.82 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.929 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.591 ' OE2' ' CE1' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 46.15 20.16 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.053 178.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.68 28.55 3.42 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.767 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.9 176.58 5.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.51 ' N ' HG13 ' A' ' 122' ' ' VAL . 39.0 tt0 -156.06 125.55 6.28 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.067 -1.453 . . . . 0.0 111.427 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.86 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -121.31 151.42 40.1 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.4 ' O ' ' OG ' ' A' ' 11' ' ' SER . 5.3 ttpt -132.31 139.61 48.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 0.0 111.282 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.517 HH11 ' HH ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -135.14 114.42 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 114' ' ' VAL . 3.3 mt -108.76 125.39 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.036 -1.04 . . . . 0.0 110.817 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.513 ' CE2' HD22 ' A' ' 38' ' ' LEU . 6.5 m-30 -97.7 174.6 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.248 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.743 ' HE2' ' HZ2' ' A' ' 130' ' ' LYS . 43.4 tttm -160.65 156.63 25.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.524 -0.735 . . . . 0.0 109.273 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.743 ' HZ2' ' HE2' ' A' ' 129' ' ' LYS . 13.3 pttp -49.13 128.91 17.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.592 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.508 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 4' ' ' SER . 20.2 p-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.251 0.548 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.58 -166.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.58 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 36.2 m -90.94 147.08 23.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.365 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.58 ' CD1' ' C ' ' A' ' 5' ' ' THR . 15.4 m95 -151.69 169.24 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 109.646 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' VAL . 36.7 pttt -153.2 126.96 8.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.029 -1.044 . . . . 0.0 109.768 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.632 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -36.4 106.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.382 -0.824 . . . . 0.0 109.422 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -91.1 -29.5 17.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' NH1' HG21 ' A' ' 127' ' ' ILE . 62.2 mtm-85 -151.54 166.68 30.4 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.225 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.4 t -177.15 166.46 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.507 -0.745 . . . . 0.0 109.091 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -166.75 166.17 15.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 0.0 110.448 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 58.9 21.78 9.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.581 -0.699 . . . . 0.0 110.243 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.59 ' OH ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.61 -57.29 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.599 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 19' ' ' GLU . 2.6 m-20 -45.85 -52.93 10.55 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.011 -1.056 . . . . 0.0 109.161 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -54.65 -41.68 70.38 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 81.9 t80 -67.84 -63.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -20.82 2.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 15' ' ' ASP . 39.1 tt0 -79.24 -38.13 36.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -65.81 -37.32 85.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.516 ' HB2' HG23 ' A' ' 23' ' ' VAL . 11.3 mtm -67.73 -8.84 38.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.322 -0.861 . . . . 0.0 109.11 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 32.51 41.69 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 21' ' ' MET . 17.7 t -80.02 139.2 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -1.108 . . . . 0.0 109.585 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' VAL . 62.6 t30 -44.83 170.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.302 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.593 ' CD1' ' CZ ' ' A' ' 28' ' ' ARG . 3.7 mm -85.33 -5.1 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.017 . . . . 0.0 109.34 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.469 HG23 ' ND2' ' A' ' 24' ' ' ASN . 58.8 t -83.88 -60.04 2.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.724 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 49.3 mttp -63.97 -24.06 67.58 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.593 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 23.4 ttp180 -73.04 -47.8 41.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.553 -0.717 . . . . 0.0 109.361 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -66.96 -34.84 78.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.793 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.71 -13.07 46.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 110.064 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -74.82 -25.92 59.36 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.167 0.508 . . . . 0.0 109.824 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -70.94 -61.0 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.103 -0.998 . . . . 0.0 109.509 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 40.0 t-80 -70.71 46.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.451 -0.78 . . . . 0.0 109.434 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.485 ' OD2' HD22 ' A' ' 36' ' ' LEU . 37.8 t0 -88.94 127.54 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HA ' HG13 ' A' ' 8' ' ' VAL . 71.5 m-20 -123.78 43.08 3.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.632 HD23 HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -68.95 159.91 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.902 0.858 . . . . 0.0 111.008 -178.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -107.64 149.06 28.53 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 38' ' ' LEU . 2.6 mp -139.17 129.01 24.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.015 . . . . 0.0 109.952 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 m -99.96 105.86 17.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.513 HG13 HG23 ' A' ' 49' ' ' VAL . 3.7 mp -95.65 123.4 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 110.926 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.01 151.79 41.54 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -129.66 148.24 51.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.024 -1.048 . . . . 0.0 109.843 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' ASN . 27.9 mt-10 -144.72 78.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.66 -81.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' GLU . 11.7 p-10 -125.56 28.87 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.67 109.67 4.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.36 166.81 12.39 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.5 m -156.17 103.67 2.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.7 p -105.97 118.67 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.491 -0.755 . . . . 0.0 109.486 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -100.01 100.25 11.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.565 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 1.8 mp0 -70.51 156.3 39.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.935 . . . . 0.0 109.05 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -158.86 106.93 1.86 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.073 -1.017 . . . . 0.0 109.022 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.645 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.61 144.64 50.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.01 7.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 109.858 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.687 ' CZ ' ' NH2' ' A' ' 56' ' ' ARG . 6.0 t80 -112.29 -20.45 11.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 111.128 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.687 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER 160.44 89.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.843 -1.16 . . . . 0.0 109.317 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -62.18 148.17 45.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 59' ' ' GLU . 2.0 mt -138.11 174.19 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.032 0.92 . . . . 0.0 110.338 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.601 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.8 pt-20 -141.79 143.29 33.37 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.9 m -150.75 117.52 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 110.263 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER -89.08 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -137.82 165.93 25.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 23.8 tt0 -152.39 169.71 21.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.457 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 78.3 mt -100.74 118.88 37.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 110.197 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.87 24.56 27.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.345 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.636 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 21.0 t -144.05 102.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.05 -1.265 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.8 143.12 43.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.752 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.81 -171.03 3.82 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -138.41 149.73 45.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.481 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 50.0 t -151.91 135.66 16.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.43 143.91 28.36 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 110.163 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.1 mt -91.82 147.04 23.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.551 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.612 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.67 -33.86 1.33 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.702 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.68 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.612 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 78.34 25.33 61.54 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 161.7 13.43 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.236 -1.155 . . . . 0.0 109.692 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.732 ' C ' HD23 ' A' ' 78' ' ' LEU . 19.0 tt0 -133.09 125.88 30.55 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.732 HD23 ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -136.78 164.76 27.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.969 -1.082 . . . . 0.0 110.574 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.526 ' HG3' HG22 ' A' ' 67' ' ' THR . 14.6 ttm180 -147.85 143.15 27.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.66 -119.59 0.83 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.519 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 173.05 158.95 0.12 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.211 -1.17 . . . . 0.0 110.53 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.484 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.2 m95 -102.0 143.26 32.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.9 m -138.76 157.14 46.64 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -96.26 129.22 43.64 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.364 -1.46 . . . . 0.0 108.286 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.683 ' N ' HD12 ' A' ' 84' ' ' LEU . 1.3 pp20? -131.31 125.43 32.76 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.51 -109.45 1.58 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -125.47 33.84 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -1.156 . . . . 0.0 110.216 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.403 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.38 155.86 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.77 -1.206 . . . . 0.0 110.165 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mt -97.58 111.23 23.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.66 164.81 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 110.476 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.25 95.41 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.717 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 12.5 ptmt -86.17 102.78 14.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.189 -1.183 . . . . 0.0 108.478 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 102' ' ' LEU . 5.1 m-30 -118.95 145.72 45.56 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.823 0.821 . . . . 0.0 110.146 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.515 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 20.3 pttm -132.46 121.58 23.59 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 99' ' ' GLY . 49.0 mtp180 -46.95 114.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.398 -0.814 . . . . 0.0 109.026 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.49 -10.15 53.63 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 122.492 1.139 . . . . 0.0 109.28 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -79.03 -50.44 11.07 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.464 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -132.34 9.54 4.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.393 -0.817 . . . . 0.0 109.84 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.78 47.22 31.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.649 ' O ' ' O ' ' A' ' 101' ' ' GLU . 13.3 m-20 -77.92 14.01 1.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -1.146 . . . . 0.0 109.581 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.8 mt-10 50.88 142.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.616 0.722 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -144.89 131.71 20.13 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.711 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -114.9 111.76 21.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 0.0 108.866 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.2 t -126.86 176.4 7.32 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.075 -1.016 . . . . 0.0 111.184 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 106' ' ' ARG . 45.2 t -147.92 162.34 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.485 ' N ' HG12 ' A' ' 105' ' ' VAL . 12.9 ttm180 -133.4 139.48 46.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.924 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -141.42 158.75 43.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.133 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.438 HD13 HD12 ' A' ' 113' ' ' LEU . 1.4 mm -119.21 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.0 mm -61.55 92.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.009 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.53 -78.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 109' ' ' ILE . 14.4 m-20 -130.73 29.9 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -1.151 . . . . 0.0 110.213 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -136.98 146.48 45.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.121 -0.987 . . . . 0.0 109.164 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.438 HD12 HD13 ' A' ' 108' ' ' ILE . 11.9 tp -102.23 115.64 30.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.995 -1.066 . . . . 0.0 109.219 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 127' ' ' ILE . 5.6 t -105.16 107.61 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 109.288 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.497 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 12.5 tt0 -107.43 109.46 21.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 144.7 28.59 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 109.767 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.681 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -127.22 150.76 49.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.841 0.829 . . . . 0.0 109.51 179.034 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.2 t -119.77 147.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.554 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -145.03 110.75 5.38 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.138 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 50.01 17.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.299 0.571 . . . . 0.0 110.979 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.29 27.76 3.8 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.751 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -121.42 176.34 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 2.3 mt-10 -156.05 117.23 3.85 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.09 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.886 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -112.17 166.94 10.81 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -145.26 137.47 25.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.912 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.59 ' NE ' ' OH ' ' A' ' 14' ' ' TYR . 14.6 mtt180 -125.15 114.1 18.58 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 114' ' ' VAL . 7.3 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 110.352 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.532 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 11.4 m-30 -100.93 166.21 10.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -150.96 146.75 26.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.58 -0.7 . . . . 0.0 109.121 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -47.83 136.43 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.496 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 130' ' ' LYS . 11.7 p30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.451 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 4' ' ' SER . 26.6 t70 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.16 0.505 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 160.29 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 109.598 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.582 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.7 m -98.03 142.59 29.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.304 -0.872 . . . . 0.0 109.352 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.582 ' CD1' ' C ' ' A' ' 5' ' ' THR . 4.4 m95 -147.29 169.43 19.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.303 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 8' ' ' VAL . 11.9 pttm -151.9 130.7 12.43 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.022 -1.049 . . . . 0.0 109.477 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.654 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -39.83 106.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.364 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.44 -32.28 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' OG ' ' A' ' 11' ' ' SER . 15.8 mtm-85 -142.58 164.65 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.686 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 67.3 m -170.47 178.22 3.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 109.294 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -155.19 157.5 37.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.056 . . . . 0.0 110.006 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 10.8 m-20 58.02 -109.53 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.678 . . . . 0.0 109.854 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 71.69 -51.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -61.36 -46.03 91.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.955 -1.091 . . . . 0.0 108.597 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -63.34 -33.84 76.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.918 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 91.0 t80 -71.39 -61.4 1.79 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.795 0.807 . . . . 0.0 108.883 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.3 mmt -59.04 -23.78 62.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -74.76 -37.82 62.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.24 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -64.67 -46.38 82.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.341 -0.849 . . . . 0.0 109.028 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.479 ' CE ' ' CE2' ' A' ' 17' ' ' PHE . 4.8 mtm -61.81 -9.07 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.041 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.26 28.02 62.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.533 HG11 ' OD1' ' A' ' 74' ' ' ASP . 3.8 t -74.85 132.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -1.091 . . . . 0.0 109.553 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -49.31 167.15 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -82.03 -1.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.181 0.991 . . . . 0.0 109.22 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -73.69 -59.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.456 0.646 . . . . 0.0 109.386 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -64.22 -29.56 70.66 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.071 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 14.3 ttp180 -72.71 -30.69 64.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.642 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -75.4 -40.02 58.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.38 -13.14 47.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.01 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 33' ' ' HIS . . . -84.7 -49.56 8.4 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.212 0.529 . . . . 0.0 109.626 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.2 -1.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.544 ' H ' ' C ' ' A' ' 31' ' ' ALA . 79.4 m80 -140.1 46.26 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.609 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' LEU . 25.6 t0 -125.56 95.95 4.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.639 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.6 p-10 -71.48 43.57 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.353 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.654 HD23 HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -43.77 155.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.901 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -106.57 148.7 27.95 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.5 HD21 HD11 ' A' ' 36' ' ' LEU . 2.7 mp -138.92 126.53 21.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -98.29 111.78 24.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.8 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.9 mp -100.76 120.48 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.448 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -120.98 151.99 39.08 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.642 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 1.6 pm0 -130.88 147.06 52.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 45' ' ' ASN . 38.5 mm-40 -144.04 78.88 1.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.65 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 43' ' ' GLU . 44.9 p-10 -124.53 28.81 6.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -1.145 . . . . 0.0 110.347 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.22 109.88 4.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 42' ' ' GLN . 3.9 m-85 -94.65 171.02 9.05 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m -155.9 103.5 2.24 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 0.0 108.992 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.67 115.69 41.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.326 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -101.09 100.25 10.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 52' ' ' SER . 5.3 tt0 -69.86 157.78 36.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 108.736 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.422 ' N ' ' CG ' ' A' ' 51' ' ' GLU . 2.3 m -160.12 107.02 1.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.152 -0.968 . . . . 0.0 109.015 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.676 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -137.05 144.36 43.15 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.18 7.62 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 109.236 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.676 ' H ' ' C ' ' A' ' 53' ' ' SER . 60.2 m-85 -109.38 -25.02 10.76 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.296 -0.878 . . . . 0.0 111.1 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 2.7 ptm180 164.34 86.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.171 . . . . 0.0 109.44 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -62.61 146.4 52.1 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.299 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -140.56 174.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.127 -0.983 . . . . 0.0 110.409 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.61 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.9 pt-20 -146.34 142.76 28.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 98.9 m -151.25 125.06 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -86.38 150.35 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -136.38 131.08 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.922 -1.112 . . . . 0.0 110.416 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' OE1' HG21 ' A' ' 66' ' ' VAL . 4.7 tt0 -120.98 170.03 9.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.61 118.94 37.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.061 -1.024 . . . . 0.0 110.333 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.08 22.87 36.79 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.479 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 12.7 t -143.71 105.85 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.959 -1.318 . . . . 0.0 109.401 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.727 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.48 142.37 44.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.637 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -149.45 -171.36 3.87 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -139.41 154.02 47.72 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.659 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.1 t -153.45 135.54 14.78 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' OD1' HG21 ' A' ' 58' ' ' ILE . 5.8 p30 -93.73 143.39 26.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.934 -1.104 . . . . 0.0 110.231 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 78' ' ' LEU . 16.4 mt -92.53 146.89 23.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.67 -34.79 0.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 0.0 109.813 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.533 ' OD1' HG11 ' A' ' 23' ' ' VAL . 11.5 t70 -60.29 8.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 72.54 27.09 70.15 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.687 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.03 162.17 13.14 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.181 -1.188 . . . . 0.0 109.624 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -132.55 120.41 21.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -133.15 162.28 32.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.932 -1.105 . . . . 0.0 110.582 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -146.31 146.88 30.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.538 -0.726 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.52 -119.52 0.79 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.88 156.87 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.3 -1.117 . . . . 0.0 110.65 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 5.2 m95 -102.85 143.48 32.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -142.08 122.35 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.475 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 118.75 7.92 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 119.951 -1.718 . . . . 0.0 109.857 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.04 115.82 29.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.67 -103.54 0.33 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -125.35 33.77 5.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -140.98 143.13 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.735 -1.228 . . . . 0.0 110.251 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.12 104.53 17.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.781 ' CG1' ' O ' ' A' ' 83' ' ' SER . 0.9 OUTLIER -81.64 163.5 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.733 -1.229 . . . . 0.0 110.04 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.665 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.19 95.86 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.712 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.1 mttm -85.75 103.35 14.45 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.401 -1.058 . . . . 0.0 108.463 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.438 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -115.71 148.27 39.94 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.82 0.819 . . . . 0.0 110.154 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -133.41 120.9 21.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.451 0.643 . . . . 0.0 109.526 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.687 HH21 ' CG2' ' A' ' 76' ' ' THR . 23.8 mtp85 -53.1 115.32 1.81 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -13.41 61.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.456 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -77.84 -49.89 13.38 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.768 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -132.33 11.2 4.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.964 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.46 42.31 9.67 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.674 ' O ' ' O ' ' A' ' 101' ' ' GLU . 74.5 m-20 -75.6 19.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -1.154 . . . . 0.0 109.512 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.674 ' O ' ' O ' ' A' ' 100' ' ' ASN . 15.6 pt-20 45.07 164.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.816 0.817 . . . . 0.0 110.911 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 117' ' ' TYR . 6.6 tp -165.12 127.25 2.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -114.4 115.96 28.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.002 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -126.19 176.32 7.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.14 -0.975 . . . . 0.0 110.807 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -149.71 153.38 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -125.92 136.51 53.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.789 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -138.16 158.54 44.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.72 82.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 109' ' ' ILE . 22.4 mt -63.58 91.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.38 -81.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -127.89 29.34 5.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -1.191 . . . . 0.0 110.271 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -134.6 144.23 47.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.5 tp -105.36 113.34 26.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.873 -1.142 . . . . 0.0 109.085 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 127' ' ' ILE . 11.1 t -99.49 108.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.503 ' NE2' ' OH ' ' A' ' 117' ' ' TYR . 46.7 tt0 -105.52 106.65 17.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.6 OUTLIER -100.33 145.78 27.73 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 110.114 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -121.99 157.03 32.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.782 0.801 . . . . 0.0 109.191 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 103' ' ' ASN . 11.9 t -127.46 147.82 32.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.552 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.2 t80 -146.53 110.58 5.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.056 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 45.77 20.29 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.134 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.8 28.54 3.39 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.72 176.65 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 66.1 tt0 -155.91 125.28 6.25 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.401 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.918 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -115.6 152.92 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -133.92 136.91 44.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.773 -1.204 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.08 114.05 14.08 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.595 HG23 HG22 ' A' ' 114' ' ' VAL . 4.4 mt -107.67 123.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.989 . . . . 0.0 110.685 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -101.05 176.02 5.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.365 -0.834 . . . . 0.0 108.786 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -165.31 156.63 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.416 -0.803 . . . . 0.0 109.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -47.64 129.17 13.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.453 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.7 t70 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.72 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 85.2 m -102.16 143.26 32.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 109.721 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.571 ' CD1' ' C ' ' A' ' 5' ' ' THR . 11.5 m95 -148.69 168.72 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.14 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 8' ' ' VAL . 9.7 pttm -153.21 130.91 11.56 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 0.0 109.588 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -38.39 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.8 -27.05 21.36 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -154.62 167.84 28.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.143 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -177.94 164.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 14' ' ' TYR . 6.7 pt-20 -166.76 166.45 15.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.81 -1.181 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.12 -5.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.653 -0.654 . . . . 0.0 110.191 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -46.78 -61.23 1.94 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.966 -1.084 . . . . 0.0 110.021 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 6.1 p-10 -44.92 -44.78 9.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.984 -1.073 . . . . 0.0 109.247 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -62.7 -41.62 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 108.664 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.847 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 23.5 t80 -68.59 -54.82 14.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.384 -0.823 . . . . 0.0 108.949 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 7.2 mmt -57.96 -31.11 66.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' A' ' 28' ' ' ARG . 26.2 tt0 -74.8 -25.33 58.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -70.68 -48.66 53.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 ttm -59.44 -10.22 3.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.058 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.81 32.4 27.0 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' ASN . 13.8 t -77.03 132.41 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -1.077 . . . . 0.0 109.55 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' VAL . 3.2 t-20 -48.32 177.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.322 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.62 -2.82 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 109.41 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.85 -60.05 2.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -65.45 -25.96 67.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.43 HH21 ' HB2' ' A' ' 19' ' ' GLU . 21.3 ttp180 -73.25 -43.4 61.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.406 -0.809 . . . . 0.0 109.263 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -70.44 -32.72 70.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.1 mt -86.45 -13.7 45.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -85.96 -47.17 9.86 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.75 -22.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' ASN . 1.2 t60 -69.29 37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 32' ' ' ALA . 5.3 p30 -49.92 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.838 . . . . 0.0 109.594 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 33' ' ' HIS . 20.5 t-20 -147.26 43.22 1.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 108.862 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -92.72 168.54 11.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 111.238 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -108.83 150.22 27.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 38' ' ' LEU . 1.3 mp -139.64 120.0 13.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.991 -1.068 . . . . 0.0 110.329 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -101.79 111.38 23.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.4 mp -111.18 144.04 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 111.41 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -133.76 152.39 51.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -128.11 146.17 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -143.17 79.06 1.63 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.978 . . . . 0.0 109.616 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.01 -88.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.8 29.11 6.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.0 110.272 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -151.52 110.07 3.8 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -100.34 174.18 6.24 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.506 0.669 . . . . 0.0 109.919 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -148.86 103.23 3.35 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.8 t -96.06 110.92 25.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.749 -0.594 . . . . 0.0 109.571 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -100.77 100.24 10.88 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.3 mt-10 -73.89 159.35 32.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 109.004 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -161.99 107.15 1.25 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.143 -0.973 . . . . 0.0 109.096 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.672 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -135.0 144.29 47.29 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.64 7.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.987 -1.071 . . . . 0.0 109.156 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.672 ' H ' ' C ' ' A' ' 53' ' ' SER . 82.8 m-85 -113.16 -19.74 11.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.393 -0.817 . . . . 0.0 111.097 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.3 mmt180 162.8 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 109.556 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -63.1 148.69 47.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.278 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.614 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -142.85 174.31 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 121.192 -0.943 . . . . 0.0 110.471 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.614 ' H ' HG22 ' A' ' 58' ' ' ILE . 7.7 pt-20 -146.88 143.72 28.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.3 m -153.25 117.71 4.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.36 151.07 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -138.78 155.13 48.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.947 -1.096 . . . . 0.0 110.433 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.515 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 50.2 tt0 -150.01 168.41 23.95 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.515 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 14.5 mt -99.64 123.94 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.008 -1.058 . . . . 0.0 110.274 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 28.72 40.73 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.616 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 42.4 t -144.05 102.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.091 -1.24 . . . . 0.0 109.201 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -57.78 141.67 48.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.201 -0.937 . . . . 0.0 109.955 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.616 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.4 -171.6 3.98 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -138.67 150.6 46.39 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.65 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.5 t -151.44 136.33 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 76' ' ' THR . 6.5 p30 -95.09 144.76 25.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 110.225 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 73' ' ' ALA . 98.0 mt -93.27 146.79 23.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.619 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.81 -35.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 19.5 t70 -57.8 4.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.142 -0.974 . . . . 0.0 109.444 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.31 26.28 64.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.14 161.99 13.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 96' ' ' THR . 30.3 tt0 -132.86 122.27 24.15 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -133.79 163.85 28.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.014 -1.054 . . . . 0.0 110.541 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.15 142.19 28.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.135 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.89 -117.01 0.63 Allowed Glycine 0 N--CA 1.477 1.382 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.551 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.42 157.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.21 -1.17 . . . . 0.0 110.428 179.442 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.7 m95 -101.99 143.11 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.592 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.4 t -140.51 156.7 46.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 108.565 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -94.31 128.27 40.7 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.321 -1.487 . . . . 0.0 108.1 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.653 ' N ' HD12 ' A' ' 84' ' ' LEU . 12.8 pt-20 -133.31 125.03 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.01 -109.66 2.7 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.67 34.37 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -1.176 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -148.3 160.77 42.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.503 -1.373 . . . . 0.0 110.61 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.06 110.37 22.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.592 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.86 164.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 110.522 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.71 95.41 0.17 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.642 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 50.9 mttt -87.49 104.78 16.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.214 -1.168 . . . . 0.0 109.242 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.9 m-30 -118.19 127.27 53.59 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.735 0.778 . . . . 0.0 109.849 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -113.07 120.6 41.87 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.518 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 43.3 mtp180 -48.05 115.11 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -80.58 -10.4 59.74 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.485 1.136 . . . . 0.0 109.113 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.98 -26.61 18.3 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.789 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -132.06 4.6 4.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.965 . . . . 0.0 109.415 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 49.99 45.57 41.72 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.547 ' OD1' ' N ' ' A' ' 101' ' ' GLU . 30.8 t-20 -88.23 -122.48 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.25 -1.147 . . . . 0.0 109.008 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.0 pt-20 -175.29 138.55 0.42 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.353 0.597 . . . . 0.0 110.179 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.762 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.8 tt -141.17 119.2 11.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -110.16 112.34 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 108.693 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -122.65 174.95 6.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.139 0.971 . . . . 0.0 111.643 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.7 t -142.98 149.23 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -126.22 132.46 51.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -135.07 157.76 46.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.06 82.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.073 -1.017 . . . . 0.0 108.63 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 111' ' ' ASP . 62.8 mt -63.6 92.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.211 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.91 -77.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.9 m-20 -130.55 29.43 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -1.179 . . . . 0.0 110.404 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -135.34 134.56 39.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.223 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 6.4 tp -100.14 112.96 25.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 127' ' ' ILE . 14.9 t -99.59 106.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.336 -0.945 . . . . 0.0 108.807 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.415 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 62.1 tt0 -111.1 104.61 13.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 108.984 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.419 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.3 144.4 30.84 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 0.0 109.464 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.762 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -129.02 144.67 51.26 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 109.687 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 122' ' ' VAL . 13.2 t -110.58 147.31 14.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.505 ' N ' HG12 ' A' ' 122' ' ' VAL . 2.4 t80 -148.22 114.18 5.78 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 52.85 14.92 0.48 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.87 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.3 28.37 3.83 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.78 176.73 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.678 ' HG2' HG22 ' A' ' 118' ' ' VAL . 19.6 mt-10 -155.56 111.79 3.13 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.454 -1.299 . . . . 0.0 110.787 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -105.01 153.47 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.06 138.27 49.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.994 -1.066 . . . . 0.0 110.68 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -131.7 114.11 14.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.9 mt -107.69 123.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.579 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 7.5 m-30 -99.73 176.17 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.288 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -161.45 146.28 13.45 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -47.8 133.67 13.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.524 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.498 ' OD1' ' OE1' ' A' ' 42' ' ' GLN . 4.0 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -175.22 -151.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 110.518 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.608 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 23.6 m -106.77 131.09 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.416 -0.802 . . . . 0.0 110.192 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.693 ' CZ3' ' N ' ' A' ' 130' ' ' LYS . 49.9 m95 -145.05 158.04 43.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -147.81 153.59 39.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.704 -1.247 . . . . 0.0 110.668 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.438 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 2.7 t -42.47 106.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.716 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -97.16 -31.07 12.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HB2' HD12 ' A' ' 127' ' ' ILE . 50.8 mtt85 -152.85 172.07 17.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.8 t -173.22 177.38 2.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.947 -1.096 . . . . 0.0 109.723 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.99 162.19 40.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.858 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 4.6 m-20 59.58 -109.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.582 -0.699 . . . . 0.0 109.865 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.678 ' CE1' ' NH2' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 72.06 -52.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -0.967 . . . . 0.0 109.703 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 13.2 p-10 -60.94 -44.42 97.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.561 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -63.62 -32.07 73.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.896 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 16.1 t80 -71.77 -64.02 1.01 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.063 0.935 . . . . 0.0 108.619 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -58.27 -24.0 58.02 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.455 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 24.2 tp10 -79.86 -29.1 39.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 109.295 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -71.37 -42.66 68.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.077 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.7 mtm -67.41 -6.37 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.343 -0.848 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.49 64.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.86 130.81 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -1.162 . . . . 0.0 109.578 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -50.09 174.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.945 . . . . 0.0 109.368 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -84.47 -1.4 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 122.159 0.98 . . . . 0.0 109.175 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.09 -59.87 2.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -37.93 71.8 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HB3' ' A' ' 15' ' ' ASP . 2.1 ttt85 -64.41 -50.3 68.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -50.07 -36.41 29.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.001 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.47 -13.11 47.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.085 0.945 . . . . 0.0 109.384 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' ASP . . . -84.39 -37.01 22.04 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.658 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.73 -37.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.346 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -98.52 33.97 2.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.109 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ALA . 22.1 t70 -79.25 38.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.461 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -73.7 43.7 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 36' ' ' LEU . 2.6 pt? -52.99 170.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.13 0.967 . . . . 0.0 111.576 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -110.47 148.2 32.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.813 HD13 ' CE2' ' A' ' 128' ' ' PHE . 0.6 OUTLIER -137.17 123.98 21.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.92 -1.113 . . . . 0.0 110.54 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.77 109.08 21.07 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.1 mp -103.33 127.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 0.0 110.801 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -128.45 151.75 49.03 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.498 ' OE1' ' OD1' ' A' ' 3' ' ' ASP . 6.7 pt20 -141.29 140.18 33.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.839 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.43 78.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.43 -88.5 0.03 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.626 -0.989 . . . . 0.0 110.626 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -116.72 28.99 8.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -1.094 . . . . 0.0 110.348 -178.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -145.65 110.25 5.08 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.415 ' O ' HG23 ' A' ' 61' ' ' VAL . 13.9 m-85 -104.86 168.52 9.01 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -156.0 103.54 2.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.137 -0.977 . . . . 0.0 109.057 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.42 121.87 49.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -112.54 100.36 8.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' ILE . 92.0 mt-10 -77.48 157.44 30.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.104 -0.998 . . . . 0.0 109.318 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -159.46 106.82 1.73 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.229 -0.92 . . . . 0.0 108.984 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.644 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -131.05 144.46 51.47 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.391 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.01 7.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.175 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.644 ' H ' ' C ' ' A' ' 53' ' ' SER . 70.9 t80 -114.47 -17.64 11.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 111.173 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 6.4 mtp85 161.71 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.714 -1.241 . . . . 0.0 109.205 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -63.03 144.12 57.17 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.339 -0.85 . . . . 0.0 109.632 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.583 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -136.35 174.23 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.86 0.838 . . . . 0.0 110.08 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.583 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -156.65 156.07 32.85 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.9 109.11 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.82 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.639 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -104.53 153.45 6.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 1.7 m-85 176.42 -179.21 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.833 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.1 tt0 -117.66 168.33 10.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.504 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 19.2 mt -81.33 139.09 35.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.04 23.24 28.01 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.64 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 52.0 t -143.92 103.76 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -1.197 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.762 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.7 143.19 25.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.946 . . . . 0.0 109.811 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.71 -171.62 3.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.567 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 5.2 p30 -137.2 151.43 48.75 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 110.312 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 71.3 m -156.89 137.41 13.09 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.469 ' ND2' HD13 ' A' ' 58' ' ' ILE . 1.2 p-10 -92.53 143.9 25.88 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 0.0 110.416 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 96.0 mt -93.22 146.97 23.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.397 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.29 -34.04 0.45 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.907 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.22 12.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 68.74 27.13 74.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.19 162.31 13.05 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.258 -1.142 . . . . 0.0 109.634 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 96' ' ' THR . 30.6 tt0 -132.22 118.7 19.86 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -133.78 162.49 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.098 . . . . 0.0 110.797 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 9.8 ptm180 -143.23 142.92 31.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.83 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.762 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.4 -117.78 0.67 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.527 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.64 158.11 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.049 -1.265 . . . . 0.0 110.693 179.259 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.425 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.77 142.52 32.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -138.78 157.05 46.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -96.56 125.85 41.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.351 -1.468 . . . . 0.0 108.234 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.594 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.5 mm-40 -123.57 111.13 15.89 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.52 -105.19 1.07 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -125.13 33.65 5.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -1.136 . . . . 0.0 110.146 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -140.8 149.18 41.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.797 -1.19 . . . . 0.0 110.229 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -96.05 107.35 19.64 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -78.32 164.22 3.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 110.684 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.657 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.15 94.78 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.681 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.1 mtpm? -87.98 104.23 16.44 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.25 -1.147 . . . . 0.0 108.879 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -116.33 139.11 50.75 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.865 0.841 . . . . 0.0 110.18 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -121.72 121.03 36.38 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 15.7 mtp180 -53.81 115.03 1.78 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -68.01 -12.37 60.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.368 1.08 . . . . 0.0 109.396 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.88 -52.14 9.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.529 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 98' ' ' ASN . 39.1 t30 -132.62 14.55 4.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.65 44.05 11.84 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.751 ' O ' ' O ' ' A' ' 101' ' ' GLU . 49.7 m-20 -76.18 19.22 0.25 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -1.095 . . . . 0.0 109.724 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.751 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.2 pt-20 42.77 158.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.062 0.934 . . . . 0.0 111.247 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.1 tt -160.14 123.65 3.56 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.725 ' N ' HD23 ' A' ' 102' ' ' LEU . 2.0 m120 -113.45 113.87 25.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.097 -1.002 . . . . 0.0 109.028 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -126.0 176.56 6.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 111.071 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.4 t -148.85 150.82 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -127.77 135.13 49.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.549 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -141.89 158.6 43.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 mm -119.39 82.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 109' ' ' ILE . 1.7 mp -65.22 91.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 121.633 0.73 . . . . 0.0 109.893 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.34 -76.15 0.0 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 109' ' ' ILE . 10.2 t70 -124.45 29.64 6.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.239 . . . . 0.0 110.838 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -145.55 136.97 25.07 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.031 -1.043 . . . . 0.0 109.33 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.31 110.77 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.503 HG23 HD13 ' A' ' 109' ' ' ILE . 38.5 t -95.93 118.05 41.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 110.08 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -120.84 103.06 8.79 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.3 OUTLIER -105.33 147.16 28.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.155 -0.965 . . . . 0.0 110.182 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -126.82 152.85 46.41 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 109.252 178.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 122' ' ' VAL . 5.7 t -121.2 148.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.52 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.94 110.52 5.57 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.878 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 47.16 19.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.146 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.43 28.56 3.47 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.81 177.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.031 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 122' ' ' VAL . 58.9 tt0 -155.65 122.29 5.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.391 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.896 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -113.47 141.02 47.61 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -119.83 140.59 50.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.778 -1.201 . . . . 0.0 111.111 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.678 ' NH2' ' CE1' ' A' ' 14' ' ' TYR . 61.3 mtp85 -134.9 113.75 11.85 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 10' ' ' ARG . 3.5 mt -108.8 124.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.709 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.813 ' CE2' HD13 ' A' ' 38' ' ' LEU . 7.1 m-30 -98.21 177.95 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.938 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.507 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 20.0 tttp -158.29 147.22 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.693 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 16.4 pttp -46.69 129.02 11.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' OD2' ' A' ' 131' ' ' ASP . 7.3 p30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.485 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.495 ' HB3' ' HE1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -168.54 -151.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.366 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.604 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 47.5 m -108.8 126.43 53.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.604 ' CD1' ' C ' ' A' ' 5' ' ' THR . 37.6 m95 -142.12 168.59 19.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.337 -0.852 . . . . 0.0 108.703 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.5 pttp -152.44 143.37 23.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.701 -1.249 . . . . 0.0 110.506 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.548 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -43.25 107.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.451 -0.78 . . . . 0.0 109.953 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.76 -31.15 12.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -149.12 164.71 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.727 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -170.46 169.79 7.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.258 -0.901 . . . . 0.0 109.255 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 14' ' ' TYR . 8.1 pt-20 -166.65 166.68 15.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.934 -1.104 . . . . 0.0 110.434 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 14' ' ' TYR . 2.5 m-20 62.57 -10.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.555 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -43.44 -59.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.019 -1.051 . . . . 0.0 109.863 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.59 -45.76 38.51 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.95 -1.094 . . . . 0.0 109.243 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -59.6 -40.66 88.21 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.907 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 24.4 t80 -67.39 -62.88 1.21 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -30.77 9.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -73.42 -29.27 62.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.072 -1.018 . . . . 0.0 109.128 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -67.94 -48.36 66.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.2 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.92 -6.95 4.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.53 26.26 47.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.9 t -72.78 136.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -1.059 . . . . 0.0 109.525 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -53.25 174.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.59 -1.98 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.093 0.949 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.9 -60.09 2.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 6.3 mptt -65.95 -21.15 66.41 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.422 ' NE ' HD13 ' A' ' 25' ' ' ILE . 15.3 ttp180 -72.64 -43.56 63.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 109.43 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -70.35 -33.45 71.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.62 -13.12 46.59 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.937 0.875 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -83.83 -52.97 5.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.245 0.545 . . . . 0.0 109.89 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.13 -50.6 4.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -73.66 46.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.511 ' HB3' HH22 ' A' ' 126' ' ' ARG . 46.6 m-20 -71.23 136.56 48.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.51 ' HA ' HG13 ' A' ' 8' ' ' VAL . 5.1 m-80 -147.37 43.06 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.692 ' CD2' HH12 ' A' ' 126' ' ' ARG . 0.8 OUTLIER -84.27 162.87 19.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 110.948 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -107.71 147.0 31.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.537 HD13 ' CE2' ' A' ' 128' ' ' PHE . 3.6 mp -136.6 121.04 18.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 110.019 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 m -92.1 104.58 16.95 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.738 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -97.69 117.84 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.22 151.92 38.45 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.444 ' CD ' ' CE2' ' A' ' 47' ' ' PHE . 49.1 tt0 -129.28 146.55 51.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.136 -0.978 . . . . 0.0 109.813 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -145.24 79.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.39 -92.95 0.16 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.04 28.56 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.382 -1.069 . . . . 0.0 109.758 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -145.96 109.6 4.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.444 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 14.1 m-85 -96.7 173.92 7.08 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.765 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -153.47 104.04 2.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 51' ' ' GLU . 2.5 t -101.22 112.79 35.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.57 -0.707 . . . . 0.0 109.373 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.47 100.6 11.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.885 . . . . 0.0 109.404 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.582 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.0 mp0 -72.65 155.73 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.183 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 1.2 m -159.34 106.71 1.75 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.119 -0.988 . . . . 0.0 108.892 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.638 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -130.44 144.28 51.3 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.258 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.94 8.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.27 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.638 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -117.03 -19.83 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 111.422 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.701 ' HE ' ' HB1' ' A' ' 73' ' ' ALA . 6.9 ptt180 167.7 84.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.641 -1.287 . . . . 0.0 109.575 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 30.0 p-10 -63.14 143.98 57.31 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -135.89 174.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.182 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.588 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.9 pt-20 -154.1 142.4 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.37 131.64 6.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.546 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -75.13 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.245 -0.91 . . . . 0.0 108.546 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -148.02 118.51 7.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.026 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.427 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 26.6 tt0 -130.32 146.82 51.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.5 pp -95.73 130.5 42.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.784 -1.197 . . . . 0.0 109.597 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.05 8.17 42.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.595 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 46.9 t -144.29 103.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.079 -1.248 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -57.16 145.1 32.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.206 1.003 . . . . 0.0 110.049 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.69 -170.77 3.53 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -145.0 149.13 34.6 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.738 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.421 ' SG ' ' N ' ' A' ' 71' ' ' ASN . 43.6 t -150.29 170.43 19.02 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 1.5 p-10 -120.52 145.86 46.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.959 -1.088 . . . . 0.0 110.311 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 73' ' ' ALA . 15.5 mt -93.82 146.9 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.545 -0.722 . . . . 0.0 109.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.701 ' HB1' ' HE ' ' A' ' 56' ' ' ARG . . . -40.56 -36.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.725 . . . . 0.0 109.833 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 38.2 t0 -57.83 6.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 109.437 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.642 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 73.86 26.16 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.25 162.17 13.13 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.204 -1.174 . . . . 0.0 109.621 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' THR . 29.3 tt0 -132.45 124.25 28.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.66 166.11 23.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.957 -1.089 . . . . 0.0 110.727 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -148.42 141.35 24.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.422 -0.799 . . . . 0.0 109.912 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.64 -118.0 0.71 Allowed Glycine 0 N--CA 1.475 1.281 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.551 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.61 159.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -1.176 . . . . 0.0 110.499 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.58 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 2.3 m95 -103.1 144.62 31.06 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.39 157.68 44.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -89.6 127.89 35.96 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.166 -1.584 . . . . 0.0 108.255 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.622 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -125.83 122.03 34.98 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.79 -107.7 1.0 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -125.28 33.3 5.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -1.133 . . . . 0.0 110.065 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 1.3 mptt -141.53 159.44 42.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.879 -1.138 . . . . 0.0 109.924 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.27 108.87 21.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -76.8 164.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.012 -1.055 . . . . 0.0 110.305 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.77 96.27 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.629 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -89.65 105.59 17.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.142 -1.21 . . . . 0.0 108.897 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.407 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.1 m-30 -118.08 125.36 50.15 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.821 0.82 . . . . 0.0 109.999 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -108.89 118.35 36.56 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.533 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 63.9 mtp180 -46.42 114.89 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.19 -10.35 59.64 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.533 1.159 . . . . 0.0 109.125 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.88 -26.15 19.49 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.61 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.16 2.1 3.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 52.76 45.71 60.44 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' A' ' 95' ' ' ARG . 15.7 t-20 -89.39 -122.07 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.367 -1.078 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -175.45 138.89 0.42 Allowed 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.948 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.734 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.0 tt -144.02 120.34 10.91 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.53 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -107.48 107.79 18.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.789 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -121.55 175.92 5.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.992 . . . . 0.0 111.559 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 106' ' ' ARG . 33.3 t -148.19 159.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 115' ' ' GLN . 9.8 ttm180 -134.63 136.97 43.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -145.71 159.12 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 109.08 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.4 83.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.683 ' O ' ' N ' ' A' ' 111' ' ' ASP . 44.4 mt -64.23 91.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.26 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.89 -80.52 0.0 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 109' ' ' ILE . 2.2 p30 -119.6 30.11 7.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -1.203 . . . . 0.0 111.052 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 129' ' ' LYS . 2.6 mt-10 -145.07 132.75 20.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.859 -1.151 . . . . 0.0 109.475 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.7 OUTLIER -98.12 113.93 25.97 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 109' ' ' ILE . 2.1 t -108.26 113.82 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.617 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.582 HE21 ' HE2' ' A' ' 117' ' ' TYR . 37.9 tt0 -110.29 105.29 14.27 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.502 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -99.59 146.35 26.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.116 -0.99 . . . . 0.0 110.006 -178.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.734 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -131.17 145.64 52.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.873 0.844 . . . . 0.0 109.737 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.7 t -111.86 148.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.518 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.6 t80 -147.23 112.09 5.39 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.032 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 51.5 16.35 0.43 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.875 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.79 28.24 3.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.759 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.97 176.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 pt-20 -155.57 113.46 3.37 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.008 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -105.75 156.84 17.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -134.06 136.08 43.73 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.012 -1.055 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.692 HH12 ' CD2' ' A' ' 36' ' ' LEU . 4.2 mmm180 -125.32 116.2 21.55 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 7.0 mt -110.64 124.17 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.537 ' CE2' HD13 ' A' ' 38' ' ' LEU . 8.9 m-30 -98.99 176.38 5.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.146 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 3.8 tppt? -155.66 150.16 26.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.528 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 12.3 tttt -46.94 135.46 9.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.456 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.6 m-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.1 m 161.63 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.617 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.3 m -103.63 140.76 37.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.617 ' CD1' ' C ' ' A' ' 5' ' ' THR . 5.3 m95 -148.04 168.88 21.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 8' ' ' VAL . 6.5 pttp -153.36 132.71 12.8 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.662 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.56 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -0.893 . . . . 0.0 109.628 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 17.7 t0 -94.73 -28.4 15.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -148.39 171.84 15.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.716 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 t -171.86 178.34 3.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.19 151.21 30.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.796 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.55 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 21.9 t-20 58.66 -108.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.0 109.842 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.593 ' CD2' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER 75.55 -54.13 0.64 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.0 110.017 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.92 -45.99 91.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.034 -1.041 . . . . 0.0 109.099 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.56 -30.72 71.09 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.866 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 15.1 t80 -72.19 -57.07 4.54 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.193 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.568 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 2.5 mpp? -59.14 -28.61 66.71 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.85 -27.71 55.18 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.149 -0.97 . . . . 0.0 109.254 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -71.54 -42.59 67.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.238 -0.913 . . . . 0.0 109.414 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.662 ' SD ' ' CE2' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -68.76 -5.41 20.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.043 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.11 25.14 56.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 24' ' ' ASN . 60.9 t -67.33 116.93 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.159 . . . . 0.0 109.461 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 23' ' ' VAL . 2.5 m-20 -41.79 155.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -67.48 -2.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 0.0 109.084 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.59 -60.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.95 -30.72 69.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -50.19 61.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -56.1 -34.17 65.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.57 -13.22 46.43 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.967 0.889 . . . . 0.0 109.759 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -84.64 -37.97 20.41 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.256 0.551 . . . . 0.0 109.603 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' ASP . . . -44.66 -14.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.305 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.4 m-70 -70.44 46.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.178 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -54.47 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.463 -0.773 . . . . 0.0 109.878 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' HIS . 31.6 t-20 -148.22 42.38 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.275 -0.89 . . . . 0.0 109.12 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.662 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -84.31 159.09 20.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 52' ' ' SER . 11.4 ttpt -119.49 145.83 45.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.6 pt? -154.5 142.48 20.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.975 -1.078 . . . . 0.0 110.346 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.464 ' C ' HD12 ' A' ' 40' ' ' ILE . 6.4 m -108.17 124.92 51.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.822 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.5 mp -109.95 124.98 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 110.81 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 151.62 36.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.3 148.77 48.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.994 -1.066 . . . . 0.0 110.071 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -148.46 79.09 1.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.36 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.17 -89.93 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.45 28.42 7.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -1.096 . . . . 0.0 109.71 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -144.51 110.54 5.43 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.473 ' O ' HG23 ' A' ' 61' ' ' VAL . 1.3 p90 -111.46 173.68 6.23 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.395 0.617 . . . . 0.0 109.686 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.7 m -150.81 103.09 3.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.699 HG12 ' OE2' ' A' ' 51' ' ' GLU . 17.7 t -90.93 108.49 19.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.623 -0.673 . . . . 0.0 109.563 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -99.42 100.2 11.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.699 ' OE2' HG12 ' A' ' 49' ' ' VAL . 3.6 mp0 -78.01 159.73 28.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 37' ' ' LYS . 1.7 m -159.96 106.65 1.62 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.669 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 55' ' ' PHE . 1.8 p -127.25 144.31 51.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.88 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 109.588 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' SER . 9.4 t80 -123.43 -11.74 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 111.641 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.1 mmt180 164.72 84.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.459 -1.401 . . . . 0.0 109.883 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -63.9 147.46 51.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.463 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -138.19 174.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 110.072 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.6 135.41 11.74 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.55 109.15 4.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -105.22 153.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.9 OUTLIER 175.95 -179.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.142 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 66' ' ' VAL . 42.1 tt0 -117.53 137.23 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.93 142.04 57.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.16 -34.33 5.48 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 66' ' ' VAL . 6.2 p -102.63 125.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.244 . . . . 0.0 109.974 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.62 142.99 51.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.91 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CZ ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -148.72 -171.62 3.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.518 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.544 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 10.9 p30 -135.94 150.74 49.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.088 -1.007 . . . . 0.0 110.345 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 60.5 m -155.79 135.88 12.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.548 ' OD1' HG21 ' A' ' 58' ' ' ILE . 2.2 p30 -95.21 144.56 25.71 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.916 -1.115 . . . . 0.0 110.607 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.6 mt -90.87 146.9 23.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.59 -0.694 . . . . 0.0 109.222 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.76 -35.17 1.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.755 . . . . 0.0 109.723 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.0 4.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.81 26.43 62.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.0 162.19 13.14 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.303 -1.116 . . . . 0.0 109.517 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.82 121.13 22.5 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -135.02 162.9 31.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.88 -1.137 . . . . 0.0 110.51 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.59 143.2 31.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 109.894 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.738 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.35 -116.62 0.62 Allowed Glycine 0 N--CA 1.477 1.368 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.547 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 171.37 158.42 0.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 0.0 110.813 179.259 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.6 141.48 34.4 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -139.53 157.17 46.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.935 . . . . 0.0 108.527 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -94.53 126.48 39.84 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.35 -1.469 . . . . 0.0 108.187 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.602 ' N ' HD12 ' A' ' 84' ' ' LEU . 14.1 mm-40 -129.37 120.62 25.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 -108.26 2.05 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -125.37 34.28 4.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -1.156 . . . . 0.0 110.549 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 161.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.6 -1.313 . . . . 0.0 110.412 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 mt -100.98 108.01 19.63 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -75.52 164.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.436 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.672 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.89 94.63 0.16 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.691 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 5.6 mtmm -88.5 102.97 15.44 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.115 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 3.7 m-30 -116.15 129.89 56.54 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.802 0.811 . . . . 0.0 109.792 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -113.06 118.2 34.13 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.493 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 42.7 mtp180 -51.07 114.99 1.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.75 -11.68 56.79 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.485 1.136 . . . . 0.0 109.086 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.22 -23.44 21.26 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -132.1 -0.87 3.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.226 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 54.58 43.48 78.47 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.597 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 16.6 t-20 -92.26 -122.85 0.08 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -1.162 . . . . 0.0 109.244 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 4.3 pt-20 -174.91 138.39 0.46 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -136.0 111.29 9.06 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.406 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.3 t30 -104.69 108.19 19.52 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.7 t -122.28 176.14 6.02 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.148 0.975 . . . . 0.0 112.099 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.41 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.7 t -145.81 147.4 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -123.64 132.88 53.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 110.198 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -131.55 158.6 40.51 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -124.49 82.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.13 -0.981 . . . . 0.0 108.43 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 111' ' ' ASP . 27.7 mt -64.33 91.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.929 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.78 -81.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -125.17 29.56 6.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -1.2 . . . . 0.0 110.187 -179.324 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.68 138.33 40.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.172 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.0 tp -103.3 111.79 24.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.039 -1.038 . . . . 0.0 109.535 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.8 109.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.052 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -112.06 103.96 12.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.308 -0.87 . . . . 0.0 108.661 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.25 143.16 32.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.551 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.697 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -125.57 147.14 49.38 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.786 0.803 . . . . 0.0 109.35 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 122' ' ' VAL . 12.6 t -114.58 149.88 16.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.662 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 1.6 t80 -143.67 110.96 5.8 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.847 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 48.67 18.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.245 0.545 . . . . 0.0 110.944 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.49 28.43 3.51 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.803 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.71 176.11 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 9.9 pt-20 -156.47 123.87 5.4 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.539 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.866 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -119.84 152.74 36.83 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -131.62 140.08 49.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.769 -1.207 . . . . 0.0 111.279 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -133.12 114.16 13.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 2.6 mt -105.31 124.25 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.084 -1.01 . . . . 0.0 110.987 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -95.53 175.91 6.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.512 -0.742 . . . . 0.0 109.555 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -164.52 148.83 9.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.519 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 20.7 mtmm -47.72 134.34 12.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.49 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.596 ' OG ' ' NE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -174.27 -152.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.146 -0.971 . . . . 0.0 110.398 -179.376 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.595 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 29.0 m -107.2 129.32 54.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.814 . . . . 0.0 110.199 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.684 ' CE3' ' N ' ' A' ' 130' ' ' LYS . 43.4 m95 -142.44 167.84 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 10.3 pttp -152.72 138.73 18.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.84 -1.162 . . . . 0.0 110.741 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -38.64 107.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.52 -0.738 . . . . 0.0 109.965 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -97.06 -32.42 11.99 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.441 ' O ' ' OG ' ' A' ' 11' ' ' SER . 14.5 mtt-85 -150.45 178.27 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.646 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 73.8 m -171.41 177.99 3.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.272 -0.893 . . . . 0.0 109.412 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -150.12 149.23 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.033 . . . . 0.0 109.888 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 16' ' ' LYS . 48.2 t-20 63.52 -104.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.61 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.521 ' HD1' ' HB1' ' A' ' 124' ' ' ALA . 0.1 OUTLIER 69.14 -44.04 0.53 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 13' ' ' ASN . 54.5 m-20 -63.68 -47.76 79.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 108.751 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB2' HD21 ' A' ' 13' ' ' ASN . 24.7 mmtp -61.07 -37.26 82.05 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.908 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 68.4 t80 -69.3 -63.76 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -54.53 -24.94 22.89 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.042 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -79.36 -26.81 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -43.89 62.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 109.032 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.473 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -67.85 -6.13 20.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 108.961 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.1 31.93 53.97 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -77.66 158.42 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 109.514 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -75.0 175.64 7.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -84.68 -1.33 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.48 -59.88 2.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 121.451 0.643 . . . . 0.0 109.268 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 21.1 mttp -63.58 -27.3 69.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 108.669 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.2 -42.15 72.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.37 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -66.74 -34.59 78.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.1 mt -86.25 -13.09 47.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.582 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -77.74 -47.39 19.16 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.808 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.54 -64.96 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.94 . . . . 0.0 109.645 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.24 46.12 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.878 . . . . 0.0 109.357 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 15.0 t70 -89.47 160.53 16.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 109.769 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.643 ' HA ' HG13 ' A' ' 8' ' ' VAL . 4.4 m-20 -143.19 42.96 1.54 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.356 -0.84 . . . . 0.0 108.991 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -54.89 148.09 13.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.163 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.813 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -119.07 139.73 51.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -146.63 153.04 39.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.909 -1.119 . . . . 0.0 110.268 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -115.03 109.53 18.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.752 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -98.51 119.28 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 110.169 -179.01 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.34 151.67 36.52 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -135.47 139.97 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 45' ' ' ASN . 7.2 mt-10 -139.01 78.82 1.69 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.06 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 43' ' ' GLU . 6.0 p-10 -118.79 28.94 8.0 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.301 -1.117 . . . . 0.0 110.507 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -154.47 111.05 3.29 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.4 p90 -107.93 173.48 6.3 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.752 -0.592 . . . . 0.0 109.491 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -155.87 103.43 2.24 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.006 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.88 109.15 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.506 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -99.76 99.65 10.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.634 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . 26.5 mt-10 -72.89 156.81 38.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.033 -1.042 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.6 m -161.78 107.23 1.29 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.198 -0.939 . . . . 0.0 109.029 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.68 ' C ' ' H ' ' A' ' 55' ' ' PHE . 6.4 p -139.96 144.43 37.05 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.18 7.6 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.68 ' H ' ' C ' ' A' ' 53' ' ' SER . 38.1 m-85 -107.96 -23.57 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 111.049 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.2 mtp-105 160.49 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -62.78 145.24 55.36 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.712 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.18 174.56 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.406 -0.809 . . . . 0.0 109.825 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.2 pt-20 -154.19 143.1 21.06 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.8 108.71 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.656 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -107.32 151.57 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.238 -0.914 . . . . 0.0 109.799 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 1.8 m-85 176.32 -179.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.808 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 27.8 tt0 -107.39 167.71 9.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.574 -0.704 . . . . 0.0 109.175 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.542 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.5 mt -80.14 130.23 35.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.36 -30.18 10.31 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.628 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 57.6 t -84.09 110.88 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.248 . . . . 0.0 110.033 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -57.57 143.67 40.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -150.63 -171.6 3.97 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.566 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 12.2 p-10 -138.18 149.63 46.02 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.131 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 57.2 m -156.15 137.78 14.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -93.61 144.05 25.74 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.358 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 74' ' ' ASP . 48.2 mt -93.98 146.97 23.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.565 -0.709 . . . . 0.0 109.421 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.63 -28.47 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.582 -0.699 . . . . 0.0 109.745 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.9 17.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.75 26.34 66.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.474 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.02 161.92 13.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.287 -1.125 . . . . 0.0 109.565 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -132.85 119.98 20.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.17 161.95 33.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.882 -1.136 . . . . 0.0 110.684 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 19.9 ptt180 -143.16 141.91 31.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 110.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.95 -116.01 0.59 Allowed Glycine 0 N--CA 1.476 1.352 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 170.76 157.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -1.187 . . . . 0.0 110.603 179.308 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.615 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.1 m95 -102.25 144.07 31.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.636 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -144.54 155.98 43.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.057 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.71 119.19 26.68 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.312 -1.492 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -109.33 104.58 13.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.68 -101.34 0.51 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -124.77 33.45 5.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -1.174 . . . . 0.0 110.177 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -140.75 157.23 45.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.816 -1.177 . . . . 0.0 109.961 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -100.1 101.85 13.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -72.12 163.62 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 110.396 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.96 95.66 0.17 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.635 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 3.8 tttm -90.25 104.92 17.44 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.181 -1.188 . . . . 0.0 108.636 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 2.9 m-30 -117.79 125.06 49.89 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.845 0.831 . . . . 0.0 109.766 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HZ1' ' HE3' ' A' ' 92' ' ' LYS . 15.2 mttp -105.63 116.41 31.9 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 39.5 mtp180 -54.45 114.74 1.78 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.37 -13.08 61.38 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.529 1.157 . . . . 0.0 109.433 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.95 -47.08 15.57 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.67 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 99' ' ' GLY . 31.9 m-80 -132.61 7.83 4.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 110.074 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.16 42.18 8.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.672 ' O ' ' O ' ' A' ' 101' ' ' GLU . 4.7 m120 -78.05 12.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 0.0 109.513 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.3 mt-10 47.79 128.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.548 0.689 . . . . 0.0 111.003 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 117' ' ' TYR . 7.4 tt -129.23 120.77 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.671 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.5 OUTLIER -108.18 107.83 18.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.062 -179.457 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.9 t -122.91 176.41 6.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.208 -0.933 . . . . 0.0 111.137 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 106' ' ' ARG . 89.1 t -148.38 159.63 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.615 ' NH1' ' CH2' ' A' ' 82' ' ' TRP . 50.6 ttm-85 -131.3 136.87 48.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.725 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -139.39 158.55 43.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 109.298 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.2 mm -122.19 82.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.722 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.3 mm -68.38 91.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.374 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 41.43 -80.42 0.0 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.722 ' N ' ' O ' ' A' ' 109' ' ' ILE . 5.3 m-20 -118.18 29.5 7.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.252 . . . . 0.0 110.884 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -146.9 134.5 20.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.127 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.5 115.96 29.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 108.28 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.966 -1.084 . . . . 0.0 110.294 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -117.17 103.26 10.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 1.1 m -102.39 148.49 25.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 110.103 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.722 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -129.51 151.94 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.482 178.852 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 122' ' ' VAL . 8.2 t -118.71 148.08 21.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.42 110.77 5.54 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.96 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 47.86 19.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.025 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.38 28.46 3.53 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.741 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.3 176.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.533 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.9 mt-10 -155.67 119.57 4.5 Favored 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.123 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.908 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -111.64 148.9 32.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -125.57 138.52 53.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.926 -1.109 . . . . 0.0 110.829 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.44 ' CZ ' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mmt85 -128.17 127.17 42.45 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 mt -118.01 123.71 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.506 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -97.96 176.62 5.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.495 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 24.6 tttt -155.24 142.46 19.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.684 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 3.3 pttp -47.5 132.13 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 109.764 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 129' ' ' LYS . 19.6 m-20 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' A' ' 4' ' ' SER . 1.5 p30 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.467 ' HB2' ' HE1' ' A' ' 6' ' ' TRP . 1.2 m -169.38 -149.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.091 -1.005 . . . . 0.0 110.289 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.62 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 6.4 m -103.1 129.84 50.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.413 -0.804 . . . . 0.0 109.987 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.692 ' CZ3' ' N ' ' A' ' 130' ' ' LYS . 56.3 m95 -148.21 167.61 24.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 108.865 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -152.76 139.53 18.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.699 -1.251 . . . . 0.0 110.62 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.663 HG11 HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -45.28 107.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -99.85 -29.79 12.4 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 mmt-85 -141.52 171.16 14.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.64 -0.662 . . . . 0.0 109.535 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.3 t -173.25 178.0 2.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.395 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -155.88 156.87 35.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.133 -0.979 . . . . 0.0 109.862 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.8 m-20 58.77 -109.56 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.605 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.504 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 73.77 -52.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.232 -0.918 . . . . 0.0 109.975 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.03 -49.15 78.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 108.919 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.38 -33.79 72.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.817 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 65.3 t80 -71.32 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.457 ' HE2' ' CE1' ' A' ' 14' ' ' TYR . 21.9 mmt -55.58 -22.37 21.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.91 -33.62 45.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.274 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' NZ ' ' HB ' ' A' ' 122' ' ' VAL . 14.6 mmtp -68.36 -42.05 79.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.611 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -66.82 -7.42 21.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.119 -0.988 . . . . 0.0 108.953 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.53 26.88 62.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 24' ' ' ASN . 41.3 t -66.34 122.27 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -1.075 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.1 m-20 -43.47 168.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -78.87 -1.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 122.141 0.972 . . . . 0.0 109.193 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.18 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -62.27 -31.0 71.52 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -69.6 -45.89 67.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 109.183 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -57.4 -37.22 72.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.267 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 30' ' ' LEU . 96.0 mt -86.5 -12.9 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.035 0.922 . . . . 0.0 109.677 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -70.86 -47.44 59.3 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.41 -21.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' ASN . 56.3 t-80 -69.07 36.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -51.59 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.6 ' HA ' HG13 ' A' ' 8' ' ' VAL . 1.1 m-20 -147.92 42.45 1.04 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.903 . . . . 0.0 109.048 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.663 HD23 HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -89.95 162.39 15.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 110.461 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -108.34 144.91 35.24 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -138.49 123.75 19.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 110.074 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 104.67 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.492 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.1 mp -97.59 127.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.928 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.9 151.88 49.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -130.35 143.27 50.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 45' ' ' ASN . 8.6 mt-10 -138.7 79.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.83 -82.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 43' ' ' GLU . 35.4 p30 -124.88 28.28 6.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -1.133 . . . . 0.0 110.204 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.84 109.9 4.34 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.608 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -97.51 172.81 7.5 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.753 -0.592 . . . . 0.0 109.728 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.0 m -154.27 104.28 2.59 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.384 -0.823 . . . . 0.0 108.832 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.54 116.5 42.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -109.92 100.54 9.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 109.628 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -77.64 157.53 30.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.066 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER -157.41 106.62 2.15 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 108.891 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.666 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.38 144.64 50.67 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.403 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.39 7.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.058 . . . . 0.0 109.642 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.666 ' H ' ' C ' ' A' ' 53' ' ' SER . 91.0 t80 -108.01 -23.83 11.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.0 111.046 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 161.2 88.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.975 -1.078 . . . . 0.0 109.009 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.403 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 16.7 p-10 -62.72 143.82 57.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.397 -0.814 . . . . 0.0 109.766 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.734 HG21 ' ND2' ' A' ' 71' ' ' ASN . 1.1 mt -134.24 173.76 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.413 -0.804 . . . . 0.0 110.203 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.3 pt-20 -157.38 142.95 17.35 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 60' ' ' CYS . 14.2 p -163.61 128.09 2.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.497 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -82.59 160.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.507 -0.746 . . . . 0.0 109.123 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.608 ' CE2' ' CB ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -156.36 133.18 10.35 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.475 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.496 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 18.4 tt0 -105.55 168.47 9.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.489 -0.757 . . . . 0.0 109.005 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.496 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 13.0 mt -88.84 122.5 32.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 0.0 110.081 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 30.13 27.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 81' ' ' THR . 23.5 t -144.18 102.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.275 . . . . 0.0 109.413 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 2.3 m -47.59 145.88 2.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.427 1.108 . . . . 0.0 109.876 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -165.93 -167.23 1.04 Allowed 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.507 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 46.9 p-10 -147.84 157.59 43.61 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.875 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.5 t -150.34 137.59 19.53 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.734 ' ND2' HG21 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -98.08 149.49 22.44 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.001 -1.062 . . . . 0.0 110.184 -178.739 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 75' ' ' GLY . 27.7 mt -96.9 146.83 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.55 -0.719 . . . . 0.0 109.552 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.65 -34.67 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.628 -0.67 . . . . 0.0 109.719 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.76 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.2 -0.938 . . . . 0.0 109.28 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 74.3 25.15 71.45 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.1 tt0 -133.4 126.16 30.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -132.97 160.06 38.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.936 -1.103 . . . . 0.0 110.322 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -135.23 149.22 49.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.434 -0.791 . . . . 0.0 110.248 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.712 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.07 -111.12 0.46 Allowed Glycine 0 C--O 1.211 -1.289 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 167.57 154.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.984 -1.304 . . . . 0.0 110.604 178.11 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.486 ' NE1' ' CZ ' ' A' ' 93' ' ' PHE . 74.1 m95 -102.12 133.38 47.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.587 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.9 m -138.2 157.18 46.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.947 -1.096 . . . . 0.0 109.338 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -94.86 128.55 41.7 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.519 -1.363 . . . . 0.0 108.193 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.653 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.7 mm-40 -129.06 118.73 23.01 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.6 -107.12 1.48 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -125.3 34.34 4.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.48 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -148.3 150.18 33.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.723 -1.236 . . . . 0.0 110.45 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 106' ' ' ARG . 2.0 mt -92.2 115.69 28.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.587 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -87.04 163.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.143 -0.973 . . . . 0.0 110.489 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.595 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.43 94.34 0.16 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.712 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 47.7 mttt -87.14 102.14 14.17 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.182 -1.187 . . . . 0.0 108.473 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.2 m-30 -122.32 137.18 54.94 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.807 0.813 . . . . 0.0 110.346 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' ARG . 9.5 ptpt -127.75 126.07 41.11 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' GLY . 43.4 mtp180 -43.79 115.46 0.81 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.313 -0.867 . . . . 0.0 108.881 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.04 -5.42 17.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.401 1.096 . . . . 0.0 109.37 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.86 -48.61 8.6 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.307 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -132.43 9.11 4.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.462 -0.774 . . . . 0.0 109.614 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.59 47.05 30.09 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 6.4 m120 -72.17 11.17 0.61 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -1.224 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.2 mt-10 48.8 134.42 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.823 0.821 . . . . 0.0 111.349 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.4 tt -139.24 131.44 28.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.535 ' N ' HD23 ' A' ' 102' ' ' LEU . 3.1 m-20 -114.15 112.6 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.025 . . . . 0.0 109.233 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -125.26 174.59 8.01 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.111 -0.993 . . . . 0.0 111.159 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 106' ' ' ARG . 48.1 t -145.93 163.92 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.551 ' N ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -138.18 135.89 36.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.713 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -139.21 158.91 43.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.088 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.15 82.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.649 ' O ' ' N ' ' A' ' 111' ' ' ASP . 20.9 mt -65.72 91.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.146 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.84 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 109' ' ' ILE . 30.6 m-20 -119.17 29.87 7.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -1.211 . . . . 0.0 110.666 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -140.98 134.12 29.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.046 -1.034 . . . . 0.0 109.566 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 1.5 tt -98.3 110.0 22.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 108.344 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.21 118.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 110.345 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -120.06 104.97 10.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -104.49 146.16 29.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.124 -0.985 . . . . 0.0 110.264 -178.767 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.718 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -126.04 150.8 47.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.787 0.803 . . . . 0.0 109.184 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 122' ' ' VAL . 13.8 t -118.87 148.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.522 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.3 t80 -145.6 111.32 5.49 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.924 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 51.76 16.3 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.319 0.581 . . . . 0.0 110.949 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.06 28.04 3.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.797 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.39 176.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.509 ' N ' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -155.99 118.52 4.13 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.175 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -111.15 150.69 29.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -131.52 139.14 49.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.833 -1.167 . . . . 0.0 111.331 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.504 ' CZ ' ' OH ' ' A' ' 14' ' ' TYR . 22.9 mtp180 -133.64 115.02 14.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 2.6 mt -104.57 129.95 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.573 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.53 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.3 m-30 -98.69 177.46 5.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.513 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 16.8 tptm -152.94 143.91 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.692 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -47.26 133.68 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.185 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.463 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 4' ' ' SER . 35.5 t0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.282 0.563 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 168.24 -159.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.38 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.551 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 88.9 m -94.42 145.39 24.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 5' ' ' THR . 20.6 m95 -151.79 167.54 27.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.9 ptmt -154.24 133.57 12.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.484 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.659 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -42.09 106.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -98.48 -27.82 13.88 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -142.71 169.62 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.912 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 26.1 t -172.39 178.14 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.838 . . . . 0.0 109.43 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -153.86 154.68 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.4 m-20 56.34 -109.71 0.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.475 -0.766 . . . . 0.0 109.61 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER 75.87 -54.21 0.62 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.315 -0.865 . . . . 0.0 109.723 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.64 -58.98 5.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.011 -1.055 . . . . 0.0 108.567 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -52.42 -35.55 52.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.358 -0.839 . . . . 0.0 108.913 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.837 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 30.6 t80 -68.46 -61.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.265 -0.897 . . . . 0.0 108.752 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.773 ' SD ' HG21 ' A' ' 23' ' ' VAL . 9.7 mmt -49.59 -33.94 16.47 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.641 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.15 -37.67 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.071 . . . . 0.0 109.447 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -62.81 -43.19 99.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.626 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.681 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 1.7 mtm -70.22 -3.17 15.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.211 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 32.5 61.99 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.773 HG21 ' SD ' ' A' ' 18' ' ' MET . 25.3 t -74.11 138.02 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 109.385 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 23' ' ' VAL . 31.8 m-20 -45.75 172.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.357 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.657 HD12 HH11 ' A' ' 28' ' ' ARG . 1.6 mm -83.77 -2.22 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.276 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -81.32 -60.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.841 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 2.4 mptm? -65.88 -20.14 66.12 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.657 HH11 HD12 ' A' ' 25' ' ' ILE . 3.2 tmm_? -75.44 -45.17 40.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.492 -0.755 . . . . 0.0 109.128 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.29 -36.34 74.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.571 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 mt -86.55 -13.23 46.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.753 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -60.98 -52.95 62.85 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.14 -32.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.459 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 33.7 m170 -74.57 42.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' ND2' ' A' ' 35' ' ' ASN . 1.2 p30 -63.21 112.12 2.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.552 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.0 m120 -147.57 42.88 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.31 -0.868 . . . . 0.0 109.242 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.659 HD23 HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -82.08 158.91 23.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' SER . 7.0 tttt -113.58 138.18 50.53 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.9 pt? -147.45 145.29 29.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.989 -1.069 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 m -110.2 125.23 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.2 mp -110.89 133.27 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.486 -179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.88 152.1 51.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -138.08 141.14 40.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 45' ' ' ASN . 35.5 mt-10 -138.59 78.92 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.416 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.27 -82.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.37 29.32 7.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -1.095 . . . . 0.0 110.114 -178.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.53 110.73 4.85 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.47 166.78 10.2 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.433 HG23 HG13 ' A' ' 61' ' ' VAL . 25.3 m -153.72 103.2 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 108.615 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.94 114.37 41.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.579 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -106.65 100.02 9.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.582 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.79 155.64 26.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' LYS . 92.4 p -159.76 107.5 1.71 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.234 1.016 . . . . 0.0 109.077 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 m -118.67 -163.16 0.94 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.41 8.73 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.345 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 21.0 m-85 -125.35 -12.69 6.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 112.108 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER 165.59 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.233 -1.542 . . . . 0.0 110.026 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -62.95 145.48 55.21 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.391 -0.818 . . . . 0.0 109.217 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -131.13 174.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.348 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.572 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -151.11 130.17 12.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.7 m -133.22 110.41 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.389 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.594 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.08 142.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.221 -0.924 . . . . 0.0 108.992 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER 176.16 173.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.672 -1.211 . . . . 0.0 110.785 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.89 162.38 13.17 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 64' ' ' LEU . 2.1 pp -82.32 135.22 35.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.918 -1.113 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.79 20.33 13.24 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 65.7 t -143.87 106.25 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.34 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -49.81 144.44 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.113 0.959 . . . . 0.0 110.25 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.612 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -156.74 -171.8 3.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.432 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -127.19 152.37 47.45 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.054 -1.028 . . . . 0.0 110.347 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.9 t -153.96 129.1 9.65 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.35 149.53 23.7 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.112 -0.993 . . . . 0.0 110.239 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 73' ' ' ALA . 74.6 mt -100.73 146.85 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.325 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.28 -33.75 1.04 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.797 . . . . 0.0 109.86 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 14.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 67.56 28.64 73.58 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.456 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -99.41 162.12 13.22 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -132.36 118.75 19.79 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -132.59 162.89 30.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 0.0 110.495 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -143.63 141.17 30.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.807 . . . . 0.0 109.831 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.817 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.91 -117.39 0.64 Allowed Glycine 0 N--CA 1.476 1.351 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.2 159.24 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.025 -1.279 . . . . 0.0 110.898 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CZ ' ' A' ' 93' ' ' PHE . 15.3 m95 -101.91 142.58 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.594 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.9 m -140.68 157.6 45.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -92.79 127.17 38.2 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.306 -1.496 . . . . 0.0 108.194 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.606 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -122.93 121.61 36.56 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.57 -105.55 0.37 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 2.1 p-10 -125.13 33.62 5.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.016 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -140.36 159.17 42.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.02 -1.05 . . . . 0.0 110.095 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.44 108.97 21.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -78.63 164.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.101 -1.0 . . . . 0.0 110.64 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.605 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.33 95.24 0.17 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.664 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.7 pttp -88.9 104.08 16.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.166 -1.197 . . . . 0.0 109.034 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.6 m-30 -116.92 131.96 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.37 119.38 36.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 69.1 mtp180 -52.71 115.14 1.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.336 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -11.95 57.03 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.387 1.089 . . . . 0.0 109.219 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.62 -26.94 24.13 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.832 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -132.18 -0.18 3.72 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 57.21 45.09 93.0 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.582 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 20.2 t-20 -91.76 -122.62 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.274 -1.133 . . . . 0.0 109.227 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.7 pt-20 -175.54 137.3 0.36 Allowed 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.138 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 117' ' ' TYR . 55.2 tp -134.25 108.98 8.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.616 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.9 OUTLIER -101.32 105.68 16.77 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.4 t -121.09 176.13 5.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 112.017 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.408 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.6 t -148.2 154.26 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.512 ' HE ' HD21 ' A' ' 113' ' ' LEU . 55.0 mtp180 -127.01 131.45 51.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 109.987 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -129.31 159.18 36.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.425 -0.797 . . . . 0.0 109.032 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.8 82.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 109' ' ' ILE . 15.5 mt -63.53 91.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.798 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.0 -81.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.3 m-20 -125.6 29.31 6.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -137.37 147.19 45.32 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 108.735 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.578 HD23 ' CD2' ' A' ' 128' ' ' PHE . 10.5 tp -107.72 110.52 22.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.499 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.404 HG13 ' CG1' ' A' ' 127' ' ' ILE . 2.5 t -90.59 115.68 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.439 -0.788 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -114.04 103.26 10.97 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.05 145.28 29.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.183 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.726 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -127.33 149.91 49.83 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.471 178.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 122' ' ' VAL . 6.9 t -117.1 150.23 19.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.582 ' CE1' ' OD1' ' A' ' 100' ' ' ASN . 1.1 t80 -142.56 110.06 5.73 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.754 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 45.57 20.44 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 119' ' ' TYR . . . 112.91 28.63 3.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.761 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.58 176.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.541 ' N ' HG13 ' A' ' 122' ' ' VAL . 2.7 tt0 -155.98 125.82 6.45 Favored 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 118.045 -1.462 . . . . 0.0 111.406 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -122.77 151.19 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 11' ' ' SER . 19.5 ttpt -130.03 140.21 50.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.916 -1.115 . . . . 0.0 111.112 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.463 ' CZ ' ' OH ' ' A' ' 117' ' ' TYR . 11.0 ttm180 -137.41 114.11 10.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.404 ' CG1' HG13 ' A' ' 114' ' ' VAL . 2.2 mp -105.99 131.41 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 0.0 111.132 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 38' ' ' LEU . 3.0 m-30 -100.9 176.05 5.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -165.16 157.08 15.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.804 . . . . 0.0 109.245 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -47.27 130.16 12.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.397 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 4' ' ' SER . 2.8 p30 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.655 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.1 t 162.47 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.655 ' N ' ' OG ' ' A' ' 4' ' ' SER . 90.6 m -89.96 145.51 25.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.566 ' CD1' ' C ' ' A' ' 5' ' ' THR . 12.2 m95 -151.41 168.26 25.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 109.542 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.4 pttp -153.15 133.53 13.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.965 . . . . 0.0 109.445 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.577 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -38.15 106.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.269 -0.894 . . . . 0.0 109.622 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -93.59 -28.25 16.14 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -152.73 173.14 15.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.882 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -172.98 178.22 2.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 0.0 109.145 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 3.1 pt-20 -157.06 154.55 29.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.067 -1.02 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.3 m-20 56.5 -109.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 109.826 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.5 -53.47 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.356 -0.84 . . . . 0.0 109.701 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -48.67 80.77 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.994 -1.066 . . . . 0.0 108.76 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -60.2 -33.26 71.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 49.1 t80 -72.0 -62.85 1.28 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.567 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 25.9 mmt -56.48 -23.57 40.15 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.345 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.95 -37.59 54.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.057 -1.027 . . . . 0.0 109.243 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -64.66 -39.93 94.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.195 -0.941 . . . . 0.0 109.21 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.6 mtp -65.12 -9.61 24.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.118 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.91 29.93 27.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 24' ' ' ASN . 19.5 t -79.78 126.3 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -1.144 . . . . 0.0 109.441 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 23' ' ' VAL . 9.0 m120 -42.4 165.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.13 -1.99 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.158 0.98 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -80.26 -59.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.678 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -65.06 -22.56 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -73.15 -44.49 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -70.77 -33.05 70.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.49 -13.21 46.7 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.007 0.908 . . . . 0.0 109.752 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -78.63 -45.64 21.08 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.608 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.06 -22.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 31' ' ' ALA . 31.6 m170 -69.28 37.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.302 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 32' ' ' ALA . 2.4 m-20 -51.05 95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.557 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' HIS . 12.0 m120 -147.66 42.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.307 -0.871 . . . . 0.0 109.206 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -97.69 170.74 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -179.084 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -108.65 142.19 39.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.746 -0.596 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 36' ' ' LEU . 1.9 mp -139.12 128.26 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -102.81 117.08 33.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.2 mp -103.95 122.86 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.622 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.43 151.8 37.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.58 145.08 50.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -139.49 78.95 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.6 -81.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 43' ' ' GLU . 19.8 m120 -122.37 28.85 7.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -1.127 . . . . 0.0 110.253 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -153.57 110.12 3.37 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -94.19 173.91 7.41 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.791 -0.568 . . . . 0.0 109.485 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.5 m -155.81 103.49 2.26 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.152 -0.967 . . . . 0.0 108.99 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.6 t -98.19 113.14 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.66 -0.65 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -99.97 100.45 11.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.2 tt0 -72.81 155.88 39.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.173 -0.954 . . . . 0.0 108.818 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.0 m -160.48 107.04 1.52 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.168 -0.958 . . . . 0.0 109.021 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.689 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -137.0 144.25 43.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.64 7.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.024 -1.048 . . . . 0.0 109.069 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.689 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.3 m-85 -112.41 -31.18 6.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.27 -0.894 . . . . 0.0 111.476 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.0 tpp85 177.84 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.655 -1.278 . . . . 0.0 109.378 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -63.18 140.29 58.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.094 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -139.17 174.41 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.601 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.2 pt-20 -152.0 141.64 21.79 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -151.46 132.21 14.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.17 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.301 -0.874 . . . . 0.0 108.847 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.34 167.35 21.19 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.115 -0.991 . . . . 0.0 109.947 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 26.5 tt0 -159.95 168.06 26.56 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.527 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 31.2 mt -98.59 122.23 41.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.25 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 24.47 47.37 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.501 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.62 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 89.5 t -144.18 102.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.275 . . . . 0.0 109.416 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.746 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.29 141.29 54.77 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.169 0.985 . . . . 0.0 110.062 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.62 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.06 -171.29 3.79 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.451 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -142.41 151.16 41.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.836 -1.146 . . . . 0.0 110.799 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.707 ' O ' HD22 ' A' ' 78' ' ' LEU . 49.5 t -144.83 170.69 15.64 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 76' ' ' THR . 1.5 p-10 -126.12 141.26 52.02 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.864 -1.147 . . . . 0.0 110.396 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.9 mt -93.12 146.85 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.542 -0.724 . . . . 0.0 109.371 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.09 -28.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.837 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.567 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 47.5 m-20 -67.68 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.28 27.78 68.16 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.523 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.03 162.02 13.24 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.424 -1.045 . . . . 0.0 109.399 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.946 ' C ' HD13 ' A' ' 78' ' ' LEU . 69.4 tt0 -132.86 116.29 16.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.021 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -119.66 150.93 39.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.011 . . . . 0.0 110.404 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.87 140.59 42.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.877 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.746 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.92 -117.24 0.63 Allowed Glycine 0 N--CA 1.477 1.378 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.536 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.8 159.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -1.181 . . . . 0.0 110.54 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.0 m95 -101.77 142.84 32.48 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.597 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.0 m -138.35 157.23 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -96.18 127.35 42.1 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.352 -1.468 . . . . 0.0 108.205 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.63 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.2 mm-40 -127.32 114.74 17.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.21 -106.45 1.33 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -125.17 34.31 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -1.131 . . . . 0.0 110.427 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.57 150.67 37.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 110.314 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.55 109.99 21.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.597 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -80.12 164.58 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.119 -0.988 . . . . 0.0 110.538 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.659 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.69 95.84 0.17 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.673 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 14.0 ptmt -86.41 107.04 17.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.27 -1.135 . . . . 0.0 108.678 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -117.07 140.35 49.6 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.84 0.828 . . . . 0.0 110.234 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -125.48 113.27 17.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.47 0.652 . . . . 0.0 109.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 99' ' ' GLY . 30.9 mtp180 -51.51 114.82 1.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.408 ' H ' ' HG1' ' A' ' 96' ' ' THR . 0.6 OUTLIER -69.87 -13.76 62.41 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.355 1.074 . . . . 0.0 109.628 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.48 -48.35 15.52 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.786 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' GLY . 34.4 m120 -132.54 10.68 4.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.151 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 44.46 39.36 5.7 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.716 ' O ' ' O ' ' A' ' 101' ' ' GLU . 34.2 m-20 -75.17 18.95 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.168 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.716 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.0 pt-20 43.7 161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.929 . . . . 0.0 111.239 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.3 tt -161.23 123.83 3.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.7 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -112.18 113.92 26.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 109.143 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -124.69 176.11 6.78 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.186 -0.946 . . . . 0.0 110.948 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.9 t -149.59 154.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -127.05 136.5 52.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.67 158.63 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -121.29 82.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 121.117 -0.989 . . . . 0.0 108.38 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 109' ' ' ILE . 24.2 mt -63.54 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.765 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.47 -81.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -129.21 29.17 5.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -1.187 . . . . 0.0 110.206 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.36 142.54 48.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 108.75 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.2 tp -103.28 110.34 22.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.932 -1.105 . . . . 0.0 109.266 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.511 HG22 HG23 ' A' ' 127' ' ' ILE . 18.1 t -95.83 110.15 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -108.45 106.86 17.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -100.92 144.6 29.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.166 -0.959 . . . . 0.0 109.792 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.3 OUTLIER -123.27 152.59 41.21 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.816 0.817 . . . . 0.0 109.161 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.2 t -121.93 147.76 25.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.539 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -144.5 110.67 5.48 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.973 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 48.59 18.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.26 0.552 . . . . 0.0 111.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.34 28.33 3.58 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.71 176.91 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.39 124.58 6.24 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.303 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.849 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.14 154.38 30.11 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.501 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 5.5 ttmt -131.99 139.72 48.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 111.175 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -135.58 113.93 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.511 HG23 HG22 ' A' ' 114' ' ' VAL . 5.4 mt -109.16 123.83 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.084 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.523 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -98.83 176.01 5.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 130' ' ' LYS . 3.0 tttp -163.78 161.65 23.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.403 ' H ' ' HG2' ' A' ' 129' ' ' LYS . 10.7 ptpt -47.61 132.3 14.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.498 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 4' ' ' SER . 11.1 t70 . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 5' ' ' THR . 28.8 t 167.5 -136.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.575 ' N ' ' OG ' ' A' ' 4' ' ' SER . 18.2 m -89.3 131.14 35.54 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.952 0.882 . . . . 0.0 111.946 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.855 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 9.6 m95 -123.41 170.62 10.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.488 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 13.9 pttp -144.57 122.43 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 110.123 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.606 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -42.35 107.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -94.69 -30.33 14.35 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -150.27 165.2 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.727 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 11.8 t -168.47 178.32 4.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.367 -0.833 . . . . 0.0 109.267 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -155.29 156.21 35.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.57 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 16.2 m-20 59.68 -109.04 0.41 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.924 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.544 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 73.07 -52.25 0.71 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.37 -43.61 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.956 -1.09 . . . . 0.0 109.019 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -67.55 -31.56 71.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.9 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 76.5 t80 -73.43 -57.0 4.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.606 ' C ' HH22 ' A' ' 28' ' ' ARG . 16.1 mmt -60.33 -29.16 68.7 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.572 ' N ' HH22 ' A' ' 28' ' ' ARG . 16.5 tp10 -77.12 -27.97 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.241 -0.912 . . . . 0.0 109.633 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -73.57 -37.66 65.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.484 ' HB2' HG23 ' A' ' 23' ' ' VAL . 2.1 mtm -69.16 -8.35 44.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.142 -0.973 . . . . 0.0 108.932 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.26 29.47 37.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 23.7 t -77.18 127.17 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -1.208 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 0.7 OUTLIER -42.61 164.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.917 HD13 ' HE ' ' A' ' 28' ' ' ARG . 1.3 mm -80.04 -1.33 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.18 0.99 . . . . 0.0 109.178 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 t -81.36 -59.85 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -63.85 -28.84 70.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.917 ' HE ' HD13 ' A' ' 25' ' ' ILE . 9.9 ttm-85 -70.64 -43.85 68.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.369 -0.832 . . . . 0.0 109.249 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.06 -33.02 74.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.414 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 -13.63 44.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.12 -36.13 19.77 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.654 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . -44.6 -15.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.592 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 35' ' ' ASN . 14.1 m80 -80.24 46.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.586 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -44.81 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 33' ' ' HIS . 62.6 t-20 -147.67 42.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.401 -0.812 . . . . 0.0 109.142 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.606 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -97.55 175.75 6.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.81 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.52 152.54 37.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 38' ' ' LEU . 3.3 mp -139.83 128.94 23.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 4' ' ' SER . 0.3 OUTLIER -97.86 104.15 16.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.855 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -105.65 126.43 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -132.71 152.07 51.81 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -135.35 142.81 45.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.913 -1.117 . . . . 0.0 110.05 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' ASN . 24.2 mm-40 -140.23 78.92 1.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.73 -86.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -117.58 29.19 8.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -146.1 110.77 5.17 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.41 166.56 10.67 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.425 HG23 HG13 ' A' ' 61' ' ' VAL . 26.1 m -154.16 103.25 2.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 108.652 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.62 HG22 HG23 ' A' ' 40' ' ' ILE . 87.5 t -104.41 141.36 20.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -135.34 100.15 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.55 157.21 37.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 108.71 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -156.56 107.06 2.36 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.075 -1.016 . . . . 0.0 109.174 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.682 ' C ' ' H ' ' A' ' 55' ' ' PHE . 2.2 p -137.67 144.64 41.92 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.42 7.51 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.995 -1.065 . . . . 0.0 109.266 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.682 ' H ' ' C ' ' A' ' 53' ' ' SER . 88.4 t80 -104.63 -26.8 12.18 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 110.85 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 160.08 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 109.027 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -62.35 145.31 54.21 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.442 -0.787 . . . . 0.0 109.449 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -133.76 173.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.214 -0.929 . . . . 0.0 110.186 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.567 ' H ' HG22 ' A' ' 58' ' ' ILE . 8.5 pt-20 -149.8 147.71 28.32 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.46 0.647 . . . . 0.0 109.711 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.13 110.33 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.833 . . . . 0.0 109.242 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.592 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -109.82 143.63 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.217 -0.927 . . . . 0.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 176.29 169.84 0.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.854 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -94.56 151.13 19.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 64' ' ' LEU . 1.3 pp -76.97 133.08 39.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.924 -1.11 . . . . 0.0 109.272 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.0 21.1 11.36 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.591 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 27.9 t -143.35 106.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -1.151 . . . . 0.0 109.31 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -46.36 145.68 1.65 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.153 0.978 . . . . 0.0 110.17 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -160.45 -171.6 3.22 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.542 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 2.0 m120 -123.26 153.45 40.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 110.149 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 93.2 m -157.79 129.29 6.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -90.68 147.92 22.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.072 -1.017 . . . . 0.0 110.259 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 52.5 mt -99.44 146.89 25.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.29 -31.68 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.838 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 21.6 t70 -65.71 15.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 109.329 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 64.94 27.16 71.84 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 162.05 13.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.312 -1.111 . . . . 0.0 109.533 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -132.47 119.71 20.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -135.8 163.85 29.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 0.0 110.448 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -142.05 140.14 32.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.74 . . . . 0.0 109.934 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.843 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.72 -117.78 0.64 Allowed Glycine 0 C--O 1.21 -1.358 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.31 157.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.107 -1.231 . . . . 0.0 110.58 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.577 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.36 142.13 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.585 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.12 157.32 45.45 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -93.21 126.63 38.42 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.306 -1.496 . . . . 0.0 108.407 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.6 ' N ' HD12 ' A' ' 84' ' ' LEU . 3.7 mm-40 -123.8 113.49 18.62 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.31 -105.25 0.99 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 87' ' ' ASN . 17.5 t-20 -125.17 34.17 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -1.128 . . . . 0.0 110.372 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.426 ' CE ' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -144.79 150.8 37.8 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.739 -1.226 . . . . 0.0 110.316 -179.701 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mt -94.77 108.77 20.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.585 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -79.4 164.0 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.099 -1.0 . . . . 0.0 110.698 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.28 95.59 0.17 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.623 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.45 108.91 19.92 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.205 -1.174 . . . . 0.0 109.016 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.518 ' HB2' HD22 ' A' ' 102' ' ' LEU . 3.0 m-30 -118.4 135.83 54.12 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.748 0.785 . . . . 0.0 109.986 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -118.01 115.25 24.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.314 0.578 . . . . 0.0 109.506 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 33.7 mtm180 -49.04 115.12 1.17 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -10.69 60.05 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.417 1.103 . . . . 0.0 109.357 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.0 -41.45 12.35 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.698 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.47 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -132.66 7.43 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.28 34.72 1.63 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.69 ' O ' ' O ' ' A' ' 101' ' ' GLU . 19.1 t-20 -74.96 18.66 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.159 -1.201 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.69 ' O ' ' O ' ' A' ' 100' ' ' ASN . 9.3 pt-20 44.5 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.012 0.91 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 93' ' ' PHE . 7.0 tt -158.5 130.63 6.82 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -117.97 118.61 32.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.96 -1.088 . . . . 0.0 109.173 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.5 t -130.47 176.46 8.13 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.12 -0.988 . . . . 0.0 110.752 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 106' ' ' ARG . 42.4 t -146.76 158.86 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.463 ' N ' HG12 ' A' ' 105' ' ' VAL . 10.9 ttp180 -131.65 135.23 46.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.79 158.64 43.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 108.92 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.53 83.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.72 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.7 mm -60.27 92.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.514 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 47.2 -74.86 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.72 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -125.73 30.02 5.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -1.202 . . . . 0.0 110.907 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -146.12 147.52 31.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.738 -1.227 . . . . 0.0 109.679 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.473 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 6.5 tp -102.49 115.24 30.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.049 -1.032 . . . . 0.0 108.855 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.6 t -102.7 108.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -109.55 106.1 15.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.8 OUTLIER -103.03 145.95 29.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -124.95 158.76 32.81 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.908 0.861 . . . . 0.0 109.486 178.738 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 122' ' ' VAL . 10.5 t -127.46 148.46 32.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.66 110.29 5.3 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.684 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 47.37 19.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.164 0.507 . . . . 0.0 111.104 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.73 28.25 3.51 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.745 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.5 176.51 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 15.1 pt-20 -156.38 126.02 6.29 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.648 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.9 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.92 150.19 38.9 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -126.23 139.37 53.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.773 -1.204 . . . . 0.0 110.757 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.544 ' NH1' ' OH ' ' A' ' 14' ' ' TYR . 7.0 mtt180 -129.81 114.16 15.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.01 122.72 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.035 . . . . 0.0 110.352 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.585 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 2.6 m-30 -107.1 177.15 4.94 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.775 0.797 . . . . 0.0 110.409 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -152.91 164.88 37.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 131' ' ' ASP . 16.5 pttp -47.19 138.65 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.031 . . . . 0.0 109.459 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 130' ' ' LYS . 4.9 p-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.448 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.838 ' CZ ' ' CG ' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 52.8 51.1 16.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.232 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 4' ' ' SER . 16.9 t70 -89.31 89.01 7.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.312 -0.868 . . . . 0.0 109.439 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.684 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 165.2 -164.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 0.0 109.729 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.684 ' N ' ' OG ' ' A' ' 4' ' ' SER . 43.2 m -102.13 146.74 27.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.663 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.838 ' CG ' ' CZ ' ' A' ' 2' ' ' PHE . 4.4 m95 -151.39 169.26 22.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 8' ' ' VAL . 18.1 pttp -152.58 128.41 10.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.097 -1.002 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.572 HG13 ' HA ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -37.45 107.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -97.69 -25.93 14.92 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.7 mtp180 -140.55 160.0 40.96 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.097 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.518 ' CB ' ' OD2' ' A' ' 34' ' ' ASP . 31.0 t -179.92 157.27 0.69 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' A' ' 125' ' ' LYS . 10.6 pt-20 -166.78 166.27 15.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.256 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.37 -6.77 0.59 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.547 -0.72 . . . . 0.0 109.738 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -47.94 -22.44 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.997 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.48 ' CA ' ' HE ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -71.99 -48.16 46.89 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.996 -1.065 . . . . 0.0 108.868 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -59.92 -36.68 77.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.956 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 49.6 t80 -68.23 -64.02 0.94 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.817 0.818 . . . . 0.0 108.93 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.0 mmt -56.52 -23.38 39.28 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.427 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.52 -23.97 34.32 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.057 -1.027 . . . . 0.0 109.118 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -74.45 -43.8 54.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -0.912 . . . . 0.0 108.995 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.592 ' SD ' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -58.76 -14.3 8.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.648 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.21 29.64 40.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 24' ' ' ASN . 2.1 t -79.33 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.391 -1.064 . . . . 0.0 109.444 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 23' ' ' VAL . 3.2 m120 -43.47 168.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.374 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -78.8 -2.32 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.38 -59.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.696 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -62.38 -24.19 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HE ' ' CA ' ' A' ' 15' ' ' ASP . 50.9 ttt180 -73.03 -47.28 46.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.508 -0.745 . . . . 0.0 109.208 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -68.96 -33.12 73.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 mt -86.52 -13.03 47.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.934 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -77.13 -52.62 8.97 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.165 0.507 . . . . 0.0 109.866 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.19 -28.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.692 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 31' ' ' ALA . 23.8 m170 -74.6 46.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' OD2' ' CB ' ' A' ' 11' ' ' SER . 6.1 p30 -66.38 115.12 5.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.572 ' HA ' HG13 ' A' ' 8' ' ' VAL . 10.4 m120 -147.74 43.21 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -89.06 165.02 14.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.469 ' C ' HD12 ' A' ' 38' ' ' LEU . 2.2 tttp -109.19 149.59 29.15 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -143.67 127.05 16.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.922 -1.111 . . . . 0.0 110.332 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 40' ' ' ILE . 3.0 m -103.14 111.41 23.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.787 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.7 mp -109.4 142.42 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 111.515 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -135.26 152.25 51.35 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.459 ' NE2' ' H ' ' A' ' 44' ' ' GLY . 2.1 tm0? -135.56 142.69 45.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 110.018 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 45' ' ' ASN . 4.9 mm-40 -142.15 78.86 1.64 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.459 ' H ' ' NE2' ' A' ' 42' ' ' GLN . . . 52.49 -88.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -113.66 29.16 8.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -1.102 . . . . 0.0 109.997 -179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.9 110.5 5.57 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.415 ' CZ ' ' HG3' ' A' ' 42' ' ' GLN . 6.0 m-85 -104.32 162.3 13.33 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.468 HG23 HG13 ' A' ' 61' ' ' VAL . 30.8 m -153.96 102.99 2.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 p -107.16 129.5 60.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -119.11 100.17 7.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.819 . . . . 0.0 109.388 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.23 160.45 31.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 108.833 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -160.48 106.93 1.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.088 -1.008 . . . . 0.0 109.303 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.644 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -129.31 144.29 51.17 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.77 7.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.985 -1.072 . . . . 0.0 109.387 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.644 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.6 OUTLIER -115.22 -20.09 10.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 111.35 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 165.57 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.55 -1.344 . . . . 0.0 109.423 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -62.35 149.45 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.343 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -136.98 174.21 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 58' ' ' ILE . 6.5 pt-20 -154.21 146.29 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.8 m -151.07 110.7 4.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.835 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -108.47 141.27 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.41 172.49 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.777 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 44.8 tt0 -98.37 164.74 12.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 64' ' ' LEU . 2.7 pp -82.04 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.842 -1.162 . . . . 0.0 109.593 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -31.99 6.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.1 p -88.4 117.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -1.23 . . . . 0.0 109.911 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -55.98 145.14 26.17 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.013 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -153.53 -171.6 3.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -130.55 150.68 51.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.995 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.69 133.65 12.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -88.97 149.24 23.38 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 75' ' ' GLY . 52.5 mt -99.53 146.82 25.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.425 -0.797 . . . . 0.0 109.374 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.89 -32.97 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.714 . . . . 0.0 109.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.67 12.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.84 27.75 72.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.421 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -99.33 162.23 13.16 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.193 -1.18 . . . . 0.0 109.471 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.473 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.8 tt0 -132.33 118.59 19.61 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -135.22 162.9 31.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.679 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB3' HH21 ' A' ' 79' ' ' ARG . 6.0 ptm85 -142.26 142.91 32.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.764 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.06 -117.43 0.64 Allowed Glycine 0 N--CA 1.476 1.35 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.4 157.54 0.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.138 -1.213 . . . . 0.0 110.913 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.496 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 6.1 m95 -102.27 141.56 34.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.639 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.2 m -142.23 156.28 45.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.097 -1.002 . . . . 0.0 108.667 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 121.37 27.11 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.115 -1.616 . . . . 0.0 110.038 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.51 107.83 17.15 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.17 -102.22 0.45 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -124.84 33.52 5.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -1.14 . . . . 0.0 109.838 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 163.64 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.062 -1.024 . . . . 0.0 109.772 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mt -102.79 104.42 14.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 108.586 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.639 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -73.55 164.42 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.987 . . . . 0.0 110.247 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.6 94.69 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.662 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 35.4 mttm -88.63 105.21 17.51 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 108.835 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -116.22 136.77 52.72 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.886 0.85 . . . . 0.0 110.091 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -116.84 116.32 27.23 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.607 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.6 mtp180 -53.01 114.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.808 . . . . 0.0 108.847 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -70.32 -12.74 61.79 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.501 1.143 . . . . 0.0 109.377 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.67 -50.96 11.38 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -132.57 11.64 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.2 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.56 41.7 12.98 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.744 ' O ' ' O ' ' A' ' 101' ' ' GLU . 2.4 m120 -78.04 19.78 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -1.199 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.744 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.9 pt-20 42.7 158.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.016 0.912 . . . . 0.0 111.212 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 103' ' ' ASN . 6.4 tt -157.39 127.12 6.12 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.745 ' N ' HD23 ' A' ' 102' ' ' LEU . 5.6 t30 -116.93 113.84 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.087 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -125.41 175.98 7.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.179 -0.951 . . . . 0.0 111.174 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 43.8 t -144.86 146.94 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.8 132.5 54.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.149 -0.969 . . . . 0.0 109.909 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.08 157.77 45.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.446 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.2 mt -125.66 82.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 120.917 -1.115 . . . . 0.0 108.627 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 111' ' ' ASP . 63.7 mt -63.02 92.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.223 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.49 -78.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -130.61 29.14 4.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.127 -1.219 . . . . 0.0 110.197 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.85 136.89 40.95 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.244 -0.91 . . . . 0.0 108.883 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.598 ' HB2' ' CE1' ' A' ' 2' ' ' PHE . 0.5 OUTLIER -98.03 110.92 23.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.903 -1.123 . . . . 0.0 109.906 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.6 t -92.35 113.39 27.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.309 -0.956 . . . . 0.0 108.577 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.445 ' CD ' ' OH ' ' A' ' 117' ' ' TYR . 48.9 tt0 -115.79 103.67 10.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.681 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.41 144.11 31.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.555 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -125.34 151.13 46.47 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.847 0.832 . . . . 0.0 109.471 178.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 122' ' ' VAL . 8.4 t -118.2 147.48 21.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.521 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.91 110.7 5.39 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.882 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 48.54 18.67 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.184 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.17 28.3 3.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.33 177.11 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.01 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 43.0 tt0 -155.44 117.04 4.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.242 -1.383 . . . . 0.0 111.368 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.956 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -106.77 150.62 26.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 12' ' ' GLU . 2.6 mtmm -126.99 137.48 53.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.904 -1.123 . . . . 0.0 110.48 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -140.14 114.01 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.1 mp -109.45 130.86 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 0.0 111.108 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.522 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -99.95 176.26 5.49 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.424 0.631 . . . . 0.0 109.407 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -164.58 151.29 11.03 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -47.43 132.89 13.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 2.3 p-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.52 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.824 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER 42.8 36.03 0.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.152 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.11 76.95 8.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.937 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 5' ' ' THR . 28.2 t -179.07 -163.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 109.619 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 70.6 m -91.86 147.35 23.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.104 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.824 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 14.9 m95 -151.09 168.73 23.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 7.4 mtpt -150.63 128.53 11.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.388 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.72 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -42.55 106.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.06 -30.24 13.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -148.97 164.95 33.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.98 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.5 m -171.77 178.09 3.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.366 -0.834 . . . . 0.0 108.992 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -156.19 158.69 38.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.12 . . . . 0.0 110.104 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.2 m-20 57.71 -109.57 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.692 -0.63 . . . . 0.0 109.739 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE2' ' NH1' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 71.55 -51.3 0.69 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.84 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HB3' HH21 ' A' ' 28' ' ' ARG . 7.7 p-10 -62.8 -40.55 97.71 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.955 -1.091 . . . . 0.0 108.97 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -70.31 -31.0 68.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.882 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 78.5 t80 -74.18 -56.93 4.33 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.561 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 11.7 mmt -60.1 -32.83 71.34 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.42 -37.49 74.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -63.98 -41.05 97.64 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.593 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 23' ' ' VAL . 2.4 mtm -66.48 -8.33 25.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.199 -0.938 . . . . 0.0 109.086 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.61 32.6 10.03 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.471 HG21 ' SD ' ' A' ' 18' ' ' MET . 26.6 t -94.05 140.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -1.146 . . . . 0.0 109.553 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.35 157.82 4.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.361 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm -82.24 -1.23 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.213 1.006 . . . . 0.0 109.142 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -80.1 -59.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -56.55 -33.9 66.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 108.85 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.604 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -65.69 -52.09 54.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.75 -33.84 57.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.413 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.51 -13.23 46.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.023 0.916 . . . . 0.0 109.518 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASP . . . -84.3 -51.03 7.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.7 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.59 -57.53 2.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.502 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -75.69 44.79 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ALA . 63.7 t0 -116.02 101.48 8.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' HA ' HG13 ' A' ' 8' ' ' VAL . 17.3 m-20 -84.66 43.55 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.406 -0.809 . . . . 0.0 109.357 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.72 HD23 HG11 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -47.09 155.65 0.27 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.748 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -105.74 148.21 27.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.821 -0.549 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.52 HD22 ' CE2' ' A' ' 128' ' ' PHE . 2.5 mp -139.28 123.64 18.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 m -101.91 107.94 19.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.546 HD13 ' HD2' ' A' ' 2' ' ' PHE . 4.1 mp -101.02 133.6 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.16 -0.962 . . . . 0.0 110.747 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.48 152.08 48.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -130.05 147.83 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 109.863 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -145.1 79.18 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.82 -87.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 7.8 p-10 -125.8 28.58 6.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -1.093 . . . . 0.0 110.093 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -147.75 110.04 4.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -98.12 174.4 6.55 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.508 0.671 . . . . 0.0 109.799 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -152.27 103.87 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -96.25 114.77 33.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -105.11 100.23 9.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.832 . . . . 0.0 109.345 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -74.64 152.82 39.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.034 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.38 105.95 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.157 0.98 . . . . 0.0 108.546 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.658 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -131.12 144.49 51.44 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.15 7.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.983 -1.073 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 53' ' ' SER . 72.6 m-85 -109.79 -25.88 10.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -0.978 . . . . 0.0 111.235 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER 165.65 87.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.704 -1.248 . . . . 0.0 109.312 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -62.29 139.81 58.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.42 -0.8 . . . . 0.0 109.643 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.602 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -132.26 174.35 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.874 0.845 . . . . 0.0 110.247 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.602 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.0 pt-20 -151.39 142.98 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.56 127.03 5.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.549 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -78.58 163.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.368 -0.832 . . . . 0.0 109.242 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.588 ' CE2' ' SG ' ' A' ' 70' ' ' CYS . 36.0 m-85 -143.37 117.87 9.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 64' ' ' LEU . 1.1 tm-20 -111.32 164.31 13.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.037 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.604 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 95.7 mt -103.34 118.24 36.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 109.915 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.58 18.37 41.73 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.46 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.622 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.0 t -141.37 105.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.948 -1.325 . . . . 0.0 109.568 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -56.29 143.52 33.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.898 . . . . 0.0 109.871 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -153.84 -170.85 3.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -132.34 151.07 52.01 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.563 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.588 ' SG ' ' CE2' ' A' ' 62' ' ' PHE . 68.1 m -149.42 127.82 12.23 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.554 ' OD1' HG21 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -89.66 144.47 25.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 110.343 -178.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.672 ' CD1' HD11 ' A' ' 78' ' ' LEU . 70.7 mt -99.35 146.88 25.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.99 -29.37 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.797 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.561 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 15.7 m-20 -66.62 17.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.164 -0.96 . . . . 0.0 109.241 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 63.57 26.92 70.18 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 161.88 13.33 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.233 -1.157 . . . . 0.0 109.696 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.497 ' O ' ' OG1' ' A' ' 96' ' ' THR . 40.7 tt0 -132.62 117.53 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.672 HD11 ' CD1' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -127.68 157.0 41.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.987 -1.07 . . . . 0.0 110.626 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 21.4 ptt85 -140.51 142.48 35.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.838 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.61 -119.63 0.8 Allowed Glycine 0 N--CA 1.475 1.277 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.504 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.8 159.62 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.153 -1.204 . . . . 0.0 110.403 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.41 143.12 32.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.229 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -137.32 157.06 47.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -97.75 128.28 44.29 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.315 -1.491 . . . . 0.0 108.273 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.646 ' N ' HD12 ' A' ' 84' ' ' LEU . 30.6 mt-10 -128.36 117.8 22.07 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.75 -106.88 1.19 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.405 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 37.4 t-20 -125.17 34.42 4.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.162 . . . . 0.0 110.55 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.405 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -144.76 147.33 32.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.693 -1.254 . . . . 0.0 110.242 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt -92.75 113.55 25.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -84.78 165.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 110.766 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.37 95.93 0.17 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.655 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.4 ptpt -87.69 104.97 17.04 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.27 -1.135 . . . . 0.0 108.757 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m-30 -117.65 145.96 44.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.9 0.857 . . . . 0.0 110.314 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -125.92 123.86 39.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 34.3 mtp180 -57.74 115.22 2.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -69.38 -12.42 61.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.423 1.106 . . . . 0.0 109.466 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.32 -46.62 13.37 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.468 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -132.54 8.67 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.137 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 43.35 41.53 5.19 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 101' ' ' GLU . 7.1 m-20 -77.01 15.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.679 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.0 mt-10 52.51 150.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.646 0.736 . . . . 0.0 110.651 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 103' ' ' ASN . 3.4 tp -152.77 128.06 9.86 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.638 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER -116.27 118.64 33.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 108.779 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.6 t -129.05 176.2 8.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.162 -0.961 . . . . 0.0 110.559 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 106' ' ' ARG . 45.5 t -145.52 160.69 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.453 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.6 ttt85 -135.09 135.11 40.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -140.36 158.35 44.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 109.105 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.12 82.3 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.699 HD12 HG21 ' A' ' 114' ' ' VAL . 32.2 mt -63.82 91.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.107 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.05 -80.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -130.85 29.5 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 129' ' ' LYS . 6.9 mt-10 -133.05 141.12 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 0.0 108.969 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 128' ' ' PHE . 11.4 tp -101.0 114.58 28.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.88 -1.137 . . . . 0.0 108.859 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.699 HG21 HD12 ' A' ' 109' ' ' ILE . 12.9 t -104.9 106.77 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.325 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -105.79 108.16 19.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.01 147.37 24.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.128 -0.983 . . . . 0.0 109.885 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.646 ' O ' ' HA ' ' A' ' 123' ' ' GLU . 2.7 m-85 -121.36 158.36 28.42 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.436 -0.79 . . . . 0.0 109.158 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 103' ' ' ASN . 10.8 t -131.2 147.07 32.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.567 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -147.38 110.25 4.73 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.099 -1.041 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 45.99 20.45 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.124 0.488 . . . . 0.0 111.238 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.81 28.32 3.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.62 176.52 5.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.7 mt-10 -156.13 126.69 6.74 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.123 -1.431 . . . . 0.0 111.284 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -114.36 159.07 20.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -134.11 137.41 44.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.874 -1.141 . . . . 0.0 110.877 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.644 ' NH1' ' CE2' ' A' ' 14' ' ' TYR . 6.7 mmt180 -129.77 114.13 15.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 8.7 mt -113.01 122.72 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.01 -1.056 . . . . 0.0 111.14 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.8 m-30 -104.92 174.11 6.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.736 . . . . 0.0 109.138 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 112' ' ' GLU . 30.4 tttp -161.81 159.78 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.324 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -47.77 131.62 14.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.931 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.3 t0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.479 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.629 ' N ' ' CD1' ' A' ' 108' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.82 ' CD1' ' CE2' ' A' ' 6' ' ' TRP . 23.7 m-85 -72.16 22.68 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.259 -0.901 . . . . 0.0 108.778 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.595 ' C ' ' O ' ' A' ' 2' ' ' PHE . 19.1 t0 32.99 57.37 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 40' ' ' ILE . 1.4 t -177.47 -138.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.688 . . . . 0.0 110.018 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.6 m -89.41 148.39 23.51 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.931 0.872 . . . . 0.0 111.482 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.82 ' CE2' ' CD1' ' A' ' 2' ' ' PHE . 17.1 m95 -144.81 168.66 19.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 2.4 pttp -152.5 125.53 8.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.513 -1.367 . . . . 0.0 110.843 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.609 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -44.04 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.285 -0.884 . . . . 0.0 109.769 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.44 -30.66 16.35 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HB2' HD12 ' A' ' 127' ' ' ILE . 6.6 mtp85 -151.3 175.33 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.677 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 t -171.33 178.11 3.36 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.226 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.75 154.72 35.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 21.7 m-20 57.68 -109.51 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.823 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.562 ' CD2' ' OD1' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.03 -52.71 0.69 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 15' ' ' ASP . 12.0 p-10 -59.71 -45.96 90.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.598 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.14 -34.62 76.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 69.7 t80 -69.79 -63.75 1.02 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mmt -55.9 -24.73 39.15 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.358 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -82.66 -23.05 34.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.065 -1.022 . . . . 0.0 109.379 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -77.33 -37.07 53.25 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.193 -0.942 . . . . 0.0 109.258 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.409 ' HG3' ' H ' ' A' ' 21' ' ' MET . 0.6 OUTLIER -67.47 -11.33 57.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.574 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.69 31.13 37.26 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 24' ' ' ASN . 5.8 t -78.78 136.86 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -1.159 . . . . 0.0 109.497 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' VAL . 5.8 m-80 -42.48 164.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.227 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.6 mm -81.79 -1.55 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.21 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.51 -59.92 2.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -64.78 -28.23 69.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.588 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -71.62 -42.5 67.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.388 -0.82 . . . . 0.0 108.977 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -63.68 -35.42 80.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.147 -0.971 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.57 -13.14 46.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.013 0.911 . . . . 0.0 109.632 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.577 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -44.14 -16.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.583 ' N ' ' O ' ' A' ' 31' ' ' ALA . 20.7 t-80 -70.9 41.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.409 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' CD2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -50.4 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' HIS . 52.9 t-20 -147.8 42.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.609 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -96.52 175.18 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.523 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' N ' HD12 ' A' ' 36' ' ' LEU . 37.7 mttt -129.74 152.01 49.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.636 -0.665 . . . . 0.0 109.497 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.511 HD21 ' CD2' ' A' ' 128' ' ' PHE . 0.6 OUTLIER -142.81 150.38 39.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.702 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 4' ' ' SER . 0.6 OUTLIER -111.57 106.44 15.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.627 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -96.25 124.21 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 109.923 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.25 152.48 48.05 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' A' ' 47' ' ' PHE . 73.5 mt-30 -126.19 149.22 49.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.954 -1.091 . . . . 0.0 110.602 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' OE1' ' CD ' ' A' ' 46' ' ' LYS . 20.1 mt-10 -144.73 79.0 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.526 -0.733 . . . . 0.0 109.164 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.51 -88.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 43' ' ' GLU . 2.8 m120 -122.8 28.55 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -1.075 . . . . 0.0 109.736 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' CD ' ' OE1' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.01 109.87 4.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 42' ' ' GLN . 3.5 m-30 -93.24 173.26 7.81 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -153.38 103.73 2.7 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 108.813 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.62 HG22 HG23 ' A' ' 40' ' ' ILE . 96.7 t -99.68 121.62 50.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.634 -0.666 . . . . 0.0 109.446 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -108.63 100.07 9.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.36 155.06 41.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.941 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -158.6 107.05 1.93 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.116 -0.99 . . . . 0.0 109.013 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.694 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -141.83 144.56 33.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.46 7.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.025 -1.047 . . . . 0.0 109.189 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.694 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.0 m-85 -105.42 -25.71 12.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.278 -0.888 . . . . 0.0 110.835 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 8.2 mtp180 159.92 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.913 -1.117 . . . . 0.0 109.166 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -62.5 144.43 56.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 0.0 109.333 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -136.65 174.02 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 110.34 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.591 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -149.06 129.56 13.93 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 87.7 m -145.75 128.56 16.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.564 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -75.5 164.98 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.269 -0.894 . . . . 0.0 108.957 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.608 ' C ' ' CD2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -144.57 116.49 8.3 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.588 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.411 ' H ' ' HE2' ' A' ' 68' ' ' PHE . 37.1 mt-10 -116.47 174.55 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.7 119.45 38.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 110.505 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.22 -5.72 83.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.319 -0.943 . . . . 0.0 110.838 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 1.6 t -103.45 105.27 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.834 -1.392 . . . . 0.0 110.13 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -61.25 143.05 56.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.439 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.17 -171.4 3.82 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -138.87 153.03 48.28 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.403 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 10.2 t -156.96 138.55 14.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 76' ' ' THR . 3.7 p30 -95.59 143.27 27.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' ALA . 19.3 mt -92.57 146.9 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.45 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.92 -33.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.742 . . . . 0.0 109.796 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -60.05 8.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 71.61 26.29 73.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -100.09 161.87 13.34 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.22 -1.165 . . . . 0.0 109.549 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.426 ' O ' ' OG1' ' A' ' 96' ' ' THR . 83.7 tt0 -132.92 121.06 22.29 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -137.93 162.99 32.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.895 -1.128 . . . . 0.0 110.821 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -143.59 146.16 33.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.708 . . . . 0.0 109.954 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.67 -118.67 0.71 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.554 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.55 157.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -1.231 . . . . 0.0 110.808 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 6.4 m95 -102.1 141.61 34.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.608 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.6 t -139.57 156.8 46.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 108.555 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.675 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -88.51 130.31 35.26 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.294 -1.504 . . . . 0.0 108.032 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.675 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -131.05 122.29 26.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.62 -108.14 1.42 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.423 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.4 m120 -125.02 33.93 5.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -1.183 . . . . 0.0 110.313 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -147.17 160.89 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.757 -1.215 . . . . 0.0 110.238 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.99 113.26 25.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.608 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -82.17 164.77 2.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 110.534 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.616 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.95 96.08 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.651 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 9.6 mtpm? -89.33 106.16 18.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.196 -1.179 . . . . 0.0 109.031 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -116.23 136.78 52.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.772 0.796 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -115.68 117.82 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.468 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.2 mtp180 -57.05 115.06 2.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -75.22 -12.61 60.32 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.497 1.141 . . . . 0.0 109.443 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -90.83 -35.76 14.62 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.872 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 99' ' ' GLY . 49.3 t-20 -132.55 4.06 3.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.337 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.11 29.8 0.66 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.705 ' O ' ' O ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -76.96 18.66 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -1.177 . . . . 0.0 109.289 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.705 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.4 pt-20 43.93 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.922 0.867 . . . . 0.0 111.101 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.624 HD12 ' N ' ' A' ' 103' ' ' ASN . 1.4 tp -158.19 128.32 6.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.624 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -116.51 115.19 25.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 108.8 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -127.0 176.42 7.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.336 -0.853 . . . . 0.0 110.908 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -147.84 156.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -131.42 134.23 46.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -142.36 158.08 44.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 108.912 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.629 ' CD1' ' N ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -126.57 83.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.301 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.0 mm -64.57 92.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.334 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.53 -80.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -128.53 29.02 5.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -1.172 . . . . 0.0 110.251 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.1 130.94 39.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.65 112.29 24.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 108.478 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.97 107.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.9 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.22 106.26 16.64 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.4 OUTLIER -102.89 145.88 29.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 110.158 -178.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.663 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.8 OUTLIER -124.38 155.27 39.07 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.881 0.848 . . . . 0.0 109.484 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.7 t -124.6 147.58 29.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -146.0 110.6 5.12 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.998 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 47.73 19.34 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.237 0.542 . . . . 0.0 111.129 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.37 28.41 3.55 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.46 176.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.67 125.18 6.34 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 118.221 -1.391 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -115.66 149.5 38.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -129.05 138.67 52.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.896 -1.128 . . . . 0.0 110.581 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -132.47 115.05 15.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.498 HD12 ' HB2' ' A' ' 10' ' ' ARG . 10.4 mt -104.74 123.68 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.601 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 6.1 m-30 -102.17 176.95 5.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -155.05 168.34 27.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 131' ' ' ASP . 10.9 ptpt -50.58 138.74 17.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 109.629 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' LYS . 5.7 t70 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.361 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.845 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER 42.15 33.22 0.37 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.37 -0.831 . . . . 0.0 109.348 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 4' ' ' SER . 12.5 t0 -76.82 95.24 4.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.616 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.3 m 161.9 -164.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.575 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.596 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 49.3 m -95.88 143.63 26.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.845 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 4.9 m95 -150.08 169.01 22.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.234 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 8' ' ' VAL . 6.4 ptmm? -152.76 133.98 14.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 109.693 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.591 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.51 106.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.0 109.508 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 32.3 t0 -98.26 -31.34 12.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -146.22 164.24 32.89 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.503 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 2.8 t -166.02 178.12 6.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.46 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -156.61 155.17 31.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 0.0 109.887 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.6 m-20 58.43 -108.82 0.43 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 109.953 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.565 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER 73.03 -52.19 0.71 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.159 -0.963 . . . . 0.0 110.19 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.578 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 17.3 t70 -59.37 -49.99 75.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.099 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -59.65 -33.23 71.27 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 65.5 t80 -71.34 -63.67 1.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.5 mmt -54.19 -25.4 22.58 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.482 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -77.41 -35.19 54.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.03 -1.044 . . . . 0.0 109.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.282 -0.887 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.625 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.3 mtp -68.5 -6.29 24.32 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.115 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.37 32.54 62.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 24' ' ' ASN . 4.0 t -74.76 129.68 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -1.207 . . . . 0.0 109.394 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' VAL . 3.7 t-20 -42.45 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 109.361 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -80.45 -1.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 0.0 109.166 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -82.39 -60.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -56.82 -38.33 72.45 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.578 ' NE ' ' OD1' ' A' ' 15' ' ' ASP . 19.9 tpt180 -61.31 -52.7 63.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.74 -38.39 33.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.331 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.64 -13.08 46.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -78.52 -48.96 14.22 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.164 0.506 . . . . 0.0 109.661 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.17 -21.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -0.822 . . . . 0.0 109.478 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.9 t-80 -73.8 35.03 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -44.09 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.476 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 6.7 t-20 -147.83 42.69 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -95.66 167.89 11.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.994 -1.066 . . . . 0.0 110.566 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HZ3' ' HB3' ' A' ' 7' ' ' LYS . 4.4 mttm -108.14 142.55 38.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 36' ' ' LEU . 1.9 mp -137.19 128.98 28.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.657 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m -102.69 119.16 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.3 mp -107.9 119.73 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.659 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.14 151.74 37.0 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.83 145.45 50.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -140.77 79.09 1.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 -83.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' GLU . 21.8 m-20 -124.9 28.67 6.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -1.134 . . . . 0.0 110.148 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' NZ ' ' OG1' ' A' ' 48' ' ' THR . 1.9 tmtm? -150.79 109.84 3.91 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.34 173.6 7.45 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.361 0.6 . . . . 0.0 109.735 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.625 ' OG1' ' NZ ' ' A' ' 46' ' ' LYS . 43.6 m -153.52 103.87 2.69 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.35 -0.843 . . . . 0.0 108.744 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.6 t -99.42 115.77 41.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -101.4 100.44 10.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.08 158.25 35.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 108.865 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -160.13 107.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.683 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -139.42 144.64 38.18 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.379 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.13 7.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.079 -1.013 . . . . 0.0 109.376 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.683 ' H ' ' C ' ' A' ' 53' ' ' SER . 28.2 t80 -107.45 -25.4 11.43 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.164 -0.96 . . . . 0.0 111.065 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 159.97 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.902 -1.124 . . . . 0.0 109.084 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -62.12 148.79 43.24 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.11 174.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.6 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -149.54 127.3 11.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.7 131.92 20.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.7 t -85.05 153.98 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.353 -0.842 . . . . 0.0 108.81 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CE1' ' SG ' ' A' ' 70' ' ' CYS . 41.1 m-85 -135.3 117.13 15.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 3.2 mp0 -104.12 172.49 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 108.902 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 64' ' ' LEU . 80.2 mt -103.74 111.77 24.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 0.0 110.317 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.2 -31.7 7.71 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 16.6 t -82.82 110.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.263 . . . . 0.0 109.877 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -60.17 143.24 52.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.085 -1.009 . . . . 0.0 109.437 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.05 -171.35 3.91 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -138.16 150.42 46.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.978 -1.076 . . . . 0.0 110.444 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' CE1' ' A' ' 62' ' ' PHE . 89.1 m -151.91 134.76 15.61 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -96.24 146.1 24.99 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.265 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 73' ' ' ALA . 17.2 mt -94.69 146.93 23.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.547 -0.721 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.31 -34.63 1.26 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.683 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -57.74 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 77.66 25.68 62.39 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.68 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.06 161.49 13.58 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.245 -1.15 . . . . 0.0 109.597 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -133.62 123.07 24.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.7 162.52 32.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.851 -1.156 . . . . 0.0 110.72 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.77 144.34 31.13 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.485 -0.759 . . . . 0.0 110.046 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.46 -117.66 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 N-CA-C 107.901 -2.079 . . . . 0.0 107.901 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.529 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.69 158.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -1.184 . . . . 0.0 110.572 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.473 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.9 m95 -102.13 143.7 31.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.6 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -140.41 157.22 45.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -90.06 129.33 36.38 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.149 -1.594 . . . . 0.0 108.136 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.656 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -129.94 119.29 22.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.09 -107.35 1.29 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -125.14 34.33 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -1.158 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 157.11 43.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.804 -1.185 . . . . 0.0 110.229 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.43 110.78 22.78 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -78.45 164.87 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.12 -0.988 . . . . 0.0 110.429 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.598 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.0 96.05 0.17 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.653 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.5 mttp -88.14 105.19 17.34 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.201 -1.176 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 5.5 m-30 -118.22 140.01 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.221 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -121.87 120.9 35.88 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.68 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 0.4 OUTLIER -53.27 114.86 1.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -12.2 61.44 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.482 1.134 . . . . 0.0 109.406 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.17 -48.82 12.55 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.622 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -132.53 11.38 4.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 110.166 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.0 44.25 13.63 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.745 ' O ' ' O ' ' A' ' 101' ' ' GLU . 42.4 m-20 -80.08 20.04 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -1.065 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.745 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.3 pt-20 42.97 158.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.005 0.907 . . . . 0.0 111.184 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.6 tt -160.49 124.97 3.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.666 ' N ' HD23 ' A' ' 102' ' ' LEU . 1.4 t-20 -113.41 112.72 24.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.036 -1.04 . . . . 0.0 109.118 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.7 t -125.3 176.51 6.72 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 111.13 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 46.2 t -148.71 156.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -124.34 133.88 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -134.78 157.98 45.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.449 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.4 mm -122.03 82.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 121.074 -1.016 . . . . 0.0 108.304 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 109' ' ' ILE . 15.9 mt -63.44 92.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.65 -80.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.5 m-20 -128.08 29.48 5.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -1.194 . . . . 0.0 110.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.02 145.24 45.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 108.943 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 12.4 tp -103.63 114.39 28.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.969 -1.082 . . . . 0.0 109.254 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.541 HG22 HG12 ' A' ' 127' ' ' ILE . 39.5 t -99.59 109.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 47.1 tt0 -107.1 104.1 13.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -100.96 145.59 28.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.215 -0.928 . . . . 0.0 109.998 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.703 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -128.51 152.28 48.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.0 t -119.39 148.12 22.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.34 110.59 5.74 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.922 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 48.25 18.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.962 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.45 28.36 3.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.753 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.67 177.13 4.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.543 ' N ' HG13 ' A' ' 122' ' ' VAL . 10.6 tt0 -154.86 122.59 5.76 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.175 -1.41 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.886 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.77 156.54 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -136.33 139.04 42.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.209 . . . . 0.0 111.331 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.565 ' NH2' ' OH ' ' A' ' 14' ' ' TYR . 1.5 ttm-85 -130.76 113.96 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.541 HG12 HG22 ' A' ' 114' ' ' VAL . 6.6 mt -109.18 123.47 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.932 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 38' ' ' LEU . 7.7 m-30 -101.22 173.94 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.227 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -162.28 161.07 27.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.566 -0.709 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 131' ' ' ASP . 9.9 mmmt -47.71 132.36 14.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.162 -0.961 . . . . 0.0 109.643 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 130' ' ' LYS . 51.7 p30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.836 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -75.11 26.69 0.09 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.214 -0.929 . . . . 0.0 109.137 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 1' ' ' ALA . 34.7 t70 -70.49 81.64 0.57 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.63 -0.669 . . . . 0.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 171.4 -158.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.572 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.6 m -94.81 143.54 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.836 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 19.8 m95 -151.3 168.25 25.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.225 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.6 pttm -153.5 130.72 11.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.059 -1.025 . . . . 0.0 109.704 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.605 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -40.3 106.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 38.9 t0 -92.97 -30.0 15.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -147.66 164.98 31.83 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.866 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.66 178.15 5.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.358 -0.839 . . . . 0.0 109.267 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 4.2 pt-20 -152.68 151.12 30.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.02 -1.05 . . . . 0.0 110.013 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.546 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 18.7 t30 58.46 -108.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.718 -0.614 . . . . 0.0 109.903 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.546 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 76.16 -53.64 0.61 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -0.87 . . . . 0.0 109.838 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 87.6 m-20 -58.41 -52.37 65.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.022 -1.049 . . . . 0.0 108.938 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 12.0 mtpp -57.81 -33.24 68.39 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.579 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.854 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 56.8 t80 -71.64 -61.65 1.7 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.552 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 21.7 mmt -56.24 -25.69 48.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.415 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 3.4 mm-40 -80.64 -28.48 36.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.048 -1.032 . . . . 0.0 109.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.89 -35.84 67.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.317 -0.865 . . . . 0.0 109.454 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 2.2 mtm -72.64 -6.58 45.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.166 -0.959 . . . . 0.0 108.844 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 32.42 55.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 21' ' ' MET . 36.2 t -72.91 135.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -1.169 . . . . 0.0 109.383 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 23' ' ' VAL . 29.0 m120 -42.74 158.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.79 -3.06 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.221 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -84.66 -60.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.52 -29.33 69.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -68.48 -50.88 49.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.541 -0.725 . . . . 0.0 109.09 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -35.78 63.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.189 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.1 mt -86.46 -13.04 47.3 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.964 0.887 . . . . 0.0 109.773 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -75.8 -47.85 24.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . -41.47 -20.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASN . 13.7 m80 -70.97 46.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -52.05 79.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.853 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' HIS . 7.1 p30 -148.36 42.86 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 109.203 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 36' ' ' LEU . 1.0 OUTLIER -93.94 168.33 11.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -106.53 145.03 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.527 HD22 ' CE2' ' A' ' 128' ' ' PHE . 2.1 mp -138.95 125.2 20.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 109.78 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.4 m -102.6 113.02 26.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.743 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.7 mp -103.08 123.64 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.715 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.37 151.96 36.74 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.492 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 12.7 pt20 -131.72 139.4 48.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.158 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 42' ' ' GLN . 19.0 mm-40 -136.14 78.95 1.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.209 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.81 -89.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 43' ' ' GLU . 12.5 p-10 -117.51 28.77 8.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.406 -1.056 . . . . 0.0 110.12 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.88 109.98 3.92 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CE2' ' CB ' ' A' ' 42' ' ' GLN . 10.6 m-85 -100.57 173.93 6.32 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.422 0.63 . . . . 0.0 109.67 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -152.2 103.03 2.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -95.33 111.2 25.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -102.31 100.65 10.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.624 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -72.97 158.89 34.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 108.906 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.6 m -160.8 107.11 1.46 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.087 -1.008 . . . . 0.0 109.248 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.654 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -134.09 144.41 48.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 7.8 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 109.638 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.654 ' H ' ' C ' ' A' ' 53' ' ' SER . 7.8 m-85 -112.96 -23.72 9.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.156 -0.965 . . . . 0.0 111.295 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 5.3 ptm180 166.59 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.811 -1.181 . . . . 0.0 109.513 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -62.32 147.65 47.54 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.429 -0.795 . . . . 0.0 109.271 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.12 174.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.619 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.8 pt-20 -150.0 140.58 22.52 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 59' ' ' GLU . 38.9 m -151.69 127.02 9.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.65 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.66 150.74 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.28 -0.888 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.612 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -132.41 116.83 17.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.181 -0.949 . . . . 0.0 109.233 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 46.2 tt0 -126.13 169.12 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.0 109.044 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.475 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.7 mt -101.98 129.01 48.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.05 26.59 63.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 56.5 t -144.04 102.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -1.21 . . . . 0.0 109.31 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -59.12 141.06 55.1 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.104 0.954 . . . . 0.0 110.064 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.05 -171.3 3.8 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 69' ' ' ASN . 26.3 p30 -139.22 149.06 43.92 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.798 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.685 ' O ' HD22 ' A' ' 78' ' ' LEU . 42.8 t -139.11 170.63 15.62 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 76' ' ' THR . 2.9 m-20 -126.21 141.39 51.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.854 -1.154 . . . . 0.0 110.36 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.522 ' HG ' HD21 ' A' ' 78' ' ' LEU . 95.5 mt -93.59 146.9 23.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.528 -0.732 . . . . 0.0 109.293 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.43 -28.43 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -0.757 . . . . 0.0 109.696 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 45.5 m-20 -70.2 19.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.285 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.59 29.94 73.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.633 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.14 162.32 13.04 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.368 -1.077 . . . . 0.0 109.43 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.94 ' C ' HD13 ' A' ' 78' ' ' LEU . 58.7 tt0 -132.56 114.78 14.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.596 -0.69 . . . . 0.0 109.189 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.987 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -118.18 150.31 39.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.099 -1.001 . . . . 0.0 110.318 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -136.9 142.67 42.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.37 -118.4 0.72 Allowed Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.596 ' CB ' ' HZ1' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 173.01 156.47 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -1.111 . . . . 0.0 110.362 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.575 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.54 143.45 32.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.6 -0.687 . . . . 0.0 109.162 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.604 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 11.4 t -141.59 156.8 45.66 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.757 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -89.02 131.63 35.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.324 -1.485 . . . . 0.0 108.125 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.757 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -136.28 124.2 22.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.21 -110.32 3.01 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.454 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.0 m120 -125.26 34.18 5.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -1.174 . . . . 0.0 110.414 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -149.2 162.43 40.02 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.659 -1.276 . . . . 0.0 110.323 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.77 113.29 25.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.604 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.2 pt -81.13 164.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.583 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.02 96.85 0.18 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.666 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 6.5 pttm -90.32 106.78 18.73 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.274 -1.133 . . . . 0.0 108.686 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.598 ' HB2' HD23 ' A' ' 102' ' ' LEU . 2.6 m-30 -116.17 148.79 40.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.775 0.798 . . . . 0.0 110.365 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -134.18 116.85 15.86 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.601 0.715 . . . . 0.0 109.943 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 48.6 mtp180 -52.05 115.29 1.63 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.68 -12.66 61.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.499 1.142 . . . . 0.0 109.628 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.71 -37.95 15.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.97 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 35.4 t-20 -132.48 5.76 4.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.297 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.38 34.36 1.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 101' ' ' GLU . 5.3 m120 -75.41 20.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -1.161 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.7 pt-20 45.49 166.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.017 0.913 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 117' ' ' TYR . 19.4 tp -161.85 120.68 2.36 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -112.19 114.03 26.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 109.165 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.0 t -129.71 176.36 8.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.096 -1.003 . . . . 0.0 111.154 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 106' ' ' ARG . 54.2 t -146.58 158.51 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.418 ' N ' HG12 ' A' ' 105' ' ' VAL . 22.0 ttp180 -132.21 137.26 47.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.139 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -140.45 158.49 43.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 113' ' ' LEU . 1.2 mt -124.23 82.77 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.122 -0.986 . . . . 0.0 108.753 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' ASP . 48.6 mt -61.86 92.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.092 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.94 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ILE . 21.7 m-20 -130.06 29.41 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -1.228 . . . . 0.0 110.404 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -134.43 138.14 44.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 108.776 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.529 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 5.2 tp -99.43 113.16 25.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.891 -1.13 . . . . 0.0 109.362 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.68 HG22 HG23 ' A' ' 127' ' ' ILE . 27.5 t -98.57 110.74 26.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.096 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -113.21 106.76 15.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.56 145.47 29.98 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.718 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -126.18 156.63 39.87 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.928 0.871 . . . . 0.0 109.599 179.004 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.5 t -124.14 148.28 28.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.537 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.2 t80 -143.25 110.29 5.64 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.811 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 47.77 19.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.66 28.24 3.53 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.24 176.57 4.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.511 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.8 tt0 -156.02 124.19 5.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.061 -1.455 . . . . 0.0 111.362 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.854 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -117.68 151.94 36.24 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -128.57 140.24 51.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.881 -1.137 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -133.24 113.96 13.25 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.68 HG23 HG22 ' A' ' 114' ' ' VAL . 5.3 mt -109.07 123.37 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.052 -1.03 . . . . 0.0 110.557 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.547 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -101.01 174.4 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.447 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -163.19 154.59 17.23 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -47.28 135.71 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.512 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.467 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.896 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.2 OUTLIER 40.93 32.42 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.292 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 4' ' ' SER . 9.1 m-20 -73.18 97.26 2.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.0 109.722 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.626 ' OG ' ' N ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 158.51 -170.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.377 -0.827 . . . . 0.0 109.3 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.626 ' N ' ' OG ' ' A' ' 4' ' ' SER . 97.5 m -86.13 150.16 24.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.896 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 13.1 m95 -151.36 168.14 25.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.086 -1.009 . . . . 0.0 109.818 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.2 pttp -153.53 125.79 8.0 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.576 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.35 106.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.581 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.97 -28.96 12.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -142.29 174.33 10.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.6 t -178.39 178.31 0.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.16 155.65 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.874 -1.141 . . . . 0.0 109.822 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 18.7 m-20 56.86 -110.08 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.588 -0.695 . . . . 0.0 109.848 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.621 ' CE2' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.59 -52.43 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.0 109.855 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.31 -48.99 77.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.885 -1.134 . . . . 0.0 108.655 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.714 ' HZ3' ' HB3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 61.0 t80 -69.12 -64.08 0.94 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.007 0.908 . . . . 0.0 108.882 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.425 ' O ' HG23 ' A' ' 23' ' ' VAL . 15.4 mmt -56.41 -21.33 24.39 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 28' ' ' ARG . 33.3 tt0 -78.66 -35.15 45.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.208 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -66.99 -44.35 80.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.144 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.4 mtm -62.85 -9.22 8.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.021 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 32.3 38.13 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' ASN . 15.4 t -76.29 133.35 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -1.081 . . . . 0.0 109.559 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.539 ' OD1' HG23 ' A' ' 26' ' ' VAL . 11.6 t-20 -46.81 174.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -85.24 -2.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.119 0.961 . . . . 0.0 109.266 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.539 HG23 ' OD1' ' A' ' 24' ' ' ASN . 65.8 t -80.84 -59.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.755 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 1.5 mptm? -66.38 -22.73 66.25 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 19' ' ' GLU . 9.2 ttm180 -73.89 -42.38 60.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 109.29 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -72.81 -34.31 66.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.892 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.9 mt -86.39 -13.03 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -72.82 -53.01 12.64 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.573 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.98 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.574 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -91.57 46.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.621 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 69.0 m-20 -62.45 121.05 12.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.853 . . . . 0.0 109.684 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' HA ' HG13 ' A' ' 8' ' ' VAL . 17.0 m120 -147.94 42.98 1.05 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.349 -0.844 . . . . 0.0 109.016 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.576 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -87.74 162.81 16.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.111 -0.993 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 52' ' ' SER . 3.1 mtpp -114.69 142.49 46.43 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.825 ' H ' HD23 ' A' ' 38' ' ' LEU . 1.7 pt? -149.98 143.66 25.35 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.084 -1.01 . . . . 0.0 109.986 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -103.91 143.32 33.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.61 129.04 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.147 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.39 152.3 50.75 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -132.04 135.05 46.21 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.8 mm-40 -129.37 78.98 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.84 -79.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.14 29.24 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.99 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -145.16 110.59 5.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.18 159.85 14.82 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.455 HG23 HG13 ' A' ' 61' ' ' VAL . 48.9 m -152.21 103.12 2.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.079 -1.013 . . . . 0.0 108.269 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.88 130.87 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.61 -0.681 . . . . 0.0 109.652 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -119.63 100.55 7.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.398 -0.814 . . . . 0.0 109.572 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -75.51 156.1 35.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.214 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.1 m -158.9 106.91 1.85 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.153 0.977 . . . . 0.0 108.851 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.658 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -133.87 144.5 48.95 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.13 7.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.085 -1.01 . . . . 0.0 109.427 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 53' ' ' SER . 67.1 m-85 -113.26 -19.52 11.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 111.25 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 3.4 mmt180 161.63 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.703 -1.248 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -62.89 146.81 52.0 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.495 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.1 mt -135.82 174.13 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.875 . . . . 0.0 110.146 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.2 pt-20 -152.82 145.53 24.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.6 m -152.01 110.38 3.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.64 140.06 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.269 -0.894 . . . . 0.0 108.743 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.7 OUTLIER 175.51 164.87 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.918 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.5 tt0 -88.57 169.14 11.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 2.7 pp -88.89 130.97 35.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.867 -1.146 . . . . 0.0 109.619 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.79 -27.1 9.47 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 19.1 t -93.53 117.35 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -1.22 . . . . 0.0 109.732 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.19 144.38 20.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.052 0.929 . . . . 0.0 110.049 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.36 -171.43 3.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -143.29 151.44 40.52 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.891 -1.131 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 86.6 m -146.51 127.85 14.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.491 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -85.47 143.38 28.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 110.234 -178.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 78' ' ' LEU . 86.7 mt -96.37 146.9 24.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.446 -0.784 . . . . 0.0 109.359 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.586 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.88 -29.86 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.515 -0.741 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.99 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.239 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.78 28.2 69.66 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -99.9 162.44 12.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' THR . 20.0 tt0 -128.83 119.34 24.3 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.563 HD23 ' C ' ' A' ' 94' ' ' LYS . 3.5 mt -125.27 141.49 52.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.076 -1.015 . . . . 0.0 110.328 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.45 145.49 43.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.963 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.765 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 169.67 -120.61 0.88 Allowed Glycine 0 C--O 1.211 -1.303 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.38 159.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.161 -1.199 . . . . 0.0 111.029 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 21.4 m95 -101.96 140.56 36.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.578 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -137.89 157.07 47.17 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -97.88 128.97 44.83 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.331 -1.481 . . . . 0.0 108.238 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.662 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.1 mm-40 -134.68 122.5 22.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.41 -110.41 3.25 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -125.56 34.19 4.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.23 158.05 43.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.494 -1.379 . . . . 0.0 110.213 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mt -97.9 110.63 23.16 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.578 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.8 164.86 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 110.418 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.05 94.96 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.765 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.2 mttp -86.17 102.53 13.98 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.175 -1.191 . . . . 0.0 108.819 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.6 m-30 -116.93 149.62 39.86 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.811 0.815 . . . . 0.0 110.103 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.563 ' C ' HD23 ' A' ' 78' ' ' LEU . 3.5 ptpt -143.33 124.02 14.13 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 31.5 mtp180 -48.07 115.15 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.349 -0.845 . . . . 0.0 108.804 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -70.55 -7.43 43.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.362 1.077 . . . . 0.0 109.322 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -89.68 -41.59 11.84 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.77 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -132.4 8.95 4.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.922 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.06 42.61 12.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.834 ' O ' ' O ' ' A' ' 101' ' ' GLU . 14.4 m120 -75.73 18.4 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -1.147 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.834 ' O ' ' O ' ' A' ' 100' ' ' ASN . 13.4 pt-20 38.62 154.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.107 0.956 . . . . 0.0 111.42 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.867 HD11 ' HB3' ' A' ' 117' ' ' TYR . 15.2 tp -153.53 129.08 9.97 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -113.93 108.68 17.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 109.341 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.7 t -123.29 175.83 6.47 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.135 0.969 . . . . 0.0 111.669 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' N ' ' OG1' ' A' ' 104' ' ' THR . 45.5 t -145.04 157.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.477 ' HE ' HD21 ' A' ' 113' ' ' LEU . 21.9 ttm180 -126.75 136.02 51.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.982 . . . . 0.0 109.837 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.55 158.3 44.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.104 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.45 HD13 HD12 ' A' ' 113' ' ' LEU . 1.4 mm -122.09 82.38 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.079 -1.013 . . . . 0.0 108.435 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 109' ' ' ILE . 19.2 mt -62.61 92.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.886 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.12 -82.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ILE . 68.8 m-20 -130.71 29.01 4.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -1.166 . . . . 0.0 109.952 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.07 139.76 49.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.874 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.499 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 11.7 tp -98.87 112.15 24.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.885 -1.134 . . . . 0.0 109.051 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 109' ' ' ILE . 20.1 t -99.51 111.53 29.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.365 -0.835 . . . . 0.0 109.472 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -111.52 106.84 15.83 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.27 143.22 32.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.867 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -127.16 148.68 50.17 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.875 0.845 . . . . 0.0 109.903 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.6 t -112.42 148.13 15.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.517 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -144.01 110.67 5.6 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 49.72 17.74 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.25 28.25 3.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.8 177.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.522 ' N ' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -154.72 116.79 4.21 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 118.309 -1.357 . . . . 0.0 111.04 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.909 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -110.41 153.76 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -133.54 138.79 46.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.824 -1.173 . . . . 0.0 111.071 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.578 ' NE ' ' OH ' ' A' ' 117' ' ' TYR . 15.1 mtm180 -132.89 120.91 22.11 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.482 HG12 HG22 ' A' ' 114' ' ' VAL . 4.3 mt -114.44 123.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.09 . . . . 0.0 111.245 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 38' ' ' LEU . 5.5 m-30 -99.13 175.94 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 130' ' ' LYS . 45.9 tttt -165.92 159.3 15.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 109.159 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -47.52 132.6 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.458 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.454 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.291 0.567 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.833 ' CE1' ' CE3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 40.25 32.08 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.852 . . . . 0.0 109.369 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 1' ' ' ALA . 10.5 m-20 -75.35 78.59 2.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.642 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.59 ' O ' ' NE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -179.28 -168.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.163 -0.96 . . . . 0.0 109.664 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.625 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.4 m -95.53 142.02 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.833 ' CE3' ' CE1' ' A' ' 2' ' ' PHE . 0.9 OUTLIER -151.45 169.24 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.51 139.63 20.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.858 . . . . 0.0 109.281 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' C ' ' O ' ' A' ' 7' ' ' LYS . 7.6 t -33.52 106.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 110.237 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.05 -31.69 14.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -153.86 173.89 15.32 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.611 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -176.37 178.17 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 0.0 109.47 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -157.25 154.08 28.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 12.3 m-20 57.92 -110.28 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.744 -0.598 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.507 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.99 -53.15 0.62 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.874 . . . . 0.0 109.922 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 15.2 p-10 -58.93 -46.42 88.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 108.827 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 78.2 mttt -63.53 -32.27 73.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.905 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 85.7 t80 -72.39 -61.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.556 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 9.6 mmt -58.64 -23.89 60.02 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' HB2' HH21 ' A' ' 28' ' ' ARG . 28.0 tt0 -77.54 -35.3 53.41 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -65.59 -42.01 92.18 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.323 -0.861 . . . . 0.0 109.184 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.482 ' CE ' ' CE2' ' A' ' 17' ' ' PHE . 5.7 mtm -59.61 -13.74 10.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.926 . . . . 0.0 108.845 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.35 22.48 56.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 24' ' ' ASN . 2.9 t -73.27 134.3 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -1.039 . . . . 0.0 109.45 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.9 m-80 -41.98 165.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -77.57 -1.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.247 1.022 . . . . 0.0 109.164 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.91 -59.79 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 31' ' ' ALA . 45.3 mmtt -59.24 -39.92 84.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 108.951 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.44 HH21 ' HB2' ' A' ' 19' ' ' GLU . 5.8 ttt180 -61.49 -39.94 92.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -60.89 -47.55 85.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.655 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.55 -12.98 47.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -51.73 -52.89 45.08 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.233 0.54 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -31.31 67.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.385 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.52 34.85 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.413 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -117.37 73.51 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.354 -0.842 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.51 ' O ' ' O ' ' A' ' 36' ' ' LEU . 3.1 p-10 -86.94 43.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.245 -0.91 . . . . 0.0 109.342 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 35' ' ' ASN . 1.1 pt? -38.81 167.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.211 1.005 . . . . 0.0 111.391 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -105.69 146.4 29.8 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -139.58 124.08 18.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.021 -1.049 . . . . 0.0 110.325 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.536 ' C ' HD12 ' A' ' 40' ' ' ILE . 6.5 m -104.05 114.77 29.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.929 ' N ' HD12 ' A' ' 40' ' ' ILE . 2.2 mp -108.4 138.97 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.672 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.11 152.0 50.85 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -136.97 145.79 44.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 109.557 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -149.6 79.23 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.028 -1.045 . . . . 0.0 109.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.04 -90.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.696 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -120.59 28.77 7.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.333 -1.098 . . . . 0.0 110.453 -178.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 pttm -152.17 111.82 3.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -106.76 174.33 5.93 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.576 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.651 HG23 HG22 ' A' ' 61' ' ' VAL . 11.6 m -148.06 103.39 3.47 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.38 115.58 31.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.148 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -112.36 100.69 8.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -82.87 157.16 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -158.4 107.01 1.97 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.063 -1.023 . . . . 0.0 108.975 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.657 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -134.19 144.46 48.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.93 7.7 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.398 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.657 ' H ' ' C ' ' A' ' 53' ' ' SER . 47.7 m-85 -112.47 -20.3 11.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -0.918 . . . . 0.0 111.227 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.0 OUTLIER 163.3 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.0 109.686 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -63.38 145.86 54.72 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.596 HD13 ' ND2' ' A' ' 71' ' ' ASN . 1.0 OUTLIER -137.59 174.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 0.0 110.312 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 6.4 pt-20 -150.62 143.56 24.69 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.14 110.46 4.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.651 HG22 HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -109.14 141.65 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.285 -0.884 . . . . 0.0 109.093 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.78 -179.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.849 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.9 mp0 -105.09 175.19 5.58 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 64' ' ' LEU . 3.3 pp -93.9 119.37 32.73 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.986 -1.071 . . . . 0.0 109.203 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.0 -34.73 3.92 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.66 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 3.1 t -83.75 115.02 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.012 -1.287 . . . . 0.0 109.98 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -54.73 147.91 13.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.041 0.924 . . . . 0.0 110.207 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -160.05 -171.08 3.08 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -129.31 150.09 50.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 110.131 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 63.5 m -152.7 132.47 13.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.596 ' ND2' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -92.24 145.9 24.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.972 -1.08 . . . . 0.0 110.415 -178.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 73' ' ' ALA . 89.3 mt -93.91 147.02 23.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 0.0 109.342 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.61 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.49 -34.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 23.8 t0 -62.57 12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.15 27.9 73.34 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.632 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.3 OUTLIER -99.07 162.14 13.23 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.232 -1.158 . . . . 0.0 109.345 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -132.71 119.56 20.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.62 -0.675 . . . . 0.0 109.227 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.93 163.04 30.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.009 -1.057 . . . . 0.0 110.335 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -141.95 146.35 35.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.885 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.749 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 170.26 -118.7 0.77 Allowed Glycine 0 C--O 1.211 -1.287 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.19 159.51 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.268 -1.136 . . . . 0.0 110.674 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.33 145.1 29.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.58 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -141.01 157.35 45.45 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -97.51 123.19 41.29 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.456 -1.403 . . . . 0.0 108.217 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' N ' HD12 ' A' ' 84' ' ' LEU . 23.9 mt-10 -120.11 111.63 18.1 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.4 ' O ' HD11 ' A' ' 84' ' ' LEU . . . 64.47 -104.95 1.0 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 87' ' ' ASN . 41.8 t30 -125.21 33.47 5.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -1.16 . . . . 0.0 110.262 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.51 148.26 40.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.795 -1.191 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.25 104.48 16.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.58 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -74.9 164.16 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.067 -1.02 . . . . 0.0 110.555 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.9 94.97 0.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.68 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 36.6 mtmt -88.8 103.1 15.67 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 109.151 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.2 m-30 -118.43 137.43 53.15 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.647 0.737 . . . . 0.0 109.709 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 14.1 pttt -124.97 122.89 38.61 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 99' ' ' GLY . 18.3 mtp85 -51.35 117.91 2.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 0.0 109.22 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -11.12 60.72 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.438 1.113 . . . . 0.0 109.29 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.21 -48.29 12.27 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.571 ' OD1' ' NH1' ' A' ' 95' ' ' ARG . 11.3 m120 -132.58 8.63 4.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.23 43.67 9.62 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.683 ' O ' ' O ' ' A' ' 101' ' ' GLU . 56.7 m-20 -72.38 11.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 109.524 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.683 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.2 mt-10 47.42 132.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.713 0.768 . . . . 0.0 111.162 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -135.31 132.51 37.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 102' ' ' LEU . 1.9 m120 -117.01 116.49 27.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 0.0 108.931 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -128.12 176.13 7.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.796 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.4 t -146.6 155.2 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.17 136.31 51.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 109.899 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -137.36 158.68 43.89 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.45 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 2.2 mt -124.71 82.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.824 -1.173 . . . . 0.0 108.642 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 109' ' ' ILE . 21.3 mt -62.8 92.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.976 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.97 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.6 t70 -130.77 29.78 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -1.188 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -133.12 141.56 48.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.016 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 7.1 tp -97.65 110.77 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.871 -1.143 . . . . 0.0 109.195 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.514 HG22 HG23 ' A' ' 127' ' ' ILE . 8.8 t -95.21 111.9 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.937 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -114.84 107.32 15.26 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -101.42 145.31 29.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.691 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -123.11 154.97 37.89 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.837 0.827 . . . . 0.0 109.48 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.1 t -125.59 147.1 30.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.562 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -144.78 110.37 5.3 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.008 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 47.52 19.31 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.198 0.523 . . . . 0.0 111.118 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.72 28.12 3.56 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.24 176.58 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 3.6 mt-10 -155.68 125.9 6.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.229 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.905 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -118.21 153.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -130.29 139.56 50.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.808 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.691 ' NH1' ' CZ ' ' A' ' 117' ' ' TYR . 41.0 mtm180 -136.74 114.03 10.79 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.514 HG23 HG22 ' A' ' 114' ' ' VAL . 5.2 mt -110.74 123.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.972 -1.08 . . . . 0.0 110.77 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 38' ' ' LEU . 8.3 m-30 -99.18 171.0 8.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 0.0 109.502 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.76 159.62 42.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.63 -0.669 . . . . 0.0 109.21 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -57.96 134.09 56.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.2 t0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.486 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.254 0.549 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.846 ' CZ ' ' CD2' ' A' ' 6' ' ' TRP . 1.4 t80 42.69 38.38 1.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.314 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 4' ' ' SER . 5.5 m-20 -78.46 96.4 5.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 109.499 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.623 ' OG ' ' N ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 159.3 -169.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.775 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.623 ' N ' ' OG ' ' A' ' 4' ' ' SER . 51.5 m -95.89 150.41 20.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.846 ' CD2' ' CZ ' ' A' ' 2' ' ' PHE . 12.4 m95 -150.39 169.13 22.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.755 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 14.9 pttm -152.25 125.24 8.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.578 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.63 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -39.31 106.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 24.2 t0 -95.06 -29.49 14.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.409 ' HB2' HD12 ' A' ' 127' ' ' ILE . 2.5 mtt-85 -147.86 162.63 38.88 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.871 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.56 178.1 7.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -154.43 158.39 39.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 6.8 m-20 58.86 -109.18 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.656 -0.653 . . . . 0.0 109.72 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 74.76 -54.22 0.67 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.658 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 2.7 m-20 -60.55 -42.37 96.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.083 -1.011 . . . . 0.0 108.574 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -64.27 -32.05 73.5 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.84 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 7.5 t80 -72.9 -64.07 1.04 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -57.66 -20.85 36.39 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.616 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 2.0 tm-20 -79.77 -36.37 37.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.061 -1.024 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -67.41 -40.85 85.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.358 -0.838 . . . . 0.0 109.246 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 mtm -68.09 -6.12 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.33 -0.856 . . . . 0.0 108.999 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.53 32.43 67.76 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.5 t -72.73 128.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.486 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.7 m120 -41.76 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.355 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -76.52 -1.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.181 0.991 . . . . 0.0 109.212 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -81.86 -59.88 2.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -62.92 -30.93 71.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -44.08 72.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -62.99 -34.19 77.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 109.511 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.5 -13.26 46.52 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.968 0.89 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -80.34 -36.31 34.35 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.566 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.39 -24.34 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 1.3 m-70 -68.82 36.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.118 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 32' ' ' ALA . 7.5 p-10 -42.57 89.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 109.771 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 21.8 t-20 -147.7 42.72 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 108.919 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -83.23 159.87 21.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.876 . . . . 0.0 110.486 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.812 ' N ' HD12 ' A' ' 36' ' ' LEU . 13.6 mtmm -119.55 150.4 40.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.6 pt? -153.8 149.53 27.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.111 -0.993 . . . . 0.0 110.0 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 m -117.45 123.32 46.07 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.752 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.0 mp -109.37 131.43 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.676 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.65 152.26 50.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.05 149.0 41.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 0.0 109.95 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.98 79.52 1.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.096 -1.003 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 -94.52 0.64 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.48 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -127.38 28.28 5.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -1.109 . . . . 0.0 109.442 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.57 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 18.6 pttm -149.37 110.83 4.46 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.3 174.23 9.75 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.013 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -143.49 103.07 4.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG13 HG13 ' A' ' 40' ' ' ILE . 42.2 t -98.94 108.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.773 -0.579 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.16 100.0 12.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.302 -0.874 . . . . 0.0 108.748 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 58' ' ' ILE . 50.2 mt-10 -69.78 155.74 40.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.241 -0.912 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 51' ' ' GLU . 3.2 m -160.83 107.24 1.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.194 -0.941 . . . . 0.0 108.818 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.702 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -143.25 144.54 32.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.77 7.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.051 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.702 ' H ' ' C ' ' A' ' 53' ' ' SER . 16.5 t80 -106.83 -24.95 11.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 110.861 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 73' ' ' ALA . 9.8 mtp180 160.01 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 109.25 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -62.45 145.86 53.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 109.18 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.8 mt -142.77 174.14 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 122.129 0.966 . . . . 0.0 110.694 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.62 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.6 pt-20 -135.42 142.52 45.64 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 t -155.05 113.76 3.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.976 -1.077 . . . . 0.0 110.306 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.18 149.35 7.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -129.94 121.07 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.033 . . . . 0.0 110.534 -179.024 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 50.2 tt0 -123.35 139.17 54.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -103.23 148.83 25.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.885 -1.135 . . . . 0.0 110.283 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.8 -5.13 59.71 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.12 118.06 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.28 . . . . 0.0 109.941 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.8 m -49.32 145.4 4.55 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.294 1.045 . . . . 0.0 109.685 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.98 -168.14 2.15 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -146.46 157.21 43.72 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.532 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 15.9 t -147.66 136.05 21.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -96.54 148.33 22.94 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.939 -1.101 . . . . 0.0 110.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 73' ' ' ALA . 18.8 mt -100.94 147.08 26.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.586 -0.696 . . . . 0.0 109.527 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.671 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -39.46 -34.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.747 -0.596 . . . . 0.0 109.816 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.65 7.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.127 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.671 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 70.12 24.63 76.43 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.29 161.25 13.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.246 -1.149 . . . . 0.0 109.53 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -133.55 124.57 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.245 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -130.39 159.61 36.5 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.063 -1.023 . . . . 0.0 110.499 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -138.89 152.33 47.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 0.0 110.458 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.15 -110.09 0.42 Allowed Glycine 0 C--O 1.212 -1.272 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 166.74 152.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -1.216 . . . . 0.0 110.93 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 28.2 m95 -108.45 130.22 55.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.649 ' H ' HD12 ' A' ' 90' ' ' ILE . 1.8 m -144.88 156.31 43.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 109.54 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.934 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -87.27 138.11 31.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.752 -1.218 . . . . 0.0 108.425 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.934 ' N ' HD12 ' A' ' 84' ' ' LEU . 49.9 mt-10 -160.32 157.21 27.59 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.497 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.07 -117.72 6.49 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -125.99 33.8 4.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -1.197 . . . . 0.0 110.638 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -165.02 163.5 20.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.436 -1.415 . . . . 0.0 110.593 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.71 124.35 31.41 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.649 HD12 ' H ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -94.13 161.05 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.983 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 104' ' ' THR . . . -148.24 100.3 0.21 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.635 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 63.6 mttt -98.08 108.76 21.54 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.371 -1.076 . . . . 0.0 108.762 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' LEU . 1.5 m-30 -126.72 137.92 53.32 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.78 0.8 . . . . 0.0 110.245 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 94' ' ' LYS . 4.4 ptmm? -126.33 128.92 47.85 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 99' ' ' GLY . 35.7 mtp180 -54.64 115.27 2.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 108.993 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -10.17 57.34 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.389 1.09 . . . . 0.0 109.34 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -83.31 -47.13 11.82 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.619 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -132.44 9.26 4.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.84 44.86 18.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.64 ' O ' ' O ' ' A' ' 101' ' ' GLU . 13.9 m120 -74.42 10.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -1.173 . . . . 0.0 109.63 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.64 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.5 mt-10 49.96 136.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.764 0.792 . . . . 0.0 111.12 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.3 tt -146.39 122.28 10.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.671 ' N ' HD23 ' A' ' 102' ' ' LEU . 4.6 m-20 -112.42 149.98 31.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.044 . . . . 0.0 108.554 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.7 t -159.59 175.71 12.89 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.266 -1.521 . . . . 0.0 111.315 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 106' ' ' ARG . 37.8 t -144.23 158.17 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 105' ' ' VAL . 4.0 ttm180 -131.81 134.12 45.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -137.0 157.88 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.24 82.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.069 -1.019 . . . . 0.0 108.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 111' ' ' ASP . 79.0 mt -63.03 92.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.237 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.68 -78.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 109' ' ' ILE . 20.9 p-10 -130.19 29.24 4.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.0 110.316 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -134.77 139.05 44.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 108.966 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 2' ' ' PHE . 7.5 tp -102.9 114.87 29.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.009 -1.057 . . . . 0.0 109.543 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.662 HG22 HG23 ' A' ' 127' ' ' ILE . 25.1 t -102.11 107.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.399 -0.813 . . . . 0.0 109.111 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -110.1 106.97 16.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.76 145.43 30.37 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.702 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.22 149.8 50.87 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.94 0.876 . . . . 0.0 109.715 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 122' ' ' VAL . 3.9 t -112.91 148.01 16.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.507 ' CB ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -140.64 110.28 6.38 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 47.31 19.22 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.122 0.487 . . . . 0.0 111.182 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.5 28.6 3.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -124.34 177.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.084 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 122' ' ' VAL . 33.9 mt-10 -153.5 121.23 5.98 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.378 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.84 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -114.0 146.19 40.5 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -125.82 140.14 52.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.929 -1.107 . . . . 0.0 111.186 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -129.71 114.2 15.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.662 HG23 HG22 ' A' ' 114' ' ' VAL . 8.7 mt -111.36 123.38 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.762 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.549 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.6 m-30 -103.65 176.06 5.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.489 -0.757 . . . . 0.0 109.577 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.58 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 24.6 tttp -163.86 152.96 14.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.547 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 4.7 pttm -47.66 132.24 14.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 13.5 p-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.604 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.293 0.568 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.853 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER 68.48 31.14 4.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 4' ' ' SER . 1.3 m-20 -75.86 92.91 3.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.676 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 163.83 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.676 ' N ' ' OG ' ' A' ' 4' ' ' SER . 96.8 m -91.49 145.27 24.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.853 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 8.2 m95 -151.36 168.24 25.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.315 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 3.0 ptmm? -153.18 133.76 13.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.988 -1.07 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.61 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -40.2 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.426 -0.796 . . . . 0.0 109.506 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.26 -30.2 12.38 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -140.67 169.82 16.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.912 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 14.4 t -175.27 178.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.279 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -156.24 154.42 30.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.9 m-20 56.79 -109.5 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.526 -0.734 . . . . 0.0 109.792 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.519 ' CE2' ' HE1' ' A' ' 18' ' ' MET . 0.3 OUTLIER 75.68 -54.14 0.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.529 ' CG ' HH21 ' A' ' 28' ' ' ARG . 7.2 m-20 -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.664 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -66.46 -32.08 73.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 21.9 t80 -72.28 -60.29 2.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.519 ' HE1' ' CE2' ' A' ' 14' ' ' TYR . 5.3 mtt -56.41 -25.09 49.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -78.87 -30.06 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.157 -0.965 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -69.76 -41.8 74.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -68.01 -6.41 22.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.91 . . . . 0.0 108.942 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 29.64 54.14 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.46 135.52 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -48.8 158.84 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.88 . . . . 0.0 109.37 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -82.96 -1.38 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.141 0.972 . . . . 0.0 109.237 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -80.07 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -57.34 -42.45 81.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.529 HH21 ' CG ' ' A' ' 15' ' ' ASP . 16.7 ttp85 -59.32 -46.67 87.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.456 -0.777 . . . . 0.0 109.204 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -53.59 -39.34 64.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.385 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.5 -13.59 45.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.803 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.44 -39.92 15.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.186 0.517 . . . . 0.0 109.668 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -38.64 -27.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.678 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 35' ' ' ASN . 46.5 m170 -70.04 39.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.908 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 32' ' ' ALA . 6.8 t0 -43.5 90.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.591 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 33' ' ' HIS . 5.8 m120 -147.7 42.97 1.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 36' ' ' LEU . 1.1 pt? -90.6 163.52 14.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -106.17 135.19 48.07 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.582 HD21 HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -132.91 128.54 36.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.975 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.446 HG23 ' HA ' ' A' ' 5' ' ' THR . 0.3 OUTLIER -102.87 120.71 41.09 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.028 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.5 mp -107.78 123.17 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 0.0 110.829 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.02 151.93 38.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.604 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 20.7 pt20 -133.37 148.95 51.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.005 -1.059 . . . . 0.0 110.188 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.513 ' OE2' ' CD ' ' A' ' 46' ' ' LYS . 58.6 mt-10 -147.73 79.31 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.183 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.14 -92.72 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.31 28.42 7.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -1.059 . . . . 0.0 109.358 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.513 ' CD ' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -140.67 109.74 6.14 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' HB2' ' CE2' ' A' ' 62' ' ' PHE . 19.1 m-85 -103.06 173.36 6.34 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -154.88 103.61 2.43 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.73 110.29 25.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -95.52 100.26 12.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.1 mp0 -73.88 159.75 32.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 51' ' ' GLU . 2.3 m -160.16 107.02 1.59 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.081 -1.012 . . . . 0.0 109.163 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -125.68 144.31 50.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.03 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.218 -0.927 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.632 ' H ' ' C ' ' A' ' 53' ' ' SER . 20.6 t80 -125.02 -19.62 5.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 111.782 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 177.02 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.303 -1.498 . . . . 0.0 110.084 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 17.5 p-10 -62.89 145.58 54.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.999 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.79 174.19 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.4 pt-20 -147.05 143.99 28.77 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.22 110.57 4.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -89.5 146.22 6.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 4.6 p90 -160.46 153.75 21.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.561 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.2 tt0 -129.15 122.72 30.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 64' ' ' LEU . 3.0 pp -56.86 126.74 28.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.04 -1.037 . . . . 0.0 109.853 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.97 3.4 24.81 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.67 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 18.5 t -144.17 113.63 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.321 . . . . 0.0 109.777 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.778 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.5 m -55.48 147.64 17.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.958 0.885 . . . . 0.0 110.308 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.67 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -156.59 -171.0 3.52 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -134.05 153.24 51.93 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 34.9 t -156.84 131.62 8.86 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -95.79 145.42 25.35 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' GLY . 19.5 mt -95.85 146.89 24.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.628 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.44 -34.96 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.65 -0.656 . . . . 0.0 109.897 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.58 3.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.628 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.37 25.27 66.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.708 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.21 161.67 13.46 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.172 -1.193 . . . . 0.0 109.555 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -133.33 121.24 22.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -135.56 161.68 34.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.946 -1.096 . . . . 0.0 110.216 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HG3' HG22 ' A' ' 67' ' ' THR . 0.7 OUTLIER -144.48 148.24 34.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 109.65 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.778 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.23 -116.95 0.69 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 174.03 159.26 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.324 . . . . 0.0 111.093 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 12.8 m95 -102.2 141.67 34.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.588 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -138.79 156.9 46.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -95.54 128.72 42.63 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.353 -1.467 . . . . 0.0 108.408 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.658 ' N ' HD12 ' A' ' 84' ' ' LEU . 14.3 pt-20 -129.61 129.33 44.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.74 -108.56 0.73 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -125.51 34.12 4.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.177 -1.19 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.95 156.23 44.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.179 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.5 mt -97.1 110.83 23.3 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.3 164.72 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.149 -0.969 . . . . 0.0 110.522 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.658 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.97 95.19 0.17 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.704 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.0 ptmm? -86.85 102.41 14.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.122 -1.222 . . . . 0.0 109.102 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.5 m-30 -116.0 142.68 46.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.775 0.798 . . . . 0.0 109.801 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 31.8 pttt -133.34 124.02 26.47 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.708 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 25.5 mtt180 -44.67 116.8 1.13 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.383 -0.823 . . . . 0.0 108.886 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -7.19 41.05 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.66 -45.9 10.56 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.516 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -132.6 8.46 4.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 47.31 45.16 21.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 21.4 m-20 -73.12 12.57 0.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.4 mt-10 49.66 146.17 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.903 0.859 . . . . 0.0 111.32 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.661 HD23 ' C ' ' A' ' 102' ' ' LEU . 8.3 tt -149.93 126.04 10.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.515 ' N ' HD23 ' A' ' 102' ' ' LEU . 13.5 t30 -111.65 112.44 24.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.415 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.9 t -124.53 176.43 6.52 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 110.994 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.1 t -148.54 154.93 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -126.65 130.29 50.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 109.688 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -129.44 158.98 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 109.083 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 2' ' ' PHE . 1.4 mm -120.08 82.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 109' ' ' ILE . 9.5 mt -64.38 91.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.735 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 51.38 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.1 p-10 -125.05 29.84 6.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -1.173 . . . . 0.0 110.422 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -138.3 147.7 43.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.029 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 11.0 tp -107.76 112.42 25.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.031 -1.043 . . . . 0.0 109.477 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.521 HG22 HG23 ' A' ' 127' ' ' ILE . 3.4 t -94.77 115.16 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -114.56 103.32 10.9 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -103.0 145.94 29.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.909 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -128.17 152.65 47.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.96 0.886 . . . . 0.0 109.641 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.0 t -120.09 149.24 22.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.591 ' CE1' ' OE2' ' A' ' 120' ' ' GLU . 1.2 t80 -143.47 110.88 5.82 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.929 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.591 ' OE2' ' CE1' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 46.15 20.16 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.053 178.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.68 28.55 3.42 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.767 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.9 176.58 5.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.51 ' N ' HG13 ' A' ' 122' ' ' VAL . 39.0 tt0 -156.06 125.55 6.28 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.067 -1.453 . . . . 0.0 111.427 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.86 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -121.31 151.42 40.1 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.4 ' O ' ' OG ' ' A' ' 11' ' ' SER . 5.3 ttpt -132.31 139.61 48.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 0.0 111.282 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.517 HH11 ' HH ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -135.14 114.42 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 114' ' ' VAL . 3.3 mt -108.76 125.39 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.036 -1.04 . . . . 0.0 110.817 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.513 ' CE2' HD22 ' A' ' 38' ' ' LEU . 6.5 m-30 -97.7 174.6 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.248 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.743 ' HE2' ' HZ2' ' A' ' 130' ' ' LYS . 43.4 tttm -160.65 156.63 25.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.524 -0.735 . . . . 0.0 109.273 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.743 ' HZ2' ' HE2' ' A' ' 129' ' ' LYS . 13.3 pttp -49.13 128.91 17.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.592 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.508 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.801 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.7 OUTLIER 42.52 33.79 0.48 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.455 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 4' ' ' SER . 20.2 p-10 -77.65 93.86 4.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.588 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.58 -166.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.58 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 36.2 m -90.94 147.08 23.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.365 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.801 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 15.4 m95 -151.69 169.24 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 109.646 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' VAL . 36.7 pttt -153.2 126.96 8.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.029 -1.044 . . . . 0.0 109.768 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.632 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -36.4 106.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.382 -0.824 . . . . 0.0 109.422 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -91.1 -29.5 17.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' NH1' HG21 ' A' ' 127' ' ' ILE . 62.2 mtm-85 -151.54 166.68 30.4 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.225 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.4 t -177.15 166.46 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.507 -0.745 . . . . 0.0 109.091 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -166.75 166.17 15.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 0.0 110.448 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 58.9 21.78 9.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.581 -0.699 . . . . 0.0 110.243 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.59 ' OH ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.61 -57.29 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.599 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 19' ' ' GLU . 2.6 m-20 -45.85 -52.93 10.55 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.011 -1.056 . . . . 0.0 109.161 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -54.65 -41.68 70.38 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 81.9 t80 -67.84 -63.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -20.82 2.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 15' ' ' ASP . 39.1 tt0 -79.24 -38.13 36.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -65.81 -37.32 85.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.516 ' HB2' HG23 ' A' ' 23' ' ' VAL . 11.3 mtm -67.73 -8.84 38.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.322 -0.861 . . . . 0.0 109.11 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 32.51 41.69 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 21' ' ' MET . 17.7 t -80.02 139.2 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -1.108 . . . . 0.0 109.585 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' VAL . 62.6 t30 -44.83 170.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.302 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.593 ' CD1' ' CZ ' ' A' ' 28' ' ' ARG . 3.7 mm -85.33 -5.1 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.017 . . . . 0.0 109.34 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.469 HG23 ' ND2' ' A' ' 24' ' ' ASN . 58.8 t -83.88 -60.04 2.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.724 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 49.3 mttp -63.97 -24.06 67.58 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.593 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 23.4 ttp180 -73.04 -47.8 41.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.553 -0.717 . . . . 0.0 109.361 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -66.96 -34.84 78.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.793 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.71 -13.07 46.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 110.064 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -74.82 -25.92 59.36 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.167 0.508 . . . . 0.0 109.824 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -70.94 -61.0 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.103 -0.998 . . . . 0.0 109.509 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 40.0 t-80 -70.71 46.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.451 -0.78 . . . . 0.0 109.434 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.485 ' OD2' HD22 ' A' ' 36' ' ' LEU . 37.8 t0 -88.94 127.54 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HA ' HG13 ' A' ' 8' ' ' VAL . 71.5 m-20 -123.78 43.08 3.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.632 HD23 HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -68.95 159.91 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.902 0.858 . . . . 0.0 111.008 -178.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -107.64 149.06 28.53 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 38' ' ' LEU . 2.6 mp -139.17 129.01 24.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.015 . . . . 0.0 109.952 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 m -99.96 105.86 17.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.523 HD13 ' CD2' ' A' ' 2' ' ' PHE . 3.7 mp -95.65 123.4 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 110.926 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.01 151.79 41.54 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -129.66 148.24 51.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.024 -1.048 . . . . 0.0 109.843 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' ASN . 27.9 mt-10 -144.72 78.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.66 -81.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' GLU . 11.7 p-10 -125.56 28.87 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.67 109.67 4.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.36 166.81 12.39 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.5 m -156.17 103.67 2.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.7 p -105.97 118.67 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.491 -0.755 . . . . 0.0 109.486 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -100.01 100.25 11.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.565 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 1.8 mp0 -70.51 156.3 39.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.935 . . . . 0.0 109.05 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -158.86 106.93 1.86 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.073 -1.017 . . . . 0.0 109.022 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.645 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.61 144.64 50.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.01 7.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 109.858 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.687 ' CZ ' ' NH2' ' A' ' 56' ' ' ARG . 6.0 t80 -112.29 -20.45 11.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 111.128 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.687 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER 160.44 89.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.843 -1.16 . . . . 0.0 109.317 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -62.18 148.17 45.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 59' ' ' GLU . 2.0 mt -138.11 174.19 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.032 0.92 . . . . 0.0 110.338 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.601 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.8 pt-20 -141.79 143.29 33.37 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.9 m -150.75 117.52 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 110.263 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER -89.08 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -137.82 165.93 25.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 23.8 tt0 -152.39 169.71 21.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.457 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 78.3 mt -100.74 118.88 37.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 110.197 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.87 24.56 27.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.345 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.636 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 21.0 t -144.05 102.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.05 -1.265 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.8 143.12 43.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.752 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.81 -171.03 3.82 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -138.41 149.73 45.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.481 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 50.0 t -151.91 135.66 16.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.43 143.91 28.36 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 110.163 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.1 mt -91.82 147.04 23.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.551 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.612 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.67 -33.86 1.33 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.702 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.68 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.612 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 78.34 25.33 61.54 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 161.7 13.43 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.236 -1.155 . . . . 0.0 109.692 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.732 ' C ' HD23 ' A' ' 78' ' ' LEU . 19.0 tt0 -133.09 125.88 30.55 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.732 HD23 ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -136.78 164.76 27.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.969 -1.082 . . . . 0.0 110.574 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.526 ' HG3' HG22 ' A' ' 67' ' ' THR . 14.6 ttm180 -147.85 143.15 27.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.66 -119.59 0.83 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.519 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 173.05 158.95 0.12 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.211 -1.17 . . . . 0.0 110.53 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.484 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.2 m95 -102.0 143.26 32.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.9 m -138.76 157.14 46.64 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -96.26 129.22 43.64 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.364 -1.46 . . . . 0.0 108.286 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.683 ' N ' HD12 ' A' ' 84' ' ' LEU . 1.3 pp20? -131.31 125.43 32.76 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.51 -109.45 1.58 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -125.47 33.84 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -1.156 . . . . 0.0 110.216 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.403 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.38 155.86 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.77 -1.206 . . . . 0.0 110.165 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mt -97.58 111.23 23.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.66 164.81 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 110.476 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.25 95.41 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.717 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 12.5 ptmt -86.17 102.78 14.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.189 -1.183 . . . . 0.0 108.478 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 102' ' ' LEU . 5.1 m-30 -118.95 145.72 45.56 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.823 0.821 . . . . 0.0 110.146 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.515 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 20.3 pttm -132.46 121.58 23.59 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 99' ' ' GLY . 49.0 mtp180 -46.95 114.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.398 -0.814 . . . . 0.0 109.026 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.49 -10.15 53.63 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 122.492 1.139 . . . . 0.0 109.28 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -79.03 -50.44 11.07 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.464 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -132.34 9.54 4.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.393 -0.817 . . . . 0.0 109.84 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.78 47.22 31.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.649 ' O ' ' O ' ' A' ' 101' ' ' GLU . 13.3 m-20 -77.92 14.01 1.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -1.146 . . . . 0.0 109.581 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.8 mt-10 50.88 142.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.616 0.722 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -144.89 131.71 20.13 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.711 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -114.9 111.76 21.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 0.0 108.866 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.2 t -126.86 176.4 7.32 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.075 -1.016 . . . . 0.0 111.184 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 106' ' ' ARG . 45.2 t -147.92 162.34 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.485 ' N ' HG12 ' A' ' 105' ' ' VAL . 12.9 ttm180 -133.4 139.48 46.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.924 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -141.42 158.75 43.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.133 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.438 HD13 HD12 ' A' ' 113' ' ' LEU . 1.4 mm -119.21 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.0 mm -61.55 92.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.009 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.53 -78.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 109' ' ' ILE . 14.4 m-20 -130.73 29.9 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -1.151 . . . . 0.0 110.213 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -136.98 146.48 45.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.121 -0.987 . . . . 0.0 109.164 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 11.9 tp -102.23 115.64 30.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.995 -1.066 . . . . 0.0 109.219 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 127' ' ' ILE . 5.6 t -105.16 107.61 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 109.288 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.497 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 12.5 tt0 -107.43 109.46 21.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 144.7 28.59 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 109.767 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.681 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -127.22 150.76 49.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.841 0.829 . . . . 0.0 109.51 179.034 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.2 t -119.77 147.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.554 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -145.03 110.75 5.38 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.138 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 50.01 17.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.299 0.571 . . . . 0.0 110.979 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.29 27.76 3.8 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.751 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -121.42 176.34 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 2.3 mt-10 -156.05 117.23 3.85 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.09 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.886 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -112.17 166.94 10.81 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -145.26 137.47 25.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.912 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.59 ' NE ' ' OH ' ' A' ' 14' ' ' TYR . 14.6 mtt180 -125.15 114.1 18.58 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 114' ' ' VAL . 7.3 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 110.352 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.532 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 11.4 m-30 -100.93 166.21 10.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -150.96 146.75 26.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.58 -0.7 . . . . 0.0 109.121 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -47.83 136.43 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.496 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 130' ' ' LYS . 11.7 p30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.451 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.859 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.3 OUTLIER 39.43 30.68 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.267 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 4' ' ' SER . 26.6 t70 -72.51 96.84 1.99 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.486 -0.759 . . . . 0.0 109.748 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 160.29 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 109.598 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.582 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.7 m -98.03 142.59 29.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.304 -0.872 . . . . 0.0 109.352 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.859 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 4.4 m95 -147.29 169.43 19.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.303 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 8' ' ' VAL . 11.9 pttm -151.9 130.7 12.43 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.022 -1.049 . . . . 0.0 109.477 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.654 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -39.83 106.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.364 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.44 -32.28 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' OG ' ' A' ' 11' ' ' SER . 15.8 mtm-85 -142.58 164.65 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.686 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 67.3 m -170.47 178.22 3.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 109.294 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -155.19 157.5 37.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.056 . . . . 0.0 110.006 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 10.8 m-20 58.02 -109.53 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.678 . . . . 0.0 109.854 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 71.69 -51.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -61.36 -46.03 91.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.955 -1.091 . . . . 0.0 108.597 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -63.34 -33.84 76.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.918 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 91.0 t80 -71.39 -61.4 1.79 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.795 0.807 . . . . 0.0 108.883 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.3 mmt -59.04 -23.78 62.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -74.76 -37.82 62.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.24 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -64.67 -46.38 82.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.341 -0.849 . . . . 0.0 109.028 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.479 ' CE ' ' CE2' ' A' ' 17' ' ' PHE . 4.8 mtm -61.81 -9.07 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.041 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.26 28.02 62.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG11 ' OD1' ' A' ' 74' ' ' ASP . 3.8 t -74.85 132.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -1.091 . . . . 0.0 109.553 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -49.31 167.15 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -82.03 -1.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.181 0.991 . . . . 0.0 109.22 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -73.69 -59.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.456 0.646 . . . . 0.0 109.386 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -64.22 -29.56 70.66 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.071 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 14.3 ttp180 -72.71 -30.69 64.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.642 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -75.4 -40.02 58.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.38 -13.14 47.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.01 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 33' ' ' HIS . . . -84.7 -49.56 8.4 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.212 0.529 . . . . 0.0 109.626 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.2 -1.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.544 ' H ' ' C ' ' A' ' 31' ' ' ALA . 79.4 m80 -140.1 46.26 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.609 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' LEU . 25.6 t0 -125.56 95.95 4.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.639 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.6 p-10 -71.48 43.57 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.353 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.654 HD23 HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -43.77 155.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.901 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -106.57 148.7 27.95 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.5 HD21 HD11 ' A' ' 36' ' ' LEU . 2.7 mp -138.92 126.53 21.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -98.29 111.78 24.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.8 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.9 mp -100.76 120.48 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.448 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -120.98 151.99 39.08 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.642 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 1.6 pm0 -130.88 147.06 52.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 45' ' ' ASN . 38.5 mm-40 -144.04 78.88 1.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.65 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 43' ' ' GLU . 44.9 p-10 -124.53 28.81 6.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -1.145 . . . . 0.0 110.347 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.22 109.88 4.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 42' ' ' GLN . 3.9 m-85 -94.65 171.02 9.05 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m -155.9 103.5 2.24 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 0.0 108.992 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.67 115.69 41.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.326 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -101.09 100.25 10.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 52' ' ' SER . 5.3 tt0 -69.86 157.78 36.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 108.736 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.422 ' N ' ' CG ' ' A' ' 51' ' ' GLU . 2.3 m -160.12 107.02 1.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.152 -0.968 . . . . 0.0 109.015 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.676 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -137.05 144.36 43.15 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.18 7.62 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 109.236 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.676 ' H ' ' C ' ' A' ' 53' ' ' SER . 60.2 m-85 -109.38 -25.02 10.76 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.296 -0.878 . . . . 0.0 111.1 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 2.7 ptm180 164.34 86.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.171 . . . . 0.0 109.44 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -62.61 146.4 52.1 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.299 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -140.56 174.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.127 -0.983 . . . . 0.0 110.409 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.61 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.9 pt-20 -146.34 142.76 28.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 98.9 m -151.25 125.06 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -86.38 150.35 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -136.38 131.08 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.922 -1.112 . . . . 0.0 110.416 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' OE1' HG21 ' A' ' 66' ' ' VAL . 4.7 tt0 -120.98 170.03 9.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.61 118.94 37.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.061 -1.024 . . . . 0.0 110.333 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.08 22.87 36.79 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.479 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 12.7 t -143.71 105.85 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.959 -1.318 . . . . 0.0 109.401 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.727 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.48 142.37 44.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.637 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -149.45 -171.36 3.87 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -139.41 154.02 47.72 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.659 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.1 t -153.45 135.54 14.78 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' OD1' HG21 ' A' ' 58' ' ' ILE . 5.8 p30 -93.73 143.39 26.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.934 -1.104 . . . . 0.0 110.231 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 78' ' ' LEU . 16.4 mt -92.53 146.89 23.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.67 -34.79 0.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 0.0 109.813 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.533 ' OD1' HG11 ' A' ' 23' ' ' VAL . 11.5 t70 -60.29 8.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 72.54 27.09 70.15 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.687 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.03 162.17 13.14 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.181 -1.188 . . . . 0.0 109.624 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -132.55 120.41 21.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -133.15 162.28 32.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.932 -1.105 . . . . 0.0 110.582 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -146.31 146.88 30.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.538 -0.726 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.52 -119.52 0.79 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.88 156.87 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.3 -1.117 . . . . 0.0 110.65 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 5.2 m95 -102.85 143.48 32.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -142.08 122.35 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.475 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 118.75 7.92 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 119.951 -1.718 . . . . 0.0 109.857 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.04 115.82 29.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.67 -103.54 0.33 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -125.35 33.77 5.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -140.98 143.13 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.735 -1.228 . . . . 0.0 110.251 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.12 104.53 17.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.781 ' CG1' ' O ' ' A' ' 83' ' ' SER . 0.9 OUTLIER -81.64 163.5 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.733 -1.229 . . . . 0.0 110.04 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.665 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.19 95.86 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.712 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.1 mttm -85.75 103.35 14.45 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.401 -1.058 . . . . 0.0 108.463 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -115.71 148.27 39.94 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.82 0.819 . . . . 0.0 110.154 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -133.41 120.9 21.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.451 0.643 . . . . 0.0 109.526 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.687 HH21 ' CG2' ' A' ' 76' ' ' THR . 23.8 mtp85 -53.1 115.32 1.81 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -13.41 61.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.456 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -77.84 -49.89 13.38 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.768 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -132.33 11.2 4.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.964 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.46 42.31 9.67 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.674 ' O ' ' O ' ' A' ' 101' ' ' GLU . 74.5 m-20 -75.6 19.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -1.154 . . . . 0.0 109.512 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.674 ' O ' ' O ' ' A' ' 100' ' ' ASN . 15.6 pt-20 45.07 164.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.816 0.817 . . . . 0.0 110.911 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 117' ' ' TYR . 6.6 tp -165.12 127.25 2.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -114.4 115.96 28.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.002 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -126.19 176.32 7.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.14 -0.975 . . . . 0.0 110.807 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -149.71 153.38 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -125.92 136.51 53.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.789 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -138.16 158.54 44.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.72 82.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 109' ' ' ILE . 22.4 mt -63.58 91.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.38 -81.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -127.89 29.34 5.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -1.191 . . . . 0.0 110.271 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -134.6 144.23 47.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 11.5 tp -105.36 113.34 26.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.873 -1.142 . . . . 0.0 109.085 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 127' ' ' ILE . 11.1 t -99.49 108.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.503 ' NE2' ' OH ' ' A' ' 117' ' ' TYR . 46.7 tt0 -105.52 106.65 17.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.6 OUTLIER -100.33 145.78 27.73 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 110.114 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -121.99 157.03 32.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.782 0.801 . . . . 0.0 109.191 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 103' ' ' ASN . 11.9 t -127.46 147.82 32.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.552 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.2 t80 -146.53 110.58 5.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.056 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 45.77 20.29 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.134 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.8 28.54 3.39 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.72 176.65 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 66.1 tt0 -155.91 125.28 6.25 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.401 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.918 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -115.6 152.92 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -133.92 136.91 44.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.773 -1.204 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.08 114.05 14.08 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.595 HG23 HG22 ' A' ' 114' ' ' VAL . 4.4 mt -107.67 123.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.989 . . . . 0.0 110.685 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -101.05 176.02 5.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.365 -0.834 . . . . 0.0 108.786 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -165.31 156.63 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.416 -0.803 . . . . 0.0 109.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -47.64 129.17 13.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.453 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.323 0.583 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.708 ' CZ ' ' CG ' ' A' ' 6' ' ' TRP . 0.7 OUTLIER 50.52 49.4 20.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.235 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.7 t70 -92.02 90.65 7.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.831 . . . . 0.0 109.196 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.72 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 85.2 m -102.16 143.26 32.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 109.721 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.708 ' CG ' ' CZ ' ' A' ' 2' ' ' PHE . 11.5 m95 -148.69 168.72 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.14 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 8' ' ' VAL . 9.7 pttm -153.21 130.91 11.56 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 0.0 109.588 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -38.39 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.8 -27.05 21.36 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -154.62 167.84 28.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.143 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -177.94 164.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 14' ' ' TYR . 6.7 pt-20 -166.76 166.45 15.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.81 -1.181 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.12 -5.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.653 -0.654 . . . . 0.0 110.191 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -46.78 -61.23 1.94 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.966 -1.084 . . . . 0.0 110.021 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 6.1 p-10 -44.92 -44.78 9.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.984 -1.073 . . . . 0.0 109.247 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -62.7 -41.62 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 108.664 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.847 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 23.5 t80 -68.59 -54.82 14.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.384 -0.823 . . . . 0.0 108.949 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 7.2 mmt -57.96 -31.11 66.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' A' ' 28' ' ' ARG . 26.2 tt0 -74.8 -25.33 58.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -70.68 -48.66 53.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 ttm -59.44 -10.22 3.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.058 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.81 32.4 27.0 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' ASN . 13.8 t -77.03 132.41 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -1.077 . . . . 0.0 109.55 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' VAL . 3.2 t-20 -48.32 177.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.322 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.62 -2.82 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 109.41 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.85 -60.05 2.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -65.45 -25.96 67.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.43 HH21 ' HB2' ' A' ' 19' ' ' GLU . 21.3 ttp180 -73.25 -43.4 61.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.406 -0.809 . . . . 0.0 109.263 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -70.44 -32.72 70.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.1 mt -86.45 -13.7 45.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -85.96 -47.17 9.86 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.75 -22.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' ASN . 1.2 t60 -69.29 37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 32' ' ' ALA . 5.3 p30 -49.92 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.838 . . . . 0.0 109.594 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 33' ' ' HIS . 20.5 t-20 -147.26 43.22 1.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 108.862 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -92.72 168.54 11.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 111.238 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -108.83 150.22 27.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 38' ' ' LEU . 1.3 mp -139.64 120.0 13.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.991 -1.068 . . . . 0.0 110.329 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -101.79 111.38 23.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.673 HD13 ' CD2' ' A' ' 2' ' ' PHE . 4.4 mp -111.18 144.04 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 111.41 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -133.76 152.39 51.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -128.11 146.17 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -143.17 79.06 1.63 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.978 . . . . 0.0 109.616 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.01 -88.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.8 29.11 6.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.0 110.272 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -151.52 110.07 3.8 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -100.34 174.18 6.24 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.506 0.669 . . . . 0.0 109.919 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -148.86 103.23 3.35 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.8 t -96.06 110.92 25.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.749 -0.594 . . . . 0.0 109.571 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -100.77 100.24 10.88 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.3 mt-10 -73.89 159.35 32.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 109.004 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -161.99 107.15 1.25 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.143 -0.973 . . . . 0.0 109.096 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.672 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -135.0 144.29 47.29 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.64 7.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.987 -1.071 . . . . 0.0 109.156 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.672 ' H ' ' C ' ' A' ' 53' ' ' SER . 82.8 m-85 -113.16 -19.74 11.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.393 -0.817 . . . . 0.0 111.097 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.3 mmt180 162.8 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 109.556 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -63.1 148.69 47.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.278 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.614 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -142.85 174.31 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 121.192 -0.943 . . . . 0.0 110.471 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.614 ' H ' HG22 ' A' ' 58' ' ' ILE . 7.7 pt-20 -146.88 143.72 28.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.3 m -153.25 117.71 4.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.36 151.07 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -138.78 155.13 48.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.947 -1.096 . . . . 0.0 110.433 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.515 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 50.2 tt0 -150.01 168.41 23.95 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.515 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 14.5 mt -99.64 123.94 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.008 -1.058 . . . . 0.0 110.274 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 28.72 40.73 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.616 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 42.4 t -144.05 102.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.091 -1.24 . . . . 0.0 109.201 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -57.78 141.67 48.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.201 -0.937 . . . . 0.0 109.955 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.616 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.4 -171.6 3.98 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -138.67 150.6 46.39 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.65 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.5 t -151.44 136.33 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 76' ' ' THR . 6.5 p30 -95.09 144.76 25.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 110.225 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 73' ' ' ALA . 98.0 mt -93.27 146.79 23.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.619 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.81 -35.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 19.5 t70 -57.8 4.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.142 -0.974 . . . . 0.0 109.444 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.31 26.28 64.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.14 161.99 13.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 96' ' ' THR . 30.3 tt0 -132.86 122.27 24.15 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -133.79 163.85 28.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.014 -1.054 . . . . 0.0 110.541 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.15 142.19 28.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.135 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.89 -117.01 0.63 Allowed Glycine 0 N--CA 1.477 1.382 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.551 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.42 157.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.21 -1.17 . . . . 0.0 110.428 179.442 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.7 m95 -101.99 143.11 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.592 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.4 t -140.51 156.7 46.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 108.565 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -94.31 128.27 40.7 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.321 -1.487 . . . . 0.0 108.1 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.653 ' N ' HD12 ' A' ' 84' ' ' LEU . 12.8 pt-20 -133.31 125.03 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.01 -109.66 2.7 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.67 34.37 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -1.176 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -148.3 160.77 42.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.503 -1.373 . . . . 0.0 110.61 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.06 110.37 22.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.592 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.86 164.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 110.522 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.71 95.41 0.17 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.642 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 50.9 mttt -87.49 104.78 16.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.214 -1.168 . . . . 0.0 109.242 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.9 m-30 -118.19 127.27 53.59 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.735 0.778 . . . . 0.0 109.849 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -113.07 120.6 41.87 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.518 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 43.3 mtp180 -48.05 115.11 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -80.58 -10.4 59.74 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.485 1.136 . . . . 0.0 109.113 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.98 -26.61 18.3 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.789 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -132.06 4.6 4.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.965 . . . . 0.0 109.415 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 49.99 45.57 41.72 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.547 ' OD1' ' N ' ' A' ' 101' ' ' GLU . 30.8 t-20 -88.23 -122.48 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.25 -1.147 . . . . 0.0 109.008 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.0 pt-20 -175.29 138.55 0.42 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.353 0.597 . . . . 0.0 110.179 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.762 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.8 tt -141.17 119.2 11.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -110.16 112.34 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 108.693 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -122.65 174.95 6.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.139 0.971 . . . . 0.0 111.643 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.7 t -142.98 149.23 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -126.22 132.46 51.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -135.07 157.76 46.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.06 82.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.073 -1.017 . . . . 0.0 108.63 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 111' ' ' ASP . 62.8 mt -63.6 92.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.211 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.91 -77.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.9 m-20 -130.55 29.43 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -1.179 . . . . 0.0 110.404 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -135.34 134.56 39.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.223 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 2' ' ' PHE . 6.4 tp -100.14 112.96 25.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 127' ' ' ILE . 14.9 t -99.59 106.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.336 -0.945 . . . . 0.0 108.807 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.415 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 62.1 tt0 -111.1 104.61 13.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 108.984 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.419 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.3 144.4 30.84 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 0.0 109.464 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.762 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -129.02 144.67 51.26 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 109.687 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 122' ' ' VAL . 13.2 t -110.58 147.31 14.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.505 ' N ' HG12 ' A' ' 122' ' ' VAL . 2.4 t80 -148.22 114.18 5.78 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 52.85 14.92 0.48 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.87 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.3 28.37 3.83 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.78 176.73 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.678 ' HG2' HG22 ' A' ' 118' ' ' VAL . 19.6 mt-10 -155.56 111.79 3.13 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.454 -1.299 . . . . 0.0 110.787 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -105.01 153.47 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.06 138.27 49.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.994 -1.066 . . . . 0.0 110.68 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -131.7 114.11 14.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.9 mt -107.69 123.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.579 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 7.5 m-30 -99.73 176.17 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.288 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -161.45 146.28 13.45 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -47.8 133.67 13.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.524 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.746 ' CG ' ' CZ2' ' A' ' 6' ' ' TRP . 7.5 m-85 -65.86 5.86 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 0.0 109.417 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 1' ' ' ALA . 4.0 m-20 36.84 56.85 1.19 Allowed 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -175.22 -151.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 110.518 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.608 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 23.6 m -106.77 131.09 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.416 -0.802 . . . . 0.0 110.192 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.746 ' CZ2' ' CG ' ' A' ' 2' ' ' PHE . 49.9 m95 -145.05 158.04 43.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -147.81 153.59 39.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.704 -1.247 . . . . 0.0 110.668 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.438 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 2.7 t -42.47 106.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.716 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -97.16 -31.07 12.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HB2' HD12 ' A' ' 127' ' ' ILE . 50.8 mtt85 -152.85 172.07 17.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.8 t -173.22 177.38 2.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.947 -1.096 . . . . 0.0 109.723 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.99 162.19 40.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.858 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 4.6 m-20 59.58 -109.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.582 -0.699 . . . . 0.0 109.865 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.678 ' CE1' ' NH2' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 72.06 -52.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -0.967 . . . . 0.0 109.703 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 13.2 p-10 -60.94 -44.42 97.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.561 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -63.62 -32.07 73.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.896 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 16.1 t80 -71.77 -64.02 1.01 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.063 0.935 . . . . 0.0 108.619 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -58.27 -24.0 58.02 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.455 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 24.2 tp10 -79.86 -29.1 39.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 109.295 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -71.37 -42.66 68.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.077 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.7 mtm -67.41 -6.37 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.343 -0.848 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.49 64.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.86 130.81 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -1.162 . . . . 0.0 109.578 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -50.09 174.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.945 . . . . 0.0 109.368 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -84.47 -1.4 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 122.159 0.98 . . . . 0.0 109.175 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.09 -59.87 2.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -37.93 71.8 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HB3' ' A' ' 15' ' ' ASP . 2.1 ttt85 -64.41 -50.3 68.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -50.07 -36.41 29.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.001 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.47 -13.11 47.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.085 0.945 . . . . 0.0 109.384 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' ASP . . . -84.39 -37.01 22.04 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.658 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.73 -37.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.346 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -98.52 33.97 2.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.109 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ALA . 22.1 t70 -79.25 38.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.461 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -73.7 43.7 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 36' ' ' LEU . 2.6 pt? -52.99 170.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.13 0.967 . . . . 0.0 111.576 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -110.47 148.2 32.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.813 HD13 ' CE2' ' A' ' 128' ' ' PHE . 0.6 OUTLIER -137.17 123.98 21.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.92 -1.113 . . . . 0.0 110.54 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.77 109.08 21.07 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.1 mp -103.33 127.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 0.0 110.801 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -128.45 151.75 49.03 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.498 ' OE1' ' OD1' ' A' ' 3' ' ' ASP . 6.7 pt20 -141.29 140.18 33.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.839 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.43 78.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.43 -88.5 0.03 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.626 -0.989 . . . . 0.0 110.626 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -116.72 28.99 8.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -1.094 . . . . 0.0 110.348 -178.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -145.65 110.25 5.08 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.415 ' O ' HG23 ' A' ' 61' ' ' VAL . 13.9 m-85 -104.86 168.52 9.01 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -156.0 103.54 2.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.137 -0.977 . . . . 0.0 109.057 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.42 121.87 49.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -112.54 100.36 8.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' ILE . 92.0 mt-10 -77.48 157.44 30.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.104 -0.998 . . . . 0.0 109.318 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -159.46 106.82 1.73 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.229 -0.92 . . . . 0.0 108.984 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.644 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -131.05 144.46 51.47 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.391 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.01 7.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.175 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.644 ' H ' ' C ' ' A' ' 53' ' ' SER . 70.9 t80 -114.47 -17.64 11.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 111.173 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 6.4 mtp85 161.71 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.714 -1.241 . . . . 0.0 109.205 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -63.03 144.12 57.17 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.339 -0.85 . . . . 0.0 109.632 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.583 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -136.35 174.23 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.86 0.838 . . . . 0.0 110.08 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.583 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -156.65 156.07 32.85 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.9 109.11 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.82 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.639 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -104.53 153.45 6.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 1.7 m-85 176.42 -179.21 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.833 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.1 tt0 -117.66 168.33 10.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.504 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 19.2 mt -81.33 139.09 35.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.04 23.24 28.01 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.64 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 52.0 t -143.92 103.76 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -1.197 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.762 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.7 143.19 25.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.946 . . . . 0.0 109.811 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.71 -171.62 3.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.567 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 5.2 p30 -137.2 151.43 48.75 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 110.312 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 71.3 m -156.89 137.41 13.09 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.469 ' ND2' HD13 ' A' ' 58' ' ' ILE . 1.2 p-10 -92.53 143.9 25.88 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 0.0 110.416 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 96.0 mt -93.22 146.97 23.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.397 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.29 -34.04 0.45 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.907 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.22 12.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 68.74 27.13 74.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.19 162.31 13.05 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.258 -1.142 . . . . 0.0 109.634 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 96' ' ' THR . 30.6 tt0 -132.22 118.7 19.86 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -133.78 162.49 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.098 . . . . 0.0 110.797 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 9.8 ptm180 -143.23 142.92 31.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.83 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.762 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.4 -117.78 0.67 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.527 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.64 158.11 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.049 -1.265 . . . . 0.0 110.693 179.259 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.425 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.77 142.52 32.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -138.78 157.05 46.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -96.56 125.85 41.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.351 -1.468 . . . . 0.0 108.234 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.594 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.5 mm-40 -123.57 111.13 15.89 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.52 -105.19 1.07 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -125.13 33.65 5.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -1.136 . . . . 0.0 110.146 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -140.8 149.18 41.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.797 -1.19 . . . . 0.0 110.229 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -96.05 107.35 19.64 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -78.32 164.22 3.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 110.684 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.657 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.15 94.78 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.681 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.1 mtpm? -87.98 104.23 16.44 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.25 -1.147 . . . . 0.0 108.879 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -116.33 139.11 50.75 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.865 0.841 . . . . 0.0 110.18 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -121.72 121.03 36.38 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 15.7 mtp180 -53.81 115.03 1.78 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -68.01 -12.37 60.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.368 1.08 . . . . 0.0 109.396 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.88 -52.14 9.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.529 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 98' ' ' ASN . 39.1 t30 -132.62 14.55 4.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.65 44.05 11.84 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.751 ' O ' ' O ' ' A' ' 101' ' ' GLU . 49.7 m-20 -76.18 19.22 0.25 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -1.095 . . . . 0.0 109.724 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.751 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.2 pt-20 42.77 158.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.062 0.934 . . . . 0.0 111.247 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.1 tt -160.14 123.65 3.56 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.725 ' N ' HD23 ' A' ' 102' ' ' LEU . 2.0 m120 -113.45 113.87 25.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.097 -1.002 . . . . 0.0 109.028 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -126.0 176.56 6.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 111.071 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.4 t -148.85 150.82 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -127.77 135.13 49.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.549 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -141.89 158.6 43.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.554 ' CG2' ' CE2' ' A' ' 2' ' ' PHE . 1.6 mm -119.39 82.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 109' ' ' ILE . 1.7 mp -65.22 91.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 121.633 0.73 . . . . 0.0 109.893 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.34 -76.15 0.0 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 109' ' ' ILE . 10.2 t70 -124.45 29.64 6.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.239 . . . . 0.0 110.838 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -145.55 136.97 25.07 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.031 -1.043 . . . . 0.0 109.33 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.31 110.77 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.503 HG23 HD13 ' A' ' 109' ' ' ILE . 38.5 t -95.93 118.05 41.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 110.08 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -120.84 103.06 8.79 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.3 OUTLIER -105.33 147.16 28.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.155 -0.965 . . . . 0.0 110.182 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -126.82 152.85 46.41 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 109.252 178.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 122' ' ' VAL . 5.7 t -121.2 148.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.52 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.94 110.52 5.57 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.878 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 47.16 19.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.146 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.43 28.56 3.47 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.81 177.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.031 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 122' ' ' VAL . 58.9 tt0 -155.65 122.29 5.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.391 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.896 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -113.47 141.02 47.61 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -119.83 140.59 50.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.778 -1.201 . . . . 0.0 111.111 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.678 ' NH2' ' CE1' ' A' ' 14' ' ' TYR . 61.3 mtp85 -134.9 113.75 11.85 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 10' ' ' ARG . 3.5 mt -108.8 124.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.709 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.813 ' CE2' HD13 ' A' ' 38' ' ' LEU . 7.1 m-30 -98.21 177.95 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.938 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.507 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 20.0 tttp -158.29 147.22 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.693 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 16.4 pttp -46.69 129.02 11.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' OD2' ' A' ' 131' ' ' ASP . 7.3 p30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.485 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.668 ' N ' HD11 ' A' ' 113' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.454 0.645 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.838 ' HB3' ' NE1' ' A' ' 6' ' ' TRP . 1.3 m-85 -63.13 10.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 109.608 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER 37.72 45.07 0.61 Allowed 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.002 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.495 ' HB3' ' HE1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -168.54 -151.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.366 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.604 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 47.5 m -108.8 126.43 53.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.838 ' NE1' ' HB3' ' A' ' 2' ' ' PHE . 37.6 m95 -142.12 168.59 19.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.337 -0.852 . . . . 0.0 108.703 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.5 pttp -152.44 143.37 23.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.701 -1.249 . . . . 0.0 110.506 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.548 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -43.25 107.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.451 -0.78 . . . . 0.0 109.953 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.76 -31.15 12.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -149.12 164.71 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.727 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -170.46 169.79 7.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.258 -0.901 . . . . 0.0 109.255 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 14' ' ' TYR . 8.1 pt-20 -166.65 166.68 15.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.934 -1.104 . . . . 0.0 110.434 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 14' ' ' TYR . 2.5 m-20 62.57 -10.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.555 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -43.44 -59.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.019 -1.051 . . . . 0.0 109.863 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.59 -45.76 38.51 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.95 -1.094 . . . . 0.0 109.243 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -59.6 -40.66 88.21 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.907 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 24.4 t80 -67.39 -62.88 1.21 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -30.77 9.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -73.42 -29.27 62.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.072 -1.018 . . . . 0.0 109.128 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -67.94 -48.36 66.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.2 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.92 -6.95 4.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.53 26.26 47.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.9 t -72.78 136.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -1.059 . . . . 0.0 109.525 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -53.25 174.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.59 -1.98 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.093 0.949 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.9 -60.09 2.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 6.3 mptt -65.95 -21.15 66.41 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' NE ' HD13 ' A' ' 25' ' ' ILE . 15.3 ttp180 -72.64 -43.56 63.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 109.43 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -70.35 -33.45 71.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.62 -13.12 46.59 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.937 0.875 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -83.83 -52.97 5.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.245 0.545 . . . . 0.0 109.89 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.13 -50.6 4.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -73.66 46.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.511 ' HB3' HH22 ' A' ' 126' ' ' ARG . 46.6 m-20 -71.23 136.56 48.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.51 ' HA ' HG13 ' A' ' 8' ' ' VAL . 5.1 m-80 -147.37 43.06 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.692 ' CD2' HH12 ' A' ' 126' ' ' ARG . 0.8 OUTLIER -84.27 162.87 19.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 110.948 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -107.71 147.0 31.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.537 HD13 ' CE2' ' A' ' 128' ' ' PHE . 3.6 mp -136.6 121.04 18.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 110.019 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 m -92.1 104.58 16.95 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.738 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -97.69 117.84 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.22 151.92 38.45 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.444 ' CD ' ' CE2' ' A' ' 47' ' ' PHE . 49.1 tt0 -129.28 146.55 51.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.136 -0.978 . . . . 0.0 109.813 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -145.24 79.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.39 -92.95 0.16 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.04 28.56 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.382 -1.069 . . . . 0.0 109.758 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -145.96 109.6 4.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.444 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 14.1 m-85 -96.7 173.92 7.08 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.765 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -153.47 104.04 2.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 51' ' ' GLU . 2.5 t -101.22 112.79 35.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.57 -0.707 . . . . 0.0 109.373 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.47 100.6 11.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.885 . . . . 0.0 109.404 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.582 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.0 mp0 -72.65 155.73 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.183 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 1.2 m -159.34 106.71 1.75 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.119 -0.988 . . . . 0.0 108.892 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.638 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -130.44 144.28 51.3 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.258 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.94 8.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.27 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.638 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -117.03 -19.83 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 111.422 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.701 ' HE ' ' HB1' ' A' ' 73' ' ' ALA . 6.9 ptt180 167.7 84.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.641 -1.287 . . . . 0.0 109.575 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 30.0 p-10 -63.14 143.98 57.31 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -135.89 174.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.182 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.588 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.9 pt-20 -154.1 142.4 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.37 131.64 6.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.546 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -75.13 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.245 -0.91 . . . . 0.0 108.546 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -148.02 118.51 7.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.026 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.427 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 26.6 tt0 -130.32 146.82 51.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.5 pp -95.73 130.5 42.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.784 -1.197 . . . . 0.0 109.597 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.05 8.17 42.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.595 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 46.9 t -144.29 103.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.079 -1.248 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -57.16 145.1 32.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.206 1.003 . . . . 0.0 110.049 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.69 -170.77 3.53 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -145.0 149.13 34.6 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.738 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.421 ' SG ' ' N ' ' A' ' 71' ' ' ASN . 43.6 t -150.29 170.43 19.02 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 1.5 p-10 -120.52 145.86 46.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.959 -1.088 . . . . 0.0 110.311 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 73' ' ' ALA . 15.5 mt -93.82 146.9 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.545 -0.722 . . . . 0.0 109.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.701 ' HB1' ' HE ' ' A' ' 56' ' ' ARG . . . -40.56 -36.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.725 . . . . 0.0 109.833 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 38.2 t0 -57.83 6.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 109.437 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.642 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 73.86 26.16 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.25 162.17 13.13 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.204 -1.174 . . . . 0.0 109.621 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' THR . 29.3 tt0 -132.45 124.25 28.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.66 166.11 23.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.957 -1.089 . . . . 0.0 110.727 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -148.42 141.35 24.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.422 -0.799 . . . . 0.0 109.912 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.64 -118.0 0.71 Allowed Glycine 0 N--CA 1.475 1.281 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.551 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.61 159.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -1.176 . . . . 0.0 110.499 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.58 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 2.3 m95 -103.1 144.62 31.06 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.39 157.68 44.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -89.6 127.89 35.96 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.166 -1.584 . . . . 0.0 108.255 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.622 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -125.83 122.03 34.98 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.79 -107.7 1.0 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -125.28 33.3 5.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -1.133 . . . . 0.0 110.065 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 1.3 mptt -141.53 159.44 42.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.879 -1.138 . . . . 0.0 109.924 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.27 108.87 21.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -76.8 164.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.012 -1.055 . . . . 0.0 110.305 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.77 96.27 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.629 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -89.65 105.59 17.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.142 -1.21 . . . . 0.0 108.897 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.407 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.1 m-30 -118.08 125.36 50.15 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.821 0.82 . . . . 0.0 109.999 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -108.89 118.35 36.56 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.533 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 63.9 mtp180 -46.42 114.89 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.19 -10.35 59.64 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.533 1.159 . . . . 0.0 109.125 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.88 -26.15 19.49 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.61 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.16 2.1 3.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 52.76 45.71 60.44 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' A' ' 95' ' ' ARG . 15.7 t-20 -89.39 -122.07 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.367 -1.078 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -175.45 138.89 0.42 Allowed 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.948 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.734 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.0 tt -144.02 120.34 10.91 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.53 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -107.48 107.79 18.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.789 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -121.55 175.92 5.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.992 . . . . 0.0 111.559 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 106' ' ' ARG . 33.3 t -148.19 159.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 115' ' ' GLN . 9.8 ttm180 -134.63 136.97 43.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -145.71 159.12 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 109.08 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.695 ' CG2' ' CE2' ' A' ' 2' ' ' PHE . 0.8 OUTLIER -120.4 83.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.683 ' O ' ' N ' ' A' ' 111' ' ' ASP . 44.4 mt -64.23 91.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.26 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.89 -80.52 0.0 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 109' ' ' ILE . 2.2 p30 -119.6 30.11 7.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -1.203 . . . . 0.0 111.052 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 129' ' ' LYS . 2.6 mt-10 -145.07 132.75 20.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.859 -1.151 . . . . 0.0 109.475 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.668 HD11 ' N ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER -98.12 113.93 25.97 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 109' ' ' ILE . 2.1 t -108.26 113.82 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.617 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.582 HE21 ' HE2' ' A' ' 117' ' ' TYR . 37.9 tt0 -110.29 105.29 14.27 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.502 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -99.59 146.35 26.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.116 -0.99 . . . . 0.0 110.006 -178.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.734 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -131.17 145.64 52.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.873 0.844 . . . . 0.0 109.737 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.7 t -111.86 148.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.518 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.6 t80 -147.23 112.09 5.39 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.032 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 51.5 16.35 0.43 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.875 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.79 28.24 3.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.759 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.97 176.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 pt-20 -155.57 113.46 3.37 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.008 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -105.75 156.84 17.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -134.06 136.08 43.73 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.012 -1.055 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.692 HH12 ' CD2' ' A' ' 36' ' ' LEU . 4.2 mmm180 -125.32 116.2 21.55 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 7.0 mt -110.64 124.17 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.537 ' CE2' HD13 ' A' ' 38' ' ' LEU . 8.9 m-30 -98.99 176.38 5.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.146 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 3.8 tppt? -155.66 150.16 26.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.528 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 12.3 tttt -46.94 135.46 9.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.456 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.808 ' CZ ' ' CD2' ' A' ' 6' ' ' TRP . 1.4 t80 38.6 31.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.779 . . . . 0.0 109.227 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.6 m-20 -71.45 95.96 1.44 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.548 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.1 m 161.63 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.617 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.3 m -103.63 140.76 37.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.808 ' CD2' ' CZ ' ' A' ' 2' ' ' PHE . 5.3 m95 -148.04 168.88 21.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 8' ' ' VAL . 6.5 pttp -153.36 132.71 12.8 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.662 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.56 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -0.893 . . . . 0.0 109.628 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 17.7 t0 -94.73 -28.4 15.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -148.39 171.84 15.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.716 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 t -171.86 178.34 3.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.19 151.21 30.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.796 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.55 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 21.9 t-20 58.66 -108.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.0 109.842 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.593 ' CD2' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER 75.55 -54.13 0.64 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.0 110.017 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.92 -45.99 91.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.034 -1.041 . . . . 0.0 109.099 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.56 -30.72 71.09 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.866 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 15.1 t80 -72.19 -57.07 4.54 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.193 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.568 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 2.5 mpp? -59.14 -28.61 66.71 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.85 -27.71 55.18 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.149 -0.97 . . . . 0.0 109.254 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -71.54 -42.59 67.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.238 -0.913 . . . . 0.0 109.414 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.662 ' SD ' ' CE2' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -68.76 -5.41 20.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.043 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.11 25.14 56.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 24' ' ' ASN . 60.9 t -67.33 116.93 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.159 . . . . 0.0 109.461 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 23' ' ' VAL . 2.5 m-20 -41.79 155.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -67.48 -2.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 0.0 109.084 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.59 -60.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.95 -30.72 69.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -50.19 61.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -56.1 -34.17 65.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.57 -13.22 46.43 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.967 0.889 . . . . 0.0 109.759 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -84.64 -37.97 20.41 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.256 0.551 . . . . 0.0 109.603 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' ASP . . . -44.66 -14.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.305 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.4 m-70 -70.44 46.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.178 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -54.47 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.463 -0.773 . . . . 0.0 109.878 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' HIS . 31.6 t-20 -148.22 42.38 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.275 -0.89 . . . . 0.0 109.12 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.662 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -84.31 159.09 20.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 52' ' ' SER . 11.4 ttpt -119.49 145.83 45.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.6 pt? -154.5 142.48 20.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.975 -1.078 . . . . 0.0 110.346 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.464 ' C ' HD12 ' A' ' 40' ' ' ILE . 6.4 m -108.17 124.92 51.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.822 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.5 mp -109.95 124.98 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 110.81 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 151.62 36.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.3 148.77 48.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.994 -1.066 . . . . 0.0 110.071 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -148.46 79.09 1.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.36 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.17 -89.93 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.45 28.42 7.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -1.096 . . . . 0.0 109.71 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -144.51 110.54 5.43 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.473 ' O ' HG23 ' A' ' 61' ' ' VAL . 1.3 p90 -111.46 173.68 6.23 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.395 0.617 . . . . 0.0 109.686 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.7 m -150.81 103.09 3.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.699 HG12 ' OE2' ' A' ' 51' ' ' GLU . 17.7 t -90.93 108.49 19.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.623 -0.673 . . . . 0.0 109.563 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -99.42 100.2 11.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.699 ' OE2' HG12 ' A' ' 49' ' ' VAL . 3.6 mp0 -78.01 159.73 28.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 37' ' ' LYS . 1.7 m -159.96 106.65 1.62 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.669 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 55' ' ' PHE . 1.8 p -127.25 144.31 51.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.88 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 109.588 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' SER . 9.4 t80 -123.43 -11.74 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 111.641 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.1 mmt180 164.72 84.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.459 -1.401 . . . . 0.0 109.883 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -63.9 147.46 51.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.463 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -138.19 174.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 110.072 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.6 135.41 11.74 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.55 109.15 4.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -105.22 153.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.9 OUTLIER 175.95 -179.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.142 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 66' ' ' VAL . 42.1 tt0 -117.53 137.23 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.93 142.04 57.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.16 -34.33 5.48 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 66' ' ' VAL . 6.2 p -102.63 125.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.244 . . . . 0.0 109.974 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.62 142.99 51.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.91 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CZ ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -148.72 -171.62 3.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.518 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.544 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 10.9 p30 -135.94 150.74 49.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.088 -1.007 . . . . 0.0 110.345 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 60.5 m -155.79 135.88 12.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.548 ' OD1' HG21 ' A' ' 58' ' ' ILE . 2.2 p30 -95.21 144.56 25.71 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.916 -1.115 . . . . 0.0 110.607 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.6 mt -90.87 146.9 23.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.59 -0.694 . . . . 0.0 109.222 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.76 -35.17 1.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.755 . . . . 0.0 109.723 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.0 4.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.81 26.43 62.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.0 162.19 13.14 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.303 -1.116 . . . . 0.0 109.517 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.82 121.13 22.5 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -135.02 162.9 31.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.88 -1.137 . . . . 0.0 110.51 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.59 143.2 31.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 109.894 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.738 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.35 -116.62 0.62 Allowed Glycine 0 N--CA 1.477 1.368 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.547 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 171.37 158.42 0.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 0.0 110.813 179.259 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.6 141.48 34.4 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -139.53 157.17 46.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.935 . . . . 0.0 108.527 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -94.53 126.48 39.84 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.35 -1.469 . . . . 0.0 108.187 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.602 ' N ' HD12 ' A' ' 84' ' ' LEU . 14.1 mm-40 -129.37 120.62 25.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 -108.26 2.05 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -125.37 34.28 4.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -1.156 . . . . 0.0 110.549 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 161.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.6 -1.313 . . . . 0.0 110.412 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 mt -100.98 108.01 19.63 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -75.52 164.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.436 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.672 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.89 94.63 0.16 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.691 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 5.6 mtmm -88.5 102.97 15.44 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.115 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 3.7 m-30 -116.15 129.89 56.54 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.802 0.811 . . . . 0.0 109.792 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -113.06 118.2 34.13 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.493 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 42.7 mtp180 -51.07 114.99 1.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.75 -11.68 56.79 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.485 1.136 . . . . 0.0 109.086 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.22 -23.44 21.26 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -132.1 -0.87 3.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.226 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 54.58 43.48 78.47 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.597 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 16.6 t-20 -92.26 -122.85 0.08 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -1.162 . . . . 0.0 109.244 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 4.3 pt-20 -174.91 138.39 0.46 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -136.0 111.29 9.06 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.406 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.3 t30 -104.69 108.19 19.52 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.7 t -122.28 176.14 6.02 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.148 0.975 . . . . 0.0 112.099 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.41 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.7 t -145.81 147.4 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -123.64 132.88 53.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 110.198 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -131.55 158.6 40.51 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -124.49 82.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.13 -0.981 . . . . 0.0 108.43 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 111' ' ' ASP . 27.7 mt -64.33 91.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.929 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.78 -81.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -125.17 29.56 6.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -1.2 . . . . 0.0 110.187 -179.324 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.68 138.33 40.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.172 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 7.0 tp -103.3 111.79 24.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.039 -1.038 . . . . 0.0 109.535 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.8 109.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.052 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -112.06 103.96 12.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.308 -0.87 . . . . 0.0 108.661 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.25 143.16 32.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.551 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.697 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -125.57 147.14 49.38 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.786 0.803 . . . . 0.0 109.35 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 122' ' ' VAL . 12.6 t -114.58 149.88 16.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.662 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 1.6 t80 -143.67 110.96 5.8 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.847 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 48.67 18.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.245 0.545 . . . . 0.0 110.944 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.49 28.43 3.51 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.803 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.71 176.11 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 9.9 pt-20 -156.47 123.87 5.4 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.539 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.866 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -119.84 152.74 36.83 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -131.62 140.08 49.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.769 -1.207 . . . . 0.0 111.279 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -133.12 114.16 13.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 2.6 mt -105.31 124.25 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.084 -1.01 . . . . 0.0 110.987 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -95.53 175.91 6.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.512 -0.742 . . . . 0.0 109.555 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -164.52 148.83 9.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.519 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 20.7 mtmm -47.72 134.34 12.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.49 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.776 ' N ' HD11 ' A' ' 113' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.264 0.554 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.765 ' HB3' ' NE1' ' A' ' 6' ' ' TRP . 1.4 m-85 -68.67 14.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 0.0 109.235 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 1' ' ' ALA . 23.1 t0 40.53 47.9 2.4 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.596 ' OG ' ' NE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -174.27 -152.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.146 -0.971 . . . . 0.0 110.398 -179.376 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.595 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 29.0 m -107.2 129.32 54.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.814 . . . . 0.0 110.199 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.765 ' NE1' ' HB3' ' A' ' 2' ' ' PHE . 43.4 m95 -142.44 167.84 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 10.3 pttp -152.72 138.73 18.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.84 -1.162 . . . . 0.0 110.741 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -38.64 107.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.52 -0.738 . . . . 0.0 109.965 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -97.06 -32.42 11.99 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.441 ' O ' ' OG ' ' A' ' 11' ' ' SER . 14.5 mtt-85 -150.45 178.27 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.646 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 73.8 m -171.41 177.99 3.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.272 -0.893 . . . . 0.0 109.412 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -150.12 149.23 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.033 . . . . 0.0 109.888 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 16' ' ' LYS . 48.2 t-20 63.52 -104.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.61 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.521 ' HD1' ' HB1' ' A' ' 124' ' ' ALA . 0.1 OUTLIER 69.14 -44.04 0.53 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 13' ' ' ASN . 54.5 m-20 -63.68 -47.76 79.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 108.751 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB2' HD21 ' A' ' 13' ' ' ASN . 24.7 mmtp -61.07 -37.26 82.05 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.908 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 68.4 t80 -69.3 -63.76 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -54.53 -24.94 22.89 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.042 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -79.36 -26.81 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -43.89 62.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 109.032 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.473 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -67.85 -6.13 20.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 108.961 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.1 31.93 53.97 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -77.66 158.42 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 109.514 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -75.0 175.64 7.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -84.68 -1.33 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.48 -59.88 2.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 121.451 0.643 . . . . 0.0 109.268 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 21.1 mttp -63.58 -27.3 69.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 108.669 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.2 -42.15 72.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.37 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -66.74 -34.59 78.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.1 mt -86.25 -13.09 47.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.582 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -77.74 -47.39 19.16 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.808 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.54 -64.96 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.94 . . . . 0.0 109.645 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.24 46.12 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.878 . . . . 0.0 109.357 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 15.0 t70 -89.47 160.53 16.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 109.769 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.643 ' HA ' HG13 ' A' ' 8' ' ' VAL . 4.4 m-20 -143.19 42.96 1.54 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.356 -0.84 . . . . 0.0 108.991 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -54.89 148.09 13.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.163 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.813 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -119.07 139.73 51.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -146.63 153.04 39.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.909 -1.119 . . . . 0.0 110.268 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -115.03 109.53 18.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.752 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -98.51 119.28 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 110.169 -179.01 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.34 151.67 36.52 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -135.47 139.97 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 45' ' ' ASN . 7.2 mt-10 -139.01 78.82 1.69 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.06 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 43' ' ' GLU . 6.0 p-10 -118.79 28.94 8.0 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.301 -1.117 . . . . 0.0 110.507 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -154.47 111.05 3.29 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.4 p90 -107.93 173.48 6.3 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.752 -0.592 . . . . 0.0 109.491 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -155.87 103.43 2.24 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.006 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.88 109.15 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.506 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -99.76 99.65 10.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.634 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . 26.5 mt-10 -72.89 156.81 38.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.033 -1.042 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.6 m -161.78 107.23 1.29 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.198 -0.939 . . . . 0.0 109.029 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.68 ' C ' ' H ' ' A' ' 55' ' ' PHE . 6.4 p -139.96 144.43 37.05 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.18 7.6 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.68 ' H ' ' C ' ' A' ' 53' ' ' SER . 38.1 m-85 -107.96 -23.57 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 111.049 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.2 mtp-105 160.49 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -62.78 145.24 55.36 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.712 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.18 174.56 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.406 -0.809 . . . . 0.0 109.825 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.2 pt-20 -154.19 143.1 21.06 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.8 108.71 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.656 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -107.32 151.57 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.238 -0.914 . . . . 0.0 109.799 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 1.8 m-85 176.32 -179.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.808 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 27.8 tt0 -107.39 167.71 9.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.574 -0.704 . . . . 0.0 109.175 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.542 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.5 mt -80.14 130.23 35.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.36 -30.18 10.31 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.628 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 57.6 t -84.09 110.88 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.248 . . . . 0.0 110.033 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -57.57 143.67 40.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -150.63 -171.6 3.97 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.566 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 12.2 p-10 -138.18 149.63 46.02 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.131 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 57.2 m -156.15 137.78 14.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -93.61 144.05 25.74 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.358 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 74' ' ' ASP . 48.2 mt -93.98 146.97 23.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.565 -0.709 . . . . 0.0 109.421 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.63 -28.47 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.582 -0.699 . . . . 0.0 109.745 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.9 17.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.75 26.34 66.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.474 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.02 161.92 13.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.287 -1.125 . . . . 0.0 109.565 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -132.85 119.98 20.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.17 161.95 33.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.882 -1.136 . . . . 0.0 110.684 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 19.9 ptt180 -143.16 141.91 31.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 110.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.95 -116.01 0.59 Allowed Glycine 0 N--CA 1.476 1.352 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 170.76 157.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -1.187 . . . . 0.0 110.603 179.308 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.615 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.1 m95 -102.25 144.07 31.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.636 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -144.54 155.98 43.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.057 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.71 119.19 26.68 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.312 -1.492 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -109.33 104.58 13.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.68 -101.34 0.51 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -124.77 33.45 5.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -1.174 . . . . 0.0 110.177 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -140.75 157.23 45.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.816 -1.177 . . . . 0.0 109.961 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -100.1 101.85 13.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -72.12 163.62 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 110.396 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.96 95.66 0.17 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.635 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 3.8 tttm -90.25 104.92 17.44 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.181 -1.188 . . . . 0.0 108.636 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 2.9 m-30 -117.79 125.06 49.89 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.845 0.831 . . . . 0.0 109.766 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HZ1' ' HE3' ' A' ' 92' ' ' LYS . 15.2 mttp -105.63 116.41 31.9 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 39.5 mtp180 -54.45 114.74 1.78 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.37 -13.08 61.38 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.529 1.157 . . . . 0.0 109.433 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.95 -47.08 15.57 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.67 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 99' ' ' GLY . 31.9 m-80 -132.61 7.83 4.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 110.074 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.16 42.18 8.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.672 ' O ' ' O ' ' A' ' 101' ' ' GLU . 4.7 m120 -78.05 12.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 0.0 109.513 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.3 mt-10 47.79 128.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.548 0.689 . . . . 0.0 111.003 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 117' ' ' TYR . 7.4 tt -129.23 120.77 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.671 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.5 OUTLIER -108.18 107.83 18.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.062 -179.457 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.9 t -122.91 176.41 6.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.208 -0.933 . . . . 0.0 111.137 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 106' ' ' ARG . 89.1 t -148.38 159.63 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.615 ' NH1' ' CH2' ' A' ' 82' ' ' TRP . 50.6 ttm-85 -131.3 136.87 48.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.725 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -139.39 158.55 43.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 109.298 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.644 ' CG2' ' CE2' ' A' ' 2' ' ' PHE . 1.2 mm -122.19 82.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.722 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.3 mm -68.38 91.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.374 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 41.43 -80.42 0.0 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.722 ' N ' ' O ' ' A' ' 109' ' ' ILE . 5.3 m-20 -118.18 29.5 7.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.252 . . . . 0.0 110.884 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -146.9 134.5 20.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.127 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.776 HD11 ' N ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -98.5 115.96 29.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 108.28 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.966 -1.084 . . . . 0.0 110.294 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -117.17 103.26 10.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 1.1 m -102.39 148.49 25.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 110.103 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.722 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -129.51 151.94 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.482 178.852 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 122' ' ' VAL . 8.2 t -118.71 148.08 21.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.42 110.77 5.54 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.96 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 47.86 19.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.025 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.38 28.46 3.53 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.741 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.3 176.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.533 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.9 mt-10 -155.67 119.57 4.5 Favored 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.123 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.908 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -111.64 148.9 32.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -125.57 138.52 53.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.926 -1.109 . . . . 0.0 110.829 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.44 ' CZ ' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mmt85 -128.17 127.17 42.45 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 mt -118.01 123.71 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.506 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -97.96 176.62 5.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.495 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 24.6 tttt -155.24 142.46 19.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.684 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 3.3 pttp -47.5 132.13 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 109.764 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 129' ' ' LYS . 19.6 m-20 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.762 ' N ' HD11 ' A' ' 113' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.791 ' CG ' ' CZ2' ' A' ' 6' ' ' TRP . 18.1 m-85 -58.42 9.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.701 ' H ' ' C ' ' A' ' 1' ' ' ALA . 1.5 p30 38.03 51.17 1.42 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m -169.38 -149.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.091 -1.005 . . . . 0.0 110.289 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.62 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 6.4 m -103.1 129.84 50.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.413 -0.804 . . . . 0.0 109.987 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.791 ' CZ2' ' CG ' ' A' ' 2' ' ' PHE . 56.3 m95 -148.21 167.61 24.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 108.865 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -152.76 139.53 18.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.699 -1.251 . . . . 0.0 110.62 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.663 HG11 HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -45.28 107.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -99.85 -29.79 12.4 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 mmt-85 -141.52 171.16 14.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.64 -0.662 . . . . 0.0 109.535 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.3 t -173.25 178.0 2.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.395 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -155.88 156.87 35.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.133 -0.979 . . . . 0.0 109.862 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.8 m-20 58.77 -109.56 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.605 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.504 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 73.77 -52.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.232 -0.918 . . . . 0.0 109.975 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.03 -49.15 78.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 108.919 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.38 -33.79 72.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.817 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 65.3 t80 -71.32 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.457 ' HE2' ' CE1' ' A' ' 14' ' ' TYR . 21.9 mmt -55.58 -22.37 21.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.91 -33.62 45.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.274 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' NZ ' ' HB ' ' A' ' 122' ' ' VAL . 14.6 mmtp -68.36 -42.05 79.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.611 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -66.82 -7.42 21.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.119 -0.988 . . . . 0.0 108.953 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.53 26.88 62.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 24' ' ' ASN . 41.3 t -66.34 122.27 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -1.075 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.1 m-20 -43.47 168.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -78.87 -1.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 122.141 0.972 . . . . 0.0 109.193 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.18 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -62.27 -31.0 71.52 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -69.6 -45.89 67.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 109.183 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -57.4 -37.22 72.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.267 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 30' ' ' LEU . 96.0 mt -86.5 -12.9 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.035 0.922 . . . . 0.0 109.677 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -70.86 -47.44 59.3 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.41 -21.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' ASN . 56.3 t-80 -69.07 36.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -51.59 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.6 ' HA ' HG13 ' A' ' 8' ' ' VAL . 1.1 m-20 -147.92 42.45 1.04 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.903 . . . . 0.0 109.048 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.663 HD23 HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -89.95 162.39 15.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 110.461 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -108.34 144.91 35.24 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -138.49 123.75 19.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 110.074 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 104.67 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.492 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.1 mp -97.59 127.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.928 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.9 151.88 49.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -130.35 143.27 50.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 45' ' ' ASN . 8.6 mt-10 -138.7 79.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.83 -82.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 43' ' ' GLU . 35.4 p30 -124.88 28.28 6.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -1.133 . . . . 0.0 110.204 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.84 109.9 4.34 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.608 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -97.51 172.81 7.5 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.753 -0.592 . . . . 0.0 109.728 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.0 m -154.27 104.28 2.59 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.384 -0.823 . . . . 0.0 108.832 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.54 116.5 42.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -109.92 100.54 9.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 109.628 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -77.64 157.53 30.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.066 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER -157.41 106.62 2.15 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 108.891 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.666 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.38 144.64 50.67 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.39 7.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.058 . . . . 0.0 109.642 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.666 ' H ' ' C ' ' A' ' 53' ' ' SER . 91.0 t80 -108.01 -23.83 11.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.0 111.046 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 161.2 88.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.975 -1.078 . . . . 0.0 109.009 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.403 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 16.7 p-10 -62.72 143.82 57.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.397 -0.814 . . . . 0.0 109.766 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.734 HG21 ' ND2' ' A' ' 71' ' ' ASN . 1.1 mt -134.24 173.76 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.413 -0.804 . . . . 0.0 110.203 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.3 pt-20 -157.38 142.95 17.35 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 60' ' ' CYS . 14.2 p -163.61 128.09 2.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.497 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -82.59 160.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.507 -0.746 . . . . 0.0 109.123 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.608 ' CE2' ' CB ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -156.36 133.18 10.35 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.475 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.496 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 18.4 tt0 -105.55 168.47 9.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.489 -0.757 . . . . 0.0 109.005 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.496 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 13.0 mt -88.84 122.5 32.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 0.0 110.081 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 30.13 27.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 81' ' ' THR . 23.5 t -144.18 102.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.275 . . . . 0.0 109.413 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 2.3 m -47.59 145.88 2.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.427 1.108 . . . . 0.0 109.876 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -165.93 -167.23 1.04 Allowed 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.507 ' N ' ' CG ' ' A' ' 68' ' ' PHE . 46.9 p-10 -147.84 157.59 43.61 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.875 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.5 t -150.34 137.59 19.53 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.734 ' ND2' HG21 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -98.08 149.49 22.44 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.001 -1.062 . . . . 0.0 110.184 -178.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 75' ' ' GLY . 27.7 mt -96.9 146.83 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.55 -0.719 . . . . 0.0 109.552 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.65 -34.67 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.628 -0.67 . . . . 0.0 109.719 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.76 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.2 -0.938 . . . . 0.0 109.28 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 74.3 25.15 71.45 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.1 tt0 -133.4 126.16 30.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -132.97 160.06 38.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.936 -1.103 . . . . 0.0 110.322 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -135.23 149.22 49.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.434 -0.791 . . . . 0.0 110.248 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.712 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.07 -111.12 0.46 Allowed Glycine 0 C--O 1.211 -1.289 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 167.57 154.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.984 -1.304 . . . . 0.0 110.604 178.11 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.486 ' NE1' ' CZ ' ' A' ' 93' ' ' PHE . 74.1 m95 -102.12 133.38 47.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.587 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.9 m -138.2 157.18 46.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.947 -1.096 . . . . 0.0 109.338 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -94.86 128.55 41.7 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.519 -1.363 . . . . 0.0 108.193 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.653 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.7 mm-40 -129.06 118.73 23.01 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.6 -107.12 1.48 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -125.3 34.34 4.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.48 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -148.3 150.18 33.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.723 -1.236 . . . . 0.0 110.45 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 106' ' ' ARG . 2.0 mt -92.2 115.69 28.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.587 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -87.04 163.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.143 -0.973 . . . . 0.0 110.489 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.595 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.43 94.34 0.16 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.712 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 47.7 mttt -87.14 102.14 14.17 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.182 -1.187 . . . . 0.0 108.473 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.2 m-30 -122.32 137.18 54.94 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.807 0.813 . . . . 0.0 110.346 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' ARG . 9.5 ptpt -127.75 126.07 41.11 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' GLY . 43.4 mtp180 -43.79 115.46 0.81 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.313 -0.867 . . . . 0.0 108.881 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.04 -5.42 17.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.401 1.096 . . . . 0.0 109.37 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.86 -48.61 8.6 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.307 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -132.43 9.11 4.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.462 -0.774 . . . . 0.0 109.614 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.59 47.05 30.09 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 6.4 m120 -72.17 11.17 0.61 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -1.224 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.2 mt-10 48.8 134.42 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.823 0.821 . . . . 0.0 111.349 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.4 tt -139.24 131.44 28.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.535 ' N ' HD23 ' A' ' 102' ' ' LEU . 3.1 m-20 -114.15 112.6 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.025 . . . . 0.0 109.233 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -125.26 174.59 8.01 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.111 -0.993 . . . . 0.0 111.159 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 106' ' ' ARG . 48.1 t -145.93 163.92 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.551 ' N ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -138.18 135.89 36.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.713 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -139.21 158.91 43.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.088 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.73 ' CG2' ' CE2' ' A' ' 2' ' ' PHE . 1.1 mt -123.15 82.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.649 ' O ' ' N ' ' A' ' 111' ' ' ASP . 20.9 mt -65.72 91.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.146 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.84 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 109' ' ' ILE . 30.6 m-20 -119.17 29.87 7.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -1.211 . . . . 0.0 110.666 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -140.98 134.12 29.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.046 -1.034 . . . . 0.0 109.566 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.762 HD11 ' N ' ' A' ' 1' ' ' ALA . 1.5 tt -98.3 110.0 22.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 108.344 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.21 118.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 110.345 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -120.06 104.97 10.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -104.49 146.16 29.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.124 -0.985 . . . . 0.0 110.264 -178.767 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.718 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -126.04 150.8 47.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.787 0.803 . . . . 0.0 109.184 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 122' ' ' VAL . 13.8 t -118.87 148.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.522 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.3 t80 -145.6 111.32 5.49 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.924 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 51.76 16.3 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.319 0.581 . . . . 0.0 110.949 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.06 28.04 3.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.797 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.39 176.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.509 ' N ' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -155.99 118.52 4.13 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.175 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -111.15 150.69 29.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -131.52 139.14 49.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.833 -1.167 . . . . 0.0 111.331 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.504 ' CZ ' ' OH ' ' A' ' 14' ' ' TYR . 22.9 mtp180 -133.64 115.02 14.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 2.6 mt -104.57 129.95 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.573 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.53 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.3 m-30 -98.69 177.46 5.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.513 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 16.8 tptm -152.94 143.91 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.692 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -47.26 133.68 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.185 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.463 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.769 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.846 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 41.71 31.96 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.853 . . . . 0.0 109.231 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 4' ' ' SER . 35.5 t0 -75.92 86.64 2.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 109.639 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 168.24 -159.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.38 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.551 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 88.9 m -94.42 145.39 24.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.846 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 20.6 m95 -151.79 167.54 27.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.9 ptmt -154.24 133.57 12.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.484 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.659 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -42.09 106.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -98.48 -27.82 13.88 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -142.71 169.62 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.912 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 26.1 t -172.39 178.14 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.838 . . . . 0.0 109.43 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -153.86 154.68 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.4 m-20 56.34 -109.71 0.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.475 -0.766 . . . . 0.0 109.61 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER 75.87 -54.21 0.62 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.315 -0.865 . . . . 0.0 109.723 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.64 -58.98 5.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.011 -1.055 . . . . 0.0 108.567 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -52.42 -35.55 52.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.358 -0.839 . . . . 0.0 108.913 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.837 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 30.6 t80 -68.46 -61.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.265 -0.897 . . . . 0.0 108.752 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.773 ' SD ' HG21 ' A' ' 23' ' ' VAL . 9.7 mmt -49.59 -33.94 16.47 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.641 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.15 -37.67 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.071 . . . . 0.0 109.447 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -62.81 -43.19 99.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.626 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.681 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 1.7 mtm -70.22 -3.17 15.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.211 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 32.5 61.99 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.773 HG21 ' SD ' ' A' ' 18' ' ' MET . 25.3 t -74.11 138.02 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 109.385 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 23' ' ' VAL . 31.8 m-20 -45.75 172.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.357 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.657 HD12 HH11 ' A' ' 28' ' ' ARG . 1.6 mm -83.77 -2.22 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.276 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -81.32 -60.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.841 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 2.4 mptm? -65.88 -20.14 66.12 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.657 HH11 HD12 ' A' ' 25' ' ' ILE . 3.2 tmm_? -75.44 -45.17 40.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.492 -0.755 . . . . 0.0 109.128 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.29 -36.34 74.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.571 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 mt -86.55 -13.23 46.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.753 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -60.98 -52.95 62.85 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.14 -32.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.459 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 33.7 m170 -74.57 42.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' ND2' ' A' ' 35' ' ' ASN . 1.2 p30 -63.21 112.12 2.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.552 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.0 m120 -147.57 42.88 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.31 -0.868 . . . . 0.0 109.242 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.659 HD23 HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -82.08 158.91 23.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' SER . 7.0 tttt -113.58 138.18 50.53 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.9 pt? -147.45 145.29 29.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.989 -1.069 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 m -110.2 125.23 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.2 mp -110.89 133.27 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.486 -179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.88 152.1 51.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.769 ' NE2' ' HB3' ' A' ' 1' ' ' ALA . 3.7 pt20 -138.08 141.14 40.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 45' ' ' ASN . 35.5 mt-10 -138.59 78.92 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.416 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.27 -82.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.37 29.32 7.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -1.095 . . . . 0.0 110.114 -178.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.53 110.73 4.85 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.47 166.78 10.2 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.433 HG23 HG13 ' A' ' 61' ' ' VAL . 25.3 m -153.72 103.2 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 108.615 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.94 114.37 41.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.579 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -106.65 100.02 9.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.582 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.79 155.64 26.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' LYS . 92.4 p -159.76 107.5 1.71 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.234 1.016 . . . . 0.0 109.077 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 m -118.67 -163.16 0.94 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.41 8.73 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.345 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 21.0 m-85 -125.35 -12.69 6.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 112.108 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER 165.59 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.233 -1.542 . . . . 0.0 110.026 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -62.95 145.48 55.21 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.391 -0.818 . . . . 0.0 109.217 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -131.13 174.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.348 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.572 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -151.11 130.17 12.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.7 m -133.22 110.41 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.389 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.594 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.08 142.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.221 -0.924 . . . . 0.0 108.992 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER 176.16 173.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.672 -1.211 . . . . 0.0 110.785 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.89 162.38 13.17 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 64' ' ' LEU . 2.1 pp -82.32 135.22 35.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.918 -1.113 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.79 20.33 13.24 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 65.7 t -143.87 106.25 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.34 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -49.81 144.44 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.113 0.959 . . . . 0.0 110.25 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.612 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -156.74 -171.8 3.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.432 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -127.19 152.37 47.45 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.054 -1.028 . . . . 0.0 110.347 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.9 t -153.96 129.1 9.65 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.35 149.53 23.7 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.112 -0.993 . . . . 0.0 110.239 -178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 73' ' ' ALA . 74.6 mt -100.73 146.85 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.325 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.28 -33.75 1.04 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.797 . . . . 0.0 109.86 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 14.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 67.56 28.64 73.58 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.456 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -99.41 162.12 13.22 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -132.36 118.75 19.79 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -132.59 162.89 30.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 0.0 110.495 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -143.63 141.17 30.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.807 . . . . 0.0 109.831 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.817 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.91 -117.39 0.64 Allowed Glycine 0 N--CA 1.476 1.351 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.2 159.24 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.025 -1.279 . . . . 0.0 110.898 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CZ ' ' A' ' 93' ' ' PHE . 15.3 m95 -101.91 142.58 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.594 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.9 m -140.68 157.6 45.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -92.79 127.17 38.2 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.306 -1.496 . . . . 0.0 108.194 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.606 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -122.93 121.61 36.56 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.57 -105.55 0.37 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 2.1 p-10 -125.13 33.62 5.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.016 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -140.36 159.17 42.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.02 -1.05 . . . . 0.0 110.095 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.44 108.97 21.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -78.63 164.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.101 -1.0 . . . . 0.0 110.64 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.605 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.33 95.24 0.17 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.664 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.7 pttp -88.9 104.08 16.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.166 -1.197 . . . . 0.0 109.034 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.6 m-30 -116.92 131.96 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.37 119.38 36.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 69.1 mtp180 -52.71 115.14 1.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.336 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -11.95 57.03 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.387 1.089 . . . . 0.0 109.219 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.62 -26.94 24.13 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.832 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -132.18 -0.18 3.72 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 57.21 45.09 93.0 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.582 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 20.2 t-20 -91.76 -122.62 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.274 -1.133 . . . . 0.0 109.227 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.7 pt-20 -175.54 137.3 0.36 Allowed 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.138 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 117' ' ' TYR . 55.2 tp -134.25 108.98 8.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.616 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.9 OUTLIER -101.32 105.68 16.77 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.4 t -121.09 176.13 5.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 112.017 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.408 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.6 t -148.2 154.26 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.512 ' HE ' HD21 ' A' ' 113' ' ' LEU . 55.0 mtp180 -127.01 131.45 51.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 109.987 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -129.31 159.18 36.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.425 -0.797 . . . . 0.0 109.032 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.8 82.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 109' ' ' ILE . 15.5 mt -63.53 91.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.798 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.0 -81.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.3 m-20 -125.6 29.31 6.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -137.37 147.19 45.32 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 108.735 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.578 HD23 ' CD2' ' A' ' 128' ' ' PHE . 10.5 tp -107.72 110.52 22.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.499 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.404 HG13 ' CG1' ' A' ' 127' ' ' ILE . 2.5 t -90.59 115.68 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.439 -0.788 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -114.04 103.26 10.97 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.05 145.28 29.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.726 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -127.33 149.91 49.83 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.471 178.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 122' ' ' VAL . 6.9 t -117.1 150.23 19.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.582 ' CE1' ' OD1' ' A' ' 100' ' ' ASN . 1.1 t80 -142.56 110.06 5.73 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.754 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 45.57 20.44 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 119' ' ' TYR . . . 112.91 28.63 3.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.761 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.58 176.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.541 ' N ' HG13 ' A' ' 122' ' ' VAL . 2.7 tt0 -155.98 125.82 6.45 Favored 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 118.045 -1.462 . . . . 0.0 111.406 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -122.77 151.19 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 11' ' ' SER . 19.5 ttpt -130.03 140.21 50.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.916 -1.115 . . . . 0.0 111.112 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.463 ' CZ ' ' OH ' ' A' ' 117' ' ' TYR . 11.0 ttm180 -137.41 114.11 10.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.404 ' CG1' HG13 ' A' ' 114' ' ' VAL . 2.2 mp -105.99 131.41 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 0.0 111.132 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 38' ' ' LEU . 3.0 m-30 -100.9 176.05 5.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -165.16 157.08 15.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.804 . . . . 0.0 109.245 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -47.27 130.16 12.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.397 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.848 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.2 OUTLIER 42.32 33.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.323 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 4' ' ' SER . 2.8 p30 -76.82 93.56 3.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.601 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.655 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.1 t 162.47 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.655 ' N ' ' OG ' ' A' ' 4' ' ' SER . 90.6 m -89.96 145.51 25.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.848 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 12.2 m95 -151.41 168.26 25.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 109.542 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.4 pttp -153.15 133.53 13.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.965 . . . . 0.0 109.445 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.577 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -38.15 106.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.269 -0.894 . . . . 0.0 109.622 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -93.59 -28.25 16.14 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -152.73 173.14 15.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.882 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -172.98 178.22 2.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 0.0 109.145 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 3.1 pt-20 -157.06 154.55 29.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.067 -1.02 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.3 m-20 56.5 -109.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 109.826 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.5 -53.47 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.356 -0.84 . . . . 0.0 109.701 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -48.67 80.77 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.994 -1.066 . . . . 0.0 108.76 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -60.2 -33.26 71.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 49.1 t80 -72.0 -62.85 1.28 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.567 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 25.9 mmt -56.48 -23.57 40.15 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.345 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.95 -37.59 54.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.057 -1.027 . . . . 0.0 109.243 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -64.66 -39.93 94.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.195 -0.941 . . . . 0.0 109.21 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.6 mtp -65.12 -9.61 24.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.118 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.91 29.93 27.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 24' ' ' ASN . 19.5 t -79.78 126.3 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -1.144 . . . . 0.0 109.441 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 23' ' ' VAL . 9.0 m120 -42.4 165.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.13 -1.99 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.158 0.98 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -80.26 -59.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.678 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -65.06 -22.56 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -73.15 -44.49 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -70.77 -33.05 70.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.49 -13.21 46.7 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.007 0.908 . . . . 0.0 109.752 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -78.63 -45.64 21.08 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.608 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.06 -22.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 31' ' ' ALA . 31.6 m170 -69.28 37.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.302 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 32' ' ' ALA . 2.4 m-20 -51.05 95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.557 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' HIS . 12.0 m120 -147.66 42.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.307 -0.871 . . . . 0.0 109.206 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -97.69 170.74 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -179.084 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -108.65 142.19 39.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.746 -0.596 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 36' ' ' LEU . 1.9 mp -139.12 128.26 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -102.81 117.08 33.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.2 mp -103.95 122.86 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.622 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.43 151.8 37.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.58 145.08 50.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -139.49 78.95 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.6 -81.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 43' ' ' GLU . 19.8 m120 -122.37 28.85 7.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -1.127 . . . . 0.0 110.253 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -153.57 110.12 3.37 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -94.19 173.91 7.41 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.791 -0.568 . . . . 0.0 109.485 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.5 m -155.81 103.49 2.26 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.152 -0.967 . . . . 0.0 108.99 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.6 t -98.19 113.14 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.66 -0.65 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -99.97 100.45 11.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.2 tt0 -72.81 155.88 39.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.173 -0.954 . . . . 0.0 108.818 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.0 m -160.48 107.04 1.52 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.168 -0.958 . . . . 0.0 109.021 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.689 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -137.0 144.25 43.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.64 7.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.024 -1.048 . . . . 0.0 109.069 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.689 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.3 m-85 -112.41 -31.18 6.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.27 -0.894 . . . . 0.0 111.476 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.0 tpp85 177.84 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.655 -1.278 . . . . 0.0 109.378 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -63.18 140.29 58.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.094 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -139.17 174.41 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.601 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.2 pt-20 -152.0 141.64 21.79 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -151.46 132.21 14.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.17 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.301 -0.874 . . . . 0.0 108.847 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.34 167.35 21.19 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.115 -0.991 . . . . 0.0 109.947 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 26.5 tt0 -159.95 168.06 26.56 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.527 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 31.2 mt -98.59 122.23 41.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.25 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 24.47 47.37 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.501 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.62 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 89.5 t -144.18 102.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.275 . . . . 0.0 109.416 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.746 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.29 141.29 54.77 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.169 0.985 . . . . 0.0 110.062 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.62 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.06 -171.29 3.79 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.451 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -142.41 151.16 41.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.836 -1.146 . . . . 0.0 110.799 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.707 ' O ' HD22 ' A' ' 78' ' ' LEU . 49.5 t -144.83 170.69 15.64 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 76' ' ' THR . 1.5 p-10 -126.12 141.26 52.02 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.864 -1.147 . . . . 0.0 110.396 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.9 mt -93.12 146.85 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.542 -0.724 . . . . 0.0 109.371 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.09 -28.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.837 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.567 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 47.5 m-20 -67.68 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.28 27.78 68.16 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.523 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.03 162.02 13.24 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.424 -1.045 . . . . 0.0 109.399 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.946 ' C ' HD13 ' A' ' 78' ' ' LEU . 69.4 tt0 -132.86 116.29 16.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.021 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -119.66 150.93 39.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.011 . . . . 0.0 110.404 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.87 140.59 42.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.877 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.746 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.92 -117.24 0.63 Allowed Glycine 0 N--CA 1.477 1.378 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.536 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.8 159.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -1.181 . . . . 0.0 110.54 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.0 m95 -101.77 142.84 32.48 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.597 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.0 m -138.35 157.23 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -96.18 127.35 42.1 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.352 -1.468 . . . . 0.0 108.205 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.63 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.2 mm-40 -127.32 114.74 17.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.21 -106.45 1.33 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -125.17 34.31 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -1.131 . . . . 0.0 110.427 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.57 150.67 37.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 110.314 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.55 109.99 21.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.597 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -80.12 164.58 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.119 -0.988 . . . . 0.0 110.538 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.659 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.69 95.84 0.17 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.673 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 14.0 ptmt -86.41 107.04 17.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.27 -1.135 . . . . 0.0 108.678 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -117.07 140.35 49.6 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.84 0.828 . . . . 0.0 110.234 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -125.48 113.27 17.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.47 0.652 . . . . 0.0 109.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 99' ' ' GLY . 30.9 mtp180 -51.51 114.82 1.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.408 ' H ' ' HG1' ' A' ' 96' ' ' THR . 0.6 OUTLIER -69.87 -13.76 62.41 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.355 1.074 . . . . 0.0 109.628 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.48 -48.35 15.52 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.786 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' GLY . 34.4 m120 -132.54 10.68 4.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.151 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 44.46 39.36 5.7 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.716 ' O ' ' O ' ' A' ' 101' ' ' GLU . 34.2 m-20 -75.17 18.95 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.168 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.716 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.0 pt-20 43.7 161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.929 . . . . 0.0 111.239 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.3 tt -161.23 123.83 3.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.7 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -112.18 113.92 26.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 109.143 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -124.69 176.11 6.78 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.186 -0.946 . . . . 0.0 110.948 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.9 t -149.59 154.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -127.05 136.5 52.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.67 158.63 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -121.29 82.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 121.117 -0.989 . . . . 0.0 108.38 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 109' ' ' ILE . 24.2 mt -63.54 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.765 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.47 -81.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -129.21 29.17 5.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -1.187 . . . . 0.0 110.206 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.36 142.54 48.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 108.75 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.475 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 12.2 tp -103.28 110.34 22.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.932 -1.105 . . . . 0.0 109.266 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.511 HG22 HG23 ' A' ' 127' ' ' ILE . 18.1 t -95.83 110.15 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -108.45 106.86 17.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -100.92 144.6 29.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.166 -0.959 . . . . 0.0 109.792 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.3 OUTLIER -123.27 152.59 41.21 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.816 0.817 . . . . 0.0 109.161 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.2 t -121.93 147.76 25.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.539 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -144.5 110.67 5.48 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.973 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 48.59 18.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.26 0.552 . . . . 0.0 111.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.34 28.33 3.58 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.71 176.91 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.39 124.58 6.24 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.303 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.849 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.14 154.38 30.11 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.501 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 5.5 ttmt -131.99 139.72 48.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 111.175 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -135.58 113.93 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.511 HG23 HG22 ' A' ' 114' ' ' VAL . 5.4 mt -109.16 123.83 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.084 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.523 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -98.83 176.01 5.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 130' ' ' LYS . 3.0 tttp -163.78 161.65 23.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.403 ' H ' ' HG2' ' A' ' 129' ' ' LYS . 10.7 ptpt -47.61 132.3 14.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.498 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.74 ' O ' ' C ' ' A' ' 3' ' ' ASP . 11.7 m-85 -79.09 25.8 0.28 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.959 . . . . 0.0 109.718 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.74 ' C ' ' O ' ' A' ' 2' ' ' PHE . 11.1 t70 -13.55 83.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.706 ' N ' ' O ' ' A' ' 2' ' ' PHE . 28.8 t 167.5 -136.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.575 ' N ' ' OG ' ' A' ' 4' ' ' SER . 18.2 m -89.3 131.14 35.54 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.952 0.882 . . . . 0.0 111.946 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.855 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 9.6 m95 -123.41 170.62 10.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.488 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 13.9 pttp -144.57 122.43 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 110.123 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.606 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -42.35 107.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -94.69 -30.33 14.35 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -150.27 165.2 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.727 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 11.8 t -168.47 178.32 4.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.367 -0.833 . . . . 0.0 109.267 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -155.29 156.21 35.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.57 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 16.2 m-20 59.68 -109.04 0.41 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.924 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.544 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 73.07 -52.25 0.71 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.37 -43.61 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.956 -1.09 . . . . 0.0 109.019 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -67.55 -31.56 71.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.9 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 76.5 t80 -73.43 -57.0 4.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.606 ' C ' HH22 ' A' ' 28' ' ' ARG . 16.1 mmt -60.33 -29.16 68.7 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.572 ' N ' HH22 ' A' ' 28' ' ' ARG . 16.5 tp10 -77.12 -27.97 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.241 -0.912 . . . . 0.0 109.633 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -73.57 -37.66 65.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.484 ' HB2' HG23 ' A' ' 23' ' ' VAL . 2.1 mtm -69.16 -8.35 44.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.142 -0.973 . . . . 0.0 108.932 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.26 29.47 37.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 23.7 t -77.18 127.17 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -1.208 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 0.7 OUTLIER -42.61 164.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.917 HD13 ' HE ' ' A' ' 28' ' ' ARG . 1.3 mm -80.04 -1.33 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.18 0.99 . . . . 0.0 109.178 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 t -81.36 -59.85 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -63.85 -28.84 70.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.917 ' HE ' HD13 ' A' ' 25' ' ' ILE . 9.9 ttm-85 -70.64 -43.85 68.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.369 -0.832 . . . . 0.0 109.249 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.06 -33.02 74.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.414 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 -13.63 44.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.12 -36.13 19.77 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.654 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . -44.6 -15.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.592 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 35' ' ' ASN . 14.1 m80 -80.24 46.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.586 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -44.81 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 33' ' ' HIS . 62.6 t-20 -147.67 42.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.401 -0.812 . . . . 0.0 109.142 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.606 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -97.55 175.75 6.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.81 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.52 152.54 37.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 38' ' ' LEU . 3.3 mp -139.83 128.94 23.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 4' ' ' SER . 0.3 OUTLIER -97.86 104.15 16.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.855 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -105.65 126.43 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -132.71 152.07 51.81 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -135.35 142.81 45.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.913 -1.117 . . . . 0.0 110.05 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' ASN . 24.2 mm-40 -140.23 78.92 1.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.73 -86.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -117.58 29.19 8.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -146.1 110.77 5.17 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.41 166.56 10.67 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.425 HG23 HG13 ' A' ' 61' ' ' VAL . 26.1 m -154.16 103.25 2.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 108.652 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.62 HG22 HG23 ' A' ' 40' ' ' ILE . 87.5 t -104.41 141.36 20.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -135.34 100.15 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.55 157.21 37.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 108.71 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -156.56 107.06 2.36 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.075 -1.016 . . . . 0.0 109.174 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.682 ' C ' ' H ' ' A' ' 55' ' ' PHE . 2.2 p -137.67 144.64 41.92 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.42 7.51 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.995 -1.065 . . . . 0.0 109.266 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.682 ' H ' ' C ' ' A' ' 53' ' ' SER . 88.4 t80 -104.63 -26.8 12.18 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 110.85 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 160.08 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 109.027 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -62.35 145.31 54.21 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.442 -0.787 . . . . 0.0 109.449 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -133.76 173.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.214 -0.929 . . . . 0.0 110.186 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.567 ' H ' HG22 ' A' ' 58' ' ' ILE . 8.5 pt-20 -149.8 147.71 28.32 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.46 0.647 . . . . 0.0 109.711 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.13 110.33 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.833 . . . . 0.0 109.242 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.592 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -109.82 143.63 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.217 -0.927 . . . . 0.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 176.29 169.84 0.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.854 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -94.56 151.13 19.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 64' ' ' LEU . 1.3 pp -76.97 133.08 39.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.924 -1.11 . . . . 0.0 109.272 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.0 21.1 11.36 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.591 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 27.9 t -143.35 106.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -1.151 . . . . 0.0 109.31 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -46.36 145.68 1.65 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.153 0.978 . . . . 0.0 110.17 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -160.45 -171.6 3.22 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.542 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 2.0 m120 -123.26 153.45 40.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 110.149 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 93.2 m -157.79 129.29 6.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -90.68 147.92 22.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.072 -1.017 . . . . 0.0 110.259 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 52.5 mt -99.44 146.89 25.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.29 -31.68 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.838 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 21.6 t70 -65.71 15.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 109.329 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 64.94 27.16 71.84 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 162.05 13.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.312 -1.111 . . . . 0.0 109.533 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -132.47 119.71 20.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -135.8 163.85 29.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 0.0 110.448 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -142.05 140.14 32.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.74 . . . . 0.0 109.934 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.843 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.72 -117.78 0.64 Allowed Glycine 0 C--O 1.21 -1.358 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.31 157.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.107 -1.231 . . . . 0.0 110.58 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.577 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.36 142.13 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.585 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.12 157.32 45.45 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -93.21 126.63 38.42 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.306 -1.496 . . . . 0.0 108.407 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.6 ' N ' HD12 ' A' ' 84' ' ' LEU . 3.7 mm-40 -123.8 113.49 18.62 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.31 -105.25 0.99 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 87' ' ' ASN . 17.5 t-20 -125.17 34.17 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -1.128 . . . . 0.0 110.372 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.426 ' CE ' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -144.79 150.8 37.8 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.739 -1.226 . . . . 0.0 110.316 -179.701 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mt -94.77 108.77 20.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.585 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -79.4 164.0 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.099 -1.0 . . . . 0.0 110.698 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.28 95.59 0.17 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.623 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.45 108.91 19.92 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.205 -1.174 . . . . 0.0 109.016 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.518 ' HB2' HD22 ' A' ' 102' ' ' LEU . 3.0 m-30 -118.4 135.83 54.12 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.748 0.785 . . . . 0.0 109.986 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -118.01 115.25 24.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.314 0.578 . . . . 0.0 109.506 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 33.7 mtm180 -49.04 115.12 1.17 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -10.69 60.05 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.417 1.103 . . . . 0.0 109.357 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.0 -41.45 12.35 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.698 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.47 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -132.66 7.43 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.28 34.72 1.63 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.69 ' O ' ' O ' ' A' ' 101' ' ' GLU . 19.1 t-20 -74.96 18.66 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.159 -1.201 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.69 ' O ' ' O ' ' A' ' 100' ' ' ASN . 9.3 pt-20 44.5 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.012 0.91 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 93' ' ' PHE . 7.0 tt -158.5 130.63 6.82 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -117.97 118.61 32.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.96 -1.088 . . . . 0.0 109.173 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.5 t -130.47 176.46 8.13 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.12 -0.988 . . . . 0.0 110.752 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 106' ' ' ARG . 42.4 t -146.76 158.86 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.463 ' N ' HG12 ' A' ' 105' ' ' VAL . 10.9 ttp180 -131.65 135.23 46.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.79 158.64 43.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 108.92 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.53 83.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.72 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.7 mm -60.27 92.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.514 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 47.2 -74.86 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.72 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -125.73 30.02 5.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -1.202 . . . . 0.0 110.907 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -146.12 147.52 31.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.738 -1.227 . . . . 0.0 109.679 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 6.5 tp -102.49 115.24 30.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.049 -1.032 . . . . 0.0 108.855 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.6 t -102.7 108.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -109.55 106.1 15.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.8 OUTLIER -103.03 145.95 29.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -124.95 158.76 32.81 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.908 0.861 . . . . 0.0 109.486 178.738 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 122' ' ' VAL . 10.5 t -127.46 148.46 32.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.66 110.29 5.3 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.684 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 47.37 19.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.164 0.507 . . . . 0.0 111.104 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.73 28.25 3.51 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.745 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.5 176.51 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 15.1 pt-20 -156.38 126.02 6.29 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.648 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.9 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.92 150.19 38.9 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -126.23 139.37 53.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.773 -1.204 . . . . 0.0 110.757 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.544 ' NH1' ' OH ' ' A' ' 14' ' ' TYR . 7.0 mtt180 -129.81 114.16 15.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.01 122.72 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.035 . . . . 0.0 110.352 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.585 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 2.6 m-30 -107.1 177.15 4.94 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.775 0.797 . . . . 0.0 110.409 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -152.91 164.88 37.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 131' ' ' ASP . 16.5 pttp -47.19 138.65 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.031 . . . . 0.0 109.459 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 130' ' ' LYS . 4.9 p-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.448 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 4' ' ' SER . 16.9 t70 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.684 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 165.2 -164.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 0.0 109.729 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.684 ' N ' ' OG ' ' A' ' 4' ' ' SER . 43.2 m -102.13 146.74 27.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.663 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.59 ' CD1' ' C ' ' A' ' 5' ' ' THR . 4.4 m95 -151.39 169.26 22.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 8' ' ' VAL . 18.1 pttp -152.58 128.41 10.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.097 -1.002 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.572 HG13 ' HA ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -37.45 107.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -97.69 -25.93 14.92 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.7 mtp180 -140.55 160.0 40.96 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.097 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.518 ' CB ' ' OD2' ' A' ' 34' ' ' ASP . 31.0 t -179.92 157.27 0.69 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' A' ' 125' ' ' LYS . 10.6 pt-20 -166.78 166.27 15.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.256 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.37 -6.77 0.59 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.547 -0.72 . . . . 0.0 109.738 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -47.94 -22.44 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.997 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.48 ' CA ' ' HE ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -71.99 -48.16 46.89 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.996 -1.065 . . . . 0.0 108.868 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -59.92 -36.68 77.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.956 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 49.6 t80 -68.23 -64.02 0.94 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.817 0.818 . . . . 0.0 108.93 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.0 mmt -56.52 -23.38 39.28 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.427 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.52 -23.97 34.32 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.057 -1.027 . . . . 0.0 109.118 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -74.45 -43.8 54.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -0.912 . . . . 0.0 108.995 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.592 ' SD ' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -58.76 -14.3 8.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.648 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.21 29.64 40.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 24' ' ' ASN . 2.1 t -79.33 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.391 -1.064 . . . . 0.0 109.444 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.3 m-80 -43.47 168.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.374 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -78.8 -2.32 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.38 -59.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.696 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -62.38 -24.19 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HE ' ' CA ' ' A' ' 15' ' ' ASP . 50.9 ttt180 -73.03 -47.28 46.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.508 -0.745 . . . . 0.0 109.208 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -68.96 -33.12 73.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 mt -86.52 -13.03 47.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.934 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -77.13 -52.62 8.97 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.165 0.507 . . . . 0.0 109.866 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.19 -28.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.692 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 31' ' ' ALA . 23.8 m170 -74.6 46.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' OD2' ' CB ' ' A' ' 11' ' ' SER . 6.1 p30 -66.38 115.12 5.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.572 ' HA ' HG13 ' A' ' 8' ' ' VAL . 10.4 m120 -147.74 43.21 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -89.06 165.02 14.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.469 ' C ' HD12 ' A' ' 38' ' ' LEU . 2.2 tttp -109.19 149.59 29.15 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -143.67 127.05 16.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.922 -1.111 . . . . 0.0 110.332 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 40' ' ' ILE . 3.0 m -103.14 111.41 23.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.787 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.7 mp -109.4 142.42 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 111.515 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -135.26 152.25 51.35 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.605 ' O ' ' NE2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -135.56 142.69 45.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 110.018 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 45' ' ' ASN . 4.9 mm-40 -142.15 78.86 1.64 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.49 -88.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -113.66 29.16 8.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -1.102 . . . . 0.0 109.997 -179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.9 110.5 5.57 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.415 ' CZ ' ' HG3' ' A' ' 42' ' ' GLN . 6.0 m-85 -104.32 162.3 13.33 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.468 HG23 HG13 ' A' ' 61' ' ' VAL . 30.8 m -153.96 102.99 2.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 p -107.16 129.5 60.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -119.11 100.17 7.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.819 . . . . 0.0 109.388 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.23 160.45 31.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 108.833 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -160.48 106.93 1.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.088 -1.008 . . . . 0.0 109.303 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.644 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -129.31 144.29 51.17 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.77 7.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.985 -1.072 . . . . 0.0 109.387 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.644 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.6 OUTLIER -115.22 -20.09 10.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 111.35 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 165.57 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.55 -1.344 . . . . 0.0 109.423 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -62.35 149.45 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.343 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -136.98 174.21 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 58' ' ' ILE . 6.5 pt-20 -154.21 146.29 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.8 m -151.07 110.7 4.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.835 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -108.47 141.27 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.41 172.49 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.777 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 44.8 tt0 -98.37 164.74 12.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 64' ' ' LEU . 2.7 pp -82.04 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.842 -1.162 . . . . 0.0 109.593 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -31.99 6.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.1 p -88.4 117.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -1.23 . . . . 0.0 109.911 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -55.98 145.14 26.17 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.013 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -153.53 -171.6 3.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.514 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -130.55 150.68 51.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.995 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.69 133.65 12.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -88.97 149.24 23.38 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 75' ' ' GLY . 52.5 mt -99.53 146.82 25.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.425 -0.797 . . . . 0.0 109.374 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.89 -32.97 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.714 . . . . 0.0 109.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.67 12.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.84 27.75 72.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.421 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -99.33 162.23 13.16 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.193 -1.18 . . . . 0.0 109.471 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.473 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.8 tt0 -132.33 118.59 19.61 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -135.22 162.9 31.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.679 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB3' HH21 ' A' ' 79' ' ' ARG . 6.0 ptm85 -142.26 142.91 32.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.764 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.06 -117.43 0.64 Allowed Glycine 0 N--CA 1.476 1.35 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.4 157.54 0.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.138 -1.213 . . . . 0.0 110.913 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.496 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 6.1 m95 -102.27 141.56 34.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.639 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.2 m -142.23 156.28 45.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.097 -1.002 . . . . 0.0 108.667 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 121.37 27.11 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.115 -1.616 . . . . 0.0 110.038 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.51 107.83 17.15 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.651 ' C ' HD22 ' A' ' 87' ' ' ASN . . . 62.17 -102.22 0.45 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.651 HD22 ' C ' ' A' ' 86' ' ' GLY . 1.7 m120 -124.84 33.52 5.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -1.14 . . . . 0.0 109.838 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 163.64 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.062 -1.024 . . . . 0.0 109.772 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mt -102.79 104.42 14.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 108.586 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.639 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -73.55 164.42 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.987 . . . . 0.0 110.247 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.6 94.69 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.662 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 35.4 mttm -88.63 105.21 17.51 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 108.835 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -116.22 136.77 52.72 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.886 0.85 . . . . 0.0 110.091 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -116.84 116.32 27.23 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.607 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.6 mtp180 -53.01 114.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.808 . . . . 0.0 108.847 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -70.32 -12.74 61.79 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.501 1.143 . . . . 0.0 109.377 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.67 -50.96 11.38 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -132.57 11.64 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.2 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.56 41.7 12.98 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.744 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.5 m-80 -78.04 19.78 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -1.199 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.744 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.9 pt-20 42.7 158.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.016 0.912 . . . . 0.0 111.212 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 103' ' ' ASN . 6.4 tt -157.39 127.12 6.12 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.745 ' N ' HD23 ' A' ' 102' ' ' LEU . 5.6 t30 -116.93 113.84 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.087 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -125.41 175.98 7.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.179 -0.951 . . . . 0.0 111.174 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 43.8 t -144.86 146.94 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.8 132.5 54.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.149 -0.969 . . . . 0.0 109.909 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.08 157.77 45.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.446 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.2 mt -125.66 82.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 120.917 -1.115 . . . . 0.0 108.627 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 111' ' ' ASP . 63.7 mt -63.02 92.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.223 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.49 -78.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -130.61 29.14 4.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.127 -1.219 . . . . 0.0 110.197 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.85 136.89 40.95 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.244 -0.91 . . . . 0.0 108.883 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -98.03 110.92 23.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.903 -1.123 . . . . 0.0 109.906 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.6 t -92.35 113.39 27.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.309 -0.956 . . . . 0.0 108.577 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.467 ' NE2' ' OH ' ' A' ' 117' ' ' TYR . 6.6 tt0 -115.79 103.67 10.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.681 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.41 144.11 31.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.555 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -125.34 151.13 46.47 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.847 0.832 . . . . 0.0 109.471 178.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 122' ' ' VAL . 8.4 t -118.2 147.48 21.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.521 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.91 110.7 5.39 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.882 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 48.54 18.67 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.184 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.17 28.3 3.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.33 177.11 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 43.0 tt0 -155.44 117.04 4.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.242 -1.383 . . . . 0.0 111.368 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.956 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -106.77 150.62 26.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 12' ' ' GLU . 2.6 mtmm -126.99 137.48 53.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.904 -1.123 . . . . 0.0 110.48 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -140.14 114.01 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.1 mp -109.45 130.86 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 0.0 111.108 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.522 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -99.95 176.26 5.49 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.424 0.631 . . . . 0.0 109.407 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -164.58 151.29 11.03 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -47.43 132.89 13.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 2.3 p-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.52 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.138 0.494 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 5' ' ' THR . 28.2 t -179.07 -163.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 109.619 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 70.6 m -91.86 147.35 23.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.104 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.573 ' CD1' ' C ' ' A' ' 5' ' ' THR . 14.9 m95 -151.09 168.73 23.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 7.4 mtpt -150.63 128.53 11.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.388 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.72 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -42.55 106.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.06 -30.24 13.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -148.97 164.95 33.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.98 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.5 m -171.77 178.09 3.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.366 -0.834 . . . . 0.0 108.992 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -156.19 158.69 38.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.12 . . . . 0.0 110.104 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.2 m-20 57.71 -109.57 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.692 -0.63 . . . . 0.0 109.739 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE2' ' NH1' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 71.55 -51.3 0.69 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.84 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HB3' HH21 ' A' ' 28' ' ' ARG . 7.7 p-10 -62.8 -40.55 97.71 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.955 -1.091 . . . . 0.0 108.97 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -70.31 -31.0 68.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.882 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 78.5 t80 -74.18 -56.93 4.33 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.561 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 11.7 mmt -60.1 -32.83 71.34 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.42 -37.49 74.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -63.98 -41.05 97.64 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.593 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 23' ' ' VAL . 2.4 mtm -66.48 -8.33 25.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.199 -0.938 . . . . 0.0 109.086 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.61 32.6 10.03 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.471 HG21 ' SD ' ' A' ' 18' ' ' MET . 26.6 t -94.05 140.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -1.146 . . . . 0.0 109.553 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.35 157.82 4.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.361 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm -82.24 -1.23 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.213 1.006 . . . . 0.0 109.142 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -80.1 -59.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -56.55 -33.9 66.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 108.85 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.604 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -65.69 -52.09 54.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.75 -33.84 57.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.413 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.51 -13.23 46.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.023 0.916 . . . . 0.0 109.518 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASP . . . -84.3 -51.03 7.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.7 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.59 -57.53 2.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.502 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -75.69 44.79 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ALA . 63.7 t0 -116.02 101.48 8.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' HA ' HG13 ' A' ' 8' ' ' VAL . 17.3 m-20 -84.66 43.55 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.406 -0.809 . . . . 0.0 109.357 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.72 HD23 HG11 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -47.09 155.65 0.27 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.748 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -105.74 148.21 27.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.821 -0.549 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.52 HD22 ' CE2' ' A' ' 128' ' ' PHE . 2.5 mp -139.28 123.64 18.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 m -101.91 107.94 19.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.1 mp -101.02 133.6 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.16 -0.962 . . . . 0.0 110.747 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.48 152.08 48.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -130.05 147.83 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 109.863 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -145.1 79.18 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.82 -87.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -125.8 28.58 6.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -1.093 . . . . 0.0 110.093 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -147.75 110.04 4.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -98.12 174.4 6.55 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.508 0.671 . . . . 0.0 109.799 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -152.27 103.87 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -96.25 114.77 33.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -105.11 100.23 9.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.832 . . . . 0.0 109.345 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -74.64 152.82 39.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.034 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.38 105.95 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.157 0.98 . . . . 0.0 108.546 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.658 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -131.12 144.49 51.44 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.15 7.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.983 -1.073 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 53' ' ' SER . 72.6 m-85 -109.79 -25.88 10.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -0.978 . . . . 0.0 111.235 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER 165.65 87.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.704 -1.248 . . . . 0.0 109.312 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -62.29 139.81 58.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.42 -0.8 . . . . 0.0 109.643 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.602 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -132.26 174.35 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.874 0.845 . . . . 0.0 110.247 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.602 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.0 pt-20 -151.39 142.98 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.56 127.03 5.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.549 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -78.58 163.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.368 -0.832 . . . . 0.0 109.242 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.588 ' CE2' ' SG ' ' A' ' 70' ' ' CYS . 36.0 m-85 -143.37 117.87 9.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 64' ' ' LEU . 1.1 tm-20 -111.32 164.31 13.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.037 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.604 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 95.7 mt -103.34 118.24 36.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 109.915 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.58 18.37 41.73 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.46 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.622 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.0 t -141.37 105.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.948 -1.325 . . . . 0.0 109.568 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -56.29 143.52 33.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.898 . . . . 0.0 109.871 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -153.84 -170.85 3.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -132.34 151.07 52.01 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.563 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.588 ' SG ' ' CE2' ' A' ' 62' ' ' PHE . 68.1 m -149.42 127.82 12.23 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.554 ' OD1' HG21 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -89.66 144.47 25.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 110.343 -178.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.672 ' CD1' HD11 ' A' ' 78' ' ' LEU . 70.7 mt -99.35 146.88 25.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.99 -29.37 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.797 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.561 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 15.7 m-20 -66.62 17.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.164 -0.96 . . . . 0.0 109.241 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 63.57 26.92 70.18 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 161.88 13.33 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.233 -1.157 . . . . 0.0 109.696 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.497 ' O ' ' OG1' ' A' ' 96' ' ' THR . 40.7 tt0 -132.62 117.53 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.672 HD11 ' CD1' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -127.68 157.0 41.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.987 -1.07 . . . . 0.0 110.626 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 21.4 ptt85 -140.51 142.48 35.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.838 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.61 -119.63 0.8 Allowed Glycine 0 N--CA 1.475 1.277 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.504 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.8 159.62 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.153 -1.204 . . . . 0.0 110.403 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.41 143.12 32.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.229 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -137.32 157.06 47.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -97.75 128.28 44.29 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.315 -1.491 . . . . 0.0 108.273 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.646 ' N ' HD12 ' A' ' 84' ' ' LEU . 30.6 mt-10 -128.36 117.8 22.07 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.75 -106.88 1.19 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.468 ' C ' HD22 ' A' ' 87' ' ' ASN . 0.3 OUTLIER -125.17 34.42 4.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.162 . . . . 0.0 110.55 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.405 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -144.76 147.33 32.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.693 -1.254 . . . . 0.0 110.242 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt -92.75 113.55 25.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -84.78 165.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 110.766 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.37 95.93 0.17 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.655 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.4 ptpt -87.69 104.97 17.04 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.27 -1.135 . . . . 0.0 108.757 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m-30 -117.65 145.96 44.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.9 0.857 . . . . 0.0 110.314 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -125.92 123.86 39.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 34.3 mtp180 -57.74 115.22 2.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -69.38 -12.42 61.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.423 1.106 . . . . 0.0 109.466 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.32 -46.62 13.37 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.61 ' ND2' ' ND2' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -132.54 8.67 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.137 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 43.35 41.53 5.19 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.61 ' ND2' ' ND2' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -77.01 15.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.679 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.0 mt-10 52.51 150.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.646 0.736 . . . . 0.0 110.651 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 103' ' ' ASN . 3.4 tp -152.77 128.06 9.86 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.638 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER -116.27 118.64 33.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 108.779 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.6 t -129.05 176.2 8.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.162 -0.961 . . . . 0.0 110.559 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 106' ' ' ARG . 45.5 t -145.52 160.69 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.453 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.6 ttt85 -135.09 135.11 40.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -140.36 158.35 44.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 109.105 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.12 82.3 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.699 HD12 HG21 ' A' ' 114' ' ' VAL . 32.2 mt -63.82 91.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.107 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.05 -80.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -130.85 29.5 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 129' ' ' LYS . 6.9 mt-10 -133.05 141.12 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 0.0 108.969 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 128' ' ' PHE . 11.4 tp -101.0 114.58 28.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.88 -1.137 . . . . 0.0 108.859 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.699 HG21 HD12 ' A' ' 109' ' ' ILE . 12.9 t -104.9 106.77 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.325 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -105.79 108.16 19.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.01 147.37 24.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.128 -0.983 . . . . 0.0 109.885 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.646 ' O ' ' HA ' ' A' ' 123' ' ' GLU . 2.7 m-85 -121.36 158.36 28.42 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.436 -0.79 . . . . 0.0 109.158 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 103' ' ' ASN . 10.8 t -131.2 147.07 32.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.567 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -147.38 110.25 4.73 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.099 -1.041 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 45.99 20.45 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.124 0.488 . . . . 0.0 111.238 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.81 28.32 3.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.62 176.52 5.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.7 mt-10 -156.13 126.69 6.74 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.123 -1.431 . . . . 0.0 111.284 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -114.36 159.07 20.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -134.11 137.41 44.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.874 -1.141 . . . . 0.0 110.877 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.644 ' NH1' ' CE2' ' A' ' 14' ' ' TYR . 6.7 mmt180 -129.77 114.13 15.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 8.7 mt -113.01 122.72 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.01 -1.056 . . . . 0.0 111.14 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.8 m-30 -104.92 174.11 6.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.736 . . . . 0.0 109.138 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 112' ' ' GLU . 30.4 tttp -161.81 159.78 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.324 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -47.77 131.62 14.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.931 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.3 t0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.479 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 19.1 t0 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 40' ' ' ILE . 1.4 t -177.47 -138.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.688 . . . . 0.0 110.018 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.6 m -89.41 148.39 23.51 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.931 0.872 . . . . 0.0 111.482 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.708 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 17.1 m95 -144.81 168.66 19.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 2.4 pttp -152.5 125.53 8.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.513 -1.367 . . . . 0.0 110.843 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.609 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -44.04 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.285 -0.884 . . . . 0.0 109.769 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.44 -30.66 16.35 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HB2' HD12 ' A' ' 127' ' ' ILE . 6.6 mtp85 -151.3 175.33 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.677 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 t -171.33 178.11 3.36 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.226 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.75 154.72 35.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 21.7 m-20 57.68 -109.51 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.823 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.562 ' CD2' ' OD1' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.03 -52.71 0.69 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 15' ' ' ASP . 12.0 p-10 -59.71 -45.96 90.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.598 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.14 -34.62 76.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 69.7 t80 -69.79 -63.75 1.02 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mmt -55.9 -24.73 39.15 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.358 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -82.66 -23.05 34.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.065 -1.022 . . . . 0.0 109.379 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -77.33 -37.07 53.25 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.193 -0.942 . . . . 0.0 109.258 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.409 ' HG3' ' H ' ' A' ' 21' ' ' MET . 0.6 OUTLIER -67.47 -11.33 57.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.574 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.69 31.13 37.26 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 24' ' ' ASN . 5.8 t -78.78 136.86 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -1.159 . . . . 0.0 109.497 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' VAL . 5.8 m-80 -42.48 164.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.227 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.6 mm -81.79 -1.55 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.21 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.51 -59.92 2.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -64.78 -28.23 69.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.588 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -71.62 -42.5 67.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.388 -0.82 . . . . 0.0 108.977 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -63.68 -35.42 80.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.147 -0.971 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.57 -13.14 46.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.013 0.911 . . . . 0.0 109.632 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.577 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -44.14 -16.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.583 ' N ' ' O ' ' A' ' 31' ' ' ALA . 20.7 t-80 -70.9 41.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.409 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' CD2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -50.4 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.7 OUTLIER -147.8 42.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.609 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -96.52 175.18 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.523 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.458 ' N ' HD12 ' A' ' 36' ' ' LEU . 37.7 mttt -129.74 152.01 49.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.636 -0.665 . . . . 0.0 109.497 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.511 HD21 ' CD2' ' A' ' 128' ' ' PHE . 0.6 OUTLIER -142.81 150.38 39.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.702 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 4' ' ' SER . 0.6 OUTLIER -111.57 106.44 15.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.627 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -96.25 124.21 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 109.923 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.25 152.48 48.05 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' A' ' 47' ' ' PHE . 73.5 mt-30 -126.19 149.22 49.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.954 -1.091 . . . . 0.0 110.602 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' OE1' ' CD ' ' A' ' 46' ' ' LYS . 20.1 mt-10 -144.73 79.0 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.526 -0.733 . . . . 0.0 109.164 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.51 -88.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.623 HD22 ' N ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER -122.8 28.55 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -1.075 . . . . 0.0 109.736 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.454 ' CD ' ' OE1' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.01 109.87 4.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 42' ' ' GLN . 3.5 m-30 -93.24 173.26 7.81 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -153.38 103.73 2.7 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 108.813 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.62 HG22 HG23 ' A' ' 40' ' ' ILE . 96.7 t -99.68 121.62 50.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.634 -0.666 . . . . 0.0 109.446 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -108.63 100.07 9.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.36 155.06 41.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.941 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -158.6 107.05 1.93 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.116 -0.99 . . . . 0.0 109.013 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.694 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -141.83 144.56 33.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.46 7.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.025 -1.047 . . . . 0.0 109.189 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.694 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.0 m-85 -105.42 -25.71 12.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.278 -0.888 . . . . 0.0 110.835 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 8.2 mtp180 159.92 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.913 -1.117 . . . . 0.0 109.166 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -62.5 144.43 56.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 0.0 109.333 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.622 HG21 HD21 ' A' ' 71' ' ' ASN . 1.0 OUTLIER -136.65 174.02 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 110.34 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.591 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -149.06 129.56 13.93 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 87.7 m -145.75 128.56 16.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.564 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -75.5 164.98 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.269 -0.894 . . . . 0.0 108.957 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.608 ' C ' ' CD2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -144.57 116.49 8.3 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.588 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.411 ' H ' ' HE2' ' A' ' 68' ' ' PHE . 37.1 mt-10 -116.47 174.55 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.7 119.45 38.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 110.505 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.22 -5.72 83.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.319 -0.943 . . . . 0.0 110.838 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 1.6 t -103.45 105.27 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.834 -1.392 . . . . 0.0 110.13 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -61.25 143.05 56.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.439 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.17 -171.4 3.82 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.623 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -138.87 153.03 48.28 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.403 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 10.2 t -156.96 138.55 14.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.622 HD21 HG21 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -95.59 143.27 27.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' ALA . 19.3 mt -92.57 146.9 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.45 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.92 -33.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.742 . . . . 0.0 109.796 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -60.05 8.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 71.61 26.29 73.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -100.09 161.87 13.34 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.22 -1.165 . . . . 0.0 109.549 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.426 ' O ' ' OG1' ' A' ' 96' ' ' THR . 83.7 tt0 -132.92 121.06 22.29 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -137.93 162.99 32.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.895 -1.128 . . . . 0.0 110.821 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -143.59 146.16 33.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.708 . . . . 0.0 109.954 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.67 -118.67 0.71 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.554 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.55 157.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -1.231 . . . . 0.0 110.808 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 6.4 m95 -102.1 141.61 34.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.608 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.6 t -139.57 156.8 46.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 108.555 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.675 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -88.51 130.31 35.26 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.294 -1.504 . . . . 0.0 108.032 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.675 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -131.05 122.29 26.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.62 -108.14 1.42 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.423 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.4 m120 -125.02 33.93 5.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -1.183 . . . . 0.0 110.313 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -147.17 160.89 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.757 -1.215 . . . . 0.0 110.238 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.99 113.26 25.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.608 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -82.17 164.77 2.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 110.534 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.616 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.95 96.08 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.651 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 9.6 mtpm? -89.33 106.16 18.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.196 -1.179 . . . . 0.0 109.031 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -116.23 136.78 52.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.772 0.796 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -115.68 117.82 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.468 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.2 mtp180 -57.05 115.06 2.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -75.22 -12.61 60.32 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.497 1.141 . . . . 0.0 109.443 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -90.83 -35.76 14.62 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.872 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 0.7 OUTLIER -132.55 4.06 3.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.337 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.11 29.8 0.66 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.705 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.4 t-20 -76.96 18.66 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -1.177 . . . . 0.0 109.289 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.705 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.4 pt-20 43.93 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.922 0.867 . . . . 0.0 111.101 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.624 HD12 ' N ' ' A' ' 103' ' ' ASN . 1.4 tp -158.19 128.32 6.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.624 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -116.51 115.19 25.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 108.8 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -127.0 176.42 7.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.336 -0.853 . . . . 0.0 110.908 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -147.84 156.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -131.42 134.23 46.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -142.36 158.08 44.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 108.912 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.57 83.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.301 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.0 mm -64.57 92.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.334 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.53 -80.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -128.53 29.02 5.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -1.172 . . . . 0.0 110.251 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.1 130.94 39.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.421 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.65 112.29 24.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 108.478 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.97 107.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.9 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.22 106.26 16.64 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.4 OUTLIER -102.89 145.88 29.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 110.158 -178.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.663 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.8 OUTLIER -124.38 155.27 39.07 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.881 0.848 . . . . 0.0 109.484 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.7 t -124.6 147.58 29.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -146.0 110.6 5.12 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.998 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 47.73 19.34 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.237 0.542 . . . . 0.0 111.129 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.37 28.41 3.55 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.46 176.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.67 125.18 6.34 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 118.221 -1.391 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -115.66 149.5 38.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -129.05 138.67 52.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.896 -1.128 . . . . 0.0 110.581 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -132.47 115.05 15.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.498 HD12 ' HB2' ' A' ' 10' ' ' ARG . 10.4 mt -104.74 123.68 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.601 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 6.1 m-30 -102.17 176.95 5.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -155.05 168.34 27.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 131' ' ' ASP . 10.9 ptpt -50.58 138.74 17.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 109.629 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' LYS . 5.7 t70 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.361 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 4' ' ' SER . 12.5 t0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.221 0.534 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.3 m 161.9 -164.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.575 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.596 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 49.3 m -95.88 143.63 26.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.596 ' CD1' ' C ' ' A' ' 5' ' ' THR . 4.9 m95 -150.08 169.01 22.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.234 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 8' ' ' VAL . 6.4 ptmm? -152.76 133.98 14.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 109.693 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.591 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.51 106.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.0 109.508 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 32.3 t0 -98.26 -31.34 12.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -146.22 164.24 32.89 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.503 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 2.8 t -166.02 178.12 6.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.46 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -156.61 155.17 31.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 0.0 109.887 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.6 m-20 58.43 -108.82 0.43 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 109.953 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.565 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER 73.03 -52.19 0.71 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.159 -0.963 . . . . 0.0 110.19 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.578 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 17.3 t70 -59.37 -49.99 75.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.099 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -59.65 -33.23 71.27 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 65.5 t80 -71.34 -63.67 1.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.5 mmt -54.19 -25.4 22.58 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.482 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -77.41 -35.19 54.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.03 -1.044 . . . . 0.0 109.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.282 -0.887 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.625 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.3 mtp -68.5 -6.29 24.32 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.115 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.37 32.54 62.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 24' ' ' ASN . 4.0 t -74.76 129.68 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -1.207 . . . . 0.0 109.394 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.767 HD22 ' N ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -42.45 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 109.361 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.767 ' N ' HD22 ' A' ' 24' ' ' ASN . 1.5 mm -80.45 -1.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 0.0 109.166 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -82.39 -60.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -56.82 -38.33 72.45 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.578 ' NE ' ' OD1' ' A' ' 15' ' ' ASP . 19.9 tpt180 -61.31 -52.7 63.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.74 -38.39 33.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.331 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.64 -13.08 46.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -78.52 -48.96 14.22 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.164 0.506 . . . . 0.0 109.661 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.17 -21.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -0.822 . . . . 0.0 109.478 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.9 t-80 -73.8 35.03 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -44.09 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.476 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 6.7 t-20 -147.83 42.69 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -95.66 167.89 11.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.994 -1.066 . . . . 0.0 110.566 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HZ3' ' HB3' ' A' ' 7' ' ' LYS . 4.4 mttm -108.14 142.55 38.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 36' ' ' LEU . 1.9 mp -137.19 128.98 28.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.657 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m -102.69 119.16 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.3 mp -107.9 119.73 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.659 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.14 151.74 37.0 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.83 145.45 50.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -140.77 79.09 1.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 -83.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' GLU . 21.8 m-20 -124.9 28.67 6.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -1.134 . . . . 0.0 110.148 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' NZ ' ' OG1' ' A' ' 48' ' ' THR . 1.9 tmtm? -150.79 109.84 3.91 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.34 173.6 7.45 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.361 0.6 . . . . 0.0 109.735 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.625 ' OG1' ' NZ ' ' A' ' 46' ' ' LYS . 43.6 m -153.52 103.87 2.69 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.35 -0.843 . . . . 0.0 108.744 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.6 t -99.42 115.77 41.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -101.4 100.44 10.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.08 158.25 35.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 108.865 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -160.13 107.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.683 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -139.42 144.64 38.18 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.13 7.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.079 -1.013 . . . . 0.0 109.376 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.683 ' H ' ' C ' ' A' ' 53' ' ' SER . 28.2 t80 -107.45 -25.4 11.43 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.164 -0.96 . . . . 0.0 111.065 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 159.97 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.902 -1.124 . . . . 0.0 109.084 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -62.12 148.79 43.24 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.11 174.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.6 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -149.54 127.3 11.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.7 131.92 20.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.7 t -85.05 153.98 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.353 -0.842 . . . . 0.0 108.81 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CE1' ' SG ' ' A' ' 70' ' ' CYS . 41.1 m-85 -135.3 117.13 15.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 3.2 mp0 -104.12 172.49 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 108.902 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 64' ' ' LEU . 80.2 mt -103.74 111.77 24.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 0.0 110.317 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.2 -31.7 7.71 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 16.6 t -82.82 110.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.263 . . . . 0.0 109.877 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -60.17 143.24 52.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.085 -1.009 . . . . 0.0 109.437 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.05 -171.35 3.91 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -138.16 150.42 46.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.978 -1.076 . . . . 0.0 110.444 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' CE1' ' A' ' 62' ' ' PHE . 89.1 m -151.91 134.76 15.61 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.776 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -96.24 146.1 24.99 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.265 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 73' ' ' ALA . 17.2 mt -94.69 146.93 23.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.547 -0.721 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.31 -34.63 1.26 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.683 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -57.74 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 77.66 25.68 62.39 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.68 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.06 161.49 13.58 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.245 -1.15 . . . . 0.0 109.597 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -133.62 123.07 24.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.7 162.52 32.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.851 -1.156 . . . . 0.0 110.72 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.77 144.34 31.13 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.485 -0.759 . . . . 0.0 110.046 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.46 -117.66 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 N-CA-C 107.901 -2.079 . . . . 0.0 107.901 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.529 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.69 158.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -1.184 . . . . 0.0 110.572 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.473 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.9 m95 -102.13 143.7 31.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.6 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -140.41 157.22 45.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -90.06 129.33 36.38 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.149 -1.594 . . . . 0.0 108.136 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.656 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -129.94 119.29 22.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.09 -107.35 1.29 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -125.14 34.33 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -1.158 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 157.11 43.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.804 -1.185 . . . . 0.0 110.229 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.43 110.78 22.78 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -78.45 164.87 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.12 -0.988 . . . . 0.0 110.429 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.598 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.0 96.05 0.17 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.653 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.5 mttp -88.14 105.19 17.34 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.201 -1.176 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 5.5 m-30 -118.22 140.01 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.221 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -121.87 120.9 35.88 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.68 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 0.4 OUTLIER -53.27 114.86 1.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -12.2 61.44 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.482 1.134 . . . . 0.0 109.406 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.17 -48.82 12.55 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.622 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -132.53 11.38 4.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 110.166 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.0 44.25 13.63 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.745 ' O ' ' O ' ' A' ' 101' ' ' GLU . 42.4 m-20 -80.08 20.04 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -1.065 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.745 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.3 pt-20 42.97 158.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.005 0.907 . . . . 0.0 111.184 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.6 tt -160.49 124.97 3.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.666 ' N ' HD23 ' A' ' 102' ' ' LEU . 1.4 t-20 -113.41 112.72 24.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.036 -1.04 . . . . 0.0 109.118 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.7 t -125.3 176.51 6.72 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 111.13 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 46.2 t -148.71 156.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -124.34 133.88 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -134.78 157.98 45.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.449 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.4 mm -122.03 82.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 121.074 -1.016 . . . . 0.0 108.304 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 109' ' ' ILE . 15.9 mt -63.44 92.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.65 -80.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.5 m-20 -128.08 29.48 5.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -1.194 . . . . 0.0 110.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.02 145.24 45.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 108.943 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.63 114.39 28.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.969 -1.082 . . . . 0.0 109.254 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.541 HG22 HG12 ' A' ' 127' ' ' ILE . 39.5 t -99.59 109.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 47.1 tt0 -107.1 104.1 13.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -100.96 145.59 28.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.215 -0.928 . . . . 0.0 109.998 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.703 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -128.51 152.28 48.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.0 t -119.39 148.12 22.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.34 110.59 5.74 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.922 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 48.25 18.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.962 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.45 28.36 3.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.753 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.67 177.13 4.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.543 ' N ' HG13 ' A' ' 122' ' ' VAL . 10.6 tt0 -154.86 122.59 5.76 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.175 -1.41 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.886 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.77 156.54 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -136.33 139.04 42.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.209 . . . . 0.0 111.331 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.565 ' NH2' ' OH ' ' A' ' 14' ' ' TYR . 1.5 ttm-85 -130.76 113.96 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.541 HG12 HG22 ' A' ' 114' ' ' VAL . 6.6 mt -109.18 123.47 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.932 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 38' ' ' LEU . 7.7 m-30 -101.22 173.94 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.227 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -162.28 161.07 27.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.566 -0.709 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 131' ' ' ASP . 9.9 mmmt -47.71 132.36 14.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.162 -0.961 . . . . 0.0 109.643 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 130' ' ' LYS . 51.7 p30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.459 ' C ' ' OG ' ' A' ' 4' ' ' SER . 34.7 t70 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.246 0.546 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 171.4 -158.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.572 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.6 m -94.81 143.54 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.572 ' CD1' ' C ' ' A' ' 5' ' ' THR . 19.8 m95 -151.3 168.25 25.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.225 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.6 pttm -153.5 130.72 11.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.059 -1.025 . . . . 0.0 109.704 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.605 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -40.3 106.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 38.9 t0 -92.97 -30.0 15.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -147.66 164.98 31.83 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.866 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.66 178.15 5.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.358 -0.839 . . . . 0.0 109.267 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 4.2 pt-20 -152.68 151.12 30.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.02 -1.05 . . . . 0.0 110.013 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.546 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 18.7 t30 58.46 -108.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.718 -0.614 . . . . 0.0 109.903 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.546 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 76.16 -53.64 0.61 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -0.87 . . . . 0.0 109.838 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 87.6 m-20 -58.41 -52.37 65.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.022 -1.049 . . . . 0.0 108.938 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 12.0 mtpp -57.81 -33.24 68.39 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.579 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.854 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 56.8 t80 -71.64 -61.65 1.7 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.552 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 21.7 mmt -56.24 -25.69 48.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.415 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 3.4 mm-40 -80.64 -28.48 36.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.048 -1.032 . . . . 0.0 109.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.89 -35.84 67.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.317 -0.865 . . . . 0.0 109.454 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 2.2 mtm -72.64 -6.58 45.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.166 -0.959 . . . . 0.0 108.844 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 32.42 55.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 21' ' ' MET . 36.2 t -72.91 135.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -1.169 . . . . 0.0 109.383 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 23' ' ' VAL . 29.0 m120 -42.74 158.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.79 -3.06 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.221 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -84.66 -60.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.52 -29.33 69.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -68.48 -50.88 49.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.541 -0.725 . . . . 0.0 109.09 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -35.78 63.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.189 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.1 mt -86.46 -13.04 47.3 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.964 0.887 . . . . 0.0 109.773 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -75.8 -47.85 24.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . -41.47 -20.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASN . 13.7 m80 -70.97 46.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -52.05 79.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.853 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' HIS . 7.1 p30 -148.36 42.86 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 109.203 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 36' ' ' LEU . 1.0 OUTLIER -93.94 168.33 11.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -106.53 145.03 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.527 HD22 ' CE2' ' A' ' 128' ' ' PHE . 2.1 mp -138.95 125.2 20.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 109.78 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.4 m -102.6 113.02 26.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.743 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.7 mp -103.08 123.64 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.715 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.37 151.96 36.74 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.492 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 12.7 pt20 -131.72 139.4 48.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.158 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 42' ' ' GLN . 19.0 mm-40 -136.14 78.95 1.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.209 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.81 -89.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.452 ' H ' HD22 ' A' ' 45' ' ' ASN . 0.9 OUTLIER -117.51 28.77 8.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.406 -1.056 . . . . 0.0 110.12 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.88 109.98 3.92 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CE2' ' CB ' ' A' ' 42' ' ' GLN . 10.6 m-85 -100.57 173.93 6.32 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.422 0.63 . . . . 0.0 109.67 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -152.2 103.03 2.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -95.33 111.2 25.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -102.31 100.65 10.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.624 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -72.97 158.89 34.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 108.906 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.6 m -160.8 107.11 1.46 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.087 -1.008 . . . . 0.0 109.248 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.654 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -134.09 144.41 48.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 7.8 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 109.638 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.654 ' H ' ' C ' ' A' ' 53' ' ' SER . 7.8 m-85 -112.96 -23.72 9.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.156 -0.965 . . . . 0.0 111.295 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 5.3 ptm180 166.59 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.811 -1.181 . . . . 0.0 109.513 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -62.32 147.65 47.54 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.429 -0.795 . . . . 0.0 109.271 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.12 174.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.619 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.8 pt-20 -150.0 140.58 22.52 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 59' ' ' GLU . 38.9 m -151.69 127.02 9.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.65 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.66 150.74 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.28 -0.888 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.612 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -132.41 116.83 17.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.181 -0.949 . . . . 0.0 109.233 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 46.2 tt0 -126.13 169.12 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.0 109.044 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.475 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.7 mt -101.98 129.01 48.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.05 26.59 63.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 56.5 t -144.04 102.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -1.21 . . . . 0.0 109.31 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -59.12 141.06 55.1 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.104 0.954 . . . . 0.0 110.064 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.05 -171.3 3.8 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 69' ' ' ASN . 26.3 p30 -139.22 149.06 43.92 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.798 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.685 ' O ' HD22 ' A' ' 78' ' ' LEU . 42.8 t -139.11 170.63 15.62 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 76' ' ' THR . 2.9 m-20 -126.21 141.39 51.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.854 -1.154 . . . . 0.0 110.36 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.522 ' HG ' HD21 ' A' ' 78' ' ' LEU . 95.5 mt -93.59 146.9 23.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.528 -0.732 . . . . 0.0 109.293 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.43 -28.43 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -0.757 . . . . 0.0 109.696 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 45.5 m-20 -70.2 19.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.285 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.59 29.94 73.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.633 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.14 162.32 13.04 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.368 -1.077 . . . . 0.0 109.43 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.94 ' C ' HD13 ' A' ' 78' ' ' LEU . 58.7 tt0 -132.56 114.78 14.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.596 -0.69 . . . . 0.0 109.189 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.987 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -118.18 150.31 39.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.099 -1.001 . . . . 0.0 110.318 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -136.9 142.67 42.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.37 -118.4 0.72 Allowed Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.596 ' CB ' ' HZ1' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 173.01 156.47 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -1.111 . . . . 0.0 110.362 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.575 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.54 143.45 32.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.6 -0.687 . . . . 0.0 109.162 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.604 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 11.4 t -141.59 156.8 45.66 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.757 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -89.02 131.63 35.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.324 -1.485 . . . . 0.0 108.125 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.757 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -136.28 124.2 22.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.21 -110.32 3.01 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.454 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.0 m120 -125.26 34.18 5.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -1.174 . . . . 0.0 110.414 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -149.2 162.43 40.02 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.659 -1.276 . . . . 0.0 110.323 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.77 113.29 25.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.604 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.2 pt -81.13 164.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.583 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.02 96.85 0.18 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.666 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 6.5 pttm -90.32 106.78 18.73 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.274 -1.133 . . . . 0.0 108.686 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.598 ' HB2' HD23 ' A' ' 102' ' ' LEU . 2.6 m-30 -116.17 148.79 40.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.775 0.798 . . . . 0.0 110.365 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -134.18 116.85 15.86 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.601 0.715 . . . . 0.0 109.943 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 48.6 mtp180 -52.05 115.29 1.63 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.68 -12.66 61.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.499 1.142 . . . . 0.0 109.628 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.71 -37.95 15.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.97 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 35.4 t-20 -132.48 5.76 4.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.297 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.38 34.36 1.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 101' ' ' GLU . 5.3 m120 -75.41 20.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -1.161 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.7 pt-20 45.49 166.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.017 0.913 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 117' ' ' TYR . 19.4 tp -161.85 120.68 2.36 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -112.19 114.03 26.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 109.165 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.0 t -129.71 176.36 8.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.096 -1.003 . . . . 0.0 111.154 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 106' ' ' ARG . 54.2 t -146.58 158.51 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.418 ' N ' HG12 ' A' ' 105' ' ' VAL . 22.0 ttp180 -132.21 137.26 47.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.139 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -140.45 158.49 43.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 113' ' ' LEU . 1.2 mt -124.23 82.77 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.122 -0.986 . . . . 0.0 108.753 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' ASP . 48.6 mt -61.86 92.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.092 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.94 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ILE . 21.7 m-20 -130.06 29.41 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -1.228 . . . . 0.0 110.404 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -134.43 138.14 44.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 108.776 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.481 HD12 HG12 ' A' ' 108' ' ' ILE . 5.2 tp -99.43 113.16 25.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.891 -1.13 . . . . 0.0 109.362 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.68 HG22 HG23 ' A' ' 127' ' ' ILE . 27.5 t -98.57 110.74 26.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.096 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -113.21 106.76 15.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.56 145.47 29.98 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.718 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -126.18 156.63 39.87 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.928 0.871 . . . . 0.0 109.599 179.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.5 t -124.14 148.28 28.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.537 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.2 t80 -143.25 110.29 5.64 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.811 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 47.77 19.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.66 28.24 3.53 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.24 176.57 4.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.511 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.8 tt0 -156.02 124.19 5.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.061 -1.455 . . . . 0.0 111.362 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.854 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -117.68 151.94 36.24 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -128.57 140.24 51.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.881 -1.137 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -133.24 113.96 13.25 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.68 HG23 HG22 ' A' ' 114' ' ' VAL . 5.3 mt -109.07 123.37 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.052 -1.03 . . . . 0.0 110.557 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.547 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -101.01 174.4 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.447 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -163.19 154.59 17.23 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -47.28 135.71 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.512 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.467 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 4' ' ' SER . 9.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.159 0.504 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.626 ' OG ' ' N ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 158.51 -170.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.377 -0.827 . . . . 0.0 109.3 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.626 ' N ' ' OG ' ' A' ' 4' ' ' SER . 97.5 m -86.13 150.16 24.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.579 ' NE1' ' O ' ' A' ' 4' ' ' SER . 13.1 m95 -151.36 168.14 25.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.086 -1.009 . . . . 0.0 109.818 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.2 pttp -153.53 125.79 8.0 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.576 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.35 106.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.581 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.97 -28.96 12.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -142.29 174.33 10.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.6 t -178.39 178.31 0.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.16 155.65 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.874 -1.141 . . . . 0.0 109.822 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 18.7 m-20 56.86 -110.08 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.588 -0.695 . . . . 0.0 109.848 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.621 ' CE2' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.59 -52.43 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.0 109.855 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.31 -48.99 77.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.885 -1.134 . . . . 0.0 108.655 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.714 ' HZ3' ' HB3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 61.0 t80 -69.12 -64.08 0.94 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.007 0.908 . . . . 0.0 108.882 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.425 ' O ' HG23 ' A' ' 23' ' ' VAL . 15.4 mmt -56.41 -21.33 24.39 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 28' ' ' ARG . 33.3 tt0 -78.66 -35.15 45.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.208 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -66.99 -44.35 80.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.144 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.4 mtm -62.85 -9.22 8.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.021 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 32.3 38.13 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' ASN . 15.4 t -76.29 133.35 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -1.081 . . . . 0.0 109.559 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.539 ' OD1' HG23 ' A' ' 26' ' ' VAL . 11.6 t-20 -46.81 174.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -85.24 -2.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.119 0.961 . . . . 0.0 109.266 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.539 HG23 ' OD1' ' A' ' 24' ' ' ASN . 65.8 t -80.84 -59.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.755 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 1.5 mptm? -66.38 -22.73 66.25 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 19' ' ' GLU . 9.2 ttm180 -73.89 -42.38 60.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 109.29 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -72.81 -34.31 66.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.892 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.9 mt -86.39 -13.03 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -72.82 -53.01 12.64 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.573 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.98 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.574 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.699 ' CE1' HD21 ' A' ' 35' ' ' ASN . 0.7 OUTLIER -91.57 46.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.621 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 69.0 m-20 -62.45 121.05 12.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.853 . . . . 0.0 109.684 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.699 HD21 ' CE1' ' A' ' 33' ' ' HIS . 67.6 m-20 -147.94 42.98 1.05 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.349 -0.844 . . . . 0.0 109.016 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.576 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -87.74 162.81 16.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.111 -0.993 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 52' ' ' SER . 3.1 mtpp -114.69 142.49 46.43 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.825 ' H ' HD23 ' A' ' 38' ' ' LEU . 1.7 pt? -149.98 143.66 25.35 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.084 -1.01 . . . . 0.0 109.986 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -103.91 143.32 33.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.61 129.04 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.147 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.39 152.3 50.75 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -132.04 135.05 46.21 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.8 mm-40 -129.37 78.98 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.84 -79.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.14 29.24 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.99 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -145.16 110.59 5.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.18 159.85 14.82 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.455 HG23 HG13 ' A' ' 61' ' ' VAL . 48.9 m -152.21 103.12 2.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.079 -1.013 . . . . 0.0 108.269 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.88 130.87 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.61 -0.681 . . . . 0.0 109.652 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -119.63 100.55 7.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.398 -0.814 . . . . 0.0 109.572 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -75.51 156.1 35.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.214 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.1 m -158.9 106.91 1.85 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.153 0.977 . . . . 0.0 108.851 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.658 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -133.87 144.5 48.95 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.13 7.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.085 -1.01 . . . . 0.0 109.427 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 53' ' ' SER . 67.1 m-85 -113.26 -19.52 11.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 111.25 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 3.4 mmt180 161.63 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.703 -1.248 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.762 ' H ' HD22 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -62.89 146.81 52.0 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.495 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.1 mt -135.82 174.13 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.875 . . . . 0.0 110.146 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.2 pt-20 -152.82 145.53 24.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.6 m -152.01 110.38 3.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.64 140.06 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.269 -0.894 . . . . 0.0 108.743 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.7 OUTLIER 175.51 164.87 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.918 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.5 tt0 -88.57 169.14 11.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 2.7 pp -88.89 130.97 35.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.867 -1.146 . . . . 0.0 109.619 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.79 -27.1 9.47 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 19.1 t -93.53 117.35 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -1.22 . . . . 0.0 109.732 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.19 144.38 20.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.052 0.929 . . . . 0.0 110.049 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.36 -171.43 3.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -143.29 151.44 40.52 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.891 -1.131 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 86.6 m -146.51 127.85 14.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.491 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -85.47 143.38 28.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 110.234 -178.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 78' ' ' LEU . 86.7 mt -96.37 146.9 24.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.446 -0.784 . . . . 0.0 109.359 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.586 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.88 -29.86 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.515 -0.741 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.99 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.239 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.78 28.2 69.66 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -99.9 162.44 12.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' THR . 20.0 tt0 -128.83 119.34 24.3 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.563 HD23 ' C ' ' A' ' 94' ' ' LYS . 3.5 mt -125.27 141.49 52.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.076 -1.015 . . . . 0.0 110.328 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.45 145.49 43.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.963 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.765 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 169.67 -120.61 0.88 Allowed Glycine 0 C--O 1.211 -1.303 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.38 159.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.161 -1.199 . . . . 0.0 111.029 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 21.4 m95 -101.96 140.56 36.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.578 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -137.89 157.07 47.17 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -97.88 128.97 44.83 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.331 -1.481 . . . . 0.0 108.238 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.662 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.1 mm-40 -134.68 122.5 22.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.41 -110.41 3.25 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -125.56 34.19 4.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.23 158.05 43.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.494 -1.379 . . . . 0.0 110.213 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mt -97.9 110.63 23.16 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.578 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.8 164.86 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 110.418 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.05 94.96 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.765 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.2 mttp -86.17 102.53 13.98 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.175 -1.191 . . . . 0.0 108.819 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.6 m-30 -116.93 149.62 39.86 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.811 0.815 . . . . 0.0 110.103 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.563 ' C ' HD23 ' A' ' 78' ' ' LEU . 3.5 ptpt -143.33 124.02 14.13 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 31.5 mtp180 -48.07 115.15 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.349 -0.845 . . . . 0.0 108.804 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -70.55 -7.43 43.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.362 1.077 . . . . 0.0 109.322 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -89.68 -41.59 11.84 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.77 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -132.4 8.95 4.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.922 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.06 42.61 12.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.834 ' O ' ' O ' ' A' ' 101' ' ' GLU . 14.4 m120 -75.73 18.4 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -1.147 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.834 ' O ' ' O ' ' A' ' 100' ' ' ASN . 13.4 pt-20 38.62 154.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.107 0.956 . . . . 0.0 111.42 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.867 HD11 ' HB3' ' A' ' 117' ' ' TYR . 15.2 tp -153.53 129.08 9.97 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.617 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -113.93 108.68 17.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 109.341 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.7 t -123.29 175.83 6.47 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.135 0.969 . . . . 0.0 111.669 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' N ' ' OG1' ' A' ' 104' ' ' THR . 45.5 t -145.04 157.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.477 ' HE ' HD21 ' A' ' 113' ' ' LEU . 21.9 ttm180 -126.75 136.02 51.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.982 . . . . 0.0 109.837 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.55 158.3 44.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.104 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.45 HD13 HD12 ' A' ' 113' ' ' LEU . 1.4 mm -122.09 82.38 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.079 -1.013 . . . . 0.0 108.435 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 109' ' ' ILE . 19.2 mt -62.61 92.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.886 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.12 -82.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ILE . 68.8 m-20 -130.71 29.01 4.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -1.166 . . . . 0.0 109.952 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.07 139.76 49.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.874 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.477 HD21 ' HE ' ' A' ' 106' ' ' ARG . 11.7 tp -98.87 112.15 24.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.885 -1.134 . . . . 0.0 109.051 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 109' ' ' ILE . 20.1 t -99.51 111.53 29.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.365 -0.835 . . . . 0.0 109.472 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -111.52 106.84 15.83 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.27 143.22 32.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.867 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -127.16 148.68 50.17 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.875 0.845 . . . . 0.0 109.903 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.6 t -112.42 148.13 15.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.517 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -144.01 110.67 5.6 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 49.72 17.74 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.25 28.25 3.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.8 177.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.522 ' N ' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -154.72 116.79 4.21 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 118.309 -1.357 . . . . 0.0 111.04 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.909 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -110.41 153.76 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -133.54 138.79 46.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.824 -1.173 . . . . 0.0 111.071 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.578 ' NE ' ' OH ' ' A' ' 117' ' ' TYR . 15.1 mtm180 -132.89 120.91 22.11 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.482 HG12 HG22 ' A' ' 114' ' ' VAL . 4.3 mt -114.44 123.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.09 . . . . 0.0 111.245 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 38' ' ' LEU . 5.5 m-30 -99.13 175.94 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 130' ' ' LYS . 45.9 tttt -165.92 159.3 15.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 109.159 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -47.52 132.6 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.458 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.454 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.59 ' O ' ' NE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -179.28 -168.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.163 -0.96 . . . . 0.0 109.664 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.625 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.4 m -95.53 142.02 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.644 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -151.45 169.24 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.51 139.63 20.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.858 . . . . 0.0 109.281 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' C ' ' O ' ' A' ' 7' ' ' LYS . 7.6 t -33.52 106.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 110.237 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.05 -31.69 14.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -153.86 173.89 15.32 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.611 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -176.37 178.17 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 0.0 109.47 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -157.25 154.08 28.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 12.3 m-20 57.92 -110.28 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.744 -0.598 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.507 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.99 -53.15 0.62 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.874 . . . . 0.0 109.922 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 15.2 p-10 -58.93 -46.42 88.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 108.827 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 78.2 mttt -63.53 -32.27 73.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.905 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 85.7 t80 -72.39 -61.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.556 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 9.6 mmt -58.64 -23.89 60.02 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' HB2' HH21 ' A' ' 28' ' ' ARG . 28.0 tt0 -77.54 -35.3 53.41 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -65.59 -42.01 92.18 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.323 -0.861 . . . . 0.0 109.184 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.482 ' CE ' ' CE2' ' A' ' 17' ' ' PHE . 5.7 mtm -59.61 -13.74 10.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.926 . . . . 0.0 108.845 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.35 22.48 56.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 24' ' ' ASN . 2.9 t -73.27 134.3 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -1.039 . . . . 0.0 109.45 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.9 m-80 -41.98 165.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -77.57 -1.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.247 1.022 . . . . 0.0 109.164 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.91 -59.79 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 31' ' ' ALA . 45.3 mmtt -59.24 -39.92 84.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 108.951 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.44 HH21 ' HB2' ' A' ' 19' ' ' GLU . 5.8 ttt180 -61.49 -39.94 92.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -60.89 -47.55 85.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.655 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.55 -12.98 47.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -51.73 -52.89 45.08 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.233 0.54 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -31.31 67.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.385 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.52 34.85 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.413 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -117.37 73.51 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.354 -0.842 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.75 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -86.94 43.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.245 -0.91 . . . . 0.0 109.342 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 35' ' ' ASN . 1.1 pt? -38.81 167.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.211 1.005 . . . . 0.0 111.391 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -105.69 146.4 29.8 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -139.58 124.08 18.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.021 -1.049 . . . . 0.0 110.325 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.536 ' C ' HD12 ' A' ' 40' ' ' ILE . 6.5 m -104.05 114.77 29.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.929 ' N ' HD12 ' A' ' 40' ' ' ILE . 2.2 mp -108.4 138.97 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.672 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.11 152.0 50.85 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -136.97 145.79 44.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 109.557 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -149.6 79.23 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.028 -1.045 . . . . 0.0 109.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.04 -90.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.696 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -120.59 28.77 7.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.333 -1.098 . . . . 0.0 110.453 -178.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 pttm -152.17 111.82 3.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -106.76 174.33 5.93 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.576 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.651 HG23 HG22 ' A' ' 61' ' ' VAL . 11.6 m -148.06 103.39 3.47 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.38 115.58 31.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.148 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -112.36 100.69 8.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -82.87 157.16 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -158.4 107.01 1.97 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.063 -1.023 . . . . 0.0 108.975 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.657 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -134.19 144.46 48.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.93 7.7 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.398 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.657 ' H ' ' C ' ' A' ' 53' ' ' SER . 47.7 m-85 -112.47 -20.3 11.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -0.918 . . . . 0.0 111.227 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.0 OUTLIER 163.3 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.0 109.686 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.723 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -63.38 145.86 54.72 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -137.59 174.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 0.0 110.312 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 6.4 pt-20 -150.62 143.56 24.69 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.14 110.46 4.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.651 HG22 HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -109.14 141.65 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.285 -0.884 . . . . 0.0 109.093 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.78 -179.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.849 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.9 mp0 -105.09 175.19 5.58 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 64' ' ' LEU . 3.3 pp -93.9 119.37 32.73 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.986 -1.071 . . . . 0.0 109.203 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.0 -34.73 3.92 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.66 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 3.1 t -83.75 115.02 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.012 -1.287 . . . . 0.0 109.98 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -54.73 147.91 13.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.041 0.924 . . . . 0.0 110.207 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -160.05 -171.08 3.08 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -129.31 150.09 50.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 110.131 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 63.5 m -152.7 132.47 13.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.766 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -92.24 145.9 24.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.972 -1.08 . . . . 0.0 110.415 -178.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 73' ' ' ALA . 89.3 mt -93.91 147.02 23.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 0.0 109.342 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.61 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.49 -34.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 23.8 t0 -62.57 12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.15 27.9 73.34 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.632 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.3 OUTLIER -99.07 162.14 13.23 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.232 -1.158 . . . . 0.0 109.345 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -132.71 119.56 20.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.62 -0.675 . . . . 0.0 109.227 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.93 163.04 30.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.009 -1.057 . . . . 0.0 110.335 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -141.95 146.35 35.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.885 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.749 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 170.26 -118.7 0.77 Allowed Glycine 0 C--O 1.211 -1.287 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.19 159.51 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.268 -1.136 . . . . 0.0 110.674 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.33 145.1 29.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.58 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -141.01 157.35 45.45 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -97.51 123.19 41.29 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.456 -1.403 . . . . 0.0 108.217 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' N ' HD12 ' A' ' 84' ' ' LEU . 23.9 mt-10 -120.11 111.63 18.1 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.4 ' O ' HD11 ' A' ' 84' ' ' LEU . . . 64.47 -104.95 1.0 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 87' ' ' ASN . 3.9 t-20 -125.21 33.47 5.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -1.16 . . . . 0.0 110.262 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.51 148.26 40.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.795 -1.191 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.25 104.48 16.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.58 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -74.9 164.16 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.067 -1.02 . . . . 0.0 110.555 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.9 94.97 0.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.68 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 36.6 mtmt -88.8 103.1 15.67 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 109.151 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.2 m-30 -118.43 137.43 53.15 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.647 0.737 . . . . 0.0 109.709 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 14.1 pttt -124.97 122.89 38.61 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 99' ' ' GLY . 18.3 mtp85 -51.35 117.91 2.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 0.0 109.22 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -11.12 60.72 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.438 1.113 . . . . 0.0 109.29 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.21 -48.29 12.27 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.571 ' OD1' ' NH1' ' A' ' 95' ' ' ARG . 11.3 m120 -132.58 8.63 4.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.23 43.67 9.62 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.683 ' O ' ' O ' ' A' ' 101' ' ' GLU . 56.7 m-20 -72.38 11.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 109.524 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.683 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.2 mt-10 47.42 132.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.713 0.768 . . . . 0.0 111.162 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -135.31 132.51 37.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 102' ' ' LEU . 1.9 m120 -117.01 116.49 27.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 0.0 108.931 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -128.12 176.13 7.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.796 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.4 t -146.6 155.2 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.17 136.31 51.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 109.899 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -137.36 158.68 43.89 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.45 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 2.2 mt -124.71 82.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.824 -1.173 . . . . 0.0 108.642 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 109' ' ' ILE . 21.3 mt -62.8 92.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.976 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.97 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.6 t70 -130.77 29.78 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -1.188 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -133.12 141.56 48.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.016 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 tp -97.65 110.77 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.871 -1.143 . . . . 0.0 109.195 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.514 HG22 HG23 ' A' ' 127' ' ' ILE . 8.8 t -95.21 111.9 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.937 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -114.84 107.32 15.26 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -101.42 145.31 29.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.691 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -123.11 154.97 37.89 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.837 0.827 . . . . 0.0 109.48 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.1 t -125.59 147.1 30.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.562 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -144.78 110.37 5.3 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.008 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 47.52 19.31 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.198 0.523 . . . . 0.0 111.118 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.72 28.12 3.56 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.24 176.58 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 3.6 mt-10 -155.68 125.9 6.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.229 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.905 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -118.21 153.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -130.29 139.56 50.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.808 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.691 ' NH1' ' CZ ' ' A' ' 117' ' ' TYR . 41.0 mtm180 -136.74 114.03 10.79 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.514 HG23 HG22 ' A' ' 114' ' ' VAL . 5.2 mt -110.74 123.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.972 -1.08 . . . . 0.0 110.77 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 38' ' ' LEU . 8.3 m-30 -99.18 171.0 8.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 0.0 109.502 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.76 159.62 42.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.63 -0.669 . . . . 0.0 109.21 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -57.96 134.09 56.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.2 t0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.486 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 4' ' ' SER . 5.5 m-20 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.623 ' OG ' ' N ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 159.3 -169.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.775 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.623 ' N ' ' OG ' ' A' ' 4' ' ' SER . 51.5 m -95.89 150.41 20.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.584 ' CD1' ' C ' ' A' ' 5' ' ' THR . 12.4 m95 -150.39 169.13 22.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.755 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 14.9 pttm -152.25 125.24 8.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.578 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.63 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -39.31 106.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 24.2 t0 -95.06 -29.49 14.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.409 ' HB2' HD12 ' A' ' 127' ' ' ILE . 2.5 mtt-85 -147.86 162.63 38.88 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.871 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.56 178.1 7.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -154.43 158.39 39.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 6.8 m-20 58.86 -109.18 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.656 -0.653 . . . . 0.0 109.72 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 74.76 -54.22 0.67 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.658 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 2.7 m-20 -60.55 -42.37 96.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.083 -1.011 . . . . 0.0 108.574 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -64.27 -32.05 73.5 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.84 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 7.5 t80 -72.9 -64.07 1.04 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -57.66 -20.85 36.39 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.616 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 2.0 tm-20 -79.77 -36.37 37.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.061 -1.024 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -67.41 -40.85 85.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.358 -0.838 . . . . 0.0 109.246 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 mtm -68.09 -6.12 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.33 -0.856 . . . . 0.0 108.999 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.53 32.43 67.76 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.5 t -72.73 128.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.486 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.7 m120 -41.76 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.355 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -76.52 -1.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.181 0.991 . . . . 0.0 109.212 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -81.86 -59.88 2.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -62.92 -30.93 71.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -44.08 72.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -62.99 -34.19 77.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 109.511 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.5 -13.26 46.52 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.968 0.89 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -80.34 -36.31 34.35 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.566 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.39 -24.34 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 1.3 m-70 -68.82 36.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.118 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 32' ' ' ALA . 7.5 p-10 -42.57 89.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 109.771 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 17.1 t30 -147.7 42.72 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 108.919 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -83.23 159.87 21.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.876 . . . . 0.0 110.486 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.812 ' N ' HD12 ' A' ' 36' ' ' LEU . 13.6 mtmm -119.55 150.4 40.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.6 pt? -153.8 149.53 27.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.111 -0.993 . . . . 0.0 110.0 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 m -117.45 123.32 46.07 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.752 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.0 mp -109.37 131.43 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.676 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.65 152.26 50.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.05 149.0 41.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 0.0 109.95 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.98 79.52 1.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.096 -1.003 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 -94.52 0.64 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -127.38 28.28 5.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -1.109 . . . . 0.0 109.442 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.57 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 18.6 pttm -149.37 110.83 4.46 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.3 174.23 9.75 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.013 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -143.49 103.07 4.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG13 HG13 ' A' ' 40' ' ' ILE . 42.2 t -98.94 108.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.773 -0.579 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.16 100.0 12.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.302 -0.874 . . . . 0.0 108.748 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 58' ' ' ILE . 50.2 mt-10 -69.78 155.74 40.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.241 -0.912 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -160.83 107.24 1.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.194 -0.941 . . . . 0.0 108.818 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.702 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -143.25 144.54 32.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.77 7.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.051 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.702 ' H ' ' C ' ' A' ' 53' ' ' SER . 16.5 t80 -106.83 -24.95 11.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 110.861 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 73' ' ' ALA . 9.8 mtp180 160.01 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 109.25 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -62.45 145.86 53.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 109.18 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.8 mt -142.77 174.14 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 122.129 0.966 . . . . 0.0 110.694 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.62 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.6 pt-20 -135.42 142.52 45.64 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 t -155.05 113.76 3.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.976 -1.077 . . . . 0.0 110.306 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.18 149.35 7.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -129.94 121.07 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.033 . . . . 0.0 110.534 -179.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.441 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 50.2 tt0 -123.35 139.17 54.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -103.23 148.83 25.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.885 -1.135 . . . . 0.0 110.283 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.8 -5.13 59.71 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.12 118.06 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.28 . . . . 0.0 109.941 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.8 m -49.32 145.4 4.55 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.294 1.045 . . . . 0.0 109.685 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.98 -168.14 2.15 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.712 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -146.46 157.21 43.72 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.532 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 15.9 t -147.66 136.05 21.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -96.54 148.33 22.94 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.939 -1.101 . . . . 0.0 110.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 73' ' ' ALA . 18.8 mt -100.94 147.08 26.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.586 -0.696 . . . . 0.0 109.527 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.671 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -39.46 -34.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.747 -0.596 . . . . 0.0 109.816 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.65 7.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.127 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.671 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 70.12 24.63 76.43 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.29 161.25 13.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.246 -1.149 . . . . 0.0 109.53 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -133.55 124.57 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.245 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -130.39 159.61 36.5 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.063 -1.023 . . . . 0.0 110.499 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -138.89 152.33 47.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 0.0 110.458 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.15 -110.09 0.42 Allowed Glycine 0 C--O 1.212 -1.272 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 166.74 152.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -1.216 . . . . 0.0 110.93 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 28.2 m95 -108.45 130.22 55.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.649 ' H ' HD12 ' A' ' 90' ' ' ILE . 1.8 m -144.88 156.31 43.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 109.54 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.934 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -87.27 138.11 31.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.752 -1.218 . . . . 0.0 108.425 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.934 ' N ' HD12 ' A' ' 84' ' ' LEU . 49.9 mt-10 -160.32 157.21 27.59 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.497 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.07 -117.72 6.49 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -125.99 33.8 4.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -1.197 . . . . 0.0 110.638 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -165.02 163.5 20.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.436 -1.415 . . . . 0.0 110.593 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.71 124.35 31.41 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.649 HD12 ' H ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -94.13 161.05 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.983 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 104' ' ' THR . . . -148.24 100.3 0.21 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.635 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 63.6 mttt -98.08 108.76 21.54 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.371 -1.076 . . . . 0.0 108.762 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' LEU . 1.5 m-30 -126.72 137.92 53.32 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.78 0.8 . . . . 0.0 110.245 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 94' ' ' LYS . 4.4 ptmm? -126.33 128.92 47.85 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 99' ' ' GLY . 35.7 mtp180 -54.64 115.27 2.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 108.993 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -10.17 57.34 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.389 1.09 . . . . 0.0 109.34 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -83.31 -47.13 11.82 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.619 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -132.44 9.26 4.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.84 44.86 18.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.64 ' O ' ' O ' ' A' ' 101' ' ' GLU . 13.9 m120 -74.42 10.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -1.173 . . . . 0.0 109.63 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.64 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.5 mt-10 49.96 136.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.764 0.792 . . . . 0.0 111.12 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.3 tt -146.39 122.28 10.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.671 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -112.42 149.98 31.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.044 . . . . 0.0 108.554 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.7 t -159.59 175.71 12.89 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.266 -1.521 . . . . 0.0 111.315 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 106' ' ' ARG . 37.8 t -144.23 158.17 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 105' ' ' VAL . 4.0 ttm180 -131.81 134.12 45.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -137.0 157.88 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.24 82.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.069 -1.019 . . . . 0.0 108.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 111' ' ' ASP . 79.0 mt -63.03 92.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.237 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.68 -78.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 109' ' ' ILE . 20.9 p-10 -130.19 29.24 4.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.0 110.316 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -134.77 139.05 44.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 108.966 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.5 tp -102.9 114.87 29.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.009 -1.057 . . . . 0.0 109.543 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.662 HG22 HG23 ' A' ' 127' ' ' ILE . 25.1 t -102.11 107.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.399 -0.813 . . . . 0.0 109.111 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -110.1 106.97 16.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.76 145.43 30.37 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.702 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.22 149.8 50.87 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.94 0.876 . . . . 0.0 109.715 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 122' ' ' VAL . 3.9 t -112.91 148.01 16.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.507 ' CB ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -140.64 110.28 6.38 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 47.31 19.22 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.122 0.487 . . . . 0.0 111.182 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.5 28.6 3.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -124.34 177.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 122' ' ' VAL . 33.9 mt-10 -153.5 121.23 5.98 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.378 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.84 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -114.0 146.19 40.5 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -125.82 140.14 52.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.929 -1.107 . . . . 0.0 111.186 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -129.71 114.2 15.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.662 HG23 HG22 ' A' ' 114' ' ' VAL . 8.7 mt -111.36 123.38 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.762 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.549 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.6 m-30 -103.65 176.06 5.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.489 -0.757 . . . . 0.0 109.577 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.58 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 24.6 tttp -163.86 152.96 14.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.547 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 4.7 pttm -47.66 132.24 14.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 13.5 p-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 4' ' ' SER . 1.3 m-20 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.676 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 163.83 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.676 ' N ' ' OG ' ' A' ' 4' ' ' SER . 96.8 m -91.49 145.27 24.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.577 ' CD1' ' C ' ' A' ' 5' ' ' THR . 8.2 m95 -151.36 168.24 25.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.315 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 3.0 ptmm? -153.18 133.76 13.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.988 -1.07 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.61 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -40.2 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.426 -0.796 . . . . 0.0 109.506 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.26 -30.2 12.38 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -140.67 169.82 16.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.912 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 14.4 t -175.27 178.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.279 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -156.24 154.42 30.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.9 m-20 56.79 -109.5 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.526 -0.734 . . . . 0.0 109.792 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.519 ' CE2' ' HE1' ' A' ' 18' ' ' MET . 0.3 OUTLIER 75.68 -54.14 0.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.529 ' CG ' HH21 ' A' ' 28' ' ' ARG . 7.2 m-20 -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.664 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -66.46 -32.08 73.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 21.9 t80 -72.28 -60.29 2.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.519 ' HE1' ' CE2' ' A' ' 14' ' ' TYR . 5.3 mtt -56.41 -25.09 49.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -78.87 -30.06 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.157 -0.965 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -69.76 -41.8 74.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -68.01 -6.41 22.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.91 . . . . 0.0 108.942 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 29.64 54.14 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.46 135.52 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -48.8 158.84 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.88 . . . . 0.0 109.37 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -82.96 -1.38 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.141 0.972 . . . . 0.0 109.237 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -80.07 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -57.34 -42.45 81.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.529 HH21 ' CG ' ' A' ' 15' ' ' ASP . 16.7 ttp85 -59.32 -46.67 87.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.456 -0.777 . . . . 0.0 109.204 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -53.59 -39.34 64.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.385 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.5 -13.59 45.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.803 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.44 -39.92 15.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.186 0.517 . . . . 0.0 109.668 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -38.64 -27.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.678 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 35' ' ' ASN . 46.5 m170 -70.04 39.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.908 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 32' ' ' ALA . 6.8 t0 -43.5 90.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.591 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 33' ' ' HIS . 5.8 m120 -147.7 42.97 1.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 36' ' ' LEU . 1.1 pt? -90.6 163.52 14.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -106.17 135.19 48.07 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.582 HD21 HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -132.91 128.54 36.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.975 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.446 HG23 ' HA ' ' A' ' 5' ' ' THR . 0.3 OUTLIER -102.87 120.71 41.09 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.028 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.5 mp -107.78 123.17 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 0.0 110.829 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.02 151.93 38.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.446 ' CD ' ' OD2' ' A' ' 3' ' ' ASP . 20.7 pt20 -133.37 148.95 51.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.005 -1.059 . . . . 0.0 110.188 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.513 ' OE2' ' CD ' ' A' ' 46' ' ' LYS . 58.6 mt-10 -147.73 79.31 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.183 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.14 -92.72 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.31 28.42 7.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -1.059 . . . . 0.0 109.358 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.513 ' CD ' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -140.67 109.74 6.14 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' HB2' ' CE2' ' A' ' 62' ' ' PHE . 19.1 m-85 -103.06 173.36 6.34 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -154.88 103.61 2.43 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.73 110.29 25.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -95.52 100.26 12.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.1 mp0 -73.88 159.75 32.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 51' ' ' GLU . 2.3 m -160.16 107.02 1.59 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.081 -1.012 . . . . 0.0 109.163 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -125.68 144.31 50.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.03 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.218 -0.927 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.632 ' H ' ' C ' ' A' ' 53' ' ' SER . 20.6 t80 -125.02 -19.62 5.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 111.782 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 177.02 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.303 -1.498 . . . . 0.0 110.084 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.774 ' H ' HD22 ' A' ' 57' ' ' ASN . 0.1 OUTLIER -62.89 145.58 54.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.999 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.79 174.19 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.4 pt-20 -147.05 143.99 28.77 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.22 110.57 4.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -89.5 146.22 6.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 4.6 p90 -160.46 153.75 21.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.561 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.2 tt0 -129.15 122.72 30.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 64' ' ' LEU . 3.0 pp -56.86 126.74 28.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.04 -1.037 . . . . 0.0 109.853 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.97 3.4 24.81 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.67 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 18.5 t -144.17 113.63 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.321 . . . . 0.0 109.777 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.778 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.5 m -55.48 147.64 17.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.958 0.885 . . . . 0.0 110.308 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.67 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -156.59 -171.0 3.52 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -134.05 153.24 51.93 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 34.9 t -156.84 131.62 8.86 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.56 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -95.79 145.42 25.35 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' GLY . 19.5 mt -95.85 146.89 24.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.628 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.44 -34.96 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.65 -0.656 . . . . 0.0 109.897 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.58 3.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.628 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.37 25.27 66.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.708 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.21 161.67 13.46 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.172 -1.193 . . . . 0.0 109.555 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -133.33 121.24 22.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -135.56 161.68 34.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.946 -1.096 . . . . 0.0 110.216 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HG3' HG22 ' A' ' 67' ' ' THR . 0.7 OUTLIER -144.48 148.24 34.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 109.65 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.778 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.23 -116.95 0.69 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 174.03 159.26 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.324 . . . . 0.0 111.093 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 12.8 m95 -102.2 141.67 34.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.588 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -138.79 156.9 46.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -95.54 128.72 42.63 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.353 -1.467 . . . . 0.0 108.408 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.658 ' N ' HD12 ' A' ' 84' ' ' LEU . 14.3 pt-20 -129.61 129.33 44.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.74 -108.56 0.73 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -125.51 34.12 4.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.177 -1.19 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.95 156.23 44.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.179 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.5 mt -97.1 110.83 23.3 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.3 164.72 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.149 -0.969 . . . . 0.0 110.522 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.658 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.97 95.19 0.17 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.704 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.0 ptmm? -86.85 102.41 14.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.122 -1.222 . . . . 0.0 109.102 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.5 m-30 -116.0 142.68 46.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.775 0.798 . . . . 0.0 109.801 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 31.8 pttt -133.34 124.02 26.47 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.708 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 25.5 mtt180 -44.67 116.8 1.13 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.383 -0.823 . . . . 0.0 108.886 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -7.19 41.05 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.66 -45.9 10.56 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.516 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -132.6 8.46 4.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 47.31 45.16 21.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 21.4 m-20 -73.12 12.57 0.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.4 mt-10 49.66 146.17 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.903 0.859 . . . . 0.0 111.32 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.661 HD23 ' C ' ' A' ' 102' ' ' LEU . 8.3 tt -149.93 126.04 10.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.515 ' N ' HD23 ' A' ' 102' ' ' LEU . 13.5 t30 -111.65 112.44 24.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.415 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.9 t -124.53 176.43 6.52 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 110.994 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.1 t -148.54 154.93 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -126.65 130.29 50.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 109.688 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -129.44 158.98 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 109.083 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -120.08 82.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 109' ' ' ILE . 9.5 mt -64.38 91.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.735 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 51.38 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.1 p-10 -125.05 29.84 6.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -1.173 . . . . 0.0 110.422 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -138.3 147.7 43.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.029 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.0 tp -107.76 112.42 25.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.031 -1.043 . . . . 0.0 109.477 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.521 HG22 HG23 ' A' ' 127' ' ' ILE . 3.4 t -94.77 115.16 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -114.56 103.32 10.9 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -103.0 145.94 29.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.909 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -128.17 152.65 47.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.96 0.886 . . . . 0.0 109.641 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.0 t -120.09 149.24 22.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.591 ' CE1' ' OE2' ' A' ' 120' ' ' GLU . 1.2 t80 -143.47 110.88 5.82 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.929 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.591 ' OE2' ' CE1' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 46.15 20.16 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.053 178.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.68 28.55 3.42 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.767 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.9 176.58 5.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.51 ' N ' HG13 ' A' ' 122' ' ' VAL . 39.0 tt0 -156.06 125.55 6.28 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.067 -1.453 . . . . 0.0 111.427 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.86 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -121.31 151.42 40.1 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.4 ' O ' ' OG ' ' A' ' 11' ' ' SER . 5.3 ttpt -132.31 139.61 48.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 0.0 111.282 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.517 HH11 ' HH ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -135.14 114.42 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 114' ' ' VAL . 3.3 mt -108.76 125.39 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.036 -1.04 . . . . 0.0 110.817 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.513 ' CE2' HD22 ' A' ' 38' ' ' LEU . 6.5 m-30 -97.7 174.6 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.248 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.743 ' HE2' ' HZ2' ' A' ' 130' ' ' LYS . 43.4 tttm -160.65 156.63 25.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.524 -0.735 . . . . 0.0 109.273 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.743 ' HZ2' ' HE2' ' A' ' 129' ' ' LYS . 13.3 pttp -49.13 128.91 17.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.592 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.508 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 4' ' ' SER . 20.2 p-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.251 0.548 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.58 -166.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.58 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 36.2 m -90.94 147.08 23.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.365 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.58 ' CD1' ' C ' ' A' ' 5' ' ' THR . 15.4 m95 -151.69 169.24 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 109.646 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' VAL . 36.7 pttt -153.2 126.96 8.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.029 -1.044 . . . . 0.0 109.768 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.632 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -36.4 106.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.382 -0.824 . . . . 0.0 109.422 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -91.1 -29.5 17.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' NH1' HG21 ' A' ' 127' ' ' ILE . 62.2 mtm-85 -151.54 166.68 30.4 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.225 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.4 t -177.15 166.46 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.507 -0.745 . . . . 0.0 109.091 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -166.75 166.17 15.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 0.0 110.448 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 58.9 21.78 9.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.581 -0.699 . . . . 0.0 110.243 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.59 ' OH ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.61 -57.29 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.599 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 19' ' ' GLU . 2.6 m-20 -45.85 -52.93 10.55 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.011 -1.056 . . . . 0.0 109.161 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -54.65 -41.68 70.38 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 81.9 t80 -67.84 -63.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -20.82 2.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 15' ' ' ASP . 39.1 tt0 -79.24 -38.13 36.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -65.81 -37.32 85.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.516 ' HB2' HG23 ' A' ' 23' ' ' VAL . 11.3 mtm -67.73 -8.84 38.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.322 -0.861 . . . . 0.0 109.11 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 32.51 41.69 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 21' ' ' MET . 17.7 t -80.02 139.2 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -1.108 . . . . 0.0 109.585 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' VAL . 62.6 t30 -44.83 170.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.302 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.593 ' CD1' ' CZ ' ' A' ' 28' ' ' ARG . 3.7 mm -85.33 -5.1 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.017 . . . . 0.0 109.34 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.469 HG23 ' ND2' ' A' ' 24' ' ' ASN . 58.8 t -83.88 -60.04 2.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.724 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 49.3 mttp -63.97 -24.06 67.58 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.593 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 23.4 ttp180 -73.04 -47.8 41.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.553 -0.717 . . . . 0.0 109.361 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -66.96 -34.84 78.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.793 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.71 -13.07 46.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 110.064 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -74.82 -25.92 59.36 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.167 0.508 . . . . 0.0 109.824 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -70.94 -61.0 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.103 -0.998 . . . . 0.0 109.509 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 82.2 t60 -70.71 46.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.451 -0.78 . . . . 0.0 109.434 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.485 ' OD2' HD22 ' A' ' 36' ' ' LEU . 37.8 t0 -88.94 127.54 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HA ' HG13 ' A' ' 8' ' ' VAL . 71.5 m-20 -123.78 43.08 3.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.632 HD23 HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -68.95 159.91 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.902 0.858 . . . . 0.0 111.008 -178.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -107.64 149.06 28.53 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 38' ' ' LEU . 2.6 mp -139.17 129.01 24.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.015 . . . . 0.0 109.952 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 m -99.96 105.86 17.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.513 HG13 HG23 ' A' ' 49' ' ' VAL . 3.7 mp -95.65 123.4 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 110.926 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.01 151.79 41.54 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -129.66 148.24 51.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.024 -1.048 . . . . 0.0 109.843 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' ASN . 27.9 mt-10 -144.72 78.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.66 -81.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' GLU . 11.7 p-10 -125.56 28.87 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.67 109.67 4.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.36 166.81 12.39 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.5 m -156.17 103.67 2.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.7 p -105.97 118.67 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.491 -0.755 . . . . 0.0 109.486 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -100.01 100.25 11.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.565 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 1.8 mp0 -70.51 156.3 39.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.935 . . . . 0.0 109.05 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -158.86 106.93 1.86 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.073 -1.017 . . . . 0.0 109.022 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.645 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.61 144.64 50.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.01 7.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 109.858 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.687 ' CZ ' ' NH2' ' A' ' 56' ' ' ARG . 6.0 t80 -112.29 -20.45 11.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 111.128 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.687 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER 160.44 89.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.843 -1.16 . . . . 0.0 109.317 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -62.18 148.17 45.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 59' ' ' GLU . 2.0 mt -138.11 174.19 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.032 0.92 . . . . 0.0 110.338 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.601 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.8 pt-20 -141.79 143.29 33.37 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.9 m -150.75 117.52 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 110.263 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER -89.08 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -137.82 165.93 25.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 23.8 tt0 -152.39 169.71 21.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.457 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 78.3 mt -100.74 118.88 37.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 110.197 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.87 24.56 27.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.345 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.636 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 21.0 t -144.05 102.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.05 -1.265 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.8 143.12 43.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.752 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.81 -171.03 3.82 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.432 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -138.41 149.73 45.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.481 -179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 50.0 t -151.91 135.66 16.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.43 143.91 28.36 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 110.163 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.1 mt -91.82 147.04 23.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.551 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.612 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.67 -33.86 1.33 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.702 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.68 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.612 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 78.34 25.33 61.54 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 161.7 13.43 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.236 -1.155 . . . . 0.0 109.692 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.732 ' C ' HD23 ' A' ' 78' ' ' LEU . 19.0 tt0 -133.09 125.88 30.55 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.732 HD23 ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -136.78 164.76 27.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.969 -1.082 . . . . 0.0 110.574 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.526 ' HG3' HG22 ' A' ' 67' ' ' THR . 14.6 ttm180 -147.85 143.15 27.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.66 -119.59 0.83 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.519 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 173.05 158.95 0.12 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.211 -1.17 . . . . 0.0 110.53 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.484 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.2 m95 -102.0 143.26 32.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.9 m -138.76 157.14 46.64 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -96.26 129.22 43.64 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.364 -1.46 . . . . 0.0 108.286 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.683 ' N ' HD12 ' A' ' 84' ' ' LEU . 1.3 pp20? -131.31 125.43 32.76 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.51 -109.45 1.58 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -125.47 33.84 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -1.156 . . . . 0.0 110.216 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.403 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.38 155.86 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.77 -1.206 . . . . 0.0 110.165 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mt -97.58 111.23 23.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.66 164.81 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 110.476 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.25 95.41 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.717 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 12.5 ptmt -86.17 102.78 14.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.189 -1.183 . . . . 0.0 108.478 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 102' ' ' LEU . 5.1 m-30 -118.95 145.72 45.56 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.823 0.821 . . . . 0.0 110.146 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.515 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 20.3 pttm -132.46 121.58 23.59 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 99' ' ' GLY . 49.0 mtp180 -46.95 114.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.398 -0.814 . . . . 0.0 109.026 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.49 -10.15 53.63 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 122.492 1.139 . . . . 0.0 109.28 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -79.03 -50.44 11.07 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.464 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -132.34 9.54 4.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.393 -0.817 . . . . 0.0 109.84 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.78 47.22 31.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.649 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.5 m120 -77.92 14.01 1.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -1.146 . . . . 0.0 109.581 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.8 mt-10 50.88 142.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.616 0.722 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -144.89 131.71 20.13 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.711 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -114.9 111.76 21.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 0.0 108.866 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.2 t -126.86 176.4 7.32 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.075 -1.016 . . . . 0.0 111.184 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 106' ' ' ARG . 45.2 t -147.92 162.34 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.485 ' N ' HG12 ' A' ' 105' ' ' VAL . 12.9 ttm180 -133.4 139.48 46.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.924 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -141.42 158.75 43.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.133 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.438 HD13 HD12 ' A' ' 113' ' ' LEU . 1.4 mm -119.21 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.0 mm -61.55 92.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.009 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.53 -78.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 109' ' ' ILE . 14.4 m-20 -130.73 29.9 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -1.151 . . . . 0.0 110.213 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -136.98 146.48 45.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.121 -0.987 . . . . 0.0 109.164 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.438 HD12 HD13 ' A' ' 108' ' ' ILE . 11.9 tp -102.23 115.64 30.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.995 -1.066 . . . . 0.0 109.219 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 127' ' ' ILE . 5.6 t -105.16 107.61 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 109.288 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.497 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 12.5 tt0 -107.43 109.46 21.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 144.7 28.59 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 109.767 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.681 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -127.22 150.76 49.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.841 0.829 . . . . 0.0 109.51 179.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.2 t -119.77 147.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.554 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -145.03 110.75 5.38 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.138 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 50.01 17.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.299 0.571 . . . . 0.0 110.979 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.29 27.76 3.8 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.751 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -121.42 176.34 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 2.3 mt-10 -156.05 117.23 3.85 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.09 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.886 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -112.17 166.94 10.81 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -145.26 137.47 25.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.912 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.59 ' NE ' ' OH ' ' A' ' 14' ' ' TYR . 14.6 mtt180 -125.15 114.1 18.58 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 114' ' ' VAL . 7.3 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 110.352 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.532 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 11.4 m-30 -100.93 166.21 10.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -150.96 146.75 26.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.58 -0.7 . . . . 0.0 109.121 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -47.83 136.43 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.496 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 130' ' ' LYS . 11.7 p30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.451 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 4' ' ' SER . 26.6 t70 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.16 0.505 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 160.29 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 109.598 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.582 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.7 m -98.03 142.59 29.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.304 -0.872 . . . . 0.0 109.352 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.582 ' CD1' ' C ' ' A' ' 5' ' ' THR . 4.4 m95 -147.29 169.43 19.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.303 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 8' ' ' VAL . 11.9 pttm -151.9 130.7 12.43 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.022 -1.049 . . . . 0.0 109.477 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.654 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -39.83 106.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.364 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.44 -32.28 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' OG ' ' A' ' 11' ' ' SER . 15.8 mtm-85 -142.58 164.65 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.686 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 67.3 m -170.47 178.22 3.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 109.294 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -155.19 157.5 37.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.056 . . . . 0.0 110.006 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 10.8 m-20 58.02 -109.53 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.678 . . . . 0.0 109.854 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 71.69 -51.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -61.36 -46.03 91.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.955 -1.091 . . . . 0.0 108.597 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -63.34 -33.84 76.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.918 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 91.0 t80 -71.39 -61.4 1.79 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.795 0.807 . . . . 0.0 108.883 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.3 mmt -59.04 -23.78 62.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -74.76 -37.82 62.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.24 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -64.67 -46.38 82.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.341 -0.849 . . . . 0.0 109.028 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.479 ' CE ' ' CE2' ' A' ' 17' ' ' PHE . 4.8 mtm -61.81 -9.07 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.041 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.26 28.02 62.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.533 HG11 ' OD1' ' A' ' 74' ' ' ASP . 3.8 t -74.85 132.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -1.091 . . . . 0.0 109.553 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.745 HD22 ' N ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -49.31 167.15 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.745 ' N ' HD22 ' A' ' 24' ' ' ASN . 1.5 mm -82.03 -1.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.181 0.991 . . . . 0.0 109.22 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -73.69 -59.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.456 0.646 . . . . 0.0 109.386 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -64.22 -29.56 70.66 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.071 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 14.3 ttp180 -72.71 -30.69 64.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.642 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -75.4 -40.02 58.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.38 -13.14 47.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.01 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 33' ' ' HIS . . . -84.7 -49.56 8.4 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.212 0.529 . . . . 0.0 109.626 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.2 -1.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.544 ' H ' ' C ' ' A' ' 31' ' ' ALA . 81.4 m-70 -140.1 46.26 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.609 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' LEU . 25.6 t0 -125.56 95.95 4.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.639 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.6 p-10 -71.48 43.57 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.353 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.654 HD23 HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -43.77 155.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.901 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -106.57 148.7 27.95 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.5 HD21 HD11 ' A' ' 36' ' ' LEU . 2.7 mp -138.92 126.53 21.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -98.29 111.78 24.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.8 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.9 mp -100.76 120.48 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.448 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -120.98 151.99 39.08 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.642 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 1.6 pm0 -130.88 147.06 52.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 45' ' ' ASN . 38.5 mm-40 -144.04 78.88 1.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.65 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.729 ' H ' HD22 ' A' ' 45' ' ' ASN . 0.0 OUTLIER -124.53 28.81 6.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -1.145 . . . . 0.0 110.347 -178.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.22 109.88 4.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 42' ' ' GLN . 3.9 m-85 -94.65 171.02 9.05 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m -155.9 103.5 2.24 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 0.0 108.992 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.67 115.69 41.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.326 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -101.09 100.25 10.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 52' ' ' SER . 5.3 tt0 -69.86 157.78 36.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 108.736 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.422 ' N ' ' CG ' ' A' ' 51' ' ' GLU . 2.3 m -160.12 107.02 1.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.152 -0.968 . . . . 0.0 109.015 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.676 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -137.05 144.36 43.15 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.18 7.62 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 109.236 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.676 ' H ' ' C ' ' A' ' 53' ' ' SER . 60.2 m-85 -109.38 -25.02 10.76 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.296 -0.878 . . . . 0.0 111.1 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 2.7 ptm180 164.34 86.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.171 . . . . 0.0 109.44 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -62.61 146.4 52.1 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.299 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -140.56 174.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.127 -0.983 . . . . 0.0 110.409 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.61 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.9 pt-20 -146.34 142.76 28.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 98.9 m -151.25 125.06 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -86.38 150.35 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -136.38 131.08 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.922 -1.112 . . . . 0.0 110.416 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' OE1' HG21 ' A' ' 66' ' ' VAL . 4.7 tt0 -120.98 170.03 9.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.61 118.94 37.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.061 -1.024 . . . . 0.0 110.333 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.08 22.87 36.79 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.479 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 12.7 t -143.71 105.85 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.959 -1.318 . . . . 0.0 109.401 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.727 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.48 142.37 44.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.637 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -149.45 -171.36 3.87 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -139.41 154.02 47.72 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.659 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.1 t -153.45 135.54 14.78 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' OD1' HG21 ' A' ' 58' ' ' ILE . 5.8 p30 -93.73 143.39 26.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.934 -1.104 . . . . 0.0 110.231 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 78' ' ' LEU . 16.4 mt -92.53 146.89 23.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.67 -34.79 0.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 0.0 109.813 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.533 ' OD1' HG11 ' A' ' 23' ' ' VAL . 11.5 t70 -60.29 8.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 72.54 27.09 70.15 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.687 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.03 162.17 13.14 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.181 -1.188 . . . . 0.0 109.624 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -132.55 120.41 21.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -133.15 162.28 32.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.932 -1.105 . . . . 0.0 110.582 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -146.31 146.88 30.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.538 -0.726 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.52 -119.52 0.79 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.88 156.87 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.3 -1.117 . . . . 0.0 110.65 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 5.2 m95 -102.85 143.48 32.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -142.08 122.35 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.475 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 118.75 7.92 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 119.951 -1.718 . . . . 0.0 109.857 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.04 115.82 29.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.67 -103.54 0.33 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.35 33.77 5.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -140.98 143.13 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.735 -1.228 . . . . 0.0 110.251 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.12 104.53 17.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.781 ' CG1' ' O ' ' A' ' 83' ' ' SER . 0.9 OUTLIER -81.64 163.5 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.733 -1.229 . . . . 0.0 110.04 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.665 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.19 95.86 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.712 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.1 mttm -85.75 103.35 14.45 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.401 -1.058 . . . . 0.0 108.463 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.438 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -115.71 148.27 39.94 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.82 0.819 . . . . 0.0 110.154 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -133.41 120.9 21.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.451 0.643 . . . . 0.0 109.526 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.687 HH21 ' CG2' ' A' ' 76' ' ' THR . 23.8 mtp85 -53.1 115.32 1.81 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -13.41 61.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.456 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.618 ' C ' HD22 ' A' ' 98' ' ' ASN . 52.9 t0 -77.84 -49.89 13.38 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.768 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.618 HD22 ' C ' ' A' ' 97' ' ' ASP . 1.0 OUTLIER -132.33 11.2 4.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.964 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.46 42.31 9.67 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.674 ' O ' ' O ' ' A' ' 101' ' ' GLU . 74.5 m-20 -75.6 19.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -1.154 . . . . 0.0 109.512 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.674 ' O ' ' O ' ' A' ' 100' ' ' ASN . 15.6 pt-20 45.07 164.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.816 0.817 . . . . 0.0 110.911 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 117' ' ' TYR . 6.6 tp -165.12 127.25 2.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -114.4 115.96 28.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.002 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -126.19 176.32 7.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.14 -0.975 . . . . 0.0 110.807 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -149.71 153.38 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.664 ' HE ' ' NE2' ' A' ' 115' ' ' GLN . 7.4 mtt180 -125.92 136.51 53.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.789 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -138.16 158.54 44.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.72 82.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 109' ' ' ILE . 22.4 mt -63.58 91.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.38 -81.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -127.89 29.34 5.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -1.191 . . . . 0.0 110.271 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -134.6 144.23 47.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.5 tp -105.36 113.34 26.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.873 -1.142 . . . . 0.0 109.085 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 127' ' ' ILE . 11.1 t -99.49 108.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.664 ' NE2' ' HE ' ' A' ' 106' ' ' ARG . 11.1 tt0 -105.52 106.65 17.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.6 OUTLIER -100.33 145.78 27.73 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 110.114 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -121.99 157.03 32.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.782 0.801 . . . . 0.0 109.191 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 103' ' ' ASN . 11.9 t -127.46 147.82 32.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.552 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.2 t80 -146.53 110.58 5.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.056 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 45.77 20.29 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.134 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.8 28.54 3.39 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.72 176.65 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 66.1 tt0 -155.91 125.28 6.25 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.401 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.918 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -115.6 152.92 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -133.92 136.91 44.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.773 -1.204 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.08 114.05 14.08 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.595 HG23 HG22 ' A' ' 114' ' ' VAL . 4.4 mt -107.67 123.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.989 . . . . 0.0 110.685 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -101.05 176.02 5.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.365 -0.834 . . . . 0.0 108.786 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -165.31 156.63 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.416 -0.803 . . . . 0.0 109.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -47.64 129.17 13.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.453 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.7 t70 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.72 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 85.2 m -102.16 143.26 32.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 109.721 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.571 ' CD1' ' C ' ' A' ' 5' ' ' THR . 11.5 m95 -148.69 168.72 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.14 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 8' ' ' VAL . 9.7 pttm -153.21 130.91 11.56 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 0.0 109.588 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -38.39 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.8 -27.05 21.36 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -154.62 167.84 28.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.143 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -177.94 164.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 14' ' ' TYR . 6.7 pt-20 -166.76 166.45 15.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.81 -1.181 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.12 -5.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.653 -0.654 . . . . 0.0 110.191 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -46.78 -61.23 1.94 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.966 -1.084 . . . . 0.0 110.021 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 6.1 p-10 -44.92 -44.78 9.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.984 -1.073 . . . . 0.0 109.247 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -62.7 -41.62 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 108.664 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.847 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 23.5 t80 -68.59 -54.82 14.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.384 -0.823 . . . . 0.0 108.949 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 7.2 mmt -57.96 -31.11 66.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' A' ' 28' ' ' ARG . 26.2 tt0 -74.8 -25.33 58.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -70.68 -48.66 53.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 ttm -59.44 -10.22 3.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.058 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.81 32.4 27.0 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' ASN . 13.8 t -77.03 132.41 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -1.077 . . . . 0.0 109.55 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' VAL . 3.2 t-20 -48.32 177.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.322 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.62 -2.82 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 109.41 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.85 -60.05 2.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -65.45 -25.96 67.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.43 HH21 ' HB2' ' A' ' 19' ' ' GLU . 21.3 ttp180 -73.25 -43.4 61.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.406 -0.809 . . . . 0.0 109.263 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -70.44 -32.72 70.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.1 mt -86.45 -13.7 45.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -85.96 -47.17 9.86 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.75 -22.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' ASN . 22.1 t-160 -69.29 37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 32' ' ' ALA . 5.3 p30 -49.92 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.838 . . . . 0.0 109.594 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.4 OUTLIER -147.26 43.22 1.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 108.862 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -92.72 168.54 11.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 111.238 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -108.83 150.22 27.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 38' ' ' LEU . 1.3 mp -139.64 120.0 13.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.991 -1.068 . . . . 0.0 110.329 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -101.79 111.38 23.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.4 mp -111.18 144.04 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 111.41 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -133.76 152.39 51.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -128.11 146.17 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -143.17 79.06 1.63 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.978 . . . . 0.0 109.616 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.01 -88.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.8 29.11 6.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.0 110.272 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -151.52 110.07 3.8 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -100.34 174.18 6.24 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.506 0.669 . . . . 0.0 109.919 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -148.86 103.23 3.35 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.8 t -96.06 110.92 25.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.749 -0.594 . . . . 0.0 109.571 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -100.77 100.24 10.88 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.3 mt-10 -73.89 159.35 32.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 109.004 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -161.99 107.15 1.25 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.143 -0.973 . . . . 0.0 109.096 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.672 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -135.0 144.29 47.29 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.64 7.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.987 -1.071 . . . . 0.0 109.156 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.672 ' H ' ' C ' ' A' ' 53' ' ' SER . 82.8 m-85 -113.16 -19.74 11.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.393 -0.817 . . . . 0.0 111.097 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.3 mmt180 162.8 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 109.556 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.729 ' H ' HD22 ' A' ' 57' ' ' ASN . 0.3 OUTLIER -63.1 148.69 47.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.278 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.614 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -142.85 174.31 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 121.192 -0.943 . . . . 0.0 110.471 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.614 ' H ' HG22 ' A' ' 58' ' ' ILE . 7.7 pt-20 -146.88 143.72 28.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.3 m -153.25 117.71 4.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.36 151.07 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -138.78 155.13 48.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.947 -1.096 . . . . 0.0 110.433 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.515 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 50.2 tt0 -150.01 168.41 23.95 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.515 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 14.5 mt -99.64 123.94 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.008 -1.058 . . . . 0.0 110.274 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 28.72 40.73 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.616 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 42.4 t -144.05 102.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.091 -1.24 . . . . 0.0 109.201 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -57.78 141.67 48.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.201 -0.937 . . . . 0.0 109.955 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.616 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.4 -171.6 3.98 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -138.67 150.6 46.39 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.65 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.5 t -151.44 136.33 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.711 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -95.09 144.76 25.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 110.225 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 73' ' ' ALA . 98.0 mt -93.27 146.79 23.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.619 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.81 -35.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 19.5 t70 -57.8 4.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.142 -0.974 . . . . 0.0 109.444 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.31 26.28 64.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.14 161.99 13.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 96' ' ' THR . 30.3 tt0 -132.86 122.27 24.15 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -133.79 163.85 28.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.014 -1.054 . . . . 0.0 110.541 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.15 142.19 28.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.135 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.89 -117.01 0.63 Allowed Glycine 0 N--CA 1.477 1.382 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.551 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.42 157.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.21 -1.17 . . . . 0.0 110.428 179.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.7 m95 -101.99 143.11 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.592 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.4 t -140.51 156.7 46.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 108.565 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -94.31 128.27 40.7 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.321 -1.487 . . . . 0.0 108.1 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.653 ' N ' HD12 ' A' ' 84' ' ' LEU . 12.8 pt-20 -133.31 125.03 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.01 -109.66 2.7 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.67 34.37 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -1.176 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -148.3 160.77 42.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.503 -1.373 . . . . 0.0 110.61 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.06 110.37 22.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.592 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.86 164.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 110.522 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.71 95.41 0.17 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.642 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 50.9 mttt -87.49 104.78 16.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.214 -1.168 . . . . 0.0 109.242 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.9 m-30 -118.19 127.27 53.59 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.735 0.778 . . . . 0.0 109.849 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -113.07 120.6 41.87 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.518 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 43.3 mtp180 -48.05 115.11 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -80.58 -10.4 59.74 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.485 1.136 . . . . 0.0 109.113 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.98 -26.61 18.3 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.789 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -132.06 4.6 4.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.965 . . . . 0.0 109.415 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 49.99 45.57 41.72 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.547 ' OD1' ' N ' ' A' ' 101' ' ' GLU . 30.8 t-20 -88.23 -122.48 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.25 -1.147 . . . . 0.0 109.008 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.0 pt-20 -175.29 138.55 0.42 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.353 0.597 . . . . 0.0 110.179 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.762 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.8 tt -141.17 119.2 11.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -110.16 112.34 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 108.693 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -122.65 174.95 6.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.139 0.971 . . . . 0.0 111.643 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.7 t -142.98 149.23 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -126.22 132.46 51.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -135.07 157.76 46.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.06 82.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.073 -1.017 . . . . 0.0 108.63 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 111' ' ' ASP . 62.8 mt -63.6 92.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.211 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.91 -77.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.9 m-20 -130.55 29.43 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -1.179 . . . . 0.0 110.404 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -135.34 134.56 39.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.223 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 6.4 tp -100.14 112.96 25.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 127' ' ' ILE . 14.9 t -99.59 106.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.336 -0.945 . . . . 0.0 108.807 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.609 ' NE2' ' OH ' ' A' ' 117' ' ' TYR . 10.0 tt0 -111.1 104.61 13.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 108.984 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.419 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.3 144.4 30.84 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 0.0 109.464 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.762 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -129.02 144.67 51.26 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 109.687 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 122' ' ' VAL . 13.2 t -110.58 147.31 14.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.505 ' N ' HG12 ' A' ' 122' ' ' VAL . 2.4 t80 -148.22 114.18 5.78 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 52.85 14.92 0.48 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.87 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.3 28.37 3.83 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.78 176.73 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.678 ' HG2' HG22 ' A' ' 118' ' ' VAL . 19.6 mt-10 -155.56 111.79 3.13 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.454 -1.299 . . . . 0.0 110.787 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -105.01 153.47 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.06 138.27 49.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.994 -1.066 . . . . 0.0 110.68 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -131.7 114.11 14.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.9 mt -107.69 123.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.579 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 7.5 m-30 -99.73 176.17 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.288 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -161.45 146.28 13.45 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -47.8 133.67 13.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.524 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.498 ' OD1' ' OE1' ' A' ' 42' ' ' GLN . 4.0 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -175.22 -151.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 110.518 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.608 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 23.6 m -106.77 131.09 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.416 -0.802 . . . . 0.0 110.192 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.693 ' CZ3' ' N ' ' A' ' 130' ' ' LYS . 49.9 m95 -145.05 158.04 43.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -147.81 153.59 39.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.704 -1.247 . . . . 0.0 110.668 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.438 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 2.7 t -42.47 106.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.716 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -97.16 -31.07 12.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HB2' HD12 ' A' ' 127' ' ' ILE . 50.8 mtt85 -152.85 172.07 17.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.8 t -173.22 177.38 2.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.947 -1.096 . . . . 0.0 109.723 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.99 162.19 40.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.858 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 4.6 m-20 59.58 -109.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.582 -0.699 . . . . 0.0 109.865 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.678 ' CE1' ' NH2' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 72.06 -52.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -0.967 . . . . 0.0 109.703 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 13.2 p-10 -60.94 -44.42 97.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.561 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -63.62 -32.07 73.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.896 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 16.1 t80 -71.77 -64.02 1.01 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.063 0.935 . . . . 0.0 108.619 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -58.27 -24.0 58.02 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.455 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 24.2 tp10 -79.86 -29.1 39.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 109.295 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -71.37 -42.66 68.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.077 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.7 mtm -67.41 -6.37 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.343 -0.848 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.49 64.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.86 130.81 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -1.162 . . . . 0.0 109.578 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.661 HD22 ' N ' ' A' ' 24' ' ' ASN . 1.1 m120 -50.09 174.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.945 . . . . 0.0 109.368 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -84.47 -1.4 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 122.159 0.98 . . . . 0.0 109.175 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.09 -59.87 2.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -37.93 71.8 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HB3' ' A' ' 15' ' ' ASP . 2.1 ttt85 -64.41 -50.3 68.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -50.07 -36.41 29.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.001 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.47 -13.11 47.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.085 0.945 . . . . 0.0 109.384 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' ASP . . . -84.39 -37.01 22.04 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.658 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.73 -37.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.346 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -98.52 33.97 2.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.109 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ALA . 22.1 t70 -79.25 38.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.461 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -73.7 43.7 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 36' ' ' LEU . 2.6 pt? -52.99 170.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.13 0.967 . . . . 0.0 111.576 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -110.47 148.2 32.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.813 HD13 ' CE2' ' A' ' 128' ' ' PHE . 0.6 OUTLIER -137.17 123.98 21.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.92 -1.113 . . . . 0.0 110.54 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.77 109.08 21.07 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.1 mp -103.33 127.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 0.0 110.801 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -128.45 151.75 49.03 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.498 ' OE1' ' OD1' ' A' ' 3' ' ' ASP . 6.7 pt20 -141.29 140.18 33.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.839 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.43 78.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.43 -88.5 0.03 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.626 -0.989 . . . . 0.0 110.626 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.675 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -116.72 28.99 8.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -1.094 . . . . 0.0 110.348 -178.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -145.65 110.25 5.08 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.415 ' O ' HG23 ' A' ' 61' ' ' VAL . 13.9 m-85 -104.86 168.52 9.01 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -156.0 103.54 2.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.137 -0.977 . . . . 0.0 109.057 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.42 121.87 49.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -112.54 100.36 8.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' ILE . 92.0 mt-10 -77.48 157.44 30.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.104 -0.998 . . . . 0.0 109.318 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -159.46 106.82 1.73 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.229 -0.92 . . . . 0.0 108.984 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.644 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -131.05 144.46 51.47 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.01 7.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.175 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.644 ' H ' ' C ' ' A' ' 53' ' ' SER . 70.9 t80 -114.47 -17.64 11.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 111.173 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 6.4 mtp85 161.71 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.714 -1.241 . . . . 0.0 109.205 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -63.03 144.12 57.17 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.339 -0.85 . . . . 0.0 109.632 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.583 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -136.35 174.23 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.86 0.838 . . . . 0.0 110.08 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.583 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -156.65 156.07 32.85 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.9 109.11 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.82 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.639 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -104.53 153.45 6.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 1.7 m-85 176.42 -179.21 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.833 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.1 tt0 -117.66 168.33 10.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.504 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 19.2 mt -81.33 139.09 35.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.04 23.24 28.01 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.64 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 52.0 t -143.92 103.76 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -1.197 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.762 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.7 143.19 25.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.946 . . . . 0.0 109.811 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.71 -171.62 3.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.567 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 5.2 p30 -137.2 151.43 48.75 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 110.312 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 71.3 m -156.89 137.41 13.09 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.652 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -92.53 143.9 25.88 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 0.0 110.416 -178.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 96.0 mt -93.22 146.97 23.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.397 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.29 -34.04 0.45 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.907 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.22 12.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 68.74 27.13 74.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.19 162.31 13.05 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.258 -1.142 . . . . 0.0 109.634 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 96' ' ' THR . 30.6 tt0 -132.22 118.7 19.86 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -133.78 162.49 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.098 . . . . 0.0 110.797 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 9.8 ptm180 -143.23 142.92 31.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.83 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.762 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.4 -117.78 0.67 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.527 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.64 158.11 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.049 -1.265 . . . . 0.0 110.693 179.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.425 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.77 142.52 32.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -138.78 157.05 46.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -96.56 125.85 41.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.351 -1.468 . . . . 0.0 108.234 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.594 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.5 mm-40 -123.57 111.13 15.89 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.52 -105.19 1.07 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -125.13 33.65 5.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -1.136 . . . . 0.0 110.146 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -140.8 149.18 41.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.797 -1.19 . . . . 0.0 110.229 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -96.05 107.35 19.64 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -78.32 164.22 3.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 110.684 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.657 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.15 94.78 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.681 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.1 mtpm? -87.98 104.23 16.44 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.25 -1.147 . . . . 0.0 108.879 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -116.33 139.11 50.75 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.865 0.841 . . . . 0.0 110.18 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -121.72 121.03 36.38 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 15.7 mtp180 -53.81 115.03 1.78 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -68.01 -12.37 60.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.368 1.08 . . . . 0.0 109.396 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.88 -52.14 9.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.529 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 1.5 t-20 -132.62 14.55 4.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.65 44.05 11.84 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.751 ' O ' ' O ' ' A' ' 101' ' ' GLU . 49.7 m-20 -76.18 19.22 0.25 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -1.095 . . . . 0.0 109.724 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.751 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.2 pt-20 42.77 158.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.062 0.934 . . . . 0.0 111.247 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.1 tt -160.14 123.65 3.56 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.725 ' N ' HD23 ' A' ' 102' ' ' LEU . 2.0 m120 -113.45 113.87 25.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.097 -1.002 . . . . 0.0 109.028 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -126.0 176.56 6.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 111.071 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.4 t -148.85 150.82 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -127.77 135.13 49.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.549 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -141.89 158.6 43.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 mm -119.39 82.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 109' ' ' ILE . 1.7 mp -65.22 91.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 121.633 0.73 . . . . 0.0 109.893 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.34 -76.15 0.0 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 109' ' ' ILE . 10.2 t70 -124.45 29.64 6.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.239 . . . . 0.0 110.838 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -145.55 136.97 25.07 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.031 -1.043 . . . . 0.0 109.33 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.31 110.77 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.503 HG23 HD13 ' A' ' 109' ' ' ILE . 38.5 t -95.93 118.05 41.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 110.08 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.84 103.06 8.79 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.3 OUTLIER -105.33 147.16 28.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.155 -0.965 . . . . 0.0 110.182 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -126.82 152.85 46.41 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 109.252 178.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 122' ' ' VAL . 5.7 t -121.2 148.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.52 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.94 110.52 5.57 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.878 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 47.16 19.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.146 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.43 28.56 3.47 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.81 177.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 122' ' ' VAL . 58.9 tt0 -155.65 122.29 5.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.391 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.896 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -113.47 141.02 47.61 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -119.83 140.59 50.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.778 -1.201 . . . . 0.0 111.111 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.678 ' NH2' ' CE1' ' A' ' 14' ' ' TYR . 61.3 mtp85 -134.9 113.75 11.85 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 10' ' ' ARG . 3.5 mt -108.8 124.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.709 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.813 ' CE2' HD13 ' A' ' 38' ' ' LEU . 7.1 m-30 -98.21 177.95 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.938 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.507 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 20.0 tttp -158.29 147.22 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.693 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 16.4 pttp -46.69 129.02 11.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' OD2' ' A' ' 131' ' ' ASP . 7.3 p30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.485 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.495 ' HB3' ' HE1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -168.54 -151.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.366 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.604 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 47.5 m -108.8 126.43 53.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.604 ' CD1' ' C ' ' A' ' 5' ' ' THR . 37.6 m95 -142.12 168.59 19.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.337 -0.852 . . . . 0.0 108.703 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.5 pttp -152.44 143.37 23.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.701 -1.249 . . . . 0.0 110.506 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.548 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -43.25 107.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.451 -0.78 . . . . 0.0 109.953 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.76 -31.15 12.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -149.12 164.71 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.727 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -170.46 169.79 7.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.258 -0.901 . . . . 0.0 109.255 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 14' ' ' TYR . 8.1 pt-20 -166.65 166.68 15.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.934 -1.104 . . . . 0.0 110.434 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 14' ' ' TYR . 2.5 m-20 62.57 -10.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.555 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -43.44 -59.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.019 -1.051 . . . . 0.0 109.863 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.59 -45.76 38.51 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.95 -1.094 . . . . 0.0 109.243 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -59.6 -40.66 88.21 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.907 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 24.4 t80 -67.39 -62.88 1.21 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -30.77 9.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -73.42 -29.27 62.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.072 -1.018 . . . . 0.0 109.128 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -67.94 -48.36 66.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.2 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.92 -6.95 4.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.53 26.26 47.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.9 t -72.78 136.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -1.059 . . . . 0.0 109.525 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -53.25 174.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.59 -1.98 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.093 0.949 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.9 -60.09 2.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 6.3 mptt -65.95 -21.15 66.41 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.422 ' NE ' HD13 ' A' ' 25' ' ' ILE . 15.3 ttp180 -72.64 -43.56 63.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 109.43 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -70.35 -33.45 71.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.62 -13.12 46.59 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.937 0.875 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -83.83 -52.97 5.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.245 0.545 . . . . 0.0 109.89 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.13 -50.6 4.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 33' ' ' HIS . 12.3 m-70 -73.66 46.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.511 ' HB3' HH22 ' A' ' 126' ' ' ARG . 46.6 m-20 -71.23 136.56 48.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.51 ' HA ' HG13 ' A' ' 8' ' ' VAL . 5.1 m-80 -147.37 43.06 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.692 ' CD2' HH12 ' A' ' 126' ' ' ARG . 0.8 OUTLIER -84.27 162.87 19.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 110.948 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -107.71 147.0 31.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.537 HD13 ' CE2' ' A' ' 128' ' ' PHE . 3.6 mp -136.6 121.04 18.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 110.019 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 m -92.1 104.58 16.95 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.738 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -97.69 117.84 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.22 151.92 38.45 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.444 ' CD ' ' CE2' ' A' ' 47' ' ' PHE . 49.1 tt0 -129.28 146.55 51.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.136 -0.978 . . . . 0.0 109.813 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -145.24 79.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.39 -92.95 0.16 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.04 28.56 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.382 -1.069 . . . . 0.0 109.758 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -145.96 109.6 4.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.444 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 14.1 m-85 -96.7 173.92 7.08 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.765 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -153.47 104.04 2.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 51' ' ' GLU . 2.5 t -101.22 112.79 35.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.57 -0.707 . . . . 0.0 109.373 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.47 100.6 11.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.885 . . . . 0.0 109.404 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.582 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.0 mp0 -72.65 155.73 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.183 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 1.2 m -159.34 106.71 1.75 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.119 -0.988 . . . . 0.0 108.892 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.638 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -130.44 144.28 51.3 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.94 8.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.27 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.638 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -117.03 -19.83 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 111.422 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.701 ' HE ' ' HB1' ' A' ' 73' ' ' ALA . 6.9 ptt180 167.7 84.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.641 -1.287 . . . . 0.0 109.575 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 30.0 p-10 -63.14 143.98 57.31 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -135.89 174.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.182 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.588 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.9 pt-20 -154.1 142.4 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.37 131.64 6.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.546 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -75.13 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.245 -0.91 . . . . 0.0 108.546 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -148.02 118.51 7.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.026 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.427 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 26.6 tt0 -130.32 146.82 51.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.5 pp -95.73 130.5 42.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.784 -1.197 . . . . 0.0 109.597 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.05 8.17 42.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.595 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 46.9 t -144.29 103.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.079 -1.248 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -57.16 145.1 32.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.206 1.003 . . . . 0.0 110.049 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.69 -170.77 3.53 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.509 ' ND2' ' C ' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -145.0 149.13 34.6 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.738 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.421 ' SG ' ' N ' ' A' ' 71' ' ' ASN . 43.6 t -150.29 170.43 19.02 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 1.5 p-10 -120.52 145.86 46.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.959 -1.088 . . . . 0.0 110.311 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 73' ' ' ALA . 15.5 mt -93.82 146.9 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.545 -0.722 . . . . 0.0 109.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.701 ' HB1' ' HE ' ' A' ' 56' ' ' ARG . . . -40.56 -36.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.725 . . . . 0.0 109.833 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 38.2 t0 -57.83 6.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 109.437 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.642 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 73.86 26.16 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.25 162.17 13.13 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.204 -1.174 . . . . 0.0 109.621 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' THR . 29.3 tt0 -132.45 124.25 28.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.66 166.11 23.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.957 -1.089 . . . . 0.0 110.727 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -148.42 141.35 24.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.422 -0.799 . . . . 0.0 109.912 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.64 -118.0 0.71 Allowed Glycine 0 N--CA 1.475 1.281 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.551 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.61 159.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -1.176 . . . . 0.0 110.499 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.58 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 2.3 m95 -103.1 144.62 31.06 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.39 157.68 44.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -89.6 127.89 35.96 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.166 -1.584 . . . . 0.0 108.255 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.622 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -125.83 122.03 34.98 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.54 ' C ' HD22 ' A' ' 87' ' ' ASN . . . 56.79 -107.7 1.0 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.54 HD22 ' C ' ' A' ' 86' ' ' GLY . 1.5 m120 -125.28 33.3 5.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -1.133 . . . . 0.0 110.065 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 1.3 mptt -141.53 159.44 42.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.879 -1.138 . . . . 0.0 109.924 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.27 108.87 21.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -76.8 164.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.012 -1.055 . . . . 0.0 110.305 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.77 96.27 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.629 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -89.65 105.59 17.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.142 -1.21 . . . . 0.0 108.897 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.407 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.1 m-30 -118.08 125.36 50.15 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.821 0.82 . . . . 0.0 109.999 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -108.89 118.35 36.56 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.533 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 63.9 mtp180 -46.42 114.89 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.19 -10.35 59.64 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.533 1.159 . . . . 0.0 109.125 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.88 -26.15 19.49 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.61 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.16 2.1 3.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 52.76 45.71 60.44 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' A' ' 95' ' ' ARG . 15.7 t-20 -89.39 -122.07 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.367 -1.078 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -175.45 138.89 0.42 Allowed 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.948 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.734 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.0 tt -144.02 120.34 10.91 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.555 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -107.48 107.79 18.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.789 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -121.55 175.92 5.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.992 . . . . 0.0 111.559 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 106' ' ' ARG . 33.3 t -148.19 159.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.675 ' NE ' ' NE2' ' A' ' 115' ' ' GLN . 9.8 ttm180 -134.63 136.97 43.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -145.71 159.12 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 109.08 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.4 83.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.683 ' O ' ' N ' ' A' ' 111' ' ' ASP . 44.4 mt -64.23 91.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.26 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.89 -80.52 0.0 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 109' ' ' ILE . 2.2 p30 -119.6 30.11 7.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -1.203 . . . . 0.0 111.052 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 129' ' ' LYS . 2.6 mt-10 -145.07 132.75 20.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.859 -1.151 . . . . 0.0 109.475 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.7 OUTLIER -98.12 113.93 25.97 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 109' ' ' ILE . 2.1 t -108.26 113.82 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.617 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.675 ' NE2' ' NE ' ' A' ' 106' ' ' ARG . 11.0 tt0 -110.29 105.29 14.27 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.502 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -99.59 146.35 26.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.116 -0.99 . . . . 0.0 110.006 -178.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.734 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -131.17 145.64 52.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.873 0.844 . . . . 0.0 109.737 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.7 t -111.86 148.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.518 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.6 t80 -147.23 112.09 5.39 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.032 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 51.5 16.35 0.43 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.875 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.79 28.24 3.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.759 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.97 176.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 pt-20 -155.57 113.46 3.37 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.008 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -105.75 156.84 17.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -134.06 136.08 43.73 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.012 -1.055 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.692 HH12 ' CD2' ' A' ' 36' ' ' LEU . 4.2 mmm180 -125.32 116.2 21.55 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 7.0 mt -110.64 124.17 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.537 ' CE2' HD13 ' A' ' 38' ' ' LEU . 8.9 m-30 -98.99 176.38 5.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.146 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 3.8 tppt? -155.66 150.16 26.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.528 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 12.3 tttt -46.94 135.46 9.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.456 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.6 m-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.1 m 161.63 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.617 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.3 m -103.63 140.76 37.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.617 ' CD1' ' C ' ' A' ' 5' ' ' THR . 5.3 m95 -148.04 168.88 21.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 8' ' ' VAL . 6.5 pttp -153.36 132.71 12.8 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.662 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.56 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -0.893 . . . . 0.0 109.628 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 17.7 t0 -94.73 -28.4 15.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -148.39 171.84 15.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.716 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 t -171.86 178.34 3.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.19 151.21 30.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.796 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.55 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 21.9 t-20 58.66 -108.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.0 109.842 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.593 ' CD2' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER 75.55 -54.13 0.64 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.0 110.017 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.92 -45.99 91.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.034 -1.041 . . . . 0.0 109.099 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.56 -30.72 71.09 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.866 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 15.1 t80 -72.19 -57.07 4.54 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.193 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.568 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 2.5 mpp? -59.14 -28.61 66.71 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.85 -27.71 55.18 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.149 -0.97 . . . . 0.0 109.254 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -71.54 -42.59 67.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.238 -0.913 . . . . 0.0 109.414 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.662 ' SD ' ' CE2' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -68.76 -5.41 20.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.043 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.11 25.14 56.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 24' ' ' ASN . 60.9 t -67.33 116.93 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.159 . . . . 0.0 109.461 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 23' ' ' VAL . 2.5 m-20 -41.79 155.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -67.48 -2.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 0.0 109.084 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.59 -60.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.95 -30.72 69.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -50.19 61.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -56.1 -34.17 65.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.57 -13.22 46.43 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.967 0.889 . . . . 0.0 109.759 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -84.64 -37.97 20.41 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.256 0.551 . . . . 0.0 109.603 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' ASP . . . -44.66 -14.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.305 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.4 m-70 -70.44 46.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.178 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -54.47 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.463 -0.773 . . . . 0.0 109.878 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.4 OUTLIER -148.22 42.38 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.275 -0.89 . . . . 0.0 109.12 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.662 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -84.31 159.09 20.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 52' ' ' SER . 11.4 ttpt -119.49 145.83 45.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.6 pt? -154.5 142.48 20.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.975 -1.078 . . . . 0.0 110.346 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.464 ' C ' HD12 ' A' ' 40' ' ' ILE . 6.4 m -108.17 124.92 51.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.822 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.5 mp -109.95 124.98 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 110.81 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 151.62 36.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.3 148.77 48.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.994 -1.066 . . . . 0.0 110.071 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -148.46 79.09 1.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.36 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.17 -89.93 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -123.45 28.42 7.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -1.096 . . . . 0.0 109.71 -179.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -144.51 110.54 5.43 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.473 ' O ' HG23 ' A' ' 61' ' ' VAL . 1.3 p90 -111.46 173.68 6.23 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.395 0.617 . . . . 0.0 109.686 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.7 m -150.81 103.09 3.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.699 HG12 ' OE2' ' A' ' 51' ' ' GLU . 17.7 t -90.93 108.49 19.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.623 -0.673 . . . . 0.0 109.563 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -99.42 100.2 11.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.699 ' OE2' HG12 ' A' ' 49' ' ' VAL . 3.6 mp0 -78.01 159.73 28.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 37' ' ' LYS . 1.7 m -159.96 106.65 1.62 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.669 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 55' ' ' PHE . 1.8 p -127.25 144.31 51.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.88 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 109.588 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' SER . 9.4 t80 -123.43 -11.74 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 111.641 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.1 mmt180 164.72 84.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.459 -1.401 . . . . 0.0 109.883 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -63.9 147.46 51.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.463 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -138.19 174.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 110.072 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.6 135.41 11.74 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.55 109.15 4.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -105.22 153.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.9 OUTLIER 175.95 -179.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.142 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 66' ' ' VAL . 42.1 tt0 -117.53 137.23 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.93 142.04 57.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.16 -34.33 5.48 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 66' ' ' VAL . 6.2 p -102.63 125.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.244 . . . . 0.0 109.974 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.62 142.99 51.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.91 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CZ ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -148.72 -171.62 3.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.518 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.544 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 2.0 p-10 -135.94 150.74 49.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.088 -1.007 . . . . 0.0 110.345 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 60.5 m -155.79 135.88 12.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.548 ' OD1' HG21 ' A' ' 58' ' ' ILE . 2.2 p30 -95.21 144.56 25.71 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.916 -1.115 . . . . 0.0 110.607 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.6 mt -90.87 146.9 23.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.59 -0.694 . . . . 0.0 109.222 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.76 -35.17 1.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.755 . . . . 0.0 109.723 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.0 4.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.81 26.43 62.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.0 162.19 13.14 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.303 -1.116 . . . . 0.0 109.517 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.82 121.13 22.5 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -135.02 162.9 31.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.88 -1.137 . . . . 0.0 110.51 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.59 143.2 31.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 109.894 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.738 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.35 -116.62 0.62 Allowed Glycine 0 N--CA 1.477 1.368 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.547 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 171.37 158.42 0.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 0.0 110.813 179.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.6 141.48 34.4 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -139.53 157.17 46.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.935 . . . . 0.0 108.527 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -94.53 126.48 39.84 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.35 -1.469 . . . . 0.0 108.187 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.602 ' N ' HD12 ' A' ' 84' ' ' LEU . 14.1 mm-40 -129.37 120.62 25.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 -108.26 2.05 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -125.37 34.28 4.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -1.156 . . . . 0.0 110.549 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 161.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.6 -1.313 . . . . 0.0 110.412 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 mt -100.98 108.01 19.63 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -75.52 164.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.436 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.672 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.89 94.63 0.16 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.691 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 5.6 mtmm -88.5 102.97 15.44 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.115 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 3.7 m-30 -116.15 129.89 56.54 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.802 0.811 . . . . 0.0 109.792 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -113.06 118.2 34.13 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.493 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 42.7 mtp180 -51.07 114.99 1.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.75 -11.68 56.79 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.485 1.136 . . . . 0.0 109.086 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.22 -23.44 21.26 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -132.1 -0.87 3.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.226 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 54.58 43.48 78.47 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.597 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 16.6 t-20 -92.26 -122.85 0.08 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -1.162 . . . . 0.0 109.244 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 4.3 pt-20 -174.91 138.39 0.46 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -136.0 111.29 9.06 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.406 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.7 OUTLIER -104.69 108.19 19.52 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.7 t -122.28 176.14 6.02 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.148 0.975 . . . . 0.0 112.099 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.41 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.7 t -145.81 147.4 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -123.64 132.88 53.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 110.198 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -131.55 158.6 40.51 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -124.49 82.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.13 -0.981 . . . . 0.0 108.43 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 111' ' ' ASP . 27.7 mt -64.33 91.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.929 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.78 -81.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -125.17 29.56 6.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -1.2 . . . . 0.0 110.187 -179.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.68 138.33 40.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.172 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.0 tp -103.3 111.79 24.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.039 -1.038 . . . . 0.0 109.535 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.8 109.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.052 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -112.06 103.96 12.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.308 -0.87 . . . . 0.0 108.661 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.25 143.16 32.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.551 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.697 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -125.57 147.14 49.38 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.786 0.803 . . . . 0.0 109.35 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 122' ' ' VAL . 12.6 t -114.58 149.88 16.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.662 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 1.6 t80 -143.67 110.96 5.8 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.847 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 48.67 18.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.245 0.545 . . . . 0.0 110.944 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.49 28.43 3.51 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.803 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.71 176.11 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 9.9 pt-20 -156.47 123.87 5.4 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.539 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.866 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -119.84 152.74 36.83 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -131.62 140.08 49.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.769 -1.207 . . . . 0.0 111.279 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -133.12 114.16 13.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 2.6 mt -105.31 124.25 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.084 -1.01 . . . . 0.0 110.987 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -95.53 175.91 6.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.512 -0.742 . . . . 0.0 109.555 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -164.52 148.83 9.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.519 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 20.7 mtmm -47.72 134.34 12.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.49 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.596 ' OG ' ' NE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -174.27 -152.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.146 -0.971 . . . . 0.0 110.398 -179.376 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.595 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 29.0 m -107.2 129.32 54.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.814 . . . . 0.0 110.199 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.684 ' CE3' ' N ' ' A' ' 130' ' ' LYS . 43.4 m95 -142.44 167.84 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 10.3 pttp -152.72 138.73 18.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.84 -1.162 . . . . 0.0 110.741 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -38.64 107.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.52 -0.738 . . . . 0.0 109.965 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -97.06 -32.42 11.99 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.441 ' O ' ' OG ' ' A' ' 11' ' ' SER . 14.5 mtt-85 -150.45 178.27 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.646 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 73.8 m -171.41 177.99 3.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.272 -0.893 . . . . 0.0 109.412 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -150.12 149.23 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.033 . . . . 0.0 109.888 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 16' ' ' LYS . 48.2 t-20 63.52 -104.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.61 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.521 ' HD1' ' HB1' ' A' ' 124' ' ' ALA . 0.1 OUTLIER 69.14 -44.04 0.53 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 13' ' ' ASN . 54.5 m-20 -63.68 -47.76 79.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 108.751 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB2' HD21 ' A' ' 13' ' ' ASN . 24.7 mmtp -61.07 -37.26 82.05 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.908 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 68.4 t80 -69.3 -63.76 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -54.53 -24.94 22.89 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.042 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -79.36 -26.81 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -43.89 62.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 109.032 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.473 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -67.85 -6.13 20.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 108.961 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.1 31.93 53.97 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -77.66 158.42 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 109.514 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.715 ' ND2' ' H ' ' A' ' 25' ' ' ILE . 1.1 t30 -75.0 175.64 7.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.715 ' H ' ' ND2' ' A' ' 24' ' ' ASN . 1.5 mm -84.68 -1.33 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG23 ' ND2' ' A' ' 24' ' ' ASN . 42.5 t -78.48 -59.88 2.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 121.451 0.643 . . . . 0.0 109.268 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 21.1 mttp -63.58 -27.3 69.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 108.669 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.2 -42.15 72.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.37 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -66.74 -34.59 78.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.1 mt -86.25 -13.09 47.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.582 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -77.74 -47.39 19.16 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.808 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.54 -64.96 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.94 . . . . 0.0 109.645 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.24 46.12 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.878 . . . . 0.0 109.357 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 15.0 t70 -89.47 160.53 16.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 109.769 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.643 ' HA ' HG13 ' A' ' 8' ' ' VAL . 4.4 m-20 -143.19 42.96 1.54 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.356 -0.84 . . . . 0.0 108.991 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -54.89 148.09 13.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.813 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -119.07 139.73 51.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -146.63 153.04 39.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.909 -1.119 . . . . 0.0 110.268 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -115.03 109.53 18.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.752 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -98.51 119.28 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 110.169 -179.01 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.34 151.67 36.52 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -135.47 139.97 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 45' ' ' ASN . 7.2 mt-10 -139.01 78.82 1.69 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.06 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 43' ' ' GLU . 6.0 p-10 -118.79 28.94 8.0 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.301 -1.117 . . . . 0.0 110.507 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -154.47 111.05 3.29 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.4 p90 -107.93 173.48 6.3 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.752 -0.592 . . . . 0.0 109.491 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -155.87 103.43 2.24 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.006 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.88 109.15 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.506 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -99.76 99.65 10.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.634 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . 26.5 mt-10 -72.89 156.81 38.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.033 -1.042 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.6 m -161.78 107.23 1.29 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.198 -0.939 . . . . 0.0 109.029 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.68 ' C ' ' H ' ' A' ' 55' ' ' PHE . 6.4 p -139.96 144.43 37.05 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.18 7.6 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.68 ' H ' ' C ' ' A' ' 53' ' ' SER . 38.1 m-85 -107.96 -23.57 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 111.049 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.2 mtp-105 160.49 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.689 ' H ' HD22 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -62.78 145.24 55.36 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.712 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.18 174.56 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.406 -0.809 . . . . 0.0 109.825 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.2 pt-20 -154.19 143.1 21.06 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.8 108.71 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.656 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -107.32 151.57 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.238 -0.914 . . . . 0.0 109.799 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 1.8 m-85 176.32 -179.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.808 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 27.8 tt0 -107.39 167.71 9.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.574 -0.704 . . . . 0.0 109.175 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.542 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.5 mt -80.14 130.23 35.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.36 -30.18 10.31 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.628 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 57.6 t -84.09 110.88 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.248 . . . . 0.0 110.033 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -57.57 143.67 40.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -150.63 -171.6 3.97 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.566 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -138.18 149.63 46.02 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.131 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 57.2 m -156.15 137.78 14.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.553 ' ND2' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -93.61 144.05 25.74 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.358 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 74' ' ' ASP . 48.2 mt -93.98 146.97 23.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.565 -0.709 . . . . 0.0 109.421 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.63 -28.47 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.582 -0.699 . . . . 0.0 109.745 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.9 17.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.75 26.34 66.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.474 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.02 161.92 13.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.287 -1.125 . . . . 0.0 109.565 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -132.85 119.98 20.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.17 161.95 33.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.882 -1.136 . . . . 0.0 110.684 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 19.9 ptt180 -143.16 141.91 31.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 110.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.95 -116.01 0.59 Allowed Glycine 0 N--CA 1.476 1.352 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 170.76 157.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -1.187 . . . . 0.0 110.603 179.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.615 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.1 m95 -102.25 144.07 31.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.636 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -144.54 155.98 43.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.057 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.71 119.19 26.68 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.312 -1.492 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -109.33 104.58 13.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.68 -101.34 0.51 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -124.77 33.45 5.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -1.174 . . . . 0.0 110.177 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -140.75 157.23 45.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.816 -1.177 . . . . 0.0 109.961 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -100.1 101.85 13.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -72.12 163.62 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 110.396 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.96 95.66 0.17 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.635 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 3.8 tttm -90.25 104.92 17.44 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.181 -1.188 . . . . 0.0 108.636 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 2.9 m-30 -117.79 125.06 49.89 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.845 0.831 . . . . 0.0 109.766 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HZ1' ' HE3' ' A' ' 92' ' ' LYS . 15.2 mttp -105.63 116.41 31.9 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 39.5 mtp180 -54.45 114.74 1.78 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.37 -13.08 61.38 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.529 1.157 . . . . 0.0 109.433 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.95 -47.08 15.57 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.67 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 99' ' ' GLY . 31.9 m-80 -132.61 7.83 4.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 110.074 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.16 42.18 8.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.672 ' O ' ' O ' ' A' ' 101' ' ' GLU . 14.8 m-80 -78.05 12.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 0.0 109.513 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.3 mt-10 47.79 128.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.548 0.689 . . . . 0.0 111.003 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 117' ' ' TYR . 7.4 tt -129.23 120.77 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.671 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.5 OUTLIER -108.18 107.83 18.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.062 -179.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.9 t -122.91 176.41 6.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.208 -0.933 . . . . 0.0 111.137 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 106' ' ' ARG . 89.1 t -148.38 159.63 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.615 ' NH1' ' CH2' ' A' ' 82' ' ' TRP . 50.6 ttm-85 -131.3 136.87 48.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.725 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -139.39 158.55 43.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 109.298 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.2 mm -122.19 82.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.722 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.3 mm -68.38 91.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.374 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 41.43 -80.42 0.0 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.722 ' N ' ' O ' ' A' ' 109' ' ' ILE . 5.3 m-20 -118.18 29.5 7.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.252 . . . . 0.0 110.884 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -146.9 134.5 20.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.127 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.5 115.96 29.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 108.28 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.966 -1.084 . . . . 0.0 110.294 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -117.17 103.26 10.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 1.1 m -102.39 148.49 25.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 110.103 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.722 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -129.51 151.94 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.482 178.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 122' ' ' VAL . 8.2 t -118.71 148.08 21.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.42 110.77 5.54 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.96 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 47.86 19.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.025 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.38 28.46 3.53 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.741 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.3 176.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.533 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.9 mt-10 -155.67 119.57 4.5 Favored 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.123 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.908 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -111.64 148.9 32.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -125.57 138.52 53.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.926 -1.109 . . . . 0.0 110.829 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.44 ' CZ ' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mmt85 -128.17 127.17 42.45 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 mt -118.01 123.71 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.506 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -97.96 176.62 5.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.495 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 24.6 tttt -155.24 142.46 19.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.684 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 3.3 pttp -47.5 132.13 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 109.764 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 129' ' ' LYS . 19.6 m-20 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' A' ' 4' ' ' SER . 1.5 p30 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.467 ' HB2' ' HE1' ' A' ' 6' ' ' TRP . 1.2 m -169.38 -149.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.091 -1.005 . . . . 0.0 110.289 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.62 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 6.4 m -103.1 129.84 50.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.413 -0.804 . . . . 0.0 109.987 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.692 ' CZ3' ' N ' ' A' ' 130' ' ' LYS . 56.3 m95 -148.21 167.61 24.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 108.865 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -152.76 139.53 18.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.699 -1.251 . . . . 0.0 110.62 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.663 HG11 HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -45.28 107.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -99.85 -29.79 12.4 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 mmt-85 -141.52 171.16 14.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.64 -0.662 . . . . 0.0 109.535 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.3 t -173.25 178.0 2.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.395 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -155.88 156.87 35.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.133 -0.979 . . . . 0.0 109.862 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.8 m-20 58.77 -109.56 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.605 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.504 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 73.77 -52.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.232 -0.918 . . . . 0.0 109.975 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.03 -49.15 78.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 108.919 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.38 -33.79 72.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.817 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 65.3 t80 -71.32 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.457 ' HE2' ' CE1' ' A' ' 14' ' ' TYR . 21.9 mmt -55.58 -22.37 21.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.91 -33.62 45.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.274 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' NZ ' ' HB ' ' A' ' 122' ' ' VAL . 14.6 mmtp -68.36 -42.05 79.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.611 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -66.82 -7.42 21.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.119 -0.988 . . . . 0.0 108.953 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.53 26.88 62.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 24' ' ' ASN . 41.3 t -66.34 122.27 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -1.075 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.1 m-20 -43.47 168.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -78.87 -1.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 122.141 0.972 . . . . 0.0 109.193 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.18 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -62.27 -31.0 71.52 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -69.6 -45.89 67.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 109.183 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -57.4 -37.22 72.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.267 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 30' ' ' LEU . 96.0 mt -86.5 -12.9 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.035 0.922 . . . . 0.0 109.677 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -70.86 -47.44 59.3 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.41 -21.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' ASN . 70.9 t60 -69.07 36.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -51.59 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.6 ' HA ' HG13 ' A' ' 8' ' ' VAL . 1.1 m-20 -147.92 42.45 1.04 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.903 . . . . 0.0 109.048 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.663 HD23 HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -89.95 162.39 15.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 110.461 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -108.34 144.91 35.24 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -138.49 123.75 19.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 110.074 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 104.67 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.492 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.1 mp -97.59 127.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.928 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.9 151.88 49.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -130.35 143.27 50.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 45' ' ' ASN . 8.6 mt-10 -138.7 79.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.83 -82.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.576 ' H ' HD22 ' A' ' 45' ' ' ASN . 0.1 OUTLIER -124.88 28.28 6.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -1.133 . . . . 0.0 110.204 -178.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.84 109.9 4.34 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.608 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -97.51 172.81 7.5 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.753 -0.592 . . . . 0.0 109.728 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.0 m -154.27 104.28 2.59 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.384 -0.823 . . . . 0.0 108.832 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.54 116.5 42.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -109.92 100.54 9.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 109.628 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -77.64 157.53 30.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.066 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER -157.41 106.62 2.15 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 108.891 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.666 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.38 144.64 50.67 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.39 7.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.058 . . . . 0.0 109.642 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.666 ' H ' ' C ' ' A' ' 53' ' ' SER . 91.0 t80 -108.01 -23.83 11.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.0 111.046 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 161.2 88.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.975 -1.078 . . . . 0.0 109.009 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.403 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 16.7 p-10 -62.72 143.82 57.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.397 -0.814 . . . . 0.0 109.766 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.734 HG21 ' ND2' ' A' ' 71' ' ' ASN . 1.1 mt -134.24 173.76 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.413 -0.804 . . . . 0.0 110.203 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.3 pt-20 -157.38 142.95 17.35 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 60' ' ' CYS . 14.2 p -163.61 128.09 2.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.497 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -82.59 160.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.507 -0.746 . . . . 0.0 109.123 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.608 ' CE2' ' CB ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -156.36 133.18 10.35 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.475 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.496 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 18.4 tt0 -105.55 168.47 9.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.489 -0.757 . . . . 0.0 109.005 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.496 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 13.0 mt -88.84 122.5 32.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 0.0 110.081 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 30.13 27.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 81' ' ' THR . 23.5 t -144.18 102.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.275 . . . . 0.0 109.413 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 2.3 m -47.59 145.88 2.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.427 1.108 . . . . 0.0 109.876 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -165.93 -167.23 1.04 Allowed 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.761 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -147.84 157.59 43.61 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.875 -178.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.5 t -150.34 137.59 19.53 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.734 ' ND2' HG21 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -98.08 149.49 22.44 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.001 -1.062 . . . . 0.0 110.184 -178.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 75' ' ' GLY . 27.7 mt -96.9 146.83 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.55 -0.719 . . . . 0.0 109.552 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.65 -34.67 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.628 -0.67 . . . . 0.0 109.719 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.76 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.2 -0.938 . . . . 0.0 109.28 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 74.3 25.15 71.45 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.1 tt0 -133.4 126.16 30.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -132.97 160.06 38.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.936 -1.103 . . . . 0.0 110.322 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -135.23 149.22 49.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.434 -0.791 . . . . 0.0 110.248 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.712 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.07 -111.12 0.46 Allowed Glycine 0 C--O 1.211 -1.289 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 167.57 154.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.984 -1.304 . . . . 0.0 110.604 178.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.486 ' NE1' ' CZ ' ' A' ' 93' ' ' PHE . 74.1 m95 -102.12 133.38 47.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.587 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.9 m -138.2 157.18 46.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.947 -1.096 . . . . 0.0 109.338 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -94.86 128.55 41.7 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.519 -1.363 . . . . 0.0 108.193 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.653 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.7 mm-40 -129.06 118.73 23.01 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.6 -107.12 1.48 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -125.3 34.34 4.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.48 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -148.3 150.18 33.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.723 -1.236 . . . . 0.0 110.45 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 106' ' ' ARG . 2.0 mt -92.2 115.69 28.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.587 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -87.04 163.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.143 -0.973 . . . . 0.0 110.489 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.595 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.43 94.34 0.16 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.712 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 47.7 mttt -87.14 102.14 14.17 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.182 -1.187 . . . . 0.0 108.473 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.2 m-30 -122.32 137.18 54.94 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.807 0.813 . . . . 0.0 110.346 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' ARG . 9.5 ptpt -127.75 126.07 41.11 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' GLY . 43.4 mtp180 -43.79 115.46 0.81 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.313 -0.867 . . . . 0.0 108.881 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.04 -5.42 17.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.401 1.096 . . . . 0.0 109.37 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.86 -48.61 8.6 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.307 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -132.43 9.11 4.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.462 -0.774 . . . . 0.0 109.614 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.59 47.05 30.09 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 58.5 m-20 -72.17 11.17 0.61 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -1.224 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.2 mt-10 48.8 134.42 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.823 0.821 . . . . 0.0 111.349 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.4 tt -139.24 131.44 28.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.535 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -114.15 112.6 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.025 . . . . 0.0 109.233 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -125.26 174.59 8.01 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.111 -0.993 . . . . 0.0 111.159 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 106' ' ' ARG . 48.1 t -145.93 163.92 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.551 ' N ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -138.18 135.89 36.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.713 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -139.21 158.91 43.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.088 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.15 82.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.649 ' O ' ' N ' ' A' ' 111' ' ' ASP . 20.9 mt -65.72 91.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.146 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.84 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 109' ' ' ILE . 30.6 m-20 -119.17 29.87 7.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -1.211 . . . . 0.0 110.666 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -140.98 134.12 29.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.046 -1.034 . . . . 0.0 109.566 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 1.5 tt -98.3 110.0 22.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 108.344 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.21 118.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 110.345 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -120.06 104.97 10.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -104.49 146.16 29.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.124 -0.985 . . . . 0.0 110.264 -178.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.718 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -126.04 150.8 47.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.787 0.803 . . . . 0.0 109.184 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 122' ' ' VAL . 13.8 t -118.87 148.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.522 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.3 t80 -145.6 111.32 5.49 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.924 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 51.76 16.3 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.319 0.581 . . . . 0.0 110.949 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.06 28.04 3.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.797 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.39 176.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.509 ' N ' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -155.99 118.52 4.13 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.175 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -111.15 150.69 29.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -131.52 139.14 49.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.833 -1.167 . . . . 0.0 111.331 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.504 ' CZ ' ' OH ' ' A' ' 14' ' ' TYR . 22.9 mtp180 -133.64 115.02 14.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 2.6 mt -104.57 129.95 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.573 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.53 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.3 m-30 -98.69 177.46 5.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.513 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 16.8 tptm -152.94 143.91 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.692 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -47.26 133.68 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.185 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.463 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 4' ' ' SER . 35.5 t0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.282 0.563 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 168.24 -159.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.38 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.551 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 88.9 m -94.42 145.39 24.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 5' ' ' THR . 20.6 m95 -151.79 167.54 27.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.9 ptmt -154.24 133.57 12.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.484 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.659 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -42.09 106.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -98.48 -27.82 13.88 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -142.71 169.62 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.912 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 26.1 t -172.39 178.14 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.838 . . . . 0.0 109.43 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -153.86 154.68 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.4 m-20 56.34 -109.71 0.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.475 -0.766 . . . . 0.0 109.61 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER 75.87 -54.21 0.62 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.315 -0.865 . . . . 0.0 109.723 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.64 -58.98 5.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.011 -1.055 . . . . 0.0 108.567 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -52.42 -35.55 52.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.358 -0.839 . . . . 0.0 108.913 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.837 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 30.6 t80 -68.46 -61.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.265 -0.897 . . . . 0.0 108.752 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.773 ' SD ' HG21 ' A' ' 23' ' ' VAL . 9.7 mmt -49.59 -33.94 16.47 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.641 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.15 -37.67 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.071 . . . . 0.0 109.447 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -62.81 -43.19 99.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.626 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.681 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 1.7 mtm -70.22 -3.17 15.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.211 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 32.5 61.99 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.773 HG21 ' SD ' ' A' ' 18' ' ' MET . 25.3 t -74.11 138.02 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 109.385 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 23' ' ' VAL . 31.8 m-20 -45.75 172.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.357 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.657 HD12 HH11 ' A' ' 28' ' ' ARG . 1.6 mm -83.77 -2.22 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.276 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -81.32 -60.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.841 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 2.4 mptm? -65.88 -20.14 66.12 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.657 HH11 HD12 ' A' ' 25' ' ' ILE . 3.2 tmm_? -75.44 -45.17 40.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.492 -0.755 . . . . 0.0 109.128 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.29 -36.34 74.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.571 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 mt -86.55 -13.23 46.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.753 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -60.98 -52.95 62.85 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.14 -32.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.459 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 33.7 m170 -74.57 42.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' ND2' ' A' ' 35' ' ' ASN . 1.2 p30 -63.21 112.12 2.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.552 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.0 m120 -147.57 42.88 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.31 -0.868 . . . . 0.0 109.242 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.659 HD23 HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -82.08 158.91 23.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' SER . 7.0 tttt -113.58 138.18 50.53 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.9 pt? -147.45 145.29 29.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.989 -1.069 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 m -110.2 125.23 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.2 mp -110.89 133.27 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.486 -179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.88 152.1 51.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -138.08 141.14 40.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 45' ' ' ASN . 35.5 mt-10 -138.59 78.92 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.416 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.27 -82.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.37 29.32 7.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -1.095 . . . . 0.0 110.114 -178.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.53 110.73 4.85 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.47 166.78 10.2 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.433 HG23 HG13 ' A' ' 61' ' ' VAL . 25.3 m -153.72 103.2 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 108.615 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.94 114.37 41.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.579 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -106.65 100.02 9.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.582 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.79 155.64 26.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' LYS . 92.4 p -159.76 107.5 1.71 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.234 1.016 . . . . 0.0 109.077 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 m -118.67 -163.16 0.94 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.41 8.73 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.345 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 21.0 m-85 -125.35 -12.69 6.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 112.108 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER 165.59 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.233 -1.542 . . . . 0.0 110.026 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -62.95 145.48 55.21 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.391 -0.818 . . . . 0.0 109.217 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -131.13 174.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.348 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.572 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -151.11 130.17 12.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.7 m -133.22 110.41 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.389 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.594 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.08 142.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.221 -0.924 . . . . 0.0 108.992 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER 176.16 173.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.672 -1.211 . . . . 0.0 110.785 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.89 162.38 13.17 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 64' ' ' LEU . 2.1 pp -82.32 135.22 35.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.918 -1.113 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.79 20.33 13.24 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 65.7 t -143.87 106.25 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.34 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -49.81 144.44 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.113 0.959 . . . . 0.0 110.25 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.612 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -156.74 -171.8 3.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -127.19 152.37 47.45 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.054 -1.028 . . . . 0.0 110.347 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.9 t -153.96 129.1 9.65 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.533 ' N ' ' ND2' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -88.35 149.53 23.7 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.112 -0.993 . . . . 0.0 110.239 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 73' ' ' ALA . 74.6 mt -100.73 146.85 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.325 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.28 -33.75 1.04 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.797 . . . . 0.0 109.86 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 14.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 67.56 28.64 73.58 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.456 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -99.41 162.12 13.22 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -132.36 118.75 19.79 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -132.59 162.89 30.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 0.0 110.495 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -143.63 141.17 30.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.807 . . . . 0.0 109.831 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.817 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.91 -117.39 0.64 Allowed Glycine 0 N--CA 1.476 1.351 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.2 159.24 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.025 -1.279 . . . . 0.0 110.898 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CZ ' ' A' ' 93' ' ' PHE . 15.3 m95 -101.91 142.58 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.594 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.9 m -140.68 157.6 45.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -92.79 127.17 38.2 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.306 -1.496 . . . . 0.0 108.194 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.606 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -122.93 121.61 36.56 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.57 -105.55 0.37 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 2.1 p-10 -125.13 33.62 5.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.016 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -140.36 159.17 42.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.02 -1.05 . . . . 0.0 110.095 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.44 108.97 21.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -78.63 164.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.101 -1.0 . . . . 0.0 110.64 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.605 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.33 95.24 0.17 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.664 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.7 pttp -88.9 104.08 16.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.166 -1.197 . . . . 0.0 109.034 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.6 m-30 -116.92 131.96 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.37 119.38 36.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 69.1 mtp180 -52.71 115.14 1.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.336 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -11.95 57.03 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.387 1.089 . . . . 0.0 109.219 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.62 -26.94 24.13 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.832 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -132.18 -0.18 3.72 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 57.21 45.09 93.0 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.582 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 20.2 t-20 -91.76 -122.62 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.274 -1.133 . . . . 0.0 109.227 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.7 pt-20 -175.54 137.3 0.36 Allowed 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.138 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 117' ' ' TYR . 55.2 tp -134.25 108.98 8.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.616 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.9 OUTLIER -101.32 105.68 16.77 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.4 t -121.09 176.13 5.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 112.017 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.408 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.6 t -148.2 154.26 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.512 ' HE ' HD21 ' A' ' 113' ' ' LEU . 55.0 mtp180 -127.01 131.45 51.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 109.987 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -129.31 159.18 36.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.425 -0.797 . . . . 0.0 109.032 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.8 82.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 109' ' ' ILE . 15.5 mt -63.53 91.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.798 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.0 -81.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.3 m-20 -125.6 29.31 6.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -137.37 147.19 45.32 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 108.735 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.578 HD23 ' CD2' ' A' ' 128' ' ' PHE . 10.5 tp -107.72 110.52 22.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.499 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.404 HG13 ' CG1' ' A' ' 127' ' ' ILE . 2.5 t -90.59 115.68 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.439 -0.788 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -114.04 103.26 10.97 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.05 145.28 29.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.726 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -127.33 149.91 49.83 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.471 178.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 122' ' ' VAL . 6.9 t -117.1 150.23 19.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.582 ' CE1' ' OD1' ' A' ' 100' ' ' ASN . 1.1 t80 -142.56 110.06 5.73 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.754 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 45.57 20.44 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 119' ' ' TYR . . . 112.91 28.63 3.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.761 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.58 176.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.541 ' N ' HG13 ' A' ' 122' ' ' VAL . 2.7 tt0 -155.98 125.82 6.45 Favored 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 118.045 -1.462 . . . . 0.0 111.406 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -122.77 151.19 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 11' ' ' SER . 19.5 ttpt -130.03 140.21 50.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.916 -1.115 . . . . 0.0 111.112 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.463 ' CZ ' ' OH ' ' A' ' 117' ' ' TYR . 11.0 ttm180 -137.41 114.11 10.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.404 ' CG1' HG13 ' A' ' 114' ' ' VAL . 2.2 mp -105.99 131.41 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 0.0 111.132 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 38' ' ' LEU . 3.0 m-30 -100.9 176.05 5.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -165.16 157.08 15.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.804 . . . . 0.0 109.245 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -47.27 130.16 12.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.397 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 4' ' ' SER . 2.8 p30 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.655 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.1 t 162.47 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.655 ' N ' ' OG ' ' A' ' 4' ' ' SER . 90.6 m -89.96 145.51 25.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.566 ' CD1' ' C ' ' A' ' 5' ' ' THR . 12.2 m95 -151.41 168.26 25.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 109.542 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.4 pttp -153.15 133.53 13.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.965 . . . . 0.0 109.445 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.577 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -38.15 106.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.269 -0.894 . . . . 0.0 109.622 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -93.59 -28.25 16.14 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -152.73 173.14 15.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.882 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -172.98 178.22 2.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 0.0 109.145 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 3.1 pt-20 -157.06 154.55 29.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.067 -1.02 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.3 m-20 56.5 -109.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 109.826 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.5 -53.47 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.356 -0.84 . . . . 0.0 109.701 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -48.67 80.77 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.994 -1.066 . . . . 0.0 108.76 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -60.2 -33.26 71.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 49.1 t80 -72.0 -62.85 1.28 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.567 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 25.9 mmt -56.48 -23.57 40.15 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.345 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.95 -37.59 54.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.057 -1.027 . . . . 0.0 109.243 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -64.66 -39.93 94.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.195 -0.941 . . . . 0.0 109.21 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.6 mtp -65.12 -9.61 24.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.118 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.91 29.93 27.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 24' ' ' ASN . 19.5 t -79.78 126.3 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -1.144 . . . . 0.0 109.441 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 23' ' ' VAL . 9.8 m-80 -42.4 165.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.13 -1.99 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.158 0.98 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -80.26 -59.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.678 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -65.06 -22.56 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -73.15 -44.49 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -70.77 -33.05 70.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.49 -13.21 46.7 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.007 0.908 . . . . 0.0 109.752 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -78.63 -45.64 21.08 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.608 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.06 -22.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 31' ' ' ALA . 31.6 m170 -69.28 37.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.302 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 32' ' ' ALA . 2.4 m-20 -51.05 95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.557 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' HIS . 12.0 m120 -147.66 42.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.307 -0.871 . . . . 0.0 109.206 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -97.69 170.74 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -179.084 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -108.65 142.19 39.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.746 -0.596 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 36' ' ' LEU . 1.9 mp -139.12 128.26 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -102.81 117.08 33.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.2 mp -103.95 122.86 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.622 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.43 151.8 37.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.58 145.08 50.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -139.49 78.95 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.6 -81.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 43' ' ' GLU . 19.8 m120 -122.37 28.85 7.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -1.127 . . . . 0.0 110.253 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -153.57 110.12 3.37 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -94.19 173.91 7.41 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.791 -0.568 . . . . 0.0 109.485 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.5 m -155.81 103.49 2.26 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.152 -0.967 . . . . 0.0 108.99 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.6 t -98.19 113.14 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.66 -0.65 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -99.97 100.45 11.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.2 tt0 -72.81 155.88 39.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.173 -0.954 . . . . 0.0 108.818 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.0 m -160.48 107.04 1.52 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.168 -0.958 . . . . 0.0 109.021 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.689 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -137.0 144.25 43.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.64 7.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.024 -1.048 . . . . 0.0 109.069 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.689 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.3 m-85 -112.41 -31.18 6.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.27 -0.894 . . . . 0.0 111.476 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.0 tpp85 177.84 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.655 -1.278 . . . . 0.0 109.378 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.78 ' H ' HD22 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -63.18 140.29 58.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.094 179.657 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -139.17 174.41 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.601 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.2 pt-20 -152.0 141.64 21.79 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -151.46 132.21 14.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.17 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.301 -0.874 . . . . 0.0 108.847 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.34 167.35 21.19 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.115 -0.991 . . . . 0.0 109.947 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 26.5 tt0 -159.95 168.06 26.56 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.527 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 31.2 mt -98.59 122.23 41.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.25 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 24.47 47.37 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.501 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.62 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 89.5 t -144.18 102.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.275 . . . . 0.0 109.416 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.746 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.29 141.29 54.77 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.169 0.985 . . . . 0.0 110.062 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.62 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.06 -171.29 3.79 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.578 ' C ' HD22 ' A' ' 69' ' ' ASN . 0.4 OUTLIER -142.41 151.16 41.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.836 -1.146 . . . . 0.0 110.799 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.707 ' O ' HD22 ' A' ' 78' ' ' LEU . 49.5 t -144.83 170.69 15.64 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 76' ' ' THR . 1.5 p-10 -126.12 141.26 52.02 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.864 -1.147 . . . . 0.0 110.396 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.9 mt -93.12 146.85 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.542 -0.724 . . . . 0.0 109.371 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.09 -28.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.837 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.567 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 47.5 m-20 -67.68 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.28 27.78 68.16 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.523 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.03 162.02 13.24 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.424 -1.045 . . . . 0.0 109.399 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.946 ' C ' HD13 ' A' ' 78' ' ' LEU . 69.4 tt0 -132.86 116.29 16.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.021 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -119.66 150.93 39.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.011 . . . . 0.0 110.404 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.87 140.59 42.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.877 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.746 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.92 -117.24 0.63 Allowed Glycine 0 N--CA 1.477 1.378 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.536 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.8 159.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -1.181 . . . . 0.0 110.54 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.0 m95 -101.77 142.84 32.48 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.597 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.0 m -138.35 157.23 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -96.18 127.35 42.1 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.352 -1.468 . . . . 0.0 108.205 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.63 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.2 mm-40 -127.32 114.74 17.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.21 -106.45 1.33 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -125.17 34.31 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -1.131 . . . . 0.0 110.427 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.57 150.67 37.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 110.314 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.55 109.99 21.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.597 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -80.12 164.58 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.119 -0.988 . . . . 0.0 110.538 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.659 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.69 95.84 0.17 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.673 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 14.0 ptmt -86.41 107.04 17.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.27 -1.135 . . . . 0.0 108.678 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -117.07 140.35 49.6 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.84 0.828 . . . . 0.0 110.234 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -125.48 113.27 17.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.47 0.652 . . . . 0.0 109.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 99' ' ' GLY . 30.9 mtp180 -51.51 114.82 1.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.408 ' H ' ' HG1' ' A' ' 96' ' ' THR . 0.6 OUTLIER -69.87 -13.76 62.41 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.355 1.074 . . . . 0.0 109.628 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.48 -48.35 15.52 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.786 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' GLY . 34.4 m120 -132.54 10.68 4.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.151 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 44.46 39.36 5.7 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.716 ' O ' ' O ' ' A' ' 101' ' ' GLU . 2.4 m120 -75.17 18.95 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.168 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.716 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.0 pt-20 43.7 161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.929 . . . . 0.0 111.239 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.3 tt -161.23 123.83 3.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.7 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -112.18 113.92 26.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 109.143 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -124.69 176.11 6.78 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.186 -0.946 . . . . 0.0 110.948 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.9 t -149.59 154.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -127.05 136.5 52.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.67 158.63 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -121.29 82.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 121.117 -0.989 . . . . 0.0 108.38 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 109' ' ' ILE . 24.2 mt -63.54 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.765 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.47 -81.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -129.21 29.17 5.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -1.187 . . . . 0.0 110.206 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.36 142.54 48.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 108.75 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.2 tp -103.28 110.34 22.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.932 -1.105 . . . . 0.0 109.266 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.511 HG22 HG23 ' A' ' 127' ' ' ILE . 18.1 t -95.83 110.15 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -108.45 106.86 17.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -100.92 144.6 29.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.166 -0.959 . . . . 0.0 109.792 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.3 OUTLIER -123.27 152.59 41.21 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.816 0.817 . . . . 0.0 109.161 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.2 t -121.93 147.76 25.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.539 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -144.5 110.67 5.48 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.973 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 48.59 18.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.26 0.552 . . . . 0.0 111.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.34 28.33 3.58 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.71 176.91 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.39 124.58 6.24 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.303 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.849 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.14 154.38 30.11 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.501 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 5.5 ttmt -131.99 139.72 48.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 111.175 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -135.58 113.93 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.511 HG23 HG22 ' A' ' 114' ' ' VAL . 5.4 mt -109.16 123.83 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.084 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.523 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -98.83 176.01 5.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 130' ' ' LYS . 3.0 tttp -163.78 161.65 23.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.403 ' H ' ' HG2' ' A' ' 129' ' ' LYS . 10.7 ptpt -47.61 132.3 14.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.498 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 4' ' ' SER . 11.1 t70 . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.575 ' OG ' ' N ' ' A' ' 5' ' ' THR . 28.8 t 167.5 -136.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.575 ' N ' ' OG ' ' A' ' 4' ' ' SER . 18.2 m -89.3 131.14 35.54 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.952 0.882 . . . . 0.0 111.946 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.855 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 9.6 m95 -123.41 170.62 10.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.488 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 13.9 pttp -144.57 122.43 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 110.123 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.606 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -42.35 107.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -94.69 -30.33 14.35 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -150.27 165.2 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.727 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 11.8 t -168.47 178.32 4.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.367 -0.833 . . . . 0.0 109.267 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -155.29 156.21 35.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.57 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 16.2 m-20 59.68 -109.04 0.41 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.924 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.544 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 73.07 -52.25 0.71 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.37 -43.61 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.956 -1.09 . . . . 0.0 109.019 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -67.55 -31.56 71.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.9 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 76.5 t80 -73.43 -57.0 4.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.606 ' C ' HH22 ' A' ' 28' ' ' ARG . 16.1 mmt -60.33 -29.16 68.7 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.572 ' N ' HH22 ' A' ' 28' ' ' ARG . 16.5 tp10 -77.12 -27.97 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.241 -0.912 . . . . 0.0 109.633 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -73.57 -37.66 65.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.484 ' HB2' HG23 ' A' ' 23' ' ' VAL . 2.1 mtm -69.16 -8.35 44.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.142 -0.973 . . . . 0.0 108.932 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.26 29.47 37.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 23.7 t -77.18 127.17 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -1.208 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.755 ' H ' ' ND2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -42.61 164.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.917 HD13 ' HE ' ' A' ' 28' ' ' ARG . 1.3 mm -80.04 -1.33 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.18 0.99 . . . . 0.0 109.178 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 t -81.36 -59.85 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -63.85 -28.84 70.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.917 ' HE ' HD13 ' A' ' 25' ' ' ILE . 9.9 ttm-85 -70.64 -43.85 68.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.369 -0.832 . . . . 0.0 109.249 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.06 -33.02 74.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.414 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 -13.63 44.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.12 -36.13 19.77 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.654 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . -44.6 -15.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.592 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 35' ' ' ASN . 14.1 m80 -80.24 46.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.586 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -44.81 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 33' ' ' HIS . 62.6 t-20 -147.67 42.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.401 -0.812 . . . . 0.0 109.142 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.606 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -97.55 175.75 6.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.81 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.52 152.54 37.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 38' ' ' LEU . 3.3 mp -139.83 128.94 23.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 4' ' ' SER . 0.3 OUTLIER -97.86 104.15 16.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.855 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -105.65 126.43 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -132.71 152.07 51.81 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -135.35 142.81 45.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.913 -1.117 . . . . 0.0 110.05 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' ASN . 24.2 mm-40 -140.23 78.92 1.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.73 -86.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -117.58 29.19 8.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -146.1 110.77 5.17 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.41 166.56 10.67 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.425 HG23 HG13 ' A' ' 61' ' ' VAL . 26.1 m -154.16 103.25 2.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 108.652 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.62 HG22 HG23 ' A' ' 40' ' ' ILE . 87.5 t -104.41 141.36 20.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -135.34 100.15 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.55 157.21 37.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 108.71 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -156.56 107.06 2.36 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.075 -1.016 . . . . 0.0 109.174 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.682 ' C ' ' H ' ' A' ' 55' ' ' PHE . 2.2 p -137.67 144.64 41.92 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.42 7.51 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.995 -1.065 . . . . 0.0 109.266 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.682 ' H ' ' C ' ' A' ' 53' ' ' SER . 88.4 t80 -104.63 -26.8 12.18 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 110.85 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 160.08 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 109.027 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -62.35 145.31 54.21 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.442 -0.787 . . . . 0.0 109.449 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -133.76 173.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.214 -0.929 . . . . 0.0 110.186 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.567 ' H ' HG22 ' A' ' 58' ' ' ILE . 8.5 pt-20 -149.8 147.71 28.32 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.46 0.647 . . . . 0.0 109.711 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.13 110.33 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.833 . . . . 0.0 109.242 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.592 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -109.82 143.63 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.217 -0.927 . . . . 0.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 176.29 169.84 0.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.854 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -94.56 151.13 19.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 64' ' ' LEU . 1.3 pp -76.97 133.08 39.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.924 -1.11 . . . . 0.0 109.272 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.0 21.1 11.36 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.591 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 27.9 t -143.35 106.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -1.151 . . . . 0.0 109.31 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -46.36 145.68 1.65 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.153 0.978 . . . . 0.0 110.17 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.594 ' C ' HD22 ' A' ' 69' ' ' ASN . 0.2 OUTLIER -160.45 -171.6 3.22 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.73 HD22 ' N ' ' A' ' 69' ' ' ASN . 0.6 OUTLIER -123.26 153.45 40.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 110.149 -179.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 93.2 m -157.79 129.29 6.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -90.68 147.92 22.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.072 -1.017 . . . . 0.0 110.259 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 52.5 mt -99.44 146.89 25.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.29 -31.68 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.838 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 21.6 t70 -65.71 15.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 109.329 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 64.94 27.16 71.84 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 162.05 13.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.312 -1.111 . . . . 0.0 109.533 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -132.47 119.71 20.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -135.8 163.85 29.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 0.0 110.448 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -142.05 140.14 32.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.74 . . . . 0.0 109.934 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.843 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.72 -117.78 0.64 Allowed Glycine 0 C--O 1.21 -1.358 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.31 157.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.107 -1.231 . . . . 0.0 110.58 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.577 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.36 142.13 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.585 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.12 157.32 45.45 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -93.21 126.63 38.42 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.306 -1.496 . . . . 0.0 108.407 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.6 ' N ' HD12 ' A' ' 84' ' ' LEU . 3.7 mm-40 -123.8 113.49 18.62 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.31 -105.25 0.99 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 87' ' ' ASN . 17.5 t-20 -125.17 34.17 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -1.128 . . . . 0.0 110.372 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.426 ' CE ' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -144.79 150.8 37.8 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.739 -1.226 . . . . 0.0 110.316 -179.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mt -94.77 108.77 20.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.585 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -79.4 164.0 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.099 -1.0 . . . . 0.0 110.698 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.28 95.59 0.17 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.623 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.45 108.91 19.92 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.205 -1.174 . . . . 0.0 109.016 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.518 ' HB2' HD22 ' A' ' 102' ' ' LEU . 3.0 m-30 -118.4 135.83 54.12 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.748 0.785 . . . . 0.0 109.986 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -118.01 115.25 24.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.314 0.578 . . . . 0.0 109.506 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 33.7 mtm180 -49.04 115.12 1.17 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -10.69 60.05 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.417 1.103 . . . . 0.0 109.357 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.0 -41.45 12.35 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.698 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.47 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -132.66 7.43 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.28 34.72 1.63 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.69 ' O ' ' O ' ' A' ' 101' ' ' GLU . 19.1 t-20 -74.96 18.66 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.159 -1.201 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.69 ' O ' ' O ' ' A' ' 100' ' ' ASN . 9.3 pt-20 44.5 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.012 0.91 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 93' ' ' PHE . 7.0 tt -158.5 130.63 6.82 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.684 HD22 ' H ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -117.97 118.61 32.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.96 -1.088 . . . . 0.0 109.173 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.5 t -130.47 176.46 8.13 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.12 -0.988 . . . . 0.0 110.752 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 106' ' ' ARG . 42.4 t -146.76 158.86 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.463 ' N ' HG12 ' A' ' 105' ' ' VAL . 10.9 ttp180 -131.65 135.23 46.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.79 158.64 43.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 108.92 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.53 83.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.72 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.7 mm -60.27 92.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.514 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 47.2 -74.86 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.72 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -125.73 30.02 5.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -1.202 . . . . 0.0 110.907 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -146.12 147.52 31.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.738 -1.227 . . . . 0.0 109.679 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.473 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 6.5 tp -102.49 115.24 30.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.049 -1.032 . . . . 0.0 108.855 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.6 t -102.7 108.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -109.55 106.1 15.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.8 OUTLIER -103.03 145.95 29.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -124.95 158.76 32.81 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.908 0.861 . . . . 0.0 109.486 178.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 122' ' ' VAL . 10.5 t -127.46 148.46 32.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.66 110.29 5.3 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.684 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 47.37 19.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.164 0.507 . . . . 0.0 111.104 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.73 28.25 3.51 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.745 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.5 176.51 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 15.1 pt-20 -156.38 126.02 6.29 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.648 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.9 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.92 150.19 38.9 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -126.23 139.37 53.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.773 -1.204 . . . . 0.0 110.757 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.544 ' NH1' ' OH ' ' A' ' 14' ' ' TYR . 7.0 mtt180 -129.81 114.16 15.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.01 122.72 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.035 . . . . 0.0 110.352 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.585 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 2.6 m-30 -107.1 177.15 4.94 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.775 0.797 . . . . 0.0 110.409 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -152.91 164.88 37.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 131' ' ' ASP . 16.5 pttp -47.19 138.65 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.031 . . . . 0.0 109.459 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 130' ' ' LYS . 4.9 p-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.448 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.838 ' CZ ' ' CG ' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 52.8 51.1 16.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.232 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 4' ' ' SER . 16.9 t70 -89.31 89.01 7.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.312 -0.868 . . . . 0.0 109.439 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.684 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 165.2 -164.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 0.0 109.729 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.684 ' N ' ' OG ' ' A' ' 4' ' ' SER . 43.2 m -102.13 146.74 27.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.663 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.838 ' CG ' ' CZ ' ' A' ' 2' ' ' PHE . 4.4 m95 -151.39 169.26 22.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' O ' ' C ' ' A' ' 8' ' ' VAL . 18.1 pttp -152.58 128.41 10.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.097 -1.002 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.572 HG13 ' HA ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -37.45 107.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.384 -0.822 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -97.69 -25.93 14.92 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.7 mtp180 -140.55 160.0 40.96 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.097 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.518 ' CB ' ' OD2' ' A' ' 34' ' ' ASP . 31.0 t -179.92 157.27 0.69 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 109.14 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' A' ' 125' ' ' LYS . 10.6 pt-20 -166.78 166.27 15.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.256 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 67.37 -6.77 0.59 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.547 -0.72 . . . . 0.0 109.738 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -47.94 -22.44 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.997 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.48 ' CA ' ' HE ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -71.99 -48.16 46.89 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.996 -1.065 . . . . 0.0 108.868 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -59.92 -36.68 77.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.956 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 49.6 t80 -68.23 -64.02 0.94 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.817 0.818 . . . . 0.0 108.93 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.0 mmt -56.52 -23.38 39.28 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.427 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.52 -23.97 34.32 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.057 -1.027 . . . . 0.0 109.118 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -74.45 -43.8 54.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -0.912 . . . . 0.0 108.995 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.592 ' SD ' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -58.76 -14.3 8.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.648 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.21 29.64 40.29 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 24' ' ' ASN . 2.1 t -79.33 141.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.391 -1.064 . . . . 0.0 109.444 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.3 m-80 -43.47 168.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.374 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -78.8 -2.32 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.38 -59.98 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.696 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -62.38 -24.19 67.24 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HE ' ' CA ' ' A' ' 15' ' ' ASP . 50.9 ttt180 -73.03 -47.28 46.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.508 -0.745 . . . . 0.0 109.208 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -68.96 -33.12 73.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 mt -86.52 -13.03 47.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.934 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -77.13 -52.62 8.97 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.165 0.507 . . . . 0.0 109.866 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.19 -28.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.692 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 31' ' ' ALA . 23.8 m170 -74.6 46.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' OD2' ' CB ' ' A' ' 11' ' ' SER . 6.1 p30 -66.38 115.12 5.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.572 ' HA ' HG13 ' A' ' 8' ' ' VAL . 10.4 m120 -147.74 43.21 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -89.06 165.02 14.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 111.335 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.469 ' C ' HD12 ' A' ' 38' ' ' LEU . 2.2 tttp -109.19 149.59 29.15 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -143.67 127.05 16.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.922 -1.111 . . . . 0.0 110.332 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 40' ' ' ILE . 3.0 m -103.14 111.41 23.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.787 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.7 mp -109.4 142.42 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 111.515 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -135.26 152.25 51.35 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.605 ' O ' ' NE2' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -135.56 142.69 45.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.953 -1.092 . . . . 0.0 110.018 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 45' ' ' ASN . 4.9 mm-40 -142.15 78.86 1.64 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.49 -88.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -113.66 29.16 8.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.326 -1.102 . . . . 0.0 109.997 -179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.9 110.5 5.57 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.415 ' CZ ' ' HG3' ' A' ' 42' ' ' GLN . 6.0 m-85 -104.32 162.3 13.33 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.468 HG23 HG13 ' A' ' 61' ' ' VAL . 30.8 m -153.96 102.99 2.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 p -107.16 129.5 60.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.584 -0.698 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -119.11 100.17 7.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.819 . . . . 0.0 109.388 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.23 160.45 31.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.26 -0.9 . . . . 0.0 108.833 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 m -160.48 106.93 1.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.088 -1.008 . . . . 0.0 109.303 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.644 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -129.31 144.29 51.17 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.77 7.95 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.985 -1.072 . . . . 0.0 109.387 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.644 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.6 OUTLIER -115.22 -20.09 10.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.218 -0.926 . . . . 0.0 111.35 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 165.57 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.55 -1.344 . . . . 0.0 109.423 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -62.35 149.45 42.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.343 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -136.98 174.21 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 58' ' ' ILE . 6.5 pt-20 -154.21 146.29 23.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.8 m -151.07 110.7 4.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.835 . . . . 0.0 109.581 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -108.47 141.27 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.202 -0.936 . . . . 0.0 109.129 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.41 172.49 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.777 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 44.8 tt0 -98.37 164.74 12.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 64' ' ' LEU . 2.7 pp -82.04 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.842 -1.162 . . . . 0.0 109.593 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.05 -31.99 6.42 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.1 p -88.4 117.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -1.23 . . . . 0.0 109.911 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -55.98 145.14 26.17 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.05 0.928 . . . . 0.0 110.013 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -153.53 -171.6 3.96 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.514 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -130.55 150.68 51.64 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.995 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.69 133.65 12.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -88.97 149.24 23.38 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 75' ' ' GLY . 52.5 mt -99.53 146.82 25.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.425 -0.797 . . . . 0.0 109.374 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.89 -32.97 0.69 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.714 . . . . 0.0 109.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.67 12.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.84 27.75 72.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.421 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -99.33 162.23 13.16 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.193 -1.18 . . . . 0.0 109.471 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.473 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.8 tt0 -132.33 118.59 19.61 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -135.22 162.9 31.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.679 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB3' HH21 ' A' ' 79' ' ' ARG . 6.0 ptm85 -142.26 142.91 32.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.764 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.06 -117.43 0.64 Allowed Glycine 0 N--CA 1.476 1.35 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.4 157.54 0.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.138 -1.213 . . . . 0.0 110.913 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.496 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 6.1 m95 -102.27 141.56 34.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.639 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.2 m -142.23 156.28 45.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.097 -1.002 . . . . 0.0 108.667 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 121.37 27.11 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.115 -1.616 . . . . 0.0 110.038 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.51 107.83 17.15 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.651 ' C ' HD22 ' A' ' 87' ' ' ASN . . . 62.17 -102.22 0.45 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.651 HD22 ' C ' ' A' ' 86' ' ' GLY . 1.7 m120 -124.84 33.52 5.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -1.14 . . . . 0.0 109.838 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 163.64 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.062 -1.024 . . . . 0.0 109.772 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mt -102.79 104.42 14.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 0.0 108.586 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.639 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -73.55 164.42 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.987 . . . . 0.0 110.247 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.6 94.69 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.374 -1.891 . . . . 0.0 108.374 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.662 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 35.4 mttm -88.63 105.21 17.51 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.256 -1.143 . . . . 0.0 108.835 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -116.22 136.77 52.72 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.886 0.85 . . . . 0.0 110.091 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -116.84 116.32 27.23 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.607 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.6 mtp180 -53.01 114.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.808 . . . . 0.0 108.847 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -70.32 -12.74 61.79 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.501 1.143 . . . . 0.0 109.377 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.67 -50.96 11.38 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -132.57 11.64 4.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.2 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.56 41.7 12.98 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.744 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.5 m-80 -78.04 19.78 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -1.199 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.744 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.9 pt-20 42.7 158.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.016 0.912 . . . . 0.0 111.212 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 103' ' ' ASN . 6.4 tt -157.39 127.12 6.12 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.745 ' N ' HD23 ' A' ' 102' ' ' LEU . 5.6 t30 -116.93 113.84 23.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 109.087 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -125.41 175.98 7.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.179 -0.951 . . . . 0.0 111.174 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 43.8 t -144.86 146.94 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.8 132.5 54.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.149 -0.969 . . . . 0.0 109.909 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.08 157.77 45.3 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.446 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.2 mt -125.66 82.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 120.917 -1.115 . . . . 0.0 108.627 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 111' ' ' ASP . 63.7 mt -63.02 92.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.223 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.49 -78.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -130.61 29.14 4.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.127 -1.219 . . . . 0.0 110.197 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.85 136.89 40.95 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.244 -0.91 . . . . 0.0 108.883 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.598 ' HB2' ' CE1' ' A' ' 2' ' ' PHE . 0.5 OUTLIER -98.03 110.92 23.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.903 -1.123 . . . . 0.0 109.906 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.6 t -92.35 113.39 27.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 119.309 -0.956 . . . . 0.0 108.577 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.467 ' NE2' ' OH ' ' A' ' 117' ' ' TYR . 6.6 tt0 -115.79 103.67 10.89 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.306 -0.871 . . . . 0.0 108.681 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.41 144.11 31.3 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 109.555 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -125.34 151.13 46.47 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.847 0.832 . . . . 0.0 109.471 178.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 122' ' ' VAL . 8.4 t -118.2 147.48 21.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.521 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.91 110.7 5.39 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.882 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 48.54 18.67 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.184 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.17 28.3 3.64 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.33 177.11 4.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 43.0 tt0 -155.44 117.04 4.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.242 -1.383 . . . . 0.0 111.368 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.956 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -106.77 150.62 26.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 12' ' ' GLU . 2.6 mtmm -126.99 137.48 53.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.904 -1.123 . . . . 0.0 110.48 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -140.14 114.01 8.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.1 mp -109.45 130.86 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 0.0 111.108 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.522 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -99.95 176.26 5.49 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.424 0.631 . . . . 0.0 109.407 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -164.58 151.29 11.03 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -47.43 132.89 13.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 2.3 p-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.52 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.824 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER 42.8 36.03 0.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.152 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.11 76.95 8.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.937 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 5' ' ' THR . 28.2 t -179.07 -163.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.915 . . . . 0.0 109.619 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 70.6 m -91.86 147.35 23.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.104 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.824 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 14.9 m95 -151.09 168.73 23.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 7.4 mtpt -150.63 128.53 11.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.388 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.72 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -42.55 106.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.06 -30.24 13.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -148.97 164.95 33.07 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.98 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.5 m -171.77 178.09 3.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.366 -0.834 . . . . 0.0 108.992 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -156.19 158.69 38.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.12 . . . . 0.0 110.104 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.2 m-20 57.71 -109.57 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.692 -0.63 . . . . 0.0 109.739 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.644 ' CE2' ' NH1' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 71.55 -51.3 0.69 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 0.0 109.84 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HB3' HH21 ' A' ' 28' ' ' ARG . 7.7 p-10 -62.8 -40.55 97.71 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.955 -1.091 . . . . 0.0 108.97 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -70.31 -31.0 68.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.882 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 78.5 t80 -74.18 -56.93 4.33 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.561 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 11.7 mmt -60.1 -32.83 71.34 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.42 -37.49 74.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -63.98 -41.05 97.64 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.298 -0.876 . . . . 0.0 109.593 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 23' ' ' VAL . 2.4 mtm -66.48 -8.33 25.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.199 -0.938 . . . . 0.0 109.086 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.61 32.6 10.03 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.471 HG21 ' SD ' ' A' ' 18' ' ' MET . 26.6 t -94.05 140.6 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -1.146 . . . . 0.0 109.553 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.35 157.82 4.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.361 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm -82.24 -1.23 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 122.213 1.006 . . . . 0.0 109.142 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -80.1 -59.8 2.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -56.55 -33.9 66.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 108.85 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.604 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -65.69 -52.09 54.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.75 -33.84 57.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.413 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.51 -13.23 46.61 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.023 0.916 . . . . 0.0 109.518 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 34' ' ' ASP . . . -84.3 -51.03 7.31 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.7 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.59 -57.53 2.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 109.502 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -75.69 44.79 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.853 . . . . 0.0 109.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 31' ' ' ALA . 63.7 t0 -116.02 101.48 8.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.353 -0.842 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' HA ' HG13 ' A' ' 8' ' ' VAL . 17.3 m-20 -84.66 43.55 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.406 -0.809 . . . . 0.0 109.357 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.72 HD23 HG11 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -47.09 155.65 0.27 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.748 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -105.74 148.21 27.71 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.821 -0.549 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.52 HD22 ' CE2' ' A' ' 128' ' ' PHE . 2.5 mp -139.28 123.64 18.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.275 -0.89 . . . . 0.0 109.887 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 m -101.91 107.94 19.25 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.546 HD13 ' HD2' ' A' ' 2' ' ' PHE . 4.1 mp -101.02 133.6 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.16 -0.962 . . . . 0.0 110.747 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.48 152.08 48.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -130.05 147.83 51.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 109.863 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -145.1 79.18 1.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.683 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.82 -87.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -125.8 28.58 6.13 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -1.093 . . . . 0.0 110.093 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -147.75 110.04 4.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.67 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -98.12 174.4 6.55 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.508 0.671 . . . . 0.0 109.799 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -152.27 103.87 2.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -96.25 114.77 33.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.511 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 tttt -105.11 100.23 9.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.832 . . . . 0.0 109.345 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -74.64 152.82 39.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.034 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.38 105.95 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.157 0.98 . . . . 0.0 108.546 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.658 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -131.12 144.49 51.44 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.15 7.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.983 -1.073 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 53' ' ' SER . 72.6 m-85 -109.79 -25.88 10.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -0.978 . . . . 0.0 111.235 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER 165.65 87.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.704 -1.248 . . . . 0.0 109.312 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -62.29 139.81 58.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.42 -0.8 . . . . 0.0 109.643 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.602 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -132.26 174.35 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.874 0.845 . . . . 0.0 110.247 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.602 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.0 pt-20 -151.39 142.98 23.62 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.56 127.03 5.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.897 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.549 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -78.58 163.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.368 -0.832 . . . . 0.0 109.242 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.588 ' CE2' ' SG ' ' A' ' 70' ' ' CYS . 36.0 m-85 -143.37 117.87 9.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 64' ' ' LEU . 1.1 tm-20 -111.32 164.31 13.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.037 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.604 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 95.7 mt -103.34 118.24 36.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 109.915 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.58 18.37 41.73 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.46 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.622 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 8.0 t -141.37 105.32 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.948 -1.325 . . . . 0.0 109.568 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -56.29 143.52 33.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.898 . . . . 0.0 109.871 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -153.84 -170.85 3.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -132.34 151.07 52.01 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.563 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.588 ' SG ' ' CE2' ' A' ' 62' ' ' PHE . 68.1 m -149.42 127.82 12.23 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.554 ' OD1' HG21 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -89.66 144.47 25.97 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 110.343 -178.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.672 ' CD1' HD11 ' A' ' 78' ' ' LEU . 70.7 mt -99.35 146.88 25.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.99 -29.37 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.0 109.797 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.561 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 15.7 m-20 -66.62 17.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.164 -0.96 . . . . 0.0 109.241 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 63.57 26.92 70.18 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 161.88 13.33 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.233 -1.157 . . . . 0.0 109.696 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.497 ' O ' ' OG1' ' A' ' 96' ' ' THR . 40.7 tt0 -132.62 117.53 18.03 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.672 HD11 ' CD1' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -127.68 157.0 41.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.987 -1.07 . . . . 0.0 110.626 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 21.4 ptt85 -140.51 142.48 35.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.838 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.61 -119.63 0.8 Allowed Glycine 0 N--CA 1.475 1.277 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.504 ' OG1' ' C ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.8 159.62 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.153 -1.204 . . . . 0.0 110.403 179.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.41 143.12 32.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 109.229 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -137.32 157.06 47.44 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -97.75 128.28 44.29 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.315 -1.491 . . . . 0.0 108.273 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.646 ' N ' HD12 ' A' ' 84' ' ' LEU . 30.6 mt-10 -128.36 117.8 22.07 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.75 -106.88 1.19 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.468 ' C ' HD22 ' A' ' 87' ' ' ASN . 0.3 OUTLIER -125.17 34.42 4.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.162 . . . . 0.0 110.55 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.405 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -144.76 147.33 32.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.693 -1.254 . . . . 0.0 110.242 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mt -92.75 113.55 25.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -84.78 165.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 110.766 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.37 95.93 0.17 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.655 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.4 ptpt -87.69 104.97 17.04 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.27 -1.135 . . . . 0.0 108.757 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 8.2 m-30 -117.65 145.96 44.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.9 0.857 . . . . 0.0 110.314 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -125.92 123.86 39.53 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 34.3 mtp180 -57.74 115.22 2.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.4 OUTLIER -69.38 -12.42 61.64 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 122.423 1.106 . . . . 0.0 109.466 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.32 -46.62 13.37 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.736 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.61 ' ND2' ' ND2' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -132.54 8.67 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.137 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 43.35 41.53 5.19 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.61 ' ND2' ' ND2' ' A' ' 98' ' ' ASN . 0.8 OUTLIER -77.01 15.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.679 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 100' ' ' ASN . 16.0 mt-10 52.51 150.72 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.646 0.736 . . . . 0.0 110.651 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 103' ' ' ASN . 3.4 tp -152.77 128.06 9.86 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.638 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER -116.27 118.64 33.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 108.779 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.6 t -129.05 176.2 8.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.162 -0.961 . . . . 0.0 110.559 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 106' ' ' ARG . 45.5 t -145.52 160.69 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.453 ' N ' HG12 ' A' ' 105' ' ' VAL . 1.6 ttt85 -135.09 135.11 40.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -140.36 158.35 44.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 109.105 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.12 82.3 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.699 HD12 HG21 ' A' ' 114' ' ' VAL . 32.2 mt -63.82 91.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.107 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.05 -80.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -130.85 29.5 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 129' ' ' LYS . 6.9 mt-10 -133.05 141.12 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 0.0 108.969 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.531 HD23 ' CD2' ' A' ' 128' ' ' PHE . 11.4 tp -101.0 114.58 28.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.88 -1.137 . . . . 0.0 108.859 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.699 HG21 HD12 ' A' ' 109' ' ' ILE . 12.9 t -104.9 106.77 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.325 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -105.79 108.16 19.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.01 147.37 24.07 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.128 -0.983 . . . . 0.0 109.885 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.646 ' O ' ' HA ' ' A' ' 123' ' ' GLU . 2.7 m-85 -121.36 158.36 28.42 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.436 -0.79 . . . . 0.0 109.158 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 103' ' ' ASN . 10.8 t -131.2 147.07 32.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.567 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -147.38 110.25 4.73 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 119.099 -1.041 . . . . 0.0 110.789 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 45.99 20.45 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.124 0.488 . . . . 0.0 111.238 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.81 28.32 3.47 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -123.62 176.52 5.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.7 mt-10 -156.13 126.69 6.74 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 118.123 -1.431 . . . . 0.0 111.284 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -114.36 159.07 20.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -134.11 137.41 44.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.874 -1.141 . . . . 0.0 110.877 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.644 ' NH1' ' CE2' ' A' ' 14' ' ' TYR . 6.7 mmt180 -129.77 114.13 15.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 8.7 mt -113.01 122.72 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.01 -1.056 . . . . 0.0 111.14 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.8 m-30 -104.92 174.11 6.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.522 -0.736 . . . . 0.0 109.138 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 112' ' ' GLU . 30.4 tttp -161.81 159.78 27.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.324 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -47.77 131.62 14.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.931 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.3 t0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.479 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.629 ' N ' ' CD1' ' A' ' 108' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.82 ' CD1' ' CE2' ' A' ' 6' ' ' TRP . 23.7 m-85 -72.16 22.68 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.259 -0.901 . . . . 0.0 108.778 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.595 ' C ' ' O ' ' A' ' 2' ' ' PHE . 19.1 t0 32.99 57.37 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 40' ' ' ILE . 1.4 t -177.47 -138.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.598 -0.688 . . . . 0.0 110.018 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.6 m -89.41 148.39 23.51 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.931 0.872 . . . . 0.0 111.482 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.82 ' CE2' ' CD1' ' A' ' 2' ' ' PHE . 17.1 m95 -144.81 168.66 19.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 2.4 pttp -152.5 125.53 8.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.513 -1.367 . . . . 0.0 110.843 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.609 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -44.04 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.285 -0.884 . . . . 0.0 109.769 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -91.44 -30.66 16.35 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HB2' HD12 ' A' ' 127' ' ' ILE . 6.6 mtp85 -151.3 175.33 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.677 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 t -171.33 178.11 3.36 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.226 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.75 154.72 35.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 21.7 m-20 57.68 -109.51 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 109.823 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.562 ' CD2' ' OD1' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.03 -52.71 0.69 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.681 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 15' ' ' ASP . 12.0 p-10 -59.71 -45.96 90.55 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.598 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.14 -34.62 76.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.913 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 69.7 t80 -69.79 -63.75 1.02 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mmt -55.9 -24.73 39.15 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.358 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -82.66 -23.05 34.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.065 -1.022 . . . . 0.0 109.379 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -77.33 -37.07 53.25 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.193 -0.942 . . . . 0.0 109.258 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.409 ' HG3' ' H ' ' A' ' 21' ' ' MET . 0.6 OUTLIER -67.47 -11.33 57.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.146 -0.971 . . . . 0.0 108.574 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.69 31.13 37.26 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 24' ' ' ASN . 5.8 t -78.78 136.86 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.231 -1.159 . . . . 0.0 109.497 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' VAL . 5.8 m-80 -42.48 164.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.227 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 2.6 mm -81.79 -1.55 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.141 -0.974 . . . . 0.0 109.21 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.51 -59.92 2.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -64.78 -28.23 69.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.588 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -71.62 -42.5 67.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.388 -0.82 . . . . 0.0 108.977 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -63.68 -35.42 80.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.147 -0.971 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.57 -13.14 46.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.013 0.911 . . . . 0.0 109.632 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.577 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -44.14 -16.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.583 ' N ' ' O ' ' A' ' 31' ' ' ALA . 20.7 t-80 -70.9 41.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.409 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' OD1' ' CD2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -50.4 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.7 OUTLIER -147.8 42.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.609 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -96.52 175.18 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.523 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' N ' HD12 ' A' ' 36' ' ' LEU . 37.7 mttt -129.74 152.01 49.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.636 -0.665 . . . . 0.0 109.497 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.511 HD21 ' CD2' ' A' ' 128' ' ' PHE . 0.6 OUTLIER -142.81 150.38 39.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.702 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 4' ' ' SER . 0.6 OUTLIER -111.57 106.44 15.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 0.0 109.627 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -96.25 124.21 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 109.923 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.25 152.48 48.05 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' A' ' 47' ' ' PHE . 73.5 mt-30 -126.19 149.22 49.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.954 -1.091 . . . . 0.0 110.602 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' OE1' ' CD ' ' A' ' 46' ' ' LYS . 20.1 mt-10 -144.73 79.0 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.526 -0.733 . . . . 0.0 109.164 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.51 -88.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.623 HD22 ' N ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER -122.8 28.55 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -1.075 . . . . 0.0 109.736 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' CD ' ' OE1' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -146.01 109.87 4.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 42' ' ' GLN . 3.5 m-30 -93.24 173.26 7.81 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.8 m -153.38 103.73 2.7 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.311 -0.868 . . . . 0.0 108.813 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.62 HG22 HG23 ' A' ' 40' ' ' ILE . 96.7 t -99.68 121.62 50.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.634 -0.666 . . . . 0.0 109.446 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -108.63 100.07 9.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.531 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.36 155.06 41.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.941 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -158.6 107.05 1.93 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.116 -0.99 . . . . 0.0 109.013 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.694 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -141.83 144.56 33.96 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.46 7.4 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.025 -1.047 . . . . 0.0 109.189 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.694 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.0 m-85 -105.42 -25.71 12.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.278 -0.888 . . . . 0.0 110.835 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 8.2 mtp180 159.92 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.913 -1.117 . . . . 0.0 109.166 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -62.5 144.43 56.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 0.0 109.333 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.622 HG21 HD21 ' A' ' 71' ' ' ASN . 1.0 OUTLIER -136.65 174.02 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 110.34 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.591 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -149.06 129.56 13.93 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 87.7 m -145.75 128.56 16.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.751 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.564 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -75.5 164.98 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.269 -0.894 . . . . 0.0 108.957 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.608 ' C ' ' CD2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -144.57 116.49 8.3 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.588 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.411 ' H ' ' HE2' ' A' ' 68' ' ' PHE . 37.1 mt-10 -116.47 174.55 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.7 119.45 38.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 110.505 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.22 -5.72 83.54 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.319 -0.943 . . . . 0.0 110.838 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 1.6 t -103.45 105.27 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.834 -1.392 . . . . 0.0 110.13 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -61.25 143.05 56.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.439 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.17 -171.4 3.82 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.623 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -138.87 153.03 48.28 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.403 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 10.2 t -156.96 138.55 14.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.622 HD21 HG21 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -95.59 143.27 27.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 73' ' ' ALA . 19.3 mt -92.57 146.9 23.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.45 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.92 -33.98 0.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.742 . . . . 0.0 109.796 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -60.05 8.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 71.61 26.29 73.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -100.09 161.87 13.34 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.22 -1.165 . . . . 0.0 109.549 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.426 ' O ' ' OG1' ' A' ' 96' ' ' THR . 83.7 tt0 -132.92 121.06 22.29 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -137.93 162.99 32.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.895 -1.128 . . . . 0.0 110.821 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -143.59 146.16 33.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.708 . . . . 0.0 109.954 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.67 -118.67 0.71 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.554 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.55 157.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -1.231 . . . . 0.0 110.808 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 6.4 m95 -102.1 141.61 34.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.608 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.6 t -139.57 156.8 46.67 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 0.0 108.555 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.675 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -88.51 130.31 35.26 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.294 -1.504 . . . . 0.0 108.032 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.675 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -131.05 122.29 26.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.62 -108.14 1.42 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.423 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.4 m120 -125.02 33.93 5.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -1.183 . . . . 0.0 110.313 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -147.17 160.89 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.757 -1.215 . . . . 0.0 110.238 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -97.99 113.26 25.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.608 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -82.17 164.77 2.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 110.534 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.616 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.95 96.08 0.17 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.651 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 9.6 mtpm? -89.33 106.16 18.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.196 -1.179 . . . . 0.0 109.031 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -116.23 136.78 52.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.772 0.796 . . . . 0.0 109.949 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -115.68 117.82 31.35 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.468 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.618 ' O ' ' N ' ' A' ' 99' ' ' GLY . 32.2 mtp180 -57.05 115.06 2.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.3 OUTLIER -75.22 -12.61 60.32 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.497 1.141 . . . . 0.0 109.443 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -90.83 -35.76 14.62 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.872 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 0.7 OUTLIER -132.55 4.06 3.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.337 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.11 29.8 0.66 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.705 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.4 t-20 -76.96 18.66 0.34 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -1.177 . . . . 0.0 109.289 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.705 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.4 pt-20 43.93 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.922 0.867 . . . . 0.0 111.101 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.624 HD12 ' N ' ' A' ' 103' ' ' ASN . 1.4 tp -158.19 128.32 6.07 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.624 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -116.51 115.19 25.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 108.8 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -127.0 176.42 7.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.336 -0.853 . . . . 0.0 110.908 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.4 t -147.84 156.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -131.42 134.23 46.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -142.36 158.08 44.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 108.912 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.629 ' CD1' ' N ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -126.57 83.36 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.301 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.0 mm -64.57 92.29 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.334 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.53 -80.82 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -128.53 29.02 5.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -1.172 . . . . 0.0 110.251 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.1 130.94 39.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.65 112.29 24.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 108.478 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.97 107.56 21.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.9 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.22 106.26 16.64 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.4 OUTLIER -102.89 145.88 29.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 110.158 -178.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.663 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.8 OUTLIER -124.38 155.27 39.07 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.881 0.848 . . . . 0.0 109.484 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.7 t -124.6 147.58 29.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -146.0 110.6 5.12 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.998 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 47.73 19.34 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.237 0.542 . . . . 0.0 111.129 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.37 28.41 3.55 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.46 176.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.67 125.18 6.34 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 118.221 -1.391 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -115.66 149.5 38.25 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -129.05 138.67 52.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.896 -1.128 . . . . 0.0 110.581 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -132.47 115.05 15.03 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.498 HD12 ' HB2' ' A' ' 10' ' ' ARG . 10.4 mt -104.74 123.68 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.601 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 6.1 m-30 -102.17 176.95 5.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.385 -0.822 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -155.05 168.34 27.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 131' ' ' ASP . 10.9 ptpt -50.58 138.74 17.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 109.629 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' LYS . 5.7 t70 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.361 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.845 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER 42.15 33.22 0.37 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.37 -0.831 . . . . 0.0 109.348 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 4' ' ' SER . 12.5 t0 -76.82 95.24 4.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.616 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.3 m 161.9 -164.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.34 -0.85 . . . . 0.0 109.575 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.596 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 49.3 m -95.88 143.63 26.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.845 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 4.9 m95 -150.08 169.01 22.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.234 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 8' ' ' VAL . 6.4 ptmm? -152.76 133.98 14.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 109.693 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.591 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.51 106.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.372 -0.83 . . . . 0.0 109.508 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 32.3 t0 -98.26 -31.34 12.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -146.22 164.24 32.89 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.503 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 2.8 t -166.02 178.12 6.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.46 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -156.61 155.17 31.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.062 -1.024 . . . . 0.0 109.887 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.6 m-20 58.43 -108.82 0.43 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.696 . . . . 0.0 109.953 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.565 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER 73.03 -52.19 0.71 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.159 -0.963 . . . . 0.0 110.19 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.578 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 17.3 t70 -59.37 -49.99 75.69 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.099 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -59.65 -33.23 71.27 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 65.5 t80 -71.34 -63.67 1.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 11.5 mmt -54.19 -25.4 22.58 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.482 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -77.41 -35.19 54.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.03 -1.044 . . . . 0.0 109.486 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.282 -0.887 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.625 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.3 mtp -68.5 -6.29 24.32 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.115 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.37 32.54 62.3 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 24' ' ' ASN . 4.0 t -74.76 129.68 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -1.207 . . . . 0.0 109.394 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.767 HD22 ' N ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -42.45 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 109.361 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.767 ' N ' HD22 ' A' ' 24' ' ' ASN . 1.5 mm -80.45 -1.98 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.135 -0.978 . . . . 0.0 109.166 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -82.39 -60.02 2.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -56.82 -38.33 72.45 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.578 ' NE ' ' OD1' ' A' ' 15' ' ' ASP . 19.9 tpt180 -61.31 -52.7 63.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -49.74 -38.39 33.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 0.0 109.331 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.64 -13.08 46.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 109.806 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -78.52 -48.96 14.22 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.164 0.506 . . . . 0.0 109.661 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.17 -21.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -0.822 . . . . 0.0 109.478 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.9 t-80 -73.8 35.03 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -44.09 89.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.476 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 6.7 t-20 -147.83 42.69 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -95.66 167.89 11.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.994 -1.066 . . . . 0.0 110.566 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HZ3' ' HB3' ' A' ' 7' ' ' LYS . 4.4 mttm -108.14 142.55 38.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 36' ' ' LEU . 1.9 mp -137.19 128.98 28.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.657 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m -102.69 119.16 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.3 mp -107.9 119.73 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.659 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.14 151.74 37.0 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -126.83 145.45 50.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 109.768 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -140.77 79.09 1.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 -83.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' GLU . 21.8 m-20 -124.9 28.67 6.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.271 -1.134 . . . . 0.0 110.148 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' NZ ' ' OG1' ' A' ' 48' ' ' THR . 1.9 tmtm? -150.79 109.84 3.91 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.34 173.6 7.45 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.361 0.6 . . . . 0.0 109.735 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.625 ' OG1' ' NZ ' ' A' ' 46' ' ' LYS . 43.6 m -153.52 103.87 2.69 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.35 -0.843 . . . . 0.0 108.744 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.6 t -99.42 115.77 41.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -101.4 100.44 10.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.08 158.25 35.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 108.865 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -160.13 107.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.056 -1.028 . . . . 0.0 109.088 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.683 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -139.42 144.64 38.18 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.13 7.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.079 -1.013 . . . . 0.0 109.376 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.683 ' H ' ' C ' ' A' ' 53' ' ' SER . 28.2 t80 -107.45 -25.4 11.43 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.164 -0.96 . . . . 0.0 111.065 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 159.97 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.902 -1.124 . . . . 0.0 109.084 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -62.12 148.79 43.24 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.11 174.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.6 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -149.54 127.3 11.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.7 131.92 20.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.7 t -85.05 153.98 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.353 -0.842 . . . . 0.0 108.81 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CE1' ' SG ' ' A' ' 70' ' ' CYS . 41.1 m-85 -135.3 117.13 15.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 3.2 mp0 -104.12 172.49 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 108.902 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 64' ' ' LEU . 80.2 mt -103.74 111.77 24.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 0.0 110.317 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.2 -31.7 7.71 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 16.6 t -82.82 110.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.053 -1.263 . . . . 0.0 109.877 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -60.17 143.24 52.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.085 -1.009 . . . . 0.0 109.437 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.05 -171.35 3.91 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -138.16 150.42 46.78 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.978 -1.076 . . . . 0.0 110.444 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' CE1' ' A' ' 62' ' ' PHE . 89.1 m -151.91 134.76 15.61 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.776 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -96.24 146.1 24.99 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.265 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 73' ' ' ALA . 17.2 mt -94.69 146.93 23.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.547 -0.721 . . . . 0.0 109.417 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.31 -34.63 1.26 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.683 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -57.74 3.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 77.66 25.68 62.39 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.68 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.06 161.49 13.58 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.245 -1.15 . . . . 0.0 109.597 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -133.62 123.07 24.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.7 162.52 32.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.851 -1.156 . . . . 0.0 110.72 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.77 144.34 31.13 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.485 -0.759 . . . . 0.0 110.046 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.46 -117.66 0.69 Allowed Glycine 0 N--CA 1.475 1.26 0 N-CA-C 107.901 -2.079 . . . . 0.0 107.901 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.529 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.69 158.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -1.184 . . . . 0.0 110.572 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.473 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.9 m95 -102.13 143.7 31.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.6 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -140.41 157.22 45.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -90.06 129.33 36.38 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.149 -1.594 . . . . 0.0 108.136 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.656 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -129.94 119.29 22.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.09 -107.35 1.29 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -125.14 34.33 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -1.158 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 157.11 43.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.804 -1.185 . . . . 0.0 110.229 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.6 mt -95.43 110.78 22.78 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -78.45 164.87 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.12 -0.988 . . . . 0.0 110.429 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.598 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.0 96.05 0.17 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.653 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.5 mttp -88.14 105.19 17.34 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.201 -1.176 . . . . 0.0 108.875 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 5.5 m-30 -118.22 140.01 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.878 0.847 . . . . 0.0 110.221 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -121.87 120.9 35.88 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.68 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 0.4 OUTLIER -53.27 114.86 1.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -12.2 61.44 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.482 1.134 . . . . 0.0 109.406 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.17 -48.82 12.55 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.622 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -132.53 11.38 4.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 0.0 110.166 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.0 44.25 13.63 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.745 ' O ' ' O ' ' A' ' 101' ' ' GLU . 42.4 m-20 -80.08 20.04 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -1.065 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.745 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.3 pt-20 42.97 158.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.005 0.907 . . . . 0.0 111.184 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.6 tt -160.49 124.97 3.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.666 ' N ' HD23 ' A' ' 102' ' ' LEU . 1.4 t-20 -113.41 112.72 24.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.036 -1.04 . . . . 0.0 109.118 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.7 t -125.3 176.51 6.72 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 111.13 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 46.2 t -148.71 156.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -124.34 133.88 53.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -134.78 157.98 45.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.449 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 1.4 mm -122.03 82.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 121.074 -1.016 . . . . 0.0 108.304 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 109' ' ' ILE . 15.9 mt -63.44 92.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.65 -80.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.5 m-20 -128.08 29.48 5.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -1.194 . . . . 0.0 110.324 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.02 145.24 45.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 108.943 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 12.4 tp -103.63 114.39 28.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.969 -1.082 . . . . 0.0 109.254 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.541 HG22 HG12 ' A' ' 127' ' ' ILE . 39.5 t -99.59 109.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 47.1 tt0 -107.1 104.1 13.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -100.96 145.59 28.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.215 -0.928 . . . . 0.0 109.998 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.703 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -128.51 152.28 48.45 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 178.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.0 t -119.39 148.12 22.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.34 110.59 5.74 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.922 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 48.25 18.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.962 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.45 28.36 3.54 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.753 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.67 177.13 4.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.543 ' N ' HG13 ' A' ' 122' ' ' VAL . 10.6 tt0 -154.86 122.59 5.76 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.175 -1.41 . . . . 0.0 111.267 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.886 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.77 156.54 27.03 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -136.33 139.04 42.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.209 . . . . 0.0 111.331 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.565 ' NH2' ' OH ' ' A' ' 14' ' ' TYR . 1.5 ttm-85 -130.76 113.96 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.541 HG12 HG22 ' A' ' 114' ' ' VAL . 6.6 mt -109.18 123.47 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.932 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 38' ' ' LEU . 7.7 m-30 -101.22 173.94 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.227 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -162.28 161.07 27.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.566 -0.709 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 131' ' ' ASP . 9.9 mmmt -47.71 132.36 14.32 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.162 -0.961 . . . . 0.0 109.643 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 130' ' ' LYS . 51.7 p30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.836 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -75.11 26.69 0.09 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.214 -0.929 . . . . 0.0 109.137 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 1' ' ' ALA . 34.7 t70 -70.49 81.64 0.57 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.63 -0.669 . . . . 0.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 171.4 -158.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.572 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.6 m -94.81 143.54 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.836 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 19.8 m95 -151.3 168.25 25.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.225 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.6 pttm -153.5 130.72 11.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.059 -1.025 . . . . 0.0 109.704 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.605 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -40.3 106.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 38.9 t0 -92.97 -30.0 15.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -147.66 164.98 31.83 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.866 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.66 178.15 5.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.358 -0.839 . . . . 0.0 109.267 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 4.2 pt-20 -152.68 151.12 30.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.02 -1.05 . . . . 0.0 110.013 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.546 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 18.7 t30 58.46 -108.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.718 -0.614 . . . . 0.0 109.903 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.546 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 76.16 -53.64 0.61 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -0.87 . . . . 0.0 109.838 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 87.6 m-20 -58.41 -52.37 65.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.022 -1.049 . . . . 0.0 108.938 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 12.0 mtpp -57.81 -33.24 68.39 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.579 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.854 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 56.8 t80 -71.64 -61.65 1.7 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.552 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 21.7 mmt -56.24 -25.69 48.6 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.415 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 3.4 mm-40 -80.64 -28.48 36.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.048 -1.032 . . . . 0.0 109.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -72.89 -35.84 67.2 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.317 -0.865 . . . . 0.0 109.454 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.515 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 2.2 mtm -72.64 -6.58 45.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.166 -0.959 . . . . 0.0 108.844 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 32.42 55.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 21' ' ' MET . 36.2 t -72.91 135.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -1.169 . . . . 0.0 109.383 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 23' ' ' VAL . 29.0 m120 -42.74 158.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.79 -3.06 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.221 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -84.66 -60.11 2.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.52 -29.33 69.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -68.48 -50.88 49.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.541 -0.725 . . . . 0.0 109.09 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -35.78 63.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.189 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.1 mt -86.46 -13.04 47.3 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.964 0.887 . . . . 0.0 109.773 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -75.8 -47.85 24.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.258 0.551 . . . . 0.0 109.706 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . -41.47 -20.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.654 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASN . 13.7 m80 -70.97 46.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.169 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -52.05 79.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.853 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' HIS . 7.1 p30 -148.36 42.86 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 109.203 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 36' ' ' LEU . 1.0 OUTLIER -93.94 168.33 11.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -106.53 145.03 32.35 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.527 HD22 ' CE2' ' A' ' 128' ' ' PHE . 2.1 mp -138.95 125.2 20.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 109.78 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.4 m -102.6 113.02 26.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.743 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.7 mp -103.08 123.64 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.715 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.37 151.96 36.74 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.492 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 12.7 pt20 -131.72 139.4 48.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.158 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 42' ' ' GLN . 19.0 mm-40 -136.14 78.95 1.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.209 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.81 -89.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.452 ' H ' HD22 ' A' ' 45' ' ' ASN . 0.9 OUTLIER -117.51 28.77 8.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.406 -1.056 . . . . 0.0 110.12 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.88 109.98 3.92 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CE2' ' CB ' ' A' ' 42' ' ' GLN . 10.6 m-85 -100.57 173.93 6.32 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.422 0.63 . . . . 0.0 109.67 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -152.2 103.03 2.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.8 t -95.33 111.2 25.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -102.31 100.65 10.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.624 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -72.97 158.89 34.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 108.906 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.6 m -160.8 107.11 1.46 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.087 -1.008 . . . . 0.0 109.248 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.654 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -134.09 144.41 48.6 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.32 7.8 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.053 -1.029 . . . . 0.0 109.638 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.654 ' H ' ' C ' ' A' ' 53' ' ' SER . 7.8 m-85 -112.96 -23.72 9.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.156 -0.965 . . . . 0.0 111.295 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 5.3 ptm180 166.59 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.811 -1.181 . . . . 0.0 109.513 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -62.32 147.65 47.54 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.429 -0.795 . . . . 0.0 109.271 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.12 174.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.255 -0.903 . . . . 0.0 110.316 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.619 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.8 pt-20 -150.0 140.58 22.52 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 59' ' ' GLU . 38.9 m -151.69 127.02 9.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.65 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.66 150.74 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.28 -0.888 . . . . 0.0 108.922 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.612 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -132.41 116.83 17.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.181 -0.949 . . . . 0.0 109.233 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 46.2 tt0 -126.13 169.12 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.0 109.044 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.475 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.7 mt -101.98 129.01 48.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 110.251 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.05 26.59 63.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 56.5 t -144.04 102.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.143 -1.21 . . . . 0.0 109.31 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -59.12 141.06 55.1 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 122.104 0.954 . . . . 0.0 110.064 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.05 -171.3 3.8 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 69' ' ' ASN . 26.3 p30 -139.22 149.06 43.92 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.944 -1.103 . . . . 0.0 110.798 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.685 ' O ' HD22 ' A' ' 78' ' ' LEU . 42.8 t -139.11 170.63 15.62 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 76' ' ' THR . 2.9 m-20 -126.21 141.39 51.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.854 -1.154 . . . . 0.0 110.36 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.522 ' HG ' HD21 ' A' ' 78' ' ' LEU . 95.5 mt -93.59 146.9 23.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.528 -0.732 . . . . 0.0 109.293 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.43 -28.43 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.489 -0.757 . . . . 0.0 109.696 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 45.5 m-20 -70.2 19.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.285 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.59 29.94 73.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.633 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.14 162.32 13.04 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.368 -1.077 . . . . 0.0 109.43 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.94 ' C ' HD13 ' A' ' 78' ' ' LEU . 58.7 tt0 -132.56 114.78 14.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.596 -0.69 . . . . 0.0 109.189 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.987 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -118.18 150.31 39.62 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.099 -1.001 . . . . 0.0 110.318 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -136.9 142.67 42.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.37 -118.4 0.72 Allowed Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.596 ' CB ' ' HZ1' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 173.01 156.47 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.312 -1.111 . . . . 0.0 110.362 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.575 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.0 m95 -102.54 143.45 32.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.6 -0.687 . . . . 0.0 109.162 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.604 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 11.4 t -141.59 156.8 45.66 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.757 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -89.02 131.63 35.11 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.324 -1.485 . . . . 0.0 108.125 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.757 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -136.28 124.2 22.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.21 -110.32 3.01 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.454 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.0 m120 -125.26 34.18 5.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -1.174 . . . . 0.0 110.414 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HD3' ' H ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -149.2 162.43 40.02 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.659 -1.276 . . . . 0.0 110.323 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.77 113.29 25.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.604 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.2 pt -81.13 164.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.251 -0.906 . . . . 0.0 110.478 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.583 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.02 96.85 0.18 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.666 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 6.5 pttm -90.32 106.78 18.73 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.274 -1.133 . . . . 0.0 108.686 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.598 ' HB2' HD23 ' A' ' 102' ' ' LEU . 2.6 m-30 -116.17 148.79 40.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.775 0.798 . . . . 0.0 110.365 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -134.18 116.85 15.86 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.601 0.715 . . . . 0.0 109.943 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 99' ' ' GLY . 48.6 mtp180 -52.05 115.29 1.63 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.68 -12.66 61.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.499 1.142 . . . . 0.0 109.628 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -88.71 -37.95 15.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.97 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.54 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 35.4 t-20 -132.48 5.76 4.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.297 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.38 34.36 1.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 101' ' ' GLU . 5.3 m120 -75.41 20.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -1.161 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.7 pt-20 45.49 166.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.017 0.913 . . . . 0.0 111.038 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 117' ' ' TYR . 19.4 tp -161.85 120.68 2.36 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -112.19 114.03 26.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 109.165 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.0 t -129.71 176.36 8.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.096 -1.003 . . . . 0.0 111.154 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 106' ' ' ARG . 54.2 t -146.58 158.51 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.418 ' N ' HG12 ' A' ' 105' ' ' VAL . 22.0 ttp180 -132.21 137.26 47.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.139 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -140.45 158.49 43.92 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 113' ' ' LEU . 1.2 mt -124.23 82.77 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.122 -0.986 . . . . 0.0 108.753 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' ASP . 48.6 mt -61.86 92.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.092 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.94 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ILE . 21.7 m-20 -130.06 29.41 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -1.228 . . . . 0.0 110.404 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -134.43 138.14 44.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 108.776 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.529 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 5.2 tp -99.43 113.16 25.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.891 -1.13 . . . . 0.0 109.362 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.68 HG22 HG23 ' A' ' 127' ' ' ILE . 27.5 t -98.57 110.74 26.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.096 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -113.21 106.76 15.02 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.56 145.47 29.98 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.718 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -126.18 156.63 39.87 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.928 0.871 . . . . 0.0 109.599 179.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.5 t -124.14 148.28 28.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.537 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.2 t80 -143.25 110.29 5.64 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.811 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 47.77 19.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.18 0.514 . . . . 0.0 111.134 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.66 28.24 3.53 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.24 176.57 4.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.511 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.8 tt0 -156.02 124.19 5.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.061 -1.455 . . . . 0.0 111.362 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.854 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -117.68 151.94 36.24 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -128.57 140.24 51.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.881 -1.137 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -133.24 113.96 13.25 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.68 HG23 HG22 ' A' ' 114' ' ' VAL . 5.3 mt -109.07 123.37 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.052 -1.03 . . . . 0.0 110.557 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.547 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -101.01 174.4 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.447 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -163.19 154.59 17.23 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -47.28 135.71 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.512 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 1.3 p30 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.467 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.896 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.2 OUTLIER 40.93 32.42 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.292 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 4' ' ' SER . 9.1 m-20 -73.18 97.26 2.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.37 -0.831 . . . . 0.0 109.722 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.626 ' OG ' ' N ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 158.51 -170.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.377 -0.827 . . . . 0.0 109.3 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.626 ' N ' ' OG ' ' A' ' 4' ' ' SER . 97.5 m -86.13 150.16 24.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.896 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 13.1 m95 -151.36 168.14 25.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.086 -1.009 . . . . 0.0 109.818 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.517 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.2 pttp -153.53 125.79 8.0 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.576 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.35 106.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.581 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.97 -28.96 12.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -142.29 174.33 10.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.6 t -178.39 178.31 0.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.16 155.65 31.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.874 -1.141 . . . . 0.0 109.822 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 18.7 m-20 56.86 -110.08 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.588 -0.695 . . . . 0.0 109.848 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.621 ' CE2' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 74.59 -52.43 0.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.0 109.855 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.31 -48.99 77.53 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.885 -1.134 . . . . 0.0 108.655 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.714 ' HZ3' ' HB3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -60.76 -34.82 75.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.909 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 61.0 t80 -69.12 -64.08 0.94 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.007 0.908 . . . . 0.0 108.882 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.425 ' O ' HG23 ' A' ' 23' ' ' VAL . 15.4 mmt -56.41 -21.33 24.39 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 28' ' ' ARG . 33.3 tt0 -78.66 -35.15 45.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.184 -0.948 . . . . 0.0 109.208 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -66.99 -44.35 80.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.854 . . . . 0.0 109.144 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.4 mtm -62.85 -9.22 8.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.021 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 32.3 38.13 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 24' ' ' ASN . 15.4 t -76.29 133.35 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -1.081 . . . . 0.0 109.559 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.539 ' OD1' HG23 ' A' ' 26' ' ' VAL . 11.6 t-20 -46.81 174.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -85.24 -2.16 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.119 0.961 . . . . 0.0 109.266 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.539 HG23 ' OD1' ' A' ' 24' ' ' ASN . 65.8 t -80.84 -59.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.755 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 1.5 mptm? -66.38 -22.73 66.25 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 19' ' ' GLU . 9.2 ttm180 -73.89 -42.38 60.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.524 -0.735 . . . . 0.0 109.29 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -72.81 -34.31 66.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.892 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.9 mt -86.39 -13.03 47.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -72.82 -53.01 12.64 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.573 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.98 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.574 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.699 ' CE1' HD21 ' A' ' 35' ' ' ASN . 0.7 OUTLIER -91.57 46.09 1.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.621 ' OD2' ' CE2' ' A' ' 14' ' ' TYR . 69.0 m-20 -62.45 121.05 12.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.853 . . . . 0.0 109.684 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.699 HD21 ' CE1' ' A' ' 33' ' ' HIS . 67.6 m-20 -147.94 42.98 1.05 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.349 -0.844 . . . . 0.0 109.016 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.576 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -87.74 162.81 16.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.111 -0.993 . . . . 0.0 111.056 -178.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 52' ' ' SER . 3.1 mtpp -114.69 142.49 46.43 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.825 ' H ' HD23 ' A' ' 38' ' ' LEU . 1.7 pt? -149.98 143.66 25.35 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.084 -1.01 . . . . 0.0 109.986 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -103.91 143.32 33.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.61 129.04 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.147 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.39 152.3 50.75 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -132.04 135.05 46.21 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.8 mm-40 -129.37 78.98 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.84 -79.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -124.14 29.24 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.335 -1.097 . . . . 0.0 109.99 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -145.16 110.59 5.3 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.18 159.85 14.82 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.455 HG23 HG13 ' A' ' 61' ' ' VAL . 48.9 m -152.21 103.12 2.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.079 -1.013 . . . . 0.0 108.269 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.88 130.87 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.61 -0.681 . . . . 0.0 109.652 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -119.63 100.55 7.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.398 -0.814 . . . . 0.0 109.572 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -75.51 156.1 35.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.214 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.1 m -158.9 106.91 1.85 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.153 0.977 . . . . 0.0 108.851 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.658 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -133.87 144.5 48.95 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.13 7.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.085 -1.01 . . . . 0.0 109.427 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 53' ' ' SER . 67.1 m-85 -113.26 -19.52 11.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 111.25 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 3.4 mmt180 161.63 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.703 -1.248 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.762 ' H ' HD22 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -62.89 146.81 52.0 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.495 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.1 mt -135.82 174.13 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.299 -0.875 . . . . 0.0 110.146 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.2 pt-20 -152.82 145.53 24.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.6 m -152.01 110.38 3.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.598 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.64 140.06 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.269 -0.894 . . . . 0.0 108.743 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.7 OUTLIER 175.51 164.87 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.918 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.5 tt0 -88.57 169.14 11.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 2.7 pp -88.89 130.97 35.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.867 -1.146 . . . . 0.0 109.619 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.79 -27.1 9.47 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 19.1 t -93.53 117.35 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -1.22 . . . . 0.0 109.732 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.19 144.38 20.08 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.052 0.929 . . . . 0.0 110.049 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.36 -171.43 3.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -143.29 151.44 40.52 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.891 -1.131 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 86.6 m -146.51 127.85 14.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.491 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -85.47 143.38 28.59 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.068 -1.02 . . . . 0.0 110.234 -178.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 78' ' ' LEU . 86.7 mt -96.37 146.9 24.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.446 -0.784 . . . . 0.0 109.359 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.586 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.88 -29.86 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.515 -0.741 . . . . 0.0 109.836 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.99 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -0.953 . . . . 0.0 109.239 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.78 28.2 69.66 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -99.9 162.44 12.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 -179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 96' ' ' THR . 20.0 tt0 -128.83 119.34 24.3 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.563 HD23 ' C ' ' A' ' 94' ' ' LYS . 3.5 mt -125.27 141.49 52.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.076 -1.015 . . . . 0.0 110.328 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.45 145.49 43.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.963 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.765 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 169.67 -120.61 0.88 Allowed Glycine 0 C--O 1.211 -1.303 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.38 159.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.161 -1.199 . . . . 0.0 111.029 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 21.4 m95 -101.96 140.56 36.08 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.578 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -137.89 157.07 47.17 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -97.88 128.97 44.83 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.331 -1.481 . . . . 0.0 108.238 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.662 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.1 mm-40 -134.68 122.5 22.31 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.41 -110.41 3.25 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -125.56 34.19 4.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.207 -1.173 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.23 158.05 43.92 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.494 -1.379 . . . . 0.0 110.213 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mt -97.9 110.63 23.16 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.578 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.8 164.86 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 110.418 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.05 94.96 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.765 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 30.2 mttp -86.17 102.53 13.98 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.175 -1.191 . . . . 0.0 108.819 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.6 m-30 -116.93 149.62 39.86 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.811 0.815 . . . . 0.0 110.103 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.563 ' C ' HD23 ' A' ' 78' ' ' LEU . 3.5 ptpt -143.33 124.02 14.13 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.49 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 31.5 mtp180 -48.07 115.15 1.09 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.349 -0.845 . . . . 0.0 108.804 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -70.55 -7.43 43.78 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.362 1.077 . . . . 0.0 109.322 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -89.68 -41.59 11.84 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.77 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -132.4 8.95 4.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -0.863 . . . . 0.0 109.922 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.06 42.61 12.26 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.834 ' O ' ' O ' ' A' ' 101' ' ' GLU . 14.4 m120 -75.73 18.4 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -1.147 . . . . 0.0 109.573 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.834 ' O ' ' O ' ' A' ' 100' ' ' ASN . 13.4 pt-20 38.62 154.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.107 0.956 . . . . 0.0 111.42 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.867 HD11 ' HB3' ' A' ' 117' ' ' TYR . 15.2 tp -153.53 129.08 9.97 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.617 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -113.93 108.68 17.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 109.341 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.7 t -123.29 175.83 6.47 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.135 0.969 . . . . 0.0 111.669 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' N ' ' OG1' ' A' ' 104' ' ' THR . 45.5 t -145.04 157.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.477 ' HE ' HD21 ' A' ' 113' ' ' LEU . 21.9 ttm180 -126.75 136.02 51.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.982 . . . . 0.0 109.837 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.55 158.3 44.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.104 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.45 HD13 HD12 ' A' ' 113' ' ' LEU . 1.4 mm -122.09 82.38 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.079 -1.013 . . . . 0.0 108.435 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 109' ' ' ILE . 19.2 mt -62.61 92.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.886 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.12 -82.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 109' ' ' ILE . 68.8 m-20 -130.71 29.01 4.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -1.166 . . . . 0.0 109.952 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.07 139.76 49.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 108.874 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.499 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 11.7 tp -98.87 112.15 24.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.885 -1.134 . . . . 0.0 109.051 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.555 HG21 HD12 ' A' ' 109' ' ' ILE . 20.1 t -99.51 111.53 29.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.365 -0.835 . . . . 0.0 109.472 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -111.52 106.84 15.83 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.27 143.22 32.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.867 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -127.16 148.68 50.17 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.875 0.845 . . . . 0.0 109.903 179.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.6 t -112.42 148.13 15.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.517 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -144.01 110.67 5.6 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 49.72 17.74 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.265 0.555 . . . . 0.0 110.984 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.25 28.25 3.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.8 177.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.522 ' N ' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -154.72 116.79 4.21 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 118.309 -1.357 . . . . 0.0 111.04 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.909 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -110.41 153.76 24.53 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -133.54 138.79 46.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.824 -1.173 . . . . 0.0 111.071 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.578 ' NE ' ' OH ' ' A' ' 117' ' ' TYR . 15.1 mtm180 -132.89 120.91 22.11 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.482 HG12 HG22 ' A' ' 114' ' ' VAL . 4.3 mt -114.44 123.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.09 . . . . 0.0 111.245 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 38' ' ' LEU . 5.5 m-30 -99.13 175.94 5.73 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.43 ' CG ' ' N ' ' A' ' 130' ' ' LYS . 45.9 tttt -165.92 159.3 15.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 0.0 109.159 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -47.52 132.6 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.458 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.454 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.291 0.567 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.833 ' CE1' ' CE3' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 40.25 32.08 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.852 . . . . 0.0 109.369 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 1' ' ' ALA . 10.5 m-20 -75.35 78.59 2.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.642 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.59 ' O ' ' NE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -179.28 -168.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.163 -0.96 . . . . 0.0 109.664 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.625 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 55.4 m -95.53 142.02 28.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.833 ' CE3' ' CE1' ' A' ' 2' ' ' PHE . 0.9 OUTLIER -151.45 169.24 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.51 139.63 20.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.328 -0.858 . . . . 0.0 109.281 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' C ' ' O ' ' A' ' 7' ' ' LYS . 7.6 t -33.52 106.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.442 -0.786 . . . . 0.0 110.237 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.05 -31.69 14.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -153.86 173.89 15.32 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.611 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -176.37 178.17 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.933 . . . . 0.0 109.47 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -157.25 154.08 28.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 12.3 m-20 57.92 -110.28 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.744 -0.598 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.507 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.99 -53.15 0.62 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.874 . . . . 0.0 109.922 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 15.2 p-10 -58.93 -46.42 88.01 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 108.827 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 78.2 mttt -63.53 -32.27 73.68 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.905 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 85.7 t80 -72.39 -61.62 1.73 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.556 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 9.6 mmt -58.64 -23.89 60.02 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.079 -0.649 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' HB2' HH21 ' A' ' 28' ' ' ARG . 28.0 tt0 -77.54 -35.3 53.41 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 109.271 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -65.59 -42.01 92.18 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.323 -0.861 . . . . 0.0 109.184 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.482 ' CE ' ' CE2' ' A' ' 17' ' ' PHE . 5.7 mtm -59.61 -13.74 10.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.926 . . . . 0.0 108.845 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.35 22.48 56.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 24' ' ' ASN . 2.9 t -73.27 134.3 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -1.039 . . . . 0.0 109.45 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.9 m-80 -41.98 165.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -77.57 -1.28 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.247 1.022 . . . . 0.0 109.164 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.91 -59.79 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 31' ' ' ALA . 45.3 mmtt -59.24 -39.92 84.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 108.951 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.44 HH21 ' HB2' ' A' ' 19' ' ' GLU . 5.8 ttt180 -61.49 -39.94 92.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -60.89 -47.55 85.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 109.655 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.55 -12.98 47.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -51.73 -52.89 45.08 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.233 0.54 . . . . 0.0 109.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -31.31 67.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.385 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -92.52 34.85 1.04 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.413 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -117.37 73.51 0.88 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.354 -0.842 . . . . 0.0 109.473 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.75 ' H ' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -86.94 43.7 1.11 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.245 -0.91 . . . . 0.0 109.342 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.51 ' O ' ' O ' ' A' ' 35' ' ' ASN . 1.1 pt? -38.81 167.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.211 1.005 . . . . 0.0 111.391 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -105.69 146.4 29.8 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -139.58 124.08 18.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.021 -1.049 . . . . 0.0 110.325 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.536 ' C ' HD12 ' A' ' 40' ' ' ILE . 6.5 m -104.05 114.77 29.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.929 ' N ' HD12 ' A' ' 40' ' ' ILE . 2.2 mp -108.4 138.97 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.672 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.11 152.0 50.85 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -136.97 145.79 44.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 109.557 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -149.6 79.23 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.028 -1.045 . . . . 0.0 109.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.04 -90.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.221 -0.99 . . . . 0.0 110.696 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -120.59 28.77 7.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.333 -1.098 . . . . 0.0 110.453 -178.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 4.8 pttm -152.17 111.82 3.97 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -106.76 174.33 5.93 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.576 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.651 HG23 HG22 ' A' ' 61' ' ' VAL . 11.6 m -148.06 103.39 3.47 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.38 115.58 31.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.585 -0.697 . . . . 0.0 109.148 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -112.36 100.69 8.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.877 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -82.87 157.16 23.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -158.4 107.01 1.97 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.063 -1.023 . . . . 0.0 108.975 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.657 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -134.19 144.46 48.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.93 7.7 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.106 -0.996 . . . . 0.0 109.398 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.657 ' H ' ' C ' ' A' ' 53' ' ' SER . 47.7 m-85 -112.47 -20.3 11.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -0.918 . . . . 0.0 111.227 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.0 OUTLIER 163.3 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.0 109.686 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.723 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -63.38 145.86 54.72 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -137.59 174.1 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 0.0 110.312 -179.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 6.4 pt-20 -150.62 143.56 24.69 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.14 110.46 4.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.651 HG22 HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -109.14 141.65 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.285 -0.884 . . . . 0.0 109.093 179.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 175.78 -179.32 0.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.849 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.9 mp0 -105.09 175.19 5.58 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 64' ' ' LEU . 3.3 pp -93.9 119.37 32.73 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.986 -1.071 . . . . 0.0 109.203 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.0 -34.73 3.92 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.66 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 3.1 t -83.75 115.02 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.012 -1.287 . . . . 0.0 109.98 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -54.73 147.91 13.85 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.041 0.924 . . . . 0.0 110.207 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -160.05 -171.08 3.08 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -129.31 150.09 50.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 110.131 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 63.5 m -152.7 132.47 13.2 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.766 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -92.24 145.9 24.13 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.972 -1.08 . . . . 0.0 110.415 -178.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 73' ' ' ALA . 89.3 mt -93.91 147.02 23.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 0.0 109.342 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.61 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.49 -34.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 23.8 t0 -62.57 12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.143 -0.973 . . . . 0.0 109.536 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 69.15 27.9 73.34 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.632 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.3 OUTLIER -99.07 162.14 13.23 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.232 -1.158 . . . . 0.0 109.345 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -132.71 119.56 20.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.62 -0.675 . . . . 0.0 109.227 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.93 163.04 30.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.009 -1.057 . . . . 0.0 110.335 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -141.95 146.35 35.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.885 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.749 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 170.26 -118.7 0.77 Allowed Glycine 0 C--O 1.211 -1.287 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.19 159.51 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.268 -1.136 . . . . 0.0 110.674 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.33 145.1 29.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.58 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -141.01 157.35 45.45 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -97.51 123.19 41.29 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.456 -1.403 . . . . 0.0 108.217 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' N ' HD12 ' A' ' 84' ' ' LEU . 23.9 mt-10 -120.11 111.63 18.1 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.4 ' O ' HD11 ' A' ' 84' ' ' LEU . . . 64.47 -104.95 1.0 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 87' ' ' ASN . 3.9 t-20 -125.21 33.47 5.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -1.16 . . . . 0.0 110.262 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.51 148.26 40.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.795 -1.191 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.25 104.48 16.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.58 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -74.9 164.16 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.067 -1.02 . . . . 0.0 110.555 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.9 94.97 0.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.68 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 36.6 mtmt -88.8 103.1 15.67 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.25 -1.147 . . . . 0.0 109.151 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.2 m-30 -118.43 137.43 53.15 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.647 0.737 . . . . 0.0 109.709 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.502 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 14.1 pttt -124.97 122.89 38.61 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 99' ' ' GLY . 18.3 mtp85 -51.35 117.91 2.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 0.0 109.22 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -11.12 60.72 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.438 1.113 . . . . 0.0 109.29 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.21 -48.29 12.27 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.571 ' OD1' ' NH1' ' A' ' 95' ' ' ARG . 11.3 m120 -132.58 8.63 4.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.23 43.67 9.62 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.683 ' O ' ' O ' ' A' ' 101' ' ' GLU . 56.7 m-20 -72.38 11.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 109.524 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.683 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.2 mt-10 47.42 132.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.713 0.768 . . . . 0.0 111.162 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -135.31 132.51 37.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.731 ' N ' HD12 ' A' ' 102' ' ' LEU . 1.9 m120 -117.01 116.49 27.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 0.0 108.931 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -128.12 176.13 7.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.223 -0.923 . . . . 0.0 110.796 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.4 t -146.6 155.2 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.17 136.31 51.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 109.899 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -137.36 158.68 43.89 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.45 ' N ' ' HG3' ' A' ' 107' ' ' GLU . 2.2 mt -124.71 82.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 120.824 -1.173 . . . . 0.0 108.642 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 109' ' ' ILE . 21.3 mt -62.8 92.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.976 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.97 -80.15 0.01 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.6 t70 -130.77 29.78 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -1.188 . . . . 0.0 110.483 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -133.12 141.56 48.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.151 -0.968 . . . . 0.0 109.016 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 7.1 tp -97.65 110.77 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.871 -1.143 . . . . 0.0 109.195 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.514 HG22 HG23 ' A' ' 127' ' ' ILE . 8.8 t -95.21 111.9 26.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.717 -0.793 . . . . 0.0 108.937 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -114.84 107.32 15.26 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -101.42 145.31 29.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.691 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -123.11 154.97 37.89 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.837 0.827 . . . . 0.0 109.48 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 122' ' ' VAL . 9.1 t -125.59 147.1 30.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.562 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -144.78 110.37 5.3 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.008 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 47.52 19.31 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.198 0.523 . . . . 0.0 111.118 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.72 28.12 3.56 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.24 176.58 4.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 3.6 mt-10 -155.68 125.9 6.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.229 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.905 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -118.21 153.37 34.0 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -130.29 139.56 50.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.808 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.691 ' NH1' ' CZ ' ' A' ' 117' ' ' TYR . 41.0 mtm180 -136.74 114.03 10.79 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.514 HG23 HG22 ' A' ' 114' ' ' VAL . 5.2 mt -110.74 123.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.972 -1.08 . . . . 0.0 110.77 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 38' ' ' LEU . 8.3 m-30 -99.18 171.0 8.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.519 -0.738 . . . . 0.0 109.502 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -153.76 159.62 42.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.63 -0.669 . . . . 0.0 109.21 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -57.96 134.09 56.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.2 t0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.486 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.254 0.549 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.846 ' CZ ' ' CD2' ' A' ' 6' ' ' TRP . 1.4 t80 42.69 38.38 1.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.314 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 4' ' ' SER . 5.5 m-20 -78.46 96.4 5.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 109.499 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.623 ' OG ' ' N ' ' A' ' 5' ' ' THR . 0.9 OUTLIER 159.3 -169.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.775 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.623 ' N ' ' OG ' ' A' ' 4' ' ' SER . 51.5 m -95.89 150.41 20.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.816 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.846 ' CD2' ' CZ ' ' A' ' 2' ' ' PHE . 12.4 m95 -150.39 169.13 22.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.755 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 14.9 pttm -152.25 125.24 8.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.578 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.63 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -39.31 106.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 24.2 t0 -95.06 -29.49 14.57 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.409 ' HB2' HD12 ' A' ' 127' ' ' ILE . 2.5 mtt-85 -147.86 162.63 38.88 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.871 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.56 178.1 7.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -154.43 158.39 39.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 6.8 m-20 58.86 -109.18 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.656 -0.653 . . . . 0.0 109.72 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 74.76 -54.22 0.67 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.658 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 2.7 m-20 -60.55 -42.37 96.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.083 -1.011 . . . . 0.0 108.574 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -64.27 -32.05 73.5 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.84 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 7.5 t80 -72.9 -64.07 1.04 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.3 OUTLIER -57.66 -20.85 36.39 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.616 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 2.0 tm-20 -79.77 -36.37 37.28 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.061 -1.024 . . . . 0.0 109.453 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -67.41 -40.85 85.59 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.358 -0.838 . . . . 0.0 109.246 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 mtm -68.09 -6.12 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.33 -0.856 . . . . 0.0 108.999 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.53 32.43 67.76 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' A' ' 24' ' ' ASN . 21.5 t -72.73 128.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.486 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 23' ' ' VAL . 6.7 m120 -41.76 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.355 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -76.52 -1.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.181 0.991 . . . . 0.0 109.212 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.2 t -81.86 -59.88 2.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -62.92 -30.93 71.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -44.08 72.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.438 -0.789 . . . . 0.0 109.312 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -62.99 -34.19 77.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 109.511 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.5 -13.26 46.52 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.968 0.89 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -80.34 -36.31 34.35 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.566 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.39 -24.34 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.618 ' O ' ' N ' ' A' ' 35' ' ' ASN . 1.3 m-70 -68.82 36.42 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.274 -0.891 . . . . 0.0 109.118 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 32' ' ' ALA . 7.5 p-10 -42.57 89.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.861 . . . . 0.0 109.771 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 33' ' ' HIS . 17.1 t30 -147.7 42.72 1.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 108.919 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -83.23 159.87 21.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.876 . . . . 0.0 110.486 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.812 ' N ' HD12 ' A' ' 36' ' ' LEU . 13.6 mtmm -119.55 150.4 40.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.6 pt? -153.8 149.53 27.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.111 -0.993 . . . . 0.0 110.0 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 m -117.45 123.32 46.07 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.752 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.0 mp -109.37 131.43 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.676 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -131.65 152.26 50.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.05 149.0 41.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 0.0 109.95 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -146.98 79.52 1.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.096 -1.003 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 -94.52 0.64 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -127.38 28.28 5.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -1.109 . . . . 0.0 109.442 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.57 ' CG ' ' O ' ' A' ' 46' ' ' LYS . 18.6 pttm -149.37 110.83 4.46 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.3 174.23 9.75 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.013 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -143.49 103.07 4.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG13 HG13 ' A' ' 40' ' ' ILE . 42.2 t -98.94 108.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 121.773 -0.579 . . . . 0.0 109.831 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.16 100.0 12.17 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.302 -0.874 . . . . 0.0 108.748 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 58' ' ' ILE . 50.2 mt-10 -69.78 155.74 40.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.241 -0.912 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 51' ' ' GLU . 3.2 m -160.83 107.24 1.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.194 -0.941 . . . . 0.0 108.818 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.702 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.7 OUTLIER -143.25 144.54 32.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.77 7.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 109.051 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.702 ' H ' ' C ' ' A' ' 53' ' ' SER . 16.5 t80 -106.83 -24.95 11.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 110.861 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 73' ' ' ALA . 9.8 mtp180 160.01 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 109.25 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -62.45 145.86 53.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 109.18 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.8 mt -142.77 174.14 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 122.129 0.966 . . . . 0.0 110.694 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.62 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.6 pt-20 -135.42 142.52 45.64 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 t -155.05 113.76 3.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.976 -1.077 . . . . 0.0 110.306 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.18 149.35 7.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -129.94 121.07 25.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.033 . . . . 0.0 110.534 -179.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 50.2 tt0 -123.35 139.17 54.31 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -103.23 148.83 25.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.885 -1.135 . . . . 0.0 110.283 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.8 -5.13 59.71 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.0 t -144.12 118.06 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.023 -1.28 . . . . 0.0 109.941 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.8 m -49.32 145.4 4.55 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.294 1.045 . . . . 0.0 109.685 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -159.98 -168.14 2.15 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.712 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -146.46 157.21 43.72 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.911 -1.116 . . . . 0.0 111.532 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 15.9 t -147.66 136.05 21.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -96.54 148.33 22.94 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.939 -1.101 . . . . 0.0 110.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 73' ' ' ALA . 18.8 mt -100.94 147.08 26.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.586 -0.696 . . . . 0.0 109.527 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.671 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -39.46 -34.73 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.747 -0.596 . . . . 0.0 109.816 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.65 7.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.127 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.671 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 70.12 24.63 76.43 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.29 161.25 13.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.246 -1.149 . . . . 0.0 109.53 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -133.55 124.57 27.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.245 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -130.39 159.61 36.5 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.063 -1.023 . . . . 0.0 110.499 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -138.89 152.33 47.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.351 -0.843 . . . . 0.0 110.458 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.15 -110.09 0.42 Allowed Glycine 0 C--O 1.212 -1.272 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 166.74 152.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -1.216 . . . . 0.0 110.93 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 28.2 m95 -108.45 130.22 55.25 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.649 ' H ' HD12 ' A' ' 90' ' ' ILE . 1.8 m -144.88 156.31 43.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.887 -1.133 . . . . 0.0 109.54 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.934 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -87.27 138.11 31.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.752 -1.218 . . . . 0.0 108.425 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.934 ' N ' HD12 ' A' ' 84' ' ' LEU . 49.9 mt-10 -160.32 157.21 27.59 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.497 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.07 -117.72 6.49 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -125.99 33.8 4.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -1.197 . . . . 0.0 110.638 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -165.02 163.5 20.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.436 -1.415 . . . . 0.0 110.593 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.71 124.35 31.41 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.649 HD12 ' H ' ' A' ' 83' ' ' SER . 0.3 OUTLIER -94.13 161.05 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.983 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 104' ' ' THR . . . -148.24 100.3 0.21 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.635 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 63.6 mttt -98.08 108.76 21.54 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.371 -1.076 . . . . 0.0 108.762 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' LEU . 1.5 m-30 -126.72 137.92 53.32 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.78 0.8 . . . . 0.0 110.245 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 94' ' ' LYS . 4.4 ptmm? -126.33 128.92 47.85 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 99' ' ' GLY . 35.7 mtp180 -54.64 115.27 2.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 108.993 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -10.17 57.34 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.389 1.09 . . . . 0.0 109.34 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -83.31 -47.13 11.82 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.619 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -132.44 9.26 4.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.977 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 46.84 44.86 18.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.64 ' O ' ' O ' ' A' ' 101' ' ' GLU . 13.9 m120 -74.42 10.54 1.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -1.173 . . . . 0.0 109.63 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.64 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.5 mt-10 49.96 136.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.764 0.792 . . . . 0.0 111.12 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.3 tt -146.39 122.28 10.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.671 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -112.42 149.98 31.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.044 . . . . 0.0 108.554 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.7 t -159.59 175.71 12.89 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.266 -1.521 . . . . 0.0 111.315 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 106' ' ' ARG . 37.8 t -144.23 158.17 15.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 105' ' ' VAL . 4.0 ttm180 -131.81 134.12 45.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -137.0 157.88 45.72 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.24 82.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.069 -1.019 . . . . 0.0 108.52 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 111' ' ' ASP . 79.0 mt -63.03 92.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.237 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.68 -78.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 109' ' ' ILE . 20.9 p-10 -130.19 29.24 4.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.0 110.316 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -134.77 139.05 44.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 108.966 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 2' ' ' PHE . 7.5 tp -102.9 114.87 29.51 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.009 -1.057 . . . . 0.0 109.543 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.662 HG22 HG23 ' A' ' 127' ' ' ILE . 25.1 t -102.11 107.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.399 -0.813 . . . . 0.0 109.111 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -110.1 106.97 16.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.76 145.43 30.37 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.258 -0.901 . . . . 0.0 109.991 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.702 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -129.22 149.8 50.87 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.94 0.876 . . . . 0.0 109.715 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 122' ' ' VAL . 3.9 t -112.91 148.01 16.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.507 ' CB ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -140.64 110.28 6.38 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 47.31 19.22 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.122 0.487 . . . . 0.0 111.182 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.5 28.6 3.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -124.34 177.23 4.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 122' ' ' VAL . 33.9 mt-10 -153.5 121.23 5.98 Favored 'General case' 0 C--N 1.285 -2.23 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.378 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.84 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -114.0 146.19 40.5 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -125.82 140.14 52.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.929 -1.107 . . . . 0.0 111.186 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -129.71 114.2 15.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.662 HG23 HG22 ' A' ' 114' ' ' VAL . 8.7 mt -111.36 123.38 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 110.762 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.549 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 4.6 m-30 -103.65 176.06 5.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.489 -0.757 . . . . 0.0 109.577 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.58 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 24.6 tttp -163.86 152.96 14.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.547 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 4.7 pttm -47.66 132.24 14.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.884 . . . . 0.0 109.655 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 13.5 p-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.604 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.293 0.568 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.853 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.4 OUTLIER 68.48 31.14 4.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 4' ' ' SER . 1.3 m-20 -75.86 92.91 3.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.44 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.676 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.0 OUTLIER 163.83 -166.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.676 ' N ' ' OG ' ' A' ' 4' ' ' SER . 96.8 m -91.49 145.27 24.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.669 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.853 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 8.2 m95 -151.36 168.24 25.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.315 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 3.0 ptmm? -153.18 133.76 13.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.988 -1.07 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.61 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -40.2 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.426 -0.796 . . . . 0.0 109.506 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.26 -30.2 12.38 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -140.67 169.82 16.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.912 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 14.4 t -175.27 178.11 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.279 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -156.24 154.42 30.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 5.9 m-20 56.79 -109.5 0.49 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.526 -0.734 . . . . 0.0 109.792 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.519 ' CE2' ' HE1' ' A' ' 18' ' ' MET . 0.3 OUTLIER 75.68 -54.14 0.63 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.529 ' CG ' HH21 ' A' ' 28' ' ' ARG . 7.2 m-20 -63.86 -42.59 97.51 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.664 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -66.46 -32.08 73.22 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.86 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 21.9 t80 -72.28 -60.29 2.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.519 ' HE1' ' CE2' ' A' ' 14' ' ' TYR . 5.3 mtt -56.41 -25.09 49.06 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -78.87 -30.06 44.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.157 -0.965 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -69.76 -41.8 74.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.39 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -68.01 -6.41 22.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.91 . . . . 0.0 108.942 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 29.64 54.14 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.46 135.52 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.532 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -48.8 158.84 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.88 . . . . 0.0 109.37 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -82.96 -1.38 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.141 0.972 . . . . 0.0 109.237 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.2 t -80.07 -60.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -57.34 -42.45 81.96 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.529 HH21 ' CG ' ' A' ' 15' ' ' ASP . 16.7 ttp85 -59.32 -46.67 87.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.456 -0.777 . . . . 0.0 109.204 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 tttp -53.59 -39.34 64.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.385 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.2 mt -86.5 -13.59 45.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.803 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.44 -39.92 15.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 121.186 0.517 . . . . 0.0 109.668 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -38.64 -27.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.678 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 35' ' ' ASN . 46.5 m170 -70.04 39.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.908 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 32' ' ' ALA . 6.8 t0 -43.5 90.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.591 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 33' ' ' HIS . 5.8 m120 -147.7 42.97 1.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 109.149 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 36' ' ' LEU . 1.1 pt? -90.6 163.52 14.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -106.17 135.19 48.07 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.582 HD21 HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -132.91 128.54 36.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.963 . . . . 0.0 109.975 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.446 HG23 ' HA ' ' A' ' 5' ' ' THR . 0.3 OUTLIER -102.87 120.71 41.09 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.028 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.5 mp -107.78 123.17 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.086 -1.009 . . . . 0.0 110.829 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.02 151.93 38.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.604 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 20.7 pt20 -133.37 148.95 51.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.005 -1.059 . . . . 0.0 110.188 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.513 ' OE2' ' CD ' ' A' ' 46' ' ' LYS . 58.6 mt-10 -147.73 79.31 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.183 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.14 -92.72 0.12 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.31 28.42 7.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -1.059 . . . . 0.0 109.358 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.513 ' CD ' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -140.67 109.74 6.14 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' HB2' ' CE2' ' A' ' 62' ' ' PHE . 19.1 m-85 -103.06 173.36 6.34 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.2 m -154.88 103.61 2.43 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.73 110.29 25.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -95.52 100.26 12.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' A' ' 51' ' ' GLU . 58.1 mp0 -73.88 159.75 32.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 51' ' ' GLU . 2.3 m -160.16 107.02 1.59 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.081 -1.012 . . . . 0.0 109.163 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.632 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -125.68 144.31 50.66 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.03 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.218 -0.927 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.632 ' H ' ' C ' ' A' ' 53' ' ' SER . 20.6 t80 -125.02 -19.62 5.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 111.782 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 177.02 81.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.303 -1.498 . . . . 0.0 110.084 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.774 ' H ' HD22 ' A' ' 57' ' ' ASN . 0.1 OUTLIER -62.89 145.58 54.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.999 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -136.79 174.19 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.4 pt-20 -147.05 143.99 28.77 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.22 110.57 4.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -89.5 146.22 6.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 4.6 p90 -160.46 153.75 21.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.561 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 45' ' ' ASN . 12.2 tt0 -129.15 122.72 30.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 64' ' ' LEU . 3.0 pp -56.86 126.74 28.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.04 -1.037 . . . . 0.0 109.853 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.97 3.4 24.81 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.67 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 18.5 t -144.17 113.63 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.954 -1.321 . . . . 0.0 109.777 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.778 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.5 m -55.48 147.64 17.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.958 0.885 . . . . 0.0 110.308 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.67 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -156.59 -171.0 3.52 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -134.05 153.24 51.93 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 34.9 t -156.84 131.62 8.86 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.56 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -95.79 145.42 25.35 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' GLY . 19.5 mt -95.85 146.89 24.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.628 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.44 -34.96 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.65 -0.656 . . . . 0.0 109.897 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -57.58 3.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.243 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.628 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.37 25.27 66.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.708 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.21 161.67 13.46 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.172 -1.193 . . . . 0.0 109.555 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -133.33 121.24 22.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -135.56 161.68 34.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.946 -1.096 . . . . 0.0 110.216 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HG3' HG22 ' A' ' 67' ' ' THR . 0.7 OUTLIER -144.48 148.24 34.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 109.65 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.778 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.23 -116.95 0.69 Allowed Glycine 0 N--CA 1.476 1.325 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 174.03 159.26 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.95 -1.324 . . . . 0.0 111.093 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 12.8 m95 -102.2 141.67 34.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.588 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.9 OUTLIER -138.79 156.9 46.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -95.54 128.72 42.63 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.353 -1.467 . . . . 0.0 108.408 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.658 ' N ' HD12 ' A' ' 84' ' ' LEU . 14.3 pt-20 -129.61 129.33 44.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 52.74 -108.56 0.73 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -125.51 34.12 4.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.177 -1.19 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.95 156.23 44.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.601 -1.312 . . . . 0.0 110.179 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.5 mt -97.1 110.83 23.3 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.3 164.72 3.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.149 -0.969 . . . . 0.0 110.522 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.658 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.97 95.19 0.17 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.704 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.0 ptmm? -86.85 102.41 14.28 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.122 -1.222 . . . . 0.0 109.102 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 102' ' ' LEU . 4.5 m-30 -116.0 142.68 46.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.775 0.798 . . . . 0.0 109.801 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 31.8 pttt -133.34 124.02 26.47 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.537 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.708 ' HE ' ' CG2' ' A' ' 76' ' ' THR . 25.5 mtt180 -44.67 116.8 1.13 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.383 -0.823 . . . . 0.0 108.886 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -7.19 41.05 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.922 -1.111 . . . . 0.0 109.328 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -86.66 -45.9 10.56 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.516 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -132.6 8.46 4.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.837 . . . . 0.0 109.84 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 47.31 45.16 21.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 21.4 m-20 -73.12 12.57 0.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -1.15 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.4 mt-10 49.66 146.17 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.903 0.859 . . . . 0.0 111.32 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.661 HD23 ' C ' ' A' ' 102' ' ' LEU . 8.3 tt -149.93 126.04 10.63 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.515 ' N ' HD23 ' A' ' 102' ' ' LEU . 13.5 t30 -111.65 112.44 24.14 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.066 -1.021 . . . . 0.0 109.415 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.9 t -124.53 176.43 6.52 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.238 -0.914 . . . . 0.0 110.994 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.1 t -148.54 154.93 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -126.65 130.29 50.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 109.688 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -129.44 158.98 37.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 109.083 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 2' ' ' PHE . 1.4 mm -120.08 82.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 109' ' ' ILE . 9.5 mt -64.38 91.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.735 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 51.38 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 109' ' ' ILE . 4.1 p-10 -125.05 29.84 6.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -1.173 . . . . 0.0 110.422 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -138.3 147.7 43.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 109.029 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 11.0 tp -107.76 112.42 25.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.031 -1.043 . . . . 0.0 109.477 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.521 HG22 HG23 ' A' ' 127' ' ' ILE . 3.4 t -94.77 115.16 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.394 -0.816 . . . . 0.0 109.286 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -114.56 103.32 10.9 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -103.0 145.94 29.1 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.909 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -128.17 152.65 47.78 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.96 0.886 . . . . 0.0 109.641 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.0 t -120.09 149.24 22.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.591 ' CE1' ' OE2' ' A' ' 120' ' ' GLU . 1.2 t80 -143.47 110.88 5.82 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.929 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.591 ' OE2' ' CE1' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 46.15 20.16 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.053 178.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.68 28.55 3.42 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.767 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.9 176.58 5.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.51 ' N ' HG13 ' A' ' 122' ' ' VAL . 39.0 tt0 -156.06 125.55 6.28 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.067 -1.453 . . . . 0.0 111.427 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.86 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -121.31 151.42 40.1 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.4 ' O ' ' OG ' ' A' ' 11' ' ' SER . 5.3 ttpt -132.31 139.61 48.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.821 -1.174 . . . . 0.0 111.282 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.517 HH11 ' HH ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -135.14 114.42 12.35 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 114' ' ' VAL . 3.3 mt -108.76 125.39 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.036 -1.04 . . . . 0.0 110.817 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.513 ' CE2' HD22 ' A' ' 38' ' ' LEU . 6.5 m-30 -97.7 174.6 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.248 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.743 ' HE2' ' HZ2' ' A' ' 130' ' ' LYS . 43.4 tttm -160.65 156.63 25.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.524 -0.735 . . . . 0.0 109.273 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.743 ' HZ2' ' HE2' ' A' ' 129' ' ' LYS . 13.3 pttp -49.13 128.91 17.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.592 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.508 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.801 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.7 OUTLIER 42.52 33.79 0.48 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.455 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 4' ' ' SER . 20.2 p-10 -77.65 93.86 4.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.588 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.58 -166.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.58 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 36.2 m -90.94 147.08 23.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.365 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.801 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 15.4 m95 -151.69 169.24 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 109.646 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' VAL . 36.7 pttt -153.2 126.96 8.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.029 -1.044 . . . . 0.0 109.768 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.632 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -36.4 106.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.382 -0.824 . . . . 0.0 109.422 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -91.1 -29.5 17.27 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' NH1' HG21 ' A' ' 127' ' ' ILE . 62.2 mtm-85 -151.54 166.68 30.4 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.225 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.4 t -177.15 166.46 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.507 -0.745 . . . . 0.0 109.091 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -166.75 166.17 15.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.023 -1.048 . . . . 0.0 110.448 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 58.9 21.78 9.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.581 -0.699 . . . . 0.0 110.243 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.59 ' OH ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.61 -57.29 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.599 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 19' ' ' GLU . 2.6 m-20 -45.85 -52.93 10.55 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.011 -1.056 . . . . 0.0 109.161 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -54.65 -41.68 70.38 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.886 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 81.9 t80 -67.84 -63.84 0.98 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -20.82 2.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 15' ' ' ASP . 39.1 tt0 -79.24 -38.13 36.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -65.81 -37.32 85.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.516 ' HB2' HG23 ' A' ' 23' ' ' VAL . 11.3 mtm -67.73 -8.84 38.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.322 -0.861 . . . . 0.0 109.11 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 32.51 41.69 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 21' ' ' MET . 17.7 t -80.02 139.2 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -1.108 . . . . 0.0 109.585 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' VAL . 62.6 t30 -44.83 170.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.302 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.593 ' CD1' ' CZ ' ' A' ' 28' ' ' ARG . 3.7 mm -85.33 -5.1 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.017 . . . . 0.0 109.34 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.469 HG23 ' ND2' ' A' ' 24' ' ' ASN . 58.8 t -83.88 -60.04 2.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.724 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 49.3 mttp -63.97 -24.06 67.58 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.593 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 23.4 ttp180 -73.04 -47.8 41.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.553 -0.717 . . . . 0.0 109.361 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -66.96 -34.84 78.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.793 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.71 -13.07 46.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 110.064 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -74.82 -25.92 59.36 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.167 0.508 . . . . 0.0 109.824 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -70.94 -61.0 1.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.103 -0.998 . . . . 0.0 109.509 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.6 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 82.2 t60 -70.71 46.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.451 -0.78 . . . . 0.0 109.434 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.485 ' OD2' HD22 ' A' ' 36' ' ' LEU . 37.8 t0 -88.94 127.54 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HA ' HG13 ' A' ' 8' ' ' VAL . 71.5 m-20 -123.78 43.08 3.07 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.632 HD23 HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -68.95 159.91 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.902 0.858 . . . . 0.0 111.008 -178.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -107.64 149.06 28.53 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 38' ' ' LEU . 2.6 mp -139.17 129.01 24.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.015 . . . . 0.0 109.952 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 m -99.96 105.86 17.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.523 HD13 ' CD2' ' A' ' 2' ' ' PHE . 3.7 mp -95.65 123.4 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.2 -0.937 . . . . 0.0 110.926 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.01 151.79 41.54 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -129.66 148.24 51.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.024 -1.048 . . . . 0.0 109.843 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 45' ' ' ASN . 27.9 mt-10 -144.72 78.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.66 -81.58 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' GLU . 11.7 p-10 -125.56 28.87 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.67 109.67 4.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.36 166.81 12.39 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.5 m -156.17 103.67 2.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.7 p -105.97 118.67 53.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.491 -0.755 . . . . 0.0 109.486 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -100.01 100.25 11.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.346 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.565 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 1.8 mp0 -70.51 156.3 39.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.203 -0.935 . . . . 0.0 109.05 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -158.86 106.93 1.86 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.073 -1.017 . . . . 0.0 109.022 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.645 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.61 144.64 50.5 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.01 7.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 109.858 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.687 ' CZ ' ' NH2' ' A' ' 56' ' ' ARG . 6.0 t80 -112.29 -20.45 11.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 111.128 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.687 ' NH2' ' CZ ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER 160.44 89.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.843 -1.16 . . . . 0.0 109.317 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -62.18 148.17 45.43 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 59' ' ' GLU . 2.0 mt -138.11 174.19 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.032 0.92 . . . . 0.0 110.338 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.601 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.8 pt-20 -141.79 143.29 33.37 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.9 m -150.75 117.52 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.003 . . . . 0.0 110.263 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER -89.08 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -137.82 165.93 25.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.991 -1.068 . . . . 0.0 110.605 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 23.8 tt0 -152.39 169.71 21.9 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.457 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 78.3 mt -100.74 118.88 37.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 110.197 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.87 24.56 27.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.345 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.636 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 21.0 t -144.05 102.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.05 -1.265 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.8 143.12 43.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.752 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.81 -171.03 3.82 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.432 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -138.41 149.73 45.8 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.481 -179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 50.0 t -151.91 135.66 16.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -98.43 143.91 28.36 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.035 -1.041 . . . . 0.0 110.163 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.1 mt -91.82 147.04 23.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.551 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.612 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.67 -33.86 1.33 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.702 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.68 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.612 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 78.34 25.33 61.54 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 161.7 13.43 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.236 -1.155 . . . . 0.0 109.692 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.732 ' C ' HD23 ' A' ' 78' ' ' LEU . 19.0 tt0 -133.09 125.88 30.55 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.732 HD23 ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -136.78 164.76 27.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.969 -1.082 . . . . 0.0 110.574 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.526 ' HG3' HG22 ' A' ' 67' ' ' THR . 14.6 ttm180 -147.85 143.15 27.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 169.66 -119.59 0.83 Allowed Glycine 0 N--CA 1.475 1.294 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.519 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 173.05 158.95 0.12 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.211 -1.17 . . . . 0.0 110.53 179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.484 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.2 m95 -102.0 143.26 32.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.9 m -138.76 157.14 46.64 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -96.26 129.22 43.64 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.364 -1.46 . . . . 0.0 108.286 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.683 ' N ' HD12 ' A' ' 84' ' ' LEU . 1.3 pp20? -131.31 125.43 32.76 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.51 -109.45 1.58 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -125.47 33.84 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -1.156 . . . . 0.0 110.216 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.403 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -141.38 155.86 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.77 -1.206 . . . . 0.0 110.165 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mt -97.58 111.23 23.59 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -80.66 164.81 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 110.476 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.25 95.41 0.17 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.717 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 12.5 ptmt -86.17 102.78 14.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.189 -1.183 . . . . 0.0 108.478 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 102' ' ' LEU . 5.1 m-30 -118.95 145.72 45.56 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.823 0.821 . . . . 0.0 110.146 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.515 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 20.3 pttm -132.46 121.58 23.59 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 99' ' ' GLY . 49.0 mtp180 -46.95 114.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.398 -0.814 . . . . 0.0 109.026 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.49 -10.15 53.63 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 122.492 1.139 . . . . 0.0 109.28 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -79.03 -50.44 11.07 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.464 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -132.34 9.54 4.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.393 -0.817 . . . . 0.0 109.84 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.78 47.22 31.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.649 ' O ' ' O ' ' A' ' 101' ' ' GLU . 1.5 m120 -77.92 14.01 1.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -1.146 . . . . 0.0 109.581 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 100' ' ' ASN . 7.8 mt-10 50.88 142.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.616 0.722 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -144.89 131.71 20.13 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.711 ' N ' HD12 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -114.9 111.76 21.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 0.0 108.866 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.2 t -126.86 176.4 7.32 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.075 -1.016 . . . . 0.0 111.184 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 106' ' ' ARG . 45.2 t -147.92 162.34 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.485 ' N ' HG12 ' A' ' 105' ' ' VAL . 12.9 ttm180 -133.4 139.48 46.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 109.924 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -141.42 158.75 43.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.133 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.438 HD13 HD12 ' A' ' 113' ' ' LEU . 1.4 mm -119.21 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.0 mm -61.55 92.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.009 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.53 -78.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 109' ' ' ILE . 14.4 m-20 -130.73 29.9 4.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -1.151 . . . . 0.0 110.213 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -136.98 146.48 45.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.121 -0.987 . . . . 0.0 109.164 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 11.9 tp -102.23 115.64 30.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.995 -1.066 . . . . 0.0 109.219 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 127' ' ' ILE . 5.6 t -105.16 107.61 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.282 -0.886 . . . . 0.0 109.288 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.497 ' O ' ' CE1' ' A' ' 117' ' ' TYR . 12.5 tt0 -107.43 109.46 21.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 144.7 28.59 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 109.767 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.681 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -127.22 150.76 49.39 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.841 0.829 . . . . 0.0 109.51 179.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.751 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.2 t -119.77 147.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.554 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.1 t80 -145.03 110.75 5.38 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.138 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 50.01 17.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.299 0.571 . . . . 0.0 110.979 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.29 27.76 3.8 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.751 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -121.42 176.34 4.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 2.3 mt-10 -156.05 117.23 3.85 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 118.26 -1.376 . . . . 0.0 111.09 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.886 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -112.17 166.94 10.81 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -145.26 137.47 25.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.885 -1.134 . . . . 0.0 110.912 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.59 ' NE ' ' OH ' ' A' ' 14' ' ' TYR . 14.6 mtt180 -125.15 114.1 18.58 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 114' ' ' VAL . 7.3 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 110.352 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.532 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 11.4 m-30 -100.93 166.21 10.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.5 tttt -150.96 146.75 26.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.58 -0.7 . . . . 0.0 109.121 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -47.83 136.43 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.496 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 130' ' ' LYS . 11.7 p30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.451 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.487 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.859 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.3 OUTLIER 39.43 30.68 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.267 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 4' ' ' SER . 26.6 t70 -72.51 96.84 1.99 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.486 -0.759 . . . . 0.0 109.748 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 160.29 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 109.598 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.582 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.7 m -98.03 142.59 29.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.304 -0.872 . . . . 0.0 109.352 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.859 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 4.4 m95 -147.29 169.43 19.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.303 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 8' ' ' VAL . 11.9 pttm -151.9 130.7 12.43 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.022 -1.049 . . . . 0.0 109.477 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.654 HG11 HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -39.83 106.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.364 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.44 -32.28 11.93 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' O ' ' OG ' ' A' ' 11' ' ' SER . 15.8 mtm-85 -142.58 164.65 29.53 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.686 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 67.3 m -170.47 178.22 3.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 109.294 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -155.19 157.5 37.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.01 -1.056 . . . . 0.0 110.006 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 10.8 m-20 58.02 -109.53 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.615 -0.678 . . . . 0.0 109.854 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 71.69 -51.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -61.36 -46.03 91.93 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.955 -1.091 . . . . 0.0 108.597 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -63.34 -33.84 76.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.918 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 91.0 t80 -71.39 -61.4 1.79 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.795 0.807 . . . . 0.0 108.883 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.3 mmt -59.04 -23.78 62.28 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -74.76 -37.82 62.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.24 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -64.67 -46.38 82.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.341 -0.849 . . . . 0.0 109.028 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.479 ' CE ' ' CE2' ' A' ' 17' ' ' PHE . 4.8 mtm -61.81 -9.07 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.041 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.26 28.02 62.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG11 ' OD1' ' A' ' 74' ' ' ASP . 3.8 t -74.85 132.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -1.091 . . . . 0.0 109.553 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.745 HD22 ' N ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -49.31 167.15 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.745 ' N ' HD22 ' A' ' 24' ' ' ASN . 1.5 mm -82.03 -1.21 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.181 0.991 . . . . 0.0 109.22 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -73.69 -59.84 2.97 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.456 0.646 . . . . 0.0 109.386 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -64.22 -29.56 70.66 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.071 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' CZ ' ' CD1' ' A' ' 25' ' ' ILE . 14.3 ttp180 -72.71 -30.69 64.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.642 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -75.4 -40.02 58.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pp -86.38 -13.14 47.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.01 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 33' ' ' HIS . . . -84.7 -49.56 8.4 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.212 0.529 . . . . 0.0 109.626 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.2 -1.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.713 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.544 ' H ' ' C ' ' A' ' 31' ' ' ALA . 81.4 m-70 -140.1 46.26 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.609 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' LEU . 25.6 t0 -125.56 95.95 4.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.639 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.6 p-10 -71.48 43.57 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.848 . . . . 0.0 109.353 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.654 HD23 HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -43.77 155.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 110.901 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -106.57 148.7 27.95 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.5 HD21 HD11 ' A' ' 36' ' ' LEU . 2.7 mp -138.92 126.53 21.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -98.29 111.78 24.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.8 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.9 mp -100.76 120.48 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.033 -1.042 . . . . 0.0 110.448 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -120.98 151.99 39.08 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.642 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 1.6 pm0 -130.88 147.06 52.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 45' ' ' ASN . 38.5 mm-40 -144.04 78.88 1.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.65 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.61 -84.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.729 ' H ' HD22 ' A' ' 45' ' ' ASN . 0.0 OUTLIER -124.53 28.81 6.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.254 -1.145 . . . . 0.0 110.347 -178.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.22 109.88 4.46 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 42' ' ' GLN . 3.9 m-85 -94.65 171.02 9.05 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.6 m -155.9 103.5 2.24 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 0.0 108.992 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.67 115.69 41.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.326 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -101.09 100.25 10.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 52' ' ' SER . 5.3 tt0 -69.86 157.78 36.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.187 -0.946 . . . . 0.0 108.736 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.422 ' N ' ' CG ' ' A' ' 51' ' ' GLU . 2.3 m -160.12 107.02 1.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.152 -0.968 . . . . 0.0 109.015 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.676 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -137.05 144.36 43.15 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.18 7.62 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 109.236 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.676 ' H ' ' C ' ' A' ' 53' ' ' SER . 60.2 m-85 -109.38 -25.02 10.76 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.296 -0.878 . . . . 0.0 111.1 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 55' ' ' PHE . 2.7 ptm180 164.34 86.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.827 -1.171 . . . . 0.0 109.44 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -62.61 146.4 52.1 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.299 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -140.56 174.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.127 -0.983 . . . . 0.0 110.409 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.61 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.9 pt-20 -146.34 142.76 28.58 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 98.9 m -151.25 125.06 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.094 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -86.38 150.35 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -136.38 131.08 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.922 -1.112 . . . . 0.0 110.416 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' OE1' HG21 ' A' ' 66' ' ' VAL . 4.7 tt0 -120.98 170.03 9.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.61 118.94 37.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.061 -1.024 . . . . 0.0 110.333 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.08 22.87 36.79 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.479 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 12.7 t -143.71 105.85 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.959 -1.318 . . . . 0.0 109.401 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.727 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -57.48 142.37 44.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.637 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -149.45 -171.36 3.87 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -139.41 154.02 47.72 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.659 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 44.1 t -153.45 135.54 14.78 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' OD1' HG21 ' A' ' 58' ' ' ILE . 5.8 p30 -93.73 143.39 26.36 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.934 -1.104 . . . . 0.0 110.231 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.532 HD12 HD11 ' A' ' 78' ' ' LEU . 16.4 mt -92.53 146.89 23.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.67 -34.79 0.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 0.0 109.813 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.533 ' OD1' HG11 ' A' ' 23' ' ' VAL . 11.5 t70 -60.29 8.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 72.54 27.09 70.15 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.687 ' CG2' HH21 ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.03 162.17 13.14 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.181 -1.188 . . . . 0.0 109.624 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -132.55 120.41 21.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -133.15 162.28 32.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.932 -1.105 . . . . 0.0 110.582 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -146.31 146.88 30.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.538 -0.726 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.52 -119.52 0.79 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.88 156.87 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.3 -1.117 . . . . 0.0 110.65 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 5.2 m95 -102.85 143.48 32.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 m -142.08 122.35 13.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.0 109.475 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.39 118.75 7.92 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 119.951 -1.718 . . . . 0.0 109.857 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.04 115.82 29.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.67 -103.54 0.33 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.35 33.77 5.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -140.98 143.13 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.735 -1.228 . . . . 0.0 110.251 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.12 104.53 17.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.781 ' CG1' ' O ' ' A' ' 83' ' ' SER . 0.9 OUTLIER -81.64 163.5 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.733 -1.229 . . . . 0.0 110.04 -179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.665 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.19 95.86 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.712 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 24.1 mttm -85.75 103.35 14.45 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.401 -1.058 . . . . 0.0 108.463 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -115.71 148.27 39.94 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.82 0.819 . . . . 0.0 110.154 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -133.41 120.9 21.52 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.451 0.643 . . . . 0.0 109.526 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.687 HH21 ' CG2' ' A' ' 76' ' ' THR . 23.8 mtp85 -53.1 115.32 1.81 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.83 -13.41 61.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.414 1.102 . . . . 0.0 109.456 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.618 ' C ' HD22 ' A' ' 98' ' ' ASN . 52.9 t0 -77.84 -49.89 13.38 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.768 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.618 HD22 ' C ' ' A' ' 97' ' ' ASP . 1.0 OUTLIER -132.33 11.2 4.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.964 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.46 42.31 9.67 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.674 ' O ' ' O ' ' A' ' 101' ' ' GLU . 74.5 m-20 -75.6 19.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.238 -1.154 . . . . 0.0 109.512 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.674 ' O ' ' O ' ' A' ' 100' ' ' ASN . 15.6 pt-20 45.07 164.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.816 0.817 . . . . 0.0 110.911 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 117' ' ' TYR . 6.6 tp -165.12 127.25 2.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -114.4 115.96 28.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.002 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -126.19 176.32 7.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.14 -0.975 . . . . 0.0 110.807 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.4 t -149.71 153.38 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.664 ' HE ' ' NE2' ' A' ' 115' ' ' GLN . 7.4 mtt180 -125.92 136.51 53.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.789 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -138.16 158.54 44.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -122.72 82.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 109' ' ' ILE . 22.4 mt -63.58 91.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.38 -81.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -127.89 29.34 5.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -1.191 . . . . 0.0 110.271 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -134.6 144.23 47.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 11.5 tp -105.36 113.34 26.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.873 -1.142 . . . . 0.0 109.085 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 127' ' ' ILE . 11.1 t -99.49 108.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.664 ' NE2' ' HE ' ' A' ' 106' ' ' ARG . 11.1 tt0 -105.52 106.65 17.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.6 OUTLIER -100.33 145.78 27.73 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 110.114 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -121.99 157.03 32.22 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.782 0.801 . . . . 0.0 109.191 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 103' ' ' ASN . 11.9 t -127.46 147.82 32.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.552 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.2 t80 -146.53 110.58 5.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.056 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 45.77 20.29 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.134 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.8 28.54 3.39 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.72 176.65 5.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 66.1 tt0 -155.91 125.28 6.25 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 118.153 -1.419 . . . . 0.0 111.401 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.918 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -115.6 152.92 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -133.92 136.91 44.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.773 -1.204 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.08 114.05 14.08 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.595 HG23 HG22 ' A' ' 114' ' ' VAL . 4.4 mt -107.67 123.27 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.117 -0.989 . . . . 0.0 110.685 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -101.05 176.02 5.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.365 -0.834 . . . . 0.0 108.786 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -165.31 156.63 14.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.416 -0.803 . . . . 0.0 109.229 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -47.64 129.17 13.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.605 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 131' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.453 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.323 0.583 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.708 ' CZ ' ' CG ' ' A' ' 6' ' ' TRP . 0.7 OUTLIER 50.52 49.4 20.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.235 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.7 t70 -92.02 90.65 7.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.831 . . . . 0.0 109.196 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m 162.72 -162.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 109.61 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 85.2 m -102.16 143.26 32.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 109.721 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.708 ' CG ' ' CZ ' ' A' ' 2' ' ' PHE . 11.5 m95 -148.69 168.72 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.14 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.493 ' O ' ' C ' ' A' ' 8' ' ' VAL . 9.7 pttm -153.21 130.91 11.56 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.936 -1.102 . . . . 0.0 109.588 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -38.39 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.8 -27.05 21.36 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -154.62 167.84 28.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.143 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -177.94 164.41 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 14' ' ' TYR . 6.7 pt-20 -166.76 166.45 15.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.81 -1.181 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.12 -5.45 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.653 -0.654 . . . . 0.0 110.191 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -46.78 -61.23 1.94 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.966 -1.084 . . . . 0.0 110.021 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 16' ' ' LYS . 6.1 p-10 -44.92 -44.78 9.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.984 -1.073 . . . . 0.0 109.247 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -62.7 -41.62 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 108.664 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.847 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 23.5 t80 -68.59 -54.82 14.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.384 -0.823 . . . . 0.0 108.949 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 74' ' ' ASP . 7.2 mmt -57.96 -31.11 66.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' A' ' 28' ' ' ARG . 26.2 tt0 -74.8 -25.33 58.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.025 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -70.68 -48.66 53.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.345 -0.847 . . . . 0.0 109.166 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.2 ttm -59.44 -10.22 3.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.058 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.81 32.4 27.0 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' ASN . 13.8 t -77.03 132.41 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -1.077 . . . . 0.0 109.55 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' VAL . 3.2 t-20 -48.32 177.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.322 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.62 -2.82 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.125 -0.984 . . . . 0.0 109.41 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.85 -60.05 2.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -65.45 -25.96 67.74 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.43 HH21 ' HB2' ' A' ' 19' ' ' GLU . 21.3 ttp180 -73.25 -43.4 61.2 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.406 -0.809 . . . . 0.0 109.263 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -70.44 -32.72 70.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.954 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.1 mt -86.45 -13.7 45.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -85.96 -47.17 9.86 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.75 -22.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' ASN . 22.1 t-160 -69.29 37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 32' ' ' ALA . 5.3 p30 -49.92 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.36 -0.838 . . . . 0.0 109.594 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.4 OUTLIER -147.26 43.22 1.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.392 -0.818 . . . . 0.0 108.862 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -92.72 168.54 11.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 111.238 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -108.83 150.22 27.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 38' ' ' LEU . 1.3 mp -139.64 120.0 13.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.991 -1.068 . . . . 0.0 110.329 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 m -101.79 111.38 23.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.673 HD13 ' CD2' ' A' ' 2' ' ' PHE . 4.4 mp -111.18 144.04 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 111.41 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -133.76 152.39 51.86 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -128.11 146.17 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.058 -1.026 . . . . 0.0 109.93 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -143.17 79.06 1.63 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.978 . . . . 0.0 109.616 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.01 -88.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.8 29.11 6.96 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.339 -1.095 . . . . 0.0 110.272 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -151.52 110.07 3.8 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -100.34 174.18 6.24 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.506 0.669 . . . . 0.0 109.919 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.2 m -148.86 103.23 3.35 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.8 t -96.06 110.92 25.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.749 -0.594 . . . . 0.0 109.571 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.9 mttp -100.77 100.24 10.88 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.3 mt-10 -73.89 159.35 32.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 109.004 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -161.99 107.15 1.25 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.143 -0.973 . . . . 0.0 109.096 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.672 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -135.0 144.29 47.29 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.64 7.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.987 -1.071 . . . . 0.0 109.156 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.672 ' H ' ' C ' ' A' ' 53' ' ' SER . 82.8 m-85 -113.16 -19.74 11.71 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.393 -0.817 . . . . 0.0 111.097 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.3 mmt180 162.8 86.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 109.556 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.729 ' H ' HD22 ' A' ' 57' ' ' ASN . 0.3 OUTLIER -63.1 148.69 47.16 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.278 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.614 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -142.85 174.31 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 O-C-N 121.192 -0.943 . . . . 0.0 110.471 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.614 ' H ' HG22 ' A' ' 58' ' ' ILE . 7.7 pt-20 -146.88 143.72 28.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.3 m -153.25 117.71 4.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.241 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.36 151.07 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -138.78 155.13 48.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.947 -1.096 . . . . 0.0 110.433 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.515 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 50.2 tt0 -150.01 168.41 23.95 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.515 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 14.5 mt -99.64 123.94 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.008 -1.058 . . . . 0.0 110.274 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.95 28.72 40.73 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.616 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 42.4 t -144.05 102.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.091 -1.24 . . . . 0.0 109.201 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -57.78 141.67 48.08 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.201 -0.937 . . . . 0.0 109.955 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.616 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -151.4 -171.6 3.98 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -138.67 150.6 46.39 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.65 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.5 t -151.44 136.33 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.711 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -95.09 144.76 25.48 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 110.225 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 73' ' ' ALA . 98.0 mt -93.27 146.79 23.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.508 -0.745 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.619 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.81 -35.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.6 -0.688 . . . . 0.0 109.849 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 18' ' ' MET . 19.5 t70 -57.8 4.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.142 -0.974 . . . . 0.0 109.444 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.31 26.28 64.11 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.14 161.99 13.25 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 96' ' ' THR . 30.3 tt0 -132.86 122.27 24.15 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -133.79 163.85 28.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.014 -1.054 . . . . 0.0 110.541 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -146.15 142.19 28.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.135 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.742 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.89 -117.01 0.63 Allowed Glycine 0 N--CA 1.477 1.382 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.551 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.42 157.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.21 -1.17 . . . . 0.0 110.428 179.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.7 m95 -101.99 143.11 32.26 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.592 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.4 t -140.51 156.7 46.25 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 108.565 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -94.31 128.27 40.7 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.321 -1.487 . . . . 0.0 108.1 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.653 ' N ' HD12 ' A' ' 84' ' ' LEU . 12.8 pt-20 -133.31 125.03 28.33 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.01 -109.66 2.7 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.67 34.37 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -1.176 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -148.3 160.77 42.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.503 -1.373 . . . . 0.0 110.61 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.06 110.37 22.97 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.592 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -78.86 164.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 110.522 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.71 95.41 0.17 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.642 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 50.9 mttt -87.49 104.78 16.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.214 -1.168 . . . . 0.0 109.242 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.9 m-30 -118.19 127.27 53.59 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.735 0.778 . . . . 0.0 109.849 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -113.07 120.6 41.87 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.518 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 43.3 mtp180 -48.05 115.11 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -80.58 -10.4 59.74 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.485 1.136 . . . . 0.0 109.113 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -91.98 -26.61 18.3 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.789 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -132.06 4.6 4.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.965 . . . . 0.0 109.415 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 49.99 45.57 41.72 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.547 ' OD1' ' N ' ' A' ' 101' ' ' GLU . 30.8 t-20 -88.23 -122.48 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.25 -1.147 . . . . 0.0 109.008 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.547 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.0 pt-20 -175.29 138.55 0.42 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 121.353 0.597 . . . . 0.0 110.179 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.762 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.8 tt -141.17 119.2 11.94 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -110.16 112.34 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 108.693 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -122.65 174.95 6.77 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.139 0.971 . . . . 0.0 111.643 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.7 t -142.98 149.23 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -126.22 132.46 51.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -135.07 157.76 46.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.06 82.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 O-C-N 121.073 -1.017 . . . . 0.0 108.63 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 111' ' ' ASP . 62.8 mt -63.6 92.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.211 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 54.91 -77.89 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.9 m-20 -130.55 29.43 4.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -1.179 . . . . 0.0 110.404 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -135.34 134.56 39.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.223 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 2' ' ' PHE . 6.4 tp -100.14 112.96 25.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 127' ' ' ILE . 14.9 t -99.59 106.93 19.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.336 -0.945 . . . . 0.0 108.807 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.609 ' NE2' ' OH ' ' A' ' 117' ' ' TYR . 10.0 tt0 -111.1 104.61 13.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 108.984 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.419 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.3 144.4 30.84 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 0.0 109.464 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.762 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -129.02 144.67 51.26 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 109.687 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 122' ' ' VAL . 13.2 t -110.58 147.31 14.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.505 ' N ' HG12 ' A' ' 122' ' ' VAL . 2.4 t80 -148.22 114.18 5.78 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 52.85 14.92 0.48 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.87 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.3 28.37 3.83 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.766 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.78 176.73 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.678 ' HG2' HG22 ' A' ' 118' ' ' VAL . 19.6 mt-10 -155.56 111.79 3.13 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.454 -1.299 . . . . 0.0 110.787 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -105.01 153.47 21.41 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -131.06 138.27 49.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.994 -1.066 . . . . 0.0 110.68 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -131.7 114.11 14.38 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 4.9 mt -107.69 123.4 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 110.64 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.579 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 7.5 m-30 -99.73 176.17 5.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.288 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -161.45 146.28 13.45 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -47.8 133.67 13.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.394 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.524 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.746 ' CG ' ' CZ2' ' A' ' 6' ' ' TRP . 7.5 m-85 -65.86 5.86 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -0.952 . . . . 0.0 109.417 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 1' ' ' ALA . 4.0 m-20 36.84 56.85 1.19 Allowed 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -175.22 -151.65 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 110.518 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.608 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 23.6 m -106.77 131.09 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.416 -0.802 . . . . 0.0 110.192 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.746 ' CZ2' ' CG ' ' A' ' 2' ' ' PHE . 49.9 m95 -145.05 158.04 43.93 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -147.81 153.59 39.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.704 -1.247 . . . . 0.0 110.668 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.438 ' HA ' ' HD1' ' A' ' 128' ' ' PHE . 2.7 t -42.47 106.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.716 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -97.16 -31.07 12.65 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HB2' HD12 ' A' ' 127' ' ' ILE . 50.8 mtt85 -152.85 172.07 17.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.8 t -173.22 177.38 2.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.947 -1.096 . . . . 0.0 109.723 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.99 162.19 40.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.858 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 4.6 m-20 59.58 -109.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.582 -0.699 . . . . 0.0 109.865 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.678 ' CE1' ' NH2' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 72.06 -52.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -0.967 . . . . 0.0 109.703 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' GLU . 13.2 p-10 -60.94 -44.42 97.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 108.561 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -63.62 -32.07 73.43 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.896 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 16.1 t80 -71.77 -64.02 1.01 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.063 0.935 . . . . 0.0 108.619 178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.2 OUTLIER -58.27 -24.0 58.02 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.455 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 24.2 tp10 -79.86 -29.1 39.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 109.295 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -71.37 -42.66 68.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.077 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.7 mtm -67.41 -6.37 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.343 -0.848 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.49 64.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -73.86 130.81 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -1.162 . . . . 0.0 109.578 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.661 HD22 ' N ' ' A' ' 24' ' ' ASN . 1.1 m120 -50.09 174.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.945 . . . . 0.0 109.368 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.4 mm -84.47 -1.4 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 122.159 0.98 . . . . 0.0 109.175 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.09 -59.87 2.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -37.93 71.8 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HB3' ' A' ' 15' ' ' ASP . 2.1 ttt85 -64.41 -50.3 68.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -50.07 -36.41 29.17 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.001 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.47 -13.11 47.07 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.085 0.945 . . . . 0.0 109.384 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' ASP . . . -84.39 -37.01 22.04 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.658 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -41.73 -37.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.346 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -98.52 33.97 2.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.109 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ALA . 22.1 t70 -79.25 38.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.461 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -73.7 43.7 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 36' ' ' LEU . 2.6 pt? -52.99 170.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.13 0.967 . . . . 0.0 111.576 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -110.47 148.2 32.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.813 HD13 ' CE2' ' A' ' 128' ' ' PHE . 0.6 OUTLIER -137.17 123.98 21.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.92 -1.113 . . . . 0.0 110.54 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.77 109.08 21.07 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.1 mp -103.33 127.67 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 0.0 110.801 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -128.45 151.75 49.03 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.498 ' OE1' ' OD1' ' A' ' 3' ' ' ASP . 6.7 pt20 -141.29 140.18 33.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.839 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -139.43 78.97 1.7 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.43 -88.5 0.03 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.626 -0.989 . . . . 0.0 110.626 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.675 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -116.72 28.99 8.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -1.094 . . . . 0.0 110.348 -178.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -145.65 110.25 5.08 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.415 ' O ' HG23 ' A' ' 61' ' ' VAL . 13.9 m-85 -104.86 168.52 9.01 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -156.0 103.54 2.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.137 -0.977 . . . . 0.0 109.057 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -98.42 121.87 49.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -112.54 100.36 8.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' ILE . 92.0 mt-10 -77.48 157.44 30.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.104 -0.998 . . . . 0.0 109.318 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m -159.46 106.82 1.73 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.229 -0.92 . . . . 0.0 108.984 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.644 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -131.05 144.46 51.47 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.01 7.86 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.175 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.644 ' H ' ' C ' ' A' ' 53' ' ' SER . 70.9 t80 -114.47 -17.64 11.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 111.173 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 6.4 mtp85 161.71 87.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.714 -1.241 . . . . 0.0 109.205 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -63.03 144.12 57.17 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.339 -0.85 . . . . 0.0 109.632 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.583 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -136.35 174.23 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 121.86 0.838 . . . . 0.0 110.08 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.583 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -156.65 156.07 32.85 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.9 109.11 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.82 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.639 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -104.53 153.45 6.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 1.7 m-85 176.42 -179.21 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.833 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 30.1 tt0 -117.66 168.33 10.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.504 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 19.2 mt -81.33 139.09 35.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.04 23.24 28.01 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.64 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 52.0 t -143.92 103.76 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -1.197 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.762 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.8 OUTLIER -54.7 143.19 25.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.946 . . . . 0.0 109.811 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -151.71 -171.62 3.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.567 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 5.2 p30 -137.2 151.43 48.75 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 110.312 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.567 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 71.3 m -156.89 137.41 13.09 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.652 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -92.53 143.9 25.88 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.041 -1.037 . . . . 0.0 110.416 -178.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 96.0 mt -93.22 146.97 23.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.397 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.29 -34.04 0.45 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.907 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.22 12.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 68.74 27.13 74.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.19 162.31 13.05 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.258 -1.142 . . . . 0.0 109.634 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 96' ' ' THR . 30.6 tt0 -132.22 118.7 19.86 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -133.78 162.49 31.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.098 . . . . 0.0 110.797 -179.004 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 9.8 ptm180 -143.23 142.92 31.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 109.83 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.762 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.4 -117.78 0.67 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.527 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.64 158.11 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.049 -1.265 . . . . 0.0 110.693 179.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.425 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.77 142.52 32.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -138.78 157.05 46.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -96.56 125.85 41.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.351 -1.468 . . . . 0.0 108.234 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.594 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.5 mm-40 -123.57 111.13 15.89 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.52 -105.19 1.07 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -125.13 33.65 5.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -1.136 . . . . 0.0 110.146 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -140.8 149.18 41.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.797 -1.19 . . . . 0.0 110.229 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -96.05 107.35 19.64 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.6 pt -78.32 164.22 3.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 110.684 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.657 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.15 94.78 0.16 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.681 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.1 mtpm? -87.98 104.23 16.44 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.25 -1.147 . . . . 0.0 108.879 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.7 m-30 -116.33 139.11 50.75 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.865 0.841 . . . . 0.0 110.18 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -121.72 121.03 36.38 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 15.7 mtp180 -53.81 115.03 1.78 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -68.01 -12.37 60.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.368 1.08 . . . . 0.0 109.396 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -77.88 -52.14 9.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.529 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 1.5 t-20 -132.62 14.55 4.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.821 . . . . 0.0 110.002 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.65 44.05 11.84 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.751 ' O ' ' O ' ' A' ' 101' ' ' GLU . 49.7 m-20 -76.18 19.22 0.25 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -1.095 . . . . 0.0 109.724 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.751 ' O ' ' O ' ' A' ' 100' ' ' ASN . 18.2 pt-20 42.77 158.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.062 0.934 . . . . 0.0 111.247 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.1 tt -160.14 123.65 3.56 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.725 ' N ' HD23 ' A' ' 102' ' ' LEU . 2.0 m120 -113.45 113.87 25.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.097 -1.002 . . . . 0.0 109.028 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -126.0 176.56 6.92 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.246 -0.909 . . . . 0.0 111.071 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.403 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.4 t -148.85 150.82 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -127.77 135.13 49.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.549 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -141.89 158.6 43.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.554 ' CG2' ' CE2' ' A' ' 2' ' ' PHE . 1.6 mm -119.39 82.25 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 109' ' ' ILE . 1.7 mp -65.22 91.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-O 121.633 0.73 . . . . 0.0 109.893 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 45.34 -76.15 0.0 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 109' ' ' ILE . 10.2 t70 -124.45 29.64 6.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.239 . . . . 0.0 110.838 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -145.55 136.97 25.07 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.031 -1.043 . . . . 0.0 109.33 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.31 110.77 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.503 HG23 HD13 ' A' ' 109' ' ' ILE . 38.5 t -95.93 118.05 41.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 110.08 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.84 103.06 8.79 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.3 OUTLIER -105.33 147.16 28.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.155 -0.965 . . . . 0.0 110.182 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -126.82 152.85 46.41 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.86 0.838 . . . . 0.0 109.252 178.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 122' ' ' VAL . 5.7 t -121.2 148.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.52 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -143.94 110.52 5.57 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.878 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 47.16 19.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.146 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.43 28.56 3.47 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.81 177.2 4.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 122' ' ' VAL . 58.9 tt0 -155.65 122.29 5.28 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.391 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.896 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -113.47 141.02 47.61 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -119.83 140.59 50.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.778 -1.201 . . . . 0.0 111.111 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.678 ' NH2' ' CE1' ' A' ' 14' ' ' TYR . 61.3 mtp85 -134.9 113.75 11.85 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 10' ' ' ARG . 3.5 mt -108.8 124.53 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.709 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.813 ' CE2' HD13 ' A' ' 38' ' ' LEU . 7.1 m-30 -98.21 177.95 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 109.938 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.507 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 20.0 tttp -158.29 147.22 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.693 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 16.4 pttp -46.69 129.02 11.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 109.82 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' OD2' ' A' ' 131' ' ' ASP . 7.3 p30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.485 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.668 ' N ' HD11 ' A' ' 113' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.454 0.645 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.838 ' HB3' ' NE1' ' A' ' 6' ' ' TRP . 1.3 m-85 -63.13 10.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 109.608 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER 37.72 45.07 0.61 Allowed 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.002 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.495 ' HB3' ' HE1' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -168.54 -151.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.145 -0.972 . . . . 0.0 110.366 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.604 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 47.5 m -108.8 126.43 53.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.87 . . . . 0.0 110.158 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.838 ' NE1' ' HB3' ' A' ' 2' ' ' PHE . 37.6 m95 -142.12 168.59 19.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.337 -0.852 . . . . 0.0 108.703 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.5 pttp -152.44 143.37 23.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.701 -1.249 . . . . 0.0 110.506 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.548 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -43.25 107.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.451 -0.78 . . . . 0.0 109.953 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.76 -31.15 12.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -149.12 164.71 33.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.727 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 t -170.46 169.79 7.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.258 -0.901 . . . . 0.0 109.255 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 14' ' ' TYR . 8.1 pt-20 -166.65 166.68 15.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.934 -1.104 . . . . 0.0 110.434 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 14' ' ' TYR . 2.5 m-20 62.57 -10.63 0.09 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.602 -0.686 . . . . 0.0 110.105 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.555 ' H ' ' C ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -43.44 -59.83 1.98 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.019 -1.051 . . . . 0.0 109.863 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.59 -45.76 38.51 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.95 -1.094 . . . . 0.0 109.243 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.4 mmtm -59.6 -40.66 88.21 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.907 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 24.4 t80 -67.39 -62.88 1.21 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -30.77 9.84 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -73.42 -29.27 62.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.072 -1.018 . . . . 0.0 109.128 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -67.94 -48.36 66.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.2 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.92 -6.95 4.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.342 -0.849 . . . . 0.0 109.166 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.53 26.26 47.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.9 t -72.78 136.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -1.059 . . . . 0.0 109.525 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -53.25 174.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.6 mm -85.59 -1.98 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.093 0.949 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.9 -60.09 2.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 6.3 mptt -65.95 -21.15 66.41 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' NE ' HD13 ' A' ' 25' ' ' ILE . 15.3 ttp180 -72.64 -43.56 63.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.556 -0.715 . . . . 0.0 109.43 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -70.35 -33.45 71.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.62 -13.12 46.59 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.937 0.875 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -83.83 -52.97 5.94 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.245 0.545 . . . . 0.0 109.89 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.13 -50.6 4.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 33' ' ' HIS . 12.3 m-70 -73.66 46.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.511 ' HB3' HH22 ' A' ' 126' ' ' ARG . 46.6 m-20 -71.23 136.56 48.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.51 ' HA ' HG13 ' A' ' 8' ' ' VAL . 5.1 m-80 -147.37 43.06 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.692 ' CD2' HH12 ' A' ' 126' ' ' ARG . 0.8 OUTLIER -84.27 162.87 19.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 110.948 -178.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -107.71 147.0 31.34 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.537 HD13 ' CE2' ' A' ' 128' ' ' PHE . 3.6 mp -136.6 121.04 18.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 110.019 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 m -92.1 104.58 16.95 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.738 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -97.69 117.84 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.22 151.92 38.45 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.444 ' CD ' ' CE2' ' A' ' 47' ' ' PHE . 49.1 tt0 -129.28 146.55 51.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.136 -0.978 . . . . 0.0 109.813 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -145.24 79.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.39 -92.95 0.16 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 0.2 OUTLIER -122.04 28.56 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.382 -1.069 . . . . 0.0 109.758 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -145.96 109.6 4.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.444 ' CE2' ' CD ' ' A' ' 42' ' ' GLN . 14.1 m-85 -96.7 173.92 7.08 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.765 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -153.47 104.04 2.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' O ' ' OE1' ' A' ' 51' ' ' GLU . 2.5 t -101.22 112.79 35.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.57 -0.707 . . . . 0.0 109.373 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.47 100.6 11.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.885 . . . . 0.0 109.404 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.582 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 2.0 mp0 -72.65 155.73 39.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 109.183 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 1.2 m -159.34 106.71 1.75 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.119 -0.988 . . . . 0.0 108.892 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.638 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -130.44 144.28 51.3 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.94 8.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.27 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.638 ' H ' ' C ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -117.03 -19.83 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 111.422 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.701 ' HE ' ' HB1' ' A' ' 73' ' ' ALA . 6.9 ptt180 167.7 84.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.641 -1.287 . . . . 0.0 109.575 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 30.0 p-10 -63.14 143.98 57.31 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -135.89 174.21 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.182 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.588 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.9 pt-20 -154.1 142.4 20.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -159.37 131.64 6.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.558 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.546 ' CG2' ' N ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -75.13 164.46 3.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.245 -0.91 . . . . 0.0 108.546 179.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -148.02 118.51 7.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.026 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.427 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 26.6 tt0 -130.32 146.82 51.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.5 pp -95.73 130.5 42.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.784 -1.197 . . . . 0.0 109.597 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.05 8.17 42.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.595 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 46.9 t -144.29 103.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.079 -1.248 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -57.16 145.1 32.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.206 1.003 . . . . 0.0 110.049 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -155.69 -170.77 3.53 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.509 ' ND2' ' C ' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -145.0 149.13 34.6 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.738 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.421 ' SG ' ' N ' ' A' ' 71' ' ' ASN . 43.6 t -150.29 170.43 19.02 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 1.5 p-10 -120.52 145.86 46.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.959 -1.088 . . . . 0.0 110.311 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 73' ' ' ALA . 15.5 mt -93.82 146.9 23.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.545 -0.722 . . . . 0.0 109.48 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.701 ' HB1' ' HE ' ' A' ' 56' ' ' ARG . . . -40.56 -36.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.541 -0.725 . . . . 0.0 109.833 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 38.2 t0 -57.83 6.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 109.437 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.642 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 73.86 26.16 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.25 162.17 13.13 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.204 -1.174 . . . . 0.0 109.621 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' THR . 29.3 tt0 -132.45 124.25 28.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.66 166.11 23.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.957 -1.089 . . . . 0.0 110.727 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -148.42 141.35 24.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.422 -0.799 . . . . 0.0 109.912 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 171.64 -118.0 0.71 Allowed Glycine 0 N--CA 1.475 1.281 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.551 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.61 159.33 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -1.176 . . . . 0.0 110.499 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.58 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 2.3 m95 -103.1 144.62 31.06 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.598 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.39 157.68 44.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -89.6 127.89 35.96 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 120.166 -1.584 . . . . 0.0 108.255 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.622 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -125.83 122.03 34.98 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.54 ' C ' HD22 ' A' ' 87' ' ' ASN . . . 56.79 -107.7 1.0 Allowed Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.54 HD22 ' C ' ' A' ' 86' ' ' GLY . 1.5 m120 -125.28 33.3 5.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -1.133 . . . . 0.0 110.065 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 1.3 mptt -141.53 159.44 42.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.879 -1.138 . . . . 0.0 109.924 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.27 108.87 21.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.3 pt -76.8 164.03 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.012 -1.055 . . . . 0.0 110.305 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.77 96.27 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.629 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -89.65 105.59 17.9 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.142 -1.21 . . . . 0.0 108.897 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.407 ' HD1' ' HA ' ' A' ' 93' ' ' PHE . 3.1 m-30 -118.08 125.36 50.15 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.821 0.82 . . . . 0.0 109.999 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -108.89 118.35 36.56 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.533 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 63.9 mtp180 -46.42 114.89 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.284 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -81.19 -10.35 59.64 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.533 1.159 . . . . 0.0 109.125 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.88 -26.15 19.49 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.61 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.16 2.1 3.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 52.76 45.71 60.44 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' A' ' 95' ' ' ARG . 15.7 t-20 -89.39 -122.07 0.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.367 -1.078 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -175.45 138.89 0.42 Allowed 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.948 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.734 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.0 tt -144.02 120.34 10.91 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.555 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -107.48 107.79 18.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.789 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -121.55 175.92 5.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.112 -0.992 . . . . 0.0 111.559 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 106' ' ' ARG . 33.3 t -148.19 159.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.675 ' NE ' ' NE2' ' A' ' 115' ' ' GLN . 9.8 ttm180 -134.63 136.97 43.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -145.71 159.12 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 109.08 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.695 ' CG2' ' CE2' ' A' ' 2' ' ' PHE . 0.8 OUTLIER -120.4 83.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.683 ' O ' ' N ' ' A' ' 111' ' ' ASP . 44.4 mt -64.23 91.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.26 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 44.89 -80.52 0.0 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 109' ' ' ILE . 2.2 p30 -119.6 30.11 7.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -1.203 . . . . 0.0 111.052 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 129' ' ' LYS . 2.6 mt-10 -145.07 132.75 20.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.859 -1.151 . . . . 0.0 109.475 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.668 HD11 ' N ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER -98.12 113.93 25.97 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 109' ' ' ILE . 2.1 t -108.26 113.82 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.617 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.675 ' NE2' ' NE ' ' A' ' 106' ' ' ARG . 11.0 tt0 -110.29 105.29 14.27 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.502 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -99.59 146.35 26.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.116 -0.99 . . . . 0.0 110.006 -178.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.734 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -131.17 145.64 52.03 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.873 0.844 . . . . 0.0 109.737 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.7 t -111.86 148.38 15.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.518 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.6 t80 -147.23 112.09 5.39 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.032 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 51.5 16.35 0.43 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.875 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.79 28.24 3.76 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.759 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.97 176.81 4.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 pt-20 -155.57 113.46 3.37 Favored 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.008 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -105.75 156.84 17.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -134.06 136.08 43.73 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.012 -1.055 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.692 HH12 ' CD2' ' A' ' 36' ' ' LEU . 4.2 mmm180 -125.32 116.2 21.55 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 7.0 mt -110.64 124.17 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.953 . . . . 0.0 110.853 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.537 ' CE2' HD13 ' A' ' 38' ' ' LEU . 8.9 m-30 -98.99 176.38 5.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.146 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 3.8 tppt? -155.66 150.16 26.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.528 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 12.3 tttt -46.94 135.46 9.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.456 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.808 ' CZ ' ' CD2' ' A' ' 6' ' ' TRP . 1.4 t80 38.6 31.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.779 . . . . 0.0 109.227 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 4' ' ' SER . 4.6 m-20 -71.45 95.96 1.44 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.548 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 1.1 m 161.63 -165.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.617 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 21.3 m -103.63 140.76 37.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.808 ' CD2' ' CZ ' ' A' ' 2' ' ' PHE . 5.3 m95 -148.04 168.88 21.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 8' ' ' VAL . 6.5 pttp -153.36 132.71 12.8 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.153 -0.967 . . . . 0.0 109.285 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.662 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -37.56 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -0.893 . . . . 0.0 109.628 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 17.7 t0 -94.73 -28.4 15.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -148.39 171.84 15.39 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.716 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 t -171.86 178.34 3.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -152.19 151.21 30.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.796 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.55 ' CG ' ' N ' ' A' ' 14' ' ' TYR . 21.9 t-20 58.66 -108.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.0 109.842 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.593 ' CD2' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER 75.55 -54.13 0.64 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.0 110.017 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.92 -45.99 91.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.034 -1.041 . . . . 0.0 109.099 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.56 -30.72 71.09 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.866 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 15.1 t80 -72.19 -57.07 4.54 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.193 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.568 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 2.5 mpp? -59.14 -28.61 66.71 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.464 -0.772 . . . . 0.0 109.135 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -76.85 -27.71 55.18 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.149 -0.97 . . . . 0.0 109.254 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -71.54 -42.59 67.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.238 -0.913 . . . . 0.0 109.414 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.662 ' SD ' ' CE2' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -68.76 -5.41 20.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.043 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.11 25.14 56.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 24' ' ' ASN . 60.9 t -67.33 116.93 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -1.159 . . . . 0.0 109.461 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 23' ' ' VAL . 2.5 m-20 -41.79 155.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -67.48 -2.75 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.058 -1.026 . . . . 0.0 109.084 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.59 -60.1 2.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.95 -30.72 69.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.33 -50.19 61.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.519 -0.738 . . . . 0.0 109.111 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -56.1 -34.17 65.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.57 -13.22 46.43 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.967 0.889 . . . . 0.0 109.759 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -84.64 -37.97 20.41 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.256 0.551 . . . . 0.0 109.603 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' ASP . . . -44.66 -14.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.305 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.689 ' O ' ' N ' ' A' ' 35' ' ' ASN . 41.4 m-70 -70.44 46.59 0.09 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.178 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.593 ' OD2' ' CD2' ' A' ' 14' ' ' TYR . 1.9 m-20 -54.47 72.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.463 -0.773 . . . . 0.0 109.878 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 33' ' ' HIS . 0.4 OUTLIER -148.22 42.38 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.275 -0.89 . . . . 0.0 109.12 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.662 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -84.31 159.09 20.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 52' ' ' SER . 11.4 ttpt -119.49 145.83 45.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.6 pt? -154.5 142.48 20.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.975 -1.078 . . . . 0.0 110.346 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.464 ' C ' HD12 ' A' ' 40' ' ' ILE . 6.4 m -108.17 124.92 51.0 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.822 ' N ' HD12 ' A' ' 40' ' ' ILE . 3.5 mp -109.95 124.98 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 0.0 110.81 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 151.62 36.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.3 148.77 48.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.994 -1.066 . . . . 0.0 110.071 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -148.46 79.09 1.44 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.36 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.17 -89.93 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -123.45 28.42 7.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -1.096 . . . . 0.0 109.71 -179.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -144.51 110.54 5.43 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.473 ' O ' HG23 ' A' ' 61' ' ' VAL . 1.3 p90 -111.46 173.68 6.23 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.395 0.617 . . . . 0.0 109.686 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.7 m -150.81 103.09 3.05 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.699 HG12 ' OE2' ' A' ' 51' ' ' GLU . 17.7 t -90.93 108.49 19.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.623 -0.673 . . . . 0.0 109.563 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -99.42 100.2 11.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.699 ' OE2' HG12 ' A' ' 49' ' ' VAL . 3.6 mp0 -78.01 159.73 28.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.383 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 37' ' ' LYS . 1.7 m -159.96 106.65 1.62 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.247 -0.908 . . . . 0.0 108.669 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 55' ' ' PHE . 1.8 p -127.25 144.31 51.07 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.88 8.33 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 109.588 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' SER . 9.4 t80 -123.43 -11.74 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 111.641 -178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.514 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.1 mmt180 164.72 84.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.459 -1.401 . . . . 0.0 109.883 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -63.9 147.46 51.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.463 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.2 mt -138.19 174.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 110.072 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.6 135.41 11.74 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -145.55 109.15 4.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -105.22 153.39 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 0.9 OUTLIER 175.95 -179.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.142 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 66' ' ' VAL . 42.1 tt0 -117.53 137.23 52.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.93 142.04 57.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.16 -34.33 5.48 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 66' ' ' VAL . 6.2 p -102.63 125.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.244 . . . . 0.0 109.974 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.62 142.99 51.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.91 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CZ ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -148.72 -171.62 3.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.518 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.544 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 2.0 p-10 -135.94 150.74 49.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.088 -1.007 . . . . 0.0 110.345 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 60.5 m -155.79 135.88 12.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.548 ' OD1' HG21 ' A' ' 58' ' ' ILE . 2.2 p30 -95.21 144.56 25.71 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.916 -1.115 . . . . 0.0 110.607 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 73' ' ' ALA . 16.6 mt -90.87 146.9 23.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.59 -0.694 . . . . 0.0 109.222 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.76 -35.17 1.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.755 . . . . 0.0 109.723 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.0 4.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 76.81 26.43 62.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -100.0 162.19 13.14 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.303 -1.116 . . . . 0.0 109.517 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.82 121.13 22.5 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -135.02 162.9 31.15 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.88 -1.137 . . . . 0.0 110.51 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.59 143.2 31.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 109.894 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.738 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.35 -116.62 0.62 Allowed Glycine 0 N--CA 1.477 1.368 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.547 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 171.37 158.42 0.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.069 -1.254 . . . . 0.0 110.813 179.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.9 m95 -101.6 141.48 34.4 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.589 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -139.53 157.17 46.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.935 . . . . 0.0 108.527 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -94.53 126.48 39.84 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.35 -1.469 . . . . 0.0 108.187 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.602 ' N ' HD12 ' A' ' 84' ' ' LEU . 14.1 mm-40 -129.37 120.62 25.87 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 -108.26 2.05 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -125.37 34.28 4.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -1.156 . . . . 0.0 110.549 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.38 161.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.6 -1.313 . . . . 0.0 110.412 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 mt -100.98 108.01 19.63 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -75.52 164.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.436 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.672 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.89 94.63 0.16 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.691 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 5.6 mtmm -88.5 102.97 15.44 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.299 -1.118 . . . . 0.0 109.115 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 3.7 m-30 -116.15 129.89 56.54 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.802 0.811 . . . . 0.0 109.792 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -113.06 118.2 34.13 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.493 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 42.7 mtp180 -51.07 114.99 1.33 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.75 -11.68 56.79 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.485 1.136 . . . . 0.0 109.086 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.22 -23.44 21.26 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -132.1 -0.87 3.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.88 . . . . 0.0 109.226 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 54.58 43.48 78.47 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.597 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 16.6 t-20 -92.26 -122.85 0.08 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.225 -1.162 . . . . 0.0 109.244 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.446 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 4.3 pt-20 -174.91 138.39 0.46 Allowed 'General case' 0 C--N 1.286 -2.182 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.3 tp -136.0 111.29 9.06 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.406 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.7 OUTLIER -104.69 108.19 19.52 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.7 t -122.28 176.14 6.02 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.148 0.975 . . . . 0.0 112.099 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.41 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.7 t -145.81 147.4 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -123.64 132.88 53.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 110.198 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -131.55 158.6 40.51 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -124.49 82.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.13 -0.981 . . . . 0.0 108.43 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 111' ' ' ASP . 27.7 mt -64.33 91.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.929 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.78 -81.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -125.17 29.56 6.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -1.2 . . . . 0.0 110.187 -179.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.68 138.33 40.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 109.172 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 7.0 tp -103.3 111.79 24.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.039 -1.038 . . . . 0.0 109.535 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.8 109.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.052 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -112.06 103.96 12.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.308 -0.87 . . . . 0.0 108.661 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.25 143.16 32.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.551 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.697 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -125.57 147.14 49.38 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.786 0.803 . . . . 0.0 109.35 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 122' ' ' VAL . 12.6 t -114.58 149.88 16.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.662 ' CE2' ' SD ' ' A' ' 21' ' ' MET . 1.6 t80 -143.67 110.96 5.8 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.847 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 48.67 18.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.245 0.545 . . . . 0.0 110.944 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.49 28.43 3.51 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.803 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.71 176.11 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 9.9 pt-20 -156.47 123.87 5.4 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.539 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.866 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -119.84 152.74 36.83 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -131.62 140.08 49.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.769 -1.207 . . . . 0.0 111.279 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -133.12 114.16 13.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 2.6 mt -105.31 124.25 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.084 -1.01 . . . . 0.0 110.987 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.9 m-30 -95.53 175.91 6.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.512 -0.742 . . . . 0.0 109.555 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -164.52 148.83 9.48 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.519 ' NZ ' ' OD2' ' A' ' 111' ' ' ASP . 20.7 mtmm -47.72 134.34 12.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.49 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.776 ' N ' HD11 ' A' ' 113' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.264 0.554 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.765 ' HB3' ' NE1' ' A' ' 6' ' ' TRP . 1.4 m-85 -68.67 14.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 0.0 109.235 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 1' ' ' ALA . 23.1 t0 40.53 47.9 2.4 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.596 ' OG ' ' NE1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -174.27 -152.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.146 -0.971 . . . . 0.0 110.398 -179.376 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.595 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 29.0 m -107.2 129.32 54.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.397 -0.814 . . . . 0.0 110.199 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.765 ' NE1' ' HB3' ' A' ' 2' ' ' PHE . 43.4 m95 -142.44 167.84 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' VAL . 10.3 pttp -152.72 138.73 18.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.84 -1.162 . . . . 0.0 110.741 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -38.64 107.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.52 -0.738 . . . . 0.0 109.965 179.272 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -97.06 -32.42 11.99 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.441 ' O ' ' OG ' ' A' ' 11' ' ' SER . 14.5 mtt-85 -150.45 178.27 9.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.646 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 73.8 m -171.41 177.99 3.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.272 -0.893 . . . . 0.0 109.412 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -150.12 149.23 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.046 -1.033 . . . . 0.0 109.888 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 16' ' ' LYS . 48.2 t-20 63.52 -104.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.61 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.521 ' HD1' ' HB1' ' A' ' 124' ' ' ALA . 0.1 OUTLIER 69.14 -44.04 0.53 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 13' ' ' ASN . 54.5 m-20 -63.68 -47.76 79.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 108.751 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB2' HD21 ' A' ' 13' ' ' ASN . 24.7 mmtp -61.07 -37.26 82.05 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.908 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 68.4 t80 -69.3 -63.76 1.0 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -54.53 -24.94 22.89 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.042 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -79.36 -26.81 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 0.0 109.201 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -43.89 62.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 109.032 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.473 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -67.85 -6.13 20.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 108.961 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.1 31.93 53.97 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 t -77.66 158.42 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 109.514 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.715 ' ND2' ' H ' ' A' ' 25' ' ' ILE . 1.1 t30 -75.0 175.64 7.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.367 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.715 ' H ' ' ND2' ' A' ' 24' ' ' ASN . 1.5 mm -84.68 -1.33 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG23 ' ND2' ' A' ' 24' ' ' ASN . 42.5 t -78.48 -59.88 2.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 CA-C-O 121.451 0.643 . . . . 0.0 109.268 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 21.1 mttp -63.58 -27.3 69.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 108.669 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.2 -42.15 72.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 109.37 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -66.74 -34.59 78.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.1 mt -86.25 -13.09 47.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.582 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -77.74 -47.39 19.16 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.808 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.54 -64.96 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.94 . . . . 0.0 109.645 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.24 46.12 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.294 -0.878 . . . . 0.0 109.357 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 15.0 t70 -89.47 160.53 16.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 109.769 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.643 ' HA ' HG13 ' A' ' 8' ' ' VAL . 4.4 m-20 -143.19 42.96 1.54 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.356 -0.84 . . . . 0.0 108.991 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -54.89 148.09 13.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 -179.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.813 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -119.07 139.73 51.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -146.63 153.04 39.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.909 -1.119 . . . . 0.0 110.268 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -115.03 109.53 18.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.752 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -98.51 119.28 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 110.169 -179.01 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.34 151.67 36.52 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -135.47 139.97 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.714 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 45' ' ' ASN . 7.2 mt-10 -139.01 78.82 1.69 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.06 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 43' ' ' GLU . 6.0 p-10 -118.79 28.94 8.0 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.301 -1.117 . . . . 0.0 110.507 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -154.47 111.05 3.29 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.4 p90 -107.93 173.48 6.3 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.752 -0.592 . . . . 0.0 109.491 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.4 m -155.87 103.43 2.24 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.006 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.88 109.15 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.506 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -99.76 99.65 10.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.634 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . 26.5 mt-10 -72.89 156.81 38.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.033 -1.042 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 37' ' ' LYS . 3.6 m -161.78 107.23 1.29 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.198 -0.939 . . . . 0.0 109.029 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.68 ' C ' ' H ' ' A' ' 55' ' ' PHE . 6.4 p -139.96 144.43 37.05 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.18 7.6 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.68 ' H ' ' C ' ' A' ' 53' ' ' SER . 38.1 m-85 -107.96 -23.57 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 111.049 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 1.2 mtp-105 160.49 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 0.0 109.027 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.689 ' H ' HD22 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -62.78 145.24 55.36 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.712 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.3 mt -139.18 174.56 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.406 -0.809 . . . . 0.0 109.825 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.2 pt-20 -154.19 143.1 21.06 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.8 108.71 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.656 ' O ' ' CD2' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -107.32 151.57 9.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.238 -0.914 . . . . 0.0 109.799 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' A' ' 61' ' ' VAL . 1.8 m-85 176.32 -179.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.808 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 27.8 tt0 -107.39 167.71 9.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.574 -0.704 . . . . 0.0 109.175 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.542 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 11.5 mt -80.14 130.23 35.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.36 -30.18 10.31 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.628 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 57.6 t -84.09 110.88 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.248 . . . . 0.0 110.033 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -57.57 143.67 40.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.537 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.628 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -150.63 -171.6 3.97 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.566 ' O ' ' SG ' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -138.18 149.63 46.02 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.131 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 57.2 m -156.15 137.78 14.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.553 ' ND2' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -93.61 144.05 25.74 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.358 -178.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 74' ' ' ASP . 48.2 mt -93.98 146.97 23.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.565 -0.709 . . . . 0.0 109.421 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.63 -28.47 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.582 -0.699 . . . . 0.0 109.745 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.9 17.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.75 26.34 66.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.474 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -100.02 161.92 13.31 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.287 -1.125 . . . . 0.0 109.565 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -132.85 119.98 20.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -134.17 161.95 33.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.882 -1.136 . . . . 0.0 110.684 -179.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 19.9 ptt180 -143.16 141.91 31.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.553 -0.717 . . . . 0.0 110.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 172.95 -116.01 0.59 Allowed Glycine 0 N--CA 1.476 1.352 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 170.76 157.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -1.187 . . . . 0.0 110.603 179.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.615 ' CH2' ' NH1' ' A' ' 106' ' ' ARG . 5.1 m95 -102.25 144.07 31.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.636 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -144.54 155.98 43.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.057 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.71 119.19 26.68 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.312 -1.492 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -109.33 104.58 13.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.68 -101.34 0.51 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -124.77 33.45 5.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -1.174 . . . . 0.0 110.177 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -140.75 157.23 45.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.816 -1.177 . . . . 0.0 109.961 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 mt -100.1 101.85 13.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.4 pt -72.12 163.62 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.042 -1.036 . . . . 0.0 110.396 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.96 95.66 0.17 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.635 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 3.8 tttm -90.25 104.92 17.44 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.181 -1.188 . . . . 0.0 108.636 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 2.9 m-30 -117.79 125.06 49.89 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.845 0.831 . . . . 0.0 109.766 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HZ1' ' HE3' ' A' ' 92' ' ' LYS . 15.2 mttp -105.63 116.41 31.9 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' GLY . 39.5 mtp180 -54.45 114.74 1.78 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.37 -13.08 61.38 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 122.529 1.157 . . . . 0.0 109.433 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -79.95 -47.08 15.57 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.67 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 99' ' ' GLY . 31.9 m-80 -132.61 7.83 4.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 110.074 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 45.16 42.18 8.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.672 ' O ' ' O ' ' A' ' 101' ' ' GLU . 14.8 m-80 -78.05 12.9 1.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 0.0 109.513 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 100' ' ' ASN . 3.3 mt-10 47.79 128.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.548 0.689 . . . . 0.0 111.003 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 117' ' ' TYR . 7.4 tt -129.23 120.77 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.671 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.5 OUTLIER -108.18 107.83 18.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.062 -179.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 1.9 t -122.91 176.41 6.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.208 -0.933 . . . . 0.0 111.137 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 106' ' ' ARG . 89.1 t -148.38 159.63 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.615 ' NH1' ' CH2' ' A' ' 82' ' ' TRP . 50.6 ttm-85 -131.3 136.87 48.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.725 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -139.39 158.55 43.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 109.298 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.644 ' CG2' ' CE2' ' A' ' 2' ' ' PHE . 1.2 mm -122.19 82.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.722 ' O ' ' N ' ' A' ' 111' ' ' ASP . 5.3 mm -68.38 91.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.374 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 41.43 -80.42 0.0 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.722 ' N ' ' O ' ' A' ' 109' ' ' ILE . 5.3 m-20 -118.18 29.5 7.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.252 . . . . 0.0 110.884 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -146.9 134.5 20.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.983 -1.073 . . . . 0.0 109.127 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.776 HD11 ' N ' ' A' ' 1' ' ' ALA . 1.0 OUTLIER -98.5 115.96 29.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 108.28 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 120.966 -1.084 . . . . 0.0 110.294 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -117.17 103.26 10.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 1.1 m -102.39 148.49 25.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 110.103 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.722 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -129.51 151.94 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.799 0.809 . . . . 0.0 109.482 178.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 122' ' ' VAL . 8.2 t -118.71 148.08 21.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.542 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.42 110.77 5.54 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.96 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 47.86 19.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.025 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.38 28.46 3.53 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.741 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.3 176.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.533 ' N ' HG13 ' A' ' 122' ' ' VAL . 1.9 mt-10 -155.67 119.57 4.5 Favored 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.123 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.908 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -111.64 148.9 32.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -125.57 138.52 53.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.926 -1.109 . . . . 0.0 110.829 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.44 ' CZ ' ' OH ' ' A' ' 14' ' ' TYR . 1.6 mmt85 -128.17 127.17 42.45 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 mt -118.01 123.71 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.506 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.7 m-30 -97.96 176.62 5.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.495 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 24.6 tttt -155.24 142.46 19.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.684 ' N ' ' CE3' ' A' ' 6' ' ' TRP . 3.3 pttp -47.5 132.13 13.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 109.764 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.473 ' OD2' ' O ' ' A' ' 129' ' ' LYS . 19.6 m-20 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.762 ' N ' HD11 ' A' ' 113' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.791 ' CG ' ' CZ2' ' A' ' 6' ' ' TRP . 18.1 m-85 -58.42 9.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.701 ' H ' ' C ' ' A' ' 1' ' ' ALA . 1.5 p30 38.03 51.17 1.42 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 3' ' ' ASP . 1.2 m -169.38 -149.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.091 -1.005 . . . . 0.0 110.289 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.62 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 6.4 m -103.1 129.84 50.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.413 -0.804 . . . . 0.0 109.987 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.791 ' CZ2' ' CG ' ' A' ' 2' ' ' PHE . 56.3 m95 -148.21 167.61 24.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.321 -0.862 . . . . 0.0 108.865 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -152.76 139.53 18.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.699 -1.251 . . . . 0.0 110.62 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.663 HG11 HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -45.28 107.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -99.85 -29.79 12.4 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.9 mmt-85 -141.52 171.16 14.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.64 -0.662 . . . . 0.0 109.535 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.3 t -173.25 178.0 2.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 109.395 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -155.88 156.87 35.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.133 -0.979 . . . . 0.0 109.862 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.8 m-20 58.77 -109.56 0.46 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.605 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.504 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 0.3 OUTLIER 73.77 -52.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.232 -0.918 . . . . 0.0 109.975 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.03 -49.15 78.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 108.919 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.38 -33.79 72.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.817 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 65.3 t80 -71.32 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.457 ' HE2' ' CE1' ' A' ' 14' ' ' TYR . 21.9 mmt -55.58 -22.37 21.68 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.91 -33.62 45.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.274 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' NZ ' ' HB ' ' A' ' 122' ' ' VAL . 14.6 mmtp -68.36 -42.05 79.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.611 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -66.82 -7.42 21.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.119 -0.988 . . . . 0.0 108.953 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.53 26.88 62.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 24' ' ' ASN . 41.3 t -66.34 122.27 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -1.075 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' VAL . 1.1 m-20 -43.47 168.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -78.87 -1.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 122.141 0.972 . . . . 0.0 109.193 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.18 -60.07 2.43 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -62.27 -31.0 71.52 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -69.6 -45.89 67.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 109.183 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -57.4 -37.22 72.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 109.267 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 30' ' ' LEU . 96.0 mt -86.5 -12.9 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.035 0.922 . . . . 0.0 109.677 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -70.86 -47.44 59.3 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -41.41 -21.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.482 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' ASN . 70.9 t60 -69.07 36.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -51.59 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.62 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.6 ' HA ' HG13 ' A' ' 8' ' ' VAL . 1.1 m-20 -147.92 42.45 1.04 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.903 . . . . 0.0 109.048 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.663 HD23 HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -89.95 162.39 15.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.081 -1.012 . . . . 0.0 110.461 -179.241 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -108.34 144.91 35.24 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -138.49 123.75 19.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 110.074 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 104.67 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.492 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.1 mp -97.59 127.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.928 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.9 151.88 49.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -130.35 143.27 50.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 109.586 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 45' ' ' ASN . 8.6 mt-10 -138.7 79.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.83 -82.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.576 ' H ' HD22 ' A' ' 45' ' ' ASN . 0.1 OUTLIER -124.88 28.28 6.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -1.133 . . . . 0.0 110.204 -178.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.84 109.9 4.34 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.608 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -97.51 172.81 7.5 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.753 -0.592 . . . . 0.0 109.728 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.0 m -154.27 104.28 2.59 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.384 -0.823 . . . . 0.0 108.832 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.54 116.5 42.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.409 -0.807 . . . . 0.0 109.393 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -109.92 100.54 9.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 109.628 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -77.64 157.53 30.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.066 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER -157.41 106.62 2.15 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.065 -1.022 . . . . 0.0 108.891 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.666 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -132.38 144.64 50.67 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.39 7.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.058 . . . . 0.0 109.642 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.666 ' H ' ' C ' ' A' ' 53' ' ' SER . 91.0 t80 -108.01 -23.83 11.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.0 111.046 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.547 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 161.2 88.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.975 -1.078 . . . . 0.0 109.009 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.403 ' CB ' ' HA ' ' A' ' 52' ' ' SER . 16.7 p-10 -62.72 143.82 57.03 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.397 -0.814 . . . . 0.0 109.766 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.734 HG21 ' ND2' ' A' ' 71' ' ' ASN . 1.1 mt -134.24 173.76 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.413 -0.804 . . . . 0.0 110.203 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 58' ' ' ILE . 4.3 pt-20 -157.38 142.95 17.35 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 60' ' ' CYS . 14.2 p -163.61 128.09 2.87 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.211 -0.931 . . . . 0.0 110.091 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.497 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -82.59 160.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.507 -0.746 . . . . 0.0 109.123 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.608 ' CE2' ' CB ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -156.36 133.18 10.35 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.475 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.496 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 18.4 tt0 -105.55 168.47 9.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.489 -0.757 . . . . 0.0 109.005 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.496 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 13.0 mt -88.84 122.5 32.29 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.128 -0.982 . . . . 0.0 110.081 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.89 30.13 27.02 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 81' ' ' THR . 23.5 t -144.18 102.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.033 -1.275 . . . . 0.0 109.413 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 2.3 m -47.59 145.88 2.44 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.427 1.108 . . . . 0.0 109.876 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -165.93 -167.23 1.04 Allowed 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.761 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -147.84 157.59 43.61 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.875 -178.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.5 t -150.34 137.59 19.53 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.734 ' ND2' HG21 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -98.08 149.49 22.44 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.001 -1.062 . . . . 0.0 110.184 -178.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 75' ' ' GLY . 27.7 mt -96.9 146.83 24.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.55 -0.719 . . . . 0.0 109.552 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -40.65 -34.67 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.628 -0.67 . . . . 0.0 109.719 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.76 5.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.2 -0.938 . . . . 0.0 109.28 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 74.3 25.15 71.45 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.256 -1.144 . . . . 0.0 109.529 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' ' OG1' ' A' ' 96' ' ' THR . 39.1 tt0 -133.4 126.16 30.65 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -132.97 160.06 38.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.936 -1.103 . . . . 0.0 110.322 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -135.23 149.22 49.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.434 -0.791 . . . . 0.0 110.248 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.712 ' HA3' ' O ' ' A' ' 92' ' ' LYS . . . 162.07 -111.12 0.46 Allowed Glycine 0 C--O 1.211 -1.289 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 167.57 154.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.984 -1.304 . . . . 0.0 110.604 178.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.486 ' NE1' ' CZ ' ' A' ' 93' ' ' PHE . 74.1 m95 -102.12 133.38 47.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.587 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.9 m -138.2 157.18 46.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.947 -1.096 . . . . 0.0 109.338 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -94.86 128.55 41.7 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.519 -1.363 . . . . 0.0 108.193 179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.653 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.7 mm-40 -129.06 118.73 23.01 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.6 -107.12 1.48 Allowed Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -125.3 34.34 4.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.48 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -148.3 150.18 33.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.723 -1.236 . . . . 0.0 110.45 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 106' ' ' ARG . 2.0 mt -92.2 115.69 28.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.587 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -87.04 163.74 2.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.143 -0.973 . . . . 0.0 110.489 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.595 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.43 94.34 0.16 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.712 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 47.7 mttt -87.14 102.14 14.17 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.182 -1.187 . . . . 0.0 108.473 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.557 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.2 m-30 -122.32 137.18 54.94 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.807 0.813 . . . . 0.0 110.346 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' ARG . 9.5 ptpt -127.75 126.07 41.11 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' GLY . 43.4 mtp180 -43.79 115.46 0.81 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.313 -0.867 . . . . 0.0 108.881 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -68.04 -5.42 17.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.401 1.096 . . . . 0.0 109.37 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.86 -48.61 8.6 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.307 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -132.43 9.11 4.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.462 -0.774 . . . . 0.0 109.614 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 48.59 47.05 30.09 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.647 ' O ' ' O ' ' A' ' 101' ' ' GLU . 58.5 m-20 -72.17 11.17 0.61 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -1.224 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.2 mt-10 48.8 134.42 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.823 0.821 . . . . 0.0 111.349 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 117' ' ' TYR . 9.4 tt -139.24 131.44 28.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.535 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -114.15 112.6 23.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.06 -1.025 . . . . 0.0 109.233 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.8 t -125.26 174.59 8.01 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.111 -0.993 . . . . 0.0 111.159 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 106' ' ' ARG . 48.1 t -145.93 163.92 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.551 ' N ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -138.18 135.89 36.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.713 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -139.21 158.91 43.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.088 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.73 ' CG2' ' CE2' ' A' ' 2' ' ' PHE . 1.1 mt -123.15 82.64 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.649 ' O ' ' N ' ' A' ' 111' ' ' ASP . 20.9 mt -65.72 91.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.146 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 46.84 -81.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 109' ' ' ILE . 30.6 m-20 -119.17 29.87 7.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -1.211 . . . . 0.0 110.666 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -140.98 134.12 29.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.046 -1.034 . . . . 0.0 109.566 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.762 HD11 ' N ' ' A' ' 1' ' ' ALA . 1.5 tt -98.3 110.0 22.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 108.344 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.21 118.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 110.345 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -120.06 104.97 10.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -104.49 146.16 29.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.124 -0.985 . . . . 0.0 110.264 -178.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.718 ' HB3' HD21 ' A' ' 102' ' ' LEU . 0.1 OUTLIER -126.04 150.8 47.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.787 0.803 . . . . 0.0 109.184 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 122' ' ' VAL . 13.8 t -118.87 148.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.522 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.3 t80 -145.6 111.32 5.49 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.129 -1.028 . . . . 0.0 110.924 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 51.76 16.3 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.319 0.581 . . . . 0.0 110.949 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.06 28.04 3.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.797 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.39 176.63 3.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.509 ' N ' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -155.99 118.52 4.13 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.142 -1.423 . . . . 0.0 111.175 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -111.15 150.69 29.11 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -131.52 139.14 49.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.833 -1.167 . . . . 0.0 111.331 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.504 ' CZ ' ' OH ' ' A' ' 14' ' ' TYR . 22.9 mtp180 -133.64 115.02 14.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 113' ' ' LEU . 2.6 mt -104.57 129.95 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.573 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.53 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 5.3 m-30 -98.69 177.46 5.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.513 ' C ' ' CE3' ' A' ' 6' ' ' TRP . 16.8 tptm -152.94 143.91 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.692 ' N ' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -47.26 133.68 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 -179.185 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.463 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.619 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.846 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 41.71 31.96 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.853 . . . . 0.0 109.231 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 4' ' ' SER . 35.5 t0 -75.92 86.64 2.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 109.639 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 168.24 -159.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.38 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.551 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 88.9 m -94.42 145.39 24.81 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.846 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 20.6 m95 -151.79 167.54 27.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 8' ' ' VAL . 14.9 ptmt -154.24 133.57 12.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 109.484 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.659 HG11 HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -42.09 106.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -98.48 -27.82 13.88 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -142.71 169.62 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.912 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 125' ' ' LYS . 26.1 t -172.39 178.14 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.838 . . . . 0.0 109.43 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -153.86 154.68 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 7.4 m-20 56.34 -109.71 0.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.475 -0.766 . . . . 0.0 109.61 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER 75.87 -54.21 0.62 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.315 -0.865 . . . . 0.0 109.723 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.64 -58.98 5.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.011 -1.055 . . . . 0.0 108.567 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -52.42 -35.55 52.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.358 -0.839 . . . . 0.0 108.913 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.837 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 30.6 t80 -68.46 -61.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.265 -0.897 . . . . 0.0 108.752 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.773 ' SD ' HG21 ' A' ' 23' ' ' VAL . 9.7 mmt -49.59 -33.94 16.47 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.641 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.15 -37.67 78.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.071 . . . . 0.0 109.447 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -62.81 -43.19 99.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.626 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.681 ' SD ' ' CZ ' ' A' ' 17' ' ' PHE . 1.7 mtm -70.22 -3.17 15.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.211 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.49 32.5 61.99 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.773 HG21 ' SD ' ' A' ' 18' ' ' MET . 25.3 t -74.11 138.02 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -1.191 . . . . 0.0 109.385 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 23' ' ' VAL . 31.8 m-20 -45.75 172.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.357 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.657 HD12 HH11 ' A' ' 28' ' ' ARG . 1.6 mm -83.77 -2.22 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.276 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 t -81.32 -60.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.841 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 2.4 mptm? -65.88 -20.14 66.12 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.657 HH11 HD12 ' A' ' 25' ' ' ILE . 3.2 tmm_? -75.44 -45.17 40.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.492 -0.755 . . . . 0.0 109.128 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.29 -36.34 74.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.571 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.6 mt -86.55 -13.23 46.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.753 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -60.98 -52.95 62.85 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.638 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 31' ' ' ALA . . . -42.14 -32.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -0.911 . . . . 0.0 109.459 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 35' ' ' ASN . 33.7 m170 -74.57 42.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' ND2' ' A' ' 35' ' ' ASN . 1.2 p30 -63.21 112.12 2.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.552 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.0 m120 -147.57 42.88 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.31 -0.868 . . . . 0.0 109.242 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.659 HD23 HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -82.08 158.91 23.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.117 -0.989 . . . . 0.0 110.717 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' SER . 7.0 tttt -113.58 138.18 50.53 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 38' ' ' LEU . 1.9 pt? -147.45 145.29 29.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.989 -1.069 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 m -110.2 125.23 52.85 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.2 mp -110.89 133.27 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.486 -179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -131.88 152.1 51.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.619 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 17.0 pt20 -138.08 141.14 40.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.023 . . . . 0.0 110.061 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 45' ' ' ASN . 35.5 mt-10 -138.59 78.92 1.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.416 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.27 -82.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.534 -1.027 . . . . 0.0 110.534 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.37 29.32 7.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.339 -1.095 . . . . 0.0 110.114 -178.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.53 110.73 4.85 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.47 166.78 10.2 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.433 HG23 HG13 ' A' ' 61' ' ' VAL . 25.3 m -153.72 103.2 2.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 108.615 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.94 114.37 41.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.483 -0.761 . . . . 0.0 109.579 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -106.65 100.02 9.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.582 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.79 155.64 26.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.042 -1.036 . . . . 0.0 109.151 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 37' ' ' LYS . 92.4 p -159.76 107.5 1.71 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 122.234 1.016 . . . . 0.0 109.077 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 m -118.67 -163.16 0.94 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.41 8.73 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.345 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 21.0 m-85 -125.35 -12.69 6.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 112.108 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER 165.59 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.233 -1.542 . . . . 0.0 110.026 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -62.95 145.48 55.21 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.391 -0.818 . . . . 0.0 109.217 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -131.13 174.0 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.348 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.572 ' H ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -151.11 130.17 12.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.7 m -133.22 110.41 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.389 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.594 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -110.08 142.91 21.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.221 -0.924 . . . . 0.0 108.992 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER 176.16 173.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.672 -1.211 . . . . 0.0 110.785 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -103.89 162.38 13.17 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 64' ' ' LEU . 2.1 pp -82.32 135.22 35.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.918 -1.113 . . . . 0.0 109.398 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.79 20.33 13.24 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 65.7 t -143.87 106.25 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.34 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.2 m -49.81 144.44 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.113 0.959 . . . . 0.0 110.25 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.612 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -156.74 -171.8 3.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -127.19 152.37 47.45 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.054 -1.028 . . . . 0.0 110.347 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.9 t -153.96 129.1 9.65 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.533 ' N ' ' ND2' ' A' ' 71' ' ' ASN . 0.6 OUTLIER -88.35 149.53 23.7 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.112 -0.993 . . . . 0.0 110.239 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 73' ' ' ALA . 74.6 mt -100.73 146.85 26.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.381 -0.824 . . . . 0.0 109.325 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -43.28 -33.75 1.04 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.797 . . . . 0.0 109.86 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 14.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 67.56 28.64 73.58 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.456 ' CG2' ' HE ' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -99.41 162.12 13.22 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -132.36 118.75 19.79 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -132.59 162.89 30.14 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 0.0 110.495 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -143.63 141.17 30.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.807 . . . . 0.0 109.831 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.817 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.91 -117.39 0.64 Allowed Glycine 0 N--CA 1.476 1.351 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 173.2 159.24 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.025 -1.279 . . . . 0.0 110.898 179.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CZ ' ' A' ' 93' ' ' PHE . 15.3 m95 -101.91 142.58 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.594 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.9 m -140.68 157.6 45.21 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -92.79 127.17 38.2 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 120.306 -1.496 . . . . 0.0 108.194 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.606 ' N ' HD12 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -122.93 121.61 36.56 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.57 -105.55 0.37 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 2.1 p-10 -125.13 33.62 5.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -1.153 . . . . 0.0 110.016 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.7 OUTLIER -140.36 159.17 42.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.02 -1.05 . . . . 0.0 110.095 -179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.44 108.97 21.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.594 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -78.63 164.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.101 -1.0 . . . . 0.0 110.64 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.605 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.33 95.24 0.17 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.664 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 1.7 pttp -88.9 104.08 16.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.166 -1.197 . . . . 0.0 109.034 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 102' ' ' LEU . 3.6 m-30 -116.92 131.96 56.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.37 119.38 36.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 69.1 mtp180 -52.71 115.14 1.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.336 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.38 -11.95 57.03 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.387 1.089 . . . . 0.0 109.219 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.62 -26.94 24.13 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.832 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -132.18 -0.18 3.72 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 57.21 45.09 93.0 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.582 ' OD1' ' CE1' ' A' ' 119' ' ' TYR . 20.2 t-20 -91.76 -122.62 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.274 -1.133 . . . . 0.0 109.227 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 6.7 pt-20 -175.54 137.3 0.36 Allowed 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.434 0.635 . . . . 0.0 110.138 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 117' ' ' TYR . 55.2 tp -134.25 108.98 8.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.616 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.9 OUTLIER -101.32 105.68 16.77 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.4 t -121.09 176.13 5.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 112.017 -177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.408 ' N ' ' OG1' ' A' ' 104' ' ' THR . 39.6 t -148.2 154.26 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.512 ' HE ' HD21 ' A' ' 113' ' ' LEU . 55.0 mtp180 -127.01 131.45 51.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 109.987 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -129.31 159.18 36.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.425 -0.797 . . . . 0.0 109.032 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.8 82.15 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 109' ' ' ILE . 15.5 mt -63.53 91.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.798 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.0 -81.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.3 m-20 -125.6 29.31 6.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.174 -1.192 . . . . 0.0 110.433 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -137.37 147.19 45.32 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 108.735 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.578 HD23 ' CD2' ' A' ' 128' ' ' PHE . 10.5 tp -107.72 110.52 22.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.499 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.404 HG13 ' CG1' ' A' ' 127' ' ' ILE . 2.5 t -90.59 115.68 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.439 -0.788 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -114.04 103.26 10.97 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.2 OUTLIER -102.05 145.28 29.54 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.726 ' HB3' HD11 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -127.33 149.91 49.83 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.841 0.829 . . . . 0.0 109.471 178.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 122' ' ' VAL . 6.9 t -117.1 150.23 19.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.582 ' CE1' ' OD1' ' A' ' 100' ' ' ASN . 1.1 t80 -142.56 110.06 5.73 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.754 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 45.57 20.44 0.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.18 0.514 . . . . 0.0 111.093 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 119' ' ' TYR . . . 112.91 28.63 3.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.761 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.58 176.64 4.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.541 ' N ' HG13 ' A' ' 122' ' ' VAL . 2.7 tt0 -155.98 125.82 6.45 Favored 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 118.045 -1.462 . . . . 0.0 111.406 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -122.77 151.19 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 11' ' ' SER . 19.5 ttpt -130.03 140.21 50.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.916 -1.115 . . . . 0.0 111.112 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.463 ' CZ ' ' OH ' ' A' ' 117' ' ' TYR . 11.0 ttm180 -137.41 114.11 10.42 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.404 ' CG1' HG13 ' A' ' 114' ' ' VAL . 2.2 mp -105.99 131.41 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 0.0 111.132 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.646 ' CE2' HD11 ' A' ' 38' ' ' LEU . 3.0 m-30 -100.9 176.05 5.41 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -165.16 157.08 15.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.804 . . . . 0.0 109.245 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -47.27 130.16 12.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.397 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 2' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.848 ' CZ ' ' CE3' ' A' ' 6' ' ' TRP . 0.2 OUTLIER 42.32 33.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.323 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 4' ' ' SER . 2.8 p30 -76.82 93.56 3.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.601 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.655 ' OG ' ' N ' ' A' ' 5' ' ' THR . 1.1 t 162.47 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.655 ' N ' ' OG ' ' A' ' 4' ' ' SER . 90.6 m -89.96 145.51 25.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 0.0 109.254 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.848 ' CE3' ' CZ ' ' A' ' 2' ' ' PHE . 12.2 m95 -151.41 168.26 25.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 109.542 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' O ' ' C ' ' A' ' 8' ' ' VAL . 15.4 pttp -153.15 133.53 13.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.155 -0.965 . . . . 0.0 109.445 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.577 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -38.15 106.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.269 -0.894 . . . . 0.0 109.622 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -93.59 -28.25 16.14 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -152.73 173.14 15.64 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.709 -0.796 . . . . 0.0 109.882 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -172.98 178.22 2.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 0.0 109.145 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' OE1' ' NZ ' ' A' ' 125' ' ' LYS . 3.1 pt-20 -157.06 154.55 29.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.067 -1.02 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 9.3 m-20 56.5 -109.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.564 -0.71 . . . . 0.0 109.826 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CB ' ' O ' ' A' ' 13' ' ' ASN . 0.3 OUTLIER 75.5 -53.47 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.356 -0.84 . . . . 0.0 109.701 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -48.67 80.77 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.994 -1.066 . . . . 0.0 108.76 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -60.2 -33.26 71.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 49.1 t80 -72.0 -62.85 1.28 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.567 ' SD ' ' OD1' ' A' ' 74' ' ' ASP . 25.9 mmt -56.48 -23.57 40.15 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.345 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.95 -37.59 54.99 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.057 -1.027 . . . . 0.0 109.243 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -64.66 -39.93 94.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.195 -0.941 . . . . 0.0 109.21 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.652 ' SD ' ' CE2' ' A' ' 17' ' ' PHE . 16.6 mtp -65.12 -9.61 24.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.118 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.91 29.93 27.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 24' ' ' ASN . 19.5 t -79.78 126.3 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -1.144 . . . . 0.0 109.441 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 23' ' ' VAL . 9.8 m-80 -42.4 165.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 25' ' ' ILE . 1.5 mm -79.13 -1.99 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-O 122.158 0.98 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -80.26 -59.95 2.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.678 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -65.06 -22.56 66.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -73.15 -44.49 59.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.466 -0.771 . . . . 0.0 109.216 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -70.77 -33.05 70.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.49 -13.21 46.7 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.007 0.908 . . . . 0.0 109.752 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 27' ' ' LYS . . . -78.63 -45.64 21.08 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.608 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 34' ' ' ASP . . . -42.06 -22.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.848 . . . . 0.0 109.45 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 31' ' ' ALA . 31.6 m170 -69.28 37.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.302 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 32' ' ' ALA . 2.4 m-20 -51.05 95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.557 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' HIS . 12.0 m120 -147.66 42.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.307 -0.871 . . . . 0.0 109.206 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -97.69 170.74 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -179.084 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -108.65 142.19 39.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.746 -0.596 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 36' ' ' LEU . 1.9 mp -139.12 128.26 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.728 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -102.81 117.08 33.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 40' ' ' ILE . 4.2 mp -103.95 122.86 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.622 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.43 151.8 37.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -125.58 145.08 50.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 45' ' ' ASN . 15.2 mt-10 -139.49 78.95 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 51.6 -81.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 43' ' ' GLU . 19.8 m120 -122.37 28.85 7.22 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.285 -1.127 . . . . 0.0 110.253 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -153.57 110.12 3.37 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -94.19 173.91 7.41 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.791 -0.568 . . . . 0.0 109.485 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 95.5 m -155.81 103.49 2.26 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.152 -0.967 . . . . 0.0 108.99 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.6 t -98.19 113.14 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 121.66 -0.65 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -99.97 100.45 11.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 58' ' ' ILE . 6.2 tt0 -72.81 155.88 39.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.173 -0.954 . . . . 0.0 108.818 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 3.0 m -160.48 107.04 1.52 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.168 -0.958 . . . . 0.0 109.021 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.689 ' C ' ' H ' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -137.0 144.25 43.2 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.64 7.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.024 -1.048 . . . . 0.0 109.069 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.689 ' H ' ' C ' ' A' ' 53' ' ' SER . 2.3 m-85 -112.41 -31.18 6.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.27 -0.894 . . . . 0.0 111.476 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 4.0 tpp85 177.84 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.655 -1.278 . . . . 0.0 109.378 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.78 ' H ' HD22 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -63.18 140.29 58.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.094 179.657 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 59' ' ' GLU . 1.4 mt -139.17 174.41 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.217 -0.927 . . . . 0.0 110.505 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.601 ' H ' HG22 ' A' ' 58' ' ' ILE . 5.2 pt-20 -152.0 141.64 21.79 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -151.46 132.21 14.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.899 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.17 150.1 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.301 -0.874 . . . . 0.0 108.847 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.34 167.35 21.19 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.115 -0.991 . . . . 0.0 109.947 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.527 ' CG ' ' N ' ' A' ' 64' ' ' LEU . 26.5 tt0 -159.95 168.06 26.56 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.527 ' N ' ' CG ' ' A' ' 63' ' ' GLU . 31.2 mt -98.59 122.23 41.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.25 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.31 24.47 47.37 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.501 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.62 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 89.5 t -144.18 102.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.275 . . . . 0.0 109.416 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.746 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -59.29 141.29 54.77 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.169 0.985 . . . . 0.0 110.062 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.62 ' CD2' ' O ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -148.06 -171.29 3.79 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.578 ' C ' HD22 ' A' ' 69' ' ' ASN . 0.4 OUTLIER -142.41 151.16 41.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.836 -1.146 . . . . 0.0 110.799 -179.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.707 ' O ' HD22 ' A' ' 78' ' ' LEU . 49.5 t -144.83 170.69 15.64 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 76' ' ' THR . 1.5 p-10 -126.12 141.26 52.02 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.864 -1.147 . . . . 0.0 110.396 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.9 mt -93.12 146.85 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.542 -0.724 . . . . 0.0 109.371 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -41.09 -28.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.837 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.567 ' OD1' ' SD ' ' A' ' 18' ' ' MET . 47.5 m-20 -67.68 17.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.276 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 61.28 27.78 68.16 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.523 ' CG2' ' NE ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -100.03 162.02 13.24 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.424 -1.045 . . . . 0.0 109.399 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.946 ' C ' HD13 ' A' ' 78' ' ' LEU . 69.4 tt0 -132.86 116.29 16.32 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.682 -0.636 . . . . 0.0 109.385 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.021 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -119.66 150.93 39.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.011 . . . . 0.0 110.404 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.87 140.59 42.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.404 -0.81 . . . . 0.0 109.877 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.746 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 173.92 -117.24 0.63 Allowed Glycine 0 N--CA 1.477 1.378 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.536 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER 172.8 159.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -1.181 . . . . 0.0 110.54 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 9.0 m95 -101.77 142.84 32.48 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.597 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 2.0 m -138.35 157.23 46.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -96.18 127.35 42.1 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.352 -1.468 . . . . 0.0 108.205 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.63 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.2 mm-40 -127.32 114.74 17.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.21 -106.45 1.33 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -125.17 34.31 4.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -1.131 . . . . 0.0 110.427 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.57 150.67 37.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 110.314 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.55 109.99 21.84 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.597 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -80.12 164.58 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.119 -0.988 . . . . 0.0 110.538 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.659 ' O ' HG22 ' A' ' 104' ' ' THR . . . -146.69 95.84 0.17 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.673 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 14.0 ptmt -86.41 107.04 17.86 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.27 -1.135 . . . . 0.0 108.678 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -117.07 140.35 49.6 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.84 0.828 . . . . 0.0 110.234 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -125.48 113.27 17.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.47 0.652 . . . . 0.0 109.91 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 99' ' ' GLY . 30.9 mtp180 -51.51 114.82 1.35 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.408 ' H ' ' HG1' ' A' ' 96' ' ' THR . 0.6 OUTLIER -69.87 -13.76 62.41 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.355 1.074 . . . . 0.0 109.628 -179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -78.48 -48.35 15.52 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.786 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' GLY . 34.4 m120 -132.54 10.68 4.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.151 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 44.46 39.36 5.7 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.716 ' O ' ' O ' ' A' ' 101' ' ' GLU . 2.4 m120 -75.17 18.95 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.168 . . . . 0.0 109.402 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.716 ' O ' ' O ' ' A' ' 100' ' ' ASN . 17.0 pt-20 43.7 161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.929 . . . . 0.0 111.239 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 102' ' ' LEU . 6.3 tt -161.23 123.83 3.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.7 ' N ' HD23 ' A' ' 102' ' ' LEU . 0.6 OUTLIER -112.18 113.92 26.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 109.143 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 91' ' ' GLY . 2.1 t -124.69 176.11 6.78 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.186 -0.946 . . . . 0.0 110.948 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.9 t -149.59 154.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -127.05 136.5 52.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.67 158.63 44.01 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mm -121.29 82.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 O-C-N 121.117 -0.989 . . . . 0.0 108.38 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 109' ' ' ILE . 24.2 mt -63.54 91.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.765 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 55.47 -81.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ILE . 1.2 m-20 -129.21 29.17 5.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -1.187 . . . . 0.0 110.206 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -133.36 142.54 48.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 108.75 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.475 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 12.2 tp -103.28 110.34 22.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.932 -1.105 . . . . 0.0 109.266 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.511 HG22 HG23 ' A' ' 127' ' ' ILE . 18.1 t -95.83 110.15 23.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -108.45 106.86 17.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -100.92 144.6 29.67 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.166 -0.959 . . . . 0.0 109.792 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.3 OUTLIER -123.27 152.59 41.21 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.816 0.817 . . . . 0.0 109.161 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 122' ' ' VAL . 11.2 t -121.93 147.76 25.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.539 ' N ' HG12 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -144.5 110.67 5.48 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.973 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 48.59 18.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.26 0.552 . . . . 0.0 111.071 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.34 28.33 3.58 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -122.71 176.91 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 4.9 mt-10 -155.39 124.58 6.24 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.303 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.849 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.14 154.38 30.11 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.501 ' NZ ' ' OE1' ' A' ' 12' ' ' GLU . 5.5 ttmt -131.99 139.72 48.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.827 -1.171 . . . . 0.0 111.175 -179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -135.58 113.93 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.511 HG23 HG22 ' A' ' 114' ' ' VAL . 5.4 mt -109.16 123.83 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.084 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.523 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 9.9 m-30 -98.83 176.01 5.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 130' ' ' LYS . 3.0 tttp -163.78 161.65 23.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.403 ' H ' ' HG2' ' A' ' 129' ' ' LYS . 10.7 ptpt -47.61 132.3 14.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.498 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.74 ' O ' ' C ' ' A' ' 3' ' ' ASP . 11.7 m-85 -79.09 25.8 0.28 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.959 . . . . 0.0 109.718 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.74 ' C ' ' O ' ' A' ' 2' ' ' PHE . 11.1 t70 -13.55 83.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.706 ' N ' ' O ' ' A' ' 2' ' ' PHE . 28.8 t 167.5 -136.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 109.562 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.575 ' N ' ' OG ' ' A' ' 4' ' ' SER . 18.2 m -89.3 131.14 35.54 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.952 0.882 . . . . 0.0 111.946 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.855 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 9.6 m95 -123.41 170.62 10.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.488 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 13.9 pttp -144.57 122.43 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 110.123 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.606 HG11 ' H ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -42.35 107.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -94.69 -30.33 14.35 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -150.27 165.2 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.727 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 11.8 t -168.47 178.32 4.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.367 -0.833 . . . . 0.0 109.267 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -155.29 156.21 35.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.015 -1.053 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.57 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 16.2 m-20 59.68 -109.04 0.41 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.924 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.544 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER 73.07 -52.25 0.71 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.37 -43.61 98.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.956 -1.09 . . . . 0.0 109.019 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -67.55 -31.56 71.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.9 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 76.5 t80 -73.43 -57.0 4.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.606 ' C ' HH22 ' A' ' 28' ' ' ARG . 16.1 mmt -60.33 -29.16 68.7 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.572 ' N ' HH22 ' A' ' 28' ' ' ARG . 16.5 tp10 -77.12 -27.97 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.241 -0.912 . . . . 0.0 109.633 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -73.57 -37.66 65.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.484 ' HB2' HG23 ' A' ' 23' ' ' VAL . 2.1 mtm -69.16 -8.35 44.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.142 -0.973 . . . . 0.0 108.932 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.26 29.47 37.01 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 23.7 t -77.18 127.17 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -1.208 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.755 ' H ' ' ND2' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -42.61 164.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 109.42 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.917 HD13 ' HE ' ' A' ' 28' ' ' ARG . 1.3 mm -80.04 -1.33 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.18 0.99 . . . . 0.0 109.178 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.7 t -81.36 -59.85 2.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -63.85 -28.84 70.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.917 ' HE ' HD13 ' A' ' 25' ' ' ILE . 9.9 ttm-85 -70.64 -43.85 68.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.369 -0.832 . . . . 0.0 109.249 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.06 -33.02 74.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.414 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 mt -86.68 -13.63 44.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.681 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 33' ' ' HIS . . . -86.12 -36.13 19.77 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.654 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . -44.6 -15.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.592 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 35' ' ' ASN . 14.1 m80 -80.24 46.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.586 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -44.81 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 33' ' ' HIS . 62.6 t-20 -147.67 42.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.401 -0.812 . . . . 0.0 109.142 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.606 ' H ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -97.55 175.75 6.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.81 -178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.52 152.54 37.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 38' ' ' LEU . 3.3 mp -139.83 128.94 23.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.005 -1.059 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 4' ' ' SER . 0.3 OUTLIER -97.86 104.15 16.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.855 ' CD1' ' CD1' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -105.65 126.43 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -132.71 152.07 51.81 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -135.35 142.81 45.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.913 -1.117 . . . . 0.0 110.05 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 45' ' ' ASN . 24.2 mm-40 -140.23 78.92 1.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.73 -86.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -117.58 29.19 8.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -1.114 . . . . 0.0 110.135 -178.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -146.1 110.77 5.17 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.41 166.56 10.67 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.425 HG23 HG13 ' A' ' 61' ' ' VAL . 26.1 m -154.16 103.25 2.53 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 108.652 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.62 HG22 HG23 ' A' ' 40' ' ' ILE . 87.5 t -104.41 141.36 20.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.451 -0.781 . . . . 0.0 109.264 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -135.34 100.15 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.55 157.21 37.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 108.71 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -156.56 107.06 2.36 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.075 -1.016 . . . . 0.0 109.174 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.682 ' C ' ' H ' ' A' ' 55' ' ' PHE . 2.2 p -137.67 144.64 41.92 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.42 7.51 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.995 -1.065 . . . . 0.0 109.266 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.682 ' H ' ' C ' ' A' ' 53' ' ' SER . 88.4 t80 -104.63 -26.8 12.18 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 110.85 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 160.08 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 109.027 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -62.35 145.31 54.21 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.442 -0.787 . . . . 0.0 109.449 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 59' ' ' GLU . 0.7 OUTLIER -133.76 173.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.214 -0.929 . . . . 0.0 110.186 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.567 ' H ' HG22 ' A' ' 58' ' ' ILE . 8.5 pt-20 -149.8 147.71 28.32 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.46 0.647 . . . . 0.0 109.711 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.13 110.33 3.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.366 -0.833 . . . . 0.0 109.242 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.592 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -109.82 143.63 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.217 -0.927 . . . . 0.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CD1' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER 176.29 169.84 0.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.854 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -94.56 151.13 19.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 64' ' ' LEU . 1.3 pp -76.97 133.08 39.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.924 -1.11 . . . . 0.0 109.272 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.0 21.1 11.36 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.591 ' O ' ' CD2' ' A' ' 68' ' ' PHE . 27.9 t -143.35 106.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -1.151 . . . . 0.0 109.31 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 1.6 m -46.36 145.68 1.65 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.153 0.978 . . . . 0.0 110.17 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.594 ' C ' HD22 ' A' ' 69' ' ' ASN . 0.2 OUTLIER -160.45 -171.6 3.22 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.73 HD22 ' N ' ' A' ' 69' ' ' ASN . 0.6 OUTLIER -123.26 153.45 40.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.039 -1.038 . . . . 0.0 110.149 -179.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 69' ' ' ASN . 93.2 m -157.79 129.29 6.78 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -90.68 147.92 22.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.072 -1.017 . . . . 0.0 110.259 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' ALA . 52.5 mt -99.44 146.89 25.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.41 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . -42.29 -31.68 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.838 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 21.6 t70 -65.71 15.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 109.329 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 73' ' ' ALA . . . 64.94 27.16 71.84 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 162.05 13.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.312 -1.111 . . . . 0.0 109.533 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -132.47 119.71 20.96 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -135.8 163.85 29.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 0.0 110.448 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -142.05 140.14 32.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.74 . . . . 0.0 109.934 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.843 ' O ' ' HA ' ' A' ' 67' ' ' THR . . . 174.72 -117.78 0.64 Allowed Glycine 0 C--O 1.21 -1.358 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER 172.31 157.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.107 -1.231 . . . . 0.0 110.58 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.577 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 4.3 m95 -102.36 142.13 34.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.585 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -141.12 157.32 45.45 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -93.21 126.63 38.42 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.306 -1.496 . . . . 0.0 108.407 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.6 ' N ' HD12 ' A' ' 84' ' ' LEU . 3.7 mm-40 -123.8 113.49 18.62 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.31 -105.25 0.99 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 87' ' ' ASN . 17.5 t-20 -125.17 34.17 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -1.128 . . . . 0.0 110.372 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.426 ' CE ' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -144.79 150.8 37.8 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.739 -1.226 . . . . 0.0 110.316 -179.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mt -94.77 108.77 20.78 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.585 ' CG1' ' O ' ' A' ' 83' ' ' SER . 1.5 pt -79.4 164.0 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.099 -1.0 . . . . 0.0 110.698 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 104' ' ' THR . . . -147.28 95.59 0.17 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.623 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.45 108.91 19.92 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.205 -1.174 . . . . 0.0 109.016 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.518 ' HB2' HD22 ' A' ' 102' ' ' LEU . 3.0 m-30 -118.4 135.83 54.12 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.748 0.785 . . . . 0.0 109.986 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -118.01 115.25 24.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.314 0.578 . . . . 0.0 109.506 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.639 ' O ' ' N ' ' A' ' 99' ' ' GLY . 33.7 mtm180 -49.04 115.12 1.17 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -10.69 60.05 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.417 1.103 . . . . 0.0 109.357 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.0 -41.45 12.35 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.698 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.47 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -132.66 7.43 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 95' ' ' ARG . . . 42.28 34.72 1.63 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.69 ' O ' ' O ' ' A' ' 101' ' ' GLU . 19.1 t-20 -74.96 18.66 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.159 -1.201 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.69 ' O ' ' O ' ' A' ' 100' ' ' ASN . 9.3 pt-20 44.5 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.012 0.91 . . . . 0.0 111.519 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 93' ' ' PHE . 7.0 tt -158.5 130.63 6.82 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.684 HD22 ' H ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -117.97 118.61 32.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.96 -1.088 . . . . 0.0 109.173 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 91' ' ' GLY . 1.5 t -130.47 176.46 8.13 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.12 -0.988 . . . . 0.0 110.752 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 106' ' ' ARG . 42.4 t -146.76 158.86 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.463 ' N ' HG12 ' A' ' 105' ' ' VAL . 10.9 ttp180 -131.65 135.23 46.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -141.79 158.64 43.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 108.92 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.53 83.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.72 ' O ' ' N ' ' A' ' 111' ' ' ASP . 3.7 mm -60.27 92.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.514 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 47.2 -74.86 0.0 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.72 ' N ' ' O ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -125.73 30.02 5.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.156 -1.202 . . . . 0.0 110.907 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -146.12 147.52 31.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.738 -1.227 . . . . 0.0 109.679 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 6.5 tp -102.49 115.24 30.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.049 -1.032 . . . . 0.0 108.855 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.6 t -102.7 108.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 109.783 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -109.55 106.1 15.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 124' ' ' ALA . 0.8 OUTLIER -103.03 145.95 29.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -124.95 158.76 32.81 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.908 0.861 . . . . 0.0 109.486 178.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 122' ' ' VAL . 10.5 t -127.46 148.46 32.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -144.66 110.29 5.3 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.684 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 47.37 19.55 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.164 0.507 . . . . 0.0 111.104 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.73 28.25 3.51 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.745 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -123.5 176.51 5.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 15.1 pt-20 -156.38 126.02 6.29 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.648 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.9 ' HB2' ' HB2' ' A' ' 17' ' ' PHE . . . -116.92 150.19 38.9 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -126.23 139.37 53.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.773 -1.204 . . . . 0.0 110.757 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.544 ' NH1' ' OH ' ' A' ' 14' ' ' TYR . 7.0 mtt180 -129.81 114.16 15.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.01 122.72 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.044 -1.035 . . . . 0.0 110.352 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.585 ' HD1' ' HA ' ' A' ' 8' ' ' VAL . 2.6 m-30 -107.1 177.15 4.94 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.775 0.797 . . . . 0.0 110.409 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -152.91 164.88 37.08 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 131' ' ' ASP . 16.5 pttp -47.19 138.65 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.051 -1.031 . . . . 0.0 109.459 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 130' ' ' LYS . 4.9 p-10 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.448 -179.946 . . . . . . . . 1 1 . 1 stop_ save_